Disease on EC 3.4.24.35 - gelatinase B
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Abortion, Spontaneous
Cervical tissue changes in women with miscarriage: a morphological and biochemical investigation.
Abortion, Spontaneous
Detection of MMP-9 and TIMP-3 mRNA expression in the villi of patients undergoing early spontaneous abortion: A report of 30 cases.
Abortion, Spontaneous
Differential Expression of EGFR-1, MMP-3, and MMP-9 in Spontaneous Abortions, Induced Abortions, and Tubal Pregnancies.
Abortion, Spontaneous
Effect of blockage of costimulatory signal on murine abortion-prone model.
Abortion, Spontaneous
Matrix metalloproteinases improves trophoblast invasion and pregnancy potential in mice.
Abortion, Spontaneous
Rapamycin prevents spontaneous abortion by triggering decidual stromal cell autophagy-mediated NK cell residence.
Abortion, Spontaneous
Reduced expression of PD-L1 in autoimmune thyroiditis attenuate trophoblast invasion through ERK/MMP pathway.
Abortion, Spontaneous
Spontaneous abortion is preceded by an altered serum concentration of matrix metalloproteinases.
Abortion, Spontaneous
The association of polymorphisms in promoter region of MMP2 and MMP9 with recurrent spontaneous abortion risk in Chinese population.
Abscess
Comparative Metabolomics Reveals the Microenvironment of Common T-Helper Cells and Differential Immune Cells Linked to Unique Periapical Lesions.
Abscess
Factors Associated with High Rates of Recurrence of Amebic Liver Abscess (ALA) in North India.
Abscess
Histochemical localization of neutral proteases released during development of rat periradicular lesion.
Abscess
Immunohistochemical analysis of neutrophils, interleukin-17, matrix metalloproteinase-9, and neoformed vessels in oral squamous cell carcinoma.
Abscess
Involvement of the Commensal Organism Bacillus subtilis in the Pathogenesis of Anastomotic Leak.
Abscess
Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro.
Abscess
The zymographic evaluation of gelatinase (MMP-2 and -9) levels in acute and chronic periapical abscesses.
Acantholysis
Defining the involvement of proteinases in pemphigus vulgaris: evidence of matrix metalloproteinase-9 overexpression in experimental models of disease.
Acidosis
d-Lactic acid interferes with the effects of platelet activating factor on bovine neutrophils.
Acidosis, Respiratory
[Effects of acidification pretreatment for respiratory acidosis on the expression of matrix metalloproteinase-9 in rat lung tissues following ischemia/reperfusion].
Acne Vulgaris
Different cutaneous innate immunity profiles in acne patients with and without atrophic scars.
Acne Vulgaris
Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin.
Acquired Immunodeficiency Syndrome
A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients.
Acquired Immunodeficiency Syndrome
Expression levels of matrix metalloproteinase (MMP)-9 and its specific inhibitor TIMP-1, in septic and aseptic arthritis of the knee.
Acquired Immunodeficiency Syndrome
HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway.
Acquired Immunodeficiency Syndrome
Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Acquired Immunodeficiency Syndrome
MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier.
Acquired Immunodeficiency Syndrome
The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
Acromegaly
Matrix metalloproteinase 2 (MMP-2) levels are increased in active acromegaly patients.
Acute Coronary Syndrome
Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome.
Acute Coronary Syndrome
Association of MMP-9 gene polymorphisms with acute coronary syndrome in the Uygur population of China.
Acute Coronary Syndrome
Atorvastatin lowers plasma matrix metalloproteinase-9 in patients with acute coronary syndrome.
Acute Coronary Syndrome
Biomarkers of plaque instability in acute coronary syndrome patients.
Acute Coronary Syndrome
Clinical Relevance of Matrix Metalloproteinase 9 in Patients With Acute Coronary Syndrome.
Acute Coronary Syndrome
Close association of matrix metalloproteinase-9 levels with the presence of thin-cap fibroatheroma in acute coronary syndrome patients: Assessment by optical coherence tomography and intravascular ultrasonography.
Acute Coronary Syndrome
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.
Acute Coronary Syndrome
Correlation between the severity of coronary artery lesions and levels of estrogen, hs-CRP and MMP-9.
Acute Coronary Syndrome
EFFECT OF RELATIVE GENE EXPRESSION ON PLAQUE VULNERABILITY IN PATIENTS WITH STABLE ANGINA AND PATIENTS WITH ACUTE CORONARY SYNDROME.
Acute Coronary Syndrome
Expression of toll-like receptor 4, tumor necrosis factor- alpha, matrix metalloproteinase-9 and effects of benazepril in patients with acute coronary syndromes.
Acute Coronary Syndrome
Factors involved in sudden coagulation observed in patients with acute myocardial infarction.
Acute Coronary Syndrome
Factors which influence the levels of ST-2, Galectin-3 and MMP-9 in Acute Coronary Syndrome.
Acute Coronary Syndrome
Identification of plaque ruptures using a novel discriminative model comprising biomarkers in patients with acute coronary syndrome.
Acute Coronary Syndrome
Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome.
Acute Coronary Syndrome
Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1.
Acute Coronary Syndrome
Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction.
Acute Coronary Syndrome
Long Term Prognostic Utility of Matrix Metalloproteinase-9 in Patients with Acute Coronary Syndrome - A Systematic Review.
Acute Coronary Syndrome
Matrix metalloproteinase-9 activity is associated to oxidative stress in patients with acute coronary syndrome.
Acute Coronary Syndrome
Matrix Metalloproteinase-9 as a Marker for Plaque Rupture and a Predictor of Adverse Clinical Outcome in Patients with Acute Coronary Syndrome: An Optical Coherence Tomography Study.
Acute Coronary Syndrome
Matrix metalloproteinase-9 for the earliest stage acute coronary syndrome.
Acute Coronary Syndrome
Matrix metalloproteinase-9 in patients with acute coronary syndrome.
Acute Coronary Syndrome
Matrix metalloproteinase-9 index as a possible parameter for predicting acute coronary syndrome in diabetics.
Acute Coronary Syndrome
Matrix metalloproteinase-9 might affect adaptive immunity in non-ST segment elevation acute coronary syndromes by increasing CD31 cleavage on CD4+ T-cells.
Acute Coronary Syndrome
Metalloproteinases in Diabetics and Nondiabetics during Acute Coronary Syndromes and after 3 Months.
Acute Coronary Syndrome
Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI.
Acute Coronary Syndrome
Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
Acute Coronary Syndrome
Peripheral blood levels of matrix and inflammatory mediators are elevated in Tunisian patients with acute coronary syndromes.
Acute Coronary Syndrome
Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: correlations with serum troponin I.
Acute Coronary Syndrome
Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor.
Acute Coronary Syndrome
Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.
Acute Coronary Syndrome
PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression.
Acute Coronary Syndrome
Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study.
Acute Coronary Syndrome
Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome.
Acute Coronary Syndrome
Serum matrix metalloproteinase-9 levels in acute coronary syndrome patients with and without hyperglycemia.
Acute Coronary Syndrome
Serum MMP-9 Diagnostics, Prognostics, and Activation in Acute Coronary Syndrome and Its Recurrence.
Acute Coronary Syndrome
T-cells in myocardial infarction: Culprit instigators or mere effectors?
Acute Coronary Syndrome
The importance of defining serum MMP-9 concentration in diabetics as an early marker of the rupture of atheromatous plaque in acute coronary syndrome.
Acute Coronary Syndrome
The Role of FAK in the Secretion of MMP9 after CD147 Stimulation in Macrophages.
Acute Coronary Syndrome
The role of serum levels of microRNA-21 and matrix metalloproteinase-9 in patients with acute coronary syndrome.
Acute Coronary Syndrome
Time course of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients presenting with acute coronary syndrome.
Acute Coronary Syndrome
Transcription activity of MMP-2 and MMP-9 metalloproteinase genes and their tissue inhibitor (TIMP-2) in acute coronary syndrome patients.
Acute Coronary Syndrome
[Association of matrix metalloproteinase-9 and platelet membrane glycoprotein VI polymorphisms with acute coronary syndrome]
Acute Coronary Syndrome
[Changes and relations of soluble plasma CD40L and matrix metalloproteinase-9 levels in patients with coronary heart disease]
Acute Coronary Syndrome
[Changes in proinflammatory cytokine and destructive metalloproteinase levels during formation of unstable atherosclerotic plaque]
Acute Coronary Syndrome
[Changes in serum level of carboxy-terminal telopeptide of type I collagen in patients with coronary heart disease].
Acute Coronary Syndrome
[Clinical significance of matrix metalloproteinase-9 and tissue factors secreted by cultured monocyte-derived macrophage of patients with coronary heart disease in vitro and the intervenient effect of puerarin on them]
Acute Coronary Syndrome
[Effects of PPAR-gamma agonist rosiglitazone on MMP-9 and TIMP-1 expression of monocyte-derived macrophages isolated from patients with acute coronary syndrome]
Acute Coronary Syndrome
[Effects of Xuezhikang on serum levels of high sensitive-C reactive protein, matrix metalloproteinase-9 and lipoprotein in patients with acute coronary syndrome]
Acute Coronary Syndrome
[Study of relations between matrix metalloproteinase-9 polymorphism (C-1562T) and acute coronary syndrome in Han population of China]
Acute Kidney Injury
Diagnostic Value of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis-Associated Acute Kidney Injury.
Acute Kidney Injury
Matrix Metalloproteinase 9 and Vasodilator-Stimulated Phosphoprotein Related to Acute Kidney Injury in Severe Acute Pancreatitis Rats.
Acute Kidney Injury
Matrix metalloproteinase-9, 10, and stress hyperglycaemia in acute kidney injury.
Acute Kidney Injury
MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients.
Acute Kidney Injury
MMP-9 gene deletion mitigates microvascular loss in a model of ischemic acute kidney injury.
Acute Lung Injury
3, 4-dihydroxybenzalacetone attenuates lipopolysaccharide-induced inflammation in acute lung injury via down-regulation of MMP-2 and MMP-9 activities through suppressing ROS-mediated MAPK and PI3K/AKT signaling pathways.
Acute Lung Injury
A rise of MMP-2 and MMP-9 in bronchoalveolar lavage fluid is associated with acute lung injury after cardiopulmonary bypass in a swine model.
Acute Lung Injury
Acidic Preconditioning Protects Against Ischemia-Reperfusion Lung Injury Via Inhibiting the Expression of Matrix Metalloproteinase 9.
Acute Lung Injury
Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury.
Acute Lung Injury
Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).
Acute Lung Injury
Dexamethasone Ameliorates H2S-Induced Acute Lung Injury by Alleviating Matrix Metalloproteinase-2 and -9 Expression.
Acute Lung Injury
Doxycycline alleviates paraquat-induced acute lung injury by inhibiting neutrophil-derived matrix metalloproteinase 9.
Acute Lung Injury
Effects of MMP-9 inhibition by doxycycline on proteome of lungs in high tidal volume mechanical ventilation-induced acute lung injury.
Acute Lung Injury
Evidence of increased matrix metalloproteinase-9 concentration in patients following cardiopulmonary bypass.
Acute Lung Injury
Gelatinase B deficiency does not protect against lipopolysaccharide-induced acute lung injury.
Acute Lung Injury
Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide.
Acute Lung Injury
Ginkgo biloba leaves extract (EGb 761) attenuates lipopolysaccharide-induced acute lung injury via inhibition of oxidative stress and NF-?B-dependent matrix metalloproteinase-9 pathway.
Acute Lung Injury
Hirsutanol A Attenuates Lipopolysaccharide-Mediated Matrix Metalloproteinase 9 Expression and Cytokines Production and Improves Endotoxemia-Induced Acute Sickness Behavior and Acute Lung Injury.
Acute Lung Injury
Increased matrix metalloproteinase-9 activity and mRNA expression in lung injury following cardiopulmonary bypass.
Acute Lung Injury
Inhibition of matrix metalloproteinase-9 with low-dose doxycycline reduces acute lung injury induced by cardiopulmonary bypass.
Acute Lung Injury
Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-?B signaling pathway and MMP-9 expression.
Acute Lung Injury
Kinetics and Role of Plasma Matrix Metalloproteinase-9 Expression in Acute Lung Injury and the Acute Respiratory Distress Syndrome.
Acute Lung Injury
LipoxinA4 attenuates acute pancreatitis-associated acute lung injury by regulating AQP-5 and MMP-9 expression, anti-apoptosis and PKC/SSeCKS-mediated F-actin activation.
Acute Lung Injury
Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury.
Acute Lung Injury
Matrix metalloproteinases in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro.
Acute Lung Injury
Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats.
Acute Lung Injury
Neutrophil elastase ameliorates matrix metalloproteinase-9 to promote lipopolysaccharide-induced acute lung injury in mice 1.
Acute Lung Injury
Neutrophil proteinases in hydrochloric acid- and endotoxin-induced acute lung injury: evaluation of interstitial protease activity by in situ zymography.
Acute Lung Injury
Novel 5-Hydroxy, 5-Substituted Benzenesulfonamide Pyrimidine-2,4,6-Triones Attenuate Lipopolysaccharide-Induced Acute Lung Injury via Inhibition of the Gelatinases, MMP-2 and MMP-9.
Acute Lung Injury
Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis.
Acute Lung Injury
Protective effect of rutin on LPS-induced acute lung injury via down-regulation of MIP-2 expression and MMP-9 activation through inhibition of Akt phosphorylation.
Acute Lung Injury
Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury.
Acute Lung Injury
Role of stromelysin 1 and gelatinase B in experimental acute lung injury.
Acute Lung Injury
The HIV protease inhibitor Saquinavir attenuates sepsis-induced acute lung injury and promotes M2 macrophage polarization via targeting matrix metalloproteinase-9.
Acute Lung Injury
The selective phosphodiesterase 4 inhibitor RP 73-401 reduced matrix metalloproteinase 9 activity and transforming growth factor-beta release during acute lung injury in mice: the role of the balance between Tumor necrosis factor-alpha and interleukin-10.
Acute Lung Injury
Time course for inhibition of lipopolysaccharide-induced lung injury by genistein: relationship to alteration in nuclear factor-kappaB activity and inflammatory agents.
Acute Lung Injury
Upregulation of matrix metalloproteinase 9 (MMP9)/tissue inhibitor of metalloproteinase 1 (TIMP1) and MMP2/TIMP2 ratios may be involved in lipopolysaccharide-induced acute lung injury.
Acute Lung Injury
Upregulation of Matrix Metalloproteinase-9 Protects against Sepsis-Induced Acute Lung Injury via Promoting the Release of Soluble Receptor for Advanced Glycation End Products.
Acute Lung Injury
Vaporized perfluorocarbon confers protection against acute lung injury by inhibiting MMP-9 expression without protective effects in other organs.
Acute Lung Injury
[Effects of dexamethasone pretreatment on expression of matix metalloproteinase-9 in rats with acute lung injury induced by phosgene].
Acute Lung Injury
[Expression of various matrix metalloproteinases in mice with hyperoxia induced acute lung injury.]
Acute Lung Injury
[Protective role of MMP-9 inhibitor batimastat in acute lung injury after cardiopulmonary bypass.]
Acute-On-Chronic Liver Failure
Bioactivity of CD34+ cells in patients with acute-on-chronic liver failure.
Adenocarcinoma
Adrenomedullin production is increased in colorectal adenocarcinomas; its relation to matrix metalloproteinase-9.
Adenocarcinoma
alpha-Mangostin, a novel dietary xanthone, suppresses TPA-mediated MMP-2 and MMP-9 expressions through the ERK signaling pathway in MCF-7 human breast adenocarcinoma cells.
Adenocarcinoma
Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.
Adenocarcinoma
Analyses of matrix metalloproteinases and their inhibitors in cyst fluid of serous ovarian tumors.
Adenocarcinoma
Association between focal adhesion kinase and matrix metalloproteinase-9 expression in prostate adenocarcinoma and their influence on the progression of prostatic adenocarcinoma.
Adenocarcinoma
Cancer-associated fibroblasts, matrix metalloproteinase-9 and lymphatic vessel density are associated with progression from adenocarcinoma in situ to invasive adenocarcinoma of the lung.
Adenocarcinoma
CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.
Adenocarcinoma
Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2.
Adenocarcinoma
Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.
Adenocarcinoma
Clarification of the active gelatinolytic sites in human ovarian neoplasms using in situ zymography.
Adenocarcinoma
Clinical significance of levels of molecular biological markers in zones of invasive front-line of colorectal cancer.
Adenocarcinoma
Col IV and Fn distribution in prostatic adenocarcinoma and correlation of 67LR, MMP-9 and TIMP-1 expression with Gleason score.
Adenocarcinoma
Comparison of circulating MMP-9, TIMP-1 and CA19-9 in the detection of pancreatic cancer.
Adenocarcinoma
Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
Adenocarcinoma
Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
Adenocarcinoma
Correlation between matrix metalloproteinase-9 and vascular endothelial growth factor expression in lung adenocarcinoma.
Adenocarcinoma
COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung. A study of 117 patients from Brazil.
Adenocarcinoma
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Adenocarcinoma
Differential modulatory effects of clarithromycin on the production of cytokines by a tumor.
Adenocarcinoma
Distinct endobronchial expression of matrix-metalloproteinases (MMP) and their endogenous inhibitors in lung cancer.
Adenocarcinoma
Diuretic response to cyclophosphamide in rats bearing a matrix metalloproteinase-9-producing tumour.
Adenocarcinoma
Effect of chitosan oligosaccharide-conjugated selenium on improving immune function and blocking gastric cancer growth.
Adenocarcinoma
Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
Adenocarcinoma
Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction.
Adenocarcinoma
Expression and significance of MMP-9 and MDM2 in the oncogenesis of lung cancer in rats.
Adenocarcinoma
Expression of extracellular matrix metalloproteinase (MMP-9), E-cadherin and proliferation-associated antigen Ki-67 and their reciprocal correlation in canine mammary adenocarcinomas.
Adenocarcinoma
Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung.
Adenocarcinoma
Expression of matrix metalloproteinase 9 (MMP-9/gelatinase B) in adenocarcinomas strongly correlated with expression of immune response genes.
Adenocarcinoma
Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer.
Adenocarcinoma
Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Adenocarcinoma
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Adenocarcinoma
Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix.
Adenocarcinoma
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Adenocarcinoma
Expression of thrombospondin-1 in human pancreatic adenocarcinomas: role in matrix metalloproteinase-9 production.
Adenocarcinoma
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Adenocarcinoma
Expression profiling using a cDNA array and immunohistochemistry for the extracellular matrix genes FN-1, ITGA-3, ITGB-5, MMP-2, and MMP-9 in colorectal carcinoma progression and dissemination.
Adenocarcinoma
Expressions of Inhibitors of DNA Binding-1 and Matrix Metalloproteinase-9 in Colorectal Adenocarcinoma Tissues and Their Correlations with Microvessel Density.
Adenocarcinoma
Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma.
Adenocarcinoma
FGF-1-induced matrix metalloproteinase-9 expression in breast cancer cells is mediated by increased activities of NF-kappaB and activating protein-1.
Adenocarcinoma
High expression of 92 kDa type IV collagenase (matrix metalloproteinase-9) in canine mammary adenocarcinoma.
Adenocarcinoma
High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma.
Adenocarcinoma
Immunohistochemical expression of matrix metalloproteinase-9 and inhibitor of matrix metalloproteinase-1 in prostate adenocarcinoma.
Adenocarcinoma
Immunohistochemical study of fibrosis and adenocarcinoma in dominant-negative p53 transgenic mice exposed to chrysotile asbestos and benzo(a)pyrene.
Adenocarcinoma
Induction of matrix metalloproteinase-9 by galectin-7 through p38 MAPK signaling in HeLa human cervical epithelial adenocarcinoma cells.
Adenocarcinoma
Inhibition of MMP-9 transcription and suppression of tumor metastasis by pyrrole-imidazole polyamide.
Adenocarcinoma
Inhibitory effect of acetylsalicylic acid on metalloproteinase activity in human lung adenocarcinoma at different stages of differentiation.
Adenocarcinoma
Involvement of COX-2/PGE(2) Pathway in the Upregulation of MMP-9 Expression in Pancreatic Cancer.
Adenocarcinoma
Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia.
Adenocarcinoma
Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer.
Adenocarcinoma
Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer.
Adenocarcinoma
Matrix metalloproteinase-9: a deleterious link between hepatic ischemia-reperfusion and colorectal cancer.
Adenocarcinoma
Matrix metalloproteinases 2 and 9 in situ mRNA expression in colorectal tumors from Iraqi patients.
Adenocarcinoma
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas.
Adenocarcinoma
Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.
Adenocarcinoma
Metalloproteinases and tissue inhibitor of metalloproteinase 1 (TIMP-1) in endometrial flushings from pre- and post-menopausal women and from women with endometrial adenocarcinoma.
Adenocarcinoma
MMP-2 activation and stepwise progression of pulmonary adenocarcinoma: analysis of MMP-2 and MMP-9 with gelatin zymography.
Adenocarcinoma
MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC).
Adenocarcinoma
MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases.
Adenocarcinoma
Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung.
Adenocarcinoma
Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines.
Adenocarcinoma
Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma.
Adenocarcinoma
New Insights on Old Biomarkers Involved in Tumor Microenvironment Changes and Their Diagnostic Relevance in Non-Small Cell Lung Carcinoma.
Adenocarcinoma
Osteoclast-derived matrix metalloproteinase-9 directly affects angiogenesis in the prostate tumor-bone microenvironment.
Adenocarcinoma
Osteopontin is linked to p65 and MMP-9 expression in pulmonary adenocarcinoma but not in malignant pleural mesothelioma.
Adenocarcinoma
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Adenocarcinoma
Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study.
Adenocarcinoma
Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
Adenocarcinoma
Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma
Adenocarcinoma
RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
Adenocarcinoma
Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.
Adenocarcinoma
Salivary Proteome and Peptidome Profiling in Type 1 Diabetes Mellitus Using a Quantitative Approach.
Adenocarcinoma
Silencing of bach1 gene by small interfering RNA-mediation regulates invasive and expression level of miR-203, miR-145, matrix metalloproteinase-9, and CXCR4 receptor in MDA-MB-468 breast cancer cells.
Adenocarcinoma
Suppression of matrix metalloproteinase-9 expression by RNA interference inhibits SGC7901 gastric adenocarcinoma cell growth and invasion in vitro and in vivo.
Adenocarcinoma
Systemic Ablation of MMP9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL-6 Expression in the Bone Marrow.
Adenocarcinoma
The ?-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor ?B signaling.
Adenocarcinoma
The assessment of matrix metalloproteinase-9 expression and angiogenesis in colorectal cancer.
Adenocarcinoma
The Cadin-2-en-1?-ol-1?-D-glucuronopyranoside Suppresses TPA-Mediated Matrix Metalloproteinase-9 Expression Through the ERK Signaling Pathway in MCF-7 Human Breast Adenocarcinoma Cells.
Adenocarcinoma
The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.
Adenocarcinoma
The Role of Serum CK18, TIMP1, and MMP-9 Levels in Predicting R0 Resection in Patients with Gastric Cancer.
Adenocarcinoma
Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer.
Adenocarcinoma
Treatment of 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 inhibits TNF-alpha-mediated expression of MMP-9 protein and cell invasion through the suppression of JNK pathway and microRNA 221 in human pancreatic adenocarcinoma cancer cells.
Adenocarcinoma
Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer.
Adenocarcinoma
[Effects of HSYA on expression of bFGF protein and MMP-9 in BGC-823 transplantation tumor of nude mice].
Adenocarcinoma
[Effects of matrix metalloproteinase-9 antisense oligonucleotide on the apoptosis and metastasis of the human lung adenocarcinoma cell.]
Adenocarcinoma
[Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma]
Adenocarcinoma
[Expression of matrix metaloproteinase and tissue inhibitors in ovarian tumors]
Adenocarcinoma
[Expression of MMP-2 and MMP-9 in non-small-cell lung cancer and their prognostic value.]
Adenocarcinoma
[Expressions of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 and their correlation with metastasis and prognosis in lung cancer.]
Adenocarcinoma
[Significance of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase and protein Ki-67 in prostate tumors].
Adenocarcinoma
[The relationship of MMP-9, VEGF and PCNA expressions and their clinical significance in gastric adenocarcinoma]
Adenocarcinoma in Situ
Cancer-associated fibroblasts, matrix metalloproteinase-9 and lymphatic vessel density are associated with progression from adenocarcinoma in situ to invasive adenocarcinoma of the lung.
Adenocarcinoma of Lung
?-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells.
Adenocarcinoma of Lung
AG1478 inhibits the migration and invasion of cisplatin-resistant human lung adenocarcinoma cells via the cell cycle regulation by matrix metalloproteinase-9.
Adenocarcinoma of Lung
Allicin inhibits the invasion of lung adenocarcinoma cells by altering tissue inhibitor of metalloproteinase/matrix metalloproteinase balance via reducing the activity of phosphoinositide 3-kinase/AKT signaling.
Adenocarcinoma of Lung
Alpha-mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via alphavbeta3 integrin/FAK/ERK and NF-kappaB signaling pathway in human lung adenocarcinoma A549 cells.
Adenocarcinoma of Lung
Cancer-associated fibroblasts, matrix metalloproteinase-9 and lymphatic vessel density are associated with progression from adenocarcinoma in situ to invasive adenocarcinoma of the lung.
Adenocarcinoma of Lung
Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
Adenocarcinoma of Lung
Computed tomographic images reflect the biologic behavior of small lung adenocarcinoma: they correlate with cell proliferation, microvascularization, cell adhesion, degradation of extracellular matrix, and K-ras mutation.
Adenocarcinoma of Lung
Correlation between matrix metalloproteinase-9 and vascular endothelial growth factor expression in lung adenocarcinoma.
Adenocarcinoma of Lung
Curcumol inhibits lung adenocarcinoma growth and metastasis via inactivation of PI3K/AKT and Wnt/ß-catenin pathway.
Adenocarcinoma of Lung
Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells.
Adenocarcinoma of Lung
Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).
Adenocarcinoma of Lung
Elevated Krüppel-like factor 5 expression in spatiotemporal mouse lungs is similar to human congenital cystic adenomatoid malformation of the lungs.
Adenocarcinoma of Lung
GABRA3 promotes lymphatic metastasis in lung adenocarcinoma by mediating upregulation of matrix metalloproteinases.
Adenocarcinoma of Lung
Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.
Adenocarcinoma of Lung
Human papillomavirus up-regulates MMP-2 and MMP-9 expression and activity by inducing interleukin-8 in lung adenocarcinomas.
Adenocarcinoma of Lung
Identifying Thoracic Malignancies Through Pleural Fluid Biomarkers: A Predictive Multivariate Model.
Adenocarcinoma of Lung
Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells.
Adenocarcinoma of Lung
Inhibitory effect of acetylsalicylic acid on metalloproteinase activity in human lung adenocarcinoma at different stages of differentiation.
Adenocarcinoma of Lung
Intrabronchial orthotopic propagation of human lung adenocarcinoma--characterizations of tumorigenicity, invasion and metastasis.
Adenocarcinoma of Lung
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinoma.
Adenocarcinoma of Lung
Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-?B-mediated matrix metalloproteinase-9 expression.
Adenocarcinoma of Lung
Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma.
Adenocarcinoma of Lung
Prognostic value of MMP9 activity level in resected stage I B lung adenocarcinoma.
Adenocarcinoma of Lung
Sevoflurane inhibits invasion and migration of lung cancer cells by inactivating the p38 MAPK signaling pathway.
Adenocarcinoma of Lung
Shortening of microsatellite deoxy(CA) repeats involved in GL331-induced down-regulation of matrix metalloproteinase-9 gene expression.
Adenocarcinoma of Lung
Silencing of LINC00461 enhances radiosensitivity of lung adenocarcinoma cells by down-regulating HOXA10 via microRNA-195.
Adenocarcinoma of Lung
Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9.
Adenocarcinoma of Lung
Upregulation of the Coatomer Protein Complex Subunit beta 2 (COPB2) Gene Targets microRNA-335-3p in NCI-H1975 Lung Adenocarcinoma Cells to Promote Cell Proliferation and Migration.
Adenocarcinoma of Lung
Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-?B pathway in tumor-bearing nude mice.
Adenocarcinoma of Lung
[Anti-sense nucleic acid of CyclinD1 induces apoptosis of lung adenocarcinoma cancer cell A549.]
Adenocarcinoma of Lung
[Comparison of the characteristics in recurrence and metastasis between bronchioloalveolar carcinoma and other lung adenocarcinomas]
Adenocarcinoma of Lung
[Construction of a CD147 lentiviral expression vector and establishment of its stably transfected A549 cell line].
Adenocarcinoma of Lung
[Effects of Cullin1 on the Biological Characteristics of Lung Adenocarcinoma?A549 and H1395 Cells].
Adenocarcinoma of Lung
[Effects of matrix metalloproteinase-9 antisense oligonucleotide on the apoptosis and metastasis of the human lung adenocarcinoma cell.]
Adenocarcinoma of Lung
[Experimental study of targeting MMP-9 deoxyribozyme role of adhesion and migration in human lung adenocarcinoma cancer cell.]
Adenocarcinoma of Lung
[MiR-373-3p Promotes Invasion and Metastasis of Lung Adenocarcinoma Cells].
Adenocarcinoma of Lung
[Propofol suppresses invasion of human lung cancer A549 cells by down-regulating aquaporin-3 and matrix metalloproteinase-9].
Adenocarcinoma, Bronchiolo-Alveolar
[Comparison of the characteristics in recurrence and metastasis between bronchioloalveolar carcinoma and other lung adenocarcinomas]
Adenocarcinoma, Follicular
Epidermal growth factor stimulates matrix metalloproteinase-9 expression and invasion in human follicular thyroid carcinoma cells through Focal adhesion kinase.
Adenocarcinoma, Follicular
[Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid.]
Adenocarcinoma, Mucinous
Analysis of matrix metalloproteinases and related tissue inhibitors in cystic fluids of ovarian tumors.
Adenoma
A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer.
Adenoma
Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers.
Adenoma
Analyses of matrix metalloproteinases and their inhibitors in cyst fluid of serous ovarian tumors.
Adenoma
Detection of colorectal adenomas using a bioactivatable probe specific for matrix metalloproteinase activity.
Adenoma
Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.
Adenoma
Evaluation of matrix metalloproteinases (MMP)-2 and MMP-9 activity in serum and biochemical and hematological parameters in spontaneous canine cutaneous tumors before and after surgical treatment.
Adenoma
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Adenoma
Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Adenoma
Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
Adenoma
Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
Adenoma
Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
Adenoma
Inhibition of pulmonary adenoma in diethylnitrosamine-induced rats by Rhizoma paridis saponins.
Adenoma
Inulin results in increased levels of beta-catenin and cyclin D1 as the adenomas increase in size from small to large in the Min/+ mouse.
Adenoma
Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer.
Adenoma
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-2: Prognostic biological markers in invasive prolactinomas.
Adenoma
Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse.
Adenoma
Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.
Adenoma
Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis.
Adenoma
Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
Adenoma
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas.
Adenoma
Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening.
Adenoma
The behavior of MMP-2, MMP-7, MMP-9 and their inhibitors TIMP-1, TIMP-2 in adenoma-colorectal cancer sequence.
Adenoma
The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.
Adenoma
Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma.
Adenoma
Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas.
Adenoma
Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Adenoma
[Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour]
Adenoma
[Relationship of the disturbed balance between matrix metalloproteinases and their tissue inhibitors and the invasion of malignant salivary gland tumours]
Adenoma
[Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior]
Adenoma, Liver Cell
Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry.
Adenoma, Oxyphilic
Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in sera and urine of patients with kidney tumors.
Adenoma, Oxyphilic
Matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in sera and urine of patients with renal carcinoma.
Adenoma, Oxyphilic
Matrix metalloproteinase-2 and -9 in the sera and in the urine of human oncocytoma and renal cell carcinoma.
Adenoma, Pleomorphic
Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas.
Adenoma, Pleomorphic
Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1 and TIMP-2 in the epithelium and stroma of salivary gland pleomorphic adenomas.
Adenoma, Pleomorphic
[The expression of matrix metalloproteinases and their tissue inhibitors in pleomorphic adenoma]
Adenoma, Villous
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas.
Adenomatous Polyposis Coli
Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse.
Adenomatous Polyposis Coli
Relationship among expression of basic-fibroblast growth factor, MTDH/Astrocyte elevated gene-1, adenomatous polyposis coli, matrix metalloproteinase 9,and COX-2 markers with prognostic factors in prostate carcinomas.
Adenomatous Polyps
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Adenomatous Polyps
Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma.
Adenomatous Polyps
Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients.
Adenomyosis
Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis.
Adenomyosis
Impaired decidualization of human endometrial stromal cells from women with adenomyosis.
Adenomyosis
Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis.
Adenomyosis
Matrix Metalloproteinase-2 and -9 Expression Correlated with Angiogenesis in Human Adenomyosis.
Adenomyosis
Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.
Adenomyosis
Positive associations between upregulated levels of stress-induced phosphoprotein 1 and matrix metalloproteinase-9 in endometriosis/adenomyosis.
Adrenal Cortex Neoplasms
Evaluation of MMP-1, MMP-8, MMP-9 serum levels in patients with adrenal tumors prior to and after surgery.
Aggressive Periodontitis
Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis.
Aggressive Periodontitis
Matrix metalloproteinase-2, -9, and tissue inhibitor of MMP-2 gene polymorphisms in Taiwanese periodontitis patients.
Aggressive Periodontitis
MMP-2, MMP-9 and TIMP-2 gene polymorphisms in Chinese patients with generalized aggressive periodontitis.
Aggressive Periodontitis
Multiple forms of gelatinases/type IV collagenases in saliva and gingival crevicular fluid of periodontitis patients.
AIDS Dementia Complex
Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia.
AIDS Dementia Complex
Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
AIDS-Associated Nephropathy
Matrix metalloproteinase-9 expression in renal biopsies of patients with HIV-associated nephropathy.
Airway Obstruction
Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection.
Airway Obstruction
Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
Airway Obstruction
Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline.
Airway Obstruction
Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10.
Airway Obstruction
Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
Airway Obstruction
[Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease]
Albuminuria
Absence of Gelatinase (MMP-9) or Collagenase (MMP-13) Attenuates Adriamycin-Induced Albuminuria and Glomerulosclerosis.
Albuminuria
Anti-Diabetic and Anti-Nephritic Activities of Grifola frondosa Mycelium Polysaccharides in Diet-Streptozotocin-Induced Diabetic Rats Via Modulation on Oxidative Stress.
Albuminuria
Canonical Wnt/?-catenin signaling mediates transforming growth factor-?1-driven podocyte injury and proteinuria.
Albuminuria
Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus.
Albuminuria
Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.
Albuminuria
Role of matrix metalloproteinase-9 in chronic kidney disease: a new biomarker of resistant albuminuria.
Albuminuria
The association between methylation levels of targeted genes and albuminuria in patients with early diabetic kidney disease.
Albuminuria
Up-regulation of matrix metalloproteinases-9 in the kidneys of diabetic rats and the association with neutrophil gelatinase-associated lipocalin.
Albuminuria
Urinary matrix metalloproteinase activities: biomarkers for plaque angiogenesis and nephropathy in diabetes.
Alopecia
Identification of clustered cells in human hair follicle responsible for MMP-9 gelatinolytic activity: consequences for the regulation of hair growth.
Alopecia Areata
Langerhans cells that express matrix metalloproteinase 9 increase in human dermis during sensitization to diphenylcyclopropenone in patients with alopecia areata.
Alveolar Bone Loss
Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs.
Alveolar Bone Loss
Effects of estrogen deficiency followed by streptozotocin-induced diabetes on periodontal tissues of female rats.
Alveolar Bone Loss
Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications.
Alveolar Bone Loss
Exenatide and Sitagliptin Decrease Interleukin 1?, Matrix Metalloproteinase 9, and Nitric Oxide Synthase 2 Gene Expression But Does Not Reduce Alveolar Bone Loss in Rats With Periodontitis.
Alveolar Bone Loss
Gelatinases and extracellular matrix metalloproteinase inducer are associated with cyclosporin-A-induced attenuation of periodontal degradation in rats.
Alveolar Bone Loss
Human ?-defensin 3 inhibits periodontitis development by suppressing inflammatory responses in macrophages.
Alveolar Bone Loss
Melatonin improves periodontitis-induced kidney damages by decreasing inflammatory stress and apoptosis in rats.
Alveolar Bone Loss
Morphologic evaluation and expression of matrix metalloproteinases-2 and 9 and nitric oxide during experimental periodontal disease in rat.
Alveolar Bone Loss
The Effects of a Novel Botanical Agent on LPS-Induced Alveolar Bone Loss in Rats.
Alveolitis, Extrinsic Allergic
Comprehensive analysis of immune, extracellular matrices and pathogens profile in lung granulomatosis of unexplained etiology.
Alzheimer Disease
A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders.
Alzheimer Disease
A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer's Disease and Type 2 Diabetes Mellitus.
Alzheimer Disease
Abeta(1-40)-induced secretion of matrix metalloproteinase-9 results in sAPPalpha release by association with cell surface APP.
Alzheimer Disease
Apolipoprotein E isoforms differentially regulate matrix metallopeptidase 9 function in Alzheimer's disease.
Alzheimer Disease
Astrocyte mediated MMP-9 activation in the synapse dysfunction: An implication in Alzheimer disease.
Alzheimer Disease
Concentrations of Matrix Metalloproteinases and their Tissue Inhibitors in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
Alzheimer Disease
Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes.
Alzheimer Disease
Effects of the beta-amyloid and carboxyl-terminal fragment of Alzheimer's amyloid precursor protein on the production of the tumor necrosis factor-alpha and matrix metalloproteinase-9 by human monocytic THP-1.
Alzheimer Disease
Elevated matrix metalloproteinase-9 levels in neuronal extracellular vesicles in Alzheimer's disease.
Alzheimer Disease
Engineering autoactivating forms of matrix metalloproteinase-9 and expression of the active enzyme in cultured cells and transgenic mouse brain.
Alzheimer Disease
Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain.
Alzheimer Disease
Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer's disease.
Alzheimer Disease
Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease.
Alzheimer Disease
Investigation of Matrix Metalloproteinases, MMP-2 and MMP-9, in Plasma Reveals a Decrease of MMP-2 in Alzheimer's Disease.
Alzheimer Disease
Involvement of matrix metalloproteinase-9 in amyloid-? 1-42-induced shedding of the pericyte proteoglycan NG2.
Alzheimer Disease
Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.
Alzheimer Disease
Matrix metalloproteinase-9, its tissue inhibitor(TIMP)-1 and CRP in Alzheimer's disease.
Alzheimer Disease
Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer's disease, and epilepsy.
Alzheimer Disease
Matrix metalloproteinases in dog brains exhibiting Alzheimer-like characteristics.
Alzheimer Disease
Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease.
Alzheimer Disease
Medroxyprogesterone Acetate Impairs Amyloid Beta Degradation in a Matrix Metalloproteinase-9 Dependent Manner.
Alzheimer Disease
MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer's disease.
Alzheimer Disease
Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer's Disease.
Alzheimer Disease
Nitric oxide-mediated regulation of ?-amyloid clearance via alterations of MMP-9/TIMP-1.
Alzheimer Disease
Overexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer's disease.
Alzheimer Disease
Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
Alzheimer Disease
Scavenging effect of Naoerkang on amyloid beta-peptide deposition in the hippocampus in a rat model of Alzheimer's disease.
Ameloblastoma
A novel ameloblastoma cell line (AM-3) secretes MMP-9 in response to Wnt-3a and induces osteoclastogenesis.
Ameloblastoma
Discrimination of ameloblastomas from odontogenic keratocysts by cytokine levels and gelatinase species of the intracystic fluids.
Ameloblastoma
Elevated hydrostatic pressure promotes ameloblastoma cell invasion through upregulation of MMP-2 and MMP-9 expression via Wnt/?-catenin signalling.
Ameloblastoma
Epigenetic regulation of matrix metalloproteinase expression in ameloblastoma.
Ameloblastoma
Expression of osteonectin/secreted protein acidic and rich in cysteine and matrix metalloproteinases in ameloblastoma.
Ameloblastoma
Gene polymorphisms in odontogenic keratocysts and ameloblastomas: A systematic review.
Ameloblastoma
Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas.
Ameloblastoma
Immunohistochemical expression of MMP-9, TIMP-2, E-cadherin and vimentin in ameloblastomas and their implication in the local aggressive behavior of these tumors.
Ameloblastoma
Immunohistochemistry of Five Molecular Markers for Typing and Management of Ameloblastomas: A Retrospective Analysis of 40 Cases.
Ameloblastoma
Interplay Between MMP-9 and TIMP-2 Regulates Ameloblastoma Behavior and Tooth Morphogenesis.
Ameloblastoma
Matrix metalloproteinase-9 (mmp-9) expression in different subtypes of ameloblastoma.
Ameloblastoma
Matrix metalloproteinases, TIMPs and growth factors regulating ameloblastoma behaviour.
Ameloblastoma
MMP-7, -8, -9, E-cadherin, and beta-catenin expression in 34 ameloblastoma cases.
Ameloblastoma
Podoplanin expression profiles characteristic of odontogenic tumor-specific tissue architectures.
Ameloblastoma
TNF-?-induced IL-6 and MMP-9 expression in immortalized ameloblastoma cell line established by hTERT.
Ameloblastoma
[Expression of nuclear factor-kappaB, Ki-67 and matrix metalloproteinase-9 in calcifying odontogenic cyst]
Ameloblastoma
[Ki-67 and matrix metalloproteinase-9 expression in the follicular cyst, keratocystic odontogenic tumor, and ameloblastoma].
Amyloid Neuropathies, Familial
Up-regulation of the extracellular matrix remodeling genes, biglycan, neutrophil gelatinase-associated lipocalin, and matrix metalloproteinase-9 in familial amyloid polyneuropathy.
Amyloidosis
Doxycycline decreases amyloidogenic light chain-induced autophagy in isolated primary cardiac myocytes.
Amyloidosis
Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
Amyotrophic Lateral Sclerosis
Association studies of mmp-9 in Parkinson's disease and amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Engineering autoactivating forms of matrix metalloproteinase-9 and expression of the active enzyme in cultured cells and transgenic mouse brain.
Amyotrophic Lateral Sclerosis
Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
The C(-1562)T polymorphism of the MMP-9 gene and the risk of sporadic amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
[Matrix metalloproteinase-9 (MMP-9) activity in cerebrospinal fluid of amyotrophic lateral sclerosis patients]
Anaphylaxis
Markers Involved in Innate Immunity and Neutrophil Activation are Elevated during Acute Human Anaphylaxis: Validation of a Microarray Study.
Anaplasia
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.
Anemia
Associations between TGF-?1 Levels and Markers of Hemolysis, Inflammation, and Tissue Remodeling in Pediatric Sickle Cell Patients.
Anemia
Modulation of the HGF/c-Met axis impacts prolonged hematopoietic progenitor mobilization following trauma and chronic stress.
Anemia, Sickle Cell
Associations between TGF-?1 Levels and Markers of Hemolysis, Inflammation, and Tissue Remodeling in Pediatric Sickle Cell Patients.
Aneurysm
A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: a role for matrix metalloproteinase 9 and 2.
Aneurysm
A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity.
Aneurysm
A novel murine elastase saccular aneurysm model for studying bone marrow progenitor-derived cell-mediated processes in aneurysm formation.
Aneurysm
A reproducible swine model of a surgically created saccular thoracic aortic aneurysm.
Aneurysm
An uncommon case of arterial aneurysms association with high plasma levels of Matrix Metalloproteinase-9 and Neutrophil Gelatinase-Associated Lipocalin.
Aneurysm
Aneurysm Organization Effects of Gellan Sulfate Core Platinum Coil with Tenascin-C in a Simulated Clinical Setting and the Possible Mechanism.
Aneurysm
Arterial wall degeneration plus hemodynamic insult cause arterial wall remodeling and nascent aneurysm formation at specific sites in dogs.
Aneurysm
Association of 1166A>C AT1R, -1562C>T MMP-9, ACE I/D, and CCR5?32 Polymorphisms with Abdominal Aortic Aneurysm in Croatian Patients.
Aneurysm
Association of MMP-9 Haplotypes and TIMP-1 Polymorphism with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population.
Aneurysm
Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.
Aneurysm
Azelnidipine decreases plasma matrix metalloproteinase-9 levels after endovascular abdominal aortic aneurysm repair.
Aneurysm
Bazedoxifene, a selective estrogen receptor modulator, reduces cerebral aneurysm rupture in Ovariectomized rats.
Aneurysm
Cigarette smoking increases aortic dilatation without affecting matrix metalloproteinase-9 and -12 expression in a modified mouse model of aneurysm formation.
Aneurysm
Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells.
Aneurysm
Combining two potential causes of metalloproteinase secretion causes abdominal aortic aneurysms in rats: a new experimental model.
Aneurysm
Comments regarding 'Plasma levels of matrix metalloproteinase-9: a possible diagnostic marker of successful endovascular aneurysm repair'.
Aneurysm
Comparative study of abdominal and thoracic aortic aneurysms: their pathogenesis and a gingival fibroblasts-based ex vivo treatment.
Aneurysm
Controlled release of osteopontin and interleukin-10 from modified endovascular coil promote cerebral aneurysm healing.
Aneurysm
Differences in Elastin and Elastolytic Enzymes between Men and Women with Abdominal Aortic Aneurysm.
Aneurysm
Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed.
Aneurysm
Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets.
Aneurysm
Early Increased MT1-MMP Expression and Late MMP-2 and MMP-9 Activity during Angiotensin II Induced Aneurysm Formation.
Aneurysm
Effect of angiotensin-converting enzyme inhibitor on matrix metalloproteinase-9 activity in patients with Kawasaki disease.
Aneurysm
Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model.
Aneurysm
Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease.
Aneurysm
Erythropoietin increases circulating endothelial progenitor cells and reduces the formation and progression of cerebral aneurysm in rats.
Aneurysm
Expression of Matrix Metalloproteinases and Endogenous Inhibitors in Abdominal Aortic Aneurysm and Aortoiliac Occlusive Disease (Syndrome Leriche).
Aneurysm
Expression of MMP-2, MMP-9, and NGAL in Tissue and Serum of Patients with Vascular Aneurysms and Their Modulation by Statin Treatment: A Pilot Study.
Aneurysm
Free radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats.
Aneurysm
Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm.
Aneurysm
Hemodynamics and pathology of an enlarging abdominal aortic aneurysm model in rabbits.
Aneurysm
Heterogeneity of tensile strength and matrix metalloproteinase activity in the wall of abdominal aortic aneurysms.
Aneurysm
Homocysteine and metalloprotease-3 and -9 in patients with ascending Aorta Aneurysms.
Aneurysm
Immunohistochemical expression of metalloproteinases MMP-2 and MMP-9 in abdominal aortic aneurysms: correlation with symptoms and aortic diameter.
Aneurysm
Important role of the angiotensin II pathway in producing matrix metalloproteinase-9 in human thoracic aortic aneurysms.
Aneurysm
In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta.
Aneurysm
Increased Plasma Levels of Metalloproteinase-9 and Neutrophil Gelatinase-Associated Lipocalin in a Rare Case of Multiple Artery Aneurysm.
Aneurysm
Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms.
Aneurysm
Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections.
Aneurysm
Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase.
Aneurysm
Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm.
Aneurysm
Interleukin-12 and -23 blockade mitigates elastase-induced abdominal aortic aneurysm.
Aneurysm
Levels of MMP-9 in patients with intracranial aneurysm: Relation with risk factors, size and clinical presentation.
Aneurysm
Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
Aneurysm
Magnetic resonance imaging assessment of proteolytic enzyme concentrations and biologic properties of intraluminal thrombus in abdominal aortic aneurysms.
Aneurysm
Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves.
Aneurysm
Matrix metalloproteinase-9 coding sequence single-nucleotide polymorphisms in caucasians with intracranial aneurysms.
Aneurysm
Matrix metalloproteinase-9 may play a role in recanalization and recurrence after therapeutic embolization of aneurysms or arteries.
Aneurysm
Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm.
Aneurysm
Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves.
Aneurysm
Measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm.
Aneurysm
Metalloproteinase-9 and neutrophil gelatinase-associated lipocalin plasma and tissue levels evaluation in middle cerebral artery aneurysms.
Aneurysm
MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
Aneurysm
MMP-9 Deletion Attenuates Arteriovenous Fistula Neointima through Reduced Perioperative Vascular Inflammation.
Aneurysm
MR imaging of iron phagocytosis in intraluminal thrombi of abdominal aortic aneurysms in humans.
Aneurysm
mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease.
Aneurysm
Nitric oxide in experimental aneurysm formation: early events and consequences of nitric oxide inhibition.
Aneurysm
Osteoclast-Like Cells in Aneurysmal Disease Exhibit an Enhanced Proteolytic Phenotype.
Aneurysm
Persistence of Intraluminal Thrombus Makes Saccular Aneurysm More Biologically Active than Fusiform in an Experimental Rat Model.
Aneurysm
Plasma levels of matrix metalloproteinase-9: a possible diagnostic marker of successful endovascular aneurysm repair.
Aneurysm
Plasma matrix metalloproteinase levels do not predict tissue levels in abdominal aortic aneurysms suitable for elective repair.
Aneurysm
Polymorphisms of Pro-Inflammatory IL-6 and IL-1? Cytokines in Ascending Aortic Aneurysms as Genetic Modifiers and Predictive and Prognostic Biomarkers.
Aneurysm
Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms.
Aneurysm
Presence of Chlamydia pneumoniae in abdominal aortic aneurysms is not associated with increased activity of matrix metalloproteinases.
Aneurysm
Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study.
Aneurysm
Re: Utility of Plasma Matrix Metalloproteinase-9 as a Possible Diagnostic Marker of Endoleak Post Endovascular Aneurysm Repair.
Aneurysm
Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implications for endoleak.
Aneurysm
Salvianolic acid A, a matrix metalloproteinase-9 inhibitor of Salvia miltiorrhiza, attenuates aortic aneurysm formation in apolipoprotein E-deficient mice.
Aneurysm
Serum MMP-2 and MMP-9 in patients with Behçet's disease: Do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Aneurysm
Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Aneurysm
Spatiotemporal expression and localization of matrix metalloproteinas-9 in a murine model of thoracic aortic aneurysm.
Aneurysm
Subarachnoid haemorrhage in pregnancy after in vitro fertilisation with egg donation: a case report and review of the literature.
Aneurysm
Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB.
Aneurysm
Suppression of experimental aortic aneurysms: comparison of inducible nitric oxide synthase and cyclooxygenase inhibitors.
Aneurysm
Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease.
Aneurysm
The Elevated Level of Circulating Matrix Metalloproteinase-9 in Patients with Abdominal Aortic Aneurysms Decreased to Levels Equal to Those of Healthy Controls after an Aortic Repair.
Aneurysm
The elevated level of circulating matrix metalloproteinase-9 in patients with abdominal aortic aneurysms decreased to levels equal to those of healthy controls after an aortic repair.
Aneurysm
The potential role of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in the development of abdominal aortic aneurysms.
Aneurysm
Time-dependent and site-dependent morphological changes in rupture-prone arteries: ovariectomized rat intracranial aneurysm model.
Aneurysm
Uptake of tetracycline by aortic aneurysm wall and its effect on inflammation and proteolysis.
Aneurysm
Utility of Plasma Matrix Metalloproteinase-9 as a Possible Diagnostic Marker of Endoleak Post Endovascular Aneurysm Repair.
Aneurysm
[Expression of matrix metalloproteinase-9 in the arachnoid membrane around posterior communicating artery aneurysms].
Aneurysm
[The role of estrogen in the formation and development of abdominal aortic aneurysm: experiment with rats]
Aneurysm, Dissecting
A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissection.
Aneurysm, Dissecting
Association of the polymorphisms of MMP-9 and TIMP-3 genes with thoracic aortic dissection in Chinese Han population.
Aneurysm, Dissecting
Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections.
Aneurysm, Dissecting
Insulin-like growth factor-binding protein 3 inhibits angiotensin II-induced aortic smooth muscle cell phenotypic switch and matrix metalloproteinase expression.
Aneurysm, Dissecting
Mechanical Strain Induced Expression of Matrix Metalloproteinase-9 via Stretch-Activated Channels in Rat Abdominal Aortic Dissection.
Aneurysm, Dissecting
Mechanical stretch aggravates aortic dissection by regulating MAPK pathway and the expression of MMP-9 and inflammation factors.
Aneurysm, Dissecting
Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection.
Aneurysm, Dissecting
Overexpression of interleukin-1? and interferon-? in type I thoracic aortic dissections and ascending thoracic aortic aneurysms: possible correlation with matrix metalloproteinase-9 expression and apoptosis of aortic media cells.
Aneurysm, Dissecting
Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms.
Aneurysm, Dissecting
Plasma concentrations of interleukin-6, C-reactive protein, tumor necrosis factor-? and matrix metalloproteinase-9 in aortic dissection.
Aneurysm, Dissecting
Plasma levels of metalloproteinases-9 and -2 in the acute and subacute phases of type A and type B aortic dissection.
Aneurysm, Dissecting
Serum levels of matrix metalloproteinase 9 and toll-like receptor 4 in acute aortic dissection: a case-control study.
Aneurysm, Dissecting
Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia.
Aneurysm, Dissecting
Targeted depletion of monocyte/macrophage suppresses aortic dissection with the spatial regulation of MMP-9 in the aorta.
Aneurysm, Dissecting
The analysis of the levels of plasma inflammation-related cytokines and endotoxins in patients with acute aortic dissection.
Aneurysm, Dissecting
Transforming growth factor-?1 induces matrix metalloproteinase-9 expression in rat vascular smooth muscle cells via ROS-dependent ERK-NF-?B pathways.
Aneurysm, Dissecting
[Effect of bilateral superior cervical sympathetic ganglion occlusion on pathological process of aortic dissection and its mechanism].
Aneurysm, Dissecting
[MMP-9 gene -1562C/T polymorphism in aortic dissection in Chinese hypertensive patients]
Aneurysm, Ruptured
Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm.
Aneurysm, Ruptured
Metalloproteinase-9 and neutrophil gelatinase-associated lipocalin plasma and tissue levels evaluation in middle cerebral artery aneurysms.
Angina Pectoris
Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris.
Angina Pectoris
Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
Angina, Stable
Altered human neutrophil Fc?RI and Fc?RIII but not Fc?RII expression is associated with the acute coronary event in patients with coronary artery disease.
Angina, Stable
C-reactive protein induces expression of matrix metalloproteinase-9: A possible link between inflammation and plaque rupture.
Angina, Stable
Clinical Relevance of Matrix Metalloproteinase 9 in Patients With Acute Coronary Syndrome.
Angina, Stable
Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris.
Angina, Stable
EFFECT OF RELATIVE GENE EXPRESSION ON PLAQUE VULNERABILITY IN PATIENTS WITH STABLE ANGINA AND PATIENTS WITH ACUTE CORONARY SYNDROME.
Angina, Stable
Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
Angina, Stable
Elevation of plasma matrix metalloproteinase-9 in the culprit coronary artery in patients with acute myocardial infarction: clinical evidence from distal protection.
Angina, Stable
Immunoglobulin E and matrix metalloproteinase-9 in patients with different stages of coronary artery diseases.
Angina, Stable
Increased levels of leukocyte-derived MMP-9 in patients with stable angina pectoris.
Angina, Stable
Innate immunity markers in culprit plaques of acute myocardial infarction or stable angina.
Angina, Stable
Local Matrix Metalloproteinase 9 Level Determines Early Clinical Presentation of ST-Segment-Elevation Myocardial Infarction.
Angina, Stable
Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI.
Angina, Stable
Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: correlations with serum troponin I.
Angina, Stable
Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome.
Angina, Stable
Release of matrix metalloproteinase-9 during balloon angioplasty in patients with stable angina. A preliminary study.
Angina, Stable
The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina.
Angina, Stable
The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina.
Angina, Unstable
Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina.
Angina, Unstable
Clinical Relevance of Matrix Metalloproteinase 9 in Patients With Acute Coronary Syndrome.
Angina, Unstable
Comparision of high sensitivity C-reactive protein and matrix metalloproteinase 9 in patients with unstable angina between with and without significant coronary artery plaques.
Angina, Unstable
Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris.
Angina, Unstable
Curcumin effects on myeloperoxidase, interleukin-18 and matrix metalloproteinase-9 inflammatory biomarkers in patients with unstable angina: A randomized clinical trial.
Angina, Unstable
Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
Angina, Unstable
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Angina, Unstable
High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction.
Angina, Unstable
Immunoglobulin E and matrix metalloproteinase-9 in patients with different stages of coronary artery diseases.
Angina, Unstable
Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome.
Angina, Unstable
Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10.
Angina, Unstable
Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris.
Angina, Unstable
Nicorandil effects on platelet function, Hs-CRP, MMP-9 and myocardial antioxidation in patients with unstable angina.
Angina, Unstable
Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.
Angina, Unstable
Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up.
Angina, Unstable
Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration.
Angina, Unstable
Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects.
Angina, Unstable
[Association of matrix metalloproteinase-9 and platelet membrane glycoprotein VI polymorphisms with acute coronary syndrome]
Angiofibroma
Prognostic value of matrix metalloproteinase 9 expression in patients with juvenile nasopharyngeal angiofibroma: tissue microarray analysis.
Anodontia
Analysis of MMP-9 and TIMP-2 gene promoter polymorphisms in individuals with hypodontia.
Aortic Aneurysm
Amelioration of salvianolic acid C on aortic structure in apolipoprotein E-deficient mice treated with angiotension II.
Aortic Aneurysm
Circulating levels of matrix metalloproteinase-9 and abdominal aortic pathology: from the Dallas Heart Study.
Aortic Aneurysm
Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions.
Aortic Aneurysm
Correlation of bacterial coinfection versus matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 expression in aortic aneurysm and atherosclerosis.
Aortic Aneurysm
Effect of miR-21 on rat thoracic aortic aneurysm model by regulating the expressions of MMP-2 and MMP-9.
Aortic Aneurysm
Elevated messenger RNA expression and plasma protein levels of osteopontin and matrix metalloproteinase types 2 and 9 in patients with ascending aortic aneurysms.
Aortic Aneurysm
Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections.
Aortic Aneurysm
Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase.
Aortic Aneurysm
Matrix metalloproteinases synthesized in autosomal dominant polycystic kidney disease play a role in development of a concurrent abdominal aortic aneurysm.
Aortic Aneurysm
MCP-1, ICAM-1 and VCAM-1 are present in early aneurysmal dilatation in experimental rats.
Aortic Aneurysm
Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms.
Aortic Aneurysm
Plasma Matrix Metalloproteinase 9 Levels May Predict Endoleaks After Endovascular Aortic Aneurysm Repair.
Aortic Aneurysm
Role of PAR1-Egr1 in the Initiation of Thoracic Aortic Aneurysm in Fbln4-Deficient Mice.
Aortic Aneurysm
Salvianolic acid A, a matrix metalloproteinase-9 inhibitor of Salvia miltiorrhiza, attenuates aortic aneurysm formation in apolipoprotein E-deficient mice.
Aortic Aneurysm
Serum matrix metalloproteinase-9 is a valuable biomarker for identification of abdominal and thoracic aortic aneurysm: a case-control study.
Aortic Aneurysm
SP600125 Attenuates Nicotine-Related Aortic Aneurysm Formation by Inhibiting Matrix Metalloproteinase Production and CC Chemokine-Mediated Macrophage Migration.
Aortic Aneurysm
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms.
Aortic Aneurysm
The association between plasma matrix metalloproteinase-9 concentration and endoleak after endovascular aortic aneurysm repair: a meta-analysis.
Aortic Aneurysm
Transforming growth factor-?1 induces matrix metalloproteinase-9 expression in rat vascular smooth muscle cells via ROS-dependent ERK-NF-?B pathways.
Aortic Aneurysm, Abdominal
A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall.
Aortic Aneurysm, Abdominal
A Randomised Placebo-controlled Double-blind Trial to Evaluate Lipid-lowering Pharmacotherapy on Proteolysis and Inflammation in Abdominal Aortic Aneurysms.
Aortic Aneurysm, Abdominal
Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.
Aortic Aneurysm, Abdominal
Association of 1166A>C AT1R, -1562C>T MMP-9, ACE I/D, and CCR5?32 Polymorphisms with Abdominal Aortic Aneurysm in Croatian Patients.
Aortic Aneurysm, Abdominal
Azelnidipine decreases plasma matrix metalloproteinase-9 levels after endovascular abdominal aortic aneurysm repair.
Aortic Aneurysm, Abdominal
Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall.
Aortic Aneurysm, Abdominal
Chymase as a novel target for the prevention of vascular diseases.
Aortic Aneurysm, Abdominal
Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events.
Aortic Aneurysm, Abdominal
Circulating matrix metalloproteinase-9 concentrations and abdominal aortic aneurysm presence: a meta-analysis.
Aortic Aneurysm, Abdominal
Clearance of matrix metalloproteinase-9 is dependent on low-density lipoprotein receptor-related protein-1 expression downregulated by microRNA-205 in human abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Decreased tissue inhibitor of metalloproteinase-2/matrix metalloproteinase ratio in the acute phase of aortic dissection.
Aortic Aneurysm, Abdominal
Differential regulation of the superoxide dismutase family in experimental aortic aneurysms and rat aortic explants.
Aortic Aneurysm, Abdominal
Dipeptidyl peptidase-4 inhibitor decreases abdominal aortic aneurysm formation through GLP-1-dependent monocytic activity in mice.
Aortic Aneurysm, Abdominal
Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content.
Aortic Aneurysm, Abdominal
Early growth response factor-1 DNA enzyme 1 inhibits the formation of abdominal aortic aneurysm in rats.
Aortic Aneurysm, Abdominal
Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease.
Aortic Aneurysm, Abdominal
Elevated messenger RNA expression and plasma protein levels of osteopontin and matrix metalloproteinase types 2 and 9 in patients with ascending aortic aneurysms.
Aortic Aneurysm, Abdominal
Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease.
Aortic Aneurysm, Abdominal
Endothelial MMP-9 drives the inflammatory response in abdominal aortic aneurysm (AAA).
Aortic Aneurysm, Abdominal
Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
EVAR and OPEN treatment of abdominal aortic aneurysm: What is the role of MMP-9 in the follow-up?
Aortic Aneurysm, Abdominal
Expansion of small-diameter abdominal aortic aneurysms is not reflected by the release of inflammatory mediators IL-6, MMP-9 and CRP in plasma.
Aortic Aneurysm, Abdominal
Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Genotype-phenotype relationships in an investigation of the role of proteases in abdominal aortic aneurysm expansion.
Aortic Aneurysm, Abdominal
HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages.
Aortic Aneurysm, Abdominal
Human Vascular Wall Mesenchymal Stromal Cells Contribute to Abdominal Aortic Aneurysm Pathogenesis Through an Impaired Immunomodulatory Activity and Increased Levels of Matrix Metalloproteinase-9.
Aortic Aneurysm, Abdominal
Immunohistochemical expression of metalloproteinases MMP-2 and MMP-9 in abdominal aortic aneurysms: correlation with symptoms and aortic diameter.
Aortic Aneurysm, Abdominal
Increased Plasma Levels of Metalloproteinase-9 and Neutrophil Gelatinase-Associated Lipocalin in a Rare Case of Multiple Artery Aneurysm.
Aortic Aneurysm, Abdominal
Loss of MURC/Cavin-4 induces JNK and MMP-9 activity enhancement in vascular smooth muscle cells and exacerbates abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Low molecular weight heparin treatment decreases MMP-9 plasma activity in patients with abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Matrix metalloproteinase 9 activity in patients before and after endovascular or surgical repair of abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
Matrix Metalloproteinase-9 Genotype as a Potential Genetic Marker for Abdominal Aortic Aneurysm.
Aortic Aneurysm, Abdominal
Matrix metalloproteinases synthesized in autosomal dominant polycystic kidney disease play a role in development of a concurrent abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
MF-tricyclic inhibits growth of experimental abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
MMP-9, homocysteine and CRP circulating levels are associated with intraluminal thrombus thickness of abdominal aortic aneurysms: new implication of the old biomarkers.
Aortic Aneurysm, Abdominal
mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease.
Aortic Aneurysm, Abdominal
Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation.
Aortic Aneurysm, Abdominal
New approaches to blockade of the renin-angiotensin-aldosterone system: chymase as an important target to prevent organ damage.
Aortic Aneurysm, Abdominal
Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Polymorphisms of the matrix metalloproteinase 9 gene and abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Pravastatin increases the expression of the tissue inhibitor of matrix metalloproteinase-1 and the oncogene Bax in human aortic abdominal aneurysms.
Aortic Aneurysm, Abdominal
Relaxin and Matrix Metalloproteinase-9 in Angiotensin II-Induced Abdominal Aortic Aneurysms.
Aortic Aneurysm, Abdominal
Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implications for endoleak.
Aortic Aneurysm, Abdominal
Serum MMP-2 and MMP-9 in patients with Behçet's disease: Do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Aortic Aneurysm, Abdominal
Significance of Matrix Metalloproteinase-9 Inhibition by Imidapril for Prevention of Abdominal Aortic Aneurysms in Angiotensin II Type 1 Receptor-Knockout Mice.
Aortic Aneurysm, Abdominal
Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue.
Aortic Aneurysm, Abdominal
Size matters: the relationship between MMP-9 expression and aortic diameter.
Aortic Aneurysm, Abdominal
Spatial differences of matrix metalloproteinase-2 and matrix metalloproteinase-9 within abdominal aortic aneurysm wall and intraluminal thrombus.
Aortic Aneurysm, Abdominal
Suppression of experimental aortic aneurysms: comparison of inducible nitric oxide synthase and cyclooxygenase inhibitors.
Aortic Aneurysm, Abdominal
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms.
Aortic Aneurysm, Abdominal
The crosstalk between vascular MSCs and inflammatory mediators determines the pro-calcific remodelling of human atherosclerotic aneurysm.
Aortic Aneurysm, Abdominal
The elevated expression of TLR4 and MMP9 in human abdominal aortic aneurysm tissues and its implication.
Aortic Aneurysm, Abdominal
The Elevated Level of Circulating Matrix Metalloproteinase-9 in Patients with Abdominal Aortic Aneurysms Decreased to Levels Equal to Those of Healthy Controls after an Aortic Repair.
Aortic Aneurysm, Abdominal
The elevated level of circulating matrix metalloproteinase-9 in patients with abdominal aortic aneurysms decreased to levels equal to those of healthy controls after an aortic repair.
Aortic Aneurysm, Abdominal
The nitric oxide donor DETA-NONOate decreases matrix metalloproteinase-9 expression and activity in rat aortic smooth muscle and abdominal aortic explants.
Aortic Aneurysm, Abdominal
The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study.
Aortic Aneurysm, Abdominal
[Metalloproteases, vascular remodeling and atherothrombotic syndromes]
Aortic Aneurysm, Thoracic
A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: a role for matrix metalloproteinase 9 and 2.
Aortic Aneurysm, Thoracic
A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissection.
Aortic Aneurysm, Thoracic
Changes in expressions of miR-22-3p and MMP-9 in rats with thoracic aortic aneurysm and their significance.
Aortic Aneurysm, Thoracic
Differential expression of MMP-2, MMP-9 and TIMP proteins in thoracic aortic aneurysm - comparison with and without bicuspid aortic valve: a meta-analysis.
Aortic Aneurysm, Thoracic
Effect of miR-21 on rat thoracic aortic aneurysm model by regulating the expressions of MMP-2 and MMP-9.
Aortic Aneurysm, Thoracic
Effects of deletion of the matrix metalloproteinase 9 gene on development of murine thoracic aortic aneurysms.
Aortic Aneurysm, Thoracic
Elevation of ADAM10, ADAM17, MMP-2 and MMP-9 expression with media degeneration features CaCl2-induced thoracic aortic aneurysm in a rat model.
Aortic Aneurysm, Thoracic
Important role of the angiotensin II pathway in producing matrix metalloproteinase-9 in human thoracic aortic aneurysms.
Aortic Aneurysm, Thoracic
Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves.
Aortic Aneurysm, Thoracic
Overexpression of interleukin-1? and interferon-? in type I thoracic aortic dissections and ascending thoracic aortic aneurysms: possible correlation with matrix metalloproteinase-9 expression and apoptosis of aortic media cells.
Aortic Aneurysm, Thoracic
Serum matrix metalloproteinase-9 is a valuable biomarker for identification of abdominal and thoracic aortic aneurysm: a case-control study.
Aortic Aneurysm, Thoracic
Spatiotemporal expression and localization of matrix metalloproteinas-9 in a murine model of thoracic aortic aneurysm.
Aortic Aneurysm, Thoracic
Temporal disparity in the induction of matrix metalloproteinases and tissue inhibitors of metalloproteinases after thoracic aortic aneurysm formation.
Aortic Diseases
Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves.
Aortic Rupture
Relaxin and Matrix Metalloproteinase-9 in Angiotensin II-Induced Abdominal Aortic Aneurysms.
Aortic Valve Stenosis
Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition.
Aortic Valve Stenosis
Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis.
Aortic Valve Stenosis
Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis.
Aortic Valve Stenosis
Impact of several proinflammatory and cell degradation factors in patients with aortic valve stenosis.
Appendicitis
A local imbalance between MMP and TIMP may have an implication on the severity and course of appendicitis.
Appendicitis
Local and systemic expressions of MMP-9, TIMP-1 and PAI-1 in patients undergoing surgery for clinically suspected appendicitis.
Appendicitis
Systemic Th17-like cytokine pattern in gangrenous appendicitis but not in phlegmonous appendicitis.
Arrhythmias, Cardiac
Pleiotropic Effects of Myocardial MMP-9 Inhibition to Prevent Ventricular Arrhythmia.
Arrhythmias, Cardiac
The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation.
Arteriosclerosis
4-O-Carboxymethylascochlorin Inhibits Expression Levels of on Inflammation-Related Cytokines and Matrix Metalloproteinase-9 Through NF-?B/MAPK/TLR4 Signaling Pathway in LPS-Activated RAW264.7 Cells.
Arteriosclerosis Obliterans
Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
Arteriovenous Fistula
MMP-9 Deletion Attenuates Arteriovenous Fistula Neointima through Reduced Perioperative Vascular Inflammation.
Arteriovenous Fistula
Periadventitial Delivery of Simvastatin-Loaded Microparticles Attenuate Venous Neointimal Hyperplasia Associated With Arteriovenous Fistula.
Arteriovenous Fistula
Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice.
Arteriovenous Fistula
Serum metalloproteinases MMP-2, MMP-9, and metalloproteinase tissue inhibitors in patients are associated with arteriovenous fistula maturation.
Arteriovenous Fistula
Simvastatin reduces venous stenosis formation in a murine hemodialysis vascular access model.
Arteriovenous Fistula
Targeted deletion of MMP-9 attenuates myocardial contractile dysfunction in heart failure.
Arteriovenous Fistula
Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity.
Arteriovenous Malformations
Analysis of the Expression of Angioarchitecture-related Factors in Patients with Cerebral Arteriovenous Malformation.
Arteriovenous Malformations
Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation.
Arteriovenous Malformations
Evidence of inflammatory cell involvement in brain arteriovenous malformations.
Arteriovenous Malformations
Imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 may contribute to hemorrhage in cerebellar arteriovenous malformations.
Arteriovenous Malformations
Increased expression of angiogenic factors in cultured human brain arteriovenous malformation endothelial cells.
Arteriovenous Malformations
MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations.
Arteriovenous Malformations
Suppression of MMP-9 by doxycycline in brain arteriovenous malformations.
Arteriovenous Malformations
The rs9509 polymorphism of MMP-9 is associated with risk of hemorrhage in brain arteriovenous malformations.
Arteritis
Association of a nonsynonymous single-nucleotide polymorphism of matrix metalloproteinase 9 with giant cell arteritis.
Arteritis
Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis.
Arteritis
Inhibition of transforming growth factor ? worsens elastin degradation in a murine model of Kawasaki disease.
Arteritis
Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease.
Arthralgia
Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells.
Arthritis
A correlation between knee cartilage degradation observed by arthroscopy and synovial proteinases activities.
Arthritis
Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
Arthritis
Aesculin inhibits matrix metalloproteinase-9 expression via p38 mitogen activated protein kinase and activator protein 1 in lipopolysachride-induced RAW264.7 cells.
Arthritis
Cathepsin B and cystatin C play an inflammatory role in gouty arthritis of the knee.
Arthritis
Changes in MMP-2 and -9 activity and MMP-8 reactivity after amphotericin B induced synovitis and treatment with bufexamac.
Arthritis
Characterization of death receptor 3-dependent aortic changes during inflammatory arthritis.
Arthritis
Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis.
Arthritis
Clinical significance of gelatinases in septic arthritis of native and replaced knees.
Arthritis
Collagen type III content of the long head of the biceps tendon as an indicator of glenohumeral arthritis.
Arthritis
Contractile, but not endothelial, dysfunction in early inflammatory arthritis: a possible role for matrix metalloproteinase-9.
Arthritis
Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.
Arthritis
Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models.
Arthritis
Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis.
Arthritis
Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-alpha-308GG genotype.
Arthritis
Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis.
Arthritis
Expression levels of matrix metalloproteinase (MMP)-9 and its specific inhibitor TIMP-1, in septic and aseptic arthritis of the knee.
Arthritis
Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
Arthritis
Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B.
Arthritis
Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
Arthritis
Infliximab therapy does not modify MMP-2 and MMP-9 serum concentrations in chronic arthritis.
Arthritis
Involvement of lymphocytes with a Th1 cytokine profile in bone cell damage associated with MMP-9 production in collagen-induced arthritis.
Arthritis
Levels of Selected Matrix Metalloproteinases, Their Inhibitors in Saliva, and Oral Status in Juvenile Idiopathic Arthritis Patients vs. Healthy Controls.
Arthritis
Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis.
Arthritis
Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis.
Arthritis
Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations.
Arthritis
MMP-9 mRNA as a therapeutic marker in acute and chronic stages of arthritis induced by type II collagen antibody.
Arthritis
Modulation of autocrine TNF-alpha-stimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells.
Arthritis
Potency of Bone Marrow-Derived Mesenchymal Stem Cells and Indomethacin in Complete Freund's Adjuvant-Induced Arthritic Rats: Roles of TNF-?, IL-10, iNOS, MMP-9, and TGF-?1.
Arthritis
Regulation of human monocyte proMMP-9 production by fetuin, an endogenous TGF-beta antagonist.
Arthritis
Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis.
Arthritis
Role of the conserved histidine and aspartic acid residues in activity and stabilization of human gelatinase B: an example of matrix metalloproteinases.
Arthritis
Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signalling pathways, Akt and Erk.
Arthritis
Serum Levels of MDC and MMP-9 and the Relationship Between Serum Levels and Disease Activity in the Patients with Systemic Lupus Erythematosus.
Arthritis
Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells.
Arthritis
Suppression of chronic streptococcal cell wall-induced arthritis in Lewis rats by liposomal clodronate.
Arthritis
The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis.
Arthritis
The significance of altered gelatinase expression in the synovium of patient with arthritic effusions.
Arthritis
Transcriptional induction of matrix metalloproteinase-9 in the chondrocyte and synoviocyte cells is regulated via a novel mechanism: evidence for functional cooperation between serum amyloid A-activating factor-1 and AP-1.
Arthritis
[Electroacupuncture at "Zusanli"(ST36) and "Xuanzhong"(GB39) improves inflammatory reactions and reduces levels of serum MMP-3 and MMP-9 in adjuvant arthritis rats].
Arthritis
[Relationship of serum levels of HGF and MMP-9 with disease activity of patients with systemic lupus erythematosus]
Arthritis, Experimental
Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.
Arthritis, Experimental
Blocking Matrix Metalloproteinase-9 Abrogates Collagen-Induced Arthritis via Inhibiting Dendritic Cell Migration.
Arthritis, Experimental
Characterization of death receptor 3-dependent aortic changes during inflammatory arthritis.
Arthritis, Experimental
Effective treatment of polydatin weakens the symptoms of collagen-induced arthritis in mice through its anti-oxidative and anti-inflammatory effects and the activation of MMP-9.
Arthritis, Experimental
Involvement of lymphocytes with a Th1 cytokine profile in bone cell damage associated with MMP-9 production in collagen-induced arthritis.
Arthritis, Experimental
Localization and characterization of matrix metalloproteinase-9 in experimental rat adjuvant arthritis.
Arthritis, Experimental
Penta-acetyl Geniposide Suppresses Migration, Invasion, and Inflammation of TNF-?-Stimulated Rheumatoid Arthritis Fibroblast-Like Synoviocytes Involving Wnt/?-Catenin Signaling Pathway.
Arthritis, Experimental
Therapeutic effects of the total lignans from Vitex negundo seeds on collagen-induced arthritis in rats.
Arthritis, Experimental
Transcription Factor SOX5 Promotes the Migration and Invasion of Fibroblast-Like Synoviocytes in Part by Regulating MMP-9 Expression in Collagen-Induced Arthritis.
Arthritis, Experimental
[Electroacupuncture at "Zusanli"(ST36) and "Xuanzhong"(GB39) improves inflammatory reactions and reduces levels of serum MMP-3 and MMP-9 in adjuvant arthritis rats].
Arthritis, Experimental
[The effect of prolactin on the expression of matrix metalloproteinase-9 in the synovium of adjuvant arthritis rats].
Arthritis, Gouty
Expression of matrix metalloproteinase-9 (gelatinase B) in gouty arthritis and stimulation of MMP-9 by urate crystals in macrophages.
Arthritis, Gouty
Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
Arthritis, Infectious
Clinical significance of gelatinases in septic arthritis of native and replaced knees.
Arthritis, Infectious
Comparison of several biomarkers (MMP-2, MMP-9, the MMP-9 inhibitor TIMP-1, CTX-II, calprotectin, and COMP) in the synovial fluid and serum of patients with and without septic arthritis.
Arthritis, Infectious
Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis.
Arthritis, Infectious
Matrix metalloproteinases 2 and 9 activity in bovine synovial fluids.
Arthritis, Infectious
Relative expression of matrix metalloproteinase-2 and -9 in synovial fluid from healthy calves and calves with experimentally induced septic arthritis.
Arthritis, Juvenile
Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-alpha-308GG genotype.
Arthritis, Juvenile
Levels of Selected Matrix Metalloproteinases, Their Inhibitors in Saliva, and Oral Status in Juvenile Idiopathic Arthritis Patients vs. Healthy Controls.
Arthritis, Juvenile
[Indices of matrix metalloproteinases (MMP-2, MMP-9, TIMP-1) with juvenile arthritis in children].
Arthritis, Psoriatic
Matrix metalloproteinase 9 (MMP-9) in patients with psoriatic arthritis and rheumatoid arthritis.
Arthritis, Psoriatic
MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis.
Arthritis, Rheumatoid
A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis.
Arthritis, Rheumatoid
A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9).
Arthritis, Rheumatoid
A New Explanation of Inflammation in Rheumatoid Arthritis Patients With Respect to Claudin-5, Matrix Metalloproteinase-9, and Neuroserpin.
Arthritis, Rheumatoid
Association of tumor necrosis factor-? (G-308A) genetic variant with matrix metalloproteinase-9 activity and joint destruction in early rheumatoid arthritis.
Arthritis, Rheumatoid
Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis.
Arthritis, Rheumatoid
Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis.
Arthritis, Rheumatoid
Correlations between matrix metalloproteinase-9 and adenosine deaminase isozymes in synovial fluid from patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity.
Arthritis, Rheumatoid
CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
Arthritis, Rheumatoid
Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis.
Arthritis, Rheumatoid
Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis.
Arthritis, Rheumatoid
Delphinidin suppresses PMA-induced MMP-9 expression by blocking the NF-?B activation through MAPK signaling pathways in MCF-7 human breast carcinoma cells.
Arthritis, Rheumatoid
Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
Arthritis, Rheumatoid
Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Dexmedetomidine inhibits the invasion, migration, and inflammation of rheumatoid arthritis fibroblast-like synoviocytes by reducing the expression of NLRC5.
Arthritis, Rheumatoid
Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: relevance to inflammation in rheumatoid arthritis.
Arthritis, Rheumatoid
E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy.
Arthritis, Rheumatoid
Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus.
Arthritis, Rheumatoid
Expression Analysis of Matrix Metalloproteinase-9 Gene in Rheumatoid Arthritis Patients on Disease Modifying Anti-Rheumatic Drugs.
Arthritis, Rheumatoid
Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
Arthritis, Rheumatoid
Expression of matrix metalloproteinase-9 (gelatinase B) in gouty arthritis and stimulation of MMP-9 by urate crystals in macrophages.
Arthritis, Rheumatoid
Gelatinase B participates in collagen II degradation and releases glycosylated remnant epitopes in rheumatoid arthritis.
Arthritis, Rheumatoid
Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B.
Arthritis, Rheumatoid
Genistein Inhibit Cytokines or Growth Factor-Induced Proliferation and Transformation Phenotype in Fibroblast-Like Synoviocytes of Rheumatoid Arthritis.
Arthritis, Rheumatoid
Human gelatinase B, a marker enzyme in rheumatoid arthritis, is inhibited by D-penicillamine: anti-rheumatic activity by protease inhibition.
Arthritis, Rheumatoid
Infliximab reduces CD147, MMP-3, and MMP-9 expression in peripheral blood monocytes in patients with active rheumatoid arthritis.
Arthritis, Rheumatoid
Infliximab therapy does not modify MMP-2 and MMP-9 serum concentrations in chronic arthritis.
Arthritis, Rheumatoid
Inhibitory effects of leflunomide therapy on the activity of matrixmetalloproteinase-9 and the release of cartilage oligomeric matrix protein in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein.
Arthritis, Rheumatoid
LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro-inflammatory cytokines and MMP-9 in macrophages.
Arthritis, Rheumatoid
Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption.
Arthritis, Rheumatoid
Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker.
Arthritis, Rheumatoid
Matrix metalloproteinase 9 (MMP-9) in patients with psoriatic arthritis and rheumatoid arthritis.
Arthritis, Rheumatoid
Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis.
Arthritis, Rheumatoid
Matrix Metalloproteinase-9 Production by Immortalized Human Chondrocyte Lines.
Arthritis, Rheumatoid
Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis.
Arthritis, Rheumatoid
Mechanism of action of celastrol against rheumatoid arthritis: A network pharmacology analysis.
Arthritis, Rheumatoid
Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.
Arthritis, Rheumatoid
MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis.
Arthritis, Rheumatoid
Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter.
Arthritis, Rheumatoid
Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity.
Arthritis, Rheumatoid
Phase 1b Study of the Safety, Pharmacokinetics, and Disease-related Outcomes of the Matrix Metalloproteinase-9 Inhibitor Andecaliximab in Patients With Rheumatoid Arthritis.
Arthritis, Rheumatoid
Predictors of Cardiovascular Affection in Patients with Active Rheumatoid Arthritis: Secondary Analysis of a Randomized Controlled Trial.
Arthritis, Rheumatoid
Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B.
Arthritis, Rheumatoid
Serum Levels of Matrix Metalloproteinase (MMP) 9, a Risk Factor for Acute Coronary Syndrome, Are Reduced Independently of Serum MMP-3 by Anti-TNF-? Antibody (Infliximab) Therapy in Patients With Rheumatoid Arthritis.
Arthritis, Rheumatoid
Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
Arthritis, Rheumatoid
Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase-inhibitor.
Arthritis, Rheumatoid
Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.
Arthritis, Rheumatoid
Taurine chloramine differentially inhibits matrix metalloproteinase 1 and 13 synthesis in interleukin-1beta stimulated fibroblast-like synoviocytes.
Arthritis, Rheumatoid
The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis.
Arthritis, Rheumatoid
[Correlations between serum matrix metalloproteinase (MMP-1, MMP-3, MMP-9, MMP-13) concentrations and markers of disease activity in early rheumatoid arthritis]
Arthritis, Rheumatoid
[Effect of lipopolysaccharide on expression of matrix metalloproteinase-9 in human synoviocyte from patients with rheumatoid arthritis]
Arthritis, Rheumatoid
[The effect of prolactin on the expression of matrix metalloproteinase-9 in the synovium of adjuvant arthritis rats].
Arthritis, Rheumatoid
[The serum levels of cytokines in patients with rheumatoid arthritis associated interstitial lung disease and their clinical significance]
Arthritis, Rheumatoid
[Usefulness of examinations of serum levels of matrix metalloproteinases 1, MMP-3, MMP-9, tissue inhibitor of metalloproteinases 1, hyaluronic acid and antibodies against cyclic citrullinated peptide in Lyme arthritis, rheumatoid arthritis and patients with arthritic complaints].
Asbestosis
Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
Ascorbic Acid Deficiency
Possible interplay between vitamin C deficiency and prolactin in pregnant women with premature rupture of membranes: facts and hypothesis.
Aspergillosis, Allergic Bronchopulmonary
Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis.
Asthma
A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion.
Asthma
A murine model of toluene diisocyanate-induced asthma can be treated with matrix metalloproteinase inhibitor.
Asthma
A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women.
Asthma
A TLR2 agonist in German cockroach frass activates MMP-9 release and is protective against allergic inflammation in mice.
Asthma
A water extract of Samchulkunbi-tang attenuates airway inflammation by inhibiting inos and MMP-9 activities in an ovalbumin-induced murine asthma model.
Asthma
Airway Remodeling in Chronic Obstructive Pulmonary Disease and Asthma: the Role of Matrix Metalloproteinase-9.
Asthma
Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma.
Asthma
An extract of Crataegus pinnatifida fruit attenuates airway inflammation by modulation of matrix metalloproteinase-9 in ovalbumin induced asthma.
Asthma
Association of Matrix Metalloproteinase 9 (MMP-9) Polymorphisms with Asthma Risk: A Meta-Analysis.
Asthma
Association of the MMP9 gene with childhood cedar pollen sensitization and pollinosis.
Asthma
Association study of polymorphisms within matrix metalloproteinase 9 with bronchial asthma.
Asthma
Balance between MMP-9 and TIMP-1 expressed by human bronchial epithelial cells: relevance to asthma.
Asthma
Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation.
Asthma
Children with stable asthma have reduced airway matrix metalloproteinase-9 and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio.
Asthma
Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus.
Asthma
Correlation between CT small airway parameters, T-lymphocyte subsets and MMP-9 level in patients with bronchial asthma.
Asthma
CTGF upregulation correlates with MMP-9 level in airway remodeling in a murine model of asthma.
Asthma
Doxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma.
Asthma
Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma.
Asthma
Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
Asthma
Epigallocatechin-3-gallate protects toluene diisocyanate-induced airway inflammation in a murine model of asthma.
Asthma
Ets-1 regulates TNF-alpha-induced matrix metalloproteinase-9 and tenascin expression in primary bronchial fibroblasts.
Asthma
Evaluation of inflammatory markers interleukin-6 (IL-6) and matrix metalloproteinase-9 (MMP-9) in asthma.
Asthma
Exhaled breath condensate MMP-9 level and its relationship w?th asthma severity and interleukin-4/10 levels in children.
Asthma
Exhaled Breath Temperature and Systemic Biomarkers for Assessment of Airway Inflammation in Asthmatics.
Asthma
Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma.
Asthma
Expression of nerve growth factor and matrix metallopeptidase-9/tissue inhibitor of metalloproteinase-1 in asthmatic patients.
Asthma
German cockroach proteases regulate matrix metalloproteinase-9 in human bronchial epithelial cells.
Asthma
HMGB1 binding to receptor for advanced glycation end products enhances inflammatory responses of human bronchial epithelial cells by activating p38 MAPK and ERK1/2.
Asthma
Imbalance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in toluene diisocyanate-induced asthma.
Asthma
Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma.
Asthma
Increase in the Mediators of Asthma in Obesity and Obesity with Type 2 Diabetes: Reduction with Weight Loss.
Asthma
Increased circulating 92 kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma.
Asthma
Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma.
Asthma
Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways.
Asthma
Increased nasal matrix metalloproteinase-1 and -9 expression in smokers with chronic rhinosinusitis and asthma.
Asthma
Increased Ratio of Matrix Metalloproteinase-9 (MMP-9)/Tissue Inhibitor Metalloproteinase-1 from Alveolar Macrophages in Chronic Asthma with a Fast Decline in FEV1 at 5-Year Follow-up.
Asthma
Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics.
Asthma
Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients.
Asthma
Influence of rutin on the effects of neonatal cigarette smoke exposure-induced exacerbated MMP-9 expression, Th17 cytokines and NF-?B/iNOS-mediated inflammatory responses in asthmatic mice model.
Asthma
Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma.
Asthma
Inhaled corticosteroids do not reduce initial high activity of matrix metalloproteinase (MMP)-9 in exhaled breath condensates of children with asthma exacerbation: a proof of concept study.
Asthma
Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma.
Asthma
Intranasal Curcumin Inhibits Pulmonary Fibrosis by Modulating Matrix Metalloproteinase-9 (MMP-9) in Ovalbumin-Induced Chronic Asthma.
Asthma
Levels of matrix metalloproteinase-9 and its inhibitor in bronchoalveolar lavage cells of asthmatic children.
Asthma
Levels of matrix metalloproteinase-9 and its inhibitor in guinea pig asthma model following ovalbumin challenge.
Asthma
Localization of Matrix Metalloproteinase (MMP)-9 in Lung Tissue of a Murine Model of Allergic Asthma.
Asthma
Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma.
Asthma
Matrix metalloproteinase 9 is involved in airway inflammation in cough variant asthma.
Asthma
Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation.
Asthma
Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids.
Asthma
Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge.
Asthma
Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in sputum from patients with bronchial asthma.
Asthma
Metalloproteinase-9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate-induced asthma.
Asthma
MFG-E8/integrin ?3 signaling contributes to airway inflammation response and airway remodeling in an ovalbumin-induced murine model of asthma.
Asthma
MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7.
Asthma
Nasal lavage VEGF and TNF-? levels during a natural cold predict asthma exacerbations.
Asthma
Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids.
Asthma
Neutrophils from allergic asthmatic patients produce and release metalloproteinase-9 upon direct exposure to allergens.
Asthma
Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors.
Asthma
PMA-induced up-regulation of MMP-9 is regulated by a PKCalpha-NF-kappaB cascade in human lung epithelial cells.
Asthma
Polymorphic Variants 279R and 668Q Augment Activity of Matrix Metalloproteinase-9 in Breath Condensates of Children with Asthma.
Asthma
Polymorphisms in metalloproteinase-9 are associated with the risk for asthma in Mexican pediatric patients.
Asthma
Prolonged Treatment with Inhaled Corticosteroids does not Normalize High Activity of Matrix Metalloproteinase-9 in Exhaled Breath Condensates of Children with Asthma.
Asthma
Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma.
Asthma
Remodeling associated expression of matrix metalloproteinase 9 but not tissue inhibitor of metalloproteinase 1 in airway epithelium: Modulation by immunostimulatory DNA.
Asthma
Rhinovirus-induced MMP-9 expression is dependent on Fra-1, which is modulated by formoterol and dexamethasone.
Asthma
Serum matrix metalloproteinase-9:Tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma.
Asthma
Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma.
Asthma
Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis.
Asthma
Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair.
Asthma
Suppression of plasma matrix metalloproteinase-9 following montelukast treatment in childhood asthma.
Asthma
Sustained elevation of systemic oxidative stress and inflammation in exacerbation and remission of asthma.
Asthma
The involvement of matrix metalloproteinase-9 in airway inflammation of patients with acute asthma.
Asthma
The role of inducible costimulatory molecular ligand (ICOSL) in children with neutrophilic asthma.
Asthma
The transcription factor Wilms tumor 1 regulates matrix metalloproteinase-9 through a nitric oxide-mediated pathway.
Asthma
The Variants in the 3' Untranslated Region of the Matrix Metalloproteinase 9 Gene as Modulators of Treatment Outcome in Children with Asthma.
Asthma
Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma.
Asthma
Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma.
Asthma
[Effect of triggering receptor expressed on myeloid cells 2 overexpression on airway inflammation and remodeling in mice with allergic asthma].
Asthma
[Effects of all-trans retinoic acid on airway responsiveness and airway remodeling in rats with asthma].
Asthma
[Effects of Fritillariae Cirrhosae Bulbus on MMP-2,MMP-9 and TIMP-1 in murine asthma model].
Asthma
[MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma]
Asthma
[Regulatory effects of inhaled steroids on expression of matrix metalloproteinase-9 and its inhibitor in asthmatic rats]
Asthma
[The effect of melatonin on the regulation of collagen accumulation and matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 mRNA and protein in a murine model of chronic asthma]
Asthma, Aspirin-Induced
Matrix metalloproteinase-9 promoter gene polymorphism (-1562C>T) in nasal polyposis.
Asthma, Occupational
A murine model of toluene diisocyanate-induced asthma can be treated with matrix metalloproteinase inhibitor.
Asthma, Occupational
Matrix metalloproteinase-9 increases in the sputum from allergic occupational asthma patients after specific inhalation challenge.
Astrocytoma
Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression.
Astrocytoma
Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells.
Astrocytoma
Differential proteomics analysis of low- and high-grade of astrocytoma using iTRAQ quantification.
Astrocytoma
Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion, and expression of matrix metalloproteinases.
Astrocytoma
Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro.
Astrocytoma
Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas.
Astrocytoma
Expression of matrix metalloproteinases and their inhibitors in human brain tumors.
Astrocytoma
Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.
Astrocytoma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Astrocytoma
Expression of the Annexin A1 and its correlation with matrix metalloproteinases and the receptor for formylated peptide-2 in diffuse astrocytic tumors.
Astrocytoma
Expression of timp-1, timp-2, 72-kda and 92-kda type-iv collagenase transcripts in human astrocytoma cell-lines - correlation with astrocytoma cell invasiveness.
Astrocytoma
Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-kappaB dependent pathway in human astrocytes.
Astrocytoma
Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells.
Astrocytoma
Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression.
Astrocytoma
Inhibition of matrix metalloproteinase-9 gene expression by an isoflavone metabolite, irisolidone in U87MG human astroglioma cells.
Astrocytoma
Intracellular signalings underlying bradykinin-induced matrix metalloproteinase-9 expression in rat brain astrocyte-1.
Astrocytoma
l-Glutamate in Middlebrook 7H9 culture medium upregulates matrix metalloproteinase-2 secretion from human astrocytoma cells.
Astrocytoma
Loss of Inhibitor of Growth (ING-4) Is Implicated in the Pathogenesis and Progression of Human Astrocytomas.
Astrocytoma
Matrix Metalloproteinase-9 Expression is Increased in Astrocytic Glioma and Associated with Prognosis of Patients.
Astrocytoma
Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas.
Astrocytoma
Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
Astrocytoma
Podocalyxin regulates astrocytoma cell invasion and survival against temozolomide.
Astrocytoma
Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China.
Astrocytoma
Radiation-induced blood-brain barrier damage in astrocytoma: relation to elevated gelatinase B and urokinase.
Astrocytoma
Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
Astrocytoma
Selective inhibition of MMP-9 gene expression by mangiferin in PMA-stimulated human astroglioma cells: involvement of PI3K/Akt and MAPK signaling pathways.
Astrocytoma
Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis.
Astrocytoma
The Effect of Sialic Acid on the Expression of miR-218, NF-kB, MMP-9, and TIMP-1.
Astrocytoma
The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells.
Astrocytoma
Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha.
Ataxia Telangiectasia
Ataxia-telangiectasia group D complementing gene (ATDC) upregulates matrix metalloproteinase 9 (MMP-9) to promote lung cancer cell invasion by activating ERK and JNK pathways.
Atherosclerosis
18F-FDG PET/MR-imaging in a Göttingen Minipig model of atherosclerosis: Correlations with histology and quantitative gene expression.
Atherosclerosis
4-Hydroxynonenal enhances MMP-9 production in murine macrophages via 5-lipoxygenase-mediated activation of ERK and p38 MAPK.
Atherosclerosis
7?-Hydroxycholesterol induces inflammation by enhancing production of chemokine (C-C motif) ligand 2.
Atherosclerosis
A decrease in the percentage of circulating mDC precursors in patients with coronary heart disease: a relation to the severity and extent of coronary artery lesions?
Atherosclerosis
Accurate targeting of activated macrophages based on synergistic activation of functional molecules uptake by scavenger receptor and matrix metalloproteinase.
Atherosclerosis
Activation of PPARalpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells.
Atherosclerosis
Aesculin inhibits matrix metalloproteinase-9 expression via p38 mitogen activated protein kinase and activator protein 1 in lipopolysachride-induced RAW264.7 cells.
Atherosclerosis
Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene.
Atherosclerosis
AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon ?.
Atherosclerosis
Association between Serum Vitamin D Concentration Status and Matrix Metalloproteinase-9 in Patients Undergoing Elective Percutaneous Coronary Intervention.
Atherosclerosis
Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the Framingham Offspring Study.
Atherosclerosis
Association of genetic polymorphisms in matrix metalloproteinase-9 and coronary artery disease in the chinese han population: a case-control study.
Atherosclerosis
Association of MMP-9 gene polymorphisms with acute coronary syndrome in the Uygur population of China.
Atherosclerosis
Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children.
Atherosclerosis
Beta-adrenoceptor Activation by Norepinephrine Enhances Lipopolysaccharide-induced Matrix Metalloproteinase-9 Expression Through the ERK/JNK-c-Fos Pathway in Human THP-1 Cells.
Atherosclerosis
Celecoxib combined with atorvastatin prevents progression of atherosclerosis.
Atherosclerosis
Chemokine Lkn-1/CCL15 enhances matrix metalloproteinase-9 release from human macrophages and macrophage-derived foam cells.
Atherosclerosis
Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice.
Atherosclerosis
Circulating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosis.
Atherosclerosis
Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions.
Atherosclerosis
Correlation of bacterial coinfection versus matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 expression in aortic aneurysm and atherosclerosis.
Atherosclerosis
Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity.
Atherosclerosis
Delphinidin suppresses PMA-induced MMP-9 expression by blocking the NF-?B activation through MAPK signaling pathways in MCF-7 human breast carcinoma cells.
Atherosclerosis
Dose-Effect of Irbesartan on Cyclooxygenase-2 and Matrix Metalloproteinase-9 Expression in Rabbit Atherosclerosis.
Atherosclerosis
Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors.
Atherosclerosis
Emodin inhibits tumor necrosis factor-?-induced migration and inflammatory responses in rat aortic smooth muscle cells.
Atherosclerosis
Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms.
Atherosclerosis
Epigallocatechin-3-Gallate Inhibits Matrix Metalloproteinase-9 and Monocyte Chemotactic Protein-1 Expression Through the 67-?Da Laminin Receptor and the TLR4/MAPK/NF-?B Signalling Pathway in Lipopolysaccharide-Induced Macrophages.
Atherosclerosis
Expression of toll-like receptor 4, tumor necrosis factor- alpha, matrix metalloproteinase-9 and effects of benazepril in patients with acute coronary syndromes.
Atherosclerosis
Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals.
Atherosclerosis
Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.
Atherosclerosis
Gelatinase B C(-1562)T polymorphism in relation to ischaemic heart disease.
Atherosclerosis
Ghrelin inhibits atherosclerotic plaque angiogenesis and promotes plaque stability in a rabbit atherosclerotic model.
Atherosclerosis
Glucocorticoid-induced tumour necrosis factor receptor family related protein (GITR) mediates inflammatory activation of macrophages that can destabilize atherosclerotic plaques.
Atherosclerosis
Group IVA phospholipase A2-associated production of MMP-9 in macrophages and formation of atherosclerotic lesions.
Atherosclerosis
Haplotype Analysis of the Stromelysin-1 (MMP3) and Gelatinase B (MMP9) Genes in Relation to Coronary Heart Disease.
Atherosclerosis
Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease.
Atherosclerosis
High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes.
Atherosclerosis
Human sLZIP promotes atherosclerosis via MMP-9 transcription and vascular smooth muscle cell migration.
Atherosclerosis
Impact of losartan and angiotensin II on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat vascular smooth muscle cells.
Atherosclerosis
Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects.
Atherosclerosis
In vitro modulation of peroxisome proliferator-activated receptor-gamma and its genes by C-reactive protein. Role of atorvastatin.
Atherosclerosis
Infection with human cytomegalovirus alters the MMP-9/TIMP-1 balance in human macrophages.
Atherosclerosis
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.
Atherosclerosis
Influence of gelatinase B polymorphic variants and its serum levels in atherosclerosis.
Atherosclerosis
Influence of Malondialdehyde and Matrix Metalloproteinase-9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic Syndrome.
Atherosclerosis
Inhibitory effect of recombinant human CXCL8(3-72)K11R/G31P on atherosclerotic plaques in a mouse model of atherosclerosis.
Atherosclerosis
Inhibitory effect of Zanthoxylum schinifolium on vascular smooth muscle proliferation.
Atherosclerosis
Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9.
Atherosclerosis
Interaction Between MMP-9 Gene Polymorphisms and Smoking in Relation to Myocardial Infarction in a Uighur Population.
Atherosclerosis
Interleukin 18 and extracellular matrix metalloproteinase inducer cross-regulation: implications in acute myocardial infarction.
Atherosclerosis
Interleukin-17 as a factor linking the pathogenesis of psoriasis with metabolic disorders.
Atherosclerosis
Intravenous immunoglobulin treatment for fibrosis, atherosclerosis, and malignant conditions.
Atherosclerosis
Investigation of RNA interference suppression of matrix metalloproteinase-9 in mouse model of atherosclerosis.
Atherosclerosis
Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis.
Atherosclerosis
Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis.
Atherosclerosis
Levels of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 mRNAs in Patients with Primary Hypertension or Hypertension-induced Atherosclerosis.
Atherosclerosis
Lipocalin-2 contributes to experimental atherosclerosis in a stage-dependent manner.
Atherosclerosis
Lithium chloride suppresses LPS-mediated matrix metalloproteinase-9 expression in macrophages through phosphorylation of GSK-3?.
Atherosclerosis
Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
Atherosclerosis
Macrophage-derived MMP-9 enhances the progression of atherosclerotic lesions and vascular calcification in transgenic rabbits.
Atherosclerosis
Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro.
Atherosclerosis
Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study.
Atherosclerosis
Matrix metallopeptidase 9 and placental growth factor may correlate with collateral status based on whole-brain perfusion combined with multiphase computed tomography angiography.
Atherosclerosis
Matrix metalloprotease-9 polymorphism and its association with Atherosclerosis - A case-control study in Pakistani population.
Atherosclerosis
Matrix metalloproteinase 9 a potential major player connecting atherosclerosis and osteoporosis in high fat diet fed rats.
Atherosclerosis
Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.
Atherosclerosis
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis.
Atherosclerosis
Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery.
Atherosclerosis
Matrix Metalloproteinases in Vascular Disease - A Potential Therapeutic Target?
Atherosclerosis
Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.
Atherosclerosis
Metalloproteinase-9 mRNA expression in monocytes from patients with chronic renal failure.
Atherosclerosis
microRNA-491-5p protects against atherosclerosis by targeting matrix metallopeptidase-9.
Atherosclerosis
MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(-/-)Apob(100/100) mouse.
Atherosclerosis
MMP-9 haplotypes and carotid artery atherosclerosis: an association study introducing a novel multicolour multiplex RealTime PCR protocol.
Atherosclerosis
MMP-9 inhibition by ACE inhibitor reduces oxidized LDL-mediated foam-cell formation.
Atherosclerosis
MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis.
Atherosclerosis
Modulation of cell signaling pathways by oxysterols in age-related human diseases.
Atherosclerosis
Neutrophil gelatinase-associated lipocalin as a risk marker in cardiovascular disease.
Atherosclerosis
No Association of Genetic Markers with Carotid Intimal Medial Thickness in ?-Thalassemia Major Patients.
Atherosclerosis
Non-Invasive Detection of Extracellular Matrix Metalloproteinase Inducer EMMPRIN, a New Therapeutic Target against Atherosclerosis, Inhibited by Endothelial Nitric Oxide.
Atherosclerosis
Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study.
Atherosclerosis
Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications.
Atherosclerosis
Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: implications for human atherosclerosis.
Atherosclerosis
Plaque Thrombosis is Reduced by Attenuating Plaque Inflammation with Pioglitazone and is Evaluated by Fluorodeoxyglucose Positron Emission Tomography.
Atherosclerosis
Possible Mechanisms of Di(2-ethylhexyl) Phthalate-Induced MMP-2 and MMP-9 Expression in A7r5 Rat Vascular Smooth Muscle Cells.
Atherosclerosis
Postprandial serum induces apoptosis in endothelial cells: Role of polymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity.
Atherosclerosis
Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease.
Atherosclerosis
Potential role of proteasome on c-jun related signaling in hypercholesterolemia induced atherosclerosis.
Atherosclerosis
Predictors of Cardiovascular Affection in Patients with Active Rheumatoid Arthritis: Secondary Analysis of a Randomized Controlled Trial.
Atherosclerosis
Regulations of the key mediators in inflammation and atherosclerosis by aspirin in human macrophages.
Atherosclerosis
Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
Atherosclerosis
Role of proinflammatory alleles in longevity and atherosclerosis: results of studies performed on -1562C/T MMP-9 in centenarians and myocardial infarction patients from Sicily.
Atherosclerosis
Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signalling pathways, Akt and Erk.
Atherosclerosis
Serum levels and polymorphisms of matrix metalloproteinases (MMPs) in carotid artery atherosclerosis: higher MMP-9 levels are associated with plaque vulnerability.
Atherosclerosis
Serum matrix metalloproteinase-9 is elevated in men with a history of myocardial infarction.
Atherosclerosis
Soluble CD40 ligand induces human coronary artery smooth muscle cells proliferation and migration.
Atherosclerosis
Synergistic enhancement of matrix metalloproteinase-9 expression and pro-inflammatory cytokines by influenza virus infection and oxidized-LDL treatment in human endothelial cells.
Atherosclerosis
Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling.
Atherosclerosis
The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: potential implication in hypertension.
Atherosclerosis
The expression of CD40-CD40L and activities of matrix metalloproteinases in atherosclerotic rats.
Atherosclerosis
The importance of defining serum MMP-9 concentration in diabetics as an early marker of the rupture of atheromatous plaque in acute coronary syndrome.
Atherosclerosis
The roles of p62/SQSTM1 on regulation of matrix metalloproteinase-9 gene expression in response to oxLDL in atherosclerosis.
Atherosclerosis
The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina.
Atherosclerosis
The Stimulation of CD147 Induces MMP-9 Expression through ERK and NF-kappaB in Macrophages: Implication for Atherosclerosis.
Atherosclerosis
Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosis.
Atherosclerosis
Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
Atherosclerosis
Transgenic expression of matrix metalloproteinase-9 modulates collagen deposition in a mouse model of atherosclerosis.
Atherosclerosis
Treatment of ?-thujaplicin counteracts di(2-ethylhexyl)phthalate (DEHP)-exposed vascular smooth muscle activation, inflammation and atherosclerosis progression.
Atherosclerosis
TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages.
Atherosclerosis
Wogonin suppresses TNF-alpha-induced MMP-9 expression by blocking the NF-kappaB activation via MAPK signaling pathways in human aortic smooth muscle cells.
Atherosclerosis
[Analysis of the gene polymorphism of matrix metalloproteinase-2 and -9 in patients with coronary heart disease]
Atherosclerosis
[Influence of periodontal therapy on serum interleukin-6 and carotid metalloproteinases in animals with chronic periodontitis associated with atherosclerosis].
Atherosclerosis
[Quantitative ultrasonic integrated backscatter of the intima-media complex, serum level of matrix metalloprotease-9 and simvastatin in hyperlipemia patients.]
Atherosclerosis
[THE ANALYSIS OF ASSOCIATION OF MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 WITH LEVEL OF ZINC IN DIFFERENT BIO SUBSTRATES IN PATIENTS WITH CAROTID STENOSIS].
Atrial Fibrillation
Association of MMP-9 gene polymorphisms with atrial fibrillation in hypertensive heart disease patients.
Atrial Fibrillation
Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation.
Atrial Fibrillation
Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
Atrial Fibrillation
Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation.
Atrial Fibrillation
Matrix metalloproteinase-9 gene polymorphisms are associated with ischemic stroke severity and early neurologic deterioration in patients with atrial fibrillation.
Atrial Fibrillation
Matrix metalloproteinase-9/tissue inhibitors of metalloproteinase-1 expression and atrial structural remodeling in a dog model of atrial fibrillation: inhibition with angiotensin-converting enzyme.
Atrial Fibrillation
Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study.
Atrial Fibrillation
The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation.
Atrial Fibrillation
Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
Atrial Fibrillation
[Effects of matrix metalloproteinase-9 and tissue inhibitor-1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation]
Atrial Fibrillation
[Expression and significance of matrix metalloproteinase-1,9, tissue inhibitor of metalloproteinase-4 and extracellular matrix metalloproteinase inducer in the myocardium of congestive heart failure in patients with rheumatic heart diseases.]
Atrial Fibrillation
[The participation of matrix metalloproteinases-9 and TIMP-1 in formation of atrial fibrillation paroxisms in patients with metabolic syndrome].
Autoimmune Diseases
A novel rationale for inhibition of gelatinase B in multiple sclerosis: MMP-9 destroys alpha B-crystallin and generates a promiscuous T cell epitope.
Autoimmune Diseases
Association Study of MMP-9 -1562C/T Gene Polymorphism with Susceptibility to Multiple Autoimmune Diseases: A Meta-analysis.
Autoimmune Diseases
Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
Autoimmune Diseases
Blocking Matrix Metalloproteinase-9 Abrogates Collagen-Induced Arthritis via Inhibiting Dendritic Cell Migration.
Autoimmune Diseases
Bullous pemphigoid outcome is associated with CXCL10-induced MMP-9 secretion from monocytes and neutrophils but not lymphocytes.
Autoimmune Diseases
Circulating Matrix Metalloproteinase-9 Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis.
Autoimmune Diseases
Elevated matrix metalloproteinase-9 in patients with systemic sclerosis.
Autoimmune Diseases
Extracellular vesicles from human umbilical cord blood plasma modulate interleukin-2 signaling of T cells to ameliorate experimental autoimmune encephalomyelitis.
Autoimmune Diseases
Flow cytometric analysis of gelatinase B (MMP-9) activity using immobilized fluorescent substrate on microspheres.
Autoimmune Diseases
Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9/gelatinase B.
Autoimmune Diseases
Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
Autoimmune Diseases
Tear Matrix Metalloproteinases and Myeloperoxidase Levels in Patients With Boston Keratoprosthesis Type I.
Autoimmune Diseases
Transcriptional Activation of Human Matrix Metalloproteinase-9 Gene Expression by Multiple Co-activators.
Autoimmune Lymphoproliferative Syndrome
Deficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune disease.
Azoospermia
Quantitative differences in matrix metalloproteinase (MMP)-2, but not in MMP-9, tissue inhibitor of metalloproteinase (TIMP)-1 or TIMP-2, in seminal plasma of normozoospermic and azoospermic patients.
Bacteremia
Potential Co-Relation Between Chronic Periodontitis And Cancer - An Emerging Concept.
Bacterial Infections
Conjunctival expression of matrix metalloproteinase and pro-inflammatory cytokine genes following trichiasis surgery.
Bacterial Infections
Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection.
Barrett Esophagus
Expression of metalloproteinase-9 in patients with mild and severe forms of gastroesophageal reflux disease.
Behcet Syndrome
The determination of matrix metalloproteinase 9 activity and gene expression levels in Behcet's disease patients with aneurysmal complications.
beta-Thalassemia
Association of thalassemia major and gingival inflammation: A pilot study.
beta-Thalassemia
No Association of Genetic Markers with Carotid Intimal Medial Thickness in ?-Thalassemia Major Patients.
Bicuspid Aortic Valve Disease
Differential expression of MMP-2, MMP-9 and TIMP proteins in thoracic aortic aneurysm - comparison with and without bicuspid aortic valve: a meta-analysis.
Bicuspid Aortic Valve Disease
Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves.
Bicuspid Aortic Valve Disease
Tissue microarray detection of matrix metalloproteinases, in diseased tricuspid and bicuspid aortic valves with or without pathology of the ascending aorta.
Bile Duct Diseases
Expression of RECK gene and MMP-9 in hilar cholangiocarcinoma and its clinical significance.
Bile Duct Neoplasms
High expression of MMP-9 is associated with better prognosis in extrahepatic bile duct cancer patients.
Bile Duct Neoplasms
High expression of MMP-9 is associated with better prognosis in extrahepatic bile duct cancer.
Biliary Tract Diseases
Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.
Biliary Tract Neoplasms
Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination.
Blast Crisis
Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cells.
Blast Crisis
Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Blepharitis
In vivo characterization of doxycycline effects on tear metalloproteinases in patients with chronic blepharitis.
Blepharitis
Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular disorders.
Blister
A case of anaphylactoid purpura with multiple blister formation: possible pathophysiological role of gelatinase (MMP-9).
Blister
Effect of Qingguangan on the expressions of MMP-2 and MMP-9 in filtering bleb after trabeculectomy in rabbits.
Blister
Histopathological and Molecular Changes in the Rabbit Cornea From Arsenical Vesicant Lewisite Exposure.
Blister
Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid.
Blister
Increased levels of matrix metalloproteinase-9 and interleukin-8 in blister fluids of dystrophic and junctional epidermolysis bullosa patients.
Blister
Influence of aging, localization, glucocorticoids and isotretinoin on matrix metalloproteases 2 (MMP-2) and 9 (MMP-9) in suction blister fluids.
Blister
Matrix metalloproteinase gelatinase B (MMP-9) is associated with leaking glaucoma filtering blebs.
Blister
Matrix metalloproteinases (MMP-1, MMP-2, MMP-3 and MMP-9, and TIMP-1, TIMP-2 and TIMP-3) and markers for vascularization in functioning and non-functioning bleb capsules of glaucoma drainage implants.
Blister
Matrix- metalloproteinase -2, -8 and -9 in serum and skin blister fluid in patients with severe sepsis.
Blister
MMP expression in leaking filtering blebs and tears after glaucoma filtering surgery.
Blister
MMP-9 and CXCL8/IL-8 are potential therapeutic targets in epidermolysis bullosa simplex.
Blister
Modulation of skin collagen metabolism by irradiation: collagen synthesis is increased in irradiated human skin.
Blister
Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
Blister
Selective up-regulation of matrix metalloproteinase-9 expression in human erythema migrans skin lesions of acute lyme disease.
Blister
Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds.
Bone Cysts
Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions.
Bone Diseases
A murine model of myeloma that allows genetic manipulation of the host microenvironment.
Bone Diseases
Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.
Bone Diseases
Inhibitory effects of sodium pentosan polysulfate on formation and function of osteoclasts derived from canine bone marrow.
Bone Diseases
MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.
Bone Diseases
Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma.
Bone Diseases
Simvastatin, an HMG-CoA reductase inhibitor, reduced the expression of matrix metalloproteinase-9 (Gelatinase B) in osteoblastic cells and HT1080 fibrosarcoma cells.
Bone Diseases
Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease.
Bone Diseases
Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro.
Bone Diseases
Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma.
Bone Diseases, Metabolic
Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.
Bone Diseases, Metabolic
Interrelationship of Circulating Matrix Metalloproteinase-9, TNF-a, and OPG/RANK/RANKL Systems in COPD Patients with Osteoporosis.
Bone Resorption
(+)-Vitisin A inhibits osteoclast differentiation by preventing TRAF6 ubiquitination and TRAF6-TAK1 formation to suppress NFATc1 activation.
Bone Resorption
Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function.
Bone Resorption
Activation of the PGC-1?/NFATc-1 Pathway in Circulating Osteoclast Precursors Associated with Bone Destruction in Rheumatoid Arthritis.
Bone Resorption
Basigin-2 upregulated by receptor activator of NF-?B ligand enhances lung cancer-induced osteolytic lesions.
Bone Resorption
CCL3 and MMP-9 are induced by TL1A during death receptor 3 (TNFRSF25)-dependent osteoclast function and systemic bone loss.
Bone Resorption
Chemerin Treatment Inhibits the Growth and Bone Invasion of Breast Cancer Cells.
Bone Resorption
Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.
Bone Resorption
Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
Bone Resorption
CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients.
Bone Resorption
Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
Bone Resorption
Deletion of FGFR3 in Osteoclast Lineage Cells Results in Increased Bone Mass in Mice by Inhibiting Osteoclastic Bone Resorption.
Bone Resorption
Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development.
Bone Resorption
Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone.
Bone Resorption
Effect of Low Intensity Laser Therapy (LILT) on MMP-9 expression in gingival crevicular fluid and rate of orthodontic tooth movement in patients undergoing canine retraction: A randomized controlled trial.
Bone Resorption
Effect of zoledronic acid on incorporation of a bioceramic bone graft substitute.
Bone Resorption
Effects of 1?,25-(OH)2D3 on the formation and activity of osteoclasts in RAW264.7 cells.
Bone Resorption
Effects of geraniin on osteoclastic bone resorption and matrix metalloproteinase-9 expression.
Bone Resorption
Effects of theaflavins on tissue inflammation and bone resorption on experimental periodontitis in rats.
Bone Resorption
EGF and IL-1 alpha modulate the release of collagenase, gelatinase and TIMP-1 as well as the release of calcium by rabbit calvarial bone explants.
Bone Resorption
Expression of matrix metalloproteinase-9 mRNA and protein during deciduous tooth resorption in bovine odontoclasts.
Bone Resorption
Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis.
Bone Resorption
Expression of MMP-2, 9 and 13 in newly formed bone after sinus augmentation using inorganic bovine bone in human.
Bone Resorption
Fengshi Qutong capsule ameliorates bone destruction of experimental rheumatoid arthritis by inhibiting osteoclastogenesis.
Bone Resorption
Fluoride decreased osteoclastic bone resorption through the inhibition of NFATc1 gene expression.
Bone Resorption
Fucoxanthin Suppresses Osteoclastogenesis via Modulation of MAP Kinase and Nrf2 Signaling.
Bone Resorption
Human breast adenocarcinoma (MDA-231) and human lung squamous cell carcinoma (Hara) do not have the ability to cause bone resorption by themselves during the establishment of bone metastasis.
Bone Resorption
IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.
Bone Resorption
Inhibition Effect of Zoledronate on the Osteoclast Differentiation of RAW264.7 Induced by Titanium Particles.
Bone Resorption
Inhibition of osteoclast differentiation and bone resorption by N-methylpyrrolidone.
Bone Resorption
Inhibitory Effect of Cudratrixanthone U on RANKL-Induced Osteoclast Differentiation and Function in Macrophages and BMM Cells.
Bone Resorption
Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts.
Bone Resorption
Inhibitory effects of sodium pentosan polysulfate on formation and function of osteoclasts derived from canine bone marrow.
Bone Resorption
Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption.
Bone Resorption
Mast cells and MMP-9 in the lamina propria during eruption of rat molars: quantitative and immunohistochemical evaluation.
Bone Resorption
Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.
Bone Resorption
Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones.
Bone Resorption
Matrix metalloproteinase-9 (mmp-9) expression in different subtypes of ameloblastoma.
Bone Resorption
MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration.
Bone Resorption
Morphologic evaluation and expression of matrix metalloproteinases-2 and 9 and nitric oxide during experimental periodontal disease in rat.
Bone Resorption
Natural products for treatment of bone erosive diseases: The effects and mechanisms on inhibiting osteoclastogenesis and bone resorption.
Bone Resorption
Nicotine affects bone resorption and suppresses the expression of cathepsin K, MMP-9 and vacuolar-type H(+)-ATPase d2 and actin organization in osteoclasts.
Bone Resorption
Osteoclast precursors acquire sensitivity to breast cancer derived factors early in differentiation.
Bone Resorption
Parathyroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B.
Bone Resorption
Porphyromonas gingivalis decreases osteoblast proliferation through IL-6-RANKL/OPG and MMP-9/TIMPs pathways.
Bone Resorption
Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss.
Bone Resorption
Radiation alters osteoclastogenesis by regulating the cytoskeleton and lytic enzymes in RAW 264.7 cells and mouse bone marrow-derived macrophages.
Bone Resorption
Regulation of matrix metalloproteinase-9 protein expression by 1?, 25-(OH)?D? during osteoclast differentiation.
Bone Resorption
Retinoic acid induces two osteocalcin isoforms and inhibits markers of osteoclast activity in Atlantic cod (Gadus morhua) ex vivo cultured craniofacial tissues.
Bone Resorption
SDF-1 increases recruitment of osteoclast precursors by upregulation of matrix metalloproteinase-9 activity.
Bone Resorption
Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration.
Bone Resorption
Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.
Bone Resorption
Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease.
Bone Resorption
The Antiosteoporosis Effects of Zhuanggu Guanjie Pill In Vitro and In Vivo.
Bone Resorption
The role of RANKL and MMP-9 in the bone resorption caused by ameloblastoma.
Bone Resorption
The synthetic triterpenoid TP-222 inhibits RANKL stimulation of osteoclastogenesis and matrix metalloproteinase-9 expression.
Bone Resorption
Timp-1, -2 and -3 show coexpression with gelatinases A and B during mouse tooth morphogenesis.
Bone Resorption
TNF-?-induced IL-6 and MMP-9 expression in immortalized ameloblastoma cell line established by hTERT.
Bone Resorption
Transmembrane protein 173 inhibits RANKL-induced osteoclast differentiation.
Bone Resorption
Ultrastructural and cytobiological studies on possible interactions between PTHrP-secreting tumor cells, stromal cells, and bone cells.
Bone Resorption
Wnt signaling pathway inhibitors as promising diagnostic serum markers of osteolytic bone metastasis.
Bone Resorption
[Potential mechanism of transcription factor peroxisome proliferator-activated receptor-gamma coactivator-1 beta on promoting osteoclastogenesis].
Bowen's Disease
Cutaneous carcinomas and preinvasive neoplastic lesions. Role of MMP-2 and MMP-9 metalloproteinases in neoplastic invasion and their relationship with proliferative activity and p53 expression.
Bowen's Disease
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
Bowen's Disease
Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
Brain Concussion
Extending the Calpain-Cathepsin Hypothesis to the Neurovasculature: Protection of Brain Endothelial Cells and Mice from Neurotrauma.
Brain Concussion
Matrix Metalloproteinase 9 and Osteopontin Interact to Support Synaptogenesis in the Olfactory Bulb after Mild Traumatic Brain Injury.
Brain Contusion
Brain contusions induce a strong local overexpression of MMP-9. Results of a pilot study.
Brain Contusion
Increases in matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 mRNA after cerebral contusion and depolarisation.
Brain Contusion
Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats.
Brain Diseases
c-Src/Jak2/PDGFR/PKC?-Dependent MMP-9 Induction Is Required for Thrombin-Stimulated Rat Brain Astrocytes Migration.
Brain Diseases
Calmodulin kinase II-dependent transactivation of PDGF receptors mediates astrocytic MMP-9 expression and cell motility induced by lipoteichoic acid.
Brain Diseases
Comparison of the levels of human herpesvirus 6 (HHV-6) DNA and cytokines in the cerebrospinal fluid and serum of children with HHV-6 encephalopathy.
Brain Diseases
Development of Brain Targeting Peptide Based MMP-9 Inhibiting Nanoparticles for the Treatment of Brain Diseases with Elevated MMP-9 Activity.
Brain Diseases
HIV-1 gp120 upregulates matrix metalloproteinases and their inhibitors in a rat model of HIV encephalopathy.
Brain Diseases
Human Herpesvirus 6-Associated Encephalopathy in a Child with Dravet Syndrome.
Brain Diseases
Increase of tumor necrosis factor-alpha in the blood induces early activation of matrix metalloproteinase-9 in the brain.
Brain Diseases
Increased MMP-9 and TIMP-1 in mouse neonatal brain and plasma and in human neonatal plasma after hypoxia-ischemia: a potential marker of neonatal encephalopathy.
Brain Diseases
Lipoteichoic Acid Induces Matrix Metalloproteinase-9 Expression via Transactivation of PDGF Receptors and NF-kappaB Activation in Rat Brain Astrocytes.
Brain Diseases
Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy.
Brain Diseases
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Brain Diseases
NADPH oxidase-mediated redox signal contributes to lipoteichoic acid-induced MMP-9 upregulation in brain astrocytes.
Brain Diseases
Neuronal self-injury mediated by IL-1? and MMP-9 in a cerebral palsy model of severe neonatal encephalopathy induced by immune activation plus hypoxia-ischemia.
Brain Diseases
Neuroprotective effects of hypothermia in inflammatory-sensitized hypoxic-ischemic encephalopathy.
Brain Diseases
Oxidized Low-Density Lipoprotein-Induced Matrix Metalloproteinase-9 Expression via PKC-delta/p42/p44 MAPK/Elk-1 Cascade in Brain Astrocytes.
Brain Diseases
Role of Matrix Metalloproteinase-9 in Neonatal Hypoxic-Ischemic Encephalopathy.
Brain Diseases
Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures.
Brain Diseases
Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy.
Brain Diseases
Thrombin Enhanced Matrix Metalloproteinase-9 Expression and Migration of SK-N-SH Cells via PAR-1, c-Src, PYK2, EGFR, Erk1/2 and AP-1.
Brain Diseases
Thrombin/Matrix Metalloproteinase-9-Dependent SK-N-SH Cell Migration is Mediated Through a PLC/PKC/MAPKs/NF-?B Cascade.
Brain Diseases
Up-regulation of ROS-Dependent Matrix Metalloproteinase-9 from High-Glucose-Challenged Astrocytes Contributes to the Neuronal Apoptosis.
Brain Edema
20-HETE Inhibition by HET0016 Decreases the Blood-Brain Barrier Permeability and Brain Edema After Traumatic Brain Injury.
Brain Edema
A TrkB receptor agonist N-acetyl serotonin provides cerebral protection after traumatic brain injury by mitigating apoptotic activation and autophagic dysfunction.
Brain Edema
Association of Matrix Metalloproteinase 9 and Cellular Fibronectin and Outcome in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Brain Edema
Astaxanthin reduces matrix metalloproteinase-9 expression and activity in the brain after experimental subarachnoid hemorrhage in rats.
Brain Edema
Astragaloside IV reduces cerebral edema post-ischemia/reperfusion correlating the suppression of MMP-9 and AQP4.
Brain Edema
Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage.
Brain Edema
Attenuated Blood-Brain Barrier Dysfunction by XQ-1H Following Ischemic Stroke in Hyperlipidemic Rats.
Brain Edema
Blockage of transient receptor potential vanilloid 4 inhibits brain edema in middle cerebral artery occlusion mice.
Brain Edema
Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats.
Brain Edema
Chlorogenic acid ameliorates brain damage and edema by inhibiting matrix metalloproteinase-2 and 9 in a rat model of focal cerebral ischemia.
Brain Edema
Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage.
Brain Edema
Deficiency of tenascin-C and attenuation of blood-brain barrier disruption following experimental subarachnoid hemorrhage in mice.
Brain Edema
Dexamethasone inhibits ICAM-1 and MMP-9 expression and reduces brain edema in intracerebral hemorrhagic rats.
Brain Edema
Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure.
Brain Edema
Early Combined Therapy with Pharmacologically Induced Hypothermia and Edaravone Exerts Neuroprotective Effects in a Rat Model of Intracerebral Hemorrhage.
Brain Edema
Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs.
Brain Edema
Effect of Baicalin on Matrix Metalloproteinase-9 Expression and Blood-Brain Barrier Permeability Following Focal Cerebral Ischemia in Rats.
Brain Edema
Effect of Propofol Post-treatment on Blood-Brain Barrier Integrity and Cerebral Edema After Transient Cerebral Ischemia in Rats.
Brain Edema
Effects of atorvastatin on pathological changes in brain tissue and plasma MMP-9 in rats with intracerebral hemorrhage.
Brain Edema
Effects of focal mild hypothermia on thrombin-induced brain edema formation and the expression of protease activated receptor-1, matrix metalloproteinase-9 and aquaporin 4 in rats.
Brain Edema
Effects of oxiracetam combined with ginkgo biloba extract in the treatment of acute intracerebral hemorrhage: A clinical study.
Brain Edema
Expression of matrix metalloproteinse-9 in thrombin-induced brain edema formation in rats.
Brain Edema
Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema.
Brain Edema
Favorable effects of MMP-9 knockdown in murine herpes simplex encephalitis using small interfering RNA.
Brain Edema
Fullerenol Nanoparticles Decrease Blood-Brain Barrier Interruption and Brain Edema during Cerebral Ischemia-Reperfusion Injury Probably by Reduction of Interleukin-6 and Matrix Metalloproteinase-9 Transcription.
Brain Edema
Ginsenoside Rd attenuates blood-brain barrier damage by suppressing proteasome-mediated signaling after transient forebrain ischemia.
Brain Edema
Human cerebral microvessel endothelial cell culture as a model system to study the blood-brain interface in ischemic/hypoxic conditions.
Brain Edema
Hydrogen sulfide attenuates brain edema in early brain injury after subarachnoid hemorrhage in rats: Possible involvement of MMP-9 induced blood-brain barrier disruption and AQP4 expression.
Brain Edema
Hydrogen sulfide attenuates hyperhomocysteinemia-induced blood-brain barrier permeability by inhibiting MMP-9.
Brain Edema
Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy.
Brain Edema
Increase of tumor necrosis factor-alpha in the blood induces early activation of matrix metalloproteinase-9 in the brain.
Brain Edema
Interleukin-10 mediates the neuroprotection of hyperbaric oxygen therapy against traumatic brain injury in mice.
Brain Edema
Involvement of the p38 MAPK signaling pathway in overexpression of matrix metalloproteinase-9 during the course of brain edema in 1,2-dichloroethane-intoxicated mice.
Brain Edema
Lipoxin A4 Methyl Ester Reduces Early Brain Injury by Inhibition of the Nuclear Factor Kappa B (NF-?B)-Dependent Matrix Metallopeptidase 9 (MMP-9) Pathway in a Rat Model of Intracerebral Hemorrhage.
Brain Edema
MAP4K4 induces early blood-brain barrier damage in a murine subarachnoid hemorrhage model.
Brain Edema
Matrix Metalloproteinase Expression in Contusional Traumatic Brain Injury: A Paired Microdialysis Study.
Brain Edema
Matrix metalloproteinase inhibition attenuates brain edema after surgical brain injury.
Brain Edema
MATRIX METALLOPROTEINASE INHIBITION ATTENUATES BRAIN EDEMA IN AN IN VIVO MODEL OF SURGICALLY-INDUCED BRAIN INJURY.
Brain Edema
Matrix metalloproteinase inhibition attenuates brain edema in an in vivo model of surgically-induced brain injury.
Brain Edema
MATRIX METALLOPROTEINASE INHIBITION ATTENUATES BRAIN EDEMA IN AN IN VIVO MODEL OF SURGICALLY-INDUCED BRAIN INJURY.
Brain Edema
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in early focal cerebral infarction following urokinase thrombolysis in rats.
Brain Edema
Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice.
Brain Edema
Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke.
Brain Edema
Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats.
Brain Edema
Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement.
Brain Edema
Mdivi-1 ameliorates early brain injury after subarachnoid hemorrhage via the suppression of inflammation-related blood-brain barrier disruption and endoplasmic reticulum stress-based apoptosis.
Brain Edema
Melanocortin MC4 receptor agonists alleviate brain damage in abdominal compartment syndrome in the rat.
Brain Edema
Melatonin Preserves Blood-Brain Barrier Integrity and Permeability via Matrix Metalloproteinase-9 Inhibition.
Brain Edema
Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
Brain Edema
MicroRNA-132 attenuates cerebral injury by protecting blood-brain-barrier in MCAO mice.
Brain Edema
Neuroinflammatory Reactions in the Brain of 1,2-DCE-Intoxicated Mice during Brain Edema.
Brain Edema
Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke.
Brain Edema
Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
Brain Edema
Novel effect of Daflon and low-dose ?-radiation in modulation of thioacetamide-induced hepatic encephalopathy in male albino rats.
Brain Edema
Osteopontin attenuates inflammation via JAK2/STAT1 pathway in hyperglycemic rats after intracerebral hemorrhage.
Brain Edema
Parecoxib exhibits anti-inflammatory and neuroprotective effects in a rat model of transient global cerebral ischemia.
Brain Edema
Peripheral thermal injury causes blood-brain barrier dysfunction and matrix metalloproteinase (MMP) expression in rat.
Brain Edema
Phosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA.
Brain Edema
Potential contribution of hypoxia-inducible factor-1?, aquaporin-4, and matrix metalloproteinase-9 to blood-brain barrier disruption and brain edema after experimental subarachnoid hemorrhage.
Brain Edema
Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date.
Brain Edema
Progesterone attenuates cerebral edema in neonatal rats with hypoxic-ischemic brain damage by inhibiting the expression of matrix metalloproteinase-9 and aquaporin-4.
Brain Edema
Progesterone attenuates early brain injury after subarachnoid hemorrhage in rats.
Brain Edema
Protective Effect of Anthocyanin on Neurovascular Unit in Cerebral Ischemia/Reperfusion Injury in Rats.
Brain Edema
Protective effects of recombinant osteopontin on early brain injury after subarachnoid hemorrhage in rats*
Brain Edema
Reduced Severity of Outcome of Recurrent Ipsilateral Transient Cerebral Ischemia Compared with Contralateral Transient Cerebral Ischemia in Rats.
Brain Edema
Role of c-Jun N-terminal kinase in early brain injury after subarachnoid hemorrhage.
Brain Edema
Role of VEGF and matrix metalloproteinase-9 in peritumoral brain edema associated with supratentorial benign meningiomas.
Brain Edema
Rutin improves functional outcome via reducing the elevated matrix metalloproteinase-9 level in a photothrombotic focal ischemic model of rats.
Brain Edema
Silencing matrix metalloproteinase 9 exerts a protective effect on astrocytes after oxygen-glucose deprivation and is correlated with suppression of aquaporin-4.
Brain Edema
SIRT1 inhibition by sirtinol aggravates brain edema after experimental subarachnoid hemorrhage.
Brain Edema
Subtle BBB alterations in brain edema associated with acute liver failure.
Brain Edema
TGF?1 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5.
Brain Edema
The effect of captopril on the expression of MMP-9 and the prognosis of neurological function in herpes simplex encephalitis mice.
Brain Edema
The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: contribution of TSG-6.
Brain Edema
The role of hypoxia-inducible factor-1?, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury.
Brain Edema
The role of p53 in brain edema after 24 h of experimental subarachnoid hemorrhage in a rat model.
Brain Edema
The roles of MMP-9/TIMP-1 in cerebral edema following experimental acute cerebral infarction in rats.
Brain Edema
Thrombopoietin could protect cerebral tissue against ischemia-reperfusion injury by suppressing NF-?B and MMP-9 expression in rats.
Brain Edema
Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
Brain Edema
von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage.
Brain Edema
Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke.
Brain Edema
[Blocking ERK signaling pathway lowers MMP-9 expression to alleviate brain edema after traumatic brain injury in rats].
Brain Edema
[Blocking p38 signal pathway lowers MMP-9 expression and reduces brain edema in rats with traumatic brain injury].
Brain Edema
[Effects of Liangxue Tongyu Formula on brain edema and expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with intracerebral hemorrhage.]
Brain Edema
[Exploration of the effect of inhibitor of matrix metalloproteinase-9 on blood brain barrier in cardiopulmonary resuscitation in rats]
Brain Edema
[Protective effect of jiedu tongluo injection on cerebral edema in rats with lesion of cerebral ischemia/reperfusion].
Brain Edema
[Study on expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in brain tissue adjacent to hemorrhage after brain hemorrhage in human]
Brain Edema
[Study on the expression and the role of macrophage migration inhibitory factor in the brain of neonatal rats with hypoxia-ischemia brain damage].
Brain Infarction
A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke.
Brain Infarction
Delayed progesterone treatment reduces brain infarction and improves functional outcomes after ischemic stroke: a time-window study in middle-aged rats.
Brain Infarction
Exercise pre-conditioning reduces brain inflammation in stroke via tumor necrosis factor-alpha, extracellular signal-regulated kinase 1/2 and matrix metalloproteinase-9 activity.
Brain Infarction
Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice.
Brain Infarction
Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice.
Brain Infarction
Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke.
Brain Infarction
Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats.
Brain Infarction
Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia.
Brain Infarction
Neuron-Specific Enolase and Matrix Metalloproteinase 9 Signal Perioperative Silent Brain Infarction During or After Transcatheter Aortic Valve Implantation.
Brain Infarction
Partial Intra-Aortic Occlusion Improves Perfusion Deficits and Infarct Size Following Focal Cerebral Ischemia.
Brain Infarction
Peripheral blood levels of matrix metalloproteinase-9 predict lesion volume in acute stroke.
Brain Infarction
Structural change and degradation of cytoskeleton due to the acrolein conjugation with vimentin and actin during brain infarction.
Brain Infarction
Thrombopoietin protects the brain and improves sensorimotor functions: reduction of stroke-induced MMP-9 upregulation and blood-brain barrier injury.
Brain Injuries
A Lipoxin A(4) Analog Ameliorates Blood-Brain Barrier Dysfunction and Reduces MMP-9 Expression in a Rat Model of Focal Cerebral Ischemia-Reperfusion Injury.
Brain Injuries
A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke.
Brain Injuries
A therapeutic target of cerebral hemorrhagic stroke: matrix metalloproteinase-9.
Brain Injuries
Activation of cerebral recovery by matrix metalloproteinase-9 after intracerebral hemorrhage.
Brain Injuries
Astaxanthin reduces matrix metalloproteinase-9 expression and activity in the brain after experimental subarachnoid hemorrhage in rats.
Brain Injuries
Brain injury biomarkers in the setting of cardiac surgery: Still a world to explore.
Brain Injuries
Carbohydrate source influences gelatinase production by mouse astrocytes in vitro.
Brain Injuries
CD47 gene knockout protects against transient focal cerebral ischemia in mice.
Brain Injuries
Certain forms of matrix metalloproteinase-9 accumulate in the extracellular space after microdialysis probe implantation and middle cerebral artery occlusion/reperfusion.
Brain Injuries
Clusters of cortical spreading depolarizations in a patient with intracerebral hemorrhage: a multimodal neuromonitoring study.
Brain Injuries
Comparison of effects of propofol versus sevoflurane for patients undergoing cardiopulmonary bypass cardiac surgery.
Brain Injuries
Critical role of matrix metalloprotease-9 in chronic high fat diet-induced cerebral vascular remodelling and increase of ischaemic brain injury in mice.
Brain Injuries
Cyclosporine A alleviated matrix metalloproteinase 9 associated blood-brain barrier disruption after subarachnoid hemorrhage in mice.
Brain Injuries
Delayed administration of a matrix metalloproteinase inhibitor limits progressive brain injury after hypoxia-ischemia in the neonatal rat.
Brain Injuries
Development of Brain Targeting Peptide Based MMP-9 Inhibiting Nanoparticles for the Treatment of Brain Diseases with Elevated MMP-9 Activity.
Brain Injuries
DL-3n-Butylphthalide Improves Blood-Brain Barrier Integrity in Rat After Middle Cerebral Artery Occlusion.
Brain Injuries
Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury.
Brain Injuries
Dymanics of matrix-metalloproteinase 9 after brain trauma--results of a pilot study.
Brain Injuries
Dynamics of MMP?9, MMP?2 and TIMP?1 in a rat model of brain injury combined with traumatic heterotopic ossification.
Brain Injuries
Early activation of matrix metalloproteinase-9 is associated with blood-brain barrier disruption after photothrombotic cerebral ischemia in rats.
Brain Injuries
Early Exercise Protects the Blood-Brain Barrier from Ischemic Brain Injury via the Regulation of MMP-9 and Occludin in Rats.
Brain Injuries
Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse.
Brain Injuries
Effects of atorvastatin on pathological changes in brain tissue and plasma MMP-9 in rats with intracerebral hemorrhage.
Brain Injuries
Elevated Peripheral Neutrophils and Matrix Metalloproteinase 9 as Biomarkers of Functional Outcome Following Subarachnoid Hemorrhage.
Brain Injuries
Endothelin-1 enhances cell migration via matrix metalloproteinase-9 up-regulation in brain astrocytes.
Brain Injuries
Ergosta-7,9(11),22-trien-3?-ol Alleviates Intracerebral Hemorrhage-Induced Brain Injury and BV-2 Microglial Activation.
Brain Injuries
Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke.
Brain Injuries
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants.
Brain Injuries
High Glucose Induces Reactive Oxygen Species-Dependent Matrix Metalloproteinase-9 Expression and Cell Migration in Brain Astrocytes.
Brain Injuries
Hydrogen sulfide attenuates brain edema in early brain injury after subarachnoid hemorrhage in rats: Possible involvement of MMP-9 induced blood-brain barrier disruption and AQP4 expression.
Brain Injuries
Hyperbaric Oxygen via Mediating SIRT1-Induced Deacetylation of HMGB1 Improved Cerebral Ischemia/Reperfusion injury.
Brain Injuries
Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke.
Brain Injuries
Increases in matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 mRNA after cerebral contusion and depolarisation.
Brain Injuries
Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis.
Brain Injuries
Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatment.
Brain Injuries
Lentivirus-mediated transfer of MMP-9 shRNA provides neuroprotection following focal ischemic brain injury in rats.
Brain Injuries
Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia.
Brain Injuries
Lipoxin A4 Methyl Ester Reduces Early Brain Injury by Inhibition of the Nuclear Factor Kappa B (NF-?B)-Dependent Matrix Metallopeptidase 9 (MMP-9) Pathway in a Rat Model of Intracerebral Hemorrhage.
Brain Injuries
Matrix metalloproteinase 9 inhibition reduces early brain injury in cortex after subarachnoid hemorrhage.
Brain Injuries
Matrix metalloproteinase 9 regulates cell death following pilocarpine-induced seizures in the developing brain.
Brain Injuries
Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
Brain Injuries
Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice.
Brain Injuries
Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion.
Brain Injuries
Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke.
Brain Injuries
Matrix Metalloproteinase-9 Mediates the Deleterious Effects of ?2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.
Brain Injuries
Matrix metalloproteinase-9 potentiates early brain injury after subarachnoid hemorrhage.
Brain Injuries
Melanocortin MC4 receptor agonists alleviate brain damage in abdominal compartment syndrome in the rat.
Brain Injuries
Microglia/Macrophage-Derived Inflammatory Mediators Galectin-3 and Quinolinic Acid are Elevated in Cerebrospinal Fluid from Newborn Infants After Birth Asphyxia.
Brain Injuries
Microvascular thrombosis, fibrinolysis, ischemic injury, and death after cerebral thromboembolism are affected by levels of circulating ?2-antiplasmin.
Brain Injuries
Minocycline protects against delayed cerebral ischemia after subarachnoid hemorrhage via matrix metalloproteinase-9 inhibition.
Brain Injuries
Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice.
Brain Injuries
MMP-9 expression and activity is concurrent with endothelial cell apoptosis in the basilar artery after subarachnoid hemorrhaging in rats.
Brain Injuries
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Brain Injuries
Molecular pathology of pulmonary edema after injury in forensic autopsy cases.
Brain Injuries
Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage.
Brain Injuries
Neuroprotective effects of hypothermia in inflammatory-sensitized hypoxic-ischemic encephalopathy.
Brain Injuries
Oxidized low-density lipoprotein induces matrix metalloproteinase-9 expression via a p42/p44 and JNK-dependent AP-1 pathway in brain astrocytes.
Brain Injuries
Physiologic variations in blood plasminogen levels affect outcomes after acute cerebral thromboembolism in mice: a pathophysiologic role for microvascular thrombosis.
Brain Injuries
PPARgamma agonist pioglitazone reduces matrix metalloproteinase-9 activity and neuronal damage after focal cerebral ischemia.
Brain Injuries
Protective effect of ginsenoside Rb1 on integrity of blood-brain barrier following cerebral ischemia.
Brain Injuries
Recombinant Osteopontin Attenuates Brain Injury after Intracerebral Hemorrhage in Mice.
Brain Injuries
Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.
Brain Injuries
Role of matrix metalloproteinase-9 in apoptosis of hippocampal neurons in rats during early brain injury after subarachnoid hemorrhage.
Brain Injuries
Role of tumor necrosis factor-alpha and matrix metalloproteinase-9 in blood-brain barrier disruption after peripheral thermal injury in rats.
Brain Injuries
Stachybotrys microspora triprenyl phenol-7, a novel fibrinolytic agent, suppresses superoxide production, matrix metalloproteinase-9 expression, and thereby attenuates ischemia/reperfusion injury in rat brain.
Brain Injuries
Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice.
Brain Injuries
The role of progestogens in regulating matrix metalloproteinase activity in macrophages and microglial cells.
Brain Injuries
Therapeutic administration of plasminogen activator inhibitor-1 prevents hypoxic-ischemic brain injury in newborns.
Brain Injuries
Thrombopoietin protects the brain and improves sensorimotor functions: reduction of stroke-induced MMP-9 upregulation and blood-brain barrier injury.
Brain Injuries
Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window.
Brain Injuries
Up-regulation of ROS-Dependent Matrix Metalloproteinase-9 from High-Glucose-Challenged Astrocytes Contributes to the Neuronal Apoptosis.
Brain Injuries
White Matter Injury After Subarachnoid Hemorrhage: Role of Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9.
Brain Injuries
[Blocking ERK signaling pathway lowers MMP-9 expression to alleviate brain edema after traumatic brain injury in rats].
Brain Injuries
[The neuroprotective effects and its mechanisms of qingkailing injection on bacterial meningitis induced by E. coli in rabbits]
Brain Injuries, Traumatic
A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders.
Brain Injuries, Traumatic
Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice.
Brain Injuries, Traumatic
Cerebral Expression of Glial Fibrillary Acidic Protein, Ubiquitin Carboxy-Terminal Hydrolase-L1, and Matrix Metalloproteinase 9 After Traumatic Brain Injury and Secondary Brain Insults in Rats.
Brain Injuries, Traumatic
Delayed progression of edema formation around a hematoma expressing high levels of VEGF and mmp-9 in a patient with traumatic brain injury: case report.
Brain Injuries, Traumatic
Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury.
Brain Injuries, Traumatic
Dymanics of matrix-metalloproteinase 9 after brain trauma--results of a pilot study.
Brain Injuries, Traumatic
Effect of Acute Poly(ADP-Ribose) Polymerase Inhibition by 3-AB on Blood-Brain Barrier Permeability and Edema Formation After Focal Traumatic Brain Injury in Rats.
Brain Injuries, Traumatic
Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury.
Brain Injuries, Traumatic
Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.
Brain Injuries, Traumatic
Elevation of MMP-9 Levels Promotes Epileptogenesis After Traumatic Brain Injury.
Brain Injuries, Traumatic
Hyperbaric oxygen preconditioning protects against traumatic brain injury at high altitude.
Brain Injuries, Traumatic
Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase-9 in the rat model of traumatic brain injury.
Brain Injuries, Traumatic
Increased matrix metalloproteinase-9 in blood in association with activation of interleukin-6 after traumatic brain injury: influence of hypothermic therapy.
Brain Injuries, Traumatic
Increases in matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 mRNA after cerebral contusion and depolarisation.
Brain Injuries, Traumatic
Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo.
Brain Injuries, Traumatic
Matrix metalloproteinase 9 and cellular fibronectin plasma concentrations are predictors of the composite endpoint of length of stay and death in the intensive care unit after severe traumatic brain injury.
Brain Injuries, Traumatic
Matrix metalloproteinase-9 in the ventricular cerebrospinal fluid correlated with the prognosis of traumatic brain injury.
Brain Injuries, Traumatic
Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats.
Brain Injuries, Traumatic
Matrix metalloproteinase-9 regulates the blood brain barrier via the hedgehog pathway in a rat model of traumatic brain injury.
Brain Injuries, Traumatic
MMP-9 Contributes to Dendritic Spine Remodeling Following Traumatic Brain Injury.
Brain Injuries, Traumatic
MMP-9 Inhibitor GM6001 Prevents the Development of ssTBI-Induced Parkinson's Disease via the Autophagy Pathway.
Brain Injuries, Traumatic
MMP-9 Inhibitor SB-3CT Attenuates Behavioral Impairments and Hippocampal Loss after Traumatic Brain Injury in Rat.
Brain Injuries, Traumatic
Plasma matrix metalloproteinase-9 levels predict intensive care unit mortality early after severe traumatic brain injury.
Brain Injuries, Traumatic
Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase.
Brain Injuries, Traumatic
Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury.
Brain Injuries, Traumatic
Simvastatin in traumatic brain injury: Effect on brain edema mechanisms.
Brain Injuries, Traumatic
SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-?B p65 acetylation and activation.
Brain Injuries, Traumatic
The Profile of MMP-9, MMP-9 mRNA Expression, -1562 C/T Polymorphism and Outcome in High-risk Traumatic Brain Injury: The Effect of Therapeutic Mild Hypothermia.
Brain Injuries, Traumatic
The role of hypoxia-inducible factor-1?, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury.
Brain Injuries, Traumatic
The role of matrix metalloproteinases in infant traumatic brain injury.
Brain Injuries, Traumatic
Two-dimensional zymography differentiates gelatinase isoforms in stimulated microglial cells and in brain tissues of acute brain injuries.
Brain Injuries, Traumatic
Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury.
Brain Injuries, Traumatic
[Blocking ERK signaling pathway lowers MMP-9 expression to alleviate brain edema after traumatic brain injury in rats].
Brain Injuries, Traumatic
[Blocking p38 signal pathway lowers MMP-9 expression and reduces brain edema in rats with traumatic brain injury].
Brain Ischemia
1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.
Brain Ischemia
5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix metalloproteinase 9.
Brain Ischemia
A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia.
Brain Ischemia
A non-steroidal anti-inflammatory agent provides significant protection during focal ischemic stroke with decreased expression of matrix metalloproteinases.
Brain Ischemia
A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
Brain Ischemia
Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia.
Brain Ischemia
Asiatic acid attenuates infarct volume, mitochondrial dysfunction, and matrix metalloproteinase-9 induction after focal cerebral ischemia.
Brain Ischemia
Blockade of Apoptosis Signal-Regulating Kinase 1 Attenuates Matrix Metalloproteinase 9 Activity in Brain Endothelial Cells and the Subsequent Apoptosis in Neurons after Ischemic Injury.
Brain Ischemia
Blockage of transient receptor potential vanilloid 4 inhibits brain edema in middle cerebral artery occlusion mice.
Brain Ischemia
Bone marrow-derived cells are the major source of MMP-9 contributing to blood-brain barrier dysfunction and infarct formation after ischemic stroke in mice.
Brain Ischemia
Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats.
Brain Ischemia
Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study.
Brain Ischemia
Clinico-pathological correlations in fatal ischemic stroke. An immunohistochemical study of human brain penumbra.
Brain Ischemia
Concentration of matrix metalloproteinase-9 in the jugular bulb during carotid endarterectomy correlates with severity of intraoperative cerebral ischemia.
Brain Ischemia
Course of matrix metalloproteinase-9 isoforms after the administration of uric acid in patients with acute stroke: a proof-of-concept study.
Brain Ischemia
Crocin protects against cerebral- ischemia-induced damage in aged rats through maintaining the integrity of blood-brain barrier.
Brain Ischemia
Differences in carotid plaque content of macrophages, T cells and MMP-9 between patients with embolic and hemodynamic cerebral ischemia due to symptomatic carotid stenosis.
Brain Ischemia
Diffusion-weighted magnetic resonance imaging reversal by gene knockdown of matrix metalloproteinase-9 activities in live animal brains.
Brain Ischemia
Discriminative Capacity of Biomarkers for Acute Stroke in the Emergency Department.
Brain Ischemia
Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels.
Brain Ischemia
Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia.
Brain Ischemia
Early activation of matrix metalloproteinase-9 is associated with blood-brain barrier disruption after photothrombotic cerebral ischemia in rats.
Brain Ischemia
Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction.
Brain Ischemia
Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion.
Brain Ischemia
Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model.
Brain Ischemia
Effect of Baicalin on Matrix Metalloproteinase-9 Expression and Blood-Brain Barrier Permeability Following Focal Cerebral Ischemia in Rats.
Brain Ischemia
Effect of neutrophil depletion on gelatinase expression, edema formation and hemorrhagic transformation after focal ischemic stroke.
Brain Ischemia
Effects of berberine on hippocampal neuronal damage and matrix metalloproteinase-9 activity following transient global cerebral ischemia.
Brain Ischemia
Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.
Brain Ischemia
Effects of Vitamin D3 on the NADPH Oxidase and Matrix Metalloproteinase 9 in an Animal Model of Global Cerebral Ischemia.
Brain Ischemia
Enhanced cerebrovascular expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 via the MEK/ERK pathway during cerebral ischemia in the rat.
Brain Ischemia
Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice.
Brain Ischemia
Exendin-4 Inhibits Matrix Metalloproteinase-9 Activation and Reduces Infarct Growth After Focal Cerebral Ischemia in Hyperglycemic Mice.
Brain Ischemia
Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia.
Brain Ischemia
Green tea polyphenol (-)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia.
Brain Ischemia
Green tea polyphenol (-)-epigallocatechin gallate reduces neuronal cell damage and up-regulation of MMP-9 activity in hippocampal CA1 and CA2 areas following transient global cerebral ischemia.
Brain Ischemia
High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia.
Brain Ischemia
Human cerebral microvessel endothelial cell culture as a model system to study the blood-brain interface in ischemic/hypoxic conditions.
Brain Ischemia
Hypobaric hypoxia preconditioning protects against hypothalamic neuron apoptosis in heat-exposed rats by reversing hypothalamic overexpression of matrix metalloproteinase-9 and ischemia.
Brain Ischemia
Hypoxia-controlled matrix metalloproteinase-9 hyperexpression promotes behavioral recovery after ischemia.
Brain Ischemia
Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
Brain Ischemia
Induction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injury.
Brain Ischemia
Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction.
Brain Ischemia
Inhibition of chemokine-like factor 1 improves blood-brain barrier dysfunction in rats following focal cerebral ischemia.
Brain Ischemia
Inhibition of matrix metalloproteinase-9 activity by trandolapril after middle cerebral artery occlusion in rats.
Brain Ischemia
Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia.
Brain Ischemia
Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke.
Brain Ischemia
Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
Brain Ischemia
Lentivirus-mediated transfer of MMP-9 shRNA provides neuroprotection following focal ischemic brain injury in rats.
Brain Ischemia
Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia.
Brain Ischemia
Limb Ischemic Perconditioning Attenuates Blood-Brain Barrier Disruption by Inhibiting Activity of MMP-9 and Occludin Degradation after Focal Cerebral Ischemia.
Brain Ischemia
Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.
Brain Ischemia
Lithium chloride suppresses LPS-mediated matrix metalloproteinase-9 expression in macrophages through phosphorylation of GSK-3?.
Brain Ischemia
Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment.
Brain Ischemia
Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice.
Brain Ischemia
Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion.
Brain Ischemia
Matrix metalloproteinase-9 and myeloperoxidase expression: quantitative analysis by antigen immunohistochemistry in a model of transient focal cerebral ischemia.
Brain Ischemia
Matrix Metalloproteinase-9 as a Marker for Acute Ischemic Stroke: A Systematic Review.
Brain Ischemia
Matrix metalloproteinase-9 deficiency has no effect on glial scar formation after transient focal cerebral ischemia in mouse.
Brain Ischemia
Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia.
Brain Ischemia
Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats.
Brain Ischemia
Matrix Metalloproteinase-9 Mediates the Deleterious Effects of ?2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.
Brain Ischemia
Matrix metalloproteinases increase very early during experimental focal cerebral ischemia.
Brain Ischemia
Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats.
Brain Ischemia
Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia.
Brain Ischemia
Met-Controlled Allosteric Module of Neural Generation as A New Therapeutic Target in Rodent Brain Ischemia.
Brain Ischemia
Microglia preconditioned by oxygen-glucose deprivation promote functional recovery in ischemic rats.
Brain Ischemia
Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
Brain Ischemia
Minocycline protects against delayed cerebral ischemia after subarachnoid hemorrhage via matrix metalloproteinase-9 inhibition.
Brain Ischemia
MiR-21 involve in ERK-mediated upregulation of MMP9 in the rat hippocampus following cerebral ischemia.
Brain Ischemia
Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice.
Brain Ischemia
MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier.
Brain Ischemia
MPO is partially associated with neutrophil deleterious effect in acute cerebral ischemia.
Brain Ischemia
Neuroprotective effect of bicyclol in rat ischemic stroke: Down-regulates TLR4, TLR9, TRAF6, NF-?B, MMP-9 and up-regulates claudin-5 expression.
Brain Ischemia
Neuroprotective effects of N-acetylcysteine via inhibition of matrix metalloproteinase in a mouse model of transient global cerebral ischemia.
Brain Ischemia
Neuroprotective effects of over-expressing tissue inhibitor of metalloproteinase TIMP-1.
Brain Ischemia
Neuroprotective effects of targeting BET proteins for degradation with dBET1 in aged mice subjected to ischemic stroke.
Brain Ischemia
New insights into mechanism for the effect of resveratrol preconditioning against cerebral ischemic stroke: Possible role of matrix metalloprotease-9.
Brain Ischemia
Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke.
Brain Ischemia
Normobaric hyperoxia protects the blood brain barrier through inhibiting Nox2 containing NADPH oxidase in ischemic stroke.
Brain Ischemia
Osthole, a natural coumarin, improves neurobehavioral functions and reduces infarct volume and matrix metalloproteinase-9 activity after transient focal cerebral ischemia in rats.
Brain Ischemia
Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats.
Brain Ischemia
Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke.
Brain Ischemia
Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke.
Brain Ischemia
Post-transcriptional inactivation of matrix metalloproteinase-12 after focal cerebral ischemia attenuates brain damage.
Brain Ischemia
PPARgamma agonist pioglitazone reduces matrix metalloproteinase-9 activity and neuronal damage after focal cerebral ischemia.
Brain Ischemia
Protective effect of melatonin against transient global cerebral ischemia-induced neuronal cell damage via inhibition of matrix metalloproteinase-9.
Brain Ischemia
Protective effect of naringenin in experimental ischemic stroke: down-regulated NOD2, RIP2, NF-?B, MMP-9 and up-regulated claudin-5 expression.
Brain Ischemia
Rapid, Nitric Oxide Synthesis-Dependent Activation of MMP-9 at Pericyte Somata During Capillary Ischemia in vivo.
Brain Ischemia
Reduced matrix metalloproteinase-9 activity and cell death after global ischemia in the brain preconditioned with hyperbaric oxygen.
Brain Ischemia
Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice.
Brain Ischemia
Repeated electroacupuncture preconditioning attenuates matrix metalloproteinase-9 expression and activity after focal cerebral ischemia in rats.
Brain Ischemia
Resveratrol Attenuates the Blood-Brain Barrier Dysfunction by Regulation of the MMP-9/TIMP-1 Balance after Cerebral Ischemia Reperfusion in Rats.
Brain Ischemia
Resveratrol downregulates the TLR4 signaling pathway to reduce brain damage in a rat model of focal cerebral ischemia.
Brain Ischemia
Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection.
Brain Ischemia
Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.
Brain Ischemia
Role of Matrix Metalloproteinase-9 in Neonatal Hypoxic-Ischemic Encephalopathy.
Brain Ischemia
Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia.
Brain Ischemia
S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death.
Brain Ischemia
Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
Brain Ischemia
Salvianolic acid A attenuates ischemia reperfusion induced rat brain damage by protecting the blood brain barrier through MMP-9 inhibition and anti-inflammation.
Brain Ischemia
Silencing matrix metalloproteinase 9 exerts a protective effect on astrocytes after oxygen-glucose deprivation and is correlated with suppression of aquaporin-4.
Brain Ischemia
The expression of matrix metalloproteinase-13 is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.
Brain Ischemia
The Intrinsic PEDF is Regulated by PPAR? in Permanent Focal Cerebral Ischemia of Rat.
Brain Ischemia
The Relationship Between Cerebral Reperfusion And Regional Expression Of Matrix Metalloproteinase-9 In Rat Brain Following Focal Cerebral Ischemia.
Brain Ischemia
The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke.
Brain Ischemia
Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusion-induced focal ischemia rat model.
Brain Ischemia
Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia.
Brain Ischemia
Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
Brain Ischemia
Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.
Brain Ischemia
Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition.
Brain Ischemia
VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1.
Brain Ischemia
[Effects of scalp acupuncture on expression of hippocampal MMP-9 in cerebral ischemia injury rats].
Brain Ischemia
[Exploration of the effect of inhibitor of matrix metalloproteinase-9 on blood brain barrier in cardiopulmonary resuscitation in rats]
Brain Neoplasms
Activity of the matrix metalloproteinase-9 promoter in human normal and tumor cells.
Brain Neoplasms
ADAM8 expression in breast cancer derived brain metastases: Functional implications on MMP-9 expression and transendothelial migration in breast cancer cells.
Brain Neoplasms
Biological characteristics of a specific brain metastatic cell line derived from human lung adenocarcinoma.
Brain Neoplasms
Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells.
Brain Neoplasms
Design of a dual aptamer-based recognition strategy for human matrix metalloproteinase 9 protein by piezoelectric biosensors.
Brain Neoplasms
Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection.
Brain Neoplasms
Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.
Brain Neoplasms
Evaluation of matrix metalloproteinase type IV-collagenases in serum of patients with tumors of the central nervous system.
Brain Neoplasms
Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis.
Brain Neoplasms
Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells.
Brain Neoplasms
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Brain Neoplasms
Modulation of MMP-2 and MMP-9 secretion by cytokines, inducers and inhibitors in human glioblastoma T-98G cells.
Brain Neoplasms
Role of VEGF and matrix metalloproteinase-9 in peritumoral brain edema associated with supratentorial benign meningiomas.
Brain Neoplasms
Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?
Brain Neoplasms
Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis.
Brain Neoplasms
Targeted proteomics guided by label-free global proteome analysis in saliva reveal transition signatures from health to periodontal disease.
Brain Neoplasms
Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype.
Brain Neoplasms
Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas.
Breast Carcinoma In Situ
Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9.
Breast Diseases
Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.
Breast Diseases
Clinical significance of plasma MMP-2 and MMP-9 levels as biomarkers for tumor expression in breast cancer patients in Egypt.
Breast Diseases
Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer.
Breast Diseases
Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
Breast Diseases
Significance of MMP-9 and VEGF-C expression in North Indian women with breast cancer diagnosis.
Breast Neoplasms
15d-PGJ2 inhibits NF-?B and AP-1-mediated MMP-9 expression and invasion of breast cancer cell by means of a heme oxygenase-1-dependent mechanism.
Breast Neoplasms
3-O-methylfunicone produced by penicillium pinophilum affects cell motility of breast cancer cells, downregulating alphavbeta5 integrin and inhibiting metalloproteinase-9 secretion.
Breast Neoplasms
6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-?B activation.
Breast Neoplasms
7-Methoxy-luteolin-8-C-?-6-deoxy-xylo-pyranos-3-uloside exactly (mLU8C-PU) isolated from Arthraxon hispidus inhibits migratory and invasive responses mediated via downregulation of MMP-9 and IL-8 expression in MCF-7 breast cancer cells.
Breast Neoplasms
A bi-specific inhibitor targeting IL-17A and MMP-9 reduces invasion and motility in MDA-MB-231 cells.
Breast Neoplasms
A functional comparison between the HER2high/HER3 and the HER2low/HER3 dimers on heregulin-?1-induced MMP-1 and MMP-9 expression in breast cancer cells.
Breast Neoplasms
A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma.
Breast Neoplasms
A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-?B and Nrf2-Keap1 signaling pathways.
Breast Neoplasms
A polyamidoamne dendrimer functionalized graphene oxide for DOX and MMP-9 shRNA plasmid co-delivery.
Breast Neoplasms
A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways.
Breast Neoplasms
A structure-activity relationship study of 1,2,4-triazolo[1,5-a][1,3,5]triazin-5,7-dione and its 5-thioxo analogues on anti-thymidine phosphorylase and associated anti-angiogenic activities.
Breast Neoplasms
Aberrant expression of CXCR4 significantly contributes to metastasis and predicts poor clinical outcome in breast cancer.
Breast Neoplasms
Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.
Breast Neoplasms
Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells.
Breast Neoplasms
Activation of kinin B1 receptor increases the release of metalloproteases-2 and -9 from both estrogen-sensitive and -insensitive breast cancer cells.
Breast Neoplasms
Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion.
Breast Neoplasms
Activator Protein-2? Promotes Tumor Growth and Predicts Poor Prognosis in Breast Cancer.
Breast Neoplasms
ADAM8 expression in breast cancer derived brain metastases: Functional implications on MMP-9 expression and transendothelial migration in breast cancer cells.
Breast Neoplasms
Adeno-associated virus-mediated expression of recombinant CBD-HepII polypeptide of human fibronectin inhibits metastasis of breast cancer.
Breast Neoplasms
Adipose Progenitor Cell Secretion of GM-CSF and MMP9 Promotes a Stromal and Immunological Microenvironment That Supports Breast Cancer Progression.
Breast Neoplasms
Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.
Breast Neoplasms
Akt- and MAPK-mediated activation and secretion of MMP-9 into stroma in breast cancer cells upon heregulin treatment.
Breast Neoplasms
Alcohol Stimulates Activation of Snail, Epidermal Growth Factor Receptor Signaling, and Biomarkers of Epithelial-Mesenchymal Transition in Colon and Breast Cancer Cells.
Breast Neoplasms
All-trans retinoic acid (ATRA) downregulates MMP-9 by modulating its regulatory molecules.
Breast Neoplasms
Alternagin-C binding to ?2?1 integrin controls matrix metalloprotease-9 and matrix metalloprotease-2 in breast tumor cells and endothelial cells.
Breast Neoplasms
Anti-cancer effects of Piper nigrum via inducing multiple molecular signaling in vivo and in vitro.
Breast Neoplasms
Anti-IL-20 monoclonal antibody suppresses breast cancer progression and bone osteolysis in murine models.
Breast Neoplasms
Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer.
Breast Neoplasms
Anti-metastatic and pro-apoptotic effects elicited by combination photodynamic therapy with sonodynamic therapy on breast cancer both in vitro and in vivo.
Breast Neoplasms
Anti-Metastatic Effect of Supercritical Extracts from the Citrus hassaku Pericarp via Inhibition of C-X-C Chemokine Receptor Type 4 (CXCR4) and Matrix Metalloproteinase-9 (MMP-9).
Breast Neoplasms
Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9.
Breast Neoplasms
Antroquinonol from Antrodia Camphorata suppresses breast tumor migration/invasion through inhibiting ERK-AP-1- and AKT-NF-?B-dependent MMP-9 and epithelial-mesenchymal transition expressions.
Breast Neoplasms
Apomorphine suppresses TNF-?-induced MMP-9 expression and cell invasion through inhibition of ERK/AP-1 signaling pathway in MCF-7 cells.
Breast Neoplasms
Apoptotic Induction and Anti-Migratory Effects of Rhazya Stricta Fruit Extracts on a Human Breast Cancer Cell Line.
Breast Neoplasms
Aqueous extract of Anisomeles indica and its purified compound exerts anti-metastatic activity through inhibition of NF-?B/AP-1-dependent MMP-9 activation in human breast cancer MCF-7 cells.
Breast Neoplasms
Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/?-Catenin Signaling.
Breast Neoplasms
Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-?B activation in TPA-induced breast cancer cells.
Breast Neoplasms
Association between Expression of Tissue Inhibitors of Metalloproteinases-1, Matrix Metalloproteinase-2, and Matrix Metalloproteinase-9 Genes and Axillary Lymph Nodes Metastasis in Patients with Breast Cancer.
Breast Neoplasms
Association between four MMP-9 polymorphisms and breast cancer risk: a meta-analysis.
Breast Neoplasms
Association between Matrix Metallopeptidase 9 Polymorphism and Breast Cancer Risk.
Breast Neoplasms
Association between matrix metalloproteinase 9 polymorphisms and breast cancer risk: An updated meta-analysis and trial sequential analysis.
Breast Neoplasms
Association between matrix metalloproteinase-9 gene polymorphism and breast cancer in Brazilian women.
Breast Neoplasms
Association of Fascin and matrix metalloproteinase-9 expression with poor prognostic parameters in breast carcinoma of Egyptian women.
Breast Neoplasms
Augmented release of matrix metalloproteinase-9 by PKC activation in organotypic cultures of human breast cancer and adjacent normal breast tissue and fibroadenoma.
Breast Neoplasms
Aurora kinases are essential for PKC-induced invasion and matrix metalloproteinase-9 expression in MCF-7 breast cancer cells.
Breast Neoplasms
Baicalein, unlike 4-hydroxytamoxifen but similar to G15, suppresses 17?-estradiol-induced cell invasion, and matrix metalloproteinase-9 expression and activation in MCF-7 human breast cancer cells.
Breast Neoplasms
Bee venom suppresses PMA-mediated MMP-9 gene activation via JNK/p38 and NF-kappaB-dependent mechanisms.
Breast Neoplasms
Berberine Suppresses the TPA-Induced MMP-1 and MMP-9 Expressions Through the Inhibition of PKC-? in Breast Cancer Cells.
Breast Neoplasms
Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells.
Breast Neoplasms
Binding of MMP-9-degraded fibronectin to ?6 integrin promotes invasion via the FAK-Src-related Erk1/2 and PI3K/Akt/Smad-1/5/8 pathways in breast cancer.
Breast Neoplasms
BMP-6 inhibits MMP-9 expression by regulating heme oxygenase-1 in MCF-7 breast cancer cells.
Breast Neoplasms
Bone morphogenetic protein 4 (BMP-4) and epidermal growth factor (EGF) inhibit metalloproteinase-9 (MMP-9) expression in cancer cells.
Breast Neoplasms
Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells.
Breast Neoplasms
Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta.
Breast Neoplasms
Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice.
Breast Neoplasms
Breast Cancer Invasion and Metastasis by mPR? Through the PI3K/Akt Signaling Pathway.
Breast Neoplasms
Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor.
Breast Neoplasms
Breast cancer risk assessment: a non-invasive multiparametric approach to stratify patients by MMP-9 serum activity and RhoA expression patterns in circulating leucocytes.
Breast Neoplasms
Broccoli and watercress suppress matrix metalloproteinase-9 activity and invasiveness of human MDA-MB-231 breast cancer cells.
Breast Neoplasms
Brucine suppresses breast cancer metastasis via inhibiting epithelial mesenchymal transition and matrix metalloproteinases expressions.
Breast Neoplasms
BTG1 expression correlates with the pathogenesis and progression of breast carcinomas.
Breast Neoplasms
By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis.
Breast Neoplasms
C-C Chemokine Ligand 2 (CCL2) Recruits Macrophage-Membrane-Camouflaged Hollow Bismuth Selenide Nanoparticles To Facilitate Photothermal Sensitivity and Inhibit Lung Metastasis of Breast Cancer.
Breast Neoplasms
Calmodulin promotes matrix metalloproteinase 9 production and cell migration by inhibiting the ubiquitination and degradation of TBC1D3 oncoprotein in human breast cancer cells.
Breast Neoplasms
Calycosin inhibits breast cancer cell migration and invasion by suppressing EMT via BATF/TGF-?1.
Breast Neoplasms
Calycosin Inhibits the Migration and Invasion of Human Breast Cancer Cells by Down-Regulation of Foxp3 Expression.
Breast Neoplasms
Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3.
Breast Neoplasms
Casticin inhibits breast cancer cell migration and invasion by down-regulation of PI3K/Akt signaling pathway.
Breast Neoplasms
CCA-1.1, a Novel Curcumin Analog, Exerts Cytotoxic anti- Migratory Activity toward TNBC and HER2-Enriched Breast Cancer Cells.
Breast Neoplasms
CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis.
Breast Neoplasms
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Breast Neoplasms
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
Breast Neoplasms
Celastrol induces the apoptosis of breast cancer cells and inhibits their invasion via downregulation of MMP-9.
Breast Neoplasms
Celastrol Inhibits Breast Cancer Cell Invasion via Suppression of NF-?B-mediated Matrix Metalloproteinase-9 Expression.
Breast Neoplasms
Cellular prion protein regulates invasion and migration of breast cancer cells through MMP-9 activity.
Breast Neoplasms
Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells.
Breast Neoplasms
Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
Breast Neoplasms
Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.
Breast Neoplasms
Cis-guggulsterone inhibits the IKK/NF-?B pathway, whereas trans-guggulsterone inhibits MAPK/AP-1 in MCF?7 breast cancer cells: guggulsterone regulates MMP?9 expression in an isomer-specific manner.
Breast Neoplasms
Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer.
Breast Neoplasms
Clinical Implications of the Influence of Ehm2 on the Aggressiveness of Breast Cancer Cells through Regulation of Matrix Metalloproteinase-9 Expression.
Breast Neoplasms
Clinical relevance of cyclooxygenase-2 and matrix metalloproteinases (MMP-2 and MT1-MMP) in human breast cancer tissue.
Breast Neoplasms
Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer.
Breast Neoplasms
Clinical significance of plasma MMP-2 and MMP-9 levels as biomarkers for tumor expression in breast cancer patients in Egypt.
Breast Neoplasms
Clinical Significance of Serum IL-12 Level in Patients with Early Breast Carcinoma and Its Correlation with Other Tumor Markers.
Breast Neoplasms
Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion.
Breast Neoplasms
Comparative expression of matrix metalloproteinases in internal malignancies and paired cutaneous metastatic lesions.
Breast Neoplasms
Comparison of hyaluronidase expression, invasiveness and tubule formation promotion in ER (-) and ER (+) breast cancer cell lines in vitro.
Breast Neoplasms
Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).
Breast Neoplasms
Cordycepin inhibits TPA-induced matrix metalloproteinase-9 expression by suppressing the MAPK/AP-1 pathway in MCF-7 human breast cancer cells.
Breast Neoplasms
Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Breast Neoplasms
Corrigendum to "Oldenlandia diffusa suppresses metastatic potential through inhibiting matrix metalloproteinase-9 and intercellular adhesion molecule-1 expression via p38 and ERK1/2 MAPK pathways and induces apoptosis in human breast cancer MCF-7 cells" [J. Ethnopharmacol. 195 (2017) 309-317].
Breast Neoplasms
CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Breast Neoplasms
Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity.
Breast Neoplasms
Curcumin inhibits TGF-?1-induced MMP-9 and invasion through ERK and Smad signaling in breast cancer MDA- MB-231 cells.
Breast Neoplasms
Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Breast Neoplasms
Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-?B Signaling Pathways.
Breast Neoplasms
Cyanidin-3-O-sambubioside from Acanthopanax sessiliflorus fruit inhibits metastasis by downregulating MMP-9 in breast cancer cells MDA-MB-231.
Breast Neoplasms
Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad.
Breast Neoplasms
Decursin prevents TPA-induced invasion through suppression of PKC?/p38/NF-?B-dependent MMP-9 expression in MCF-7 human breast carcinoma cells.
Breast Neoplasms
Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells.
Breast Neoplasms
Delphinidin suppresses PMA-induced MMP-9 expression by blocking the NF-?B activation through MAPK signaling pathways in MCF-7 human breast carcinoma cells.
Breast Neoplasms
Detection of serum VEGF and MMP-9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma.
Breast Neoplasms
Diagnostic power of VEGF, MMP-9 and TIMP-1 in patients with breast cancer. A multivariate statistical analysis with ROC curve.
Breast Neoplasms
Dietary Fatty Acids from Leaves of Clerodendrum Volubile Induce Cell Cycle Arrest, Downregulate Matrix Metalloproteinase-9 Expression, and Modulate Redox Status in Human Breast Cancer.
Breast Neoplasms
Differential glycosylation of gelatinase B from neutrophils and breast cancer cells.
Breast Neoplasms
Differential role of psoriasin (S100A7) in estrogen receptor ? positive and negative breast cancer cells occur through actin remodeling.
Breast Neoplasms
Dihydroavenanthramide D inhibits human breast cancer cell invasion through suppression of MMP-9 expression.
Breast Neoplasms
DN-R175H p53 mutation is more effective than p53 interference in inducing epithelial disorganization and activation of proliferation signals in human carcinoma cells: role of E-cadherin.
Breast Neoplasms
Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells.
Breast Neoplasms
Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis.
Breast Neoplasms
Down-regulation of uPA and uPAR by 3,3'-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells.
Breast Neoplasms
Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis.
Breast Neoplasms
Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.
Breast Neoplasms
Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background.
Breast Neoplasms
Effect of bevacizumab combined with docetaxel in the treatment of HER-2-negative recurrent metastatic breast cancer.
Breast Neoplasms
Effect of Bicalutamide on the proliferation and invasion of human triple negative breast cancer MDA-MB-231 cells.
Breast Neoplasms
Effect of High Intensity Interval Training on Matrix Metalloproteinases in Women with Breast Cancer Receiving Anthracycline-Based Chemotherapy.
Breast Neoplasms
Effect of methanolic and water extract of Leucobryum bowringii Mitt. on growth, migration and invasion of MCF 7 human breast cancer cells in vitro.
Breast Neoplasms
Effect of microRNA-206 on cytoskeleton remodelling by downregulating Cdc42 in MDA-MB-231 cells.
Breast Neoplasms
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Breast Neoplasms
Effects of tissue factor, PAR-2 and MMP-9 expression on human breast cancer cell line MCF-7 invasion.
Breast Neoplasms
Effects of ulinastatin and cyclophosphamide on the growth of xenograft breast cancer and expression of CXC chemokine receptor 4 and matrix metalloproteinase-9 in cancers.
Breast Neoplasms
Effects of various treatment approaches for treatment efficacy for late stage breast cancer and expression level of TIMP-1 and MMP-9.
Breast Neoplasms
EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line.
Breast Neoplasms
EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line.
Breast Neoplasms
Electrochemical immunoplatform to assist in the diagnosis and classification of breast cancer through the determination of matrix-metalloproteinase-9.
Breast Neoplasms
Enhanced Expression of Rab27A Gene by Breast Cancer Cells Promoting Invasiveness and the Metastasis Potential by Secretion of Insulin-Like Growth Factor-II.
Breast Neoplasms
Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence.
Breast Neoplasms
Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells.
Breast Neoplasms
Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells.
Breast Neoplasms
Epidermal growth factor receptor-mediated regulation of matrix metalloproteinase-2 and matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Breast Neoplasms
Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor ?5?1 in the process.
Breast Neoplasms
Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231.
Breast Neoplasms
Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells.
Breast Neoplasms
Estradiol-Induced MMP-9 Expression via PELP1-Mediated Membrane-Initiated Signaling in ER?-Positive Breast Cancer Cells.
Breast Neoplasms
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells.
Breast Neoplasms
Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt-NF-?B signaling.
Breast Neoplasms
Euphorbia humifusa Willd exerts inhibition of breast cancer cell invasion and metastasis through inhibition of TNF?-induced MMP-9 expression.
Breast Neoplasms
Evaluation of Serum Levels of HER2, MMP-9, Nitric Oxide, and Total Antioxidant Capacity in Egyptian Breast Cancer Patients: Correlation with Clinico-Pathological Parameters.
Breast Neoplasms
Exogenous prostaglandin E2 inhibits TPA induced matrix metalloproteinase-9 production in MCF-7 cells.
Breast Neoplasms
Expression and clinical significance of matrix metalloproteinase-9 in lymphatic invasiveness and metastasis of breast cancer.
Breast Neoplasms
Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer.
Breast Neoplasms
Expression and the molecular forms of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase 9 in canine mammary tumours.
Breast Neoplasms
Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors.
Breast Neoplasms
Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer.
Breast Neoplasms
Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Breast Neoplasms
Expression of matrix metalloproteinase 2 and 9 in breast cancer and breast fibroadenoma: a randomized, double-blind study.
Breast Neoplasms
Expression of matrix metalloproteinase 9 in primary and recurrent breast carcinomas.
Breast Neoplasms
Expression of Matrix Metalloproteinases (MMPs) in Primary Human Breast Cancer: MMP-9 as a Potential Biomarker for Cancer Invasion and Metastasis.
Breast Neoplasms
Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer.
Breast Neoplasms
Expression of MiR-335 and its target metalloproteinase genes: clinical significance in breast cancer.
Breast Neoplasms
Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
Breast Neoplasms
Expression of MMPs and TIMPs genes in human breast cancer epithelial cells depends on cell culture conditions and is associated with their invasive potential.
Breast Neoplasms
Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression.
Breast Neoplasms
Expression of proteinases and inhibitors in human breast cancer progression and survival.
Breast Neoplasms
Expression of Quiescin Sulfhydryl Oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer.
Breast Neoplasms
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
Breast Neoplasms
Expression of VEGF, COX-2 and MMP-9 in breast cancer and their relationship with ultrasound findings.
Breast Neoplasms
Extracellular Matrix Components Regulate Bone Sialoprotein Expression in MDA-MB-231 Breast Cancer Cells.
Breast Neoplasms
Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor-signaling.
Breast Neoplasms
Extracellular matrix protein laminin induces matrix metalloproteinase-9 in human breast cancer cell line mcf-7.
Breast Neoplasms
Extract of Makgeolli suldeot downregulates NF-?B-mediated MMP-9 expression, thereby inhibiting invasive activity in a human breast cancer cell line, MDA-MB-231.
Breast Neoplasms
FGF-1-induced matrix metalloproteinase-9 expression in breast cancer cells is mediated by increased activities of NF-kappaB and activating protein-1.
Breast Neoplasms
Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production.
Breast Neoplasms
Fine particulate matter PM2.5 generated by building demolition increases the malignancy of breast cancer MDA-MB-231 cells.
Breast Neoplasms
Fisetin regulates TPA-induced breast cell invasion by suppressing matrix metalloproteinase-9 activation via the PKC/ROS/MAPK pathways.
Breast Neoplasms
Flavanols from Japanese quince (chaenomeles japonica) fruit inhibit human prostate and breast cancer cell line invasiveness and cause favorable changes in bax/bcl-2 mRNA ratio.
Breast Neoplasms
Formononetin Inhibits Migration and Invasion of MDA-MB-231 and 4T1 Breast Cancer Cells by Suppressing MMP-2 and MMP-9 Through PI3K/AKT Signaling Pathways.
Breast Neoplasms
Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-?B and AP-1 signaling in human breast cancer cells.
Breast Neoplasms
Fucosyltransferase 8 deficiency suppresses breast cancer cell migration by interference of the FAK/integrin pathway.
Breast Neoplasms
Functional expression of voltage-gated sodium channels Nav1.5 in human breast caner cell line MDA-MB-231.
Breast Neoplasms
Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-beta-mediated cancer cell invasiveness.
Breast Neoplasms
Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells.
Breast Neoplasms
Galectin-1 knockdown in carcinoma-associated fibroblasts inhibits migration and invasion of human MDA-MB-231 breast cancer cells by modulating MMP-9 expression.
Breast Neoplasms
Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Breast Neoplasms
Gallic acid-capped gold nanoparticles inhibit EGF-induced MMP-9 expression through suppression of p300 stabilization and NF?B/c-Jun activation in breast cancer MDA-MB-231 cells.
Breast Neoplasms
Gelatinase B (-1562C/T) polymorphism in tumor progression and invasion of breast cancer.
Breast Neoplasms
Gene Polymorphisms and Circulating Levels of MMP-2 and MMP-9: A Review of Their Role in Breast Cancer Risk.
Breast Neoplasms
Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
Breast Neoplasms
Genetic and Pharmacologic Inhibition of eIF4E Reduces Breast Cancer Cell Migration, Invasion, and Metastasis.
Breast Neoplasms
Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.
Breast Neoplasms
GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer.
Breast Neoplasms
Glaucine inhibits breast cancer cell migration and invasion by inhibiting MMP-9 gene expression through the suppression of NF-?B activation.
Breast Neoplasms
Gold-conjugated resveratrol nanoparticles attenuate the invasion and MMP-9 and COX-2 expression in breast cancer cells.
Breast Neoplasms
GPR54 (KISS1R) transactivates EGFR to promote breast cancer cell invasiveness.
Breast Neoplasms
Green tea catechins inhibit angiogenesis through suppression of STAT3 activation.
Breast Neoplasms
Halofuginone induces the apoptosis of breast cancer cells and inhibits migration via downregulation of matrix metalloproteinase-9.
Breast Neoplasms
Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9.
Breast Neoplasms
Hepatocyte growth factor induces breast cancer cell invasion via the PI3K/Akt and p38 MAPK signaling pathways to up-regulate the expression of COX2.
Breast Neoplasms
High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer: Gene set enrichment analysis and validation in large-scale cohorts.
Breast Neoplasms
Hispolon inhibits TPA-induced invasion by reducing MMP-9 expression through the NF-?B signaling pathway in MDA-MB-231 human breast cancer cells.
Breast Neoplasms
How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study.
Breast Neoplasms
HRPAP20: a novel calmodulin-binding protein that increases breast cancer cell invasion.
Breast Neoplasms
Hsa-miR-206 represses the proliferation and invasion of breast cancer cells by targeting Cx43.
Breast Neoplasms
Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis.
Breast Neoplasms
Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK1/2 signaling pathway in MCF-7 human breast cancer cells.
Breast Neoplasms
Identification of Caspase-6 as a New Regulator of Alternatively Activated Macrophages.
Breast Neoplasms
Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Breast Neoplasms
Imidazole Antifungal Drugs Inhibit the Cell Proliferation and Invasion of Human Breast Cancer Cells.
Breast Neoplasms
Immunoexpression of ROCK-1 and MMP-9 as prognostic markers in breast cancer.
Breast Neoplasms
Immunoglobulin g from breast cancer patients regulates MCF-7 cells migration and MMP-9 activity by stimulating muscarinic acetylcholine receptors.
Breast Neoplasms
Immunohistochemical study of KiSS1 and KiSS1R expression in human primary breast cancer: Association with breast cancer receptor status, proliferation markers and clinicopathological features.
Breast Neoplasms
Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
Breast Neoplasms
Impairment of the Gn?11-controlled expression of claudin-1 and MMP-9 and collective migration of human breast cancer MCF-7 cells by DHEAS.
Breast Neoplasms
Increased endostatin generation and decreased angiogenesis via MMP-9 by tamoxifen in hormone dependent ovarian cancer.
Breast Neoplasms
Increased expression of miR-551a by c-Fos reduces Focal Adhesion Kinase (FAK) levels and blocks tumorigenesis.
Breast Neoplasms
Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors.
Breast Neoplasms
Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapy.
Breast Neoplasms
Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.
Breast Neoplasms
Induction of matrix metalloproteinase 9 expression in breast carcinoma cells by a soluble factor from fibroblasts.
Breast Neoplasms
Inflammation Induced by MMP-9 Enhances Tumor Regression of Experimental Breast Cancer.
Breast Neoplasms
Influence of VEGF, COX-2, and MMP-9 expression on the molybdenum-targeted X-ray in breast cancer.
Breast Neoplasms
Inhibition of angiogenesis and invasion by DMBT is mediated by downregulation of VEGF and MMP-9 through Akt pathway in MDA-MB-231 breast cancer cells.
Breast Neoplasms
Inhibition of matrix metalloproteinase-9 expression by docosahexaenoic acid mediated by heme oxygenase 1 in 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 human breast cancer cells.
Breast Neoplasms
Inhibition of MDA-MB-231 breast cancer cell migration and invasion activity by andrographolide via suppression of nuclear factor-?B-dependent matrix metalloproteinase-9 expression.
Breast Neoplasms
Inhibition of tumor cell invasiveness by chemically modified tetracyclines.
Breast Neoplasms
Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo.
Breast Neoplasms
Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9.
Breast Neoplasms
Inhibitory effects of wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9.
Breast Neoplasms
Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment.
Breast Neoplasms
Interaction between CD147 and P-glycoprotein and their regulation by ubiquitination in breast cancer cells.
Breast Neoplasms
Interleukin-1? activates focal adhesion kinase and Src to induce matrix metalloproteinase-9 production and invasion of MCF-7 breast cancer cells.
Breast Neoplasms
Interleukin-22 Mediates the Chemotactic Migration of Breast Cancer Cells and Macrophage Infiltration of the Bone Microenvironment by Potentiating S1P/SIPR Signaling.
Breast Neoplasms
Inverse correlation between Naa10p and MMP-9 expression and the combined prognostic value in breast cancer patients.
Breast Neoplasms
Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt-dependent matrix metalloproteinase-9 expression.
Breast Neoplasms
Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKC{delta}-mediated signaling in MCF-7 human breast cancer cells.
Breast Neoplasms
Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9.
Breast Neoplasms
Krüppel-like factor 9 down-regulates matrix metalloproteinase 9 transcription and suppresses human breast cancer invasion.
Breast Neoplasms
Laminin ?5-derived peptides modulate the properties of metastatic breast tumour cells.
Breast Neoplasms
Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells.
Breast Neoplasms
Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?
Breast Neoplasms
Luteolin 8-C-?-fucopyranoside downregulates IL-6 expression by inhibiting MAPKs and the NF-?B signaling pathway in human monocytic cells.
Breast Neoplasms
Luteolin 8-C-?-fucopyranoside inhibits invasion and suppresses TPA-induced MMP-9 and IL-8 via ERK/AP-1 and ERK/NF-?B signaling in MCF-7 breast cancer cells.
Breast Neoplasms
Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway.
Breast Neoplasms
LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression.
Breast Neoplasms
M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.
Breast Neoplasms
Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.
Breast Neoplasms
Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy.
Breast Neoplasms
Matrix Metalloproteinase-9 -1562T Allele and its Combination with MMP-2 -735 C Allele are Risk Factors for Breast Cancer.
Breast Neoplasms
Matrix metalloproteinase-9 inhibition down-regulates radiation-induced nuclear factor-kappa B activity leading to apoptosis in breast tumors.
Breast Neoplasms
Matrix metalloproteinase-9 is required for tubular network formation and migration of resistant breast cancer cells MCF-7 through PKC and ERK1/2 signalling pathways.
Breast Neoplasms
Matrix metalloproteinases 2, 7, and 9 in tumors and sera of patients with breast cancer.
Breast Neoplasms
MDM2 promotes invasion and metastasis in invasive ductal breast carcinoma by inducing matrix metalloproteinase-9.
Breast Neoplasms
Mechanically stimulated osteocytes reduce the bone-metastatic potential of breast cancer cells in vitro by signaling through endothelial cells.
Breast Neoplasms
Metalloproteinases 1 and 3 as Potential Biomarkers in Breast Cancer Development.
Breast Neoplasms
Metallothionein-2A overexpression increases the expression of matrix metalloproteinase-9 and invasion of breast cancer cells.
Breast Neoplasms
Metastatic potential in MDA-MB-231 human breast cancer cells is inhibited by proton beam irradiation via the Akt/nuclear factor-?B signaling pathway.
Breast Neoplasms
Methanol extract of Codium fragile inhibits tumor necrosis factor-?-induced matrix metalloproteinase-9 and invasiveness of MDA-MB-231 cells by suppressing nuclear factor-?B activation.
Breast Neoplasms
Methyl linderone suppresses TPA-stimulated IL-8 and MMP-9 expression via the ERK/STAT3 pathway in MCF-7 breast cancer cells.
Breast Neoplasms
MHP-1 inhibits cancer metastasis and restores topotecan sensitivity via regulating epithelial-mesenchymal transition and TGF-? signaling in human breast cancer cells.
Breast Neoplasms
MicroRNA-429 inhibits bone metastasis in breast cancer by regulating CrkL and MMP-9.
Breast Neoplasms
Migration and invasion enhancer 1 (MIEN1) is overexpressed in breast cancer and is a potential new therapeutic molecular target.
Breast Neoplasms
miR-130b-3p inhibits cell invasion and migration by targeting the Notch ligand Delta-like 1 in breast carcinoma.
Breast Neoplasms
MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells.
Breast Neoplasms
MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells.
Breast Neoplasms
MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions.
Breast Neoplasms
MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.
Breast Neoplasms
MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors.
Breast Neoplasms
MMP-9 increases HER2/neu expression and alters apoptosis levels in human mammary epithelial cells (HMEC).
Breast Neoplasms
MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors.
Breast Neoplasms
MMP9 gene expression regulation by intragenic epigenetic modifications in breast cancer.
Breast Neoplasms
Molecular mechanisms of nitric oxide-dependent inhibition of TPA-induced matrix metalloproteinase-9 (MMP-9) in MCF-7 cells.
Breast Neoplasms
Momordica cochinchinensis Seed Extracts Suppress Migration and Invasion of Human Breast Cancer ZR-75-30 Cells Via Down-regulating MMP-2 and MMP-9.
Breast Neoplasms
Monensin inhibits proliferation, migration, and promotes apoptosis of breast cancer cells via downregulating UBA2.
Breast Neoplasms
Monitoring multiple angiogenesis-related molecules in the blood of cancer patients shows a correlation between VEGF-A and MMP-9 levels before treatment and divergent changes after surgical vs. conservative therapy.
Breast Neoplasms
Morphine and breast tumor metastasis: the role of matrix-degrading enzymes.
Breast Neoplasms
MPPa-PDT suppresses breast tumor migration/invasion by inhibiting Akt-NF-?B-dependent MMP-9 expression via ROS.
Breast Neoplasms
Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells.
Breast Neoplasms
N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell invasion through suppressing NF-KB activation and inhibiting matrix metalloproteinase-9 expression.
Breast Neoplasms
Nanoliposomal Short-Chain Ceramide Inhibits Agonist-Dependent Translocation of Neurotensin Receptor 1 to Structured Membrane Microdomains in Breast Cancer Cells.
Breast Neoplasms
New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells.
Breast Neoplasms
Nicardipine Inhibits Breast Cancer Migration via Nrf2/HO-1 Axis and Matrix Metalloproteinase-9 Regulation.
Breast Neoplasms
Novel dual-targeting anti-proliferative dihydrotriazine-chalcone derivatives display suppression of cancer cell invasion and inflammation by inhibiting the NF-?B signaling pathway.
Breast Neoplasms
Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases.
Breast Neoplasms
Oldenlandia diffusa suppresses metastatic potential through inhibiting matrix metalloproteinase-9 and intercellular adhesion molecule-1 expression via p38 and ERK1/2 MAPK pathways and induces apoptosis in human breast cancer MCF-7 cells.
Breast Neoplasms
Oleic acid induces migration through a FFAR1/4, EGFR and Akt-dependent pathway in breast cancer cells.
Breast Neoplasms
Orientin inhibits invasion by suppressing MMP-9 and IL-8 expression via the PKC?/ ERK/AP-1/STAT3-mediated signaling pathways in TPA-treated MCF-7 breast cancer cells.
Breast Neoplasms
Overexpression of matrix metalloproteinase-9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta/SMAD signalling.
Breast Neoplasms
Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients.
Breast Neoplasms
Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Breast Neoplasms
Overexpression of MMP-9 and HIF-1? in Breast Cancer Cells under Hypoxic Conditions.
Breast Neoplasms
Overexpression of the urokinase receptor splice variant uPAR-del4/5 in breast cancer cells affects cell adhesion and invasion in a dose-dependent manner and modulates transcription of tumor-associated genes.
Breast Neoplasms
Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells.
Breast Neoplasms
Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression.
Breast Neoplasms
Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours.
Breast Neoplasms
Pattern of collagen fibers and localization of matrix metalloproteinase 2 and 9 during breast cancer invasion.
Breast Neoplasms
Phosphocitrate inhibits calcium hydroxyapatite induced mitogenesis and upregulation of matrix metalloproteinase-1, interleukin-1beta and cyclooxygenase-2 mRNA in human breast cancer cell lines.
Breast Neoplasms
Physical exercise modulates the level of serum MMP-2 and MMP-9 in patients with breast cancer.
Breast Neoplasms
Piceatannol suppresses breast cancer cell invasion through the inhibition of MMP-9: involvement of PI3K/AKT and NF-?B pathways.
Breast Neoplasms
Pigment epithelium-derived factor inhibits advanced glycation end product-induced proliferation, VEGF and MMP-9 expression in breast cancer cells via interaction with laminin receptor.
Breast Neoplasms
PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-?B/MMP-9 signaling pathway.
Breast Neoplasms
Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2.
Breast Neoplasms
Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer.
Breast Neoplasms
Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer.
Breast Neoplasms
Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer.
Breast Neoplasms
Plasma levels of matrix metalloproteinases 2 and 9 correlate with histological grade in breast cancer patients.
Breast Neoplasms
Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer: a retrospective study.
Breast Neoplasms
Plasma matrix metalloproteinases 7 and 9 in patients with metastatic breast cancer treated with marimastat or placebo: Eastern Cooperative Oncology Group trial E2196.
Breast Neoplasms
Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients.
Breast Neoplasms
Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKK?-Mediated NF-?B Activation.
Breast Neoplasms
Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Breast Neoplasms
Polyphenols Extracted from Artemisia annua L. Exhibit Anti-Cancer Effects on Radio-Resistant MDA-MB-231 Human Breast Cancer Cells by Suppressing Stem Cell Phenotype, ?-Catenin, and MMP-9.
Breast Neoplasms
Polyphenols from Artemisia annua L Inhibit Adhesion and EMT of Highly Metastatic Breast Cancer Cells MDA-MB-231.
Breast Neoplasms
Polysaccharides from Korean Citrus hallabong peels inhibit angiogenesis and breast cancer cell migration.
Breast Neoplasms
Potential of fluorescent metalloproteinase substrates for cancer detection.
Breast Neoplasms
Preoperative serum MMP-9 immunoreactive protein is a prognostic indicator for relapse-free survival in breast carcinoma.
Breast Neoplasms
Presence of insulin-like growth factor binding proteins correlates with tumor-promoting effects of matrix metalloproteinase 9 in breast cancer.
Breast Neoplasms
Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.
Breast Neoplasms
Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
Breast Neoplasms
Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
Breast Neoplasms
Prognostic significance of the combined expression of matrix metalloproteinase-9, urokinase type plasminogen activator and its receptor in breast cancer as measured by Northern blot analysis.
Breast Neoplasms
Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis.
Breast Neoplasms
Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients.
Breast Neoplasms
Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma.
Breast Neoplasms
Prognostic values of ETS-1, MMP-2 and MMP-9 expression and co-expression in breast cancer patients.
Breast Neoplasms
Protective effects of dendrosomal curcumin on an animal metastatic breast tumor.
Breast Neoplasms
Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression.
Breast Neoplasms
Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.
Breast Neoplasms
Protein tyrosine phosphatase controls breast cancer invasion through the expression of matrix metalloproteinase-9.
Breast Neoplasms
Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells.
Breast Neoplasms
Quercetin-3-O-glucuronide inhibits noradrenaline-promoted invasion of MDA-MB-231 human breast cancer cells by blocking ??-adrenergic signaling.
Breast Neoplasms
RABEX-5 plays an oncogenic role in breast cancer by activating MMP-9 pathway.
Breast Neoplasms
Radix clematidis extract inhibits TPA-induced MMP-9 expression by suppressing NF-?B activation in MCF-7 human breast cancer cells.
Breast Neoplasms
Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium.
Breast Neoplasms
Reciprocal activation of macrophages and breast carcinoma cells by nitric oxide and colony-stimulating factor-1.
Breast Neoplasms
Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.
Breast Neoplasms
Regulatory effects of ?FosB on proliferation and apoptosis of MCF-7 breast cancer cells.
Breast Neoplasms
Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma.
Breast Neoplasms
Relationship between matrix metalloproteinase-9 and some clinicopathological prognostic factors of breast carcinoma.
Breast Neoplasms
Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer.
Breast Neoplasms
Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C.
Breast Neoplasms
Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells.
Breast Neoplasms
RNA interference targeting CD147 inhibits metastasis and invasion of human breast cancer MCF-7 cells by downregulating MMP-9/VEGF expression.
Breast Neoplasms
RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.
Breast Neoplasms
Role of arachidonic acid metabolism in Stat5 activation induced by oleic acid in MDA-MB-231 breast cancer cells.
Breast Neoplasms
Role of DDR1 in the gelatinases secretion induced by native type IV collagen in MDA-MB-231 breast cancer cells.
Breast Neoplasms
Role of epidermal growth factor receptor signaling in a Pt(II)-resistant human breast cancer cell line.
Breast Neoplasms
Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells.
Breast Neoplasms
Role of NF-?B activation in matrix metalloproteinase 9, vascular endothelial growth factor and interleukin 8 expression and secretion in human breast cancer cells.
Breast Neoplasms
Role of secreted type I collagen derived from stromal cells in two breast cancer cell lines.
Breast Neoplasms
S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-?B signaling.
Breast Neoplasms
Salvia miltiorrhiza extract inhibits TPA-induced MMP-9 expression and invasion through the MAPK/AP-1 signaling pathway in human breast cancer MCF-7 cells.
Breast Neoplasms
Sam68 Promotes the Progression of Human Breast Cancer through Inducing Activation of EphA3.
Breast Neoplasms
Sanguinarine inhibits invasiveness and the MMP-9 and COX-2 expression in TPA-induced breast cancer cells by inducing HO-1 expression.
Breast Neoplasms
Saussurea lappa Clarke-Derived Costunolide Prevents TNF ? -Induced Breast Cancer Cell Migration and Invasion by Inhibiting NF- ? B Activity.
Breast Neoplasms
Saussurea lappa extract suppresses TPA-induced cell invasion via inhibition of NF-?B-dependent MMP-9 expression in MCF-7 breast cancer cells.
Breast Neoplasms
Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment.
Breast Neoplasms
Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells.
Breast Neoplasms
Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression.
Breast Neoplasms
Serum levels of matrix metalloproteinase-9 predict lymph node metastasis in breast cancer patients.
Breast Neoplasms
Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their tissue natural inhibitors in breast tumors.
Breast Neoplasms
Serum MMP-9 Level Associated With Progression of Breast Cancer in Iranian Population.
Breast Neoplasms
Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?
Breast Neoplasms
Sesamin Inhibits Macrophage-Induced Vascular Endothelial Growth Factor and Matrix Metalloproteinase-9 Expression and Proangiogenic Activity in Breast Cancer Cells.
Breast Neoplasms
Shikonin blocks migration and invasion of human breast cancer cells through inhibition of matrix metalloproteinase-9 activation.
Breast Neoplasms
ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
Breast Neoplasms
Significance of Matrix Metalloproteinase 9 Expression as Supporting Marker to Cytokeratin 19 mRNA in Sentinel Lymph Nodes in Breast Cancer Patients.
Breast Neoplasms
Significance of MMP-9 and VEGF-C expression in North Indian women with breast cancer diagnosis.
Breast Neoplasms
Silencing of bach1 gene by small interfering RNA-mediation regulates invasive and expression level of miR-203, miR-145, matrix metalloproteinase-9, and CXCR4 receptor in MDA-MB-468 breast cancer cells.
Breast Neoplasms
Silencing of KIF3B Suppresses Breast Cancer Progression by Regulating EMT and Wnt/?-Catenin Signaling.
Breast Neoplasms
Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells.
Breast Neoplasms
Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells.
Breast Neoplasms
Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells.
Breast Neoplasms
Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells.
Breast Neoplasms
Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-?B signaling pathway using Celastrol-loaded micelles.
Breast Neoplasms
Size-adaptable and ligand (biotin)-sheddable nanocarriers equipped with avidin scavenging technology for deep tumor penetration and reduced toxicity.
Breast Neoplasms
Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells.
Breast Neoplasms
Spatiotemporal organization and protein dynamics involved in regulated exocytosis of MMP-9 in breast cancer cells.
Breast Neoplasms
Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells.
Breast Neoplasms
ST3Gal III modulates breast cancer cell adhesion and invasion by altering the expression of invasion-related molecules.
Breast Neoplasms
Stable knockdown of clusterin by vectorbased RNA interference in a human breast cancer cell line inhibits tumour cell invasion and metastasis.
Breast Neoplasms
Star-Shaped Amphiphilic Hyperbranched Polyglycerol Conjugated with Dendritic Poly(l-lysine) for the Codelivery of Docetaxel and MMP-9 siRNA in Cancer Therapy.
Breast Neoplasms
Starfish polysaccharides downregulate metastatic activity through the MAPK signaling pathway in MCF-7 human breast cancer cells.
Breast Neoplasms
Strobilanthes crispus inhibits migration, invasion and metastasis in breast cancer.
Breast Neoplasms
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, enhances radiosensitivity and suppresses lung metastasis in breast cancer in vitro and in vivo.
Breast Neoplasms
Sulforaphane controls TPA-induced MMP-9 expression through the NF-?B signaling pathway, but not AP-1, in MCF-7 breast cancer cells.
Breast Neoplasms
Sulforaphene Interferes with Human Breast Cancer Cell Migration and Invasion through Inhibition of Hedgehog Signaling.
Breast Neoplasms
Super Magnetic Niosomal Nanocarrier as a New Approach for Treatment of Breast Cancer: A Case Study on SK-BR-3 and MDA-MB-231 Cell Lines.
Breast Neoplasms
Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.
Breast Neoplasms
Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.
Breast Neoplasms
Suppression of Heregulin-{beta}1/HER2-Modulated Invasive and Aggressive Phenotype of Breast Carcinoma by Pterostilbene via Inhibition of Matrix Metalloproteinase-9, p38 Kinase Cascade and Akt Activation.
Breast Neoplasms
Suppression of metastasis of human breast cancer cells by chitosan oligosaccharides.
Breast Neoplasms
Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-?B/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells.
Breast Neoplasms
Suppression of PMA-induced tumor cell invasion and migration by ginsenoside Rg1 via the inhibition of NF-?B-dependent MMP-9 expression.
Breast Neoplasms
Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression.
Breast Neoplasms
Suppression of TPA-induced cancer cell invasion by Peucedanum japonicum Thunb. extract through the inhibition of PKC?/NF-?B-dependent MMP-9 expression in MCF-7 cells.
Breast Neoplasms
Suppression of TPA-induced tumor cell invasion by sulfuretin via inhibition of NF-?B-dependent MMP-9 expression.
Breast Neoplasms
Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells via the Inhibition of STAT3 Signaling and Down-regulation of Inflammatory Cytokine Expressions.
Breast Neoplasms
Surfactin suppresses TPA-induced breast cancer cell invasion through the inhibition of MMP-9 expression.
Breast Neoplasms
Surgical excision promotes tumor growth and metastasis by promoting expression of MMP-9 and VEGF in a breast cancer model.
Breast Neoplasms
Synergistic effects of tamoxifen and tranilast on VEGF and MMP-9 regulation in cultured human breast cancer cells.
Breast Neoplasms
Synthesis and characterization of a PDMS-PMOXA based polymersomes sensitive to MMP-9 for application in breast cancer.
Breast Neoplasms
T cell-derived matrix metalloproteinase-9 in breast cancer: friend or foe?
Breast Neoplasms
TAK1 is required for TGF-beta 1-mediated regulation of matrix metalloproteinase-9 and metastasis.
Breast Neoplasms
Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity.
Breast Neoplasms
Targeting Notch1 inhibits invasion and angiogenesis of human breast cancer cells via inhibition Nuclear Factor-?B signaling.
Breast Neoplasms
Targeting the Temporal Dynamics of Hypoxia-Induced Tumor-Secreted Factors Halts Tumor Migration.
Breast Neoplasms
Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1.
Breast Neoplasms
Tetrabromobisphenol A Induces MMP-9 Expression via NADPH Oxidase and the activation of ROS, MAPK, and Akt Pathways in Human Breast Cancer MCF-7 Cells.
Breast Neoplasms
The anti-metastatic effects of the phytoestrogen arctigenin on human breast cancer cell lines regardless of the status of ER expression.
Breast Neoplasms
The Anti-tumoral Effect of ?-D-Mannuronic Acid (M2000) as a Novel NSAID on Treg Cells Frequency and MMP-2, MMP-9, CCL22 and TGF?1 Gene Expression in Pre-surgical Breast Cancer Patients.
Breast Neoplasms
The association between the preoperative serum levels of lipocalin-2 and matrix metalloproteinase-9 (MMP-9) and prognosis of breast cancer.
Breast Neoplasms
The association of co-expression of CD44v4/MMP-9 with different nodal status in high-grade breast carcinoma patients.
Breast Neoplasms
The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma.
Breast Neoplasms
The Effect of (E)-1-(4'-aminophenyl)-3-phenylprop-2-en-1-one on MicroRNA-18a, Dicer1, and MMP-9 Expressions against DMBA-Induced Breast Cancer.
Breast Neoplasms
The Effect of Chrysin Loaded PLGA-PEG on Metalloproteinase Gene Expression in Mouse 4T1 Tumor Model.
Breast Neoplasms
The effect of opine on matrix metalloproteinase expression in mice with breast cancer.
Breast Neoplasms
The Effects of Houttuynia cordata Thunb and Piper ribesioides Wall Extracts on Breast Carcinoma Cell Proliferation, Migration, Invasion and Apoptosis.
Breast Neoplasms
The Effects of Trifolium pratense L. Sprouts' Phenolic Compounds on Cell Growth and Migration of MDA-MB-231, MCF-7 and HUVEC Cells.
Breast Neoplasms
The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer.
Breast Neoplasms
The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL.
Breast Neoplasms
The influence of functional polymorphisms in matrix metalloproteinase 9 on survival of breast cancer patients in a Chinese population.
Breast Neoplasms
The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients.
Breast Neoplasms
The prognostic role of interleukin-8 (IL-8) and matrix metalloproteinases -2 and -9 in lymph node-negative untreated breast cancer patients.
Breast Neoplasms
The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis.
Breast Neoplasms
The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells.
Breast Neoplasms
The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression.
Breast Neoplasms
The Sample Type used Affects the Levels of Gelatinases (MMP-2 and -9) and their Inhibitors (TIMP-1 and -2) in Circulating Blood of Healthy Controls and Breast Cancer Patients.
Breast Neoplasms
The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
Breast Neoplasms
The UPR inducer DPP23 inhibits the metastatic potential of MDA-MB-231 human breast cancer cells by targeting the Akt-IKK-NF-?B-MMP-9 axis.
Breast Neoplasms
Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model.
Breast Neoplasms
Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells.
Breast Neoplasms
Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes ?v?3-mediated adhesion and invasive migration.
Breast Neoplasms
Triptolide inhibits matrix metalloproteinase-9 expression and invasion of breast cancer cells through the inhibition of NF-?B and AP-1 signaling pathways.
Breast Neoplasms
Troglitazone Inhibits Matrix Metalloproteinase-9 Expression and Invasion of Breast Cancer Cell through a Peroxisome Proliferator-Activated Receptor ?-Dependent Mechanism.
Breast Neoplasms
Tubular network formation by adriamycin-resistant MCF-7 breast cancer cells is closely linked to MMP-9 and VEGFR-2/VEGFR-3 over-expressions.
Breast Neoplasms
Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.
Breast Neoplasms
Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer.
Breast Neoplasms
Unifloral ajwain honey ameliorates differential inhibition of matrix metalloproteinases 2 and 9 protein, cytotoxicity, and antioxidant potential.
Breast Neoplasms
Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells.
Breast Neoplasms
Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessment.
Breast Neoplasms
Values of MMP-2 and MMP-9 in Tumor Tissue of Basal-Like Breast Cancer Patients.
Breast Neoplasms
Vitamin D Receptor Genetic Variation and Cancer Biomarkers among Breast Cancer Patients Supplemented with Vitamin D3: A Single-Arm Non-Randomized Before and After Trial.
Breast Neoplasms
WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells.
Breast Neoplasms
Wortmannin Reduces Metastasis and Angiogenesis of Human Breast Cancer Cells via Nuclear Factor- B-dependent Matrix Metalloproteinase-9 and Interleukin-8 Pathways.
Breast Neoplasms
Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera.
Breast Neoplasms
[Associating of polymorphism in the promoter regions of genes of metalloproteinase (MMP2, MMP3, MMP9) with options of the clinical course of breast cancer in Russian women].
Breast Neoplasms
[Correlation between expression of metastasis-associated gene 1 and matrix metalloproteinase 9 and invasion and metastasis of breast cancer]
Breast Neoplasms
[Corrigendum] Inhibition of MDA-MB-231 breast cancer cell migration and invasion activity by andrographolide via suppression of nuclear factor-?B-dependent matrix metalloproteinase-9 expression.
Breast Neoplasms
[Effect of ethyl gallate on invasion abilities and its mechanism of breast cancer MDA-MB-231 cells].
Breast Neoplasms
[Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma]
Breast Neoplasms
[Expression of CD147, matrix metalloproteinases and transforming growth factor beta1 in breast cancer]
Breast Neoplasms
[Expression of matrix metalloproteinase 9 (MMP-9) and laminin-receptor in breast carcinoma and their correlation with tumor metastasis and prognosis]
Breast Neoplasms
[Expression of matrix metalloproteinase-9 and its complex in the urine of breast cancer patients]
Breast Neoplasms
[Expression of MMP-9 and VEGF in breast cancer: correlation with other prognostic indicators]
Breast Neoplasms
[Expression of TGF-beta1 and the mechanism of invasiveness and metastasis induced by TGF-beta1 in breast cancer]
Breast Neoplasms
[Relationship and clinical significance of KiSS-1, nuclear factor kappa B (NF-kappaB), p50, and matrix metalloproteinase 9 expression in breast cancer]
Breast Neoplasms
[Relationship between LKB1 gene and invasion-related factors of breast cancer cells]
Breast Neoplasms
[Relationship between lymph node metastasis and the expressions of E-cadherin, N-cadherin, and matrix metalloproteinase in breast carcinoma]
Breast Neoplasms
[Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer]
Breast Neoplasms
[Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer.]
Breast Neoplasms
[The correlation of synuclein-? and matrix metalloproteinase 9 in breast cancer].
Breast Neoplasms
[The expression of MMPs and TIMPs in human breast cancer tissues and importance of their balance in cancer invasion and metastasis]
Breast Neoplasms
[Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer]
Breast Neoplasms, Male
Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.
Bronchiectasis
Effect of pseudomonas aeruginosa on the expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the airway of bronchiectasis patients.
Bronchiectasis
Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis.
Bronchiectasis
Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis.
Bronchiectasis
Neutrophils and Activated Macrophages Control Mucosal Immunity by Proteolytic Cleavage of Antileukoproteinase.
Bronchiectasis
Sputum matrix metalloproteinase-8 and -9 and tissue inhibitor of metalloproteinase-1 in bronchiectasis: clinical correlates and prognostic implications.
Bronchiolitis Obliterans
Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans.
Bronchiolitis Obliterans
Lung transplant metalloproteinase levels are elevated prior to bronchiolitis obliterans syndrome.
Bronchiolitis Obliterans
Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation.
Bronchiolitis Obliterans
Relevance of Plasma Matrix Metalloproteinase-9 for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation.
Bronchitis, Chronic
Cellular and Soluble Inflammatory Markers in Induced Sputum of Composting Plant Workers.
Bronchitis, Chronic
Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma.
Bronchitis, Chronic
Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis.
Bronchopulmonary Dysplasia
Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia.
Bronchopulmonary Dysplasia
Levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are related to cardiopulmonary injury in fetal inflammatory response syndrome.
Bronchopulmonary Dysplasia
Matrix Metalloproteinase-9 Deficiency Worsens Lung Injury in a Model of Bronchopulmonary Dysplasia.
Bronchopulmonary Dysplasia
Role of matrix metalloprotease-9 in hyperoxic injury in developing lung.
Brucellosis
Brucella-infected hepatocytes mediate potentially tissue-damaging immune responses.
Burkitt Lymphoma
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells.
Burkitt Lymphoma
Interference with the CXCL12/CXCR4 axis as potential antitumor strategy: superiority of a sulfated galactofucan from the brown alga Saccharina latissima and fucoidan over heparins.
Calcinosis
[MATRIX METALLOPROTEINASE 9 AND TISSUE INHIBITOR OF MATRIX METALLOPROTEINASES TYPE 1 SERUM CONCENTRATIONS AND GENETIC POLYMORPHISM IN SENILE AORTIC STENOSIS].
Campylobacter Infections
Colonic Expression of Genes Encoding Inflammatory Mediators and Gelatinases During Campylobacter Jejuni Infection of Conventional Infant Mice.
Carcinogenesis
5-deoxykaempferol plays a potential therapeutic role by targeting multiple signaling pathways in skin cancer.
Carcinogenesis
A DNA-directed covalent conjugation fluorescence probe for in vitro detection of functional matrix metalloproteinases.
Carcinogenesis
A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression.
Carcinogenesis
A significant elevation of plasma level of matrix metalloproteinase-9 in patients with high-grade intraepithelial neoplasia and early squamous cell carcinoma of the uterine cervix.
Carcinogenesis
A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma.
Carcinogenesis
Aberrant expression of S100A6 and matrix metalloproteinase 9, but not S100A2, S100A4, and S100A7, is associated with epidermal carcinogenesis.
Carcinogenesis
Abiotic Mimic of Matrix Metalloproteinase-9 Inhibitor against Advanced Metastatic Cancer.
Carcinogenesis
Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers.
Carcinogenesis
Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.
Carcinogenesis
Amorphous calcium phosphate-mediated binding of matrix metalloproteinase-9 to fibrin is inhibited by pyrophosphate and bisphosphonate.
Carcinogenesis
Antitumorigenic effect of plumbagin by induction of SH2-containing protein tyrosine phosphatase 1 in human gastric cancer cells.
Carcinogenesis
Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2.
Carcinogenesis
BLCA-4 expression is related to MMP-9, VEGF, IL-1? and IL-8 in bladder cancer but not to PEDF, TNF-? or angiogenesis.
Carcinogenesis
Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor.
Carcinogenesis
CKAP2 Promotes Ovarian Cancer Proliferation and Tumorigenesis Through the FAK-ERK Pathway.
Carcinogenesis
Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
Carcinogenesis
Cutaneous carcinomas and preinvasive neoplastic lesions. Role of MMP-2 and MMP-9 metalloproteinases in neoplastic invasion and their relationship with proliferative activity and p53 expression.
Carcinogenesis
Decreased CUL4B expression inhibits malignant proliferation of glioma in vitro and in vivo.
Carcinogenesis
Discovery of lesser known flavones as inhibitors of NF-?B signaling in MDA-MB-231 breast cancer cells--A SAR study.
Carcinogenesis
Effect and mechanism of RUNX3 gene on biological characteristics of human esophageal squamous cell carcinoma (ESCC).
Carcinogenesis
Effective suppression of azoxymethane-induced aberrant crypt foci formation in mice with citrus peel flavonoids.
Carcinogenesis
Epithelial carcinogenesis: dynamic interplay between neoplastic cells and their microenvironment.
Carcinogenesis
Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels.
Carcinogenesis
Expression and biological relationship of vascular endothelial growth factor-a and matrix metalloproteinase-9 in gastric carcinoma.
Carcinogenesis
Expression and significance of MMP-9 and MDM2 in the oncogenesis of lung cancer in rats.
Carcinogenesis
Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
Carcinogenesis
Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
Carcinogenesis
Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer.
Carcinogenesis
Expression of Matrix Metalloproteinase-9, Pituitary Tumor Transforming Gene, High Mobility Group A 2, and Ki-67 in Adrenocorticotropic Hormone-Secreting Pituitary Tumors and Their Association with Tumor Recurrence.
Carcinogenesis
Expression of matrix metalloproteinases in gallbladder carcinoma and their significance in carcinogenesis.
Carcinogenesis
Gelatinases A and B expression in human colorectal cancer in upper Egypt: a clinicopathological study.
Carcinogenesis
Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor kappaB.
Carcinogenesis
Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells.
Carcinogenesis
HSP40 co-chaperone protein Tid1 suppresses metastasis of head and neck cancer by inhibiting Galectin-7-TCF3-MMP9 axis signaling.
Carcinogenesis
Human leucine zipper protein sLZIP induces migration and invasion of cervical cancer cells via expression of matrix metalloproteinase-9.
Carcinogenesis
Immunohistochemical Demonstration of Membrane-bound Prostaglandin E(2) Synthase-1 in Papillary Thyroid Carcinoma.
Carcinogenesis
Immunohistochemical Expression of MMP-9, TIMP-1, and Vimentin and its Correlation With Inflammatory Reaction and Clinical Parameters in Oral Epithelial Dysplasia.
Carcinogenesis
Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
Carcinogenesis
Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
Carcinogenesis
Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis.
Carcinogenesis
Ingestion of proteoglycan fraction from shark cartilage increases serum inhibitory activity against matrix metalloproteinase-9 and suppresses development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic duct carcinogenesis in hamster.
Carcinogenesis
Integrin alpha3beta1 potentiates TGFbeta-mediated induction of MMP-9 in immortalized keratinocytes.
Carcinogenesis
Inulin results in increased levels of beta-catenin and cyclin D1 as the adenomas increase in size from small to large in the Min/+ mouse.
Carcinogenesis
Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells.
Carcinogenesis
Knockdown of Matrix Metallopeptidase 9 Inhibits Metastasis of Oral Squamous Cell Carcinoma Cells in a Zebrafish Xenograft Model.
Carcinogenesis
Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Carcinogenesis
Late SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9).
Carcinogenesis
Liver-specific overexpression of matrix metalloproteinase 9 (MMP-9) in transgenic mice accelerates development of hepatocellular carcinoma.
Carcinogenesis
Long noncoding RNA DANCR aggravates retinoblastoma through miR-34c and miR-613 by targeting MMP-9.
Carcinogenesis
Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis.
Carcinogenesis
Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis.
Carcinogenesis
LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression.
Carcinogenesis
Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy?
Carcinogenesis
Matrix Metalloproteinase-2 and -9, Lactate, and Malate Dehydrogenase and Lipid Peroxides in Sera of Patients with Colorectal Carcinoma.
Carcinogenesis
Matrix metalloproteinase-7, -8, -9, -15, and -25 in minor salivary gland adenoid cystic carcinoma.
Carcinogenesis
Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse.
Carcinogenesis
Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.
Carcinogenesis
Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population.
Carcinogenesis
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.
Carcinogenesis
MiADMSA ameliorate arsenic induced urinary bladder carcinogenesis in vivo and in vitro.
Carcinogenesis
MMP-9 directed shRNAs as relevant inhibitors of matrix metalloproteinase 9 activity and signaling.
Carcinogenesis
MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.
Carcinogenesis
MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy.
Carcinogenesis
Modulatory effect of hesperidin on benzo(a)pyrene induced experimental lung carcinogenesis with reference to COX-2, MMP-2 and MMP-9.
Carcinogenesis
Nuclear factor-?B plays an important role in Tamarixetin-mediated inhibition of matrix metalloproteinase-9 expression.
Carcinogenesis
Olive Leaf Extract and Its Main Component Oleuropein Prevent Chronic Ultraviolet B Radiation-Induced Skin Damage and Carcinogenesis in Hairless Mice.
Carcinogenesis
Oncogenic transformation of human benign prostate hyperplasia with chronic cadmium exposure.
Carcinogenesis
Opposite effect of stable transfection of bioactive transforming growth factor-beta 1 (TGF beta 1) versus exogenous TGF beta 1 treatment on expression of 92-kDa type IV collagenase in mouse skin squamous cell carcinoma CH72 cells.
Carcinogenesis
Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression.
Carcinogenesis
Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response.
Carcinogenesis
Predictive role of nuclear factor-kappaB activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester.
Carcinogenesis
Preventive effects of butyric acid, nicotinamide, calcium glucarate alone or in combination during the 7, 12-dimethylbenz (a) anthracene induced mouse skin tumorigenesis via modulation of K-Ras-PI3K-AKTpathway and associated micro RNAs.
Carcinogenesis
Prodigiosin produced by Serratia marcescens inhibits expression of MMP-9 and survivin and promotes caspase-3 activation with induction of apoptosis in acute lymphoblastic leukaemia cells.
Carcinogenesis
Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C.
Carcinogenesis
RNAi-mediated MMP-9 silencing inhibits mouse melanoma cell invasion and migration in vitro and in vivo.
Carcinogenesis
Role of matrix metalloproteinase-9 in progression of mouse skin carcinogenesis.
Carcinogenesis
S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.
Carcinogenesis
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.
Carcinogenesis
Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer.
Carcinogenesis
Silymarin attenuated mast cell recruitment thereby decreased the expressions of matrix metalloproteinases-2 and 9 in rat liver carcinogenesis.
Carcinogenesis
Stimulation of MMP-9 of oral epithelial cells by areca nut extract is related to TGF-?/Smad2-dependent and -independent pathways and prevented by betel leaf extract, hydroxychavicol and melatonin.
Carcinogenesis
Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.
Carcinogenesis
Synergistic Effect of Benzethonium Chloride Combined with Endoxan against Hepatocellular Carcinoma in Rats through Targeting Apoptosis Signaling Pathway.
Carcinogenesis
Ten-gene signature reveals the significance of clinical prognosis and immuno-correlation of osteosarcoma and study on novel skeleton inhibitors regarding MMP9.
Carcinogenesis
The anti-invasive role of novel synthesized pyridazine hydrazide appended phenoxy acetic acid against neoplastic development targeting matrix metallo proteases.
Carcinogenesis
The Anti-tumoral Effect of ?-D-Mannuronic Acid (M2000) as a Novel NSAID on Treg Cells Frequency and MMP-2, MMP-9, CCL22 and TGF?1 Gene Expression in Pre-surgical Breast Cancer Patients.
Carcinogenesis
The Association of Simultaneous Increase in Interleukin-6, C Reactive Protein, and Matrix Metalloproteinase-9 Serum Levels with Increasing Stages of Colorectal Cancer.
Carcinogenesis
The effect of a DNA repair gene on cellular invasiveness: XRCC3 over-expression in breast cancer cells.
Carcinogenesis
The effects of microRNA-183 promots cell proliferation and invasion by targeting MMP-9 in endometrial cancer.
Carcinogenesis
The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Carcinogenesis
The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-alpha in human keratinocytes.
Carcinogenesis
The interaction between aromatase, metalloproteinase 2,9 and cd44 in breast cancer.
Carcinogenesis
The role of matrix metalloproteinases 2 and 9 during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide.
Carcinogenesis
TNF-alpha drives matrix metalloproteinase-9 in squamous oral carcinogenesis.
Carcinogenesis
TNF-alpha regulates epithelial expression of MMP-9 and integrin alphavbeta6 during tumour promotion. A role for TNF-alpha in keratinocyte migration?
Carcinogenesis
Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma.
Carcinogenesis
Upregulated expression of MMP-9 in gingival epithelial cells induced by prolonged stimulation with arecoline.
Carcinogenesis
Vietnamese coriander inhibits cell proliferation, survival and migration via suppression of Akt/mTOR pathway in oral squamous cell carcinoma.
Carcinogenesis
[Expressions of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 and their correlation with metastasis and prognosis in lung cancer.]
Carcinogenesis
[Gelatinases A and B and their endogenous regulators in the corpus uteri in squamous cell cervical carcinoma].
Carcinogenesis
[Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells]
Carcinogenesis
[The matrix metalloproteinase in oral and oropharyngeol cancer - literature review].
Carcinogenesis
[The relationship of MMP-9, VEGF and PCNA expressions and their clinical significance in gastric adenocarcinoma]
Carcinoid Tumor
GHRH antagonist inhibits focal adhesion kinase (FAK) and decreases expression of vascular endothelial growth factor (VEGF) in human lung cancer cells in vitro.
Carcinoma
72-kD (MMP-2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells.
Carcinoma
A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9.
Carcinoma
A circular RNA derived from MMP9 facilitates oral squamous cell carcinoma metastasis through regulation of MMP9 mRNA stability.
Carcinoma
A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma.
Carcinoma
A significant elevation of plasma level of matrix metalloproteinase-9 in patients with high-grade intraepithelial neoplasia and early squamous cell carcinoma of the uterine cervix.
Carcinoma
Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells.
Carcinoma
Active matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers.
Carcinoma
Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9.
Carcinoma
Activity of type IV collagenases (MMP-2 and MMP-9) in primary pulmonary carcinomas: a quantitative analysis.
Carcinoma
ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.
Carcinoma
Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis.
Carcinoma
ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer.
Carcinoma
Alpha-mangostin suppresses MMP-2 and MMP-9 expression in head and neck squamous carcinoma cells.
Carcinoma
An orthotopic floor-of-mouth cancer model allows quantification of tumor invasion.
Carcinoma
Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization.
Carcinoma
Androgen receptor promotes the migration and invasion of upper urinary tract urothelial carcinoma cells through the upregulation of MMP-9 and COX-2.
Carcinoma
Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines.
Carcinoma
Anticancer effect of lysine, proline, arginine, ascorbic acid and green tea extract on human renal adenocarcinoma line 786-0.
Carcinoma
AP-1 and ERK1 but not p38 nor JNK is required for CRPV early protein 2-dependent MMP-9 promoter activation in rabbit epithelial cells.
Carcinoma
Apple- and Hop-Polyphenols Inhibit Porphyromonas gingivalis-Mediated Precursor of Matrix Metalloproteinase-9 Activation and Invasion of Oral Squamous Cell Carcinoma Cells.
Carcinoma
Areca quid chewing enhances the expression of salivary matrix metalloproteinase-9.
Carcinoma
Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
Carcinoma
Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Carcinoma
Association of matrix metalloproteinases-9 gene polymorphisms with genetic susceptibility to esophageal squamous cell carcinoma.
Carcinoma
Associations of Promoter Methylations and mRNA Expressions of MMP-2, MMP-7 and MMP-9 with Primary Fallopian Tube Carcinoma.
Carcinoma
ATIQCTPC targeting MMP-9: a key step to slowing primary tumor growth and inhibiting metastasis of lewis lung carcinoma
Carcinoma
Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood.
Carcinoma
CADPE Inhibits PMA-Stimulated Gastric Carcinoma Cell Invasion and Matrix Metalloproteinase-9 Expression by FAK/MEK/ERK-Mediated AP-1 Activation.
Carcinoma
Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity.
Carcinoma
Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by ERK1/2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma.
Carcinoma
Capsaicin inhibits the migration and invasion via the AMPK/NF-?B signaling pathway in esophagus sequamous cell carcinoma by decreasing matrix metalloproteinase-9 expression.
Carcinoma
Carcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR.
Carcinoma
Caspase-10, matrix metalloproteinase-9 and total laminin are correlated with the tumor malignancy of clear cell renal cell carcinoma.
Carcinoma
Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-?B in esophageal squamous cell carcinoma cells.
Carcinoma
CD147 promotes invasion and MMP-9 expression through MEK signaling and predicts poor prognosis in hypopharyngeal squamous cell carcinoma.
Carcinoma
CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.
Carcinoma
CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: imbalance between NF-kappaB and STAT3 activation.
Carcinoma
CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
Carcinoma
CD44+/CD133+ immunophenotype and matrix metalloproteinase-9: Influence on prognosis in early-stage oral squamous cell carcinoma.
Carcinoma
Chemokine receptor 7 enhances cell chemotaxis and migration of metastatic squamous cell carcinoma of head and neck through activation of matrix metalloproteinase-9.
Carcinoma
Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma.
Carcinoma
Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma.
Carcinoma
Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma.
Carcinoma
Clinicopathological and prognostic role of MMP-9 in esophageal squamous cell carcinoma: a meta-analysis.
Carcinoma
Comparative analysis of basal lamina type IV collagen ? chains, matrix metalloproteinases-2 and -9 expressions in oral dysplasia and invasive carcinoma.
Carcinoma
Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
Carcinoma
Comparative expression of matrix metalloproteinases in low-grade mucoepidermoid carcinoma and typical lung cancer.
Carcinoma
Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas.
Carcinoma
Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway?
Carcinoma
Correlation Between the Expression of Matrix Metalloproteinase-9, Matrix Metalloproteinase-13, Tissue Inhibitor of Metalloproteinases-1, p16 and Differentiation of Head and Neck Squamous Cell Carcinoma: A Prospective Observational Study.
Carcinoma
Correlation between the progression of cancer and the expression of matrix metalloproteinase-9 in metastatic spinal tumor.
Carcinoma
Correlation of matrix metalloproteinase-9 expression with morphometric analysis of mucosal vasculature in oral squamous cell carcinoma, oral epithelial dysplasia, and normal oral mucosa.
Carcinoma
Correlation of survivin and MMP9 expressions with prognosis and clinicopathological parameters in surface epithelial ovarian carcinomas.
Carcinoma
Correlative studies on bFGF mRNA and MMP-9 mRNA expressions with microvascular density, progression, and prognosis of gastric carcinomas.
Carcinoma
Cortactin and Exo70 mediated invasion of hepatoma carcinoma cells by MMP-9 secretion.
Carcinoma
Cutaneous carcinomas and preinvasive neoplastic lesions. Role of MMP-2 and MMP-9 metalloproteinases in neoplastic invasion and their relationship with proliferative activity and p53 expression.
Carcinoma
CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.
Carcinoma
CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma.
Carcinoma
Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9.
Carcinoma
CYFRA 21-1 and MMP-9 as salivary biomarkers for the detection of oral squamous cell carcinoma: a systematic review of diagnostic test accuracy.
Carcinoma
Determination of matrix metalloproteinase 9 (MMP-9) protein expression in laryngeal squamous cell carcinomas based on digital image analysis.
Carcinoma
Diagnostic and prognostic ability of salivary MMP-9 for oral squamous cell carcinoma: A pre-/post-surgery case and matched control study.
Carcinoma
Differential expression and activity status of MMP-1, MMP-2 and MMP-9 in tumor and stromal cells of squamous cell carcinomas of the lung.
Carcinoma
Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs.
Carcinoma
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
Carcinoma
Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.
Carcinoma
Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.
Carcinoma
Differential expression of stromal MMP-1, MMP-9 and TIMP-1 in basal cell carcinomas of immunosuppressed patients and controls.
Carcinoma
Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis.
Carcinoma
Distribution and clinical significance of circulating tumor cells in nasopharyngeal carcinoma.
Carcinoma
DJ-1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway.
Carcinoma
DN-R175H p53 mutation is more effective than p53 interference in inducing epithelial disorganization and activation of proliferation signals in human carcinoma cells: role of E-cadherin.
Carcinoma
DNA ploidy analysis and expression of MMP-9, TIMP-2, and E-cadherin in gastric carcinoma.
Carcinoma
Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression.
Carcinoma
Downregulated lncRNA UCA1 accelerates proliferation and migration of vascular smooth muscle cells by epigenetic regulation of MMP9.
Carcinoma
Downregulation of G3BPs inhibits the growth, migration and invasion of human lung carcinoma H1299 cells by suppressing the Src/FAK-associated signaling pathway.
Carcinoma
Early changes in the apparent diffusion coefficient and MMP-9 expression of a cervical carcinoma U14 allograft model following irradiation.
Carcinoma
Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
Carcinoma
Effect and mechanism of RUNX3 gene on biological characteristics of human esophageal squamous cell carcinoma (ESCC).
Carcinoma
Effect of NLK on the proliferation and invasion of laryngeal carcinoma cells by regulating CDCP1.
Carcinoma
Effect of selective small molecule inhibitors on MMP-9 and VEGFR-1 expression in p16-positive and -negative squamous cell carcinoma.
Carcinoma
Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines.
Carcinoma
Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer.
Carcinoma
Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
Carcinoma
Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma.
Carcinoma
Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer.
Carcinoma
EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
Carcinoma
Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas.
Carcinoma
Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
Carcinoma
Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers.
Carcinoma
Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.
Carcinoma
Epigenetic DNA-methylation regulation of genes coding for lipid raft-associated components: a role for raft proteins in cell transformation and cancer progression (review).
Carcinoma
ESE-1 inhibits the invasion of oral squamous cell carcinoma in conjunction with MMP-9 suppression.
Carcinoma
Establishment of field change by expression of cytokeratins 8/18, 19, and MMP-9 in an apparently normal oral mucosa adjacent to squamous cell carcinoma: A immunohistochemical study.
Carcinoma
ETS-1 regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell SKOV-3.
Carcinoma
Evaluation of Serum Levels of HER2, MMP-9, Nitric Oxide, and Total Antioxidant Capacity in Egyptian Breast Cancer Patients: Correlation with Clinico-Pathological Parameters.
Carcinoma
Expression and biological relationship of vascular endothelial growth factor-a and matrix metalloproteinase-9 in gastric carcinoma.
Carcinoma
Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
Carcinoma
Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma.
Carcinoma
Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor.
Carcinoma
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Carcinoma
Expression and prognostic relevance of Cyclophilin A and matrix metalloproteinase 9 in esophageal squamous cell carcinoma.
Carcinoma
Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors.
Carcinoma
Expression and significance of MMP-9 and MDM2 in the oncogenesis of lung cancer in rats.
Carcinoma
Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma.
Carcinoma
Expression of 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma.
Carcinoma
Expression of C-X-C chemokine receptor types 1/2 in patients with gastric carcinoma: Clinicopathological correlations and significance.
Carcinoma
Expression of Concern: Capsaicin inhibits migration and invasion via the AMPK/NF-kB signaling pathway in esophagus sequamous cell carcinoma by decreasing matrix metalloproteinase-9 expression.
Carcinoma
Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis.
Carcinoma
Expression of Cytokeratin Subtypes: MMP-9, p53, and ?SMA to Differentiate Basaloid Squamous Cell Carcinoma From Other Basaloid Tumors of the Oral Cavity.
Carcinoma
Expression of E-cadherin and matrix metalloproteinase-9 in oral squamous cell carcinoma and histologically negative surgical margins and association with clinicopathological parameters.
Carcinoma
Expression of epidermal growth-factor (EGF), matrix metalloproteinase-9 (mmp-9) and proliferating cell nuclear antigen (pcna) in esophageal cancer.
Carcinoma
Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Carcinoma
Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.
Carcinoma
Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
Carcinoma
Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells - Associations with histopathology and patients outcome.
Carcinoma
Expression of matrix metalloproteinase 9 in pancreatic ductal carcinoma is associated with tumor metastasis formation.
Carcinoma
Expression of matrix metalloproteinase-2 and 9 in cervical intraepithelial neoplasia and cervical carcinoma among different age groups of premenopausal and postmenopausal women.
Carcinoma
Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions.
Carcinoma
Expression of matrix metalloproteinase-9 (MMP-9) and blood vessel density in laryngeal squamous cell carcinomas.
Carcinoma
Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis.
Carcinoma
Expression of matrix metalloproteinase-9 in high-grade salivary gland carcinomas is associated with their metastatic potential.
Carcinoma
Expression of matrix metalloproteinase-9 in oral potentially malignant disorders: A systematic review.
Carcinoma
Expression of matrix metalloproteinase-9 in patients with squamous cell carcinoma of the larynx.
Carcinoma
Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
Carcinoma
Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.
Carcinoma
Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer.
Carcinoma
Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Carcinoma
Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Carcinoma
Expression of matrix metalloproteinases (MMP-2 and MMP-9) in recurrent respiratory papillomas and laryngeal carcinoma: clinical and morphological parallels.
Carcinoma
Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Carcinoma
Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas.
Carcinoma
Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
Carcinoma
Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Carcinoma
Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
Carcinoma
Expression of matrix metalloproteinases in gallbladder carcinoma and their significance in carcinogenesis.
Carcinoma
Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Carcinoma
Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland.
Carcinoma
Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma.
Carcinoma
Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
Carcinoma
Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas.
Carcinoma
Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival.
Carcinoma
Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
Carcinoma
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Carcinoma
Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue.
Carcinoma
Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.
Carcinoma
Expression of reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase 9 in middle ear squamous cell carcinoma.
Carcinoma
Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC.
Carcinoma
Expression of SKA1 and MMP-9 in primary salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis.
Carcinoma
Expression of thrombospondin-1 in human pancreatic adenocarcinomas: role in matrix metalloproteinase-9 production.
Carcinoma
Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung.
Carcinoma
Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer.
Carcinoma
Expression of VEGF, HGF, IL-6, IL-8, MMP-9, Telomerase in Peripheral Blood of Patients with Head and Neck Squamous Cell Carcinoma.
Carcinoma
Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.
Carcinoma
Expressions of CD147, MMP-2 and MMP-9 in Laryngeal Carcinoma and its Correlation with Poor Prognosis.
Carcinoma
Expressions of E-cadherin, Cortactin and MMP-9 in Pseudoepitheliomatous Hyperplasia and Squamous Cell Carcinoma of the Head and Neck: Their Relationships with Clinicopathologic Factors and Prognostic Implication.
Carcinoma
Expressions of Matrix Metalloproteinase-7 and -9 and their Prognostic Significances in Rectal Cancer.
Carcinoma
Expressions of matrix metalloproteinase-9 (MMP-9), dentin sialophosphoprotein (DSPP), and osteopontin (OPN) at histologically negative surgical margins may predict recurrence of oral squamous cell carcinoma.
Carcinoma
Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma.
Carcinoma
Fibroblast-directed expression and localization of 92-kDa type IV collagenase along the tumor-stroma interface in an in vitro three-dimensional model of human squamous cell carcinoma.
Carcinoma
Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells.
Carcinoma
Fibronectin induces matrix metalloproteinase-9 (MMP-9) in human laryngeal carcinoma cells by involving multiple signaling pathways.
Carcinoma
Formal model of the interplay between TGF?1 and MMP-9 and their dynamics in hepatocellular carcinoma.
Carcinoma
Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Carcinoma
Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity.
Carcinoma
Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression.
Carcinoma
Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
Carcinoma
Glycogen synthase kinase-3? mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion.
Carcinoma
Heat shock protein 60 overexpression is associated with the progression and prognosis in gastric cancer.
Carcinoma
Hemoglobin induces the production and release of matrix metalloproteinase-9 from human malignant cells.
Carcinoma
Heparin-binding epidermal growth factor-like growth factor is a potent regulator of invasion activity in oral squamous cell carcinoma.
Carcinoma
High expression of heat shock protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer.
Carcinoma
High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinoma.
Carcinoma
High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma.
Carcinoma
Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence.
Carcinoma
HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction.
Carcinoma
HPV16 infection promotes an M2 macrophage phenotype to promote the invasion and metastasis of esophageal squamous cell carcinoma.
Carcinoma
HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis.
Carcinoma
Human tongue carcinoma growth is inhibited by selective antigelatinolytic peptides.
Carcinoma
Hypoxia-Induced Cleavage Of Soluble ephrinA1 From Cancer Cells Is Mediated By MMP-2 And Associates With Angiogenesis In Oral Squamous Cell Carcinoma.
Carcinoma
Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and -7.
Carcinoma
Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array.
Carcinoma
Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Carcinoma
Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue.
Carcinoma
Immunohistochemical analysis of neutrophils, interleukin-17, matrix metalloproteinase-9, and neoformed vessels in oral squamous cell carcinoma.
Carcinoma
Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
Carcinoma
Immunohistochemical Demonstration of Membrane-bound Prostaglandin E(2) Synthase-1 in Papillary Thyroid Carcinoma.
Carcinoma
Immunohistochemical evaluation of MMP-2, MMP-9 and CD31/microvascular density in squamous cell carcinomas of the floor of the mouth.
Carcinoma
Immunohistochemical expression of epidermal growth factor receptor, E-cadherin, and matrix metalloproteinase-9 in ovarian epithelial cancer and relation to patient deaths.
Carcinoma
Immunohistochemical expression of matrix metalloproteinase-1, matrix metalloproteinase-2 and matrix metalloproteinase-9, myofibroblasts and Ki-67 in actinic cheilitis and lip squamous cell carcinoma.
Carcinoma
Immunohistochemical expression of MMP-9 and VEGF in squamous cell carcinoma of the tongue.
Carcinoma
Immunohistochemical predictors in squamous cell carcinoma of the tongue and floor of the mouth.
Carcinoma
Immunohistochemical Study of Laminin-332 ?2 Chain and MMP-9 in High Risk of Malignant Transformation Oral Lesions and OSCC.
Carcinoma
Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
Carcinoma
Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer.
Carcinoma
Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma.
Carcinoma
Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma.
Carcinoma
Increased expression of tissue inhibitor of metalloproteinase-2 in clear cell carcinoma of the ovary.
Carcinoma
Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells.
Carcinoma
Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma.
Carcinoma
Increased VEGFR2 and MMP9 protein levels are associated with epithelial dysplasia grading.
Carcinoma
Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Carcinoma
Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts.
Carcinoma
Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer.
Carcinoma
Influence of lymphatic endothelial cells on proliferation and invasiveness of esophageal carcinoma cells in vitro and lymphangiogenesis in vivo.
Carcinoma
Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
Carcinoma
Inhibition of laryngeal cancer cell invasion and growth with lentiviral-vector delivered short hairpin RNA targeting human MMP-9 gene.
Carcinoma
Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma.
Carcinoma
Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion.
Carcinoma
Inhibitory effect of Au@Pt-NSs on proliferation, migration, and invasion of EJ bladder carcinoma cells: involvement of cell cycle regulators, signaling pathways, and transcription factor-mediated MMP-9 expression.
Carcinoma
Inonotus obliquus-derived polysaccharide inhibits the migration and invasion of human non-small cell lung carcinoma cells via suppression of MMP-2 and MMP-9.
Carcinoma
Integrin ?6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC).
Carcinoma
Integrin ?v?6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Carcinoma
Interactions between filamin A and MMP-9 regulate proliferation and invasion in renal cell carcinoma.
Carcinoma
Interleukin 1beta enhances invasive ability of gastric carcinoma through nuclear factor-kappaB activation.
Carcinoma
Interleukin 8 and vascular endothelial growth factor -- prognostic factors in human gastric carcinomas?
Carcinoma
Interplay of N-Cadherin and matrix metalloproteinase 9 enhances human nasopharyngeal carcinoma cell invasion.
Carcinoma
Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma.
Carcinoma
Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma.
Carcinoma
Involvement of proteasomes in migration and matrix metalloproteinase-9 production of oral squamous cell carcinoma.
Carcinoma
Involvement of transforming growth factor beta1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells.
Carcinoma
Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression.
Carcinoma
KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line.
Carcinoma
Kalopanaxsaponin a inhibits the invasion of human oral squamous cell carcinoma by reducing metalloproteinase-9 mRNA stability and protein trafficking.
Carcinoma
Knockdown of Angiopoietin-2 Suppresses Metastasis in Human Pancreatic Carcinoma by Reduced Matrix Metalloproteinase-2.
Carcinoma
Knockdown of Matrix Metallopeptidase 9 Inhibits Metastasis of Oral Squamous Cell Carcinoma Cells in a Zebrafish Xenograft Model.
Carcinoma
Legume seeds and colorectal cancer revisited: Protease inhibitors reduce MMP-9 activity and colon cancer cell migration.
Carcinoma
Leptin acts on neoplastic behavior and expression levels of genes related to hypoxia, angiogenesis, and invasiveness in oral squamous cell carcinoma.
Carcinoma
LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
Carcinoma
Localization of 92-kDa type IV collagenase in human skin tumors: comparison with normal human fetal and adult skin.
Carcinoma
Localization of Matrix Metalloproteinase (MMP)-9 in Lung Tissue of a Murine Model of Allergic Asthma.
Carcinoma
Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption.
Carcinoma
Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.
Carcinoma
Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma.
Carcinoma
Lower Serum Matrix Metalloproteinase?9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis.
Carcinoma
Mast cells and matrix metalloproteinase 9 expression in actinic cheilitis and lip squamous cell carcinoma.
Carcinoma
Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer.
Carcinoma
Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer.
Carcinoma
Matrix metalloproteinase (MMP)-2 and MMP-9 polymorphisms and haplotypes as disease biomarkers.
Carcinoma
Matrix metalloproteinase (MMP-2 and MMP-9) and steroid receptor expressions in feline mammary tumors.
Carcinoma
Matrix metalloproteinase 2 and matrix metalloproteinase 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: preliminary observations.
Carcinoma
Matrix metalloproteinase 9 and relapse in patients with early stage squamous cervical carcinoma.
Carcinoma
Matrix metalloproteinase 9 inhibits the motility of highly aggressive HSC-3 oral squamous cell carcinoma cells.
Carcinoma
Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.
Carcinoma
Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression.
Carcinoma
Matrix metalloproteinase expression in normal skin associated with basal cell carcinoma and in distal skin from the same patients.
Carcinoma
Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population.
Carcinoma
Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma.
Carcinoma
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.
Carcinoma
Matrix metalloproteinase-9 (MMP-9) Expression in Non-Small Cell Lung Carcinoma and Its Association with Clinicopathologic Factors.
Carcinoma
Matrix metalloproteinase-9 (MMP-9) immunoreactive protein in urinary bladder cancer: a marker of favorable prognosis.
Carcinoma
Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition.
Carcinoma
Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy.
Carcinoma
Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade.
Carcinoma
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.
Carcinoma
Matrix metalloproteinase-9 is a prognostic marker to predict survival of patients who underwent surgery due to rectal carcinoma.
Carcinoma
Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population.
Carcinoma
Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1.
Carcinoma
Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma.
Carcinoma
Matrix metalloproteinases 2 and 9 immunoexpression in prostate carcinoma at the positive margin of radical prostatectomy specimens.
Carcinoma
Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer.
Carcinoma
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions.
Carcinoma
Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Carcinoma
Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma.
Carcinoma
Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-?B DNA-binding activity.
Carcinoma
Merkel Cell Polyomavirus Small Tumor Antigen Activates Matrix Metallopeptidase-9 Gene Expression for Cell Migration and Invasion.
Carcinoma
Metalloprotease-specific poly(ethylene glycol) methyl ether-peptide-doxorubicin conjugate for targeting anticancer drug delivery based on angiogenesis.
Carcinoma
Metalloproteinases and their inhibitors: Influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas.
Carcinoma
Metalloproteinases and tissue inhibitor of metalloproteinase 1 (TIMP-1) in endometrial flushings from pre- and post-menopausal women and from women with endometrial adenocarcinoma.
Carcinoma
Methanol extract of Hydroclathrus clathratus suppresses matrix metalloproteinase-9 in T24 bladder carcinoma cells by suppressing the NF-?B and MAPK pathways.
Carcinoma
MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
Carcinoma
MMP production in human fibrosarcoma cells and their invasiveness are regulated by group IB secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2.
Carcinoma
MMP-2 and MMP-9 as prognostic markers for the early detection of urinary bladder cancer.
Carcinoma
MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma.
Carcinoma
MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells.
Carcinoma
MMP-9 activity in urine from patients with various tumors, as measured by a novel MMP activity assay using modified urokinase as a substrate.
Carcinoma
MMP-9 as a?potential biomarker for carcinoma of oral cavity: a?study in?eastern India.
Carcinoma
MMP-9 expression increases according to the grade of squamous intraepithelial lesion in cervical smears.
Carcinoma
MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis.
Carcinoma
MMP-9 Knockdown Inhibits Oral Squamous Cell Carcinoma Lymph Node Metastasis in the Nude Mouse Tongue-Xenografted Model through the RhoC/Src Pathway.
Carcinoma
MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits.
Carcinoma
Modulation of human renal cell carcinoma 786-0 MMP-2 and MMP-9 activity by inhibitors and inducers in vitro.
Carcinoma
Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma.
Carcinoma
Monocyte differentiation induced by co-culture with tumor cells involves RGD-dependent cell adhesion to extracellular matrix.
Carcinoma
mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas.
Carcinoma
mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue.
Carcinoma
New relationships between prostatic intraepithelial neoplasia and prostatic carcinoma.
Carcinoma
Nimbolide Represses the Proliferation, Migration, and Invasion of Bladder Carcinoma Cells via Chk2-Mediated G2/M Phase Cell Cycle Arrest, Altered Signaling Pathways, and Reduced Transcription Factors-Associated MMP-9 Expression.
Carcinoma
nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression.
Carcinoma
No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Carcinoma
Notch1 signaling pathway participates in cancer invasion by regulating MMPs in lingual squamous cell carcinoma.
Carcinoma
Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45.
Carcinoma
Oncocytoma-like renal tumor with transformation toward high-grade oncocytic carcinoma: a unique case with morphologic, immunohistochemical, and genomic characterization.
Carcinoma
Opposite effect of stable transfection of bioactive transforming growth factor-beta 1 (TGF beta 1) versus exogenous TGF beta 1 treatment on expression of 92-kDa type IV collagenase in mouse skin squamous cell carcinoma CH72 cells.
Carcinoma
Over-expression of mir-124 inhibits MMP-9 expression and decreases invasion of renal cell carcinoma cells.
Carcinoma
Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells.
Carcinoma
Overexpression of MMP-2 and MMP-9 in squamous cell carcinomas of immunosuppressed patients.
Carcinoma
Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma.
Carcinoma
p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity.
Carcinoma
Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures.
Carcinoma
Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray.
Carcinoma
Periostin promotes migration and invasion of renal cell carcinoma through the integrin/focal adhesion kinase/c-Jun N-terminal kinase pathway.
Carcinoma
Peritumoral Clefting and Expression of MMP-2 and MMP-9 in Basal Cell Carcinoma of the Skin.
Carcinoma
Phenotypes of human esophageal squamous cell carcinoma based on matrix metalloproteinase production.
Carcinoma
Pituitary tumor-transforming 1 expression in laryngeal cancer and its association with prognosis.
Carcinoma
Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Carcinoma
Prediction of metastasis in oral squamous cell carcinoma through phenotypic evaluation and gene expression of E-cadherin, ?-catenin, matrix metalloproteinase-2, and matrix metalloproteinase-9 biomarkers with clinical correlation.
Carcinoma
Preoperative serum MMP-9 immunoreactive protein is a prognostic indicator for relapse-free survival in breast carcinoma.
Carcinoma
Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma.
Carcinoma
Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells.
Carcinoma
Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor.
Carcinoma
Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
Carcinoma
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Carcinoma
Prognostic impact of MMP-2 and MMP-9 expression in pathologic stage IA non-small cell lung cancer.
Carcinoma
Prognostic role of MMP-9 expression in head and neck carcinoma patients treated with radiotherapy or chemoradiotherapy.
Carcinoma
Prognostic significance of CD44v6, p63, Podoplanin, and MMP-9 in oral squamous cell carcinomas.
Carcinoma
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma.
Carcinoma
Prognostic significance of matrix metalloproteinases-2 activation ratio in renal cell carcinoma.
Carcinoma
Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis.
Carcinoma
Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
Carcinoma
Prognostic value of matrix metalloproteinase-9 expression in oral squamous cell carcinoma and its association with angiogenesis.
Carcinoma
Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma.
Carcinoma
Prognostic value of microvessel density, matrix metalloproteinase-9 and p53 protein expression in esophageal cancer.
Carcinoma
Prognostic value of transforming growth factor beta 1 [TGF-?1] and matrix metalloproteinase 9 [MMP-9] in oral squamous cell carcinoma.
Carcinoma
Prominent expression of metalloproteinases in early stages of ovarian tumorigenesis.
Carcinoma
Protein Expression and Significance of VEGF, EGFR and MMP-9 in Non-Small Cell Lung Carcinomas.
Carcinoma
Proteinase suppression by E-cadherin-mediated cell-cell attachment in premalignant oral keratinocytes.
Carcinoma
Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma.
Carcinoma
Reduced expression of tissue inhibitor of metalloproteinase in nodal metastasis of stomach cancer.
Carcinoma
Regulation of matrix metalloproteinase-9 (MMP-9) by translational efficiency in murine prostate carcinoma cells.
Carcinoma
Regulation of matrix metalloproteinase-9 transcription in squamous cell carcinoma of uterine cervix: the role of human papillomavirus gene E2 expression and activation of transcription factor NF-kappaB.
Carcinoma
Regulatory effect of MiR103 on proliferation, EMT and invasion of oral squamous carcinoma cell through SALL4.
Carcinoma
Relationship between preoperative staging by endoscopic ultrasonography and MMP-9 expression in gastric carcinoma.
Carcinoma
Relationship of 99mTc-HYNIC annexin V uptake to microvessel density, FasL and MMP-9 expression, and the number of tumour-infiltrating lymphocytes in head and neck carcinoma.
Carcinoma
Relationships between clinical behavior of laryngeal squamous cell carcinomas and expression of VEGF, MMP-9 and E-cadherin.
Carcinoma
Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer.
Carcinoma
Repressions of MMP-9 expression and NF-kappa B localization are involved in inhibition of lung carcinoma 95-D cell invasion by (-)-epigallocatechin-3-gallate.
Carcinoma
Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma.
Carcinoma
Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells.
Carcinoma
Retinoic acid and extracellular matrix inhibition of matrix metalloproteinase 9 expression is mediated by the mitogen activated protein kinase pathway.
Carcinoma
Retraction. Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells.
Carcinoma
Retraction: Capsaicin inhibits migration and invasion via the AMPK/NF-kB signaling pathway in esophagus sequamous cell carcinoma by decreasing matrix metalloproteinase-9 expression.
Carcinoma
Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity.
Carcinoma
Role of cyclooxygenase-2, ezrin and matrix metalloproteinase-9 as predictive markers for recurrence of basal cell carcinoma.
Carcinoma
Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population.
Carcinoma
Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer.
Carcinoma
Role of matrix metalloproteinase-9 in in vitro invasion of esophageal carcinoma cells.
Carcinoma
Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas.
Carcinoma
Role of matrix metalloproteinase-9 in transforming growth factor-?1-induced epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Carcinoma
Safety Analysis of Apatinib Combined with Chemotherapy in the Treatment of Advanced Gastric Carcinoma: A Randomised Controlled Trial.
Carcinoma
Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma - a Systematic Review with Meta Analysis.
Carcinoma
Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Carcinoma
Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.
Carcinoma
Serum concentrations of matrix metalloproteinase-9 and vascular endothelial growth factor affect the prognosis of primary hepatic carcinoma patients treated with percutaneous ethanol injection.
Carcinoma
Serum Level of Matrix Metalloproteinase-9 in Patients with Head and Neck Squamous Cell Carcinoma.
Carcinoma
Serum levels of endostatin and matrix metalloproteinase-9 associated with high stage and grade primary transitional cell carcinoma of the bladder.
Carcinoma
Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma.
Carcinoma
Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker.
Carcinoma
Serum melatonin is inversely associated with matrix metalloproteinase-9 in oral squamous cell carcinoma.
Carcinoma
Shortened microsatellite d(CA)21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene.
Carcinoma
Significance of circulating matrix metalloproteinase-9 to tissue inhibitor of metalloproteinases-2 ratio as a predictor of disease progression in patients with metastatic renal cell carcinoma receiving sunitinib.
Carcinoma
Significance of matrix metalloproteinase 9 and CD34 expressions in esophageal carcinoma: correlation with DNA content.
Carcinoma
Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
Carcinoma
Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
Carcinoma
Sirtuin-1 Controls Poly (I:C)-Dependent Matrix Metalloproteinase 9 Activation in Primary Human Nasal Epithelial Cells.
Carcinoma
Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma.
Carcinoma
Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling.
Carcinoma
Sodium caffeate induces endothelial cell apoptosis and inhibits VEGF expression in cancer cells.
Carcinoma
Sonic hedgehog signaling may promote invasion and metastasis of oral squamous cell carcinoma by activating MMP-9 and E-cadherin expression.
Carcinoma
Stimulation of Peritoneal Mesothelial Cells to Secrete Matrix Metalloproteinase-9 (MMP-9) by TNF-?: A Role in the Invasion of Gastric Carcinoma Cells.
Carcinoma
Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy.
Carcinoma
Stromal factors involved in human prostate cancer development, progression and castration resistance.
Carcinoma
Stromal reaction in cancer tissue: pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions.
Carcinoma
Stromal versus tumoral inflammation differentially contribute to metastasis and poor survival in laryngeal squamous cell carcinoma.
Carcinoma
Strong significant correlation between MMP-9 and systemic symptoms in patients with localized renal cell carcinoma.
Carcinoma
Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.
Carcinoma
Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion.
Carcinoma
Suppressive effect of calcipotriol on the induction of matrix metalloproteinase (MMP)-9 and MMP-13 in a human squamous cell carcinoma cell line.
Carcinoma
Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cells.
Carcinoma
Taxifolin inhibits the scar cell carcinoma growth by inducing apoptosis, cell cycle arrest and suppression of PI3K/AKT/mTOR pathway.
Carcinoma
The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity.
Carcinoma
The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells.
Carcinoma
The aqueous extract of Prunella vulgaris suppresses cell invasion and migration in human liver cancer cells by attenuating matrix metalloproteinases.
Carcinoma
The chemokine CCL7 regulates invadopodia maturation and MMP-9 mediated collagen degradation in liver-metastatic carcinoma cells.
Carcinoma
The effects of periodontitis associated microbiota on the development of oral squamous cell carcinoma.
Carcinoma
The expression of invasive behavior of differentiated squamous carcinoma cell line evaluated by an in vitro invasion model.
Carcinoma
The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival.
Carcinoma
The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Carcinoma
The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.
Carcinoma
The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
Carcinoma
The influence of matrix metalloproteinase-2, -9, and -12 promoter polymorphisms on Iranian patients with oesophageal squamous cell carcinoma.
Carcinoma
The inhibitory effects of capillarisin on cell proliferation and invasion of prostate carcinoma cells.
Carcinoma
The inhibitory effects of immunosuppressive factors, dexamethasone and interleukin-4, on NF-kappaB-mediated protease production by oral cancer.
Carcinoma
The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells.
Carcinoma
The Mechanism of Asparagine Endopeptidase in the Progression of Malignant Tumors: A Review.
Carcinoma
The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
Carcinoma
The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery.
Carcinoma
The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma.
Carcinoma
The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter.
Carcinoma
The role of CD44 and matrix metalloproteinase-9 expression in predicting neck metastasis of supraglottic laryngeal carcinoma.
Carcinoma
The role of matrix metalloproteinases 2 and 9 during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide.
Carcinoma
The role of MMP-2 and MMP-9 as prognostic markers in the early stages of tongue squamous cell carcinoma.
Carcinoma
The role of MMP-2 and MMP-9 in the metastasis and development of hypopharyngeal carcinoma.
Carcinoma
Therapeutic effect of topical 5-fluorouracil in conjunctival squamous carcinoma is associated with changes in matrix metalloproteinases and tissue inhibitor of metalloproteinases expression.
Carcinoma
Tianeptine sodium salt suppresses TNF-?-induced expression of matrix metalloproteinase-9 in human carcinoma cells via suppression of the PI3K/Akt-mediated NF-?B pathway.
Carcinoma
Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.
Carcinoma
Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
Carcinoma
Transcriptional factor snail controls tumor neovascularization, growth and metastasis in mouse model of human ovarian carcinoma.
Carcinoma
Transforming growth factor-beta facilitates breast carcinoma metastasis by promoting tumor cell survival.
Carcinoma
Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells.
Carcinoma
Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Carcinoma
Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma.
Carcinoma
Tumor-associated serpin, squamous cell carcinoma antigen stimulates matrix metalloproteinase-9 production in cervical squamous cell carcinoma cell lines.
Carcinoma
Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species.
Carcinoma
Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.
Carcinoma
Upregulated expression and activation of membrane?associated proteases in esophageal squamous cell carcinoma.
Carcinoma
Urinary trypsin inhibitor suppresses surgical stress-facilitated lung metastasis of murine colon 26-L5 carcinoma cells.
Carcinoma
Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Carcinoma
Usefulness of MMP-9/TIMP-1 in predicting tumor recurrence in patients undergoing curative surgical resection for gastric carcinoma.
Carcinoma
Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas.
Carcinoma
VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis.
Carcinoma
WIP1 stimulates migration and invasion of salivary adenoid cystic carcinoma by inducing MMP-9 and VEGF-C.
Carcinoma
Withdrawal: ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3.
Carcinoma
XBP1 induces MMP-9 expression to promote proliferation and invasion in human esophageal squamous cell carcinoma.
Carcinoma
XRCC1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis through suppressing MMP-2 and MMP-9.
Carcinoma
Yokukansan Alleviates Cancer Pain by Suppressing Matrix Metalloproteinase-9 in a Mouse Bone Metastasis Model.
Carcinoma
Zinc dependent endopeptidases of matrix metalloproteinases-9 expressions is associated with tumor metastases of oral squamous cell carcinoma in Chinese population: a meta-analysis.
Carcinoma
Zymographic analysis of circulating and tissue forms of colon carcinoma gelatinase A (MMP-2) and B (MMP-9) separated by mono- and two-dimensional electrophoresis.
Carcinoma
[Biological implication of PTEN gene expression in human gastric cancer and related molecular mechanisms]
Carcinoma
[Clinical significance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in peripheral blood of patients with gastric carcinoma]
Carcinoma
[Correlation study between OPN, CD44v6, MMP-9 and distant metastasis in laryngeal squamous cell carcinoma].
Carcinoma
[Correlations of serous levels of matrix metalloproteinases (MMP-2 and MMP-9) to invasion and metastasis of papillary thyroid carcinoma]
Carcinoma
[Diagnosis and follow-up value of quantitative examination of MMP9 in the urine of BTCC patients]
Carcinoma
[Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck]
Carcinoma
[Digoxin inhibits migration and invasion of human gastric carcinoma MKN45 cells through down-regulation of AEG-1].
Carcinoma
[Effect of GM6001 on the model that cervical squamous carcinoma cell line HCE1 multicellular spheroids invade live human umbilical vein endothelium cell monolayers.]
Carcinoma
[Effect of mechanical stimulation on the invasion in salivary adenoid cystic carcinoma]
Carcinoma
[Effect of ray cartilage glycosaminoglycans (RCG) on the expression of MMP-9 in Lewis lung carcinoma]
Carcinoma
[Effects of docosahexaenoic acid on cell apoptosis, invasion and migration of cervical cancer cells in vitro].
Carcinoma
[Effects of HPV 16-E6/E7 oncogene on expression of vascular endothelial growth factor and matrix metalloproteinase 9 in human laryngeal squamous cell carcinoma cell line]
Carcinoma
[Effects of RhoA gene silencing by RNA interference on invasion of tongue carcinoma].
Carcinoma
[Expression and clinical significance of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinomas]
Carcinoma
[Expression and clinical value of eukaryotic initiation factor4E and matrix metalloproteinase-9 in supraglottic and hypopharyngeal carcinoma and metastasic lymph]
Carcinoma
[Expression and hypoxic regulation of vascular endothelial growth factor and matrix metalloproteinase-9 in esophageal carcinoma]
Carcinoma
[Expression and significance of CD44v6 and MMP-9 in laryngeal squamous cell carcinoma]
Carcinoma
[Expression and significance of matrix metalloproteinase and tissue inhibitor of metalloproteinase in nasal cavity squamous cell carcinoma].
Carcinoma
[Expression and significance of MTDH and MMP-9 in laryngeal squamous cell carcinoma].
Carcinoma
[Expression and significance of the matrix metalloprofeinase inhibitor RECK gene in prostate cell strains]
Carcinoma
[Expression of AKT2, Cyclin D1, and MMP-9 and Their Correlations to Clinicopathologic Features of Non-small Cell Lung Cancer.]
Carcinoma
[Expression of COX-2 and MMP-9 in cervical carcinoma and their clinical significance]
Carcinoma
[Expression of erythroblastic leukemia viral oncogene homolog 3 (ErbB-3) binding protein-1, matrix metalloproteinases, eplthelial cadherin in adenoid cystic carcinoma and correlation analysis].
Carcinoma
[Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma]
Carcinoma
[Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix]
Carcinoma
[Expression of matrix metalloproteinase-2,9 in hypopharyngeal carcinoma and its relationship with lymphatic metastasis]
Carcinoma
[Expression of MMP-2 and MMP-9 in non-small-cell lung cancer and their prognostic value.]
Carcinoma
[Expression of MMP-9 and MMP-9 mRNA in gastric carcinoma and its correlation with angiogenesis]
Carcinoma
[Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance]
Carcinoma
[Expressions of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 and their correlation with metastasis and prognosis in lung cancer.]
Carcinoma
[Expressions of matrix metalloproteinase-9 and interleukin-8 in nasopharygeal carcinoma and association with Epstein-Barr virus latent membrane protein-1]
Carcinoma
[Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues]
Carcinoma
[Gelatinases A and B and their endogenous regulators in the corpus uteri in squamous cell cervical carcinoma].
Carcinoma
[Immunohistochemical study of the specific features of expression of matrix metalloproteinases 1, 9 in the photoaged skin, the foci of actinic keratosis and basal cell carcinoma].
Carcinoma
[Inhibitory effects of matrix metalloproteinase (MMP) inhibitor LY52 on expression of MMP-2 and MMP-9 and invasive ability of human ovarian carcinoma cell line SKOV3]
Carcinoma
[Interactions of ovarian carcinoma cells and human peritoneal mesothelial cells involved in matrix metalloproteinases expressions of ovarian carcinoma cells]
Carcinoma
[Matrix metalloproteinase 2 and 9 as the factor of head and neck tumor metastasis]
Carcinoma
[Matrix metalloproteinases (MMP)--MMP-1,-2,-9 and its endogenous activity regulators in transformed by E7 oncogene HPV16 and HPV18 cervical carcinoma cell lines].
Carcinoma
[Matrix metalloproteinases and their tissue inhibitors in malignancies of the female genital tract]
Carcinoma
[miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression].
Carcinoma
[mRNA expression analysis of metastatic markers in clear-cell renal cell carcinoma]
Carcinoma
[Relationship between bFGF mRNA and MMP-9 mRNA expression in gastric carcinoma and their clinicopathological features as well as patients survival]
Carcinoma
[Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix]
Carcinoma
[Relationship between expression of matrix metalloproteinase-9 (MMP-9) and angiogenesis in renal cell carcinoma]
Carcinoma
[Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas]
Carcinoma
[Relationship of the disturbed balance between matrix metalloproteinases and their tissue inhibitors and the invasion of malignant salivary gland tumours]
Carcinoma
[Role of matrix metalloproteinases (MMPs) in tumor invasion and metastasis: serial studies on MMPs and TIMPs]
Carcinoma
[Role of tissue factor in the invasion of cultured human colon carcinoma cells and its correlation with matrix metalloproteinases]
Carcinoma
[Significance expression and relationships with endothelin-1, matrix metalloproteinase-9 in the laryngeal carcinoma].
Carcinoma
[The expression of a novel estrogen receptor, GPR30, in epithelial ovarian carcinoma and its correlation with MMP-9.]
Carcinoma
[The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship]
Carcinoma
[The expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in transplanted tumor of salivary adenoid cystic carcinoma cell lines]
Carcinoma
[The expression of MMP-2 and MMP-9 in adenoid cystic carcinoma of lacrimal gland].
Carcinoma
[The expression of MMP-2, -9 in the uterine leiomyoma and its significance in prognosis].
Carcinoma
[The influence of urothelial carcinoembryonic antigen 1 on invasion and migration of oral carcinoma cell lines].
Carcinoma
[The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma].
Carcinoma
[Type IV collagenase expression in human prostate carcinoma cell lines with different metastasis potentials]
Carcinoma
[Zymographic analysis of MMPs in human carcinoma cell lines with different metastasis potential]
Carcinoma in Situ
Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.
Carcinoma in Situ
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions.
Carcinoma in Situ
[The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship]
Carcinoma, Acinar Cell
Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland.
Carcinoma, Adenoid Cystic
Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas.
Carcinoma, Adenoid Cystic
Expression of SKA1 and MMP-9 in primary salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis.
Carcinoma, Adenoid Cystic
Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer.
Carcinoma, Adenoid Cystic
WIP1 stimulates migration and invasion of salivary adenoid cystic carcinoma by inducing MMP-9 and VEGF-C.
Carcinoma, Adenoid Cystic
[Effect of mechanical stimulation on the invasion in salivary adenoid cystic carcinoma]
Carcinoma, Adenoid Cystic
[Expression of erythroblastic leukemia viral oncogene homolog 3 (ErbB-3) binding protein-1, matrix metalloproteinases, eplthelial cadherin in adenoid cystic carcinoma and correlation analysis].
Carcinoma, Adenoid Cystic
[The expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in transplanted tumor of salivary adenoid cystic carcinoma cell lines]
Carcinoma, Adenoid Cystic
[The expression of MMP-2 and MMP-9 in adenoid cystic carcinoma of lacrimal gland].
Carcinoma, Adenosquamous
[Expression of MMP-2 and MMP-9 in non-small-cell lung cancer and their prognostic value.]
Carcinoma, Basal Cell
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
Carcinoma, Basal Cell
Differential expression of stromal MMP-1, MMP-9 and TIMP-1 in basal cell carcinomas of immunosuppressed patients and controls.
Carcinoma, Basal Cell
Expression of 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma.
Carcinoma, Basal Cell
Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
Carcinoma, Basal Cell
Localization of 92-kDa type IV collagenase in human skin tumors: comparison with normal human fetal and adult skin.
Carcinoma, Basal Cell
Matrix metalloproteinase expression in normal skin associated with basal cell carcinoma and in distal skin from the same patients.
Carcinoma, Basal Cell
Peritumoral Clefting and Expression of MMP-2 and MMP-9 in Basal Cell Carcinoma of the Skin.
Carcinoma, Basal Cell
Role of cyclooxygenase-2, ezrin and matrix metalloproteinase-9 as predictive markers for recurrence of basal cell carcinoma.
Carcinoma, Basal Cell
[Immunohistochemical study of the specific features of expression of matrix metalloproteinases 1, 9 in the photoaged skin, the foci of actinic keratosis and basal cell carcinoma].
Carcinoma, Ductal
Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.
Carcinoma, Ductal
Detection of serum VEGF and MMP-9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma.
Carcinoma, Ductal
Epidermal growth factor receptor-mediated regulation of matrix metalloproteinase-2 and matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Carcinoma, Ductal
Expression of extracellular matrix metalloproteinase (MMP-9), E-cadherin and proliferation-associated antigen Ki-67 and their reciprocal correlation in canine mammary adenocarcinomas.
Carcinoma, Ductal
Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
Carcinoma, Ductal
Immunohistochemical study of matrix metalloproteinases and their inhibitors in pure and mixed invasive and in situ ductal carcinomas of the breast.
Carcinoma, Ductal
Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.
Carcinoma, Ductal
RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
Carcinoma, Ductal
The interaction between aromatase, metalloproteinase 2,9 and cd44 in breast cancer.
Carcinoma, Ductal
Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (?35 Years).
Carcinoma, Endometrioid
Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population.
Carcinoma, Endometrioid
Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Carcinoma, Hepatocellular
(+)-Episesamin exerts anti-neoplastic effects in human hepatocellular carcinoma cell lines via suppression of nuclear factor-kappa B and inhibition of MMP-9.
Carcinoma, Hepatocellular
?-mangostin suppresses human hepatocellular carcinoma cell invasion through inhibition of MMP-2 and MMP-9 expression and activating the ERK and JNK pathways.
Carcinoma, Hepatocellular
A new pseudo-peptide of Arg-Gly-Asp (RGD) inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma.
Carcinoma, Hepatocellular
A novel cantharidin analog N-Benzylcantharidinamide reduces the expression of MMP-9 and invasive potentials of Hep3B via inhibiting cytosolic translocation of HuR.
Carcinoma, Hepatocellular
A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes.
Carcinoma, Hepatocellular
Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosis.
Carcinoma, Hepatocellular
Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-kappaB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: Association with the invasive potential.
Carcinoma, Hepatocellular
An absolute role of the PKC-dependent NF-kappaB activation for induction of MMP-9 in hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Analysis of matrix metalloproteinase mRNAs expressed in hepatocellular carcinoma cell lines.
Carcinoma, Hepatocellular
Anti-invasion effects of 6-shogaol and 6-gingerol, two active components in ginger, on human hepatocarcinoma cells.
Carcinoma, Hepatocellular
Anti-invasive activity of anthocyanins isolated from Vitis coignetiae in human hepatocarcinoma cells.
Carcinoma, Hepatocellular
Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity.
Carcinoma, Hepatocellular
Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Assessment of the clinical significance of serum vascular endothelial growth factor and matrix metalloproteinase-9 in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
Carcinoma, Hepatocellular
Bacoside A downregulates matrix metalloproteinases 2 and 9 in DEN-induced hepatocellular carcinoma.
Carcinoma, Hepatocellular
Baicalein Inhibits the Invasion and Metastatic Capabilities of Hepatocellular Carcinoma Cells via Down-Regulation of the ERK Pathway.
Carcinoma, Hepatocellular
Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes.
Carcinoma, Hepatocellular
Black tea polyphenols target matrix metalloproteinases, RECK, proangiogenic molecules and histone deacetylase in a rat hepatocarcinogenesis model.
Carcinoma, Hepatocellular
Brucella-infected hepatocytes mediate potentially tissue-damaging immune responses.
Carcinoma, Hepatocellular
Caffeic acid phenethyl ester inhibits invasion and expression of matrix metalloproteinase in SK-Hep1 human hepatocellular carcinoma cells by targeting nuclear factor kappa B.
Carcinoma, Hepatocellular
CD147, MMP-2, MMP-9 and MVD-CD34 are Significant Predictors of Recurrence After Liver Transplantation in Hepatocellular Carcinoma Patients.
Carcinoma, Hepatocellular
CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Cellular distribution of 92-kd type IV collagenase/gelatinase B in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
CHM-1 inhibits hepatocyte growth factor-induced invasion of SK-Hep-1 human hepatocellular carcinoma cells by suppressing matrix metalloproteinase-9 expression.
Carcinoma, Hepatocellular
Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines.
Carcinoma, Hepatocellular
Correction: Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity.
Carcinoma, Hepatocellular
Corrigendum to "Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-?B and AP-1 Activity".
Carcinoma, Hepatocellular
Cortactin and Exo70 mediated invasion of hepatoma carcinoma cells by MMP-9 secretion.
Carcinoma, Hepatocellular
Cucurbitacin B inhibits 12-O-tetradecanoylphorbol 13-acetate-induced invasion and migration of human hepatoma cells through inactivating mitogen-activated protein kinase and PI3K/Akt signal transduction pathways.
Carcinoma, Hepatocellular
Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion.
Carcinoma, Hepatocellular
Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Carcinoma, Hepatocellular
Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression.
Carcinoma, Hepatocellular
Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry.
Carcinoma, Hepatocellular
Effects of lamivudine on cell proliferation of liver cancer and expressions of HBsAg, HBeAg, and MMP-9 in patients.
Carcinoma, Hepatocellular
Elevated expression levels of androgen receptors and matrix metalloproteinase-2 and -9 in 30 cases of hepatocellular carcinoma compared with adjacent tissues as predictors of cancer invasion and staging.
Carcinoma, Hepatocellular
Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Epithelial-mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Evaluation of anti-invasion effect of resveratrol and related methoxy analogues on human hepatocarcinoma cells.
Carcinoma, Hepatocellular
Expression of Concern: CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Expression of LGR8 and related biomarkers in hepatocellular carcinoma: correlation with clinicopathological parameters.
Carcinoma, Hepatocellular
Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Carcinoma, Hepatocellular
Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
Carcinoma, Hepatocellular
Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues.
Carcinoma, Hepatocellular
Expression of the lysyl oxidase propeptide in hepatocellular carcinoma and its clinical relevance.
Carcinoma, Hepatocellular
Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Formal model of the interplay between TGF?1 and MMP-9 and their dynamics in hepatocellular carcinoma.
Carcinoma, Hepatocellular
FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibition.
Carcinoma, Hepatocellular
Functional polymorphisms in the promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 are not associated with hepatocellular carcinoma risk.
Carcinoma, Hepatocellular
Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells.
Carcinoma, Hepatocellular
Hepatitis C virus NS3 protein enhances cancer cell invasion by activating matrix metalloproteinase-9 and cyclooxygenase-2 through ERK/p38/NF-?B signal cascade.
Carcinoma, Hepatocellular
Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers.
Carcinoma, Hepatocellular
Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Hydroquinone stimulates cell invasion through activator protein-1-dependent induction of MMP-9 in HepG2 human hepatoma cells.
Carcinoma, Hepatocellular
Increased autophagy sustains the survival and pro-tumourigenic effects of neutrophils in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Increased Six1 expression in macrophages promotes hepatocellular carcinoma growth and invasion by regulating MMP-9.
Carcinoma, Hepatocellular
Inhibitory effect of immature plum on PMA-induced MMP-9 expression in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Inhibitory Effect of Semen Litchi Drug Serum on the Proliferation of Human Hepatoma HepG2 Cells and Expression of VEGF and MMP-9.
Carcinoma, Hepatocellular
Interaction of the hepatitis B spliced protein with cathepsin B promotes hepatoma cell migration and invasion.
Carcinoma, Hepatocellular
Interactions of alpha2-HS-glycoprotein (fetuin) with MMP-3 and murine squamous cell carcinoma cells.
Carcinoma, Hepatocellular
Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression.
Carcinoma, Hepatocellular
Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1.
Carcinoma, Hepatocellular
Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9.
Carcinoma, Hepatocellular
Isocitrate Dehydrogenase 2 Suppresses the Invasion of Hepatocellular Carcinoma Cells via Matrix Metalloproteinase 9.
Carcinoma, Hepatocellular
Kaempferol inhibits the cell migration of human hepatocellular carcinoma cells by suppressing MMP-9 and Akt signaling.
Carcinoma, Hepatocellular
Liver-specific overexpression of matrix metalloproteinase 9 (MMP-9) in transgenic mice accelerates development of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas.
Carcinoma, Hepatocellular
Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression.
Carcinoma, Hepatocellular
Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Matrine suppresses lung metastasis of human hepatocellular carcinoma by directly targeting matrix metalloproteinase-9.
Carcinoma, Hepatocellular
Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling.
Carcinoma, Hepatocellular
Matrix metalloproteinase-9 gene polymorphism in hepatocellular carcinoma patients with hepatitis B and C viruses.
Carcinoma, Hepatocellular
Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis.
Carcinoma, Hepatocellular
Melatonin maximizes the therapeutic potential of non-preconditioned MSCs in a DEN-induced rat model of HCC.
Carcinoma, Hepatocellular
Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-?B-dependent pathway that reduces uPA and MMP-9 expression.
Carcinoma, Hepatocellular
MicroRNA-133a inhibits cell proliferation, colony formation ability, migration and invasion by targeting matrix metallopeptidase 9 in hepatocellular carcinoma.
Carcinoma, Hepatocellular
MicroRNA-328-3p inhibits malignant progression of hepatocellular carcinoma by regulating MMP-9 level.
Carcinoma, Hepatocellular
Modulation of the Tumor Metastatic Microenvironment and Multiple Signal Pathways by Prunella vulgaris in Human Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma.
Carcinoma, Hepatocellular
Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Niclosamide suppresses migration of hepatocellular carcinoma cells and downregulates matrix metalloproteinase-9 expression.
Carcinoma, Hepatocellular
No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population.
Carcinoma, Hepatocellular
Over-expression of VEGF and MMP-9 in residual tumor cells of hepatocellular carcinoma after embolization with lipidol.
Carcinoma, Hepatocellular
Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)?2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway.
Carcinoma, Hepatocellular
Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis.
Carcinoma, Hepatocellular
Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential.
Carcinoma, Hepatocellular
Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion.
Carcinoma, Hepatocellular
Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Pigment epithelium-derived factor and matrix metalloproteinase-9 in liver cirrhosis.
Carcinoma, Hepatocellular
Plasma matrix metalloproteinase-9 (gelatinase B) in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Carcinoma, Hepatocellular
Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA-199a and downregulating MMP-9 expression.
Carcinoma, Hepatocellular
Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway.
Carcinoma, Hepatocellular
Radiosensitizing Potential of Curcumin in Different Cancer Models.
Carcinoma, Hepatocellular
Relevance of EGFR Between Serum VEGF and MMP-9 in Primary Hepatocellular Carcinoma Patients with Transarterial Chemoembolization.
Carcinoma, Hepatocellular
Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Role of tight junction-associated MARVEL protein marvelD3 in migration and epithelial-mesenchymal transition of hepatocellular carcinoma.
Carcinoma, Hepatocellular
S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-?B-dependent MMP-9 signal.
Carcinoma, Hepatocellular
Sinulariolide Suppresses Human Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 through MAPKs and PI3K/Akt Signaling Pathways.
Carcinoma, Hepatocellular
Sonic Hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer.
Carcinoma, Hepatocellular
Sorafenib inhibits TPA-induced MMP-9 and VEGF expression via suppression of ERK/NF-?B pathway in hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-?B and AP-1 Activity.
Carcinoma, Hepatocellular
The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus.
Carcinoma, Hepatocellular
The Chinese medicine Sini-San inhibits HBx-induced migration and invasiveness of human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.
Carcinoma, Hepatocellular
The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma.
Carcinoma, Hepatocellular
The role of Twist1 in hepatocellular carcinoma angiogenesis: a clinical study.
Carcinoma, Hepatocellular
The Significance of MMP-9 Over MMP-2 in HCC Invasiveness and Recurrence of Hepatocellular Carcinoma After Curative Resection.
Carcinoma, Hepatocellular
TIMP-1 mediates the inhibitory effect of interleukin-6 on the proliferation of a hepatocarcinoma cell line in a STAT3-dependent manner.
Carcinoma, Hepatocellular
Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model.
Carcinoma, Hepatocellular
Vanillin inhibits matrix metalloproteinase-9 expression through down-regulation of nuclear factor-kappaB signaling pathway in human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Wogonin Suppresses the Activity of Matrix Metalloproteinase-9 and Inhibits Migration and Invasion in Human Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
[Effects of resveratrol on matrix metalloproteinase-9 expression in hepatoma cells]
Carcinoma, Hepatocellular
[Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas]
Carcinoma, Hepatocellular
[Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma]
Carcinoma, Hepatocellular
[The role of angiostatin, vascular endothelial growth factor, matrix metalloproteinase 9 and 12 in the angiogenesis of hepatocellular carcinoma]
Carcinoma, Intraductal, Noninfiltrating
Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.
Carcinoma, Intraductal, Noninfiltrating
Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion.
Carcinoma, Intraductal, Noninfiltrating
Essential role of STAT5a in DCIS formation and invasion following estrogen treatment.
Carcinoma, Intraductal, Noninfiltrating
Everolimus Inhibits the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer Via Downregulation of MMP9 Expression.
Carcinoma, Intraductal, Noninfiltrating
Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
Carcinoma, Intraductal, Noninfiltrating
Immunohistochemical study of matrix metalloproteinases and their inhibitors in pure and mixed invasive and in situ ductal carcinomas of the breast.
Carcinoma, Intraductal, Noninfiltrating
Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast.
Carcinoma, Intraductal, Noninfiltrating
The interaction between aromatase, metalloproteinase 2,9 and cd44 in breast cancer.
Carcinoma, Large Cell
Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
Carcinoma, Lewis Lung
ATIQCTPC targeting MMP-9: a key step to slowing primary tumor growth and inhibiting metastasis of lewis lung carcinoma
Carcinoma, Lewis Lung
Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression.
Carcinoma, Lewis Lung
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.
Carcinoma, Lewis Lung
Metalloprotease-specific poly(ethylene glycol) methyl ether-peptide-doxorubicin conjugate for targeting anticancer drug delivery based on angiogenesis.
Carcinoma, Lewis Lung
MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis.
Carcinoma, Lewis Lung
Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cells.
Carcinoma, Lewis Lung
[Effect of ray cartilage glycosaminoglycans (RCG) on the expression of MMP-9 in Lewis lung carcinoma]
Carcinoma, Lobular
Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9.
Carcinoma, Medullary
Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.
Carcinoma, Merkel Cell
Merkel Cell Polyomavirus Small Tumor Antigen Activates Matrix Metallopeptidase-9 Gene Expression for Cell Migration and Invasion.
Carcinoma, Non-Small-Cell Lung
A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude mice.
Carcinoma, Non-Small-Cell Lung
Association of MMP9-1562C/T and MMP13-77A/G Polymorphisms with Non-Small Cell Lung Cancer in Southern Chinese Population.
Carcinoma, Non-Small-Cell Lung
Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9.
Carcinoma, Non-Small-Cell Lung
Cytochrome P450 ?-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Derlin-1 Is Overexpressed in Non-Small Cell Lung Cancer and Promotes Cancer Cell Invasion via EGFR-ERK-Mediated Up-Regulation of MMP-2 and MMP-9.
Carcinoma, Non-Small-Cell Lung
Detection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technology.
Carcinoma, Non-Small-Cell Lung
Downregulation of cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9.
Carcinoma, Non-Small-Cell Lung
Effect of Osimertinib on the expression of serum mmp-7 and mmp-9 in patients with non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Efficacy of hypofractionated radiotherapy combined with docetaxel in middle and advanced non-small cell lung cancer and its effects on serum MMP-9 and VEGF expressions.
Carcinoma, Non-Small-Cell Lung
Elevated levels of circulating matrix metalloproteinase-9 in non-small cell lung cancer patients.
Carcinoma, Non-Small-Cell Lung
Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
Carcinoma, Non-Small-Cell Lung
Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination.
Carcinoma, Non-Small-Cell Lung
Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC).
Carcinoma, Non-Small-Cell Lung
Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
Carcinoma, Non-Small-Cell Lung
Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer Relation to clinicopathological factors, beta-catenin and prognosis.
Carcinoma, Non-Small-Cell Lung
Expression of metastasis-associated molecules in non-small cell lung cancer and their prognostic significance.
Carcinoma, Non-Small-Cell Lung
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Carcinoma, Non-Small-Cell Lung
Expression of SHP2 and Related Markers in Non-Small Cell Lung Cancer: A Tissue Microarray Study of 80 Cases.
Carcinoma, Non-Small-Cell Lung
GOLPH3 Overexpression is Closely Correlated with Poor Prognosis in Human Non-Small Cell Lung Cancer and Mediates its Metastasis Through Upregulating MMP-2 and MMP-9.
Carcinoma, Non-Small-Cell Lung
HMGB1-Mediated MMP-9 Expression in Non-Small Cell Lung Cancer Contributes to Tumor Cell Invasiveness.
Carcinoma, Non-Small-Cell Lung
ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB.
Carcinoma, Non-Small-Cell Lung
IL-17A/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via p38 MAPK signaling pathway in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Increased plasma levels of urokinase plasminogen activator and matrix metalloproteinase-9 in nonsmall cell lung cancer patients.
Carcinoma, Non-Small-Cell Lung
Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Inhibition of cell proliferation, migration and invasion by DNAzyme targeting MMP-9 in A549 cells.
Carcinoma, Non-Small-Cell Lung
Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.
Carcinoma, Non-Small-Cell Lung
Inonotus obliquus-derived polysaccharide inhibits the migration and invasion of human non-small cell lung carcinoma cells via suppression of MMP-2 and MMP-9.
Carcinoma, Non-Small-Cell Lung
KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line.
Carcinoma, Non-Small-Cell Lung
Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Matrix metalloproteinase-9 (MMP-9) elevated in serum but not in bronchial lavage fluid in patients with lung cancer.
Carcinoma, Non-Small-Cell Lung
Matrix metalloproteinase-9 (MMP-9) Expression in Non-Small Cell Lung Carcinoma and Its Association with Clinicopathologic Factors.
Carcinoma, Non-Small-Cell Lung
Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Matrix metalloproteinase-9 in broncho-alveolar lavage fluid of patients with non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Carcinoma, Non-Small-Cell Lung
Non-invasive profiling of protease-specific elastin turnover in lung cancer: biomarker potential.
Carcinoma, Non-Small-Cell Lung
Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression.
Carcinoma, Non-Small-Cell Lung
Overexpression of CXCR4 promotes invasion and migration of non-small cell lung cancer via EGFR and MMP-9.
Carcinoma, Non-Small-Cell Lung
Percutaneous microwave ablation (MWA) increased the serum levels of VEGF and MMP-9 in Stage I non-small cell lung cancer (NSCLC).
Carcinoma, Non-Small-Cell Lung
Predicting non-small cell lung cancer expression of epidermal growth factor receptor and matrix metalloproteinase 9 from immunohistochemical staining of diagnostic biopsy samples.
Carcinoma, Non-Small-Cell Lung
Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC).
Carcinoma, Non-Small-Cell Lung
Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study.
Carcinoma, Non-Small-Cell Lung
Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Prognostic impact of MMP-2 and MMP-9 expression in pathologic stage IA non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Prognostic impact of serum and tissue MMP-9 in non-small cell lung cancer: a systematic review and meta-analysis.
Carcinoma, Non-Small-Cell Lung
Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma.
Carcinoma, Non-Small-Cell Lung
Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Radiosensitizing Potential of Curcumin in Different Cancer Models.
Carcinoma, Non-Small-Cell Lung
Salinomycin suppresses TGF-?1-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK/SIRT1 pathway in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Sodium hydrogen exchanger and phospholipase D are required for alpha1-adrenergic receptor stimulation of metalloproteinase-9 and cellular invasion in CCL39 fibroblasts.
Carcinoma, Non-Small-Cell Lung
Study on the expression of p53 and MMP-2 in patients with lung cancer after interventional therapy.
Carcinoma, Non-Small-Cell Lung
Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells.
Carcinoma, Non-Small-Cell Lung
The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
The role of serum vascular endothelial growth factor and matrix metalloproteinase-9 in predicting response to chemotherapy in patients with advanced nonsmall cell lung cancer.
Carcinoma, Non-Small-Cell Lung
The significance of serum active matrix metalloproteinase-9 in patients with non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
The value of MMP-9 for breast and non-small cell lung cancer patients' survival.
Carcinoma, Non-Small-Cell Lung
TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-?-catenin signaling.
Carcinoma, Non-Small-Cell Lung
Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin.
Carcinoma, Non-Small-Cell Lung
Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables.
Carcinoma, Non-Small-Cell Lung
[Clinical and prognostic significance of serum MMP-9, endostatin and VEGF in patients with advanced non-small cell lung cancer.]
Carcinoma, Non-Small-Cell Lung
[Clinical research of perioperative serum VEGF and MMP-9 levels in patients with non-small cell lung cancer.]
Carcinoma, Non-Small-Cell Lung
[Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer]
Carcinoma, Non-Small-Cell Lung
[Effect of Src tyrosine kinase inhibition on secretion of MMP-2 and MMP-9 by non-small cell lung cancer cells].
Carcinoma, Non-Small-Cell Lung
[Expression of adiponectin in non-small cell lung cancer and its relationship with MMP-9 and angiogenesis].
Carcinoma, Non-Small-Cell Lung
[Expression of AKT2, Cyclin D1, and MMP-9 and Their Correlations to Clinicopathologic Features of Non-small Cell Lung Cancer.]
Carcinoma, Non-Small-Cell Lung
[Expression of MMP-2 and MMP-9 in non-small-cell lung cancer and their prognostic value.]
Carcinoma, Non-Small-Cell Lung
[Joint serum tumor markers serve as survival predictive model of erlotinib in the treatment of recurrent non-small cell lung cancer].
Carcinoma, Non-Small-Cell Lung
[Overexpression of IL-8 and MMP-9 confer high malignant phenotype in patients with non-small cell lung cancer]
Carcinoma, Non-Small-Cell Lung
[Prognostic impact of matrix metalloproteinases 2,9, and 11 in stromal cells stage I non-small cell lung cancer]
Carcinoma, Non-Small-Cell Lung
[The expression and its clinical significance of MMP-2 and MMP-9 in non-small cell lung cancer.]
Carcinoma, Non-Small-Cell Lung
[The serum concentration of metalloproteinase 9 and 2 in non-small cell lung cancer patients]
Carcinoma, Ovarian Epithelial
Correlation of survivin and MMP9 expressions with prognosis and clinicopathological parameters in surface epithelial ovarian carcinomas.
Carcinoma, Ovarian Epithelial
Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.
Carcinoma, Ovarian Epithelial
Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor.
Carcinoma, Ovarian Epithelial
Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.
Carcinoma, Ovarian Epithelial
Immunohistochemical expression of epidermal growth factor receptor, E-cadherin, and matrix metalloproteinase-9 in ovarian epithelial cancer and relation to patient deaths.
Carcinoma, Ovarian Epithelial
MMP-2 mRNA Expression in Ovarian Cancer Tissues Predicts Patients' Response to Platinum-Taxane Chemotherapy.
Carcinoma, Ovarian Epithelial
Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer.
Carcinoma, Ovarian Epithelial
Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells.
Carcinoma, Ovarian Epithelial
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer.
Carcinoma, Ovarian Epithelial
Serum Levels of S100A11 and MMP-9 in Patients with Epithelial Ovarian Cancer and Their Clinical Significance.
Carcinoma, Ovarian Epithelial
Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2.
Carcinoma, Ovarian Epithelial
The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells.
Carcinoma, Ovarian Epithelial
Transcriptional factor snail controls tumor neovascularization, growth and metastasis in mouse model of human ovarian carcinoma.
Carcinoma, Ovarian Epithelial
[Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer]
Carcinoma, Ovarian Epithelial
[Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour]
Carcinoma, Ovarian Epithelial
[The expression of a novel estrogen receptor, GPR30, in epithelial ovarian carcinoma and its correlation with MMP-9.]
Carcinoma, Pancreatic Ductal
Expression of matrix metalloproteinase 9 in pancreatic ductal carcinoma is associated with tumor metastasis formation.
Carcinoma, Papillary
[Study of matrix metalloproteinase-2 and -9 in thyroid papillary cancer]
Carcinoma, Renal Cell
Alpha-Mangostin Suppresses the Metastasis of Human Renal Carcinoma Cells by Targeting MEK/ERK Expression and MMP-9 Transcription Activity.
Carcinoma, Renal Cell
Anticancer effect of lysine, proline, arginine, ascorbic acid and green tea extract on human renal adenocarcinoma line 786-0.
Carcinoma, Renal Cell
Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells.
Carcinoma, Renal Cell
Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood.
Carcinoma, Renal Cell
Caspase-10, matrix metalloproteinase-9 and total laminin are correlated with the tumor malignancy of clear cell renal cell carcinoma.
Carcinoma, Renal Cell
Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9.
Carcinoma, Renal Cell
Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors.
Carcinoma, Renal Cell
Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma.
Carcinoma, Renal Cell
Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.
Carcinoma, Renal Cell
Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC.
Carcinoma, Renal Cell
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma.
Carcinoma, Renal Cell
Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array.
Carcinoma, Renal Cell
Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma.
Carcinoma, Renal Cell
Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Carcinoma, Renal Cell
Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma.
Carcinoma, Renal Cell
Interactions between filamin A and MMP-9 regulate proliferation and invasion in renal cell carcinoma.
Carcinoma, Renal Cell
Low concentrations of the recombinant toxin protein rLj-RGD3 suppress TNF-?-induced human renal carcinoma cell invasion.
Carcinoma, Renal Cell
Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.
Carcinoma, Renal Cell
Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population.
Carcinoma, Renal Cell
Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma.
Carcinoma, Renal Cell
Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-?B DNA-binding activity.
Carcinoma, Renal Cell
MicroRNA-132 suppresses migration and invasion of renal carcinoma cells.
Carcinoma, Renal Cell
Modifications of the radiosensitivity of a renal cancer cell line as a consequence of stable TIMP-1 overexpression.
Carcinoma, Renal Cell
Modulation of human renal cell carcinoma 786-0 MMP-2 and MMP-9 activity by inhibitors and inducers in vitro.
Carcinoma, Renal Cell
mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas.
Carcinoma, Renal Cell
Over-expression of mir-124 inhibits MMP-9 expression and decreases invasion of renal cell carcinoma cells.
Carcinoma, Renal Cell
Periostin promotes migration and invasion of renal cell carcinoma through the integrin/focal adhesion kinase/c-Jun N-terminal kinase pathway.
Carcinoma, Renal Cell
Prognostic Role of Matrix Metalloproteinases 2, 7, 8, 9 and Their Type 1 Tissue Inhibitor in Blood Serum of Patients with Kidney Cancer.
Carcinoma, Renal Cell
Significance of circulating matrix metalloproteinase-9 to tissue inhibitor of metalloproteinases-2 ratio as a predictor of disease progression in patients with metastatic renal cell carcinoma receiving sunitinib.
Carcinoma, Renal Cell
Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
Carcinoma, Renal Cell
Strong significant correlation between MMP-9 and systemic symptoms in patients with localized renal cell carcinoma.
Carcinoma, Renal Cell
Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion.
Carcinoma, Renal Cell
Suppression of tunicamycin-induced CD44v6 ectodomain shedding and apoptosis is correlated with temporal expression patterns of active ADAM10, MMP-9 and MMP-13 proteins in Caki-2 renal carcinoma cells.
Carcinoma, Renal Cell
Tumor M2-Pyruvate Kinase, Matrix Carbonic Anhydrase IX, and Metalloproteinase 9 - Novel Prognostic Markers of Renal Cell Carcinoma.
Carcinoma, Renal Cell
XRCC1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis through suppressing MMP-2 and MMP-9.
Carcinoma, Renal Cell
[mRNA expression analysis of metastatic markers in clear-cell renal cell carcinoma]
Carcinoma, Renal Cell
[Relationship between expression of matrix metalloproteinase-9 (MMP-9) and angiogenesis in renal cell carcinoma]
Carcinoma, Renal Cell
[The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma].
Carcinoma, Small Cell
Expression and significance of MMP-9 and MDM2 in the oncogenesis of lung cancer in rats.
Carcinoma, Small Cell
[Expressions of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 and their correlation with metastasis and prognosis in lung cancer.]
Carcinoma, Squamous Cell
A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9.
Carcinoma, Squamous Cell
A significant elevation of plasma level of matrix metalloproteinase-9 in patients with high-grade intraepithelial neoplasia and early squamous cell carcinoma of the uterine cervix.
Carcinoma, Squamous Cell
Alpha-mangostin suppresses MMP-2 and MMP-9 expression in head and neck squamous carcinoma cells.
Carcinoma, Squamous Cell
AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9.
Carcinoma, Squamous Cell
An orthotopic floor-of-mouth cancer model allows quantification of tumor invasion.
Carcinoma, Squamous Cell
Chemokine receptor 7 enhances cell chemotaxis and migration of metastatic squamous cell carcinoma of head and neck through activation of matrix metalloproteinase-9.
Carcinoma, Squamous Cell
Correlation Between the Expression of Matrix Metalloproteinase-9, Matrix Metalloproteinase-13, Tissue Inhibitor of Metalloproteinases-1, p16 and Differentiation of Head and Neck Squamous Cell Carcinoma: A Prospective Observational Study.
Carcinoma, Squamous Cell
CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Density-dependent induction of 92-kd type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells.
Carcinoma, Squamous Cell
Determination of matrix metalloproteinase 9 (MMP-9) protein expression in laryngeal squamous cell carcinomas based on digital image analysis.
Carcinoma, Squamous Cell
Differential expression and activity status of MMP-1, MMP-2 and MMP-9 in tumor and stromal cells of squamous cell carcinomas of the lung.
Carcinoma, Squamous Cell
Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs.
Carcinoma, Squamous Cell
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
Carcinoma, Squamous Cell
Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis.
Carcinoma, Squamous Cell
Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
Carcinoma, Squamous Cell
Effect of selective small molecule inhibitors on MMP-9 and VEGFR-1 expression in p16-positive and -negative squamous cell carcinoma.
Carcinoma, Squamous Cell
Effects of panduratin A isolated from Kaempferia pandurata ROXB. on the expression of matrix metalloproteinase-9 by porphyromonas gingivalis supernatant-induced KB cells.
Carcinoma, Squamous Cell
Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
Carcinoma, Squamous Cell
Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma.
Carcinoma, Squamous Cell
Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
Carcinoma, Squamous Cell
Establishment of field change by expression of cytokeratins 8/18, 19, and MMP-9 in an apparently normal oral mucosa adjacent to squamous cell carcinoma: A immunohistochemical study.
Carcinoma, Squamous Cell
Expression and significance of MMP-9 and MDM2 in the oncogenesis of lung cancer in rats.
Carcinoma, Squamous Cell
Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Expression of Cytokeratin Subtypes: MMP-9, p53, and ?SMA to Differentiate Basaloid Squamous Cell Carcinoma From Other Basaloid Tumors of the Oral Cavity.
Carcinoma, Squamous Cell
Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions.
Carcinoma, Squamous Cell
Expression of matrix metalloproteinase-9 (MMP-9) and blood vessel density in laryngeal squamous cell carcinomas.
Carcinoma, Squamous Cell
Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis.
Carcinoma, Squamous Cell
Expression of matrix metalloproteinase-9 in patients with squamous cell carcinoma of the larynx.
Carcinoma, Squamous Cell
Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.
Carcinoma, Squamous Cell
Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Carcinoma, Squamous Cell
Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue.
Carcinoma, Squamous Cell
Expression of reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase 9 in middle ear squamous cell carcinoma.
Carcinoma, Squamous Cell
Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung.
Carcinoma, Squamous Cell
Expression of VEGF, HGF, IL-6, IL-8, MMP-9, Telomerase in Peripheral Blood of Patients with Head and Neck Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Expressions of E-cadherin, Cortactin and MMP-9 in Pseudoepitheliomatous Hyperplasia and Squamous Cell Carcinoma of the Head and Neck: Their Relationships with Clinicopathologic Factors and Prognostic Implication.
Carcinoma, Squamous Cell
Fibroblast-directed expression and localization of 92-kDa type IV collagenase along the tumor-stroma interface in an in vitro three-dimensional model of human squamous cell carcinoma.
Carcinoma, Squamous Cell
Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and -7.
Carcinoma, Squamous Cell
Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue.
Carcinoma, Squamous Cell
Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
Carcinoma, Squamous Cell
Immunohistochemical evaluation of MMP-2, MMP-9 and CD31/microvascular density in squamous cell carcinomas of the floor of the mouth.
Carcinoma, Squamous Cell
Immunohistochemical expression of matrix metalloproteinase-1, matrix metalloproteinase-2 and matrix metalloproteinase-9, myofibroblasts and Ki-67 in actinic cheilitis and lip squamous cell carcinoma.
Carcinoma, Squamous Cell
Immunohistochemical expression of MMP-9 and VEGF in squamous cell carcinoma of the tongue.
Carcinoma, Squamous Cell
Immunohistochemical predictors in squamous cell carcinoma of the tongue and floor of the mouth.
Carcinoma, Squamous Cell
Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer.
Carcinoma, Squamous Cell
Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma.
Carcinoma, Squamous Cell
Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts.
Carcinoma, Squamous Cell
Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
Carcinoma, Squamous Cell
Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion.
Carcinoma, Squamous Cell
Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma.
Carcinoma, Squamous Cell
Iron increases MMP-9 expression through activation of AP-1 via ERK/Akt pathway in human head and neck squamous carcinoma cells.
Carcinoma, Squamous Cell
Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression.
Carcinoma, Squamous Cell
LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
Carcinoma, Squamous Cell
Localization of 92-kDa type IV collagenase in human skin tumors: comparison with normal human fetal and adult skin.
Carcinoma, Squamous Cell
Low-level laser therapy promotes proliferation and invasion of oral squamous cell carcinoma cells.
Carcinoma, Squamous Cell
Mast cells and matrix metalloproteinase 9 expression in actinic cheilitis and lip squamous cell carcinoma.
Carcinoma, Squamous Cell
Matrix metalloproteinase (MMP)-2 and MMP-9 polymorphisms and haplotypes as disease biomarkers.
Carcinoma, Squamous Cell
MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomas.
Carcinoma, Squamous Cell
Notch1 signaling pathway participates in cancer invasion by regulating MMPs in lingual squamous cell carcinoma.
Carcinoma, Squamous Cell
Opposite effect of stable transfection of bioactive transforming growth factor-beta 1 (TGF beta 1) versus exogenous TGF beta 1 treatment on expression of 92-kDa type IV collagenase in mouse skin squamous cell carcinoma CH72 cells.
Carcinoma, Squamous Cell
Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion.
Carcinoma, Squamous Cell
Overexpression of MMP-2 and MMP-9 in squamous cell carcinomas of immunosuppressed patients.
Carcinoma, Squamous Cell
Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures.
Carcinoma, Squamous Cell
Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Carcinoma, Squamous Cell
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Carcinoma, Squamous Cell
Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
Carcinoma, Squamous Cell
Radiosensitizing Potential of Curcumin in Different Cancer Models.
Carcinoma, Squamous Cell
Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma.
Carcinoma, Squamous Cell
Regulation of matrix metalloproteinase-9 transcription in squamous cell carcinoma of uterine cervix: the role of human papillomavirus gene E2 expression and activation of transcription factor NF-kappaB.
Carcinoma, Squamous Cell
Relationship of 99mTc-HYNIC annexin V uptake to microvessel density, FasL and MMP-9 expression, and the number of tumour-infiltrating lymphocytes in head and neck carcinoma.
Carcinoma, Squamous Cell
Relationships between clinical behavior of laryngeal squamous cell carcinomas and expression of VEGF, MMP-9 and E-cadherin.
Carcinoma, Squamous Cell
RNA interference targeting CD147 inhibits the invasion of human cervical squamous carcinoma cells by downregulating MMP-9.
Carcinoma, Squamous Cell
Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population.
Carcinoma, Squamous Cell
Roles of galectin-7 and S100A9 in cervical squamous carcinoma: Clinicopathological and in vitro evidence.
Carcinoma, Squamous Cell
Serum Level of Matrix Metalloproteinase-9 in Patients with Head and Neck Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker.
Carcinoma, Squamous Cell
Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells.
Carcinoma, Squamous Cell
Suppressive effect of calcipotriol on the induction of matrix metalloproteinase (MMP)-9 and MMP-13 in a human squamous cell carcinoma cell line.
Carcinoma, Squamous Cell
TGF-beta1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway.
Carcinoma, Squamous Cell
The cytoplasmic domain of N-cadherin modulates MMP?9 induction in oral squamous carcinoma cells.
Carcinoma, Squamous Cell
The expression of invasive behavior of differentiated squamous carcinoma cell line evaluated by an in vitro invasion model.
Carcinoma, Squamous Cell
The inhibitory effects of immunosuppressive factors, dexamethasone and interleukin-4, on NF-kappaB-mediated protease production by oral cancer.
Carcinoma, Squamous Cell
The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery.
Carcinoma, Squamous Cell
The prognostic value of CXCR4, MMP-2 and MMP-9 in tongue squamous carcinoma.
Carcinoma, Squamous Cell
The role of matrix metalloproteinases 2 and 9 during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide.
Carcinoma, Squamous Cell
The role of MMP-2 and MMP-9 as prognostic markers in the early stages of tongue squamous cell carcinoma.
Carcinoma, Squamous Cell
Therapeutic effect of topical 5-fluorouracil in conjunctival squamous carcinoma is associated with changes in matrix metalloproteinases and tissue inhibitor of metalloproteinases expression.
Carcinoma, Squamous Cell
Tumor-associated serpin, squamous cell carcinoma antigen stimulates matrix metalloproteinase-9 production in cervical squamous cell carcinoma cell lines.
Carcinoma, Squamous Cell
[Correlation study between OPN, CD44v6, MMP-9 and distant metastasis in laryngeal squamous cell carcinoma].
Carcinoma, Squamous Cell
[Diagnostic value of E-cadherin, MMP-9, activated MMP-13 and anti-p53 antibodies in squamous cell carcinomas of head and neck]
Carcinoma, Squamous Cell
[Expression and significance of matrix metalloproteinase and tissue inhibitor of metalloproteinase in nasal cavity squamous cell carcinoma].
Carcinoma, Squamous Cell
[Expression of AKT2, Cyclin D1, and MMP-9 and Their Correlations to Clinicopathologic Features of Non-small Cell Lung Cancer.]
Carcinoma, Squamous Cell
[Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix]
Carcinoma, Squamous Cell
[Expression of MMP-2 and MMP-9 in non-small-cell lung cancer and their prognostic value.]
Carcinoma, Squamous Cell
[Expressions of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 and their correlation with metastasis and prognosis in lung cancer.]
Carcinoma, Transitional Cell
Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
Carcinoma, Transitional Cell
Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade.
Carcinoma, Transitional Cell
p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity.
Carcinoma, Transitional Cell
Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas.
Carcinoma, Transitional Cell
Serum levels of endostatin and matrix metalloproteinase-9 associated with high stage and grade primary transitional cell carcinoma of the bladder.
Carcinoma, Transitional Cell
Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
Carcinoma, Transitional Cell
The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter.
Carcinoma, Transitional Cell
Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Carcinoma, Transitional Cell
[Diagnosis and follow-up value of quantitative examination of MMP9 in the urine of BTCC patients]
Carcinoma, Verrucous
Immunohistochemical study of p53, Ki-67, MMP-2 and MMP-9 expression at invasive front of squamous cell and verrucous carcinoma in oral cavity.
Cardiomegaly
Angiotensin II induces nuclear factor- kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway.
Cardiomegaly
Efficacy of nobiletin, a citrus flavonoid, in the treatment of the cardiovascular dysfunction of diabetes in rats.
Cardiomegaly
Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure.
Cardiomegaly
Induction of heparanase gene expression in ventricular myocardium of rats with isoproterenol-induced cardiac hypertrophy.
Cardiomegaly
Investigation of MMP-2 and MMP-9 activities in canine sera with dilated cardiomyopathy.
Cardiomegaly
Mitochondrial division/mitophagy inhibitor (Mdivi) ameliorates pressure overload induced heart failure.
Cardiomegaly
Oestradiol Treatment Counteracts the Effect of Fructose-Rich Diet on Matrix Metalloproteinase 9 Expression and NF?B Activation.
Cardiomegaly
Simvastatin inhibited cardiac hypertrophy and fibrosis in apolipoprotein E-deficient mice fed a "Western-style diet" by increasing PPAR ? and ? expression and reducing TC, MMP-9, and Cat S levels.
Cardiomegaly
Transgenic overexpression of macrophage matrix metalloproteinase-9 exacerbates age-related cardiac hypertrophy, vessel rarefaction, inflammation, and fibrosis.
Cardiomegaly
Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.
Cardiomyopathies
Enhanced gene expression of myocardial matrix metalloproteinases 2 and 9 after acute treatment with doxorubicin in mice.
Cardiomyopathies
Interrelation between Expression of ADAM 10 and MMP 9 and Synthesis of Peroxynitrite in Doxorubicin Induced Cardiomyopathy.
Cardiomyopathies
Matrix Metalloproteinases MMP-1 and MMP-9 and Their Inhibitor TIMP-1 as Markers of Dilated Cardiomyopathy in Patients of Different Age.
Cardiomyopathies
Osteopontin-Stimulated Expression of Matrix Metalloproteinase-9 Causes Cardiomyopathy in the mdx Model of Duchenne Muscular Dystrophy.
Cardiomyopathies
Plasma metalloproteinase-9 and restrictive filling pattern as major predictors of outcome in patients with ischemic cardiomyopathy.
Cardiomyopathy, Dilated
Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation.
Cardiomyopathy, Dilated
Endothelin-1 critically influences cardiac function via superoxide-MMP9 cascade.
Cardiomyopathy, Dilated
Immunoexpression of MMP-8, MMP-9 and TIMP-2 in dilated cardiomyopathy.
Cardiomyopathy, Dilated
Investigation of MMP-2 and MMP-9 activities in canine sera with dilated cardiomyopathy.
Cardiomyopathy, Dilated
Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, B(+) tenascin-C and ED-A(+) fibronectin in dilated cardiomyopathy: Potential impact on disease progression and patients' prognosis.
Cardiomyopathy, Dilated
Matrix Metalloproteinases MMP-1 and MMP-9 and Their Inhibitor TIMP-1 as Markers of Dilated Cardiomyopathy in Patients of Different Age.
Cardiomyopathy, Dilated
Opposing roles of PARP-1 in MMP-9 and TIMP-2 expression and mast cell degranulation in dyslipidemic dilated cardiomyopathy.
Cardiomyopathy, Hypertrophic
Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
Cardiomyopathy, Hypertrophic
Role of double knockdown of tPA and MMP-9 on regulating the left ventricular function and remodeling followed by transverse aortic constriction-induced hypertrophic cardiomyopathy in mice.
Cardiotoxicity
Enhanced gene expression of myocardial matrix metalloproteinases 2 and 9 after acute treatment with doxorubicin in mice.
Cardiotoxicity
Study of cardioprotective activity of the methanolic extract of the aerial parts of Bauhinia madagascariensis compared to Bauhinia purpurea against adrenaline-induced myocardial toxicity in rats.
Cardiovascular Diseases
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.
Cardiovascular Diseases
Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults.
Cardiovascular Diseases
Association of matrix metalloproteinase 9 genotypes and cardiovascular disease risk factors with serum matrix metalloproteinase 9 concentrations in Taiwanese individuals.
Cardiovascular Diseases
Association of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 With Endothelial Dysfunction, Cardiovascular Disease Risk Factors and thrombotic events in Children With End-stage Renal Disease.
Cardiovascular Diseases
Association of MMP-9 gene polymorphisms with nephrolithiasis patients.
Cardiovascular Diseases
Association of the MMP-9 polymorphism and ischemic stroke risk in southern Chinese Han population.
Cardiovascular Diseases
Associations of Interleukin 10, Matrix Metallopeptidase 9, and Legumain with Blood Pressure Variability and Neurologic Outcomes in Patients with Ischemic Stroke.
Cardiovascular Diseases
Cardioprotective effect of novel sulphonamides-1,3,5-triazine conjugates against ischaemic-reperfusion injury via selective inhibition of MMP-9.
Cardiovascular Diseases
CO-releasing molecules CORM2 attenuates angiotensin II-induced human aortic smooth muscle cell migration through inhibition of ROS/IL-6 generation and matrix metalloproteinases-9 expression.
Cardiovascular Diseases
Contractile, but not endothelial, dysfunction in early inflammatory arthritis: a possible role for matrix metalloproteinase-9.
Cardiovascular Diseases
Effect of the emphysema subtypes of patients with chronic obstructive pulmonary disease on airway inflammation and COTE index.
Cardiovascular Diseases
Elevated levels of circulating matrix metalloproteinase-9 are associated with a dysregulated cortisol rhythm-A case-control study of coronary artery disease.
Cardiovascular Diseases
Endogenous nitric oxide formation correlates negatively with circulating matrix metalloproteinase (MMP)-2 and MMP-9 levels in black subjects.
Cardiovascular Diseases
Evidence for an exclusive association of matrix metalloproteinase-9 with dysfunctional high-density lipoprotein: a novel finding.
Cardiovascular Diseases
Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine.
Cardiovascular Diseases
Functional polymorphisms in matrix metalloproteinases-1, -3, -9 are associated with arteriovenous fistula patency in hemodialysis patients.
Cardiovascular Diseases
Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects.
Cardiovascular Diseases
Genetic Variants in Matrix Metalloproteinase-9 Gene Modify Metalloproteinase-9 Levels in Black Subjects.
Cardiovascular Diseases
Identifying the regulative role of NF-?B binding sites within promoter region of human matrix metalloproteinase 9 (mmp-9) by TNF-? induction.
Cardiovascular Diseases
Impact of Matrix Metalloproteinase-9 during Periodontitis and Cardiovascular Diseases.
Cardiovascular Diseases
Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression.
Cardiovascular Diseases
Insulin-like growth factor-binding protein 3 inhibits angiotensin II-induced aortic smooth muscle cell phenotypic switch and matrix metalloproteinase expression.
Cardiovascular Diseases
Matrix Metalloproteinase (MMP)-9 Levels in Children on Hemodialysis: Association with MMP-9 C(-1562)T Gene Polymorphism and Vitamin D Levels.
Cardiovascular Diseases
Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
Cardiovascular Diseases
Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders.
Cardiovascular Diseases
Matrix metalloproteinase-9 as a messenger in the crosstalk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review.
Cardiovascular Diseases
Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children.
Cardiovascular Diseases
Matrix Metalloproteinase-9 Is a Predictive Factor for Systematic Hypertension and Heart Dysfunction in Patients with Obstructive Sleep Apnea Syndrome.
Cardiovascular Diseases
Matrix Metalloproteinase-9 Level and Gene Polymorphism in Sleep Disordered Breathing Patients with or without Cardiovascular Disorders.
Cardiovascular Diseases
Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis.
Cardiovascular Diseases
Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.
Cardiovascular Diseases
Mice lacking the gene encoding for MMP-9 and resistance artery reactivity.
Cardiovascular Diseases
Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension.
Cardiovascular Diseases
Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease.
Cardiovascular Diseases
Plasma levels of matrix metalloproteinase 9 in patients undergoing off-pump coronary artery bypass grafting.
Cardiovascular Diseases
Plasma matrix metalloproteinase (MMP)-9 levels are reduced following low-calorie cranberry juice supplementation in men.
Cardiovascular Diseases
Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease.
Cardiovascular Diseases
Provitamin A carotenoids are independently associated with matrix metalloproteinase-9 in plasma samples from a general population.
Cardiovascular Diseases
Role of Salivary Biomarkers in Detection of Cardiovascular Diseases (CVD).
Cardiovascular Diseases
Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling.
Cardiovascular Diseases
Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
Cardiovascular Diseases
Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease.
Cardiovascular Diseases
Serum matrix metalloproteinase-9 in children exposed to arsenic from playground dust at elementary schools in Hermosillo, Sonora, Mexico.
Cardiovascular Diseases
Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis.
Cardiovascular Diseases
The role of serum levels of microRNA-21 and matrix metalloproteinase-9 in patients with acute coronary syndrome.
Cardiovascular Diseases
Vascular Remodeling and Prothrombotic Markers in Subjects Affected by Familial Combined Hyperlipidemia and/or Metabolic Syndrome in Primary Prevention for Cardiovascular Disease.
Carotid Artery Diseases
Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the Framingham Offspring Study.
Carotid Artery Diseases
Associations of matrix metalloproteinase-9 and monocyte chemoattractant protein-1 concentrations with carotid atherosclerosis, based on measurements of plaque and intima-media thickness.
Carotid Artery Diseases
Circulating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosis.
Carotid Artery Diseases
Increased YKL-40 expression in patients with carotid atherosclerosis.
Carotid Artery Diseases
Influence of Malondialdehyde and Matrix Metalloproteinase-9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic Syndrome.
Carotid Artery Diseases
Levels of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 mRNAs in Patients with Primary Hypertension or Hypertension-induced Atherosclerosis.
Carotid Artery Diseases
Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.
Carotid Artery Diseases
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis.
Carotid Artery Diseases
MMP-9 haplotypes and carotid artery atherosclerosis: an association study introducing a novel multicolour multiplex RealTime PCR protocol.
Carotid Artery Diseases
MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis.
Carotid Artery Diseases
Overexpression of matrix metalloproteinase-9 is correlated with carotid intraplaque hemorrhage in a swine model.
Carotid Artery Diseases
Preliminary studies on human aldosterone synthase (CYP11B2) gene polymorphism, matrix metalloprotease-9, apoptosis, and carotid atherosclerosis plaque size by proton magnetic resonance imaging.
Carotid Artery Diseases
Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice.
Carotid Artery Diseases
Using plasma matrix metalloproteinase-9 and monocyte chemoattractant protein-1 to predict future cardiovascular events in subjects with carotid atherosclerosis.
Carotid Stenosis
Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the Framingham Offspring Study.
Carotid Stenosis
Carotid Atherosclerotic Plaque Features in Patients with Acute Ischemic Stroke.
Carotid Stenosis
Differences in carotid plaque content of macrophages, T cells and MMP-9 between patients with embolic and hemodynamic cerebral ischemia due to symptomatic carotid stenosis.
Carotid Stenosis
Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: a prospective cohort study.
Carotid Stenosis
Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis.
Carotid Stenosis
Markers of instability in high-risk carotid plaques are reduced by statins.
Carotid Stenosis
Metalloproteinase expression in carotid plaque and its correlation with plasma levels before and after carotid endarterectomy.
Carotid Stenosis
MMP-1 and MMP-9 regulate epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells.
Carotid Stenosis
MMP-9 and/or TIMP as predictors of ischaemic stroke in patients with symptomatic and asymptomatic atherosclerotic stenosis of carotid artery treated by stenting or endarterectomy - A review.
Carotid Stenosis
Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: implications for human atherosclerosis.
Carotid Stenosis
Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis.
Carotid Stenosis
Tumor necrosis factor-? regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis.
Carotid Stenosis
[THE ANALYSIS OF ASSOCIATION OF MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 WITH LEVEL OF ZINC IN DIFFERENT BIO SUBSTRATES IN PATIENTS WITH CAROTID STENOSIS].
Cataract
A feasible tool to detect mRNA expression of matrix metalloproteinases and their tissue inhibitors in human Tenon's capsule.
Cataract
Altered expression of transforming growth factor beta 1 and matrix metalloproteinase-9 results in elevated intraocular pressure in mice.
Cataract
Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
Cataract
Functional Activity of Matrix Metalloproteinases 2 and 9 in Tears of Patients With Glaucoma.
Cataract
Gelatinase B/matrix metalloproteinase-9 provokes cataract by cleaving lens betaB1 crystallin.
Cataract
Higher aqueous levels of matrix metalloproteinases indicated visual impairment in patients with retina vein occlusion after anti-VEGF therapy.
Cataract
Investigation of expression and effects of TGF-?1 and MMP-9 in lens epithelial cells of diabetic cataract rats.
Cataract
Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients.
Cataract
Matrix metalloproteinase-2 and -9 activities in the human lens epithelial cells and serum of steroid induced posterior subcapsular cataracts.
Cataract
Matrix metalloproteinase-9 activity in human lens epithelial cells of cortical, posterior subcapsular, and nuclear cataracts.
Cataract
MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration.
Cataract
Potential Therapeutic Agents, Polymethoxylated Flavones Isolated from Kaempferia parviflora for Cataract Prevention through Inhibition of Matrix Metalloproteinase-9 in Lens Epithelial Cells.
Cataract
Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular disorders.
Cataract
The Protective Effects of Flavonoids in Cataract Formation through the Activation of Nrf2 and the Inhibition of MMP-9.
cathepsin s deficiency
Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.
Cell Transformation, Neoplastic
Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells.
Central Nervous System Diseases
A matrix metalloproteinase 9 (MMP9) gene single nucleotide polymorphism is associated with predisposition to tick-borne encephalitis virus-induced severe central nervous system disease.
Central Nervous System Diseases
Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children.
Central Nervous System Diseases
Chlamydia pneumoniae infection of microglial cells in vitro: a model of microbial infection for neurological disease.
Central Nervous System Diseases
Impact of manganese neurotoxicity on mmp-9 production and superoxide dismutase activity in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases.
Central Nervous System Diseases
Oxidized Low-Density Lipoprotein-Induced Matrix Metalloproteinase-9 Expression via PKC-delta/p42/p44 MAPK/Elk-1 Cascade in Brain Astrocytes.
Central Nervous System Diseases
Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients.
Central Nervous System Neoplasms
Recruited leukocytes and local synthesis account for increased matrix metalloproteinase-9 activity in cerebrospinal fluid of dogs with central nervous system neoplasm.
Cerebral Amyloid Angiopathy
Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy.
Cerebral Hemorrhage
A gelatin in situ-overlay technique localizes brain matrix metalloproteinase activity in experimental focal cerebral ischemia.
Cerebral Hemorrhage
Activation of cerebral recovery by matrix metalloproteinase-9 after intracerebral hemorrhage.
Cerebral Hemorrhage
Analysis of the Expression of Angioarchitecture-related Factors in Patients with Cerebral Arteriovenous Malformation.
Cerebral Hemorrhage
Association of MMP-9 Haplotypes and TIMP-1 Polymorphism with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population.
Cerebral Hemorrhage
Beneficial effects of edaravone on the expression of serum matrix metalloproteinase-9 after cerebral hemorrhage.
Cerebral Hemorrhage
Caveolin-1 mediates tissue plasminogen activator-induced MMP-9 up-regulation in cultured brain microvascular endothelial cells.
Cerebral Hemorrhage
Combination of thrombin and matrix metalloproteinase-9 exacerbates neurotoxicity in cell culture and intracerebral hemorrhage in mice.
Cerebral Hemorrhage
Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy.
Cerebral Hemorrhage
Correlations of inflammatory factors, CCCK-18, MMP-9 and D-Dimer with APACHE II score and prognosis of patients with acute cerebral hemorrhage.
Cerebral Hemorrhage
Donor spontaneous intracerebral hemorrhage is associated with systemic activation of matrix metalloproteinase-2 and matrix metalloproteinase-9 and subsequent development of coronary vasculopathy in the heart transplant recipient.
Cerebral Hemorrhage
Dynamic changes of inflammatory markers in brain after hemorrhagic stroke in humans: A postmortem study.
Cerebral Hemorrhage
Early stage minimally invasive procedures reduce perihematomal MMP-9 and blood-brain barrier disruption in a rabbit model of intracerebral hemorrhage.
Cerebral Hemorrhage
Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.
Cerebral Hemorrhage
Effect of genetic depletion of MMP-9 on neurological manifestations of hypertension-induced intracerebral hemorrhages in aged mice.
Cerebral Hemorrhage
Effect of Propofol on the Expression of MMP-9 and Its Relevant Inflammatory Factors in Brain of Rat with Intracerebral Hemorrhage.
Cerebral Hemorrhage
Effect of Tianhuang Granule on intracranial pressure and serum matrix metalloproteinase-9 in patients with acute cerebral hemorrhage.
Cerebral Hemorrhage
Effects of atorvastatin on pathological changes in brain tissue and plasma MMP-9 in rats with intracerebral hemorrhage.
Cerebral Hemorrhage
Effects of minimally invasive procedures for evacuation of intracerebral hematoma in early stages on MMP-9 and BBB permeability in rabbits.
Cerebral Hemorrhage
Effects of oxiracetam combined with ginkgo biloba extract in the treatment of acute intracerebral hemorrhage: A clinical study.
Cerebral Hemorrhage
Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice.
Cerebral Hemorrhage
Genetic variations of MMP9 gene and intracerebral hemorrhage outcome: a cohort study in Chinese Han population.
Cerebral Hemorrhage
Genetic variations of MMP9 gene and intracerebral hemorrhage susceptibility: a case-control study in Chinese Han population.
Cerebral Hemorrhage
Ginsenoside Represses Symptomatic Intracerebral Hemorrhage after Recombinant Tissue Plasminogen Activator Therapy by Promoting Transforming Growth Factor-?1.
Cerebral Hemorrhage
Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
Cerebral Hemorrhage
Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism.
Cerebral Hemorrhage
Lipoxin A4 Methyl Ester Reduces Early Brain Injury by Inhibition of the Nuclear Factor Kappa B (NF-?B)-Dependent Matrix Metallopeptidase 9 (MMP-9) Pathway in a Rat Model of Intracerebral Hemorrhage.
Cerebral Hemorrhage
Matrix metalloproteinase 9-mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy.
Cerebral Hemorrhage
Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy.
Cerebral Hemorrhage
Matrix Metalloproteinase-9 as a Marker for Acute Ischemic Stroke: A Systematic Review.
Cerebral Hemorrhage
Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage.
Cerebral Hemorrhage
Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhage.
Cerebral Hemorrhage
Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage.
Cerebral Hemorrhage
Matrix metalloproteinase-9: dual role and temporal profile in intracerebral hemorrhage.
Cerebral Hemorrhage
Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation.
Cerebral Hemorrhage
Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice.
Cerebral Hemorrhage
PPAR? activation suppresses the expression of MMP9 by downregulating NF-?B post intracerebral hemorrhage.
Cerebral Hemorrhage
Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
Cerebral Hemorrhage
Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocycline.
Cerebral Hemorrhage
Role of blood biomarkers in spontaneous intracerebral hemorrhage - a prospectively studied cohort of patients.
Cerebral Hemorrhage
Rosiglitazone infusion therapy following minimally invasive surgery for intracerebral hemorrhage evacuation decreases matrix metalloproteinase-9 and blood-brain barrier disruption in rabbits.
Cerebral Hemorrhage
Serum tissue inhibitor of MMP-1 levels at any moment of the first week of spontaneous intracerebral hemorrhage may predict early mortality.
Cerebral Hemorrhage
Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
Cerebral Hemorrhage
The Combination of Astragalus membranaceus and Ligustrazine Protects Against Thrombolysis-Induced Hemorrhagic Transformation Through PKC?/Marcks Pathway in Cerebral Ischemia Rats.
Cerebral Hemorrhage
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage.
Cerebral Hemorrhage
Warfarin pretreatment reduces cell death and mmp-9 activity in experimental intracerebral hemorrhage.
Cerebral Hemorrhage
[Effects of Liangxue Tongyu Formula on brain edema and expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with intracerebral hemorrhage.]
Cerebral Hemorrhage
[Expression of matrix metalloproteinase MMP-9 in the plasma and hematoma fluid of intracerebral hemorrhage patients]
Cerebral Infarction
A functional polymorphism at miR-491-5p binding site in the 3'-UTR of MMP-9 gene confers increased risk for atherosclerotic cerebral infarction in a Chinese population.
Cerebral Infarction
A therapeutic target of cerebral hemorrhagic stroke: matrix metalloproteinase-9.
Cerebral Infarction
Adipocyte fatty acid-binding protein exacerbates cerebral ischaemia injury by disrupting the blood-brain barrier.
Cerebral Infarction
Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action.
Cerebral Infarction
Carotid thickness and atherosclerotic plaque stability, serum inflammation, serum MMP-2 and MMP-9 were associated with acute cerebral infarction.
Cerebral Infarction
Characterisation of DWI-MRI confirmed cerebral infarcts in patients with subarachnoid haemorrhage and their association with MMP-9 levels.
Cerebral Infarction
Correlation between acute myocardial infarction complicated with cerebral infarction and expression levels of MMP-2 and MMP-9.
Cerebral Infarction
Dl-3-n-butylphthalide protects the blood brain barrier of cerebral infarction by activating the Nrf-2/HO-1 signaling pathway in mice.
Cerebral Infarction
Early Exercise Protects the Blood-Brain Barrier from Ischemic Brain Injury via the Regulation of MMP-9 and Occludin in Rats.
Cerebral Infarction
Effect of hirudin on serum matrix metalloproteinase-9 of acute cerebral infarction: A protocol of systematic review and meta-analysis.
Cerebral Infarction
Expression and significance of angiostatin, vascular endothelial growth factor and matrix metalloproteinase-9 in brain tissue of diabetic rats with ischemia reperfusion.
Cerebral Infarction
Heregulin, cysteine rich-61 and matrix metalloproteinase 9 expression in human carotid atherosclerotic plaques: relationship with clinical data.
Cerebral Infarction
High matrix metalloproteinase-9 expression induces angiogenesis and basement membrane degradation in stroke-prone spontaneously hypertensive rats after cerebral infarction.
Cerebral Infarction
Huoxue Rongluo Tablet reduces matrix metalloproteinase-9 expression in infarcted brain tissue.
Cerebral Infarction
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in early focal cerebral infarction following urokinase thrombolysis in rats.
Cerebral Infarction
Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats.
Cerebral Infarction
microRNA-21 Confers Neuroprotection Against Cerebral Ischemia-Reperfusion Injury and Alleviates Blood-Brain Barrier Disruption in Rats via the MAPK Signaling Pathway.
Cerebral Infarction
Neuroprotection by platelet-activating factor acetylhydrolase in a mouse model of transient cerebral ischemia.
Cerebral Infarction
Neuroprotective effects of oleanolic acid against cerebral ischemia-reperfusion injury in mice.
Cerebral Infarction
Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke.
Cerebral Infarction
Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Cerebral Infarction
Relationship between lysophosphatidic acid and matrix metalloproteinase-9 plasma concentrations and carotid atheromatous plaque stability in patients with cerebral infarction.
Cerebral Infarction
S100ß, Matrix Metalloproteinase-9, D-dimer, and Heat Shock Protein 70 Are Serologic Biomarkers of Acute Cerebral Infarction in a Mouse Model of Transient MCA Occlusion.
Cerebral Infarction
Simvastatin reduces OX40 and OX40 ligand expression in human peripheral blood mononuclear cells and in patients with atherosclerotic cerebral infarction.
Cerebral Infarction
Stachybotrys microspora triprenyl phenol-7, a novel fibrinolytic agent, suppresses superoxide production, matrix metalloproteinase-9 expression, and thereby attenuates ischemia/reperfusion injury in rat brain.
Cerebral Infarction
Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice.
Cerebral Infarction
The Combination of Astragalus membranaceus and Ligustrazine Protects Against Thrombolysis-Induced Hemorrhagic Transformation Through PKC?/Marcks Pathway in Cerebral Ischemia Rats.
Cerebral Infarction
The serum levels of MMP-9, MMP-2 and vWF in patients with low doses of urokinase peritoneal dialysis decreased uremia complicated with cerebral infarction.
Cerebral Infarction
Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusion-induced focal ischemia rat model.
Cerebral Infarction
White matter damage is associated with matrix metalloproteinases in vascular dementia.
Cerebral Infarction
[Cerebral vascular protective effect of ginkgo diterpene lactone meglumine injection].
Cerebral Infarction
[Changes in plasma content of matrix metallo proteinase-9 in acute cerebral infarction patients before and after thrombolytic therapy and its significance.]
Cerebral Infarction
[Diffusion tensor imaging study of the protective effect of shRNA on matrix metalloproteinase-9 in middle cerebral artery occlusion rats].
Cerebral Infarction
[Effect of Shenxiong injection on inflammation injury of ischemia-reperfusion injury rats].
Cerebral Infarction
[Matrix metalloproteinase-9 expression by endothelial cells incubated with peripheral blood leukocytes from patients with cerebral infarction]
Cerebral Palsy
Neuronal self-injury mediated by IL-1? and MMP-9 in a cerebral palsy model of severe neonatal encephalopathy induced by immune activation plus hypoxia-ischemia.
Cerebrovascular Disorders
A radical scavenger edaravone inhibits matrix metalloproteinase-9 upregulation and blood-brain barrier breakdown in a mouse model of prolonged cerebral hypoperfusion.
Cerebrovascular Disorders
Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice.
Cerebrovascular Disorders
Association between the -1562 C/T MMP-9 polymorphism and cerebrovascular disease in a Polish population.
Cerebrovascular Disorders
Increased Levels of Soluble Cluster of Differentiation 40 Ligand, Matrix Metalloproteinase 9, and Matrix Metalloproteinase 2 Are Associated with Carotid Plaque Vulnerability in Patients with Ischemic Cerebrovascular Disease.
Cerebrovascular Disorders
Markers of instability in high-risk carotid plaques are reduced by statins.
Cerebrovascular Disorders
Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke.
Cervical Intraepithelial Neoplasia
Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.
Cervical Intraepithelial Neoplasia
Expression of MMP-2, MMP-9, and urokinase-type plasminogen activator in cervical intraepithelial neoplasia.
Cervical Intraepithelial Neoplasia
Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells.
Cervical Intraepithelial Neoplasia
Molecular pathobiology of human cervical high-grade lesions: paracrine STAT3 activation in tumor-instructed myeloid cells drives local MMP-9 expression.
Cervical Intraepithelial Neoplasia
[Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix]
Chagas Cardiomyopathy
Synergic and antagonistic relationship between MMP-2 and MMP-9 with fibrosis and inflammation in Chagas' cardiomyopathy.
Chagas Disease
Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease.
Chagas Disease
Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection.
Chagas Disease
Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of chagas disease.
Chagas Disease
MMP-2 and MMP-9 plasma levels are potential biomarkers for indeterminate and cardiac clinical forms progression in chronic Chagas disease.
Chagas Disease
Synergic and antagonistic relationship between MMP-2 and MMP-9 with fibrosis and inflammation in Chagas' cardiomyopathy.
Cheilitis
Immunohistochemical expression of matrix metalloproteinase-1, matrix metalloproteinase-2 and matrix metalloproteinase-9, myofibroblasts and Ki-67 in actinic cheilitis and lip squamous cell carcinoma.
Cheilitis
Mast cells and matrix metalloproteinase 9 expression in actinic cheilitis and lip squamous cell carcinoma.
Cholangiocarcinoma
A role for focal adhesion kinase signaling in tumor necrosis factor-alpha-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1.
Cholangiocarcinoma
Anticancer activity of streptochlorin, a novel antineoplastic agent, in cholangiocarcinoma.
Cholangiocarcinoma
Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK-NF-?B signaling pathway.
Cholangiocarcinoma
Clonorchis sinensis excretory-secretory products regulate migration and invasion in cholangiocarcinoma cells via extracellular signal-regulated kinase 1/2/nuclear factor-?B-dependent matrix metalloproteinase-9 expression.
Cholangiocarcinoma
Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha.
Cholangiocarcinoma
Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.
Cholangiocarcinoma
Expression of epidermal growth factor receptor, apomucins, matrix metalloproteinases, and p53 in rat and human cholangiocarcinoma: appraisal of an animal model of cholangiocarcinoma.
Cholangiocarcinoma
Expression of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in intraductal and nonintraductal growth type of cholangiocarcinoma.
Cholangiocarcinoma
Expression of matrix metalloproteinase-9 in surgically resected intrahepatic cholangiocarcinoma.
Cholangiocarcinoma
Gab1 regulates proliferation and migration through the PI3K/Akt signaling pathway in intrahepatic cholangiocarcinoma.
Cholangiocarcinoma
Inflammation and Tumor Progression: A Lesson from TNF-alpha-Dependent FAK Signaling in Cholangiocarcinoma.
Cholangiocarcinoma
NGAL knockdown by siRNA in human cholangiocarcinoma cells suppressed invasion by reducing NGAL/MMP-9 complex formation.
Cholangiocarcinoma
Phosphorylation of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase and nuclear translocation of nuclear factor-kappaB are involved in upregulation of matrix metalloproteinase-9 by tumour necrosis factor-alpha.
Cholangiocarcinoma
Raf kinase inhibitor protein inhibits cholangiocarcinoma cell metastasis by downregulating matrix metalloproteinase 9 and upregulating tissue inhibitor of metalloproteinase 4 expression.
Cholangiocarcinoma
Serum and biliary MMP-9 and TIMP-1 concentrations in the diagnosis of cholangiocarcinoma.
Cholangiocarcinoma
The effect of gemcitabine combined with AMD3100 applying to cholangiocarcinoma RBE cell lines to CXCR4/CXCL12 axis.
Cholangiocarcinoma
TPX2 level correlates with cholangiocarcinoma cell proliferation, apoptosis, and EMT.
Cholangiocarcinoma
[Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma]
Cholecystitis
Expression of matrix metalloproteinases in gallbladder carcinoma and their significance in carcinogenesis.
Cholelithiasis
[DYNAMIC OF CLINICAL, LABORATORY AND SONOGRAPHIC PARAMETERS AFTER SUCCESSFUL LITHOLITIC THERAPY AT PATIENTS WITH GALLSTONE DISEASE IN ASSOCIATION WITH METABOLIC SYNDROME].
Cholelithiasis
[Evaluation of prognostic factors for the development of cholelithiasis in patients with metabolic syndrome].
Cholera
Arfaptin 1 inhibits ADP-ribosylation factor-dependent matrix metalloproteinase-9 secretion induced by phorbol ester in HT 1080 fibrosarcoma cells.
Cholestasis
Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis.
Cholestasis, Intrahepatic
Celastrol Attenuates Intrahepatic Cholestasis of Pregnancy by Inhibiting Matrix Metalloproteinases-2 and 9.
Cholestasis, Intrahepatic
Epigallocatechin-3-gallate ameliorates intrahepatic cholestasis of pregnancy by inhibiting matrix metalloproteinase-2 and matrix metalloproteinase-9.
Cholestasis, Intrahepatic
Resveratrol reduces matrix metalloproteinases and alleviates intrahepatic cholestasis of pregnancy in rats.
Cholesteatoma
Analysis of KRT1, KRT10, KRT19, TP53 and MMP9 expression in pediatric and adult cholesteatoma.
Cholesteatoma
Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3.
Cholesteatoma
Diagnostic value of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinases 1 in cholesteatoma.
Cholesteatoma
Effect of CT manifestations of cholesteatoma on MMP-2, MMP-9 and IL-6 in the serum of patients.
Cholesteatoma
Elevated Level of Tenascin and Matrix Metalloproteinase 9 Correlates With the Bone Destruction Capacity of Cholesteatomas.
Cholesteatoma
Evaluation of significant gene expression changes in congenital and acquired cholesteatoma.
Cholesteatoma
Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas.
Cholesteatoma
Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma.
Cholesteatoma
Induction of matrix metalloproteinases in keratinocytes by cholesteatoma debris and granulation tissue extracts.
Cholesteatoma
Matrix metalloproteinase-2 and matrix metalloproteinase-9 in cholesteatoma and deep meatal skin.
Cholesteatoma
Up-regulation of matrix metalloprotease-9 in middle ear cholesteatoma--correlations with growth factor expression in vivo?
Cholesteatoma
[Detection and correlation of lipopolysaccharide, vitamin D receptor and matrix metalloproteinase-9 in the middle ear cholesteatoma].
Cholesteatoma
[Expression of matrix metalloproteinasa-2,9 in cholesteatoma and middle ear cancer]
Cholesteatoma
[Expression of matrix metalloproteinase-2,9 in cholesteatoma from different positions]
Cholesteatoma
[The expression of matrix metalloproteinase-9 and tumor necrosis factor-alpha in cholesteatoma]
Cholesteatoma
[The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma].
Cholesteatoma, Middle Ear
Stromal expression of matrix metalloprotease-9 in middle ear cholesteatomas.
Cholesteatoma, Middle Ear
[Detection and correlation of lipopolysaccharide, vitamin D receptor and matrix metalloproteinase-9 in the middle ear cholesteatoma].
Cholesteatoma, Middle Ear
[The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma].
Chondroma
Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Chondrosarcoma
CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-?B signaling pathway.
Chondrosarcoma
CCN6-mediated MMP-9 activation enhances metastatic potential of human chondrosarcoma.
Chondrosarcoma
Effect of pulsed electromagnetic field on MMP-9 and TIMP-1 levels in chondrosarcoma cells stimulated with IL-1?.
Chondrosarcoma
Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitor-1 in cartilage-forming osteal tumors.
Chondrosarcoma
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.
Chondrosarcoma
Expression of MMP-9 decreases metastatic potential of Chondrosarcoma: an immunohistochemical study.
Chondrosarcoma
In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
Chondrosarcoma
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines.
Chondrosarcoma
Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
Chondrosarcoma
Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Chondrosarcoma
Production of matrix metalloproteinases and a metalloproteinase inhibitor by swarm rat chondrosarcoma.
Chondrosarcoma
Resveratrol attenuates matrix metalloproteinase-9 and -2-regulated differentiation of HTB94 chondrosarcoma cells through the p38 kinase and JNK pathways.
Chordoma
Expression of Ezrin, Mmp-9 and Cox-2 in 50 Chordoma Specimens: A Clinical and Immunohistochemical Analysis.
Chordoma
Expression of matrix metalloproteinase (MMP)-1, MMP-2, MMP-9, cathepsin B, and urokinase plasminogen activator in non-skull base chordoma.
Chordoma
Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma.
Chordoma
Reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase-9 are prognostic markers in skull base chordomas.
Chorioamnionitis
Amniotic fluid concentrations of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during pregnancy and labor.
Chorioamnionitis
Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels: implications for antenatal origins of chronic lung disease.
Chorioamnionitis
Maternal Betamethasone and Chorioamnionitis Induce Different Collagenases during Lung Maturation in Fetal Sheep.
Chorioamnionitis
Predictive value of intra-amniotic and serum markers for inflammatory lesions of preterm placenta.
Chorioamnionitis
Ureaplasma Infection Mediated Release of Matrix Metalloproteinase-9 and PGP - a Novel Mechanism of Preterm Rupture of Membranes and Chorioamnionitis.
Chorioamnionitis
[Clinical significance of matrix metalloproteinase-9/tissue inhibitors of matrix metalloproteinase -1 imbalance in maternal serum, amniotic fluid, umbilical cord serum in patients with premature rupture of the membranes]
Choriocarcinoma
Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.
Choriocarcinoma
Inhibition of cytotrophoblastic (JEG-3) cell invasion by interleukin 12 involves an interferon gamma-mediated pathway.
Choriocarcinoma
Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
Choriocarcinoma
Osteopontin facilitates invasion in human trophoblastic cells via promoting matrix metalloproteinase-9 in vitro.
Choriocarcinoma
Reduced expression of tissue inhibitor of metalloproteinase (TIMP)-2 in gestational trophoblastic diseases.
Choriocarcinoma
Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta.
Choriocarcinoma
[The role of KiSS-1 and matrix metalloproteinase-9 in regulation of invasion of trophoblasts]
Choroidal Neovascularization
Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization.
Choroidal Neovascularization
Matrix metalloproteinase-9 contributes to choroidal neovascularization.
Choroidal Neovascularization
MMP-2 and MMP-9 synergize in promoting choroidal neovascularization.
Choroidal Neovascularization
Over-expression of BMP4 inhibits experimental choroidal neovascularization by modulating VEGF and MMP-9.
Choroidal Neovascularization
The non-antibiotic properties of tetracyclines: Clinical potential in ophthalmic disease.
Chronic Limb-Threatening Ischemia
Coexistence of proangiogenic potential and increased MMP-9, TIMP-1, and TIMP-2 levels in the plasma of patients with critical limb ischemia.
Chronic Periodontitis
A meta-analysis of MMP-9 promoter -1562 C/T polymorphism on susceptibility of chronic periodontitis.
Chronic Periodontitis
Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis.
Chronic Periodontitis
Association of Matrix Metalloproteinase-9 Promoter Gene Polymorphism With Chronic Periodontitis.
Chronic Periodontitis
Comparative evaluation of inhibitory effect of curcumin and doxycycline on matrix metalloproteinase-9 activity in chronic periodontitis.
Chronic Periodontitis
Cyclooxygenase-2 and matrix metalloproteinase-9 expressions correlate with tissue inflammation degree in periodontal disease.
Chronic Periodontitis
Diabetes may affect the expression of matrix metalloproteinases and their inhibitors more than smoking in chronic periodontitis.
Chronic Periodontitis
Effect of Azadirachta indica (Neem) and Aloe vera as compared to subantimicrobial dose doxycycline on matrix metalloproteinases (MMP)-2 and MMP-9: An in-vitro study.
Chronic Periodontitis
Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis.
Chronic Periodontitis
Elastase and metalloproteinase-9 concentrations in saliva in patients with chronic periodontitis.
Chronic Periodontitis
Evaluation of Systemic Levels of Neutrophilic Enzymes in Hypertensive Patients With Chronic Periodontitis.
Chronic Periodontitis
Expression of matrix metalloproteinases-2, -9 and reversion-inducing cysteine-rich protein with Kazal motifs in gingiva in periodontal health and disease.
Chronic Periodontitis
Functional polymorphisms in the matrix metalloproteinase-9 gene in relation to severity of chronic periodontitis.
Chronic Periodontitis
Gene polymorphisms of matrix metalloproteinase-2, -9 and -12 in periodontal health and severe chronic periodontitis.
Chronic Periodontitis
Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2, and MPO decrease after periodontal therapy.
Chronic Periodontitis
Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis.
Chronic Periodontitis
Matrix metalloproteinase-2, -9, and tissue inhibitor of MMP-2 gene polymorphisms in Taiwanese periodontitis patients.
Chronic Periodontitis
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis.
Chronic Periodontitis
Multiple forms of gelatinases/type IV collagenases in saliva and gingival crevicular fluid of periodontitis patients.
Chronic Periodontitis
Neutrophil elastase is involved in the initial destruction of human periodontal ligament.
Chronic Periodontitis
Prevotella intermedia induces matrix metalloproteinase-9 expression in human periodontal ligament cells.
Chronic Periodontitis
Quantitative Evaluation of MMP-9 and TIMP-1 Promoter Methylation in Chronic Periodontitis.
Chronic Periodontitis
The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis.
Chronic Periodontitis
The impact of smoking on levels of chronic periodontitis-associated biomarkers.
Chronic Periodontitis
Toll-like receptor (TLR) and matrix metalloproteinase (MMP) polymorphisms and periodontitis susceptibility: a meta-analysis.
Chronic Periodontitis
[Correlation of matrix metalloproteinase-9 polymorphisms with chronic periodontitis in Uygur adults].
Chronic Periodontitis
[Influence of periodontal therapy on serum interleukin-6 and carotid metalloproteinases in animals with chronic periodontitis associated with atherosclerosis].
Chronic Periodontitis
[The relationship between chronic periodontitis and the instability of carotid atherosclerotic plaque by serum level of MMP-9, MCP-1 and MMP-7].
Chronic Urticaria
Increased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticaria.
Chronic Urticaria
Matrix metalloproteinase-9: a novel biomarker for monitoring disease activity in patients with chronic urticaria patients?
Chronic Urticaria
Plasma Levels of Matrix Metalloproteinase-9 in Children With Chronic Spontaneous Urticaria.
Chronic Urticaria
Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors.
Churg-Strauss Syndrome
Modulation of MMP-2 and MMP-9 in Churg-Strauss syndrome respiratory mucosa: potential monitoring parameters.
Cleft Lip
Concentrations of MMP-9 and TIMP-1 in lip tissue and their impact on cleft lip surgery healing.
Coccidiosis
IL-17A regulates Eimeria tenella schizont maturation and migration in avian coccidiosis.
Coinfection
Active form of gelatinases in tear fluidin patients with corneal ulcer or ocular burn.
Coinfection
Correlation of bacterial coinfection versus matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 expression in aortic aneurysm and atherosclerosis.
Coinfection
Impact of co-infection with Lepeophtheirus salmonis and Moritella viscosa on inflammatory and immune responses of Atlantic salmon (Salmo salar).
Coinfection
Inflammatory responses of a macrophage/epithelial cell co-culture model to mono and mixed infections with Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia.
Coinfection
Reversal of TREM-1 ectodomain shedding and improved bacterial clearance by intranasal metalloproteinase inhibitors.
Colic
Detecting early kidney damage in horses with colic by measuring matrix metalloproteinase -9 and -2, other enzymes, urinary glucose and total proteins.
Colic
MMP-9 Concentration in Peritoneal Fluid Is a Valuable Biomarker Associated with Endotoxemia in Equine Colic.
Colitis
Absence of intestinal PPAR? aggravates acute infectious colitis in mice through a lipocalin-2-dependent pathway.
Colitis
Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice.
Colitis
Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
Colitis
Betulinic acid alleviates dextran sulfate sodium-induced colitis and visceral pain in mice.
Colitis
Butein effects in colitis and interleukin-6/signal transducer and activator of transcription 3 expression.
Colitis
Dyospiros kaki phenolics inhibit colitis and colon cancer cell proliferation, but not gelatinase activities.
Colitis
Fumigaclavine C, an fungal metabolite, improves experimental colitis in mice via downregulating Th1 cytokine production and matrix metalloproteinase activity.
Colitis
Increased activity and expression of matrix metalloproteinase-9 in a rat model of distal colitis.
Colitis
Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease.
Colitis
Inhibition of matrix metalloproteinase-9 by a barbiturate-nitrate hybrid ameliorates dextran sulphate sodium-induced colitis: effect on inflammation-related genes.
Colitis
Inhibitor of PI3K? ameliorates TNBS-induced colitis in mice by affecting the functional activity of CD4(+) CD25(+) FoxP3(+) regulatory T cells.
Colitis
Matrix metalloproteinase 9 contributes to gut microbe homeostasis in a model of infectious colitis.
Colitis
Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis.
Colitis
Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer.
Colitis
Matrix metalloproteinase-9 modulates intestinal injury in rats with transmural colitis.
Colitis
Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis.
Colitis
MMP-9 Processing of Intestinal Smooth Muscle-derived GDNF is Required for Neurotrophic Action on Enteric Neurons.
Colitis
Polyphenol-rich grape pomace extracts protect against dextran sulfate sodium-induced colitis in rats.
Colitis
Role of chymase-dependent matrix metalloproteinase-9 activation in mice with dextran sodium sulfate-induced colitis.
Colitis
Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis.
Colitis
Serotonin-Exacerbated DSS-Induced Colitis Is Associated with Increase in MMP-3 and MMP-9 Expression in the Mouse Colon.
Colitis
Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP.
Colitis
Toward Point-of-Care Diagnostics to Monitor MMP-9 and TNF-? Levels in Inflammatory Bowel Disease.
Colitis
VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
Colitis
WGCNA Reveals Key Roles of IL8 and MMP-9 in Progression of Involvement Area in Colon of Patients with Ulcerative Colitis.
Colitis, Collagenous
Allelic variation of the matrix metalloproteinase-9 gene is associated with collagenous colitis.
Colitis, Collagenous
The Behavior of Matrix Metalloproteinase-9 in Lymphocytic Colitis, Collagenous Colitis and Ulcerative Colitis.
Colitis, Lymphocytic
The Behavior of Matrix Metalloproteinase-9 in Lymphocytic Colitis, Collagenous Colitis and Ulcerative Colitis.
Colitis, Microscopic
The Behavior of Matrix Metalloproteinase-9 in Lymphocytic Colitis, Collagenous Colitis and Ulcerative Colitis.
Colitis, Ulcerative
A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer.
Colitis, Ulcerative
Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease.
Colitis, Ulcerative
Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults.
Colitis, Ulcerative
Changes in MMP-2, MMP-9, inflammation, blood coagulation and intestinal mucosal permeability in patients with active ulcerative colitis.
Colitis, Ulcerative
Effects of mesalazine combined with bifid triple viable on intestinal flora, immunoglobulin and levels of cal, MMP-9, and MPO in feces of patients with ulcerative colitis.
Colitis, Ulcerative
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Colitis, Ulcerative
Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.
Colitis, Ulcerative
Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases.
Colitis, Ulcerative
Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel Diseases.
Colitis, Ulcerative
Fecal MMP-9: A new noninvasive differential diagnostic and activity marker in ulcerative colitis.
Colitis, Ulcerative
Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease.
Colitis, Ulcerative
Inhibition of matrix metalloproteinase-9 by a barbiturate-nitrate hybrid ameliorates dextran sulphate sodium-induced colitis: effect on inflammation-related genes.
Colitis, Ulcerative
Markers of inflammation and influence of nitric oxide on platelet activation in the course of
Colitis, Ulcerative
Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.
Colitis, Ulcerative
Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseases.
Colitis, Ulcerative
Metalloproteinase-3 and -9 as novel markers in the evaluation of ulcerative colitis activity in children.
Colitis, Ulcerative
Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis.
Colitis, Ulcerative
Neutrophils in Ulcerative Colitis: A review of selected biomarkers and their potential therapeutic implications.
Colitis, Ulcerative
Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen.
Colitis, Ulcerative
Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis.
Colitis, Ulcerative
Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer.
Colitis, Ulcerative
Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
Colitis, Ulcerative
The Behavior of Matrix Metalloproteinase-9 in Lymphocytic Colitis, Collagenous Colitis and Ulcerative Colitis.
Colitis, Ulcerative
The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases.
Colitis, Ulcerative
WGCNA Reveals Key Roles of IL8 and MMP-9 in Progression of Involvement Area in Colon of Patients with Ulcerative Colitis.
Colitis-Associated Neoplasms
Matrix metalloproteinase 9 (MMP9) limits reactive oxygen species (ROS) accumulation and DNA damage in colitis-associated cancer.
Colitis-Associated Neoplasms
Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer.
Colitis-Associated Neoplasms
Notch1 Regulates the Effects of Matrix Metalloproteinase-9 on Colitis-Associated Cancer in Mice.
Colonic Neoplasms
92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer.
Colonic Neoplasms
An Up-Scalable and Cost-Effective Methodology for Isolating a Polypeptide Matrix Metalloproteinase-9 Inhibitor from Lupinus albus Seeds.
Colonic Neoplasms
Cell-Free Supernatants from Probiotic Lactobacillus casei and Lactobacillus rhamnosus GG Decrease Colon Cancer Cell Invasion In Vitro.
Colonic Neoplasms
Characterization of a profile of the anthocyanins isolated from Vitis coignetiae Pulliat and their anti-invasive activity on HT-29 human colon cancer cells.
Colonic Neoplasms
Cholic Acid Stimulates MMP-9 in Human Colon Cancer Cells via Activation of MAPK, AP-1, and NF-?B Activity.
Colonic Neoplasms
Clinical significance of the content of biomolecular markers in invasive front of colon carcinomas.
Colonic Neoplasms
Combined Therapeutic Effects of Vinblastine and Astragalus Saponins in Human Colon Cancer Cells and Tumor Xenograft via Inhibition of Tumor Growth and Proangiogenic Factors.
Colonic Neoplasms
Comparison of protein immunoprecipitation-multiple reaction monitoring with ELISA for assay of biomarker candidates in plasma.
Colonic Neoplasms
Construction of a recombinant eukaryotic expression vector containing DNM3 gene and its expression in colon cancer cells.
Colonic Neoplasms
Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor.
Colonic Neoplasms
Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44.
Colonic Neoplasms
Differential inhibition of gelatinase activity in human colon adenocarcinoma cells by Aloe vera and Aloe arborescens extracts.
Colonic Neoplasms
Esculentoside H inhibits colon cancer cell migration and growth through suppression of MMP-9 gene expression via NF-kB signaling pathway.
Colonic Neoplasms
Expression and clinical significance of CD74 and MMP-9 in colon adenocarcinomas.
Colonic Neoplasms
Extracellular vesicles carrying miR-193a derived from mesenchymal stem cells impede cell proliferation, migration and invasion of colon cancer by downregulating FAK.
Colonic Neoplasms
FABP4 promotes invasion and metastasis of colon cancer by regulating fatty acid transport.
Colonic Neoplasms
Factor VIIa regulates the expression of caspase-3, MMP-9, and CD44 in SW620 colon cancer cells involving PAR2/MAPKs/NF-?B signaling pathways.
Colonic Neoplasms
Fermentation supernatants of Lactobacillus delbrueckii inhibit growth of human colon cancer cells and induce apoptosis through a caspase 3-dependent pathway.
Colonic Neoplasms
Flavanols from Japanese quince (Chaenomeles japonica) fruit suppress expression of cyclooxygenase-2, metalloproteinase-9, and nuclear factor-kappaB in human colon cancer cells.
Colonic Neoplasms
Glucose regulated protein 78 promotes cell invasion via regulation of uPA production and secretion in colon cancer cells.
Colonic Neoplasms
Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9.
Colonic Neoplasms
Hyperglycemia Promotes Liver Metastasis of Colorectal Cancer via Upregulation of Integrin ?v?6.
Colonic Neoplasms
Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma.
Colonic Neoplasms
In situ localization of gelatinolytic activity in the extracellular matrix of metastases of colon cancer in rat liver using quenched fluorogenic DQ-gelatin.
Colonic Neoplasms
Influence of conjugated linoleic acid isomers on the metastasis of colon cancer cells in vitro and in vivo.
Colonic Neoplasms
Inhibition of arachidonic acid metabolism decreases tumor cell invasion and matrix metalloproteinase expression.
Colonic Neoplasms
Inhibition of Experimental Colon Cancer Metastasis by the GABA-Receptor Agonist Nembutal.
Colonic Neoplasms
Integrin alpha(v)beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells.
Colonic Neoplasms
Integrin-mediated signalling of gelatinase B secretion in colon cancer cells.
Colonic Neoplasms
JNK Suppression is Essential for 17beta-Estradiol Inhibits Prostaglandin E2-Induced uPA and MMP-9 Expressions and Cell Migration in Human LoVo Colon Cancer Cells.
Colonic Neoplasms
Ketogenic Diet Elicits Antitumor Properties through Inducing Oxidative Stress, Inhibiting MMP-9 Expression, and Rebalancing M1/M2 Tumor-Associated Macrophage Phenotype in a Mouse Model of Colon Cancer.
Colonic Neoplasms
Legume seeds and colorectal cancer revisited: Protease inhibitors reduce MMP-9 activity and colon cancer cell migration.
Colonic Neoplasms
Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo.
Colonic Neoplasms
M2-like macrophages induce colon cancer cell invasion via matrix metalloproteinases.
Colonic Neoplasms
Matrix metalloproteinase-9 associated with heparan sulphate chains of GPI-anchored cell surface proteoglycans mediates motility of murine colon adenocarcinoma cells.
Colonic Neoplasms
Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer.
Colonic Neoplasms
Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer.
Colonic Neoplasms
Mechanisms of Platelet-Stimulated Colon Cancer Invasion: Role of Clusterin and Thrombospondin-1 in Regulation of the P38MAPK-MMP-9 Pathway.
Colonic Neoplasms
MicroRNA-139-5p regulates chronic inflammation by suppressing nuclear factor-?B activity to inhibit cell proliferation and invasion in colorectal cancer.
Colonic Neoplasms
MicroRNA-340 inhibits the proliferation and promotes the apoptosis of colon cancer cells by modulating REV3L.
Colonic Neoplasms
MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases.
Colonic Neoplasms
MMP-9-hemopexin domain hampers adhesion and migration of colorectal cancer cells.
Colonic Neoplasms
Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells.
Colonic Neoplasms
Overexpression of matrix metalloproteinase 9 in tumor epithelial cells correlates with colorectal cancer metastasis.
Colonic Neoplasms
p38? MAPK Mediates 17?-Estradiol Inhibition of MMP-2 and -9 Expression and Cell Migration in Human LoVo Colon Cancer Cells.
Colonic Neoplasms
Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NFkappaB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells.
Colonic Neoplasms
Piwil2 modulates the proliferation and metastasis of colon cancer via regulation of matrix metallopeptidase 9 transcriptional activity.
Colonic Neoplasms
Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients.
Colonic Neoplasms
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Colonic Neoplasms
RUNX3 Inhibits the Invasion and Metastasis of Human Colon Cancer HT-29 Cells by Upregulating MMP-2/9.
Colonic Neoplasms
Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers.
Colonic Neoplasms
Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect.
Colonic Neoplasms
Technological Potential of a Lupin Protein Concentrate as a Nutraceutical Delivery System in Baked Cookies.
Colonic Neoplasms
Tetrandrine suppresses adhesion, migration and invasion of human colon cancer SW620 cells via inhibition of nuclear factor-?B, matrix metalloproteinase-2 and matrix metalloproteinase-9 signaling pathways.
Colonic Neoplasms
The alpha v beta 6 integrin induces gelatinase B secretion in colon cancer cells.
Colonic Neoplasms
The alphaVbeta6 integrin regulates its own expression with cell crowding: implications for tumour progression.
Colonic Neoplasms
The CCL21/CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase-9.
Colonic Neoplasms
The Cellular Uptake and Apoptotic Efficiency of Colchicine is Correlated with Down-regulation of MMP-9 mRNA Expression in SW480 Colon Cancer Cells.
Colonic Neoplasms
The clinical significance and biological function of tropomyosin 4 in colon cancer.
Colonic Neoplasms
The combined treatment of brassinin and imatinib synergistically downregulated the expression of MMP-9 in SW480 colon cancer cells.
Colonic Neoplasms
The traditional Chinese medicine Achyranthes bidentata and our de novo conception of its metastatic chemoprevention: from phytochemistry to pharmacology.
Colonic Neoplasms
Transforming growth factor-beta1 modulates metalloproteinase-2 and -9, nitric oxide, RhoA and alpha-smooth muscle actin expression in colon adenocarcinoma cells.
Colonic Neoplasms
Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
Colonic Neoplasms
Ulinastatin reduces cancer recurrence after resection of hepatic metastases from colon cancer by inhibiting MMP-9 activation via the antifibrinolytic pathway.
Colonic Neoplasms
VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis.
Colonic Neoplasms
[Effects of phosphatase of regenerating liver cell-3 gene silence by RNA interference on the expression of matrix metalloproteinases-2,-9 in human colon cancer cells]
Colonic Neoplasms
[Jiedu sangen decoction intervened carcinoma-associated fibroblasts and inhibited migration and invasion of colon cancer: an experimental research].
Colorectal Neoplasms
(-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
Colorectal Neoplasms
A molecular basis for the synergy between 17?allylamino?17?demethoxy geldanamycin with Capecitabine and Irinotecan in human colorectal cancer cells through VEFG and MMP-9 gene expression.
Colorectal Neoplasms
A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer.
Colorectal Neoplasms
A prospective study to assess the value of MMP-9 in improving the appropriateness of urgent referrals for colorectal cancer.
Colorectal Neoplasms
A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells.
Colorectal Neoplasms
Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Colorectal Neoplasms
Adrenomedullin production is increased in colorectal adenocarcinomas; its relation to matrix metalloproteinase-9.
Colorectal Neoplasms
Antiproliferative Activity of Triterpene Glycoside Nutrient from Monk Fruit in Colorectal Cancer and Throat Cancer.
Colorectal Neoplasms
Assessing the value of matrix metalloproteinase 9 (MMP9) in improving the appropriateness of referrals for colorectal cancer.
Colorectal Neoplasms
Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk.
Colorectal Neoplasms
Brefeldin a effectively inhibits cancer stem cell-like properties and mmp-9 activity in human colorectal cancer colo 205 cells.
Colorectal Neoplasms
Celastrol suppresses nitric oxide synthases and the angiogenesis pathway in colorectal cancer.
Colorectal Neoplasms
Cell-Free Supernatants from Probiotic Lactobacillus casei and Lactobacillus rhamnosus GG Decrease Colon Cancer Cell Invasion In Vitro.
Colorectal Neoplasms
Changes in extracellular matrix in different stages of colorectal cancer and their effects on proliferation of cancer cells.
Colorectal Neoplasms
Circulating Levels of Matrix Metalloproteinase-9 in Patients with Colorectal Cancer.
Colorectal Neoplasms
Clinical relevance of MMP-9, MMP-2, TIMP-1 and TIMP-2 in colorectal cancer.
Colorectal Neoplasms
Clinical significance of levels of molecular biological markers in zones of invasive front-line of colorectal cancer.
Colorectal Neoplasms
Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis.
Colorectal Neoplasms
Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
Colorectal Neoplasms
Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells.
Colorectal Neoplasms
Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer.
Colorectal Neoplasms
Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.
Colorectal Neoplasms
CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation.
Colorectal Neoplasms
Determining the levels of matrix metalloproteinase-9 in portal and peripheral blood is useful for predicting liver metastasis of colorectal cancer.
Colorectal Neoplasms
Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer.
Colorectal Neoplasms
Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.
Colorectal Neoplasms
Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma.
Colorectal Neoplasms
Effects of HMGA2 siRNA and doxorubicin dual delivery by chitosan nanoparticles on cytotoxicity and gene expression of HT-29 colorectal cancer cell line.
Colorectal Neoplasms
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Colorectal Neoplasms
Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.
Colorectal Neoplasms
Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme.
Colorectal Neoplasms
Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
Colorectal Neoplasms
Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population.
Colorectal Neoplasms
Evaluation of the expression of metalloproteinases 2 and 9 and their tissue inhibitors in colon cancer cells treated with phytic acid.
Colorectal Neoplasms
Expression and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases as a prognostic factor in advanced colorectal carcinomas.
Colorectal Neoplasms
Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells - Associations with histopathology and patients outcome.
Colorectal Neoplasms
Expression of matrix metalloproteinases 2, 7 and 9 in patients with colorectal cancer.
Colorectal Neoplasms
Expression of MMP-9 and WAVE3 in colorectal cancer and its relationship to clinicopathological features.
Colorectal Neoplasms
Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage.
Colorectal Neoplasms
Expression of Twist protein in colorectal carcinoma and its effect on proliferation and invasion of colorectal cancer cells.
Colorectal Neoplasms
Expression profiling using a cDNA array and immunohistochemistry for the extracellular matrix genes FN-1, ITGA-3, ITGB-5, MMP-2, and MMP-9 in colorectal carcinoma progression and dissemination.
Colorectal Neoplasms
Expressions of CD23, IL-17 and MMP-9 in Patients with Colorectal Cancer.
Colorectal Neoplasms
Expressions of Inhibitors of DNA Binding-1 and Matrix Metalloproteinase-9 in Colorectal Adenocarcinoma Tissues and Their Correlations with Microvessel Density.
Colorectal Neoplasms
Gelatinase B (MMP-9) expression and survival in colorectal cancer patients.
Colorectal Neoplasms
Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9.
Colorectal Neoplasms
High expression of matrix metalloproteinases: MMP-2 and MMP-9 predicts poor survival outcome in colorectal carcinoma.
Colorectal Neoplasms
High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
Colorectal Neoplasms
High molecular weight coffee melanoidins are inhibitors for matrix metalloproteases.
Colorectal Neoplasms
Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma.
Colorectal Neoplasms
Immunohistochemical expression of Notch1, Jagged1, NF-?B and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
Colorectal Neoplasms
Impairment of stromelysin-1 transcriptional activity by promoter mutations in high microsatellite instability colorectal tumors.
Colorectal Neoplasms
In vitro determination of basement membrane invasion predicts liver metastases in human gastrointestinal carcinoma.
Colorectal Neoplasms
Increased activity of matrix metalloproteinase 2 and 9 after hepatic radiofrequency ablation.
Colorectal Neoplasms
Increased metastases are associated with inflammation and matrix metalloproteinase-9 activity at incision sites in a murine model of peritoneal dissemination of colorectal cancer.
Colorectal Neoplasms
Increased Sushi repeat-containing protein X-linked 2 is associated with progression of colorectal cancer.
Colorectal Neoplasms
Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases.
Colorectal Neoplasms
Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro.
Colorectal Neoplasms
Inositol Hexaphosphate and Inositol Inhibit Colorectal Cancer Metastasis to the Liver in BALB/c Mice.
Colorectal Neoplasms
Knockdown of LI-cadherin alters expression of matrix metalloproteinase-2 and -9 and galectin-3.
Colorectal Neoplasms
Knockdown of Li-cadherin increases metastatic behaviors of LoVo cells.
Colorectal Neoplasms
Lack of MMP-9 expression is a marker for poor prognosis in Dukes' B colorectal cancer.
Colorectal Neoplasms
Legume seeds and colorectal cancer revisited: Protease inhibitors reduce MMP-9 activity and colon cancer cell migration.
Colorectal Neoplasms
Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Colorectal Neoplasms
Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis.
Colorectal Neoplasms
Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer.
Colorectal Neoplasms
Matrix metalloproteinase 9 -1562C/T polymorphism increased protein levels in patients with colorectal cancer in a sample from southeastern Brazil.
Colorectal Neoplasms
Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis.
Colorectal Neoplasms
Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer.
Colorectal Neoplasms
Matrix Metalloproteinase-2 and -9, Lactate, and Malate Dehydrogenase and Lipid Peroxides in Sera of Patients with Colorectal Carcinoma.
Colorectal Neoplasms
Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.
Colorectal Neoplasms
Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.
Colorectal Neoplasms
Matrix Metalloproteinase-9 Is Associated with Relapse and Prognosis of Patients with Colorectal Cancer.
Colorectal Neoplasms
Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
Colorectal Neoplasms
Matrix metalloproteinase-9-1562C>T polymorphism may increase the risk of lymphatic metastasis of colorectal cancer.
Colorectal Neoplasms
Matrix metalloproteinase-9: a deleterious link between hepatic ischemia-reperfusion and colorectal cancer.
Colorectal Neoplasms
Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
Colorectal Neoplasms
Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications.
Colorectal Neoplasms
MFG-E8 overexpression promotes colorectal cancer progression via AKT/MMPs signalling.
Colorectal Neoplasms
miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancer.
Colorectal Neoplasms
MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients.
Colorectal Neoplasms
MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not.
Colorectal Neoplasms
MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients.
Colorectal Neoplasms
MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC).
Colorectal Neoplasms
MMP-9 Expression after Metallic Stent Placement in Patients with Colorectal Cancer: Association with In-Stent Restenosis.
Colorectal Neoplasms
MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases.
Colorectal Neoplasms
MMP-9 polymorphisms are related to serum lipids levels but not associated with colorectal cancer susceptibility in Chinese population.
Colorectal Neoplasms
MMP-9-hemopexin domain hampers adhesion and migration of colorectal cancer cells.
Colorectal Neoplasms
Monitoring multiple angiogenesis-related molecules in the blood of cancer patients shows a correlation between VEGF-A and MMP-9 levels before treatment and divergent changes after surgical vs. conservative therapy.
Colorectal Neoplasms
Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics.
Colorectal Neoplasms
Naturally occurring glycyrrhizin triterpene exerts anticancer effects on colorectal cancer cells via induction of apoptosis and autophagy and suppression of cell migration and invasion by targeting MMP-9 and MMP-2 expression.
Colorectal Neoplasms
Naturally occurring triterpene Lupane exerts anticancer effects on colorectal cancer cells via induction of apoptosis and autophagy and suppresses cell migration and invasion by targeting MMP-9.
Colorectal Neoplasms
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma.
Colorectal Neoplasms
Orphan nuclear receptor Nur77 promotes colorectal cancer invasion and metastasis by regulating MMP-9 and E-cadherin.
Colorectal Neoplasms
Overexpression of KiSS-1 reduces colorectal cancer cell invasion by downregulating MMP-9 via blocking PI3K/Akt/NF-?B signal pathway.
Colorectal Neoplasms
Overexpression of matrix metalloproteinase 9 in tumor epithelial cells correlates with colorectal cancer metastasis.
Colorectal Neoplasms
Overexpression of MMP-13 gene in colorectal cancer with liver metastasis.
Colorectal Neoplasms
Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NFkappaB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells.
Colorectal Neoplasms
Platelet-derived growth factor-D promotes colorectal cancer cell migration, invasion and proliferation by regulating Notch1 and matrix metalloproteinase-9.
Colorectal Neoplasms
Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.
Colorectal Neoplasms
Profile of Expression of Genes Encoding Matrix Metallopeptidase 9 (MMP9), Matrix Metallopeptidase 28 (MMP28) and TIMP Metallopeptidase Inhibitor 1 (TIMP1) in Colorectal Cancer: Assessment of the Role in Diagnosis and Prognostication.
Colorectal Neoplasms
Prognostic and diagnostic implications of MMP-2, MMP-9, and VEGF-? expressions in colorectal cancer.
Colorectal Neoplasms
Prognostic significance of expression of matrix metalloproteinase in colorectal adenocarcinomas and their metastases.
Colorectal Neoplasms
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma.
Colorectal Neoplasms
Promising targets of chrysin and daidzein in colorectal cancer: Amphiregulin, CXCL1, and MMP-9.
Colorectal Neoplasms
Resident stromal cell-derived MMP-9 promotes the growth of colorectal metastases in the liver microenvironment.
Colorectal Neoplasms
Role of IKK and oscillatory NFkappaB kinetics in MMP-9 gene expression and chemoresistance to 5-fluorouracil in RKO colorectal cancer cells.
Colorectal Neoplasms
Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer.
Colorectal Neoplasms
Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening.
Colorectal Neoplasms
Serum matrix metalloproteinase-9 level as a biomarker for colorectal cancer: a diagnostic meta-analysis.
Colorectal Neoplasms
Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
Colorectal Neoplasms
Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
Colorectal Neoplasms
Stability of matrix metalloproteinase-9 as biological marker in colorectal cancer.
Colorectal Neoplasms
Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect.
Colorectal Neoplasms
Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors.
Colorectal Neoplasms
Synergism from the combination of ulinastatin and curcumin offers greater inhibition against colorectal cancer liver metastases via modulating matrix metalloproteinase-9 and E-cadherin expression.
Colorectal Neoplasms
The adenomatous polyposis coli-associated exchange factors Asef and Asef2 are required for adenoma formation in Apc(Min/+)mice.
Colorectal Neoplasms
The assessment of matrix metalloproteinase-9 expression and angiogenesis in colorectal cancer.
Colorectal Neoplasms
The association between the serum levels of matrix metalloproteinase 9 and colorectal cancer.
Colorectal Neoplasms
The Association of Simultaneous Increase in Interleukin-6, C Reactive Protein, and Matrix Metalloproteinase-9 Serum Levels with Increasing Stages of Colorectal Cancer.
Colorectal Neoplasms
The Cellular Uptake and Apoptotic Efficiency of Colchicine is Correlated with Down-regulation of MMP-9 mRNA Expression in SW480 Colon Cancer Cells.
Colorectal Neoplasms
The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.
Colorectal Neoplasms
The localization of thrombospondin-1 (TSP-1), cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) TSP receptor, and matrix metalloproteinase-9 (MMP-9) in colorectal cancer.
Colorectal Neoplasms
The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
Colorectal Neoplasms
The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Colorectal Neoplasms
The role of gelatinases in colorectal cancer progression and metastasis.
Colorectal Neoplasms
TIMP-2 inhibits metastasis and predicts prognosis of colorectal cancer via regulating MMP-9.
Colorectal Neoplasms
TIPE-mediated up-regulation of MMP-9 promotes colorectal cancer invasion and metastasis through MKK-3/p38/NF-?B pro-oncogenic signaling pathway.
Colorectal Neoplasms
Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
Colorectal Neoplasms
Unique activation of matrix metalloproteinase-9 within human liver metastasis from colorectal cancer.
Colorectal Neoplasms
Update analysis of studies on the MMP-9 -1562 C>T polymorphism and cancer risk.
Colorectal Neoplasms
Upregulation of activator protein-4 in human colorectal cancer with metastasis.
Colorectal Neoplasms
Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients.
Colorectal Neoplasms
VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis.
Colorectal Neoplasms
Volatile Anesthetics Reduce Invasion of Colorectal Cancer Cells through Down-regulation of Matrix Metalloproteinase-9.
Colorectal Neoplasms
Warm hepatic ischemia-reperfusion promotes growth of colorectal carcinoma micrometastases in mouse liver via matrix metalloproteinase-9 induction.
Colorectal Neoplasms
Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer.
Colorectal Neoplasms
[Expression and significance of RECK, metalloproteinase-9 and vascular endothelial growth factor-C in colorectal cancer]
Colorectal Neoplasms
[Expression of MMP-2, MMP-9 and collagen type IV and their relationship in colorectal carcinomas.]
Colorectal Neoplasms
[Implication of VEGF and MMPs in hepatic metastasis of human colon cancer]
Colorectal Neoplasms
[Matrix metalloproteinase 9 (92kDa gelatinase/type IV collagenase) is implicated in liver metastasis in colorectal cancers: preliminary report]
Colorectal Neoplasms
[Short hairpin RNA-mediated suvivin gene silencing inhibits invasion and metastasis of human colon carcinoma cell line SW480 in vitro]
Colorectal Neoplasms
[Significance in gene expression of matrix metalloproteinase-9, urokinase-type plasminogen activator and tissue inhibitor of metalloproteinase for metastases of gastric and/or colo-rectal cancer]
Colorectal Neoplasms
[Significance of MMP-9 and TIMP-1 production during liver metastasis in colorectal cancer]
Colorectal Neoplasms
[The correlation between polymorphisms of matrix metalloproteinase-2 and -9 genes and colorectal cancer of Chinese patients]
Colorectal Neoplasms
[The role of selected matrix metalloproteinases and their inhibitors in colorectal cancer development]
Coma
Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice.
Coma
Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice.
Communicable Diseases
Differential expression of matrix metalloproteinases in bacterial meningitis.
Communicable Diseases
High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis.
Complex Regional Pain Syndromes
Local and Systemic Expression Pattern of MMP-2 and MMP-9 in Complex Regional Pain Syndrome.
Confusion
Areca nut procyanidins prevent ultraviolet light B-induced photoaging via suppression of cyclooxygenase-2 and matrix metalloproteinases in mouse skin.
Confusion
Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo.
Congenital Abnormalities
Differential Molecular Expression of Extracellular Matrix and Inflammatory Genes at the Corneal Cone Apex Drives Focal Weakening in Keratoconus.
Conjunctivitis, Allergic
Active matrix metalloproteinases in the tear fluid of individuals with vernal keratoconjunctivitis.
Conjunctivitis, Allergic
Relationship between tear eotaxin-2 and MMP-9 with ocular allergy and corneal topography in keratoconus patients.
Conjunctivitis, Allergic
Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis.
Contracture
Effect of Tissue Inhibitors of Metalloproteinases and Matrix Metalloproteinases on Capsular Formation Around Smooth and Textured Silicone Gel Implants.
Contracture
Hypoxia-induced epithelial-mesenchymal transition and fibrosis for the development of breast capsular contracture.
Contracture
Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants.
Corneal Diseases
Effects of N-acetylcysteine on matrix metalloproteinase-9 secretion and cell migration of human corneal epithelial cells.
Corneal Diseases
Expression of matrix metalloproteinases 2 and 9 in experimental corneal injury and fungal keratitis.
Corneal Diseases
Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.
Corneal Injuries
Acute corneal injury in rabbits following nitrogen mustard ocular exposure.
Corneal Injuries
Expression of matrix metalloproteinases 2 and 9 in experimental corneal injury and fungal keratitis.
Corneal Neovascularization
Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1.
Corneal Neovascularization
Delayed neovascularization in inflammation-induced corneal neovascularization in interleukin-10-deficient mice.
Corneal Neovascularization
Effects of nicotine on corneal wound healing following acute alkali burn.
Corneal Neovascularization
Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation.
Corneal Neovascularization
Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization.
Corneal Neovascularization
Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.
Corneal Neovascularization
Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology.
Corneal Neovascularization
MMP-9 Downregulation with Lipid Nanoparticles for Inhibiting Corneal Neovascularization by Gene Silencing.
Corneal Neovascularization
Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus.
Corneal Neovascularization
[Amniotic membrane transplantation improves experimental herpetic keratitis. Modulation of matrix metalloproteinase-9]
Corneal Ulcer
Active form of gelatinases in tear fluidin patients with corneal ulcer or ocular burn.
Corneal Ulcer
Matrix metalloproteinases (MMP-2 and MMP-9) activity in corneal ulcer and ocular surface disorders determined by gelatin zymography.
Corneal Ulcer
Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2.
Coronary Aneurysm
Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease.
Coronary Aneurysm
Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease.
Coronary Artery Disease
A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction.
Coronary Artery Disease
Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease.
Coronary Artery Disease
Association between -1562C>T polymorphism in the promoter region of matrix metalloproteinase-9 and coronary artery disease: a meta-analysis.
Coronary Artery Disease
Association between matrix metalloproteinase 9 C-1562T polymorphism and the risk of coronary artery disease: an update systematic review and meta-analysis.
Coronary Artery Disease
Association between matrix metalloproteinase-9 rs3918242 polymorphism and development of coronary artery disease in a Chinese population.
Coronary Artery Disease
Association between MMP-3 and MMP-9 polymorphisms and coronary artery disease.
Coronary Artery Disease
Association of genetic polymorphisms in matrix metalloproteinase-9 and coronary artery disease in the chinese han population: a case-control study.
Coronary Artery Disease
Association of matrix metalloproteinase 9 genotypes and cardiovascular disease risk factors with serum matrix metalloproteinase 9 concentrations in Taiwanese individuals.
Coronary Artery Disease
Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis.
Coronary Artery Disease
Association of R279Q and C1562T polymorphisms of matrix metalloproteinase 9 gene and increased risk for myocardial infarction in patients with premature coronary artery disease.
Coronary Artery Disease
Automatic text-mining as an unbiased approach to uncover molecular associations between periodontitis and coronary artery disease.
Coronary Artery Disease
Baseline serum matrix metalloproteinase-9 level predicts long-term prognosis after coronary revascularizations in stable coronary artery disease.
Coronary Artery Disease
Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages.
Coronary Artery Disease
Can the expression of the metalloproteinase 9 gene and its inhibitor be considered as markers of heart failure?
Coronary Artery Disease
Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP.
Coronary Artery Disease
Changes in plasma levels of MMP-9, MMP-7 and their inhibitors in patients with coronary artery disease.
Coronary Artery Disease
Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina.
Coronary Artery Disease
Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population.
Coronary Artery Disease
Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction.
Coronary Artery Disease
Correlation between genetic polymorphism of matrix metalloproteinase-9 in patients with coronary artery disease and cardiac remodeling.
Coronary Artery Disease
Cyclophilin A and matrix metalloproteinase-9: Their relationship, association with, and diagnostic relevance in stable coronary artery disease.
Coronary Artery Disease
Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia.
Coronary Artery Disease
Effect of curcumin on permeability of coronary artery and expression of related proteins in rat coronary atherosclerosis heart disease model.
Coronary Artery Disease
Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome.
Coronary Artery Disease
Effect of Nd:YAG laser-assisted non-surgical periodontal therapy on clinical periodontal and serum biomarkers in patients with and without coronary artery disease: A short-term pilot study.
Coronary Artery Disease
Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial.
Coronary Artery Disease
Elastolytic matrix metalloproteinases and coronary outcome in children with Kawasaki disease.
Coronary Artery Disease
Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
Coronary Artery Disease
Elevated levels of circulating matrix metalloproteinase-9 are associated with a dysregulated cortisol rhythm-A case-control study of coronary artery disease.
Coronary Artery Disease
Expression of toll-like receptor 4, tumor necrosis factor- alpha, matrix metalloproteinase-9 and effects of benazepril in patients with acute coronary syndromes.
Coronary Artery Disease
Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention.
Coronary Artery Disease
Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.
Coronary Artery Disease
Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population.
Coronary Artery Disease
Gelatinase B C(-1562)T polymorphism in relation to ischaemic heart disease.
Coronary Artery Disease
Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease.
Coronary Artery Disease
Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease.
Coronary Artery Disease
Immunoglobulin E and matrix metalloproteinase-9 in patients with different stages of coronary artery diseases.
Coronary Artery Disease
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization.
Coronary Artery Disease
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.
Coronary Artery Disease
Influence of gelatinase B polymorphic variants and its serum levels in atherosclerosis.
Coronary Artery Disease
Lack of Association Between Matrix Metalloproteinase-9 and Endothelial Nitric Oxide Synthase Gene Polymorphisms and Coronary Artery Disease in Turkish Population.
Coronary Artery Disease
Matrix Metalloproteinase-9 (MMP-9) and Myeloperoxidase (MPO) Levels in Patients with Nonobstructive Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography.
Coronary Artery Disease
Matrix metalloproteinase-9 and paraoxonase 1 Q/R192 gene polymorphisms and the risk of coronary artery stenosis in Iranian subjects.
Coronary Artery Disease
Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques.
Coronary Artery Disease
Matrix metalloproteinase-9 gene polymorphisms and their interaction with environment on subarachnoid hemorrhage risk.
Coronary Artery Disease
Matrix metalloproteinase-9 Gene-1562C>T Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population: A Meta-Analysis of 5468 Subjects.
Coronary Artery Disease
Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression.
Coronary Artery Disease
MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study.
Coronary Artery Disease
Optimisation of methods for quantifying plasma mRNA levels from genes responsible for coronary artery plaque development and destabilization.
Coronary Artery Disease
Plasma active matrix metalloproteinase 9 and indices of diastolic function in patients with preserved systolic function.
Coronary Artery Disease
Plasma active matrix metalloproteinase 9 associated to diastolic dysfunction in patients with coronary artery disease.
Coronary Artery Disease
Plasma concentration, genetic variation, and gene expression levels of matrix metalloproteinase 9 in Iranian patients with coronary artery disease.
Coronary Artery Disease
Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease.
Coronary Artery Disease
Plasma haemoxygenase-1 in coronary artery disease. A comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor.
Coronary Artery Disease
Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study.
Coronary Artery Disease
Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease.
Coronary Artery Disease
Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
Coronary Artery Disease
Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.
Coronary Artery Disease
Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease.
Coronary Artery Disease
Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
Coronary Artery Disease
Relationship Between MMP-1, MMP-9, TIMP-1, IL-6 and Risk Factors, Clinical Presentation, Extent and Severity of Atherosclerotic Coronary Artery Disease.
Coronary Artery Disease
Relationship between serum cytokines receptors and matrix metalloproteinase 9 levels and coronary artery disease.
Coronary Artery Disease
Release of matrix metalloproteinases-1 and -2, but not -9, from activated platelets measured by enzyme-linked immunosorbent assay.
Coronary Artery Disease
Role of serum MMP-9 levels and vitamin D receptor polymorphisms in the susceptibility to coronary artery disease: An association study in Iranian population.
Coronary Artery Disease
Salivary and plasma levels of matrix metalloproteinase-9 and myeloperoxidase at rest and after acute physical exercise in patients with coronary artery disease.
Coronary Artery Disease
Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease.
Coronary Artery Disease
Serum metalloproteinase 9 levels in patients with coronary artery disease: a novel marker of inflammation.
Coronary Artery Disease
Stress-induced release of matrix metalloproteinase-9 in patients with coronary artery disease: The possible influence of cortisol.
Coronary Artery Disease
The association between Matrix Metallo-proteinases-9 (MMP-9) gene family polymorphisms and risk of Coronary Artery Disease (CAD): a systematic review and meta-analysis.
Coronary Artery Disease
The Co-Existence of the IL-18+183 A/G and MMP-9 -1562 C/T Polymorphisms Is Associated with Clinical Events in Coronary Artery Disease Patients.
Coronary Artery Disease
The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease.
Coronary Artery Disease
Urinary levels of matrix metalloproteinase 9 and 2 and tissue inhibitor of matrix metalloproteinase in patients with coronary artery disease.
Coronary Artery Disease
Variation in the human matrix metalloproteinase-9 gene is associated with arterial stiffness in healthy individuals.
Coronary Artery Disease
[Changes in proinflammatory cytokine and destructive metalloproteinase levels during formation of unstable atherosclerotic plaque]
Coronary Artery Disease
[Changes in serum level of carboxy-terminal telopeptide of type I collagen in patients with coronary heart disease].
Coronary Artery Disease
[The C(-1562)T polymorphism in the promoter of the matrix metalloproteinase-9 (MMP-9) gene and coronary atherosclerosis]
Coronary Disease
Can the expression of the metalloproteinase 9 gene and its inhibitor be considered as markers of heart failure?
Coronary Disease
Carotid thickness and atherosclerotic plaque stability, serum inflammation, serum MMP-2 and MMP-9 were associated with acute cerebral infarction.
Coronary Disease
Correlation analysis of levels of adiponectin and matrix metalloproteinase-9 with stability of coronary heart disease.
Coronary Disease
Effect of curcumin on permeability of coronary artery and expression of related proteins in rat coronary atherosclerosis heart disease model.
Coronary Disease
Effect of the emphysema subtypes of patients with chronic obstructive pulmonary disease on airway inflammation and COTE index.
Coronary Disease
Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
Coronary Disease
Gelatinase B C(-1562)T polymorphism in relation to ischaemic heart disease.
Coronary Disease
Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1.
Coronary Disease
Haplotype Analysis of the Stromelysin-1 (MMP3) and Gelatinase B (MMP9) Genes in Relation to Coronary Heart Disease.
Coronary Disease
Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease.
Coronary Disease
Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein-A in men at high risk of coronary heart disease.
Coronary Disease
Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels.
Coronary Disease
Plasma Matrix Metalloproteinase-9 Levels Predict First-Time Coronary Heart Disease: An 8-Year Follow-Up of a Community-Based Middle Aged Population.
Coronary Disease
Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up.
Coronary Disease
Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men.
Coronary Disease
Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke.
Coronary Disease
The Long-Term Influence of Tissue Inhibitor of Matrix Metalloproteinase-1 in Patients with Mild to Moderate Coronary Artery Lesions in a Chinese Population: A 7-Year Follow-Up Study.
Coronary Disease
[Association between plasma macrophage migration inhibitory factor concentration and coronary artery lesion severity.]
Coronary Disease
[Changes and relations of soluble plasma CD40L and matrix metalloproteinase-9 levels in patients with coronary heart disease]
Coronary Disease
[Clinical significance of matrix metalloproteinase-9 and tissue factors secreted by cultured monocyte-derived macrophage of patients with coronary heart disease in vitro and the intervenient effect of puerarin on them]
Coronary Disease
[Effects of electroacupuncture intervention on blood lipid levels and expression of CD 40 L and MMP-9 in the coronary artery tissue in coronary heart disease rats].
Coronary Stenosis
Matrix metalloproteinase-9 and paraoxonase 1 Q/R192 gene polymorphisms and the risk of coronary artery stenosis in Iranian subjects.
Coronary Stenosis
Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease.
Coronary Stenosis
Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease.
Cough
Matrix metalloproteinase 9 is involved in airway inflammation in cough variant asthma.
Cough
Prospective assessment of protracted bacterial bronchitis: airway inflammation and innate immune activation.
Cough
Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.
COVID-19
Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019.
COVID-19
Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure.
COVID-19
Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis.
COVID-19
Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019.
COVID-19
MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients.
Craniocerebral Trauma
Dymanics of matrix-metalloproteinase 9 after brain trauma--results of a pilot study.
Craniocerebral Trauma
Increases in matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 mRNA after cerebral contusion and depolarisation.
Craniopharyngioma
Expression of Matrix Metalloproteinase-9, Type IV Collagen and Vascular Endothelial Growth Factor in Adamantinous Craniopharyngioma.
Crohn Disease
A phase 2, Randomized, Placebo-controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients with Moderately to Severely Active Crohn's Disease.
Crohn Disease
Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine.
Crohn Disease
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Crohn Disease
Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.
Crohn Disease
Expression of protease-activated receptor-1 and -2 in orofacial granulomatosis.
Crohn Disease
Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases.
Crohn Disease
Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel Diseases.
Crohn Disease
Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease.
Crohn Disease
Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.
Crohn Disease
Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseases.
Crohn Disease
Misbalance in type III collagen formation/degradation as a novel serological biomarker for penetrating (Montreal B3) Crohn's disease.
Crohn Disease
P180. The new faecal marker matrix metalloprotease-9 is more sensitive for postoperative endoscopic recurrence than fecal calprotectin in Crohn's disease.
Crohn Disease
P269. Serum neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 (NGAL-MMP-9) complex as a surrogate marker for mucosal healing in patients with Crohn's disease.
Crohn Disease
Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen.
Crohn Disease
Recognition of Streptococcus pneumoniae and muramyl dipeptide by NOD2 results in potent induction of MMP-9, which can be controlled by lipopolysaccharide stimulation.
Crohn Disease
Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
Crohn Disease
Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn's disease, a post hoc analysis.
Crohn Disease
Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease.
Crohn Disease
The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases.
Cryptococcosis
Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Cryptogenic Organizing Pneumonia
Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias.
Cryptogenic Organizing Pneumonia
Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Cryptogenic Organizing Pneumonia
The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia.
Cutis Laxa
Cutis Laxa: analysis of metalloproteinases and extracellular matrix expression by immunohistochemistry and histochemistry.
Cutis Laxa
Regulation of matrix metalloproteinase (MMP) expression in cutis laxa fibroblasts: upregulation of MMP-1, MMP-3 and MMP-9 genes but not of the MMP-2 gene.
Cystadenoma
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
cystathionine beta-synthase deficiency
X-ray imaging of differential vascular density in MMP-9-/-, PAR-1-/+, hyperhomocysteinemic (CBS-/+) and diabetic (Ins2-/+) mice*
Cystic Fibrosis
Abnormal activation of calpain and protein kinase C? promotes a constitutive release of matrix metalloproteinase 9 in peripheral blood mononuclear cells from cystic fibrosis patients.
Cystic Fibrosis
Activation of MMP-9 by human lung epithelial cells in response to cystic fibrosis associated pathogen Burkholderia cenocepacia reduced wound healing in vitro.
Cystic Fibrosis
Citrullination as a novel posttranslational modification of matrix metalloproteinases.
Cystic Fibrosis
Correlations of salivary biomarkers with clinical assessments in patients with cystic fibrosis.
Cystic Fibrosis
Doxycycline improves clinical outcomes during cystic fibrosis exacerbations.
Cystic Fibrosis
Human Neutrophil Elastase-Mediated Cleavage Sites of MMP-9 and TIMP-1: Implications to Cystic Fibrosis Proteolytic Dysfunction.
Cystic Fibrosis
Increased GPNMB, phospho-ERK1/2, and MMP-9 in cystic fibrosis in association with reduced arylsulfatase B.
Cystic Fibrosis
Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Cystic Fibrosis
Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients.
Cystic Fibrosis
Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis.
Cysts
A relevant enzyme in granulomatous reaction, active matrix metalloproteinase-9, found in bovine Echinococcus granulosus hydatid cyst wall and fluid.
Cysts
Adhesion molecules, chemokines and matrix metallo-proteinases response after albendazole and albendazole plus steroid therapy in swine neurocysticercosis.
Cysts
Analyses of matrix metalloproteinases and their inhibitors in cyst fluid of serous ovarian tumors.
Cysts
Association of Oxidative Stress and Production of Inflammatory Mediators Matrix Metalloproteinase-9 and Interleukin 6: Systemic Events in Radicular Cysts.
Cysts
Co-micronized Palmitoylethanolamide/Polydatin Treatment Causes Endometriotic Lesion Regression in a Rodent Model of Surgically Induced Endometriosis.
Cysts
Comparative analysis of the immunohistochemical expression of vascular endothelial growth factor and matrix metalloproteinase-9 in keratocystic odontogenic tumor, dentigerous cyst and radicular cyst.
Cysts
Difference in expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in patients with persistent ovarian cysts.
Cysts
Doxycycline use in patients with lymphangioleiomyomatosis: safety and efficacy in metalloproteinase blockade.
Cysts
Exposure to cigarette smoke via respiratory system may induce abnormal alterations of reproductive organs in female diabetic rats.
Cysts
Expression of adhesion molecules, chemokines and matrix metallo- proteinases (MMPs) in viable and degenerating stage of Taenia solium metacestode in swine neurocysticercosis.
Cysts
Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).
Cysts
Immunohistological features related to functional impairment in lymphangioleiomyomatosis.
Cysts
Interleukin-1alpha-dependent regulation of matrix metalloproteinase-9(MMP-9) secretion and activation in the epithelial cells of odontogenic jaw cysts.
Cysts
Involvement of Matrix Metalloproteinases and their Inhibitors in Bovine Cystic Ovarian Disease.
Cysts
Marked induction of gelatinases, especially type B, in host fibroblasts by human ovarian cancer cells in athymic mice.
Cysts
The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
Cysts
Transmembrane estrogen receptor GPR30 is more frequently expressed in malignant than benign ovarian endometriotic cysts and correlates with MMP-9 expression.
Cysts
[Ki-67 and matrix metalloproteinase-9 expression in the follicular cyst, keratocystic odontogenic tumor, and ameloblastoma].
Cysts
[Preventive and therapeutic effect of E-leng capsule on post-operation recurrence of ovarian endometriotic cysts and its influence on expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in eutopic and ectopic endometrium]
Deafness
Single-sided Deafness Leads to Changes in Vesicular Synaptic Transporters and Matrix Metalloproteinase 9 in the Primary Auditory Cortex.
Death, Sudden, Cardiac
Dystrophin and metalloproteinase 9 in myocardial ischemia: A post-mortem immunohistochemical study.
Death, Sudden, Cardiac
Matrix Metalloproteinase-9 (MMP-9) and Myeloperoxidase (MPO) Levels in Patients with Nonobstructive Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography.
Death, Sudden, Cardiac
Simultaneous immunophenotypical assessment of troponin and extracellular matrix molecules in myocardium of patients with sudden cardiac death.
Delirium
Associations of markers of inflammation and coagulation with delirium during critical illness.
Dementia
Concentrations of Matrix Metalloproteinases and their Tissue Inhibitors in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
Dementia
HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway.
Dementia
Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Dementia
MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier.
Dementia
Possible relationship between periodontitis and dementia in a North Indian old age population: a pilot study.
Dementia
Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
Dementia
The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study.
Dementia, Vascular
Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain.
Dementia, Vascular
Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease.
Dementia, Vascular
Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
Demyelinating Diseases
A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer's Disease and Type 2 Diabetes Mellitus.
Demyelinating Diseases
AUY954, a selective S1P(1) modulator, prevents experimental autoimmune neuritis.
Demyelinating Diseases
Cordycepin-enriched WIB-801C from Cordyceps militaris improves functional recovery by attenuating blood-spinal cord barrier disruption after spinal cord injury.
Demyelinating Diseases
Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve.
Demyelinating Diseases
Endoneurial remodeling by TNFalph- and TNFalpha-releasing proteases. A spatial and temporal co-localization study in painful neuropathy.
Demyelinating Diseases
Fibronectin- and vitronectin-induced microglial activation and matrix metalloproteinase-9 expression is mediated by integrins alpha5beta1 and alphavbeta5.
Demyelinating Diseases
Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein.
Demyelinating Diseases
Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy.
Demyelinating Diseases
MMP9 Gene Expression Variation by Ingesting Tart Cherry and P-Coumaric Acid During Remyelination in the Cuprizone Mouse Model.
Demyelinating Diseases
Phosphodiesterase-5 inhibition promotes remyelination by MCP-1/CCR-2 and MMP-9 regulation in a cuprizone-induced demyelination model.
Demyelinating Diseases
Zymographic patterns of MMP-2 and MMP-9 in the CSF and cerebellum of dogs with subacute distemper leukoencephalitis.
Dengue
Relationship between MMP Expression and Virulence of Dengue Virus Type-2 in Infected Mosquito and Mammalian Cells.
Dengue
Severity of Plasma Leakage Is Associated With High Levels of Interferon ?-Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection.
Dental Caries
A Potential New Risk Factor for Stroke: Streptococcus Mutans With Collagen-Binding Protein.
Dental Plaque
Effect of smoking cessation for 1 year on periodontal biomarkers in gingival crevicular fluid.
Dentigerous Cyst
Comparative analysis of the immunohistochemical expression of vascular endothelial growth factor and matrix metalloproteinase-9 in keratocystic odontogenic tumor, dentigerous cyst and radicular cyst.
Dentigerous Cyst
Correlation between radiographic area and immunolocation of MMP-2 and MMP-9 in unilocular radiographic lesions.
Dentigerous Cyst
Immunohistochemical expression of nuclear factor ?B, matrix metalloproteinase 9, and endoglin (CD105) in odontogenic keratocysts, dentigerous cysts, and radicular cysts.
Dentigerous Cyst
Interleukin-1alpha-dependent regulation of matrix metalloproteinase-9(MMP-9) secretion and activation in the epithelial cells of odontogenic jaw cysts.
Dermatitis, Allergic Contact
Is matrix metalloproteinase-9 a culprit involved in dermatitis? Increased expression of gelatinolytic activity in allergic contact dermatitis.
Dermatitis, Atopic
Elevated levels of plasma matrix metalloproteinase-9 in patients with atopic dermatitis: a pilot study.
Dermatitis, Atopic
Suppression of TNF-alpha-induced MMP-9 expression by a cell-permeable superoxide dismutase in keratinocytes.
Dermatitis, Contact
Langerhans' cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens.
Dermatitis, Contact
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response.
Dermatitis, Phototoxic
Protective effect of chromene isolated from Sargassum horneri against UV-A-induced damage in skin dermal fibroblasts.
Dermatofibrosarcoma
Expression of MMP-2, MMP-9 and MMP-11 in dermatofibroma and dermatofibrosarcoma protuberans.
Dermatomyositis
Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Dermatomyositis
Expression of specific matrix metalloproteinases in inflammatory myopathies.
Dermatomyositis
Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers.
Diabetes Mellitus
A feasible tool to detect mRNA expression of matrix metalloproteinases and their tissue inhibitors in human Tenon's capsule.
Diabetes Mellitus
A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer's Disease and Type 2 Diabetes Mellitus.
Diabetes Mellitus
Association of functional SNP-1562C>T in MMP9 promoter with proliferative diabetic retinopathy in north Indian type 2 diabetes mellitus patients.
Diabetes Mellitus
Association of urinary activity of MMP-9 with renal impairment in Mexican patients with type 2 diabetes mellitus.
Diabetes Mellitus
Blood pressure control predicts plasma matrix metalloproteinase-9 in diabetes mellitus type II.
Diabetes Mellitus
Carotid thickness and atherosclerotic plaque stability, serum inflammation, serum MMP-2 and MMP-9 were associated with acute cerebral infarction.
Diabetes Mellitus
Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction.
Diabetes Mellitus
Differential Expression of Matrix Metalloproteinase-9 Gene in Wounds of Type 2 Diabetes Mellitus Cases With Susceptible -1562C>T Genotypes and Wound Severity.
Diabetes Mellitus
Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus.
Diabetes Mellitus
Effect of Cyclophosphamide on Expression of MMP-9 and TGF-?1 in Renal Tissue of Rats with Diabetes Mellitus.
Diabetes Mellitus
Effect of Non-Surgical Periodontal Therapy on CRP, Oxidative Stress, MMP-9 and MMP-2 Levels in Patients With Type 2 Diabetes. A Randomized Controlled Study.
Diabetes Mellitus
Effect of Subantimicrobial Dose Doxycycline Treatment on Gingival Crevicular Fluid Levels of MMP-9 and MMP-13 in Periodontitis Stage 2, Grade B in Subjects with Type 2 Diabetes Mellitus.
Diabetes Mellitus
Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial.
Diabetes Mellitus
Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Diabetes Mellitus
Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders.
Diabetes Mellitus
Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in Apis mellifera Lawang propolis extract gel-treated traumatic ulcers in diabetic rats.
Diabetes Mellitus
Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population.
Diabetes Mellitus
Gelatinases and their tissue inhibitors in a group of subjects with metabolic syndrome.
Diabetes Mellitus
Genetic polymorphism c.1562C>T of the MMP-9 is associated with macroangiopathy in type 2 diabetes mellitus.
Diabetes Mellitus
Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus.
Diabetes Mellitus
Intraocular matrix metalloproteinase 2 and 9 in patients with diabetes mellitus with and without diabetic retinopathy.
Diabetes Mellitus
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension.
Diabetes Mellitus
Levels of Myeloperoxidase and Metalloproteinase-9 in Gingival Crevicular Fluid from Diabetic Subjects with and without Stage 2, Grade B Periodontitis.
Diabetes Mellitus
Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.
Diabetes Mellitus
MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study.
Diabetes Mellitus
Multiple forms of gelatinases/type IV collagenases in saliva and gingival crevicular fluid of periodontitis patients.
Diabetes Mellitus
Plasma Brain Natriuretic Peptide, Endothelin-1, and Matrix Metalloproteinase 9 Expression and Significance in Type 2 Diabetes Mellitus Patients with Ischemic Heart Disease.
Diabetes Mellitus
Plasma levels of MMP-2, MMP-9 and TIMP-1 are not associated with arterial stiffness in subjects with type 2 diabetes mellitus.
Diabetes Mellitus
Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke.
Diabetes Mellitus
Serum Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9/ Neutrophil Gelatinase-associated Lipocalin Complex Levels in Patients With Early-stage Diabetic Nephropathy.
Diabetes Mellitus
Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
Diabetes Mellitus
System of matrix metalloproteinases and cytokine secretion in type 2 diabetes mellitus and impaired carbohydrate tolerance associated with arterial hypertension.
Diabetes Mellitus
The importance of defining serum MMP-9 concentration in diabetics as an early marker of the rupture of atheromatous plaque in acute coronary syndrome.
Diabetes Mellitus
[Features of angenesis against the background of negative pressure wound therapy in patients with neuropathic and neuroischemic forms of diabetic foot ulcers].
Diabetes Mellitus, Type 1
Differences in the mechanism of type 1 and type 2 diabetes-induced skin dryness by using model mice.
Diabetes Mellitus, Type 1
Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus.
Diabetes Mellitus, Type 1
Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy.
Diabetes Mellitus, Type 1
Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus.
Diabetes Mellitus, Type 1
Matrix metalloproteinase -2, -9 and arterial stiffness in children and adolescents: The role of chronic kidney disease, diabetes, and hypertension.
Diabetes Mellitus, Type 1
Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes.
Diabetes Mellitus, Type 1
Plasma levels of tissue inhibitor of metalloproteinase-1 in patients with type 1 diabetes mellitus associate with early diabetic neuropathy and nephropathy.
Diabetes Mellitus, Type 1
[Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes.]
Diabetes Mellitus, Type 2
A Functional Single Nucleotide Polymorphism -1562C>T in the Matrix Metalloproteinase-9 Promoter Is Associated With Type 2 Diabetes and Diabetic Foot Ulcers.
Diabetes Mellitus, Type 2
A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer's Disease and Type 2 Diabetes Mellitus.
Diabetes Mellitus, Type 2
Association of COL4A3 (rs55703767), MMP-9 (rs17576)and TIMP-1 (rs6609533) gene polymorphisms with susceptibility to type 2 diabetes.
Diabetes Mellitus, Type 2
Association of functional SNP-1562C>T in MMP9 promoter with proliferative diabetic retinopathy in north Indian type 2 diabetes mellitus patients.
Diabetes Mellitus, Type 2
Association of urinary activity of MMP-9 with renal impairment in Mexican patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Differential Expression of Matrix Metalloproteinase-9 Gene in Wounds of Type 2 Diabetes Mellitus Cases With Susceptible -1562C>T Genotypes and Wound Severity.
Diabetes Mellitus, Type 2
Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy.
Diabetes Mellitus, Type 2
Effect of Non-Surgical Periodontal Therapy on CRP, Oxidative Stress, MMP-9 and MMP-2 Levels in Patients With Type 2 Diabetes. A Randomized Controlled Study.
Diabetes Mellitus, Type 2
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Effect of Subantimicrobial Dose Doxycycline Treatment on Gingival Crevicular Fluid Levels of MMP-9 and MMP-13 in Periodontitis Stage 2, Grade B in Subjects with Type 2 Diabetes Mellitus.
Diabetes Mellitus, Type 2
Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial.
Diabetes Mellitus, Type 2
Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Exercise ameliorates serum MMP-9 and TIMP-2 levels in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Genetic polymorphism c.1562C>T of the MMP-9 is associated with macroangiopathy in type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
High serum matrix metalloproteinase-9 level predict increased risk of in-hospital cardiac events in patients with type 2 diabetes and ST segment elevation myocardial infarction.
Diabetes Mellitus, Type 2
Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Influence of Type 2 Diabetes on Prevalence of Key Periodontal Pathogens, Salivary Matrix Metalloproteinases, and Bone Remodeling Markers in Sudanese Adults with and without Chronic Periodontitis.
Diabetes Mellitus, Type 2
Levels of Myeloperoxidase and Metalloproteinase-9 in Gingival Crevicular Fluid from Diabetic Subjects with and without Stage 2, Grade B Periodontitis.
Diabetes Mellitus, Type 2
Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers atherosclerosis in type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy.
Diabetes Mellitus, Type 2
Matrix Metalloproteinase-9 Protects Islets from Amyloid-induced Toxicity.
Diabetes Mellitus, Type 2
Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.
Diabetes Mellitus, Type 2
Metformin ameliorates core deficits in a mouse model of fragile X syndrome.
Diabetes Mellitus, Type 2
Monocyte matrix and ADAM metalloproteinase expression in type 2 diabetes after aspirin therapy.
Diabetes Mellitus, Type 2
Plasma Brain Natriuretic Peptide, Endothelin-1, and Matrix Metalloproteinase 9 Expression and Significance in Type 2 Diabetes Mellitus Patients with Ischemic Heart Disease.
Diabetes Mellitus, Type 2
Plasma levels of MMP-2, MMP-9 and TIMP-1 are not associated with arterial stiffness in subjects with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Role of matrix metalloproteinase 9 and its tissue inhibitor 1 in development and prognosis of diabetic retinopathy.
Diabetes Mellitus, Type 2
Serum Matrix Metalloproteinase 9 and Macrophage Migration Inhibitory Factor (MIF) Are Increased in Young Healthy Nonobese Subjects with Positive Family History of Type 2 Diabetes.
Diabetes Mellitus, Type 2
Serum Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9/ Neutrophil Gelatinase-associated Lipocalin Complex Levels in Patients With Early-stage Diabetic Nephropathy.
Diabetes Mellitus, Type 2
Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
Diabetes Mellitus, Type 2
System of matrix metalloproteinases and cytokine secretion in type 2 diabetes mellitus and impaired carbohydrate tolerance associated with arterial hypertension.
Diabetes, Gestational
Membrane-type matrix metalloproteinase-9 activity in placental tissue from patients with pre-existing and gestational diabetes mellitus.
Diabetes, Gestational
Postpartum human breast milk levels of neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9)/NGAL complex in normal and pregnancies complicated with insulin-dependent gestational diabetes mellitus. A prospective pilot case-control study.
Diabetes, Gestational
Proteolytic Mediators in Gestational Diabetes Mellitus and Gingivitis.
Diabetes, Gestational
Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors in women with glucose intolerance in pregnancy and normal controls.
Diabetic Angiopathies
Advanced Glycation End Product-Mediated Matrix Metallo-proteinase-9 and Apoptosis via Renin-Angiotensin System in Type 2 Diabetes.
Diabetic Angiopathies
Blockade of Renin-Angiotensin System Attenuates Advanced Glycation End Products-Mediated Signaling Pathways.
Diabetic Angiopathies
Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress.
Diabetic Cardiomyopathies
[Effects of tamoxifen on CD147 glycosylation and MMPs in the diabetic rat myocardium].
Diabetic Foot
A Functional Single Nucleotide Polymorphism -1562C>T in the Matrix Metalloproteinase-9 Promoter Is Associated With Type 2 Diabetes and Diabetic Foot Ulcers.
Diabetic Foot
AGE-induced Keratinocyte MMP-9 Expression is Linked to TET2-mediated CpG Demethylation.
Diabetic Foot
Changes in biological behaviors of rat dermal fibroblasts induced by high expression of MMP9.
Diabetic Foot
Collagen/GAG scaffolds activated by RALA-siMMP-9 complexes with potential for improved diabetic foot ulcer healing.
Diabetic Foot
Effect of daptomycin on local interleukin-6, matrix metalloproteinase-9, and metallopeptidase inhibitor 1 in patients with MRSA-infected diabetic foot.
Diabetic Foot
Effect of Daptomycin on Local Interleukin-6, Matrix Metalloproteinase-9, and Metallopeptidase Inhibitor 1 in Patients With MRSA-Infected Diabetic Foot.
Diabetic Foot
Expression of active matrix metalloproteinase-9 as a likely contributor to the clinical failure of aclerastide in treatment of diabetic foot ulcers.
Diabetic Foot
High glucose activates ERK1/2 to stabilize AP1 and increase MMP9 expression in diabetic foot ulcers.
Diabetic Foot
Hyperbaric oxygen therapy accelerates wound healing in diabetic mice by decreasing active matrix metalloproteinase-9.
Diabetic Foot
Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers.
Diabetic Foot
Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers: Response to Liu et al.
Diabetic Foot
Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers: Response to Muller et al.
Diabetic Foot
Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers.
Diabetic Foot
Role of site-specific DNA demethylation in TNFa-induced MMP9 expression in keratinocytes.
Diabetic Foot
Validation of Matrix Metalloproteinase-9 (MMP-9) as a Novel Target for Treatment of Diabetic Foot Ulcers in Humans and Discovery of a Potent and Selective Small-Molecule MMP-9 Inhibitor That Accelerates Healing.
Diabetic Foot
Wound Fluid Matrix Metalloproteinase-9 as a Potential Predictive Marker for the Poor Healing Outcome in Diabetic Foot Ulcers.
Diabetic Ketoacidosis
Intracerebral matrix metalloproteinase 9 in fatal diabetic ketoacidosis.
Diabetic Nephropathies
Angiotensin II receptor blocker valsartan ameliorates cardiac fibrosis partly by inhibiting miR-21 expression in diabetic nephropathy mice.
Diabetic Nephropathies
Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy.
Diabetic Nephropathies
Association of a decreased number of d(CA) repeats in the matrix metalloproteinase-9 promoter with glomerulosclerosis susceptibility in mice.
Diabetic Nephropathies
Association of MMP-9 polymorphisms with diabetic nephropathy risk: A protocol for systematic review and meta-analysis.
Diabetic Nephropathies
Association of urinary activity of MMP-9 with renal impairment in Mexican patients with type 2 diabetes mellitus.
Diabetic Nephropathies
Cubilin Single Nucleotide Polymorphism Variants are Associated with Macroangiopathy While a Matrix Metalloproteinase-9 Single Nucleotide Polymorphism Flip-Flop may Indicate Susceptibility of Diabetic Nephropathy in Type-2 Diabetic Patients.
Diabetic Nephropathies
CXCR4 promotes renal tubular cell survival in male diabetic rats: implications for ligand inactivation in the human kidney.
Diabetic Nephropathies
Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy.
Diabetic Nephropathies
Effect of miR-21 on Renal Fibrosis by Regulating MMP-9 and TIMP1 in kk-ay Diabetic Nephropathy Mice.
Diabetic Nephropathies
Effects of pioglitazone on expressions of matrix metalloproteinases 2 and 9 in kidneys of diabetic rats.
Diabetic Nephropathies
Endocytosis of Albumin Induces Matrix Metalloproteinase-9 by Activating the ERK Signaling Pathway in Renal Tubule Epithelial Cells.
Diabetic Nephropathies
Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria.
Diabetic Nephropathies
Expression pattern of genes in peripheral blood mononuclear cells in diabetic nephropathy.
Diabetic Nephropathies
High ambient glucose levels modulates the production of MMP-9 and alpha5(IV) collagen by cultured podocytes.
Diabetic Nephropathies
Hyperoside ameliorates glomerulosclerosis in diabetic nephropathy by downregulating miR-21.
Diabetic Nephropathies
Inhibitory effects of salvianolic acid B on the high glucose-induced mesangial proliferation via NF-kappaB-dependent pathway.
Diabetic Nephropathies
Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy.
Diabetic Nephropathies
Long noncoding RNA growth arrest-specific transcript 5 alleviates renal fibrosis in diabetic nephropathy by downregulating matrix metalloproteinase 9 through recruitment of enhancer of zeste homolog 2.
Diabetic Nephropathies
Matrix Metalloproteinase-9 -1562C/T Gene Polymorphism Is Associated with Diabetic Nephropathy.
Diabetic Nephropathies
Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation.
Diabetic Nephropathies
Matrix metalloproteinase-9 expression is enhanced in renal parietal epithelial cells of zucker diabetic Fatty rats and is induced by albumin in in vitro primary parietal cell culture.
Diabetic Nephropathies
Metformin mediates MicroRNA-21 regulated circulating matrix metalloproteinase-9 in diabetic nephropathy: an in-silico and clinical study.
Diabetic Nephropathies
Minocycline with aspirin: an approach to attenuate diabetic nephropathy in rats.
Diabetic Nephropathies
Pueraria tuberose (PTY-2) attenuates diabetic nephropathy by up-regulating the MMP-9 expression in the kidney of diabetic rats.
Diabetic Nephropathies
Serum Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9/ Neutrophil Gelatinase-associated Lipocalin Complex Levels in Patients With Early-stage Diabetic Nephropathy.
Diabetic Nephropathies
Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
Diabetic Nephropathies
Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression.
Diabetic Nephropathies
Study on the relationship between the methylation of the MMP-9 gene promoter region and diabetic nephropathy.
Diabetic Nephropathies
The kidney expression of matrix metalloproteinase-9 in the diabetic nephropathy of Kkay mice.
Diabetic Nephropathies
The role of megsin, a serine protease inhibitor, in diabetic mesangial matrix accumulation.
Diabetic Nephropathies
Urinary matrix metalloproteinase -8, -9, -14 and their regulators (TRY-1, TRY-2, TATI) in patients with diabetic nephropathy.
Diabetic Nephropathies
[Effects of shenbao recipe on expressions of CTGF and MMP-9 in diabetic nephropathy rats]
Diabetic Nephropathies
[Role of matrix metalloproteinases in the progression of renal lesions]
Diabetic Nephropathies
[The mechanism of homocysteine in Kkay mice diabetic nephropathy model]
Diabetic Neuropathies
Minocycline with aspirin: a therapeutic approach in the treatment of diabetic neuropathy.
Diabetic Retinopathy
Association of functional SNP-1562C>T in MMP9 promoter with proliferative diabetic retinopathy in north Indian type 2 diabetes mellitus patients.
Diabetic Retinopathy
Attenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic rats.
Diabetic Retinopathy
Calcium hydroxybenesulfonate improves vascular proliferation in patients with diabetic retinopathy via reducing VEGF, CAM-1 and MMP-9.
Diabetic Retinopathy
Circ-ITCH restrains the expression of MMP-2, MMP-9 and TNF-? in diabetic retinopathy by inhibiting miR-22.
Diabetic Retinopathy
Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy.
Diabetic Retinopathy
Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy.
Diabetic Retinopathy
Correlations of MMP-3 and MMP-9 gene polymorphisms with diabetic retinopathy.
Diabetic Retinopathy
Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase-9.
Diabetic Retinopathy
Differential expression and localization of human tissue inhibitors of metalloproteinases in proliferative diabetic retinopathy.
Diabetic Retinopathy
Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy.
Diabetic Retinopathy
Effects of quercetin on the expression of MCP-1, MMP-9 and VEGF in rats with diabetic retinopathy.
Diabetic Retinopathy
Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy.
Diabetic Retinopathy
Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation.
Diabetic Retinopathy
Erratum to: Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy.
Diabetic Retinopathy
Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders.
Diabetic Retinopathy
Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy.
Diabetic Retinopathy
Functional links between gelatinase B/matrix metalloproteinase-9 and prominin-1/CD133 in diabetic retinal vasculopathy and neuropathy.
Diabetic Retinopathy
Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy.
Diabetic Retinopathy
Homocysteine Disrupts Balance between MMP-9 and Its Tissue Inhibitor in Diabetic Retinopathy: The Role of DNA Methylation.
Diabetic Retinopathy
Hydrogen Sulfide: A Potential Therapeutic Target in the Development of Diabetic Retinopathy.
Diabetic Retinopathy
Intraocular matrix metalloproteinase 2 and 9 in patients with diabetes mellitus with and without diabetic retinopathy.
Diabetic Retinopathy
Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.
Diabetic Retinopathy
Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9.
Diabetic Retinopathy
Molecular Mechanism of Transcriptional Regulation of Matrix Metalloproteinase-9 in Diabetic Retinopathy.
Diabetic Retinopathy
Oral supplementation with melatonin reduces oxidative damage and concentrations of inducible nitric oxide synthase, VEGF and matrix metalloproteinase 9 in the retina of rats with streptozotocin/nicotinamide induced pre-diabetes.
Diabetic Retinopathy
Paeoniflorin Suppressed High Glucose-Induced Retinal Microglia MMP-9 Expression and Inflammatory Response via Inhibition of TLR4/NF-?B Pathway Through Upregulation of SOCS3 in Diabetic Retinopathy.
Diabetic Retinopathy
Peripheral Blood Mitochondrial DNA Damage as a Potential Noninvasive Biomarker of Diabetic Retinopathy.
Diabetic Retinopathy
Regulation of matrix metallopeptidase-9 by epigenetic modifications, and the development of diabetic retinopathy.
Diabetic Retinopathy
Role of matrix metalloproteinase 9 and its tissue inhibitor 1 in development and prognosis of diabetic retinopathy.
Diabetic Retinopathy
Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy.
Diabetic Retinopathy
Role of Matrix Metalloproteinase-9 in the Development of Diabetic Retinopathy and its Regulation by H-Ras.
Diabetic Retinopathy
Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy.
Diabetic Retinopathy
Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy.
Diabetic Retinopathy
Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.
Diabetic Retinopathy
The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage.
Diabetic Retinopathy
The ERK1/2 Inhibitor U0126 Attenuates Diabetes-Induced Upregulation of MMP-9 and Biomarkers of Inflammation in the Retina.
Distemper
Contribution of astrocytes and macrophage migration inhibitory factor to immune-mediated canine encephalitis caused by the distemper virus.
Distemper
Up-regulation of mRNA for matrix metalloproteinases-9 and -14 in advanced lesions of demyelinating canine distemper leukoencephalitis.
Distemper
Zymographic patterns of MMP-2 and MMP-9 in the CSF and cerebellum of dogs with subacute distemper leukoencephalitis.
Diverticular Diseases
The Behavior of Matrix Metalloproteinase-9 in Lymphocytic Colitis, Collagenous Colitis and Ulcerative Colitis.
Diverticulitis
Comparative analysis of the expression of metalloproteases and their inhibitors in resected crohn's disease and complicated diverticular disease.
Diverticulitis
Glucocorticoid induced TNF receptor (GITR) expression: potential molecular link between steroid intake and complicated diverticulitis?
Diverticulitis
The Behavior of Matrix Metalloproteinase-9 in Lymphocytic Colitis, Collagenous Colitis and Ulcerative Colitis.
Down Syndrome
Enhanced levels of prostaglandin E2, leukotriene B4, and matrix metalloproteinase-9 in gingival crevicular fluid from patients with Down syndrome.
Drug Resistant Epilepsy
Matrix metalloproteinase-9 (MMP-9) in human intractable epilepsy caused by focal cortical dysplasia.
Dry Eye Syndromes
A Highly Soluble Matrix Metalloproteinase-9 Inhibitor for Potential Treatment of Dry Eye Syndrome.
Dry Eye Syndromes
Alpha-lipoic acid: A possible pharmacological agent for treating dry eye disease and retinopathy in diabetes.
Dry Eye Syndromes
Association of Ramadan daytime fasting with ocular surface inflammation and dry eye.
Dry Eye Syndromes
Beneficial effect of daidzin in dry eye rat model through the suppression of inflammation and oxidative stress in the cornea.
Dry Eye Syndromes
Benign Reactive Lymphoid Hyperplasia of the Conjunctiva Treated With Cyclosporine.
Dry Eye Syndromes
Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients.
Dry Eye Syndromes
Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.
Dry Eye Syndromes
Dry Eye Profiles in Patients with a Positive Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test Versus Negative Patients.
Dry Eye Syndromes
Effect of Oral Re-esterified Omega-3 Nutritional Supplementation on Dry Eyes.
Dry Eye Syndromes
Effect of thermal pulsation treatment on tear film parameters in dry eye disease patients.
Dry Eye Syndromes
Effects of Punctal Occlusion on Clinical Signs and Symptoms and Tear Cytokine Levels in Patients With Dry Eye.
Dry Eye Syndromes
Effects of the re-esterified triglyceride (rTG) form of omega-3 supplements on dry eye following cataract surgery.
Dry Eye Syndromes
EMMPRIN Modulates Epithelial Barrier Function through a MMP-Mediated Occludin Cleavage Implications in Dry Eye Disease.
Dry Eye Syndromes
Error in Missing Journal Club Designation in: Sensitivity and Specificity of a Point-of-Care Matrix Metalloproteinase 9 Immunoassay for Diagnosing Inflammation Related to Dry Eye.
Dry Eye Syndromes
Evaluation of point-of-care test for elevated tear matrix metalloproteinase 9 in post-LASIK dry eyes.
Dry Eye Syndromes
Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
Dry Eye Syndromes
Extracellular MMP-9-Based Assessment of Ocular Surface Inflammation in Patients with Primary Open-Angle Glaucoma.
Dry Eye Syndromes
High Levels of 17?-Estradiol Are Associated with Increased Matrix Metalloproteinase-2 and Metalloproteinase-9 Activity in Tears of Postmenopausal Women with Dry Eye.
Dry Eye Syndromes
Importance of tear volume for positivity of tear matrix metalloproteinase-9 immunoassay.
Dry Eye Syndromes
In Vivo Effect of RSH-12, a Novel Selective MMP-9 Inhibitor Peptide, in the Treatment of Experimentally Induced Dry Eye Model.
Dry Eye Syndromes
Inhibition of matrix metalloproteinase-9 for the treatment of dry eye syndrome; a review study.
Dry Eye Syndromes
Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation.
Dry Eye Syndromes
Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease.
Dry Eye Syndromes
Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease.
Dry Eye Syndromes
Matrix metalloproteinase 9 positivity predicts long term decreased tear production.
Dry Eye Syndromes
Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
Dry Eye Syndromes
Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye.
Dry Eye Syndromes
Optimization and validation of an existing, surgical and robust dry eye rat model for the evaluation of therapeutic compounds.
Dry Eye Syndromes
Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye.
Dry Eye Syndromes
Prospective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease.
Dry Eye Syndromes
Proteoglycan 4 (PRG4) expression and function in dry eye associated inflammation.
Dry Eye Syndromes
Quantification of a panel for dry-eye protein biomarkers in tears: A comparative pilot study using standard ELISA and customized microarrays.
Dry Eye Syndromes
Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye.
Dry Eye Syndromes
Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker.
Dry Eye Syndromes
Synthesis and binding monitoring of a new nanomolar PAMAM-based matrix metalloproteinases inhibitor (MMPIs).
Dry Eye Syndromes
The effect of acute exercise on environmentally induced symptoms of dry eye.
Dry Eye Syndromes
The Practical Detection of MMP-9 Diagnoses Ocular Surface Disease and May Help Prevent Its Complications.
Dry Eye Syndromes
The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model.
Dry Eye Syndromes
Topical cyclosporine in thyroid orbitopathy-related dry eye: clinical findings, conjunctival epithelial apoptosis, and MMP-9 expression.
Dry Eye Syndromes
[Immunoassay for matrix metalloproteinase-9 in the tear film of patients with pseudoexfoliation syndrome - a pilot study].
Dry Eye Syndromes
[Significance of New Methods of Examining the Tear Film in Dry Eye Disease: Tear Film Osmolarity and Matrix Metalloproteinases (MMP-9)].
Duodenal Ulcer
[Relationship between gene polymorphisms in MMP-9 and Helicobacter pylori-related upper gastrointestinal disease in children.]
Duodenal Ulcer
[Role of Allelic Genes of Matrix Metalloproteinases and Their Tissue Inhibitors in the Peptic Ulcer Disease Development].
Dupuytren Contracture
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
Dwarfism
The ras-GTPase activity of neurofibromin restrains ERK-dependent FGFR signaling during endochondral bone formation.
Dyslipidemias
Association between serum matrix metalloproteinase-9 and poor prognosis in acute ischemic stroke patients: The role of dyslipidemia.
Dyslipidemias
Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population.
Dyslipidemias
Does metabolic status affect serum levels of BDNF and MMP-9 in patients with schizophrenia?
Dyslipidemias
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia.
Dyslipidemias
MMP-9 microsatellite polymorphism: association with the progression of intima-media thickening and constrictive remodeling of carotid atherosclerotic plaques.
Dyslipidemias
Plasma thrombin-cleaved osteopontin as a potential biomarker of acute atherothrombotic ischemic stroke.
Dyslipidemias
Rice bran protein hydrolysates reduce arterial stiffening, vascular remodeling and oxidative stress in rats fed a high-carbohydrate and high-fat diet.
Dyslipidemias
The effect of obesity and tobacco smoke exposure on inflammatory mediators and matrix metalloproteinases in rat model.
Dysplastic Nevus Syndrome
Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Dyspnea
TIMP-1 and MMP-9 expressions in COPD patients complicated with spontaneous pneumothorax and their correlations with treatment outcomes.
Ear Neoplasms
[Expression of matrix metalloproteinasa-2,9 in cholesteatoma and middle ear cancer]
Echinococcosis
A relevant enzyme in granulomatous reaction, active matrix metalloproteinase-9, found in bovine Echinococcus granulosus hydatid cyst wall and fluid.
Eczema
Risk factors for recurrent wheezing after bronchiolitis in infants: 2-year follow up in China.
Embolic Stroke
Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke.
Embolic Stroke
Large vessel cardioembolic stroke and embolic stroke of undetermined source share a common profile of matrix metalloproteinase-9 level and susceptibility vessel sign length.
Embolic Stroke
Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment.
Embolic Stroke
Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke.
Embolic Stroke
Variants in matrix metalloproteinase-9 gene are associated with hemorrhagic transformation in acute ischemic stroke patients with atherothrombosis, small artery disease, and cardioembolic stroke.
Embolism
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Embolism
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.
Empyema
Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions.
Empyema
Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions.
Encephalitis
Autoimmune encephalitis after Japanese encephalitis in children: A prospective study.
Encephalitis
Cerebrospinal fluid levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in subacute sclerosing panencephalitis.
Encephalitis
Chemokines and matrix metalloproteinases in cerebrospinal fluid of patients with central nervous system complications caused by varicella-zoster virus.
Encephalitis
Circulating levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases during Japanese encephalitis virus infection.
Encephalitis
Contribution of astrocytes and macrophage migration inhibitory factor to immune-mediated canine encephalitis caused by the distemper virus.
Encephalitis
Different characteristics of human herpesvirus 6 encephalitis between primary infection and viral reactivation.
Encephalitis
Exercise pre-conditioning reduces brain inflammation in stroke via tumor necrosis factor-alpha, extracellular signal-regulated kinase 1/2 and matrix metalloproteinase-9 activity.
Encephalitis
Favorable effects of MMP-9 knockdown in murine herpes simplex encephalitis using small interfering RNA.
Encephalitis
Herpes-simplex virus encephalitis is characterized by an early MMP-9 increase and collagen type IV degradation.
Encephalitis
IL-1? Induces MMP-9-Dependent Brain Astrocytic Migration via Transactivation of PDGF Receptor/NADPH Oxidase 2-Derived Reactive Oxygen Species Signals.
Encephalitis
Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Encephalitis
Induction of matrix metalloproteinase-2 and -9 via Erk1/2-NF-?B pathway in human astroglia infected with Toxoplasma gondii.
Encephalitis
Matrix metalloproteinase-2 and -9 lead to fibronectin degradation in astroglia infected with Toxoplasma gondii.
Encephalitis
Melatonin inhibits matrix metalloproteinase-9 (MMP-9) activation in the lipopolysaccharide (LPS)-stimulated RAW 264.7 and BV2 cells and a mouse model of meningitis.
Encephalitis
Neuroprotective Effects of Dehydroepiandrosterone Sulfate Through Inhibiting Expression of Matrix Metalloproteinase-9 from Bradykinin-Challenged Astroglia.
Encephalitis
Protective and causative killer Ig-like receptor (KIR) and metalloproteinase genetic patterns associated with Herpes simplex virus 1 (HSV-1) encephalitis occurrence.
Encephalitis
The COX-2-derived PGE2 autocrine contributes to bradykinin-induced matrix metalloproteinase-9 expression and astrocytic migration via STAT3 signaling.
Encephalitis
The effect of captopril on the expression of MMP-9 and the prognosis of neurological function in herpes simplex encephalitis mice.
Encephalitis
Thrombin Mediates Migration of Rat Brain Astrocytes via PLC, Ca(2+), CaMKII, PKC?, and AP-1-Dependent Matrix Metalloproteinase-9 Expression.
Encephalitis
Up-regulation of mRNA for matrix metalloproteinases-9 and -14 in advanced lesions of demyelinating canine distemper leukoencephalitis.
Encephalitis, Herpes Simplex
Favorable effects of MMP-9 knockdown in murine herpes simplex encephalitis using small interfering RNA.
Encephalitis, Herpes Simplex
The effect of captopril on the expression of MMP-9 and the prognosis of neurological function in herpes simplex encephalitis mice.
Encephalitis, Japanese
Japanese encephalitis virus induces matrix metalloproteinase-9 expression via a ROS/c-Src/PDGFR/PI3K/Akt/MAPKs-dependent AP-1 pathway in rat brain astrocytes.
Encephalitis, Japanese
Japanese encephalitis virus induces matrix metalloproteinase-9 in rat brain astrocytes via NF-?B signalling dependent on MAPKs and reactive oxygen species.
Encephalitis, Tick-Borne
A matrix metalloproteinase 9 (MMP9) gene single nucleotide polymorphism is associated with predisposition to tick-borne encephalitis virus-induced severe central nervous system disease.
Encephalitis, Tick-Borne
Elevation of matrix metalloproteinase-9 level in cerebrospinal fluid of tick-borne encephalitis patients is associated with IgG extravassation and disease severity.
Encephalitis, Tick-Borne
Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis.
Encephalitis, Viral
Protective and causative killer Ig-like receptor (KIR) and metalloproteinase genetic patterns associated with Herpes simplex virus 1 (HSV-1) encephalitis occurrence.
Encephalomyelitis
A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis.
Encephalomyelitis
ApoE-Deficient Promotes Blood-Brain Barrier Disruption in Experimental Autoimmune Encephalomyelitis via Alteration of MMP-9.
Encephalomyelitis
Dependency of Experimental Autoimmune Encephalomyelitis Induction on MOG35-55 Properties Modulating Matrix Metalloproteinase-9 and Interleukin-6.
Encephalomyelitis
Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).
Encephalomyelitis
Experimental autoimmune encephalomyelitis and age-related correlations of NADPH oxidase, MMP-9, and cell adhesion molecules: The increased disease severity and blood-brain barrier permeability in middle-aged mice.
Encephalomyelitis
Expression and activation of matrix metalloproteinase-9 and NADPH oxidase in tissues and plasma of experimental autoimmune encephalomyelitis in mice.
Encephalomyelitis
Fibronectin- and vitronectin-induced microglial activation and matrix metalloproteinase-9 expression is mediated by integrins alpha5beta1 and alphavbeta5.
Encephalomyelitis
Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis.
Encephalomyelitis
Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein.
Encephalomyelitis
Gelatinase B/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy.
Encephalomyelitis
Increased levels of brain serotonin correlated with MMP-9 activity and IL-4 levels resulted in severe experimental autoimmune encephalomyelitis (EAE) in obese mice.
Encephalomyelitis
Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis.
Encephalomyelitis
Minocycline suppresses experimental autoimmune encephalomyelitis by increasing tissue inhibitors of metalloproteinases.
Encephalomyelitis
MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity.
Encephalomyelitis
On the structure and functions of gelatinase B/matrix metalloproteinase-9 in neuroinflammation.
Encephalomyelitis
Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.
Encephalomyelitis
Rolipram impairs NF-kappaB activity and MMP-9 expression in experimental autoimmune encephalomyelitis.
Encephalomyelitis
Serum levels of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) in acute disseminated encephalomyelitis.
Encephalomyelitis
The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes.
Encephalomyelitis
The protective effect of berberine against neuronal damage by inhibiting matrix metalloproteinase-9 and laminin degradation in experimental autoimmune encephalomyelitis.
Encephalomyelitis
Treatment of experimental autoimmune encephalomyelitis with a neurotropic alphavirus vector expressing tissue inhibitor of metalloproteinase-2.
Encephalomyelitis
Trichinella spiralis excretory-secretory products downregulate MMP-9 in Dark Agouti rats affected by experimental autoimmune encephalomyelitis.
Encephalomyelitis
Up-regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis.
Encephalomyelitis, Acute Disseminated
Serum levels of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) in acute disseminated encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
ApoE-Deficient Promotes Blood-Brain Barrier Disruption in Experimental Autoimmune Encephalomyelitis via Alteration of MMP-9.
Encephalomyelitis, Autoimmune, Experimental
Dependency of Experimental Autoimmune Encephalomyelitis Induction on MOG35-55 Properties Modulating Matrix Metalloproteinase-9 and Interleukin-6.
Encephalomyelitis, Autoimmune, Experimental
Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).
Encephalomyelitis, Autoimmune, Experimental
Experimental autoimmune encephalomyelitis and age-related correlations of NADPH oxidase, MMP-9, and cell adhesion molecules: The increased disease severity and blood-brain barrier permeability in middle-aged mice.
Encephalomyelitis, Autoimmune, Experimental
Expression and activation of matrix metalloproteinase-9 and NADPH oxidase in tissues and plasma of experimental autoimmune encephalomyelitis in mice.
Encephalomyelitis, Autoimmune, Experimental
Fibronectin- and vitronectin-induced microglial activation and matrix metalloproteinase-9 expression is mediated by integrins alpha5beta1 and alphavbeta5.
Encephalomyelitis, Autoimmune, Experimental
Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein.
Encephalomyelitis, Autoimmune, Experimental
Gelatinase B/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy.
Encephalomyelitis, Autoimmune, Experimental
Increased levels of brain serotonin correlated with MMP-9 activity and IL-4 levels resulted in severe experimental autoimmune encephalomyelitis (EAE) in obese mice.
Encephalomyelitis, Autoimmune, Experimental
Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
Minocycline suppresses experimental autoimmune encephalomyelitis by increasing tissue inhibitors of metalloproteinases.
Encephalomyelitis, Autoimmune, Experimental
MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity.
Encephalomyelitis, Autoimmune, Experimental
Pathological findings in rats with experimental allergic encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.
Encephalomyelitis, Autoimmune, Experimental
Rolipram impairs NF-kappaB activity and MMP-9 expression in experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes.
Encephalomyelitis, Autoimmune, Experimental
The protective effect of berberine against neuronal damage by inhibiting matrix metalloproteinase-9 and laminin degradation in experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
Treatment of experimental autoimmune encephalomyelitis with a neurotropic alphavirus vector expressing tissue inhibitor of metalloproteinase-2.
Encephalomyelitis, Autoimmune, Experimental
Trichinella spiralis excretory-secretory products downregulate MMP-9 in Dark Agouti rats affected by experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
Up-regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis.
Endoleak
A randomized, placebo-controlled trial of doxycycline after endoluminal aneurysm repair.
Endoleak
Azelnidipine decreases plasma matrix metalloproteinase-9 levels after endovascular abdominal aortic aneurysm repair.
Endoleak
Circulating biomarkers are not associated with endoleaks after endovascular repair of abdominal aortic aneurysms.
Endoleak
Correlation of Baseline Plasma and Inguinal Connective Tissue Metalloproteinases and Their Inhibitors With Late High-Pressure Endoleak After Endovascular Aneurysm Repair: Long-term Results.
Endoleak
EVAR and OPEN treatment of abdominal aortic aneurysm: What is the role of MMP-9 in the follow-up?
Endoleak
Plasma Matrix Metalloproteinase 9 Levels May Predict Endoleaks After Endovascular Aortic Aneurysm Repair.
Endoleak
Re: Utility of Plasma Matrix Metalloproteinase-9 as a Possible Diagnostic Marker of Endoleak Post Endovascular Aneurysm Repair.
Endoleak
Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implications for endoleak.
Endoleak
The association between plasma matrix metalloproteinase-9 concentration and endoleak after endovascular aortic aneurysm repair: a meta-analysis.
Endoleak
Utility of Plasma Matrix Metalloproteinase-9 as a Possible Diagnostic Marker of Endoleak Post Endovascular Aneurysm Repair.
Endometrial Hyperplasia
Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations.
Endometrial Hyperplasia
Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma
Endometrial Neoplasms
?9-tetrahydrocannabinol inhibits epithelial-mesenchymal transition and metastasis by targeting matrix metalloproteinase-9 in endometrial cancer.
Endometrial Neoplasms
Abnormal expression of matrix metalloproteinase-9 (MMP9) correlates with clinical course in Chinese patients with endometrial cancer.
Endometrial Neoplasms
Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form.
Endometrial Neoplasms
Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer.
Endometrial Neoplasms
Clinicopathological Role of Serum-Derived Hyaluronan-Associated Protein (SHAP)-Hyaluronan Complex in Endometrial Cancer.
Endometrial Neoplasms
Correlation of TNFAIP8 overexpression with the proliferation, metastasis, and disease-free survival in endometrial cancer.
Endometrial Neoplasms
Corticotropin-releasing hormone enhances the invasiveness and migration of Ishikawa cells, possibly by increasing matrix metalloproteinase-2 and matrix metalloproteinase-9.
Endometrial Neoplasms
Detection of endometrial cancer by determination of matrix metalloproteinases in the uterine cavity.
Endometrial Neoplasms
Differential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carcinoma.
Endometrial Neoplasms
Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture.
Endometrial Neoplasms
Expression and clinical significance of ARTN and MMP-9 in endometrial carcinoma.
Endometrial Neoplasms
Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma.
Endometrial Neoplasms
Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status.
Endometrial Neoplasms
Expression profile of eukaryotic translation initiation factor and matrix metalloproteinase 9 in endometrial cancer tissue.
Endometrial Neoplasms
Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage.
Endometrial Neoplasms
GnRH-(1-5) activates matrix metallopeptidase-9 to release epidermal growth factor and promote cellular invasion.
Endometrial Neoplasms
Immunohistochemical expression of MMP-2, MMP-9 and COX-2 in Stage IA malignant polyps of the endometrium.
Endometrial Neoplasms
Immunohistochemical studies on matrix metalloproteinase-9 (MMP-9) and type-IV collagen in endometrial carcinoma.
Endometrial Neoplasms
Lipocalin-2 and matrix metalloproteinase-9 expression in high-grade endometrial cancer and their prognostic value.
Endometrial Neoplasms
Matrix metalloproteinase (MMP)-2 and MMP-9 Expression in Tumor Infiltrating CD3 Lymphocytes From Women With Endometrial Cancer.
Endometrial Neoplasms
Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population.
Endometrial Neoplasms
Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations.
Endometrial Neoplasms
MMP-2 expression associates with CA 125 and clinical course in endometrial carcinoma.
Endometrial Neoplasms
Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Endometrial Neoplasms
Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor kappaB.
Endometrial Neoplasms
The effects of microRNA-183 promots cell proliferation and invasion by targeting MMP-9 in endometrial cancer.
Endometrial Neoplasms
The relationships between the immunoexpression of KAI1, MMP-2, MMP-9 and steroid receptors expression in endometrial cancer.
Endometrial Neoplasms
Transforming growth factor-beta3 increases the invasiveness of endometrial carcinoma cells through phosphatidylinositol 3-kinase-dependent up-regulation of X-linked inhibitor of apoptosis and protein kinase c-dependent induction of matrix metalloproteinase-9.
Endometrial Neoplasms
[Activity of matrix metalloproteinases -2 and -9 (MMP-2 and MMP-9) and content of their tissue inhibitors in endometrial cancer--a preliminary study]
Endometrial Neoplasms
[Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma]
Endometrial Neoplasms
[Matrix metalloproteinases and their tissue inhibitors in malignancies of the female genital tract]
Endometriosis
15-Epi-lipoxin A(4) inhibits the progression of endometriosis in a murine model.
Endometriosis
A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis.
Endometriosis
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomas.
Endometriosis
Application of the nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate for the treatment of endometriosis: an in vitro study.
Endometriosis
Association between matrix metalloproteinase-2 and matrix metalloproteinase-9 polymorphisms and endometriosis: A systematic review and meta-analysis.
Endometriosis
Associations between various possible promoter polymorphisms of MMPs genes and endometriosis risk: a meta-analysis.
Endometriosis
Autoantibodies common in patients with gastrointestinal diseases are not found in patients with endometriosis: A cross-sectional study.
Endometriosis
Autocrine Production of Interleukin-34 Promotes the Development of Endometriosis through CSF1R/JAK3/STAT6 signaling.
Endometriosis
Change profiles in matrix metalloproteinase-2 and -9 in induced endometriosis in mice.
Endometriosis
Curcumin arrests endometriosis by downregulation of matrix metalloproteinase-9 activity.
Endometriosis
Differential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carcinoma.
Endometriosis
Doxycycline reduces MMP-2 activity and inhibits invasion of 12Z epithelial endometriotic cells as well as MMP-2 and -9 activity in primary endometriotic stromal cells in vitro.
Endometriosis
Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis.
Endometriosis
Effect of traditional Chinese medicine (Xiaochaihu Tang) on the expression of MMP-2 and MMP-9 in rats with endometriosis.
Endometriosis
Endometriotic epithelial cells induce MMPs expression in endometrial stromal cells via an NFkappaB-dependent pathway.
Endometriosis
Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9.
Endometriosis
Excessive oxidative stress in cumulus granulosa cells induced cell senescence contributes to endometriosis-associated infertility.
Endometriosis
Expression and Significance of Matrix Metalloproteinase-2 and Matrix Metalloproteinas-9 in Endometriosis.
Endometriosis
Expression of cellular adherent and invasive molecules in recurrent ovarian endometriosis.
Endometriosis
Expression of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Endometriosis Menstrual Blood.
Endometriosis
Expression of metalloproteinase-9 in ectopic endometrium in women with endometriosis.
Endometriosis
Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis.
Endometriosis
Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis.
Endometriosis
Haplotype analysis of the matrix metalloproteinase-9 gene associated with advanced-stage endometriosis.
Endometriosis
Human Wharton's jelly stem cells inhibit endometriosis through apoptosis induction.
Endometriosis
Increased Circulating MMP-2 Levels in Infertile Patients With Moderate and Severe Pelvic Endometriosis.
Endometriosis
Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients.
Endometriosis
Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis.
Endometriosis
Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis.
Endometriosis
Inhibition of IDO1 suppresses cyclooxygenase-2 and matrix metalloproteinase-9 expression and decreases proliferation, adhesion and invasion of endometrial stromal cells.
Endometriosis
Interleukin-33 promotes invasiveness of human ovarian endometriotic stromal cells through the ST2/MAPK/MMP-9 pathway activated by 17?-estradiol.
Endometriosis
Intracellular Wnt/Beta-Catenin Signaling Underlying 17beta-Estradiol-Induced Matrix Metalloproteinase 9 Expression in Human Endometriosis.
Endometriosis
Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-?2 (TGF-?2) expression in eutopic endometrium of women with peritoneal endometriosis.
Endometriosis
Matrix Metalloproteinase-3 mRNA: A Promising Peripheral Blood Marker for Diagnosis of Endometriosis.
Endometriosis
Matrix metalloproteinase-9 activity in the plasma of patients after surgical resection of endometriomas.
Endometriosis
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis.
Endometriosis
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness.
Endometriosis
Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Endometriosis
Matrix metalloproteinases are elevated in the urine of patients with endometriosis.
Endometriosis
Melatonin protects against endometriosis via regulation of matrix metalloproteinase-3 and an apoptotic pathway.
Endometriosis
Overexpression of chloride channel-3 is associated with the increased migration and invasion ability of ectopic endometrial cells from patients with endometriosis.
Endometriosis
Performance of peripheral (serum and molecular) blood markers for diagnosis of endometriosis.
Endometriosis
Polymorphisms in MMP-2 and MMP-9 promoter regions are associated with endometriosis.
Endometriosis
Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.
Endometriosis
Positive associations between upregulated levels of stress-induced phosphoprotein 1 and matrix metalloproteinase-9 in endometriosis/adenomyosis.
Endometriosis
Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis.
Endometriosis
Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis.
Endometriosis
The Effect of Imbalanced Progesterone Receptor-A/-B Ratio on Gelatinase Expressions in Endometriosis.
Endometriosis
The effects of resveratrol on the expression of VEGF, TGF-?, and MMP-9 in endometrial stromal cells of women with endometriosis.
Endometriosis
The involvement of osteopontin and matrix metalloproteinase- 9 in the migration of endometrial epithelial cells in patients with endometriosis.
Endometriosis
The levels of matrix metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in different stages of endometriosis.
Endometriosis
The modulating effects of Resveratrol on the expression of MMP-2 and MMP-9 in endometriosis women: a randomized exploratory trial.
Endometriosis
The plasma and peritoneal fluid concentrations of matrix metalloproteinase-9 are elevated in patients with endometriosis.
Endometriosis
[DNA demethylation at the promoter region enhances the expression of MMP-9 in ectopic endometrial stromal cells of endometriosis].
Endometriosis
[Effect of progesterone on the secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 in human ectopic endometrial stromal cells]
Endometriosis
[Expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in ectopic and eutopic endometrium]
Endometriosis
[Expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 mRNA in endometriosis]
Endometriosis
[Study of tissue morphology and vascular endothelial growth factor and matrix metalloproteinase-9 gene expressions in nude mouse endometriosis model]
Endometriosis
[Targeted interruption of COX-2 gene by siRNA inhibits the expression of VEGF, MMP-9, the activity of COX-2 and stimulates the apoptosis in eutopic, ectopic endometrial stromal cells of women with endometriosis].
Endotoxemia
ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels.
Endotoxemia
Endotoxemia shifts neutrophils with TIMP-free gelatinase B/ MMP-9 from bone marrow to periphery and induces systematic upregulation of TIMP-1.
Endotoxemia
Hydrogen Attenuates Endotoxin-Induced Lung Injury by Activating Thioredoxin 1 and Decreasing Tissue Factor Expression.
Endotoxemia
Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9.
Endotoxemia
MMP-9 Concentration in Peritoneal Fluid Is a Valuable Biomarker Associated with Endotoxemia in Equine Colic.
Endotoxemia
Peptidoglycan of Staphylococcus aureus induces enhanced levels of matrix metalloproteinase-9 in human blood originating from neutrophils.
Endotoxemia
Roles of MMP-2/-9 in cardiac dysfunction during early multiple organ failure in an ovine animal model.
Enteritis
Role of matrix metalloproteinases in the pathogenesis of childhood gastroenteritis.
Enterocolitis, Necrotizing
Maternal Serum Interleukin-6, C-Reactive Protein, and Matrix Metalloproteinase-9 Concentrations as Risk Factors for Preterm Birth <32 Weeks and Adverse Neonatal Outcomes.
Eosinophilia
Association of plasminogen activators and matrix metalloproteinase-9 proteolytic cascade with blood-CNS barrier damage of angiostrongyliasis.
Eosinophilia
Changes to plasminogen activators and matrix metalloproteinase-9 in dogs with toxocarosis.
Eosinophilia
Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma.
Eosinophilia
Kochia scoparia fruit attenuates allergic airway inflammation in ovalbumin (OVA)-induced murine asthma model.
Eosinophilia
Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation.
Eosinophilia
Matrix metalloproteinase-9 leads to blood-brain barrier leakage in mice with eosinophilic meningoencephalitis caused by Angiostrongylus cantonensis.
Eosinophilia
Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9.
Eosinophilia
Upregulation of MMP-9/TIMP-1 enzymatic system in eosinophilic meningitis caused by Angiostrongylus cantonensis.
Eosinophilic Granuloma
Expression of matrix metalloproteinase-9 and significance of a macrophage assay in eosinophilic granuloma.
Ependymoma
The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells.
Epidermolysis Bullosa Acquisita
Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Epidermolysis Bullosa Dystrophica
Skin expression of metalloproteinases and tissue inhibitor of metalloproteinases in sibling patients with recessive dystrophic epidermolysis and intrafamilial phenotypic variation.
Epidermolysis Bullosa Simplex
MMP-9 and CXCL8/IL-8 are potential therapeutic targets in epidermolysis bullosa simplex.
Epidermolysis Bullosa, Junctional
Increased levels of matrix metalloproteinase-9 and interleukin-8 in blister fluids of dystrophic and junctional epidermolysis bullosa patients.
Epilepsy
Altered S100 Calcium-Binding Protein B and Matrix Metallopeptidase 9 as Biomarkers of Mesial Temporal Lobe Epilepsy with Hippocampus Sclerosis.
Epilepsy
Analysis of the Expression of Angioarchitecture-related Factors in Patients with Cerebral Arteriovenous Malformation.
Epilepsy
Chronic Intermittent Ethanol Exposure Induces Upregulation of Matrix Metalloproteinase-9 in the Rat Medial Prefrontal Cortex and Hippocampus.
Epilepsy
Correlation of MMP-9 and HMGB1 expression with the cognitive function in patients with epilepsy and factors affecting the prognosis.
Epilepsy
Different circulating metalloproteinases profiles in women with migraine with and without aura.
Epilepsy
Elevated Serum Matrix Metalloproteinase-9, Interleukin-6, Hypersensitive C-Reactive Protein, and Homocysteine Levels in Patients with Epilepsy.
Epilepsy
Epigenetics of Epileptogenesis-Evoked Upregulation of Matrix Metalloproteinase-9 in Hippocampus.
Epilepsy
From c-Fos to MMP-9: In control of synaptic plasticity to produce healthy and diseased mind, a personal view.
Epilepsy
Imbalance of matrix metalloproteinase-9 and matrix metalloproteinase tissue inhibitor-1 may contribute to hemorrhage in cerebellar arteriovenous malformations.
Epilepsy
Increased Expression of Matrix Metalloproteinase-9 in Patients with Temporal Lobe Epilepsy.
Epilepsy
Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
Epilepsy
Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development.
Epilepsy
Matrix metalloproteinase-9 (MMP-9) in human intractable epilepsy caused by focal cortical dysplasia.
Epilepsy
Matrix metalloproteinase-9 activity increased by two different types of epileptic seizures that do not induce neuronal death: a possible role in homeostatic synaptic plasticity.
Epilepsy
Matrix metalloproteinase-9 involvement in the structural plasticity of dendritic spines.
Epilepsy
Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer's disease, and epilepsy.
Epilepsy
Neuroprotection from Tissue Inhibitor of Metalloproteinase-1 and its nanoparticles.
Epilepsy
Temporal lobe epilepsy and matrix metalloproteinase 9: a tempting relation but negative genetic association.
Epilepsy
The role of MMP-9 in integrin-mediated hippocampal cell death after pilocarpine-induced status epilepticus.
Epilepsy
The role of UCH-L1, MMP-9, and GFAP as peripheral markers of different susceptibility to seizure development in a preclinical model of epilepsy.
Epilepsy, Absence
Doxycycline could aggravate the absence-like epileptic seizures of WAG/Rij rats via matrix metalloproteinase inhibition.
Epilepsy, Temporal Lobe
Altered S100 Calcium-Binding Protein B and Matrix Metallopeptidase 9 as Biomarkers of Mesial Temporal Lobe Epilepsy with Hippocampus Sclerosis.
Epilepsy, Temporal Lobe
Increased Expression of Matrix Metalloproteinase-9 in Patients with Temporal Lobe Epilepsy.
Epilepsy, Temporal Lobe
Temporal lobe epilepsy and matrix metalloproteinase 9: a tempting relation but negative genetic association.
Epileptic Syndromes
Temporal lobe epilepsy and matrix metalloproteinase 9: a tempting relation but negative genetic association.
Epiretinal Membrane
Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders.
Epiretinal Membrane
Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy.
Epiretinal Membrane
Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy.
Epiretinal Membrane
Vitreous TIMP-1 levels associate with neovascularization and TGF-?2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy.
Epstein-Barr Virus Infections
Expression of matrix metalloproteinase 9 in nasopharyngeal carcinoma and association with Epstein-Barr virus infection.
Epstein-Barr Virus Infections
[Expressions of matrix metalloproteinase 9 in mucosal natural killer/T cell and mature T cell lymphomas and its relation to Epstein-Barr virus infection]
Erythema
Borrelia burgdorferi-induced monocyte chemoattractant protein-1 production in vivo and in vitro.
Erythema
CD14 mediates cross talk between mononuclear cells and fibroblasts for upregulation of matrix metalloproteinase 9 by Borrelia burgdorferi.
Erythema
Selective up-regulation of matrix metalloproteinase-9 expression in human erythema migrans skin lesions of acute lyme disease.
Escherichia coli Infections
Metalloproteinases TACE and MMP-9 Differentially Regulate Death Factors on Adult and Neonatal Monocytes After Infection with Escherichia coli.
Esophageal Achalasia
Gelatinase B/Matrix Metalloproteinase-9 as Innate Immune Effector Molecule in Achalasia.
Esophageal Neoplasms
Esophageal cancer stem cells express PLGF to increase cancer invasion through MMP9 activation.
Esophageal Neoplasms
Expression of epidermal growth-factor (EGF), matrix metalloproteinase-9 (mmp-9) and proliferating cell nuclear antigen (pcna) in esophageal cancer.
Esophageal Neoplasms
Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer.
Esophageal Neoplasms
Expression of metalloproteinase-9 in patients with mild and severe forms of gastroesophageal reflux disease.
Esophageal Neoplasms
Melatonin Inhibits TE-1 Esophageal Cancer Cells Metastasis by Suppressing the NF-?B Signaling Pathway and Decreasing MMP-9.
Esophageal Neoplasms
Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma.
Esophageal Neoplasms
PAR-2 promotes invasion and migration of esophageal cancer cells by activating MEK/ERK and PI3K/Akt signaling pathway.
Esophageal Neoplasms
Prognostic value of microvessel density, matrix metalloproteinase-9 and p53 protein expression in esophageal cancer.
Esophageal Neoplasms
Serum MMP-9 and SAA in the Diagnosis of Severe Pneumonia Caused by Radiotherapy of Esophageal Cancer.
Esophageal Neoplasms
The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
Esophageal Neoplasms
Upregulated expression and activation of membrane?associated proteases in esophageal squamous cell carcinoma.
Esophageal Neoplasms
[Expression and hypoxic regulation of vascular endothelial growth factor and matrix metalloproteinase-9 in esophageal carcinoma]
Esophageal Squamous Cell Carcinoma
Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Association of matrix metalloproteinases-9 gene polymorphisms with genetic susceptibility to esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-?B in esophageal squamous cell carcinoma cells.
Esophageal Squamous Cell Carcinoma
CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Clinicopathological and prognostic role of MMP-9 in esophageal squamous cell carcinoma: a meta-analysis.
Esophageal Squamous Cell Carcinoma
Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Effect and mechanism of RUNX3 gene on biological characteristics of human esophageal squamous cell carcinoma (ESCC).
Esophageal Squamous Cell Carcinoma
Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Expression and prognostic relevance of Cyclophilin A and matrix metalloproteinase 9 in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer.
Esophageal Squamous Cell Carcinoma
Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer.
Esophageal Squamous Cell Carcinoma
HPV16 infection promotes an M2 macrophage phenotype to promote the invasion and metastasis of esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Lower Serum Matrix Metalloproteinase?9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis.
Esophageal Squamous Cell Carcinoma
Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Phenotypes of human esophageal squamous cell carcinoma based on matrix metalloproteinase production.
Esophageal Squamous Cell Carcinoma
Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor.
Esophageal Squamous Cell Carcinoma
Role of matrix metalloproteinase-9 in transforming growth factor-?1-induced epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.
Esophageal Squamous Cell Carcinoma
The influence of matrix metalloproteinase-2, -9, and -12 promoter polymorphisms on Iranian patients with oesophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
Upregulated expression and activation of membrane?associated proteases in esophageal squamous cell carcinoma.
Esophageal Squamous Cell Carcinoma
XBP1 induces MMP-9 expression to promote proliferation and invasion in human esophageal squamous cell carcinoma.
Esophagitis
Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.
Esophagitis
Expression of metalloproteinase-9 in patients with mild and severe forms of gastroesophageal reflux disease.
Esophagitis, Peptic
Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.
Essential Hypertension
Association of Matrix Metalloproteinase-9 Gene -1562C/T Polymorphism with Essential Hypertension: A Systematic Review and Meta-Analysis Article.
Essential Hypertension
Elevated Levels of MMP-9 in Untreated Patients with Stage I Essential Hypertension.
Essential Hypertension
Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals.
Essential Hypertension
Is there any genetic predisposition of MMP-9 gene C1562T and MTHFR gene C677T polymorphisms with essential hypertension?
Essential Hypertension
Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy.
Essential Hypertension
Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension.
Essential Hypertension
Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment.
Essential Hypertension
The Correlation between High-Sensitivity C-Reactive Protein, Matrix Metallopeptidase 9, and Traditional Chinese Medicine Syndrome in Patients with Hypertension.
Exanthema
Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus.
Exanthema
Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system.
Exfoliation Syndrome
Functional Activity of Matrix Metalloproteinases 2 and 9 in Tears of Patients With Glaucoma.
Exfoliation Syndrome
[Immunoassay for matrix metalloproteinase-9 in the tear film of patients with pseudoexfoliation syndrome - a pilot study].
Exotropia
MMPs, TIMPs and BMP-4 in medial rectus muscle obtained from intermittent exotropia patients and their clinical correlations.
Extranodal Extension
Association between focal adhesion kinase and matrix metalloproteinase-9 expression in prostate adenocarcinoma and their influence on the progression of prostatic adenocarcinoma.
Extranodal Extension
Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs.
Eye Infections
Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus.
Facial Paralysis
The Alterations of Matrix Metalloproteinase-9 in Mouse Brainstem During Herpes Simplex Virus Type 1-Induced Facial Palsy.
Factor XIII Deficiency
Association between expression of MMP-2 and MMP-9 genes and pathogenesis of intracranial hemorrhage in severe coagulation factor XIII deficiency.
Factor XIII Deficiency
Expression and CpG island methylation pattern of MMP-2 and MMP-9 genes in patients with congenital factor XIII deficiency and intracranial hemorrhage.
Familial Mediterranean Fever
Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in patients with familial Mediterranean fever.
Fanconi Anemia
IL-6, IL-8, MMP-2, MMP-9 are overexpressed in Fanconi anemia cells through a NF-?B/TNF-? dependent mechanism.
Fatty Liver
Analysis of cytotoxic T-lymphocyte-associated antigen-4 and MMP-9 genes' methylation and their expression profiles with risk of non-alcoholic fatty liver disease.
Fatty Liver
Deficiency of inducible nitric oxide synthase exacerbates hepatic fibrosis in mice fed high-fat diet.
Fatty Liver
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection.
Fatty Liver
MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis.
Fatty Liver
Theophylline-Based KMUP-1 Improves Steatohepatitis via MMP-9/IL-10 and Lipolysis via HSL/p-HSL in Obese Mice.
Fetal Growth Retardation
Differences in Brain-Derived Neurotrophic Factor and Matrix Metalloproteinase-9 between Appropriate Neonates between Normal Birth Weight and Intrauterine Growth Restriction.
Fetal Growth Retardation
Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction.
Fibroadenoma
Augmented release of matrix metalloproteinase-9 by PKC activation in organotypic cultures of human breast cancer and adjacent normal breast tissue and fibroadenoma.
Fibroadenoma
Detection of serum VEGF and MMP-9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma.
Fibroadenoma
Expression of matrix metalloproteinase 2 and 9 in breast cancer and breast fibroadenoma: a randomized, double-blind study.
Fibroadenoma
Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors.
Fibroadenoma
Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
Fibroma
High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients.
Fibrosarcoma
1-(5-Bromo-2-hydroxy-4-methoxyphenyl)ethanone [SE1] Inhibits MMP-9 Expression by Regulating NF-?B and MAPKs Signaling Pathways in HT1080 Human Fibrosarcoma Cells.
Fibrosarcoma
1-furan-2-yl-3-pyridin-2-yl-propenone inhibits the invasion and migration of HT1080 human fibrosarcoma cells through the inhibition of proMMP-2 activation and down regulation of MMP-9 and MT1-MMP.
Fibrosarcoma
3,5-Dicaffeoyl-epi-quinic acid inhibits the PMA-stimulated activation and expression of MMP-9 but not MMP-2 via downregulation of MAPK pathway.
Fibrosarcoma
5-Azacytidine regulates matrix metalloproteinase-9 expression, and the migration and invasion of human fibrosarcoma HT1080 cells via PI3-kinase and ERK1/2 pathways.
Fibrosarcoma
A small compound that inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-9 upregulation.
Fibrosarcoma
Acteoside inhibits PMA-induced matrix metalloproteinase-9 expression via CaMK/ERK- and JNK/NF-?B-dependent signaling.
Fibrosarcoma
Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.
Fibrosarcoma
Antimetastatic activity of pinosylvin, a natural stilbenoid, is associated with the suppression of matrix metalloproteinases.
Fibrosarcoma
AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon ?.
Fibrosarcoma
Arfaptin 1 inhibits ADP-ribosylation factor-dependent matrix metalloproteinase-9 secretion induced by phorbol ester in HT 1080 fibrosarcoma cells.
Fibrosarcoma
Bone morphogenetic protein 4 (BMP-4) and epidermal growth factor (EGF) inhibit metalloproteinase-9 (MMP-9) expression in cancer cells.
Fibrosarcoma
Carboxy derivatized glucosamine is a potent inhibitor of matrix metalloproteinase-9 in HT1080 cells.
Fibrosarcoma
Carboxylated chitooligosaccharides (CCOS) inhibit MMP-9 expression in human fibrosarcoma cells via down-regulation of AP-1.
Fibrosarcoma
Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines.
Fibrosarcoma
Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells.
Fibrosarcoma
Constituents of Aquilaria sinensis Leaves Upregulate the Expression of Matrix Metalloproteases 2 and 9.
Fibrosarcoma
Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA.
Fibrosarcoma
Dieckol from Ecklonia cava Regulates Invasion of Human Fibrosarcoma Cells and Modulates MMP-2 and MMP-9 Expression via NF-?B Pathway.
Fibrosarcoma
Eugenol with antioxidant activity inhibits MMP-9 related to metastasis in human fibrosarcoma cells.
Fibrosarcoma
Evaluation of matrix metalloproteinases (MMP)-2 and MMP-9 activity in serum and biochemical and hematological parameters in spontaneous canine cutaneous tumors before and after surgical treatment.
Fibrosarcoma
Flavonoid glycosides isolated from Salicornia herbacea inhibit matrix metalloproteinase in HT1080 cells.
Fibrosarcoma
Galangin and Kaempferol Suppress Phorbol-12-Myristate-13-Acetate-Induced Matrix Metalloproteinase-9 Expression in Human Fibrosarcoma HT-1080 Cells.
Fibrosarcoma
Glucocorticoid receptor-induced down-regulation of MMP-9 by ginseng components, PD and PT contributes to inhibition of the invasive capacity of HT1080 human fibrosarcoma cells.
Fibrosarcoma
Human fibronectin and MMP-2 collagen binding domains compete for collagen binding sites and modify cellular activation of MMP-2.
Fibrosarcoma
Hydrophilic extract from Posidonia oceanica inhibits activity and expression of gelatinases and prevents HT1080 human fibrosarcoma cell line invasion.
Fibrosarcoma
In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
Fibrosarcoma
In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on human fibrosarcoma cells HT-1080.
Fibrosarcoma
Inhibition of endothelial cell migration through the down?regulation of MMP-9 by A-kinase anchoring protein 12.
Fibrosarcoma
Inhibition of human collagenase activity by antisense oligonucleoside methylphosphonates.
Fibrosarcoma
Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine models.
Fibrosarcoma
Inhibitive effect of triptolide on invasiveness of human fibrosarcoma cells by downregulating matrix metalloproteinase-9 expression.
Fibrosarcoma
Inhibitory effect of chitooligosaccharides on matrix metalloproteinase-9 in human fibrosarcoma cells (HT1080).
Fibrosarcoma
Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases.
Fibrosarcoma
Inhibitory effect of the carnosine-gallic acid synthetic peptide on MMP-2 and MMP-9 in human fibrosarcoma HT1080 cells.
Fibrosarcoma
Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Fibrosarcoma
Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt-dependent matrix metalloproteinase-9 expression.
Fibrosarcoma
Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption.
Fibrosarcoma
Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
Fibrosarcoma
Matrix metalloproteinase 9 expression is coordinately modulated by the KRE-M9 and 12-O-tetradecanoyl-phorbol-13-acetate responsive elements.
Fibrosarcoma
Matrix metalloproteinase-9 silencing by RNA interference promotes the adhesive-invasive switch in HT1080 human fibrosarcoma cells.
Fibrosarcoma
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines.
Fibrosarcoma
Mosaic structure of the secreted ECM metalloproteases and interaction of the type IV collagenases with inhibitors.
Fibrosarcoma
Near-infrared triple-helical peptide with quenched fluorophores for optical imaging of MMP-2 and MMP-9 proteolytic activity in vivo.
Fibrosarcoma
Novel Antitumor Invasive Actions of p-Cymene by Decreasing MMP-9/TIMP-1 Expression Ratio in Human Fibrosarcoma HT-1080 Cells.
Fibrosarcoma
Phospholipase D mediates matrix metalloproteinase-9 secretion in phorbol ester-stimulated human fibrosarcoma cells.
Fibrosarcoma
Phthalide derivative CD21 attenuates tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke by enhancing macrophage scavenger receptor 1-mediated DAMP (peroxiredoxin 1) clearance.
Fibrosarcoma
Proangiogenic role of neutrophil-like inflammatory heterophils during neovascularization induced by growth factors and human tumor cells.
Fibrosarcoma
Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
Fibrosarcoma
Resveratrol induces MMP-9 and cell migration via the p38 kinase and PI-3K pathways in HT1080 human fibrosarcoma cells.
Fibrosarcoma
Simvastatin, an HMG-CoA reductase inhibitor, reduced the expression of matrix metalloproteinase-9 (Gelatinase B) in osteoblastic cells and HT1080 fibrosarcoma cells.
Fibrosarcoma
Single treatment with cisplatin or UFT, but not their combination treatment enhances the metastatic capacity of mouse fibrosarcoma cells.
Fibrosarcoma
SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.
Fibrosarcoma
Stimulation of matrix metalloproteinase-9 expression in human fibrosarcoma cells by synthetic matrix metalloproteinase inhibitors.
Fibrosarcoma
Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells.
Fibrosarcoma
Suppression of EGF-induced tumor cell migration and matrix metalloproteinase-9 expression by capsaicin via the inhibition of EGFR-mediated FAK/Akt, PKC/Raf/ERK, p38 MAPK, and AP-1 signaling.
Fibrosarcoma
Tetraspanin CD9 promotes the invasive phenotype of human fibrosarcoma cells via upregulation of matrix metalloproteinase-9.
Fibrosarcoma
The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions.
Fibrosarcoma
Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha.
Fibrosarcoma
Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells.
Fibrosarcoma
Wilfoside K1N isolated from Cynanchum wilfordii inhibits angiogenesis and tumor cell invasion.
Fibrosarcoma
[Triptolide evaluates DNA methylation level of matrix metalloproteinase 9 gene in human fibrosarcoma HT-1080 cells]
Follicular Cyst
Involvement of Matrix Metalloproteinases and their Inhibitors in Bovine Cystic Ovarian Disease.
Follicular Cyst
[Ki-67 and matrix metalloproteinase-9 expression in the follicular cyst, keratocystic odontogenic tumor, and ameloblastoma].
Foot Ulcer
A Functional Single Nucleotide Polymorphism -1562C>T in the Matrix Metalloproteinase-9 Promoter Is Associated With Type 2 Diabetes and Diabetic Foot Ulcers.
Foot Ulcer
AGE-induced Keratinocyte MMP-9 Expression is Linked to TET2-mediated CpG Demethylation.
Foot Ulcer
Changes in biological behaviors of rat dermal fibroblasts induced by high expression of MMP9.
Foot Ulcer
Cilostazol prevents foot ulcers in diabetic patients with peripheral vascular disease.
Foot Ulcer
Collagen/GAG scaffolds activated by RALA-siMMP-9 complexes with potential for improved diabetic foot ulcer healing.
Foot Ulcer
Expression of active matrix metalloproteinase-9 as a likely contributor to the clinical failure of aclerastide in treatment of diabetic foot ulcers.
Foot Ulcer
Expression of miR-217 and HIF-1?/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats.
Foot Ulcer
High glucose activates ERK1/2 to stabilize AP1 and increase MMP9 expression in diabetic foot ulcers.
Foot Ulcer
Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers.
Foot Ulcer
Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers: Response to Liu et al.
Foot Ulcer
Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers: Response to Muller et al.
Foot Ulcer
Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers.
Foot Ulcer
Inhibition of matrix metalloproteinase 9 expression in rat dermal fibroblasts using small interfering RNA.
Foot Ulcer
Role of site-specific DNA demethylation in TNFa-induced MMP9 expression in keratinocytes.
Foot Ulcer
Validation of Matrix Metalloproteinase-9 (MMP-9) as a Novel Target for Treatment of Diabetic Foot Ulcers in Humans and Discovery of a Potent and Selective Small-Molecule MMP-9 Inhibitor That Accelerates Healing.
Foot Ulcer
Wound Fluid Matrix Metalloproteinase-9 as a Potential Predictive Marker for the Poor Healing Outcome in Diabetic Foot Ulcers.
Fragile X Syndrome
A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders.
Fragile X Syndrome
From c-Fos to MMP-9: In control of synaptic plasticity to produce healthy and diseased mind, a personal view.
Fragile X Syndrome
Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model.
Fragile X Syndrome
High MMP-9 activity levels in fragile X syndrome are lowered by minocycline.
Fragile X Syndrome
Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
Fragile X Syndrome
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Fragile X Syndrome
Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9.
Fragile X Syndrome
The Perineuronal 'Safety' Net? Perineuronal Net Abnormalities in Neurological Disorders.
Frontotemporal Dementia
MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations.
Frontotemporal Dementia
Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.
Gallbladder Neoplasms
Enhanced expression of trophinin promotes invasive and metastatic potential of human gallbladder cancer cells.
Gallstones
[DYNAMIC OF CLINICAL, LABORATORY AND SONOGRAPHIC PARAMETERS AFTER SUCCESSFUL LITHOLITIC THERAPY AT PATIENTS WITH GALLSTONE DISEASE IN ASSOCIATION WITH METABOLIC SYNDROME].
Gallstones
[Evaluation of prognostic factors for the development of cholelithiasis in patients with metabolic syndrome].
Gastritis
A novel gastroprotective effect of zeaxanthin against stress-induced gastritis in male rats targeting the expression of HIF-1?, TFF-1 and MMP-9 through PI3K/Akt/JNK signaling pathway.
Gastritis
Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.
Gastritis
Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels.
Gastritis
Gastric gelatinase B/matrix metalloproteinase-9 is rapidly increased in Helicobacter felis-induced gastritis.
Gastritis
Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer.
Gastritis
Serum IL-10, MMP-7, MMP-9 Levels in Helicobacter pylori Infection and Correlation with Degree of Gastritis.
Gastritis
[Relationship between gene polymorphisms in MMP-9 and Helicobacter pylori-related upper gastrointestinal disease in children.]
Gastritis
[The changes of matrix metalloproteinase-9 expression in the gastric antral mucosa after Helicobacter pylori eradication: immunohistochemical study]
Gastrointestinal Diseases
Fecal MMP-9: A new noninvasive differential diagnostic and activity marker in ulcerative colitis.
Gastrointestinal Diseases
Technological Potential of a Lupin Protein Concentrate as a Nutraceutical Delivery System in Baked Cookies.
Gastrointestinal Diseases
[Relationship between gene polymorphisms in MMP-9 and Helicobacter pylori-related upper gastrointestinal disease in children.]
Gastrointestinal Neoplasms
M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.
Gastrointestinal Neoplasms
Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer.
Gastrointestinal Neoplasms
Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers.
Gastrointestinal Stromal Tumors
Expression of matrix metalloproteinase-9, cyclooxygenase-2 and vascular endothelial growth factor are increased in gastrointestinal stromal tumors.
Gastrointestinal Stromal Tumors
[Correlation between expressions of matrix metalloproteinase-2 & 9 and vasculogenic mimicry in gastrointestinal stromal tumors]
gelatinase a deficiency
Matrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic Ischemia and Reperfusion Injury in Mice.
gelatinase a deficiency
Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion.
gelatinase b deficiency
Aberrant Collagen Composition of the Trabecular Meshwork Results in Reduced Aqueous Humor Drainage and Elevated IOP in MMP-9 Null Mice.
gelatinase b deficiency
Cerebral ischaemia and matrix metalloproteinase-9 modulate the angiogenic function of early and late outgrowth endothelial progenitor cells.
gelatinase b deficiency
Compensatory vascular remodeling during atherosclerotic lesion growth depends on matrix metalloproteinase-9 activity.
gelatinase b deficiency
Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation.
gelatinase b deficiency
Deficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune disease.
gelatinase b deficiency
Effect of genetic depletion of MMP-9 on neurological manifestations of hypertension-induced intracerebral hemorrhages in aged mice.
gelatinase b deficiency
Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury.
gelatinase b deficiency
Gelatinase B (MMP-9) deficiency does not affect murine adipose tissue development.
gelatinase b deficiency
Gelatinase B deficiency does not protect against lipopolysaccharide-induced acute lung injury.
gelatinase b deficiency
Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model.
gelatinase b deficiency
Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cells.
gelatinase b deficiency
Histochemical aspects of the vascular invasion at the erosion zone of the epiphyseal cartilage in MMP-9-deficient mice.
gelatinase b deficiency
In vivo activation of gelatinase B/MMP-9 by trypsin in acute pancreatitis is a permissive factor in streptozotocin-induced diabetes.
gelatinase b deficiency
In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse.
gelatinase b deficiency
Inhibition of obliterative airway disease development in murine tracheal allografts by matrix metalloproteinase-9 deficiency.
gelatinase b deficiency
Matrix metalloproteinase 9 facilitates collagen remodeling and angiogenesis for vascular constructs.
gelatinase b deficiency
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response.
gelatinase b deficiency
Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization.
gelatinase b deficiency
Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion.
gelatinase b deficiency
Matrix metalloproteinase-9 contributes to the mobilization of bone marrow cells in the injured liver.
gelatinase b deficiency
Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation.
gelatinase b deficiency
Matrix metalloproteinase-9 deficiency has no effect on glial scar formation after transient focal cerebral ischemia in mouse.
gelatinase b deficiency
Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation.
gelatinase b deficiency
Matrix Metalloproteinase-9 Deficiency Impairs Host Defense against Abdominal Sepsis.
gelatinase b deficiency
Matrix metalloproteinase-9 deficiency impairs host defense mechanisms against Streptococcus pneumoniae in a mouse model of bacterial meningitis.
gelatinase b deficiency
Matrix metalloproteinase-9 deficiency leads to prolonged foreign body response in the brain associated with increased IL-1beta levels and leakage of the blood-brain barrier.
gelatinase b deficiency
Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction.
gelatinase b deficiency
Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection.
gelatinase b deficiency
Matrix Metalloproteinase-9 Deficiency Results in Decreased Fiber Cross-Sectional Area and Alters Fiber Type Distribution in Mouse Hindlimb Skeletal Muscle.
gelatinase b deficiency
Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation.
gelatinase b deficiency
Matrix Metalloproteinase-9 Deficiency Worsens Lung Injury in a Model of Bronchopulmonary Dysplasia.
gelatinase b deficiency
Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells.
gelatinase b deficiency
Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis.
gelatinase b deficiency
Matrix metalloproteinase-9-dependent mechanisms of reduced contractility and increased stiffness in the aging heart.
gelatinase b deficiency
Mechanisms of inflammatory lung injury in the neonate: lessons from a transgenic mouse model of bronchopulmonary dysplasia.
gelatinase b deficiency
Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis.
gelatinase b deficiency
MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum.
gelatinase b deficiency
Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice.
gelatinase b deficiency
MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury.
gelatinase b deficiency
Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B.
gelatinase b deficiency
Novel Role for Matrix Metalloproteinase 9 in Modulation of Cholesterol Metabolism.
gelatinase b deficiency
Pleiotropic Effects of Myocardial MMP-9 Inhibition to Prevent Ventricular Arrhythmia.
gelatinase b deficiency
Relaxin and Matrix Metalloproteinase-9 in Angiotensin II-Induced Abdominal Aortic Aneurysms.
gelatinase b deficiency
Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling.
gelatinase b deficiency
The Role of Matrix Metalloproteinase-9 in Atherosclerotic Plaque Instability.
gelatinase b deficiency
Thymocyte development in the absence of matrix metalloproteinase-9/gelatinase B.
gelatinase b deficiency
Use of matrix metalloproteinase (MMP)-9 knockout mice demonstrates that MMP-9 activity is not absolutely required for G-CSF or Flt-3 ligand-induced hematopoietic progenitor cell mobilization or engraftment.
Gestational Trophoblastic Disease
[The role of KiSS-1 and matrix metalloproteinase-9 in regulation of invasion of trophoblasts]
Giant Cell Arteritis
Association of a nonsynonymous single-nucleotide polymorphism of matrix metalloproteinase 9 with giant cell arteritis.
Giant Cell Arteritis
Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis.
Giant Cell Arteritis
Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis.
Giant Cell Arteritis
Serum MMP-2 and MMP-9 in patients with Behçet's disease: Do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Giant Cell Tumor of Bone
Expression of Matrix Metalloproteinase-9 and CD34 in Giant Cell Tumor of Bone.
Giant Cell Tumor of Bone
Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions.
Giant Cell Tumor of Bone
Interleukin-1beta upregulates MMP-9 expression in stromal cells of human giant cell tumor of bone.
Giant Cell Tumor of Bone
Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.
Giant Cell Tumor of Bone
Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone.
Giant Cell Tumor of Bone
Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha.
Giant Cell Tumors
Expression of Matrix Metalloproteinase-9 and CD34 in Giant Cell Tumor of Bone.
Giant Cell Tumors
Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions.
Giant Cell Tumors
Interleukin-1beta upregulates MMP-9 expression in stromal cells of human giant cell tumor of bone.
Giant Cell Tumors
Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.
Giant Cell Tumors
Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone.
Giant Cell Tumors
Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha.
Gingival Hypertrophy
Matrix metalloproteinase 9 levels in gingival crevicular fluid in patients after periodontal microsurgery for orthodontic induced gingival hypertrophy.
Gingival Overgrowth
Collagen IV and MMP-9 expression in hypertrophic gingiva during orthodontic treatment.
Gingival Overgrowth
Local Inflammation Alters MMP-2 and MMP-9 Gelatinase Expression Associated with the Severity of Nifedipine-Induced Gingival Overgrowth: a Rat Model Study.
Gingival Overgrowth
Quantification of matrix metalloproteinases MMP-8 and MMP-9 in gingival overgrowth.
Gingival Overgrowth
SPOCK1 is a novel inducer of epithelial to mesenchymal transition in drug-induced gingival overgrowth.
Gingival Pocket
Levels of matrix metalloproteinases-8 and -9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase-9 and cholesterol in blood.
Gingival Recession
Cytokine (interleukin-1beta) and MMP levels in gingival crevicular fluid after use of platelet-rich fibrin or connective tissue graft in the treatment of localized gingival recessions.
Gingival Recession
MMP-9 -1562 C>T (rs3918242) Promoter Polymorphism as a Susceptibility Factor for Multiple Gingival Recessions.
Gingivitis
Characteristics of neutrophil extracellular traps in patients with periodontitis and gingivitis.
Gingivitis
Cyclooxygenase-2 and matrix metalloproteinase-9 expressions correlate with tissue inflammation degree in periodontal disease.
Gingivitis
Effect of a structured plaque control on MMP-1 and MMP-9 crevicular levels in patients with desquamative gingivitis associated with oral lichen planus.
Gingivitis
Gingival Inflammation and Salivary or Serum Granulocyte Secreted Enzymes in Patients With Polycystic Ovary Syndrome.
Gingivitis
Levels of metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-1 in gingival crevicular fluid of patients with periodontitis, gingivitis, and healthy gingiva.
Gingivitis
MMP-1, MMP-9, and TIMP-1 levels in oral lichen planus patients with gingivitis or periodontitis.
Gingivitis
The association of MMP-9 and IL-18 gene promoter polymorphisms with gingivitis in adolescents.
Gingivitis
The associations between gingival crevice fluid matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and periodontitis in human immunodeficiency virus-positive patients.
Glaucoma
A feasible tool to detect mRNA expression of matrix metalloproteinases and their tissue inhibitors in human Tenon's capsule.
Glaucoma
Alteration of MCP-1 and MMP-9 in aqueous humor is associated with secondary glaucoma in Fuchs uveitis syndrome.
Glaucoma
Altered transcripts expression of matrix metalloproteinases and their tissue inhibitors in tenon capsule of patients with glaucoma.
Glaucoma
Analysis of Systemic Endothelin-1, Matrix Metalloproteinase-9, Macrophage Chemoattractant Protein-1, and High-Sensitivity C-Reactive Protein in Normal-Tension Glaucoma.
Glaucoma
Association of Matrix Metalloproteinase-9 (MMP9) Variants with Primary Angle Closure and Primary Angle Closure Glaucoma.
Glaucoma
Association of the single nucleotide polymorphisms in the extracellular matrix metalloprotease-9 gene with PACG in southern China.
Glaucoma
Associations between matrix metalloproteinase gene polymorphisms and glaucoma susceptibility: a meta-analysis.
Glaucoma
Evaluation of ocular surface disease in elderly patients with glaucoma: expression of matrix metalloproteinase-9 in tears.
Glaucoma
Functional Activity of Matrix Metalloproteinases 2 and 9 in Tears of Patients With Glaucoma.
Glaucoma
Identification of ocular matrix metalloproteinases present within the aqueous humor and iridocorneal drainage angle tissue of normal and glaucomatous canine eyes.
Glaucoma
Lack of association between the rs2664538 polymorphism in the MMP-9 gene and primary angle closure glaucoma in Singaporean subjects.
Glaucoma
Latanoprost therapy reduces the levels of TGF beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma.
Glaucoma
Lycium Barbarum Exerts Protection against Glaucoma-Like Injury Via Inhibition of MMP-9 Signaling In Vitro.
Glaucoma
Matrix metalloproteinase gelatinase B (MMP-9) is associated with leaking glaucoma filtering blebs.
Glaucoma
Matrix metalloproteinase-9 genetic variation and primary angle closure glaucoma in a Caucasian population.
Glaucoma
Metalloproteinase 9 and TIMP-1 expression in retina and optic nerve in absolute angle closure glaucoma.
Glaucoma
Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix.
Glaucoma
Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular disorders.
Glaucoma
Role of matrix metalloproteinase-9 gene polymorphisms in glaucoma: A hospital-based study in Chinese patients.
Glaucoma
The Association of Nailfold Capillaroscopy with Systemic Matrix Metalloproteinase-9 Concentration in Normal-Tension Glaucoma.
Glaucoma
The association of single nucleotide polymorphisms in the MMP-9 genes with susceptibility to acute primary angle closure glaucoma in Taiwanese patients.
Glaucoma
The Association of Single-Nucleotide Polymorphisms in the MMP-9 Gene with Normal Tension Glaucoma and Primary Open-Angle Glaucoma.
Glaucoma
The fungus-derived retinoprotectant theissenolactone C improves glaucoma-like injury mediated by MMP-9 inhibition.
Glaucoma
[Expression of matrix metalloproteinases and inhibitors on the scleral tissue of lamina cribrosa in rat with experimental chronic ocular hypertension]
Glaucoma, Angle-Closure
Altered transcripts expression of matrix metalloproteinases and their tissue inhibitors in tenon capsule of patients with glaucoma.
Glaucoma, Angle-Closure
Association of Matrix Metalloproteinase-9 (MMP9) Variants with Primary Angle Closure and Primary Angle Closure Glaucoma.
Glaucoma, Angle-Closure
Association of the single nucleotide polymorphisms in the extracellular matrix metalloprotease-9 gene with PACG in southern China.
Glaucoma, Angle-Closure
Lack of association between the rs2664538 polymorphism in the MMP-9 gene and primary angle closure glaucoma in Singaporean subjects.
Glaucoma, Angle-Closure
Matrix metalloproteinase-9 genetic variation and primary angle closure glaucoma in a Caucasian population.
Glaucoma, Angle-Closure
The association between matrix metalloprotease-9 gene polymorphisms and primary angle-closure glaucoma in a Chinese Han population.
Glaucoma, Angle-Closure
The association of single nucleotide polymorphisms in the MMP-9 genes with susceptibility to acute primary angle closure glaucoma in Taiwanese patients.
Glaucoma, Open-Angle
Altered transcripts expression of matrix metalloproteinases and their tissue inhibitors in tenon capsule of patients with glaucoma.
Glaucoma, Open-Angle
Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshwork.
Glaucoma, Open-Angle
Evaluation of ocular surface disease in elderly patients with glaucoma: expression of matrix metalloproteinase-9 in tears.
Glaucoma, Open-Angle
Extracellular MMP-9-Based Assessment of Ocular Surface Inflammation in Patients with Primary Open-Angle Glaucoma.
Glaucoma, Open-Angle
Hyaluronic acid increases MMP-2 and MMP-9 expressions in cultured trabecular meshwork cells from patients with primary open-angle glaucoma.
Glaucoma, Open-Angle
The Association of Single-Nucleotide Polymorphisms in the MMP-9 Gene with Normal Tension Glaucoma and Primary Open-Angle Glaucoma.
Glioblastoma
12-O-tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKCalpha/ERK/NF-kappaB-dependent MMP-9 expression.
Glioblastoma
Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
Glioblastoma
Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion.
Glioblastoma
Altered actin cytoskeleton and inhibition of matrix metalloproteinase expression by vanadate and phenylarsine oxide, inhibitors of phosphotyrosine phosphatases: modulation of migration and invasion of human malignant glioma cells.
Glioblastoma
An Extensive Invasive Intracranial Human Glioblastoma Xenograft Model. Role of High Level Matrix Metalloproteinase 9.
Glioblastoma
Arsenic Trioxide Induces Apoptosis and Incapacitates Proliferation and Invasive Properties of U87MG Glioblastoma Cells through a Possible NF-?B-Mediated Mechanism.
Glioblastoma
Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines.
Glioblastoma
Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE(2) activation.
Glioblastoma
CRM197 in Combination With shRNA Interference of VCAM-1 Displays Enhanced Inhibitory Effects on Human Glioblastoma Cells.
Glioblastoma
Cross-talk between Smad and p38 MAPK signalling in transforming growth factor beta signal transduction in human glioblastoma cells.
Glioblastoma
Cysteinyl Leukotriene Receptor Antagonists Inhibit Migration, Invasion, and Expression of MMP-2/9 in Human Glioblastoma.
Glioblastoma
Differential proteomics analysis of low- and high-grade of astrocytoma using iTRAQ quantification.
Glioblastoma
Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors.
Glioblastoma
Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.
Glioblastoma
Dynamic contrast-enhanced magnetic resonance imaging-derived kep as a potential biomarker of matrix metalloproteinase 9 expression in patients with glioblastoma multiforme: a pilot study.
Glioblastoma
Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.
Glioblastoma
EGF stimulates glioblastoma metastasis by induction of matrix metalloproteinase-9 in an EGFR-dependent mechanism.
Glioblastoma
Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas.
Glioblastoma
Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas.
Glioblastoma
Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumors.
Glioblastoma
Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.
Glioblastoma
Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas.
Glioblastoma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Glioblastoma
Glial cell-induced endothelial morphogenesis is inhibited by interfering with extracellular signal-regulated kinase signaling.
Glioblastoma
Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9.
Glioblastoma
Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme.
Glioblastoma
Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
Glioblastoma
Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells.
Glioblastoma
Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.
Glioblastoma
Luteolin reduces migration of human glioblastoma cell lines via inhibition of the p-IGF-1R/PI3K/AKT/mTOR signaling pathway.
Glioblastoma
Matrix metalloproteinase-2 and -9 in glioblastoma: a trio of old drugs-captopril, disulfiram and nelfinavir-are inhibitors with potential as adjunctive treatments in glioblastoma.
Glioblastoma
Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
Glioblastoma
MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma.
Glioblastoma
MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells.
Glioblastoma
Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions.
Glioblastoma
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors.
Glioblastoma
Modulation of MMP-2 and MMP-9 secretion by cytokines, inducers and inhibitors in human glioblastoma T-98G cells.
Glioblastoma
Naringin inhibits the invasion and migration of human glioblastoma cell via downregulation of MMP-2 and MMP-9 expression and inactivation of p38 signaling pathway.
Glioblastoma
P53 stratification reveals the prognostic utility of matrix metalloproteinase-9 protein expression in glioblastoma.
Glioblastoma
Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays.
Glioblastoma
PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.
Glioblastoma
Protein kinase C activation by phorbol ester increases in vitro invasion through regulation of matrix metalloproteinases/tissue inhibitors of metalloproteinases system in D54 human glioblastoma cells.
Glioblastoma
PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation.
Glioblastoma
Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells.
Glioblastoma
Regional specificity of matrix metalloproteinase-9 expression in the brain: voxel-level mapping in primary glioblastomas.
Glioblastoma
Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades.
Glioblastoma
Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model.
Glioblastoma
Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion.
Glioblastoma
Silencing microRNA-221/222 cluster suppresses glioblastoma angiogenesis by suppressor of cytokine signaling-3-dependent JAK/STAT pathway.
Glioblastoma
Silibinin inhibits invasive properties of human glioblastoma U87MG cells through suppression of cathepsin B and nuclear factor kappa B-mediated induction of matrix metalloproteinase 9.
Glioblastoma
Sprouty 4 suppresses glioblastoma invasion by inhibiting ERK phosphorylation and ETS-1-induced matrix metalloproteinase-9.
Glioblastoma
Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
Glioblastoma
Text mining of full-text journal articles combined with gene expression analysis reveals a relationship between sphingosine-1-phosphate and invasiveness of a glioblastoma cell line.
Glioblastoma
The hemopexin domain of MMP-9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude mice.
Glioblastoma
The regulating role of mutant IkappaBalpha in expression of TIMP-2 and MMP-9 in human glioblastoma multiform.
Glioblastoma
Thymoquinone reduces migration and invasion of human glioblastoma cells associated with FAK, MMP-2 and MMP-9 down-regulation.
Glioblastoma
TLR4 signal transduction pathways neutralize the effect of Fas signals on glioblastoma cell proliferation and migration.
Glioblastoma
Urokinase directly activates matrix metalloproteinases-9: a potential role in glioblastoma invasion.
Glioblastoma
Urokinase plasminogen activator receptor and/or matrix metalloproteinase-9 inhibition induces apoptosis signaling through lipid rafts in glioblastoma xenograft cells.
Glioblastoma
Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas.
Glioblastoma
Verbascoside Inhibits Glioblastoma Cell Proliferation, Migration and Invasion While Promoting Apoptosis Through Upregulation of Protein Tyrosine Phosphatase SHP-1 and Inhibition of STAT3 Phosphorylation.
Glioblastoma
YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.
Glioblastoma
[Increased expression of gelatinases A and B, matrilysin and TIMP-1 genes in human malignant gliomas ]
Glioma
12-O-tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKCalpha/ERK/NF-kappaB-dependent MMP-9 expression.
Glioma
17-Allylamino-17-demethoxygeldanamycin down-regulates hyaluronic acid-induced glioma invasion by blocking matrix metalloproteinase-9 secretion.
Glioma
Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion.
Glioma
All-trans retinoic acid inhibits migration, invasion and proliferation, and promotes apoptosis in glioma cells in vitro.
Glioma
Association between expression of HOTAIR and invasiveness of gliomas, and its predictive value.
Glioma
Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas.
Glioma
Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion.
Glioma
Baicalein reduces the invasion of glioma cells via reducing the activity of p38 signaling pathway.
Glioma
Bergamottin, a natural furanocoumarin abundantly present in grapefruit juice, suppresses the invasiveness of human glioma cells via inactivation of Rac1 signaling.
Glioma
Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization.
Glioma
Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway.
Glioma
Cerebrospinal fluid matrix metalloproteinase-9 increases during treatment of recurrent malignant gliomas.
Glioma
Chronic Intermittent Ethanol Exposure Induces Upregulation of Matrix Metalloproteinase-9 in the Rat Medial Prefrontal Cortex and Hippocampus.
Glioma
Coronarin D suppresses proliferation, invasion and migration of glioma cells via activating JNK signaling pathway.
Glioma
Creation of an apoptin-derived peptide that interacts with SH3 domains and inhibits glioma cell migration and invasion.
Glioma
Cysteinyl Leukotriene Receptor Antagonists Inhibit Migration, Invasion, and Expression of MMP-2/9 in Human Glioblastoma.
Glioma
Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.
Glioma
Decreased CUL4B expression inhibits malignant proliferation of glioma in vitro and in vivo.
Glioma
Design, synthesis and biological evaluation of N-anthraniloyl tryptamine derivatives as pleiotropic molecules for the therapy of malignant glioma.
Glioma
Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma.
Glioma
Differences in multidrug resistance phenotype and matrix metalloproteinases activity between endothelial cells from normal brain and glioma.
Glioma
Differential expression of laminin and fibronectin and of their related metalloproteinases in human glioma cell lines: relation to invasion.
Glioma
Dlxin-1, a member of MAGE family, inhibits cell proliferation, invasion and tumorigenicity of glioma stem cells.
Glioma
Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes.
Glioma
Down-modulation of Bis reduces the invasive ability of glioma cells induced by TPA through NF-?B mediated activation of MMP-9.
Glioma
Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.
Glioma
Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth.
Glioma
Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection.
Glioma
EFEMP2 is upregulated in gliomas and promotes glioma cell proliferation and invasion.
Glioma
Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells.
Glioma
Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity.
Glioma
Epimedium koreanum Nakai inhibits PMA-induced cancer cell migration and invasion by modulating NF-?B/MMP-9 signaling in monomorphic malignant human glioma cells.
Glioma
Ethanol extract of Lycopodium serratum Thunb. Attenuates lipopolysaccharide-induced C6 glioma cells migration via matrix metalloproteinase-9 expression.
Glioma
Evaluation of matrix metalloproteinase type IV-collagenases in serum of patients with tumors of the central nervous system.
Glioma
Exosomes from glioma cells induce a tumor-like phenotype in mesenchymal stem cells by activating glycolysis.
Glioma
Expression and function of chondroitin 4-sulfate and chondroitin 6-sulfate in human glioma.
Glioma
Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas.
Glioma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Glioma
Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells.
Glioma
Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells.
Glioma
Glial cell line-derived neurotrophic factor increases matrix metallopeptidase 9 and 14 expression in microglia and promotes microglia-mediated glioma progression.
Glioma
Glioma cells enhance endothelial progenitor cell angiogenesis via VEGFR-2, not VEGFR-1.
Glioma
Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression.
Glioma
HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways.
Glioma
High expression of MMP9 in glioma affects cell proliferation and is associated with patient survival rates.
Glioma
HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway.
Glioma
HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis.
Glioma
Hypomethylated Rab27b is a progression-associated prognostic biomarker of glioma regulating MMP-9 to promote invasion.
Glioma
Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme.
Glioma
In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to inflammatory mediators.
Glioma
Inactivation of Ets 1 transcription factor by a specific decoy strategy reduces rat C6 glioma cell proliferation and mmp-9 expression.
Glioma
Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence.
Glioma
Induced expression of MMP-9 in C6 glioma cells is inhibited by PDGF via a PI 3-kinase-dependent pathway.
Glioma
Induction of matrix metalloproteinase-9 requires a polymerized actin cytoskeleton in human malignant glioma cells.
Glioma
Inflammatory cytokine modulation of matrix metalloproteinase expression and invasiveness of glioma cells in a 3-dimensional collagen matrix.
Glioma
Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
Glioma
Inhibition of glioblastoma growth and invasion by (125)I brachytherapy in rat glioma model.
Glioma
Inhibition of matrix metalloproteinase-9 gene expression by an isoflavone metabolite, irisolidone in U87MG human astroglioma cells.
Glioma
Integrin ?9?1-mediated cell migration in glioblastoma via SSAT and Kir4.2 potassium channel pathway.
Glioma
Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration.
Glioma
Isothiocyanates inhibit the invasion and migration of C6 glioma cells by blocking FAK/JNK-mediated MMP-9 expression.
Glioma
Knockdown of stomatin-like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF-?B/MMP-9 pathway.
Glioma
Levels of vascular endothelial growth factor and matrix metalloproteinase-9 proteins in patients with glioma.
Glioma
Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.
Glioma
Mangiferin regulates proliferation and apoptosis in glioma cells by induction of microRNA-15b and inhibition of MMP-9 expression.
Glioma
Matrix metalloproteinase 9 (MMP-9)-dependent processing of ?ig-h3 protein regulates cell migration, invasion, and adhesion.
Glioma
Matrix Metalloproteinase-9 Expression is Increased in Astrocytic Glioma and Associated with Prognosis of Patients.
Glioma
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Glioma
Melatonin suppresses migration and invasion via inhibition of oxidative stress pathway in glioma cells.
Glioma
Metabolic remodeling precedes mitochondrial outer membrane permeabilization in human glioma xenograft cells.
Glioma
MicroRNA-133a inhibits the malignant behavior of glioma via downregulation of matrix metallopeptidase 9.
Glioma
miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-?.
Glioma
MMP-9 silencing regulates hTERT expression via ?1 integrin-mediated FAK signaling and induces senescence in glioma xenograft cells.
Glioma
MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice.
Glioma
Osthole suppresses the proliferation and accelerates the apoptosis of human glioma cells via the upregulation of microRNA-16 and downregulation of MMP-9.
Glioma
Overexpression of riboflavin transporter 2 contributes toward progression and invasion of glioma.
Glioma
Paeoniflorin inhibits proliferation and induces apoptosis of human glioma cells via microRNA-16 upregulation and matrix metalloproteinase-9 downregulation.
Glioma
Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays.
Glioma
Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients.
Glioma
Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B.
Glioma
Proteolipid Protein 2 Overexpression Indicates Aggressive Tumor Behavior and Adverse Prognosis in Human Gliomas.
Glioma
PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules.
Glioma
PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation.
Glioma
Quercetin promotes cell apoptosis and inhibits the expression of MMP-9 and fibronectin via the AKT and ERK signalling pathways in human glioma cells.
Glioma
Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades.
Glioma
regulation of the invasion and metastasis of human glioma cells by polypeptide N-acetylgalactosaminyltransferase 2.
Glioma
Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma.
Glioma
RelB, a good prognosis predictor, links cell-cycle and migration to glioma tumorigenesis.
Glioma
Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
Glioma
Retraction Note to: The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Glioma
Retraction: Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
Glioma
Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
Glioma
RNAi-mediated downregulation of MMP-2 activates the extrinsic apoptotic pathway in human glioma xenograft cells.
Glioma
Role of metallothionein 1E in the migration and invasion of human glioma cell lines.
Glioma
Roundabout 4 regulates blood-tumor barrier permeability through the modulation of ZO-1, Occludin, and Claudin-5 expression.
Glioma
Selective inhibition of MMP-9 gene expression by mangiferin in PMA-stimulated human astroglioma cells: involvement of PI3K/Akt and MAPK signaling pathways.
Glioma
Silibinin inhibits invasive properties of human glioblastoma U87MG cells through suppression of cathepsin B and nuclear factor kappa B-mediated induction of matrix metalloproteinase 9.
Glioma
Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas.
Glioma
Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
Glioma
Steroid receptor coactivator-1 regulates glioma angiogenesis through polyomavirus enhancer activator 3 signaling.
Glioma
Stromal protein periostin identified as a progression associated and prognostic biomarker in glioma via inducing an invasive and proliferative phenotype.
Glioma
Suppression of CLC-3 chloride channel reduces the aggressiveness of glioma through inhibiting nuclear factor-?B pathway.
Glioma
Syndecan-1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src/FAK-associated signaling pathway.
Glioma
Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
Glioma
Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9.
Glioma
The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis.
Glioma
The effect of yacon (Samallanthus sonchifolius) ethanol extract on cell proliferation and migration of C6 glioma cells stimulated with fetal bovine serum.
Glioma
The effects of chitosan-based materials on glioma: Recent advances in its applications for diagnosis and treatment.
Glioma
The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells.
Glioma
The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades.
Glioma
The mechanical and pharmacological regulation of glioblastoma cell migration in 3D matrices.
Glioma
The regulating role of mutant IkappaBalpha in expression of TIMP-2 and MMP-9 in human glioblastoma multiform.
Glioma
Thrombin-induced Migration and Matrix Metalloproteinase-9 Expression Are Regulated by MAPK and PI3K Pathways in C6 Glioma Cells.
Glioma
Title: role of matrix metalloproteinase -9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease.
Glioma
TLR9 expression is associated with prognosis in patients with glioblastoma multiforme.
Glioma
TPM3, a strong prognosis predictor, is involved in malignant progression through MMP family members and EMT-like activators in gliomas.
Glioma
Transcription Factor ELF1 Activates MEIS1 Transcription and Then Regulates the GFI1/FBW7 Axis to Promote the Development of Glioma.
Glioma
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-¿B-inducing kinase (NIK) and noncanonical NF-¿B signaling.
Glioma
Ursolic acid inhibits IL-1beta or TNF-alpha-induced C6 glioma invasion through suppressing the association ZIP/p62 with PKC-zeta and downregulating the MMP-9 expression.
Glioma
YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.
Glioma
[Increased expression of gelatinases A and B, matrilysin and TIMP-1 genes in human malignant gliomas ]
Glioma
[Isoliquiritigenin can inhibit migration and invasion of human glioma stem cells by down-regulating matrix metalloproteinases].
Gliosarcoma
Transcriptional Factors for Epithelial-Mesenchymal Transition Are Associated with Mesenchymal Differentiation in Gliosarcoma.
Glomerulonephritis
Expression of matrix metalloproteinase-9 associated with ets-1 proto-oncogene in rat tubulointerstitial cells.
Glomerulonephritis
Expression of MMP-9 in mesangial cells and its changes in anti-GBM glomerulonephritis in WKY rats.
Glomerulonephritis
In vivo transfer of engineered macrophages into the glomerulus: endogenous TGF-beta-mediated defense against macrophage-induced glomerular cell activation.
Glomerulonephritis
Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy.
Glomerulonephritis
Leukocyte-derived MMP9 is crucial for the recruitment of proinflammatory macrophages in experimental glomerulonephritis.
Glomerulonephritis
Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis.
Glomerulonephritis, IGA
Differential glomerular immunoexpression of matrix metalloproteinases MMP-2 and MMP-9 in idiopathic IgA nephropathy and Schoenlein-Henoch nephritis.
Glomerulonephritis, IGA
Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy.
Glomerulonephritis, IGA
[Expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in IgA nephropathy]
Glomerulonephritis, IGA
[The effects of TCM Yishen Decoction on the expression of MMP-9 and TIMP-1 in kidney of mouse with IgA nephropathy]
Glomerulonephritis, Membranoproliferative
Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy.
Glomerulonephritis, Membranous
Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy.
Glomerulonephritis, Membranous
Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy.
Glomerulonephritis, Membranous
Matrix metalloproteinase-9 expression in renal biopsies of patients with HIV-associated nephropathy.
Glomerulosclerosis, Focal Segmental
Distinct metalloproteinase excretion patterns in focal segmental glomerulosclerosis.
Glomerulosclerosis, Focal Segmental
Increase in extracellular cross-linking by tissue transglutaminase and reduction in expression of MMP-9 contribute differentially to focal segmental glomerulosclerosis in rats.
Glomerulosclerosis, Focal Segmental
Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy.
Glomerulosclerosis, Focal Segmental
Matrix metalloproteinase-9 expression in renal biopsies of patients with HIV-associated nephropathy.
Glomus Tumor
Matrix metalloproteinase-9 expression in a CD34-positive glomus tumor with myxoid stromal change.
Glucose Intolerance
Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors in women with glucose intolerance in pregnancy and normal controls.
Graft vs Host Disease
Conjunctival Matrix Metalloproteinase-9 Clinical Assessment in Early Ocular Graft versus Host Disease.
Graft vs Host Disease
Increased serum levels of matrix metalloproteinase-9 in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Gram-Positive Bacterial Infections
Lipoteichoic Acid Induces Matrix Metalloproteinase-9 Expression via Transactivation of PDGF Receptors and NF-kappaB Activation in Rat Brain Astrocytes.
Granuloma
Activity of matrix metalloproteinase 2 and 9 isoforms in sputum samples from individuals infected with M. tuberculosis.
Granuloma
Comparative Metabolomics Reveals the Microenvironment of Common T-Helper Cells and Differential Immune Cells Linked to Unique Periapical Lesions.
Granuloma
Complex regulation of neutrophil-derived MMP-9 secretion in central nervous system tuberculosis.
Granuloma
Comprehensive analysis of immune, extracellular matrices and pathogens profile in lung granulomatosis of unexplained etiology.
Granuloma
Continuous recruitment, co-expression of tumour necrosis factor-alpha and matrix metalloproteinases, and apoptosis of macrophages in gout tophi.
Granuloma
Cytokines, MMP-2, and MMP-9 levels in patients with a solitary cysticercus granuloma.
Granuloma
Doxycycline hyclate: A schistosomicidal agent in vitro with immunomodulatory potential on granulomatous inflammation in vivo.
Granuloma
Dynamic changes in the collagen metabolism of liver fibrosis at the transcription level in rabbits with Schistosomiasis japonica.
Granuloma
Expression kinetics of metalloproteinases and their tissue inhibitors in experimental murine pulmonary tuberculosis.
Granuloma
Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.
Granuloma
Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions.
Granuloma
High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation.
Granuloma
Immunohistochemical analysis of neutrophils, interleukin-17, matrix metalloproteinase-9, and neoformed vessels in oral squamous cell carcinoma.
Granuloma
Immunohistochemical expression of matrix metalloproteinases in the granulomatous rosacea compared with the non-granulomatous rosacea.
Granuloma
Interleukin-17 and matrix metalloprotease-9 expression in the mycetoma granuloma.
Granuloma
Matrix metalloproteinase proteolysis of the mycobacterial HSP65 protein as a potential source of immunogenic peptides in human tuberculosis.
Granuloma
Matrix metalloproteinase-2 and -9 in the granulomatous fibrosis of rats infected with Angiostrongylus cantonensis.
Granuloma
Matrix metalloproteinase-2 and matrix metalloproteinase-9 in mice with ocular toxocariasis.
Granuloma
Matrix metalloproteinases with gelatinolytic activity induced by Paracoccidioides brasiliensis infection.
Granuloma
MMP-9 activity is induced by Leishmania braziliensis infection and correlates with mucosal leishmaniasis.
Granuloma
MMP-9 and CD68(+) cells are required for tissue remodeling in response to natural hydroxyapatite.
Granuloma
Mycobacterial trehalose dimycolate reprograms macrophage global gene expression and activates matrix metalloproteinases.
Granuloma
Mycobacterium indicus pranii downregulates MMP-9 and iNOS through COX-2 dependent and TNF-? independent pathway in mouse peritoneal macrophages in vitro.
Granuloma
N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy?
Granuloma
Nitric oxide participation in granulomatous response induced by Paracoccidioides brasiliensis infection in mice.
Granuloma
Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection.
Granuloma
Schwann cells producing matrix metalloproteinases under Mycobacterium leprae stimulation may play a role in the outcome of leprous neuropathy.
Granuloma
The ocular pyogranulomatous lesion in a Gentoo penguin (Pygoscelis papua) from the Antarctic Peninsula: evaluation of microbiological and histopathological analysis outcomes.
Granuloma
Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium.
Granuloma
Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNF-alpha-dependent monocyte networks.
Granuloma
Ziziphus spina-christi leaf extract ameliorates schistosomiasis liver granuloma, fibrosis, and oxidative stress through downregulation of fibrinogenic signaling in mice.
Granuloma
[Studies on synthesis and degradation of collagen at transcription level in liver fibrosis of rabbits with schistosomiasis japonica]
Granuloma Annulare
Expression of interstitial collagenase, 92-kDa gelatinase, and tissue inhibitor of metalloproteinases-1 in granuloma annulare and necrobiosis lipoidica diabeticorum.
Graves Disease
Elevated serum concentrations of metalloproteinases (MMP-2, MMP-9) and their inhibitors (TIMP-1, TIMP-2) in patients with Graves' orbitopathy.
Graves Ophthalmopathy
[Serum gelatinases (MMP-2 and MMP-9) and VCAM-1 as a guideline in a therapeutic approach in Graves' ophthalmopathy.]
Guillain-Barre Syndrome
Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barré syndrome.
Guillain-Barre Syndrome
Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis.
Guillain-Barre Syndrome
Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
Guillain-Barre Syndrome
MMP-9 correlates with electrophysiologic abnormalities in Guillain-Barré syndrome.
Hamartoma
Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
Head and Neck Neoplasms
Correlation between protein expression of PTEN in human pancreatic cancer and the proliferation, infiltration, metastasis and prognosis.
Head and Neck Neoplasms
Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
Head and Neck Neoplasms
Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma.
Head and Neck Neoplasms
Fibroblasts and extracellular matrix differently modulate MMP activation by primary and metastatic head and neck cancer cells.
Head and Neck Neoplasms
Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Head and Neck Neoplasms
Genistein elicits pleiotropic molecular effects on head and neck cancer cells.
Head and Neck Neoplasms
Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.
Head and Neck Neoplasms
The relationship between MMPs and pH in whole saliva of radiated head and neck cancer patients.
Hearing Loss
Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
Heart Arrest
Diffusion-weighted magnetic resonance imaging reversal by gene knockdown of matrix metalloproteinase-9 activities in live animal brains.
Heart Arrest
Hypothermic treatment reduces matrix metalloproteinase-9 expression and damage in the liver following asphyxial cardiac arrest in rats.
Heart Arrest
Serum matrix metalloproteinases in patients resuscitated from cardiac arrest. The association with therapeutic hypothermia.
Heart Arrest
Usefulness of admission matrix metalloproteinase 9 as a predictor of early mortality after cardiopulmonary resuscitation in cardiac arrest patients.
Heart Diseases
Analysis of matrix metalloproteinase-9 levels among acute heart failure patients with ACE inhibitor therapy (Dr. Soetomo Regional General Hospital, Surabaya).
Heart Diseases
Association of MMP-9 gene polymorphisms with atrial fibrillation in hypertensive heart disease patients.
Heart Diseases
Effect of curcumin on permeability of coronary artery and expression of related proteins in rat coronary atherosclerosis heart disease model.
Heart Diseases
Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients.
Heart Diseases
Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene in alcohol dependence: family and case control study.
Heart Diseases
Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression.
Heart Diseases
Mechanical stretching of pulmonary vein stimulates matrix metalloproteinase-9 and transforming growth factor-?1 through stretch-activated channel/MAPK pathways in pulmonary hypertension due to left heart disease model rats.
Heart Failure
Adrenoceptor blockade alters plasma gelatinase activity in patients with heart failure and MMP-9 promoter activity in a human cell line (ECV304).
Heart Failure
Analysis of matrix metalloproteinase-9 levels among acute heart failure patients with ACE inhibitor therapy (Dr. Soetomo Regional General Hospital, Surabaya).
Heart Failure
Association between matrix metalloproteinase-9 and worsening heart failure events in patients with chronic heart failure.
Heart Failure
Can the expression of the metalloproteinase 9 gene and its inhibitor be considered as markers of heart failure?
Heart Failure
Changes in activities of circulating MMP-2 and MMP-9 in patients suffering from heart failure in relation to gender, hypertension and treatment: a cross-sectional study.
Heart Failure
Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
Heart Failure
Clinical Relevance of Matrix Metalloproteinase 9 in Patients With Acute Coronary Syndrome.
Heart Failure
Comparison of matrix metalloproteinase 9 and brain natriuretic peptide as clinical biomarkers in chronic heart failure.
Heart Failure
Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions.
Heart Failure
Cycloastragenol ameliorates experimental heart damage in rats by promoting myocardial autophagy via inhibition of AKT1-RPS6KB1 signaling.
Heart Failure
Down-regulation of matrix metalloproteinase-9 (MMP-9) expression in the myocardium of congestive heart failure patients.
Heart Failure
Echocardiography-based qualification and response assessment to cardiac resynchronisation therapy in patients with chronic heart failure. The matrix metalloproteinase-9 substudy.
Heart Failure
Effect of typhaneoside on ventricular remodeling and regulation of PI3K/Akt/mTOR pathway.
Heart Failure
Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females.
Heart Failure
High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation.
Heart Failure
Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure.
Heart Failure
Impact of metalloproteinases on left ventricular remodeling and heart failure events in patients with hypertrophic cardiomyopathy.
Heart Failure
Influencing factors of NT-proBNP level inheart failure patients with different cardiacfunctions and correlation with prognosis.
Heart Failure
Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme.
Heart Failure
Long-term therapy with the acorn cardiac support device normalizes gene expression of growth factors and gelatinases in dogs with heart failure.
Heart Failure
Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?
Heart Failure
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure.
Heart Failure
Matrix metalloproteinase-9 as a messenger in the crosstalk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review.
Heart Failure
Matrix metalloproteinase-9 in pediatric rheumatic heart disease with and without heart failure.
Heart Failure
Matrix Metalloproteinase-9 Is a Marker of Heart Failure After Acute Myocardial Infarction.
Heart Failure
Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexia.
Heart Failure
Mitochondrial division/mitophagy inhibitor (Mdivi) ameliorates pressure overload induced heart failure.
Heart Failure
NADPH oxidase/ROS-dependent PYK2 activation is involved in TNF-?-induced matrix metalloproteinase-9 expression in rat heart-derived H9c2 cells.
Heart Failure
No Association of Genetic Markers with Carotid Intimal Medial Thickness in ?-Thalassemia Major Patients.
Heart Failure
Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.
Heart Failure
Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction.
Heart Failure
Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study.
Heart Failure
Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.
Heart Failure
Reverse remodeling is associated with changes in extracellular matrix proteases and tissue inhibitors after mesenchymal stem cell (MSC) treatment of pressure overload hypertrophy.
Heart Failure
Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice.
Heart Failure
Salvianolic Acid a, a novel matrix metalloproteinase-9 inhibitor, prevents cardiac remodeling in spontaneously hypertensive rats.
Heart Failure
Serum insulin-like growth factor-axis and matrix metalloproteinases in patients with rheumatic arthritis or rheumatic heart disease.
Heart Failure
Serum MMP-9 activity as a diagnosing marker for the developing heart failure of post MI patients.
Heart Failure
Targeted deletion of MMP-9 attenuates myocardial contractile dysfunction in heart failure.
Heart Failure
The prognostic value of elevated matrix metalloproteinase-9 in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A two-year prospective study.
Heart Failure
Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates.
Heart Failure
Water-soluble alkaloids extracted from Aconiti Radix lateralis praeparata protect against chronic heart failure in rats via a calcium signaling pathway.
Heart Failure
[Effects of bone marrow mesenchymal stem cells transplantation on heart function and ventricular remodeling in rats with isoproterenol-induced congestive heart failure]
Heart Failure
[Endotoxinemia and systemic inflammation in pathogenesis of chronic heart failure].
Heart Failure
[Evaluation of myocardial systolic function of heart failure induced by myocardial infarction in rats with strain and strain rate imagine]
Heart Failure
[Evaluation of the myocardial systolic function and ventricular remodeling of rats with experimental myocardial infarction by strain/strain rate imaging and MMP-9].
Heart Failure
[Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion]
Heart Failure
[The activity of components of system of matrix metalloproteinase and tissue inhibitors of metalloproteinase on different stages of chronic cardiac failure].
Heart Failure, Systolic
Circulating matrix metalloproteinase-3 and metalloproteinase-9 and tissue Doppler measures of diastolic dysfunction to risk stratify patients with systolic heart failure.
Heart Failure, Systolic
Comparison of matrix metalloproteinase 9 and brain natriuretic peptide as clinical biomarkers in chronic heart failure.
Heart Failure, Systolic
Matrix metalloproteinase 9/neutrophil gelatinase associated lipocalin/tissue inhibitor of metalloproteinasess type 1 complexes are localized within cardiomyocytes and serve as a reservoir of active metalloproteinase in porcine female myocardium.
Heart Failure, Systolic
Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease.
Heart Rupture
Age-related differences in postinfarct left ventricular rupture and remodeling.
Heart Rupture
Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction.
Heart Rupture
Estrogen induces cardioprotection in male C57BL/6J mice after acute myocardial infarction via decreased activity of matrix metalloproteinase-9 and increased Akt-Bcl-2 anti-apoptotic signaling.
Heart Rupture
Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction.
Heart Rupture
Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction.
Heart Rupture
Hepatokine ?1-Microglobulin Signaling Exacerbates Inflammation and Disturbs Fibrotic Repair in Mouse Myocardial Infarction.
Heart Rupture
Increased pericardial fluid level of matrix metalloproteinase-9 activity in patients with acute myocardial infarction: possible role in the development of cardiac rupture.
Heart Rupture
MK5 haplodeficiency decreases collagen deposition and scar size during post-myocardial infarction wound repair.
Heart Rupture
Porphyromonas gingivalis, a periodontal pathogen, enhances myocardial vulnerability, thereby promoting post-infarct cardiac rupture.
Heart Rupture
S100A8/A9 promotes MMP-9 expression in the fibroblasts from cardiac rupture after myocardial infarction by inducing macrophages secreting TNF?.
Heart Rupture
Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction.
Heart Rupture
Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice.
Heart Rupture
Trimetazidine suppresses oxidative stress, inhibits MMP-2 and MMP-9 expression, and prevents cardiac rupture in mice with myocardial infarction.
Heart Rupture
Twinkle overexpression prevents cardiac rupture after myocardial infarction by alleviating impaired mitochondrial biogenesis.
Heart Valve Diseases
Peripheral blood levels of matrix metalloproteinases in patients referred for percutaneous balloon mitral valve commissurotomy.
Heart Valve Diseases
[Matrix metalloproteinases: significance in remodeling of the myocardium in valvular heart disease.]
Helicobacter Infections
Gastric gelatinase B/matrix metalloproteinase-9 is rapidly increased in Helicobacter felis-induced gastritis.
Hemangioma
Clinical efficacy of propranolol in the treatment of hemangioma and changes in serum VEGF, bFGF and MMP-9.
Hemangioma
Evaluation of plasma and urinary levels of vascular endothelial growth factor and matrix metalloproteinase-9 in patients with infantile hemangioma.
Hemangioma
Possibilities and potential roles of estrogen in the pathogenesis of proliferation hemangiomas formation.
Hemangioma
Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas.
Hemangioma
[Effect of propranolol gel on plasma VEGF, bFGF and MMP-9 in proliferating infantile hemangiomas of superficial type].
Hemangiosarcoma
A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-alpha2b in patients with solid tumors.
Hemangiosarcoma
Inhibition of endoglin exerts anti-tumor effects through the regulation of non-Smad TGF-? signaling in angiosarcoma.
Hematologic Diseases
Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
Hematologic Neoplasms
Association of MMP-2 (-1306 C>T), MMP-9 (-1562 C>T) Gene Polymorphism and the Formation of the Hematological Malignancies.
Hematologic Neoplasms
The kinetics of hematopoietic niche cytokines and their influence on mobilization efficacy and timing in patients with hematological malignancies.
Hematologic Neoplasms
[Effect of As(2)O(3) on Expressions of COX-2 and Matrix Metalloproteinases in SGC7901 and K562 Cells.]
Hematoma, Subdural, Chronic
Role of MMP-2, MMP-9 and VEGF in the development of chronic subdural hematoma.
Hematoma, Subdural, Chronic
[Role of matrix metalloproteinase in transformation of subdural effusion into chronic subdural hematoma]
Hematuria
Melatonin treatment further improves adipose-derived mesenchymal stem cell therapy for acute interstitial cystitis in rat.
Hemiplegia
Profiles of blood biomarkers in alternating hemiplegia of childhood - Increased MMP-9 and decreased substance P indicates its pathophysiology.
Hemoglobin SC Disease
Associations between TGF-?1 Levels and Markers of Hemolysis, Inflammation, and Tissue Remodeling in Pediatric Sickle Cell Patients.
Hemoptysis
Correlation between MMP-9 and MMP-9/ TIMPs Complex with Pulmonary Function in Sulfur Mustard Exposed Civilians: Sardasht-Iran Cohort Study.
Hemorrhagic Stroke
A therapeutic target of cerebral hemorrhagic stroke: matrix metalloproteinase-9.
Hemorrhagic Stroke
Apolipoprotein A-I and Paraoxonase-1 Are Potential Blood Biomarkers for Ischemic Stroke Diagnosis.
Hemorrhagic Stroke
Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage.
Hemorrhagic Stroke
Blood biomarkers for the diagnosis and differentiation of stroke: A systematic review and meta-analysis.
Hemorrhagic Stroke
Donor spontaneous intracerebral hemorrhage is associated with systemic activation of matrix metalloproteinase-2 and matrix metalloproteinase-9 and subsequent development of coronary vasculopathy in the heart transplant recipient.
Hemorrhagic Stroke
Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke.
Hemorrhagic Stroke
MMP-2/MMP-9 plasma level and brain expression in Cerebral Amyloid Angiopathy-associated hemorrhagic stroke.
Hemorrhagic Stroke
MMP-9 as a Biomarker for Predicting Hemorrhagic Strokes in Moyamoya Disease.
Hemorrhoids
Hemorrhoids and matrix metalloproteinases: A multicenter study on the predictive role of biomarkers.
Hemosiderosis
Matrix metalloproteinase-9 and its inhibitor in idiopathic pulmonary hemosiderosis.
Hepatic Encephalopathy
Blood-Brain Barrier Permeability Is Exacerbated in Experimental Model of Hepatic Encephalopathy via MMP-9 Activation and Downregulation of Tight Junction Proteins.
Hepatic Encephalopathy
Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice.
Hepatic Encephalopathy
TGF?1 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5.
Hepatic Veno-Occlusive Disease
Bevacizumab exacerbates sinusoidal obstruction syndrome (SOS) in the animal model and increases MMP 9 production.
Hepatic Veno-Occlusive Disease
Expression of MMP-9 in hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Hepatic Veno-Occlusive Disease
Prophylactic Sesame Oil Attenuates Sinusoidal Obstruction Syndrome by Inhibiting Matrix Metalloproteinase-9 and Oxidative Stress.
Hepatic Veno-Occlusive Disease
Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition.
Hepatic Veno-Occlusive Disease
Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9.
Hepatic Veno-Occlusive Disease
Therapeutic Sesamol Attenuates Monocrotaline-Induced Sinusoidal Obstruction Syndrome in Rats by Inhibiting Matrix Metalloproteinase-9.
Hepatitis
Aesculin inhibits matrix metalloproteinase-9 expression via p38 mitogen activated protein kinase and activator protein 1 in lipopolysachride-induced RAW264.7 cells.
Hepatitis
Antifibrogenic effect of IFN-alpha2b on hepatic stellate cell activation by human hepatocytes.
Hepatitis
Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
Hepatitis
Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.
Hepatitis
Matrix metalloproteinase-9 gene polymorphism in hepatocellular carcinoma patients with hepatitis B and C viruses.
Hepatitis
Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients.
Hepatitis B
Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.
Hepatitis B
Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells.
Hepatitis B
Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.
Hepatitis B
Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling.
Hepatitis B
Matrix metalloproteinase-9 gene polymorphism in hepatocellular carcinoma patients with hepatitis B and C viruses.
Hepatitis B
The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus.
Hepatitis B, Chronic
Differences in circulating MMP-9 levels with regard to viral load and AST:ALT ratio between chronic hepatitis B and C patients.
Hepatitis B, Chronic
Expression of MMP-9 in different degrees of chronic hepatitis B and its correlation with inflammation.
Hepatitis B, Chronic
Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling.
Hepatitis B, Chronic
Matrix metalloproteinases and their tissue inhibitors in children with chronic hepatitis B treated with lamivudine.
Hepatitis B, Chronic
Mechanism and Efficacy of Mobilization of Granulocyte Colony-Stimulating Factor in the Treatment of Chronic Hepatic Failure.
Hepatitis C
Association between matrix metalloproteinase (MMP)-2, MMP-9 and total antioxidant status of patients with asymptomatic hepatitis C virus infection.
Hepatitis C
Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C.
Hepatitis C
Hepatitis C virus NS3 protein enhances cancer cell invasion by activating matrix metalloproteinase-9 and cyclooxygenase-2 through ERK/p38/NF-?B signal cascade.
Hepatitis C
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection.
Hepatitis C
Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.
Hepatitis C
Matrix metalloproteinase-9 gene polymorphism in hepatocellular carcinoma patients with hepatitis B and C viruses.
Hepatitis C
The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma.
Hepatitis C, Chronic
Clinical role of serum and tissue matrix metalloprotease-9 expression in chronic HCV patients treated with pegylated IFN-alpha2b and ribavirin.
Hepatitis C, Chronic
Effects of interferon plus ribavirin treatment on NF-kappaB, TGF-beta1, and metalloproteinase activity in chronic hepatitis C.
Hepatitis C, Chronic
Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins.
Hepatitis C, Chronic
Increased urinary lipocalin-2 reflects matrix metalloproteinase-9 activity in chronic hepatitis C with hepatic fibrosis.
Hepatitis C, Chronic
Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
Hepatitis C, Chronic
Plasma Levels of Matrix Metalloproteinase (MMP)-2, MMP-9 and Tumor Necrosis Factor-? in Chronic Hepatitis C Virus Patients.
Hepatitis C, Chronic
Portal, but not lobular, macrophages express matrix metalloproteinase-9: association with the ductular reaction and fibrosis in chronic hepatitis C.
Hepatitis C, Chronic
Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients.
Hepatitis, Chronic
Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Hepatitis, Chronic
Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C.
Hepatitis, Chronic
Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.
Hepatitis, Chronic
Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients.
Hepatitis, Chronic
[Clinical usefulness of plasma activities of gelatinase (matrix metalloproteinase-2 and 9) in chronic liver disease]
Hepatopulmonary Syndrome
Correlations of MMP-2 and MMP-9 gene polymorphisms with the risk of hepatopulmonary syndrome in cirrhotic patients: A case-control study.
Hernias, Diaphragmatic, Congenital
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1: expression in the lung of fetal rats with nitrofen-induced diaphragmatic hernia.
Hernias, Diaphragmatic, Congenital
Matrix metalloproteinase-9 expression in congenital diaphragmatic hernia during mechanical ventilation.
Herpes Simplex
Blocking mouse MMP-9 production in tumor cells and mouse cornea by short hairpin (sh) RNA encoding plasmids.
Herpes Simplex
Neutralization of matrix metalloproteinase-9 potentially enhances oncolytic efficacy of tanapox virus for melanoma therapy.
Herpes Simplex
Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus.
Herpes Simplex
The Alterations of Matrix Metalloproteinase-9 in Mouse Brainstem During Herpes Simplex Virus Type 1-Induced Facial Palsy.
Herpes Simplex
The effect of captopril on the expression of MMP-9 and the prognosis of neurological function in herpes simplex encephalitis mice.
Herpes Zoster
2,2',4,4'-Tetrabromodiphenyl ether promotes human neuroblastoma SH-SY5Y cells migration via the GPER/PI3K/Akt signal pathway.
Herpes Zoster
Ac-YVAD-CMK Decreases Blood-Brain Barrier Degradation by Inhibiting Caspase-1 Activation of Interleukin-1beta in Intracerebral Hemorrhage Mouse Model.
Herpes Zoster
Blast-induced temporal alterations in blood-brain barrier properties in a rodent model.
Herpes Zoster
Caspase-1 Inhibitor Prevents Neurogenic Pulmonary Edema After Subarachnoid Hemorrhage in Mice.
Herpes Zoster
Cell-Free Supernatants from Probiotic Lactobacillus casei and Lactobacillus rhamnosus GG Decrease Colon Cancer Cell Invasion In Vitro.
Herpes Zoster
DENV NS1 and MMP-9 cooperate to induce vascular leakage by altering endothelial cell adhesion and tight junction.
Herpes Zoster
eNOS gene deletion restores blood-brain barrier integrity and attenuates neurodegeneration in the thiamine-deficient mouse brain.
Herpes Zoster
Lipopolysaccharide disrupts the cochlear blood-labyrinth barrier by activating perivascular resident macrophages and up-regulating MMP-9.
Herpes Zoster
Nano-Curcumin Simultaneously Protects the Blood-Brain Barrier and Reduces M1 Microglial Activation During Cerebral Ischemia-Reperfusion Injury.
Herpes Zoster
Protective effects of recombinant osteopontin on early brain injury after subarachnoid hemorrhage in rats*
Herpes Zoster
Resolvin D1 ameliorates Inflammation-Mediated Blood-Brain Barrier Disruption After Subarachnoid Hemorrhage in rats by Modulating A20 and NLRP3 Inflammasome.
Herpes Zoster
Role of Periostin in Early Brain Injury After Subarachnoid Hemorrhage in Mice.
Herpes Zoster
Selective Toll-Like Receptor 4 Antagonists Prevent Acute Blood-Brain Barrier Disruption After Subarachnoid Hemorrhage in Mice.
Herpes Zoster
T cell-mediated biliary epithelial-to-mesenchymal transition in liver allograft rejection.
Hidradenitis Suppurativa
Adalimumab Induces a Wound Healing Profile in Patients with Hidradenitis Suppurativa by Regulating Macrophage Differentiation and Matrix Metalloproteinase Expression.
Hip Dislocation
Protein Biomarkers in Serum and Urine for Determining Presence or Absence of Hip Dysplasia in a Canine Model.
Histiocytoma, Benign Fibrous
Expression of MMP-2, MMP-9 and MMP-11 in dermatofibroma and dermatofibrosarcoma protuberans.
Histiocytoma, Malignant Fibrous
Expression of matrix metalloproteinase-9 correlates with poor prognosis in human malignant fibrous histiocytoma.
HIV Infections
72-kDa and 92-kDa gelatinases in saliva of patients with human immunodeficiency virus infection.
HIV Infections
Association between smoking status assessed with plasma-cotinine and inflammatory and endothelial biomarkers in HIV-positive and HIV-negative individuals.
HIV Infections
CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.
HIV Infections
Effects of norepinephrine, HIV type 1 infection, and leukocyte interactions with endothelial cells on the expression of matrix metalloproteinases.
HIV Infections
Matrix metalloproteinase levels in early HIV infection and relation to in vivo brain status.
HIV Infections
Matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 in plasma of patients co-infected with HCV and HIV.
HIV Infections
Peripheral blood RNA gene expression in children with pneumococcal meningitis: a prospective case-control study.
Hodgkin Disease
Diverse role of MMP-2 and MMP-9 in the clinicopathological behavior of Hodgkin's lymphoma.
Hodgkin Disease
Expression of 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma.
Hodgkin Disease
Expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in tissues with a diagnosis of childhood lymphoma.
Hodgkin Disease
Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status.
Hodgkin Disease
Matrix Metalloproteinase-9 Expression by Hodgkin-Reed-Sternberg Cells Is Associated with Reduced Overall Survival in Young Adult Patients with Classical Hodgkin Lymphoma.
Hodgkin Disease
Matrix metalloproteinase-9 is consistently expressed in Hodgkin/Reed-Sternberg cells and has no impact on survival in patients with Epstein-Barr virus (EBV)-related and non-related Hodgkin lymphoma in Brazil.
Hodgkin Disease
Plasma MMP-2-TIMP-2 complex levels measured during follow-up predict a risk of relapse in patients with malignant lymphoma.
Hodgkin Disease
Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in Hodgkin's and non-Hodgkin's lymphoma.
Homocystinuria
X-ray imaging of differential vascular density in MMP-9-/-, PAR-1-/+, hyperhomocysteinemic (CBS-/+) and diabetic (Ins2-/+) mice*
HTLV-I Infections
Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I).
HTLV-I Infections
Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness.
HTLV-I Infections
Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers.
Huntington Disease
Role of MMP-9 in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease.
Hutchinson's Melanotic Freckle
Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin.
Hydatidiform Mole
Reduced expression of tissue inhibitor of metalloproteinase (TIMP)-2 in gestational trophoblastic diseases.
Hydatidiform Mole
[Prediction of malignant transformation of hydatidiform mole by mRNA determination of matrix metalloproteinases and tissue inhibitor of metalloproteinases]
Hydatidiform Mole
[The role of KiSS-1 and matrix metalloproteinase-9 in regulation of invasion of trophoblasts]
Hydatidiform Mole, Invasive
[The role of KiSS-1 and matrix metalloproteinase-9 in regulation of invasion of trophoblasts]
Hydrocephalus
Alterations in matrix metalloproteinase-9 levels and tissue inhibitor of matrix metalloproteinases-1 expression in a transforming growth factor-beta transgenic model of hydrocephalus.
Hydrocephalus
Effect of Tianhuang Granule on intracranial pressure and serum matrix metalloproteinase-9 in patients with acute cerebral hemorrhage.
Hydrocephalus
Effects of atorvastatin on pathological changes in brain tissue and plasma MMP-9 in rats with intracerebral hemorrhage.
Hydrocephalus
Expression of HGF, MMP-9 and TGF-?1 in the CSF and cerebral tissue of adult rats with hydrocephalus.
Hydrocephalus
Human Cord Blood Derived Unrestricted Somatic Stem Cells Restore Aquaporin Channel Expression, Reduce Inflammation and Inhibit the Development of Hydrocephalus After Experimentally Induced Perinatal Intraventricular Hemorrhage.
Hydrocephalus
Increased expression of matrix metalloproteinase-9 and hepatocyte growth factor in the cerebrospinal fluid of infants with posthemorrhagic hydrocephalus.
Hydrocephalus
[Expression of matrix metalloproteinase MMP-9 in the plasma and hematoma fluid of intracerebral hemorrhage patients]
Hydrocephalus
[Pathomorphology of the ventricular germinal zone and neocortex in newborn infants with posthemorrhagic hydrocephalus].
Hydronephrosis
Selected Metal Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases as Potential Biomarkers for Tubulointerstitial Fibrosis in Children with Unilateral Hydronephrosis.
Hyperalgesia
Acute morphine induces matrix metalloproteinase-9 up-regulation in primary sensory neurons to mask opioid-induced analgesia in mice.
Hyperalgesia
Attenuation of Remifentanil-Induced Hyperalgesia by Betulinic Acid Associates with Inhibiting Oxidative Stress and Inflammation in Spinal Dorsal Horn.
Hyperalgesia
Effect of a Novel, Orally Active Matrix Metalloproteinase-2 and -9 Inhibitor in Spinal and Trigeminal Rat Models of Neuropathic Pain.
Hyperalgesia
Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis.
Hyperalgesia
High Estrogen Level Modifies Postoperative Hyperalgesia via GPR30 and MMP-9 in Dorsal Root Ganglia Neurons.
Hyperalgesia
MMP-9 regulates CX3CL1/CX3CR1 in the early phase of neuropathic pain in chronic sciatic nerve constriction injury (CCI) rats.
Hyperalgesia
N-acetyl-cysteine attenuates remifentanil-induced postoperative hyperalgesia via inhibiting matrix metalloproteinase-9 in dorsal root ganglia.
Hyperalgesia
Naringenin ameliorates diabetic neuropathic pain by modulation of oxidative-nitrosative stress, cytokines and MMP-9 levels.
Hyperalgesia
Nicotine Attenuates Osteoarthritis Pain and Matrix Metalloproteinase-9 Expression via the ?7 Nicotinic Acetylcholine Receptor.
Hyperalgesia
NOV/CCN3 attenuates inflammatory pain through regulation of matrix metalloproteinases-2 and -9.
Hyperalgesia
Spinal matrix metalloproteinase-9 contributes to physical dependence on morphine in mice.
Hypercholesterolemia
Carbamoyl-PROXYL-enhanced MRI detects very small disruptions in brain vascular permeability induced by dietary cholesterol.
Hypercholesterolemia
Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia.
Hypercholesterolemia
Effects of fluvastatin, an HMG-CoA reductase inhibitor, on serum levels of interleukin-18 and matrix metalloproteinase-9 in patients with hypercholesterolemia.
Hypercholesterolemia
Salvianolic acid B attenuates MMP-2 and MMP-9 expression in vivo in apolipoprotein-E-deficient mouse aorta and in vitro in LPS-treated human aortic smooth muscle cells.
Hyperemia
Comparative effects of diet and statin on NO bioactivity and matrix metalloproteinases in hypercholesterolemic patients with coronary artery disease.
Hyperemia
Effects of fluvastatin, an HMG-CoA reductase inhibitor, on serum levels of interleukin-18 and matrix metalloproteinase-9 in patients with hypercholesterolemia.
Hyperglycemia
Accelerated degradation of collagen membranes in type 1 diabetic rats is associated with increased expression and production of several inflammatory molecules.
Hyperglycemia
Association between Increased Matrix Metalloproteinase-9 (MMP-9) Levels with Hyperglycaemia Incidence in Acute Ischemic Stroke Patients.
Hyperglycemia
Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin.
Hyperglycemia
Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.
Hyperglycemia
Diabetes mellitus aggravates hemorrhagic transformation after ischemic stroke via mitochondrial defects leading to endothelial apoptosis.
Hyperglycemia
Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress.
Hyperglycemia
Dual effects of hyperglycemia on endothelial cells and cardiomyocytes to enhance coronary LPL activity.
Hyperglycemia
Hyperglycemia Promotes Liver Metastasis of Colorectal Cancer via Upregulation of Integrin ?v?6.
Hyperglycemia
Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction.
Hyperglycemia
Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy.
Hyperglycemia
Oral supplementation with melatonin reduces oxidative damage and concentrations of inducible nitric oxide synthase, VEGF and matrix metalloproteinase 9 in the retina of rats with streptozotocin/nicotinamide induced pre-diabetes.
Hyperglycemia
Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats.
Hyperglycemia
Rice bran protein hydrolysates reduce arterial stiffening, vascular remodeling and oxidative stress in rats fed a high-carbohydrate and high-fat diet.
Hyperglycemia
Serum matrix metalloproteinase-9 levels in acute coronary syndrome patients with and without hyperglycemia.
Hyperglycemia
Use of Glycated Hemoglobin (A1c) as a Biomarker for Vascular Risk in Type 2 Diabetes: Its Relationship with Matrix Metalloproteinases-2, -9 and the Metabolism of Collagen IV and Elastin.
Hyperglycemia
Why does acute hyperglycemia worsen the outcome of transient focal cerebral ischemia? Role of corticosteroids, inflammation, and protein O-glycosylation.
Hyperhomocysteinemia
Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia.
Hyperhomocysteinemia
Exercise mitigates the adverse effects of hyperhomocysteinemia on macrophages, MMP-9, skeletal muscle, and white adipocytes.
Hyperhomocysteinemia
Exercise mitigates the effects of hyperhomocysteinemia on adverse muscle remodeling.
Hyperhomocysteinemia
Homocysteine Disrupts Balance between MMP-9 and Its Tissue Inhibitor in Diabetic Retinopathy: The Role of DNA Methylation.
Hyperhomocysteinemia
Homocysteine enriched diet leads to prolonged QT interval and reduced left ventricular performance in telemetric monitored mice.
Hyperhomocysteinemia
Hyperhomocysteinemia induced by excessive methionine intake promotes rupture of cerebral aneurysms in ovariectomized rats.
Hyperhomocysteinemia
X-ray imaging of differential vascular density in MMP-9-/-, PAR-1-/+, hyperhomocysteinemic (CBS-/+) and diabetic (Ins2-/+) mice*
Hyperhomocysteinemia
[The mechanism of homocysteine in Kkay mice diabetic nephropathy model]
Hyperinsulinism
Effects of hyperinsulinemia on hepatic metalloproteinases and their tissue inhibitors.
Hyperinsulinism
In vivo effects of insulin and free fatty acids on matrix metalloproteinases in rat aorta.
Hyperinsulinism
Insulin facilitates monocyte migration: a possible link to tissue inflammation in insulin-resistance.
Hyperlipidemias
Matrix metalloproteinase-9 in spontaneously hypertensive hyperlipidemic rats.
Hyperlipidemias
Protosappanin A protects against atherosclerosis via anti- hyperlipidemia, anti-inflammation and NF-?B signaling pathway in hyperlipidemic rabbits.
Hyperlipidemias
[Quantitative ultrasonic integrated backscatter of the intima-media complex, serum level of matrix metalloprotease-9 and simvastatin in hyperlipemia patients.]
Hypersensitivity
Acute pharmacological inhibition of matrix metalloproteinase-9 activity during development restores perineuronal net formation and normalizes auditory processing in Fmr1 KO mice.
Hypersensitivity
Diacerein reduces joint damage, pain behavior and inhibits transient receptor potential vanilloid 1, matrix metalloproteinase and glial cells in rat spinal cord.
Hypersensitivity
Expression of matrix metalloproteinase-9 and -2 in pediatric chronic otitis media with effusion.
Hypersensitivity
Genetic Reduction of Matrix Metalloproteinase-9 Promotes Formation of Perineuronal Nets Around Parvalbumin-Expressing Interneurons and Normalizes Auditory Cortex Responses in Developing Fmr1 Knock-Out Mice.
Hypersensitivity
Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.
Hypersensitivity
High Estrogen Level Modifies Postoperative Hyperalgesia via GPR30 and MMP-9 in Dorsal Root Ganglia Neurons.
Hypersensitivity
Keratoconus Progression in Patients With Allergy and Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test.
Hypersensitivity
Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
Hypersensitivity
Non-invasive markers of airway inflammation and remodeling in childhood asthma.
Hypersensitivity
Ocular allergic inflammation: interaction between the cornea and conjunctiva.
Hypersensitivity
Perineural expression of high-mobility group box-1 contributes to long-lasting mechanical hypersensitivity via matrix metalloproteinase-9 upregulation in mice with painful peripheral neuropathy.
Hypersensitivity
Relationship between tear eotaxin-2 and MMP-9 with ocular allergy and corneal topography in keratoconus patients.
Hypersensitivity
Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation.
Hypersensitivity
The involvement of spinal annexin A10/NF-?B/MMP-9 pathway in the development of neuropathic pain in rats.
Hypersensitivity
TIMP-1 Attenuates the Development of Inflammatory Pain Through MMP-Dependent and Receptor-Mediated Cell Signaling Mechanisms.
Hypertension
A lower admission level of interleukin-6 is associated with first-pass effect in ischemic stroke patients.
Hypertension
Age- and Phenotype-Dependent Changes in Circulating MMP-2 and MMP-9 Activities in Normotensive and Hypertensive Rats.
Hypertension
Altered matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 levels in children with primary hypertension.
Hypertension
Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults.
Hypertension
Baicalin Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension to Improve Hypoxic Cor Pulmonale by Reducing the Activity of the p38 MAPK Signaling Pathway and MMP-9.
Hypertension
Blood pressure control predicts plasma matrix metalloproteinase-9 in diabetes mellitus type II.
Hypertension
Changes in activities of circulating MMP-2 and MMP-9 in patients suffering from heart failure in relation to gender, hypertension and treatment: a cross-sectional study.
Hypertension
Circulating matrix metalloproteinase-9 level is associated with cerebral white matter hyperintensities in non-stroke individuals.
Hypertension
Clinical Relevance of Matrix Metalloproteinase 9 in Patients With Acute Coronary Syndrome.
Hypertension
Consistent Alterations of Circulating Matrix Metalloproteinases Levels in Untreated Hypertensives and in Spontaneously Hypertensive Rats: A Relevant Pharmacological Target.
Hypertension
Cortisol/cortisone ratio and matrix metalloproteinase-9 activity are associated with pediatric primary hypertension.
Hypertension
Critical role for copper/zinc-superoxide dismutase in preventing spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice.
Hypertension
Critical Role of Matrix Metalloproteinase-9 in Acute Cold Exposure-Induced Stroke in Renovascular Hypertensive Rats.
Hypertension
Crosstalk between obesity and MMP-9 in cardiac remodelling -a cross-sectional study in apparent treatment-resistant hypertension.
Hypertension
Curcumin attenuates migration of vascular smooth muscle cells via inhibiting NF?B-mediated NLRP3 expression in spontaneously hypertensive rats.
Hypertension
Does Arterial Hypertension Affect Plasma Levels of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Stable Coronary Artery Disease? A Preliminary Study.
Hypertension
Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
Hypertension
Effect of blood pressure on early neurological deterioration of acute ischemic stroke patients with intravenous rt-PA thrombolysis may be mediated through oxidative stress induced blood-brain barrier disruption and AQP4 upregulation.
Hypertension
Effect of genetic depletion of MMP-9 on neurological manifestations of hypertension-induced intracerebral hemorrhages in aged mice.
Hypertension
Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents.
Hypertension
Endothelin-1 critically influences cardiac function via superoxide-MMP9 cascade.
Hypertension
Expression and response to Angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with Renin-dependent hypertension.
Hypertension
Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals.
Hypertension
Focus on the unique mechanisms involved in thoracic aortic aneurysm formation in bicuspid aortic valve vs tricuspid aortic valve patients: clinical implications of a pilot study.
Hypertension
High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction.
Hypertension
Inhibition of MMP-9 attenuates hypertensive cerebrovascular dysfunction in Dahl salt-sensitive rats.
Hypertension
Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound.
Hypertension
Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme.
Hypertension
Is there any genetic predisposition of MMP-9 gene C1562T and MTHFR gene C677T polymorphisms with essential hypertension?
Hypertension
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension.
Hypertension
Levels of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 mRNAs in Patients with Primary Hypertension or Hypertension-induced Atherosclerosis.
Hypertension
Levels of MMP-9 in patients with intracranial aneurysm: Relation with risk factors, size and clinical presentation.
Hypertension
Matrix metalloproteinase -2, -9 and arterial stiffness in children and adolescents: The role of chronic kidney disease, diabetes, and hypertension.
Hypertension
Matrix metalloproteinase 9 gene haplotypes affect left ventricular hypertrophy in hypertensive patients.
Hypertension
Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
Hypertension
Matrix metalloproteinase-2 and -9 in glioblastoma: a trio of old drugs-captopril, disulfiram and nelfinavir-are inhibitors with potential as adjunctive treatments in glioblastoma.
Hypertension
Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.
Hypertension
Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness.
Hypertension
Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy.
Hypertension
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis.
Hypertension
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Hypertension
Matrix metalloproteinase-9 as a messenger in the crosstalk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review.
Hypertension
Matrix Metalloproteinase-9 Is a Predictive Factor for Systematic Hypertension and Heart Dysfunction in Patients with Obstructive Sleep Apnea Syndrome.
Hypertension
Matrix Metalloproteinases in Vascular Disease - A Potential Therapeutic Target?
Hypertension
Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease.
Hypertension
Metalloproteinase Inhibition Protects against Reductions in Circulating Adrenomedullin during Lead-induced Acute Hypertension.
Hypertension
MMP-2 and MMP-9 contribute to the angiogenic effect produced by hypoxia/15-HETE in pulmonary endothelial cells.
Hypertension
MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients.
Hypertension
MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis.
Hypertension
Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-? and MMPs, and decreases vascular remodeling in renovascular hypertension.
Hypertension
Nonischemic cerebral venous hypertension promotes a pro-angiogenic stage through HIF-1 downstream genes and leukocyte-derived MMP-9.
Hypertension
Plasma matrix metalloproteinase (MMP)-9 levels are reduced following low-calorie cranberry juice supplementation in men.
Hypertension
Plasma thrombin-cleaved osteopontin as a potential biomarker of acute atherothrombotic ischemic stroke.
Hypertension
Prediction of the early response to spironolactone in resistant hypertension by the combination of matrix metalloproteinase-9 activity and arterial stiffness parameters.
Hypertension
Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats.
Hypertension
Pyrrolidine dithiocarbamate downregulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodeling in renovascular hypertension.
Hypertension
Reduction of endothelial tight junction proteins is related to cerebral aneurysm formation in rats.
Hypertension
Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community.
Hypertension
Renin-angiotensin system activation and imbalance of matrix metalloproteinase-9/tissue inhibitor of matrix metalloproteinase-1 in cold-induced stroke.
Hypertension
Rice bran protein hydrolysates reduce arterial stiffening, vascular remodeling and oxidative stress in rats fed a high-carbohydrate and high-fat diet.
Hypertension
Role of MMP-2 and MMP-9 in resistance to drug therapy in patients with resistant hypertension.
Hypertension
Salvianolic Acid a, a novel matrix metalloproteinase-9 inhibitor, prevents cardiac remodeling in spontaneously hypertensive rats.
Hypertension
Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment.
Hypertension
Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke.
Hypertension
Smooth muscle-specific TMEM16A expression protects against angiotensin II-induced cerebrovascular remodeling via suppressing extracellular matrix deposition.
Hypertension
Spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice.
Hypertension
System of matrix metalloproteinases and cytokine secretion in type 2 diabetes mellitus and impaired carbohydrate tolerance associated with arterial hypertension.
Hypertension
The Correlation between High-Sensitivity C-Reactive Protein, Matrix Metallopeptidase 9, and Traditional Chinese Medicine Syndrome in Patients with Hypertension.
Hypertension
Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation.
Hypertension
TNF-alpha regulates vascular smooth muscle cell responses in genetic hypertension.
Hypertension
Transgenic expression of human matrix metalloproteinase-9 augments monocrotaline-induced pulmonary arterial hypertension in mice.
Hypertension
[Selected matrix metalloproteinases (MMP-2, MMP-9) in obese children and adolescents]
Hypertension, Portal
Effect of cold ischemia/reperfusion injury and/or shear stress with portal hypertension on the expression of matrix metalloproteinase-9.
Hypertension, Portal
Matrix metalloproteinase-9 after the cold ischemia/reperfusion injury and/or shear stress with portal hypertension: an overview.
Hypertension, Portal
Nitro-oxidative stress, VEGF and MMP-9 in patients with cirrhotic and non-cirrhotic portal hypertension.
Hypertension, Pregnancy-Induced
Characterization of maternal plasma biomarkers associated with delivery of small and large for gestational age infants in the MIREC study cohort.
Hypertension, Pregnancy-Induced
Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
Hypertension, Pregnancy-Induced
Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension.
Hypertension, Pregnancy-Induced
First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome.
Hypertension, Pregnancy-Induced
Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension.
Hypertension, Pregnancy-Induced
Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 and 2 as potential biomarkers for gestational hypertension.
Hypertension, Pregnancy-Induced
Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Hypertension, Pregnancy-Induced
MMP-9 and TIMP-1 in placenta of hypertensive disorder complicating pregnancy.
Hypertension, Pregnancy-Induced
Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Hypertension, Pregnancy-Induced
[Expression of matrix metalloproteinase-9 and tumor necrosis factor-alpha in the placenta of patients with pregnancy-induced hypertension]
Hypertension, Pregnancy-Induced
[Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia]
Hypertension, Pulmonary
A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism.
Hypertension, Pulmonary
Effects of angiotensin II intervention on MMP-2, MMP-9, TIMP-1, and collagen expression in rats with pulmonary hypertension.
Hypertension, Pulmonary
L-arginine attenuates acute pulmonary embolism-induced increases in lung matrix metalloproteinase-2 and matrix metalloproteinase-9.
Hypertension, Pulmonary
Mechanical stretching of pulmonary vein stimulates matrix metalloproteinase-9 and transforming growth factor-?1 through stretch-activated channel/MAPK pathways in pulmonary hypertension due to left heart disease model rats.
Hypertension, Pulmonary
Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9.
Hypertension, Pulmonary
Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs.
Hypertension, Pulmonary
The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertension.
Hypertension, Pulmonary
[Effects of cigarette smoke exposure on pulmonary vascular intercellular adhesion molecule-1 and matrix metalloproteinase-9 in rats]
Hypertension, Renovascular
Renovascular hypertension by two-kidney one-clip enhances endothelial progenitor cell mobilization in a p47phox-dependent manner.
Hypertrophy, Left Ventricular
Altered matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 levels in children with primary hypertension.
Hypertrophy, Left Ventricular
Crosstalk between obesity and MMP-9 in cardiac remodelling -a cross-sectional study in apparent treatment-resistant hypertension.
Hypertrophy, Left Ventricular
Effects of crocetin on the matrix metalloproteinases in cardiac hypertrophy induced by norepinephrine in rats.
Hypertrophy, Left Ventricular
Matrix metalloproteinase 9 gene haplotypes affect left ventricular hypertrophy in hypertensive patients.
Hypertrophy, Left Ventricular
Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy.
Hypertrophy, Right Ventricular
Captopril attenuates matrix metalloproteinase-2 and -9 in monocrotaline-induced right ventricular hypertrophy in rats.
Hypogonadism
Strontium fructose 1,6-diphosphate alleviates early diabetic testopathy by suppressing abnormal testicular matrix metalloproteinase system in streptozocin-treated rats.
Hypopharyngeal Neoplasms
Analysis of vascular-associated factors and the prognosis of poorly differentiated hypopharyngeal carcinoma.
Hypopharyngeal Neoplasms
CD147 promotes invasion and MMP-9 expression through MEK signaling and predicts poor prognosis in hypopharyngeal squamous cell carcinoma.
Hypopharyngeal Neoplasms
Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and -7.
Hypopharyngeal Neoplasms
TWIST expression in hypopharyngeal cancer and the mechanism of TWIST-induced promotion of metastasis.
Hypoxia-Ischemia, Brain
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia.
Hypoxia-Ischemia, Brain
Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia.
Hypoxia-Ischemia, Brain
MMP-9 and MMP-3 gene polymorphisms in neonatal hypoxic ischemic encephalopathy.
Hypoxia-Ischemia, Brain
Role of Matrix Metalloproteinase-9 in Neonatal Hypoxic-Ischemic Encephalopathy.
Idiopathic Pulmonary Fibrosis
Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis.
Idiopathic Pulmonary Fibrosis
Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis.
Idiopathic Pulmonary Fibrosis
Genetic polymorphism in matrix metalloproteinase-9 and transforming growth factor-?1 and susceptibility to combined pulmonary fibrosis and emphysema in a Chinese population.
Idiopathic Pulmonary Fibrosis
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF.
Idiopathic Pulmonary Fibrosis
MMP-9 1562C>T Gene Polymorphism and Efficacy of Glucocorticoid Therapy in Idiopathic Pulmonary Fibrosis Patients.
Idiopathic Pulmonary Fibrosis
Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment.
Idiopathic Pulmonary Fibrosis
Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
Idiopathic Pulmonary Fibrosis
[Changes of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the bronchoalveolar lavage fluid and the serum of patients with idiopathic pulmonary fibrosis]
IgA Vasculitis
Cut-off values for serum matrix metalloproteinase-9: is there a threshold to predict renal involvement for Henoch-Schonlein purpura in children?
Ileus
Iatrogenic extracellular matrix disruption as a local trigger for postoperative ileus.
Ileus
Matrix Metalloproteinase-9 Inhibition Reduces Inflammation and Improves Motility in Murine Models of Postoperative Ileus.
Immune System Diseases
Polytrauma in Older Adults Leads to Significantly Increased TIMP-1 Levels in the Early Posttraumatic Period.
Infarction, Middle Cerebral Artery
Brain regional and cellular localization of gelatinase activity in rat that have undergone transient middle cerebral artery occlusion.
Infarction, Middle Cerebral Artery
Caspase-1-independent maturation of IL-1? in Ischemic Brain Injury: is there a role for gelatinases?
Infarction, Middle Cerebral Artery
Crotalus atrox disintegrin reduces hemorrhagic transformation by attenuating matrix metalloproteinase-9 activity after middle cerebral artery occlusion in hyperglycemic male rats.
Infarction, Middle Cerebral Artery
Hyperbaric oxygen preconditioning attenuates hyperglycemia-enhanced hemorrhagic transformation by inhibiting matrix metalloproteinases in focal cerebral ischemia in rats.
Infarction, Middle Cerebral Artery
Hypoxia Response Element-Regulated MMP-9 Promotes Neurological Recovery via Glial Scar Degradation and Angiogenesis in Delayed Stroke.
Infarction, Middle Cerebral Artery
Hypoxia-controlled matrix metalloproteinase-9 hyperexpression promotes behavioral recovery after ischemia.
Infarction, Middle Cerebral Artery
Inhibition of matrix metalloproteinase-9 activity by trandolapril after middle cerebral artery occlusion in rats.
Infarction, Middle Cerebral Artery
Involvement of matrix metalloproteinase-mediated proteolysis of neural cell adhesion molecule in the development of cerebral ischemic neuronal damage.
Infarction, Middle Cerebral Artery
Ischemic Postconditioning Diminishes Matrix Metalloproteinase 9 Expression and Attenuates Loss of the Extracellular Matrix Proteins in Rats Following Middle Cerebral Artery Occlusion and Reperfusion.
Infarction, Middle Cerebral Artery
Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment.
Infarction, Middle Cerebral Artery
Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
Infarction, Middle Cerebral Artery
Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke.
Infarction, Middle Cerebral Artery
Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats.
Infarction, Middle Cerebral Artery
Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Infarction, Middle Cerebral Artery
Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.
Infarction, Middle Cerebral Artery
Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice.
Infarction, Middle Cerebral Artery
The effect of cyclosporin a on ischemia-reperfusion damage in a mouse model of ischemic stroke.
Infarction, Middle Cerebral Artery
The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke.
Infarction, Middle Cerebral Artery
The Relationship Between Cerebral Reperfusion And Regional Expression Of Matrix Metalloproteinase-9 In Rat Brain Following Focal Cerebral Ischemia.
Infarction, Middle Cerebral Artery
Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia.
Infarction, Middle Cerebral Artery
Vitamin D deficiency increases blood-brain barrier dysfunction after ischemic stroke in male rats.
Infarction, Middle Cerebral Artery
[Diffusion tensor imaging study of the protective effect of shRNA on matrix metalloproteinase-9 in middle cerebral artery occlusion rats].
Infections
115kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-? induced down-regulation of TNF-? mediated MMP-9 activity.
Infections
1alpha,25-dihydroxyvitamin D inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection.
Infections
A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection.
Infections
A link between neutrophils and chronic disease manifestations of Chlamydia muridarum urogenital infection of mice.
Infections
A role for matrix metalloproteinase-9 in pathogenesis of urogenital Chlamydia muridarum infection in mice.
Infections
A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes.
Infections
Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice.
Infections
Activation of MMP-9 by human lung epithelial cells in response to cystic fibrosis associated pathogen Burkholderia cenocepacia reduced wound healing in vitro.
Infections
Activity of matrix metalloproteinase 2 and 9 isoforms in sputum samples from individuals infected with M. tuberculosis.
Infections
Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection.
Infections
Addendum: Kong, M.Y.; Whitley, R.J.; Peng, N.; Oster, R.; Schoeb, T.R.; Sullender, W.; Ambalavanan, N.; Clancy, J.P.; Gaggar, A.; Blalock J.E. Matrix Metalloproteinase-9 Mediates RSV Infection in Vitro and in Vivo. Viruses 2015, 30, 7, 42304253.
Infections
Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion.
Infections
Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice.
Infections
Adrenal steroids modulate the immune response during B. abortus infection by a mechanism that depends on the regulation of cytokine production.
Infections
Amniotic fluid concentrations of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during pregnancy and labor.
Infections
Amniotic fluid matrix metalloproteinase-9 and interleukin-6 in predicting intra-amniotic infection.
Infections
Amniotic fluid matrix metalloproteinase-9 levels in women with preterm labor and suspected intra-amniotic infection.
Infections
Angiostrongylus cantonensis infection induces MMP-9 and causes tight junction protein disruption associated with Purkinje cell degeneration.
Infections
Association of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinase-4 in cerebrospinal fluid with blood-brain barrier dysfunction in patients with eosinophilic meningitis caused by Angiostrongylus cantonensis.
Infections
Association of urinary activity of MMP-9 with renal impairment in Mexican patients with type 2 diabetes mellitus.
Infections
Brucella abortus induces collagen deposition and MMP-9 down-modulation in hepatic stellate cells via TGF-?1 production.
Infections
Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection.
Infections
Characterization of Matrix Metalloprotease-9 Gene from Nile tilapia (Oreochromis niloticus) and Its High-Level Expression Induced by the Streptococcus agalactiae Challenge.
Infections
Chlamydia pneumoniae infection of microglial cells in vitro: a model of microbial infection for neurological disease.
Infections
Chlamydia trachomatis enhances the expression of matrix metalloproteinases in an in vitro model of the human fallopian tube infection.
Infections
Circulating levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases during Japanese encephalitis virus infection.
Infections
Clarithromycin suppresses induction of monocyte chemoattractant protein-1 and matrix metalloproteinase-9 and improves pathological changes in the lungs and heart of mice infected with influenza A virus.
Infections
Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membrane.
Infections
Colonic Expression of Genes Encoding Inflammatory Mediators and Gelatinases During Campylobacter Jejuni Infection of Conventional Infant Mice.
Infections
Comparative Analysis of Cytokine Expression in Oral Keratinocytes and THP-1 Macrophages in Response to the Most Prevalent Serotypes of Aggregatibacter actinomycetemcomitans.
Infections
Dalbavancin and wound healing: new evidences/insights in a mouse model of skin infection.
Infections
Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3.
Infections
Development of immunosensors for direct detection of three wound infection biomarkers at point of care using electrochemical impedance spectroscopy.
Infections
Dexamethasone downregulates the expressions of MMP-9 and oxidative stress in mice with eosinophilic meningitis caused by Angiostrongylus cantonensis infection.
Infections
Difference in Host Immune response to Methicillin-Resistant and Methicillin Sensitive Staphylococcus aureus (MRSA and MSSA) Endophthalmitis.
Infections
Differences in circulating MMP-9 levels with regard to viral load and AST:ALT ratio between chronic hepatitis B and C patients.
Infections
Different characteristics of human herpesvirus 6 encephalitis between primary infection and viral reactivation.
Infections
Different responses in MMPs/TIMPs expression of U937 and HepG2 cells to dengue virus infection.
Infections
Differential effect of p47phox and gp91phox deficiency on the course of Pneumococcal Meningitis.
Infections
Differential expression of hepatic fibrosis mediators in sick and spontaneously recovered mice with experimental biliary atresia.
Infections
Downregulation of microRNA-204 increases the expression of matrix metallopeptidase 9 in pediatric patients with pulpitis and Helicobacter pylori infection in the stomach.
Infections
Doxycycline treatment prevents alveolar destruction in VEGF-deficient mouse lung.
Infections
Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection.
Infections
Effect of adenovirus-mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts.
Infections
Effect of pseudomonas aeruginosa on the expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the airway of bronchiectasis patients.
Infections
Effect of respiratory syncytial virus on the activity of matrix metalloproteinase in mice.
Infections
Effect of silibinin in reducing inflammatory pathways in in vitro and in vivo models of infection-induced preterm birth.
Infections
Elevated Plasma Matrix Metalloproteinase-9 and Its Correlations with Severity of Disease in Patients with Ventilator-Associated Pneumonia.
Infections
Elucidating the function and tolerance mechanism of gamma delta (? ?) T cells in a Helicobacter pylori infection model.
Infections
EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
Infections
Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells.
Infections
Enterovirus 71 infection induced Aquaporin-4 depolarization by increasing matrix metalloproteinase-9 activity.
Infections
Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels.
Infections
Essential role of choline for pneumococcal virulence in an experimental model of meningitis.
Infections
Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection.
Infections
Expression levels of matrix metalloproteinase (MMP)-9 and its specific inhibitor TIMP-1, in septic and aseptic arthritis of the knee.
Infections
Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum infection of mice.
Infections
Fusobacterium nucleatum Binding to Complement Regulatory Protein CD46 Modulates the Expression and Secretion of Cytokines and Matrix Metalloproteinases by Oral Epithelial Cells.
Infections
Gastric gelatinase B/matrix metalloproteinase-9 is rapidly increased in Helicobacter felis-induced gastritis.
Infections
Gelatinolytic matrix metalloproteinases-2 and -9 in tracheobronchial lavage fluid obtained from calves with concurrent infections of Pasteurella multocida and Mycoplasma bovirhinis.
Infections
Generation of a Monoclonal Antibody Against Staphylococcal Superantigen-Like Protein 5 (SSL5) That Discriminates SSL5 from Other SSL Proteins.
Infections
GM-CSF- and TNF-{alpha}-mediated matrix metalloproteinase production by human osteoblasts and monocytes upon infection with Brucella abortus.
Infections
H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation.
Infections
Helicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2-mediated pathway.
Infections
Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.
Infections
HIV-1 infection stimulates T cell invasiveness and synthesis of the 92-kDa type IV collagenase.
Infections
Host single nucleotide polymorphisms of MMP-9 -1562/TIMP-1 372 have gender differences in the risk of gastric intestinal metaplasia after Helicobacter pylori infection.
Infections
HPV 16 infection up-regulates Piwil2, which affects cell proliferation and invasion in cervical cancer by regulating MMP-9 via the MAPK pathway.
Infections
Human cytomegalovirus infection is correlated with atherosclerotic plaque vulnerability in carotid artery.
Infections
Human cytomegalovirus-induced inhibition of cytotrophoblast invasion in a first trimester extravillous cytotrophoblast cell line.
Infections
Human Rhinovirus Infection Upregulates MMP-9 Production in Airway Epithelial Cells via NF-{kappa}B.
Infections
Identification of matrix metalloproteinase-9 in amniotic fluid and amniochorion in spontaneous labor and after experimental intrauterine infection or interleukin-1 beta infusion in pregnant rhesus monkeys.
Infections
Immunohistochemical analysis of MMP-9, MMP-2 and TIMP-1, TIMP-2 expression in the central nervous system following infection with viral and bacterial meningitis.
Infections
Impact of 4-hydroxynonenal on matrix metalloproteinase-9 regulation in lipopolysaccharide-stimulated RAW 264.7 cells.
Infections
In situ detection of matrix metalloproteinase-9 (MMP-9) in gingival epithelium in human periodontal disease.
Infections
In vitro downregulation of matrix metalloproteinase-9 in rat glial cells by CCR5 antagonist maraviroc: therapeutic implication for HIV brain infection.
Infections
Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection.
Infections
Increased gelatinase B/matrix metalloproteinase 9 (MMP-9) activity in a murine model of acute coxsackievirus B4-induced pancreatitis.
Infections
Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins.
Infections
Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
Infections
Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis.
Infections
Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Infections
Induction of matrix metalloproteinase-2 and -9 via Erk1/2-NF-?B pathway in human astroglia infected with Toxoplasma gondii.
Infections
Induction of matrix metalloproteinase-9 in mice during Toxocara canis larvae migration.
Infections
Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
Infections
Induction of VEGF and MMP-9 expression by toll-like receptor 2/4 in human endothelial cells infected with Chlamydia pneumoniae.
Infections
Infection of human monocyte-derived dendritic cells by ANDES Hantavirus enhances pro-inflammatory state, the secretion of active MMP-9 and indirectly enhances endothelial permeability.
Infections
Infection with human cytomegalovirus alters the MMP-9/TIMP-1 balance in human macrophages.
Infections
Infection with Theileria annulata induces expression of matrix metalloproteinase 9 and transcription factor AP-1 in bovine leucocytes.
Infections
Influenza A virus lacking the effector and C terminal domains of NS1 protein induces cytokines associated with high pathogenicity in mice.
Infections
Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells.
Infections
Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.
Infections
Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis.
Infections
Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epithelial cells with metabolic and protein-protein interaction networks.
Infections
Interaction of matrix metalloproteinase-9 and Zpx in Cronobacter turicensis LMG 23827T mediated infections in the zebrafish model.
Infections
Involvement of matrix metalloproteinases in human immunodeficiency virus type 1-induced replication by clinical Mycobacterium avium isolates.
Infections
Japanese encephalitis virus induces matrix metalloproteinase-9 in rat brain astrocytes via NF-?B signalling dependent on MAPKs and reactive oxygen species.
Infections
Lack of alpha-1 integrin alters lesion morphology during pulmonary Mycobacterium tuberculosis infection.
Infections
Levels of Matrix Metalloproteinase-2 and -9 in the Cerebrospinal Fluid of Dogs with Visceral Leishmaniasis.
Infections
Levels of matrix metalloproteinase-9 within cerebrospinal fluid in a rabbit model of coccidioidal meningitis and vasculitis.
Infections
Levels of plasma matrix metalloproteinases (MMP-2 and MMP-9) in response to INTEGRA® dermal regeneration template implantation.
Infections
Levocetirizine inhibits rhinovirus-induced up-regulation of fibrogenic and angiogenic factors in nasal polyp fibroblasts.
Infections
Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7 cells.
Infections
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection.
Infections
Lung dendritic cells facilitate extrapulmonary bacterial dissemination during pneumococcal pneumonia.
Infections
Lung transplant metalloproteinase levels are elevated prior to bronchiolitis obliterans syndrome.
Infections
M. tuberculosis induction of matrix metalloproteinase-9: the role of mannose and receptor-mediated mechanisms.
Infections
Macrophage activation associated with chronic murine cytomegalovirus infection results in more severe experimental choroidal neovascularization.
Infections
Mathematical Modeling of the Biomarker Milieu to Characterize Preterm Birth and Predict Adverse Neonatal Outcomes.
Infections
Matrix metalloproteinase (MMP)-2 and MMP-9 as inflammation markers of Trichinella spiralis and Trichinella pseudospiralis infections in mice.
Infections
Matrix metalloproteinase 9 activity enhances host susceptibility to pulmonary infection with type A and B strains of Francisella tularensis.
Infections
Matrix Metalloproteinase 9 Exerts Antiviral Activity against Respiratory Syncytial Virus.
Infections
Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling.
Infections
Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis.
Infections
Matrix metalloproteinase proteolysis of the mycobacterial HSP65 protein as a potential source of immunogenic peptides in human tuberculosis.
Infections
Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.
Infections
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection.
Infections
Matrix metalloproteinase-9 as new biomarkers of severity in multiple organ dysfunction syndrome caused by trauma and infection.
Infections
Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection.
Infections
Matrix metalloproteinase-9 gene polymorphism in hepatocellular carcinoma patients with hepatitis B and C viruses.
Infections
Matrix Metalloproteinase-9 in Monocytic Myeloid-Derived Suppressor Cells Correlate with Early Infections and Clinical Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation.
Infections
Matrix metalloproteinase-9 inhibition down-regulates radiation-induced nuclear factor-kappa B activity leading to apoptosis in breast tumors.
Infections
Matrix metalloproteinase-9 plays a role in protecting zebrafish from lethal infection with Listeria monocytogenes by enhancing macrophage migration.
Infections
Matrix metalloproteinase-9 polymorphism 1562 C > T (rs3918242) associated with protection against placental malaria.
Infections
Matrix Metalloproteinase-9-Generated COOH-, but Not NH2-Terminal Fragments of Serum Amyloid A1 Retain Potentiating Activity in Neutrophil Migration to CXCL8, With Loss of Direct Chemotactic and Cytokine-Inducing Capacity.
Infections
Matrix metalloproteinases 2 and 9 correlate with alanine aminotransferase and hepatitis C virus in blood donors.
Infections
Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of children with Japanese encephalitis virus infection.
Infections
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis.
Infections
Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.
Infections
Matrix metalloproteinases in the cervical mucus plug in relation to gestational age, plug compartment, and preterm labor.
Infections
Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro.
Infections
Matrix metalloproteinases with gelatinolytic activity induced by Paracoccidioides brasiliensis infection.
Infections
Mechanisms of matrix metalloproteinase-9 upregulation and tissue destruction in various organs in influenza A virus infection.
Infections
Metalloproteinases 2 and 9 Immunoexpression in Periapical Lesions from Primary Endodontic Infection: Possible Relationship with the Histopathological Diagnosis and the Presence of Pain.
Infections
Metalloproteinases TACE and MMP-9 Differentially Regulate Death Factors on Adult and Neonatal Monocytes After Infection with Escherichia coli.
Infections
miR-1303 regulates BBB permeability and promotes CNS lesions following CA16 infections by directly targeting MMP9.
Infections
MMP-9 activity is induced by Leishmania braziliensis infection and correlates with mucosal leishmaniasis.
Infections
MMP-9 short interfering RNA induced senescence resulting in inhibition of medulloblastoma growth via p16(INK4a) and mitogen-activated protein kinase pathway.
Infections
Modified Profile of Matrix Metalloproteinase 2 and 9 Production by Human Fallopian Tube Epithelial Cells After Infection In Vitro With Neisseria gonorrhoeae.
Infections
Modulations of 92kDa gelatinase B and its inhibitors are associated with HIV-1 infection in human macrophage cultures.
Infections
Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia.
Infections
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Positively Modulates Matrix Metalloproteinase-9 Production in Alveolar Macrophages upon Toll-Like Receptor 7 Signaling and Influenza Virus Infection.
Infections
Mycobacterium indicus pranii downregulates MMP-9 and iNOS through COX-2 dependent and TNF-? independent pathway in mouse peritoneal macrophages in vitro.
Infections
Neisseria gonorrhoeae Challenge Increases Matrix Metalloproteinase-8 Expression in Fallopian Tube Explants.
Infections
Neutralization of matrix metalloproteinase-9 potentially enhances oncolytic efficacy of tanapox virus for melanoma therapy.
Infections
Pattern of matrix metalloproteinases-9, P53 and BCL-2 proteins in Egyptian patients with pulmonary Mycobacterium tuberculosis.
Infections
Plasma inflammatory and immune proteins as predictors of intra-amniotic infection and spontaneous preterm delivery in women with preterm labor: a retrospective study.
Infections
Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients.
Infections
Porphyromonas gingivalis, a periodontal pathogen, enhances myocardial vulnerability, thereby promoting post-infarct cardiac rupture.
Infections
Predictive role of nuclear factor-kappaB activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester.
Infections
Predictive value of intra-amniotic and serum markers for inflammatory lesions of preterm placenta.
Infections
Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.
Infections
Production and characterization of recombinant active mouse gelatinase B from eukaryotic cells and in vivo effects after intravenous administration.
Infections
Production of MMP-9 and inflammatory cytokines by Trypanosoma cruzi-infected macrophages.
Infections
Proteasome serves as pivotal regulator in Angiostrongylus cantonensis-induced eosinophilic meningoencephalitis.
Infections
Pulmonary matrix metalloproteinase-9 activity in mechanically ventilated children with respiratory syncytial virus.
Infections
Rat amnion type IV collagen composition and metabolism: implications for membrane breakdown.
Infections
Recognition of Streptococcus pneumoniae and muramyl dipeptide by NOD2 results in potent induction of MMP-9, which can be controlled by lipopolysaccharide stimulation.
Infections
Regulation of matrix metalloproteinase-9 (MMP-9) by translational efficiency in murine prostate carcinoma cells.
Infections
Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection.
Infections
Relationship between metalloproteinase-2 and -9 levels in plasma and vaginal secretion with preterm birth.
Infections
Relationship between MMP Expression and Virulence of Dengue Virus Type-2 in Infected Mosquito and Mammalian Cells.
Infections
Relationship between Toxoplasma gondii seropositivity and schizophrenia in the Lebanese population: potential implication of genetic polymorphism of MMP-9.
Infections
Relationship of proteinases and proteinase inhibitors with microbial presence in chronic lung disease of prematurity.
Infections
Relative expression of matrix metalloproteinase-2 and -9 in synovial fluid from healthy calves and calves with experimentally induced septic arthritis.
Infections
Respiratory syncytial virus infection induces matrix metalloproteinase-9 expression in epithelial cells.
Infections
Rhinovirus upregulates matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor expression in nasal polyp fibroblasts.
Infections
Rhinovirus-induced MMP-9 expression is dependent on Fra-1, which is modulated by formoterol and dexamethasone.
Infections
Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection.
Infections
Role of host cellular proteases in the pathogenesis of influenza and influenza-induced multiple organ failure.
Infections
Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus.
Infections
Serum IL-10, MMP-7, MMP-9 Levels in Helicobacter pylori Infection and Correlation with Degree of Gastritis.
Infections
Serum levels of matrix metalloproteinase-2, -9, and vitamin D in patients with multiple sclerosis with or without herpesvirus-6 seropositivity.
Infections
Serum levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in human herpesvirus-6-infected infants with or without febrile seizures.
Infections
Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients.
Infections
Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers.
Infections
SMAD7 regulates proinflammatory and prolabor mediators in amnion and myometrium.
Infections
SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.
Infections
Spontaneous abortion is preceded by an altered serum concentration of matrix metalloproteinases.
Infections
Staphylococcus aureus increases cytokine and matrix metalloproteinase expression in nasal mucosae of patients with chronic rhinosinusitis and nasal polyps.
Infections
Synergic and antagonistic relationship between MMP-2 and MMP-9 with fibrosis and inflammation in Chagas' cardiomyopathy.
Infections
Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
Infections
Synergistic enhancement of matrix metalloproteinase-9 expression and pro-inflammatory cytokines by influenza virus infection and oxidized-LDL treatment in human endothelial cells.
Infections
Synergistic up-regulation of epithelial cell matrix metalloproteinase-9 secretion in tuberculosis.
Infections
The effect of captopril on the expression of MMP-9 and the prognosis of neurological function in herpes simplex encephalitis mice.
Infections
The role of IL-10 in immune responses against Pseudomonas aeruginosa during acute lung infection.
Infections
Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers.
Infections
Title: role of matrix metalloproteinase -9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease.
Infections
TLR2 and AP-1/NF-kappaB are involved in the regulation of MMP-9 elicited by heat killed Listeria monocytogenes in human monocytic THP-1 cells.
Infections
Ultrastructural localization of matrix metalloproteinase-9 in eosinophils from the cerebrospinal fluid of mice with eosinophilic meningitis caused by Angiostrongylus cantonensis.
Infections
Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNF-alpha-dependent monocyte networks.
Infections
Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis.
Infections
Urinary matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 biomarkers for predicting renal scar in children with urinary tract infection.
Infections
Use of MMP-8 and MMP-9 to assess disease severity in children with viral lower respiratory tract infections.
Infections
Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats.
Infections
Zymographic analysis of latent and activated forms of matrix metalloproteinase-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to infection.
Infections
[Correlation between bacterial L-form infection, expression of HIF-1?/MMP-9 and vasculogenic mimicry in epithelial ovarian cancer].
Infections
[Expressions of matrix metalloproteinase 9 in mucosal natural killer/T cell and mature T cell lymphomas and its relation to Epstein-Barr virus infection]
Infections
[Infection with L-form of Helicobacter pylori and expressions of MIF, MMP9 and VEGF in gastric carcinoma].
Infections
[Studies on synthesis and degradation of collagen at transcription level in liver fibrosis of rabbits with schistosomiasis japonica]
Infections
[The changes of matrix metalloproteinase-9 expression in the gastric antral mucosa after Helicobacter pylori eradication: immunohistochemical study]
Infections
[Therapeutic effect of Haobieyangyinruanjianfang on the mouse liver fibrosis caused by schistosomiasis]
Infertility
A role for matrix metalloproteinase-9 in pathogenesis of urogenital Chlamydia muridarum infection in mice.
Infertility
Matrix metalloproteinase-9 increases and Interleukin-10 reduces with increase in body mass index in polycystic ovary syndrome: A cross-sectional study.
Infertility
[Effect of Qilin Pill Combined Metformin on Polycystic Ovaries Induced Infertility Patients].
Infertility
[Effect of yangjing zhongyu decoction on matrix metalloproteinase-9 expression in endometrium and sex hormone regulation in women with cryptogenic infertility]
Infertility, Male
Matrix metalloproteinase-9 is elevated and related to interleukin-17 and psychological stress in male infertility: A cross-sectional study.
Infertility, Male
MMP2, MMP9 and TIMP2 polymorphisms affect sperm parameters but not fertility in Polish males.
Inflammatory Bowel Diseases
Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
Inflammatory Bowel Diseases
Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases.
Inflammatory Bowel Diseases
Fecal calprotectin, MMP-9, and human beta-defensin-2 levels in pediatric inflammatory bowel disease.
Inflammatory Bowel Diseases
Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel Diseases.
Inflammatory Bowel Diseases
Fecal Matrix Metalloproteinase-9 Measurement for Optimizing Detection of Disease Activity in Inflammatory Bowel Disease.
Inflammatory Bowel Diseases
Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease.
Inflammatory Bowel Diseases
Mangiferin attenuates DSS colitis in mice: Molecular docking and in vivo approach.
Inflammatory Bowel Diseases
Matrix Metalloproteinase-9 (MMP-9) induced disruption of intestinal epithelial tight junction barrier is mediated by NF-?B activation.
Inflammatory Bowel Diseases
Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseases.
Inflammatory Bowel Diseases
MMP-9-induced increase in intestinal epithelial tight permeability is mediated by p38 kinase signaling pathway activation of MLCK gene.
Inflammatory Bowel Diseases
Novel Barbiturate-Nitrate Compounds Inhibit the Upregulation of Matrix Metalloproteinase-9 Gene Expression in Intestinal Inflammation through a cGMP-Mediated Pathway.
Inflammatory Bowel Diseases
Production of matrix metalloproteinase-9 in CaCO-2 cells in response to inflammatory stimuli.
Inflammatory Bowel Diseases
Role of MMP-2 and MMP-9 and their natural inhibitors in liver fibrosis, chronic pancreatitis and non-specific inflammatory bowel diseases.
Inflammatory Bowel Diseases
Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis.
Inflammatory Bowel Diseases
Synthesis and biological evaluation of curcuminoid pyrazoles as new therapeutic agents in inflammatory bowel disease: effect on matrix metalloproteinases.
Inflammatory Bowel Diseases
Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP.
Inflammatory Bowel Diseases
The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases.
Inflammatory Bowel Diseases
Toward Point-of-Care Diagnostics to Monitor MMP-9 and TNF-? Levels in Inflammatory Bowel Disease.
Inflammatory Bowel Diseases
Vascular smooth muscle cells and pericytes express MMP-1, MMP-9, TIMP-1 and type I procollagen in inflammatory bowel disease.
Influenza, Human
Clarithromycin suppresses induction of monocyte chemoattractant protein-1 and matrix metalloproteinase-9 and improves pathological changes in the lungs and heart of mice infected with influenza A virus.
Influenza, Human
Elevated serum levels of neutrophil elastase in patients with influenza virus-associated encephalopathy.
Influenza, Human
Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
Influenza, Human
INFLUENCE OF INFLUENZA A VIRUS AND BACTERIAL LIPOPOLYSACCHARIDE ON PROLIFERATION AND GENE EXPRESSION OF CYTOKINES AND OTHER CELLULAR FACTORS IN CELLS OF ESTABLISHED ENDOTHELIAL CELL LINE ECV-304.
Influenza, Human
Influenza A virus induction of oxidative stress and MMP-9 is associated with severe lung pathology in a mouse model.
Influenza, Human
Influenza A virus infection modulates the expression of type IV collagenase in epithelial cells.
Influenza, Human
Influenza A Virus Pre-Infection Exacerbates Pseudomonas aeruginosa-Mediated Lung Damage Through Increased MMP-9 Expression, Decreased Elafin Production and Tissue Resilience.
Influenza, Human
Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy.
Influenza, Human
Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection.
Influenza, Human
Mechanisms of matrix metalloproteinase-9 upregulation and tissue destruction in various organs in influenza A virus infection.
Influenza, Human
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Positively Modulates Matrix Metalloproteinase-9 Production in Alveolar Macrophages upon Toll-Like Receptor 7 Signaling and Influenza Virus Infection.
Influenza, Human
Regulation of Matrix Metalloproteinases-2 and -9 Gene Expression in Cultured Human Fetal Membrane Cells by Influenza Virus Infection.
Influenza, Human
Role of matrix metalloproteinases and their inhibitor in the development of early pulmonary fibrosis in mice infected with influenza A/H5N1 A/goose/Krasnoozerskoye/627/05 virus.
Influenza, Human
Synergistic enhancement of matrix metalloproteinase-9 expression and pro-inflammatory cytokines by influenza virus infection and oxidized-LDL treatment in human endothelial cells.
Influenza, Human
[Effects of Dureping Injection on the contents of MMP-g and TIMP-1 in the lung tissue of mice with pneumonia of influenza virus infection].
Insulin Resistance
A randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: study design and protocol.
Insulin Resistance
Association of matrix metalloproteinase 9 genotypes and cardiovascular disease risk factors with serum matrix metalloproteinase 9 concentrations in Taiwanese individuals.
Insulin Resistance
Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus.
Insulin Resistance
Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina.
Insulin Resistance
Cortisol/cortisone ratio and matrix metalloproteinase-9 activity are associated with pediatric primary hypertension.
Insulin Resistance
Do different bariatric surgical procedures influence plasma levels of matrix metalloproteinase-2, -7, and -9 among patients with type 2 diabetes mellitus?
Insulin Resistance
Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors.
Insulin Resistance
Effects of hyperinsulinemia on hepatic metalloproteinases and their tissue inhibitors.
Insulin Resistance
Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents.
Insulin Resistance
Exercise ameliorates serum MMP-9 and TIMP-2 levels in patients with type 2 diabetes.
Insulin Resistance
Ezetimibe Ameliorates Atherosclerotic and Inflammatory Markers, Atherogenic Lipid Profiles, Insulin Sensitivity, and Liver Dysfunction in Japanese Patients with Hypercholesterolemia.
Insulin Resistance
Insulin resistance determines phagocytic nicotinamide adenine dinucleotide phosphate oxidase overactivation in metabolic syndrome patients.
Insulin Resistance
Markers of remodeling in subcutaneous adipose tissue are strongly associated with overweight and insulin sensitivity in healthy non-obese men.
Insulin Resistance
Matrix metalloproteinase 9 opposes diet-induced muscle insulin resistance in mice.
Insulin Resistance
Matrix Metalloproteinase-9 Is Increased in Obese Subjects and Decreases in Response to Pioglitazone.
Insulin Resistance
Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.
Insulin Resistance
Rice bran protein hydrolysates reduce arterial stiffening, vascular remodeling and oxidative stress in rats fed a high-carbohydrate and high-fat diet.
Insulin Resistance
Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors in women with glucose intolerance in pregnancy and normal controls.
Insulin Resistance
Serum Matrix Metalloproteinase 9 and Macrophage Migration Inhibitory Factor (MIF) Are Increased in Young Healthy Nonobese Subjects with Positive Family History of Type 2 Diabetes.
Insulin Resistance
The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Insulin Resistance
The function of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in several clinical conditions: Results and analysis of our survey.
Insulin Resistance
[Effect of Qilin Pill Combined Metformin on Polycystic Ovaries Induced Infertility Patients].
Insulin Resistance
[Effect of tongmal recipe on atherosclerosis in patients with early lower extremity arteriopathy caused by type 2 diabetes mellitus]
Intellectual Disability
A normal genetic variation modulates synaptic MMP-9 protein levels and the severity of schizophrenia symptoms.
Intellectual Disability
Hypermobile Ehlers-Danlos syndrome (hEDS) phenotype in fragile X premutation carriers: case series.
Intellectual Disability
The Fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses.
Intermittent Claudication
Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity.
Intervertebral Disc Degeneration
Association between the -1562 C/T Polymorphism of Matrix Metalloproteinase-9 Gene and Lumbar Disc Disease in the Young Adult Population in North China.
Intervertebral Disc Degeneration
Degenerative disc disease of herniated intervertebral discs is associated with extracellular matrix remodeling, vimentin-positive cells and cell death.
Intervertebral Disc Degeneration
Dysregulated miR-133a Mediates Loss of Type II Collagen by Directly Targeting Matrix Metalloproteinase 9 (MMP9) in Human Intervertebral Disc Degeneration.
Intervertebral Disc Degeneration
Expressions of IL-1? and MMP-9 in degenerated lumbar disc tissues and their clinical significance.
Intervertebral Disc Degeneration
Meta-analysis of the effects of genetic polymorphisms on intervertebral disc degeneration.
Intervertebral Disc Degeneration
The role of matrix metalloproteinase 9 in intervertebral disc degeneration.
Intervertebral Disc Displacement
Analysis of cartilage oligomeric matrix protein and matrix metalloproteinase-9 in cerebrospinal fluid of miniature dachshund with intervertebral disc herniation.
Intervertebral Disc Displacement
Degenerative disc disease of herniated intervertebral discs is associated with extracellular matrix remodeling, vimentin-positive cells and cell death.
Intervertebral Disc Displacement
Evaluation of Common Variants in Matrix Metalloproteinase-9 Gene with Lumbar Disc Herniation in Han Chinese Population.
Intervertebral Disc Displacement
Matrix metalloprotease-9 activity in the cerebrospinal fluid and spinal injury severity in dogs with intervertebral disc herniation.
Intervertebral Disc Displacement
The impact of changes in serum levels of metalloproteinase-2 and metalloproteinase-9 on pain perception in patients with disc herniation before and after surgery.
Intervertebral Disc Displacement
The role of matrix metalloproteinase 9 in intervertebral disc degeneration.
Intracranial Aneurysm
A novel murine elastase saccular aneurysm model for studying bone marrow progenitor-derived cell-mediated processes in aneurysm formation.
Intracranial Aneurysm
Expression of NF-?B, MCP-1 and MMP-9 in a Cerebral Aneurysm Rabbit Model.
Intracranial Aneurysm
Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm.
Intracranial Aneurysm
Ibudilast inhibits cerebral aneurysms by down-regulating inflammation-related molecules in the vascular wall of rats.
Intracranial Aneurysm
Levels of MMP-9 in patients with intracranial aneurysm: Relation with risk factors, size and clinical presentation.
Intracranial Aneurysm
Lower miR-143/145 and higher matrix metalloproteinase-9 levels in circulation may be associated with intracranial aneurysm formation and rupture: A pilot study.
Intracranial Aneurysm
Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats.
Intracranial Aneurysm
Matrix metalloproteinase-9 coding sequence single-nucleotide polymorphisms in caucasians with intracranial aneurysms.
Intracranial Aneurysm
Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm.
Intracranial Aneurysm
Metalloproteinase-9 and neutrophil gelatinase-associated lipocalin plasma and tissue levels evaluation in middle cerebral artery aneurysms.
Intracranial Aneurysm
Site-specific elevation of interleukin-1? and matrix metalloproteinase-9 in the Willis circle by hemodynamic changes is associated with rupture in a novel rat cerebral aneurysm model.
Intracranial Aneurysm
The effect of intravascular interventional embolization and craniotomy on MMP-2, MMP-9 and caspase3 in serum of intracranial aneurysm patients.
Intracranial Aneurysm
The efficacy of microsurgery in the treatment of cerebral aneurysm rupture and its effect on NF-?B, MCP-1 and MMP-9.
Intracranial Aneurysm
The role of MMP-2 and MMP-9 polymorphisms in sporadic intracranial aneurysms.
Intracranial Arteriosclerosis
Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis.
Intracranial Arteriovenous Malformations
Relevance of IL-6 and MMP-9 to cerebral arteriovenous malformation and hemorrhage.
Intracranial Arteriovenous Malformations
Systemic expression of matrix metalloproteinase-9 in patients with cerebral arteriovenous malformations.
Intracranial Arteriovenous Malformations
[High expression level of interleukin-6 led to elevated hemorrhagic risk of cerebral arteriovenous malformations].
Intracranial Hemorrhage, Hypertensive
Relationship of plasma matrix metalloproteinase-9 and hematoma expansion in acute hypertensive cerebral hemorrhage.
Intracranial Hemorrhage, Traumatic
Delayed progression of edema formation around a hematoma expressing high levels of VEGF and mmp-9 in a patient with traumatic brain injury: case report.
Intracranial Hemorrhages
A therapeutic target of cerebral hemorrhagic stroke: matrix metalloproteinase-9.
Intracranial Hemorrhages
Association between expression of MMP-2 and MMP-9 genes and pathogenesis of intracranial hemorrhage in severe coagulation factor XIII deficiency.
Intracranial Hemorrhages
Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage.
Intracranial Hemorrhages
Combination of reactive oxygen species and tissue-type plasminogen activator enhances the induction of gelatinase B in brain endothelial cells.
Intracranial Hemorrhages
Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke.
Intracranial Hemorrhages
Expression and CpG island methylation pattern of MMP-2 and MMP-9 genes in patients with congenital factor XIII deficiency and intracranial hemorrhage.
Intracranial Hemorrhages
Extension of the thrombolytic time window with minocycline in experimental stroke.
Intracranial Hemorrhages
Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke.
Intracranial Hemorrhages
Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion.
Intracranial Hemorrhages
Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke.
Intracranial Hemorrhages
Miconazole protects blood vessels from MMP9-dependent rupture and hemorrhage.
Intracranial Hemorrhages
The rs9509 polymorphism of MMP-9 is associated with risk of hemorrhage in brain arteriovenous malformations.
Intracranial Hemorrhages
Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release.
Intracranial Hemorrhages
Tissue plasminogen activator treatment of stroke in type-1 diabetes rats.
Intracranial Hemorrhages
[Study on expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in brain tissue adjacent to hemorrhage after brain hemorrhage in human]
Iron Deficiencies
Iron deficiency activates pro-inflammatory signaling in macrophages and foam cells via the p38 MAPK-NF-kappaB pathway.
Iron Overload
Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice.
Ischemic Attack, Transient
Adoptive Regulatory T-Cell Therapy Preserves Systemic Immune Homeostasis After Cerebral Ischemia.
Ischemic Attack, Transient
Effect of Propofol Post-treatment on Blood-Brain Barrier Integrity and Cerebral Edema After Transient Cerebral Ischemia in Rats.
Ischemic Attack, Transient
Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke.
Ischemic Attack, Transient
The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.
Ischemic Stroke
A gelatin in situ-overlay technique localizes brain matrix metalloproteinase activity in experimental focal cerebral ischemia.
Ischemic Stroke
ADAMTS-13 Activity Predicts Outcome in Acute Ischaemic Stroke Patients Undergoing Endovascular Treatment.
Ischemic Stroke
An MRI Hyperintense Acute Reperfusion Marker Is Related to Elevated Peripheral Monocyte Count in Acute Ischemic Stroke.
Ischemic Stroke
Apolipoprotein A-I and Paraoxonase-1 Are Potential Blood Biomarkers for Ischemic Stroke Diagnosis.
Ischemic Stroke
Association between Increased Matrix Metalloproteinase-9 (MMP-9) Levels with Hyperglycaemia Incidence in Acute Ischemic Stroke Patients.
Ischemic Stroke
Association between Inflammatory Biomarkers and Progression of Intracranial Large Artery Stenosis after Ischemic Stroke.
Ischemic Stroke
Association Between Matrix Metalloproteinase Family Gene Polymorphisms and Ischemic Stroke: a Meta-analysis.
Ischemic Stroke
Association between microRNA binding site polymorphisms in immunoinflammatory genes and recurrence risk of ischemic stroke.
Ischemic Stroke
Association between serum matrix metalloproteinase-9 and poor prognosis in acute ischemic stroke patients: The role of dyslipidemia.
Ischemic Stroke
Association between the -1562 C/T MMP-9 polymorphism and cerebrovascular disease in a Polish population.
Ischemic Stroke
Association between the Matrix Metalloproteinase-9 rs3918242 Polymorphism and Ischemic Stroke Susceptibility: A Meta-Analysis.
Ischemic Stroke
Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
Ischemic Stroke
Association of Matrix Metalloproteinase 9 and Cellular Fibronectin and Outcome in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Ischemic Stroke
Association of Polymorphisms of the Matrix Metalloproteinase 9 Gene with Ischaemic Stroke in a Southern Chinese Population.
Ischemic Stroke
Association of the MMP-9 polymorphism and ischemic stroke risk in southern Chinese Han population.
Ischemic Stroke
Associations of Interleukin 10, Matrix Metallopeptidase 9, and Legumain with Blood Pressure Variability and Neurologic Outcomes in Patients with Ischemic Stroke.
Ischemic Stroke
Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO
Ischemic Stroke
Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome.
Ischemic Stroke
Blood biomarkers for the diagnosis and differentiation of stroke: A systematic review and meta-analysis.
Ischemic Stroke
Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.
Ischemic Stroke
Bone marrow-derived cells are the major source of MMP-9 contributing to blood-brain barrier dysfunction and infarct formation after ischemic stroke in mice.
Ischemic Stroke
CEACAM1 Inhibited I?B-?/NF-?B Signal Pathway Via Targeting MMP-9/TIMP-1 Axis in Diabetic Atherosclerosis.
Ischemic Stroke
CEACAM1: a novel adhesion molecule that regulates the secretion of matrix metalloproteinase-9 in neutrophils and protects the blood-brain barrier after ischemic stroke.
Ischemic Stroke
Changes in plasma matrix metalloproteinase-9 levels in patients with acute ischemic stroke.
Ischemic Stroke
Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients.
Ischemic Stroke
Combination treatment with U0126 and rt-PA prevents adverse effects of the delayed rt-PA treatment after acute ischemic stroke.
Ischemic Stroke
Complexity in differentiating truncated or matured forms of MMP-2 and MMP-9 by zymography in acute ischemic stroke induced rat brain tissues.
Ischemic Stroke
Connectivity map identifies luteolin as a treatment option of ischemic stroke by inhibiting MMP9 and activation of the PI3K/Akt signaling pathway.
Ischemic Stroke
Correlation between MMP-9 and extracellular cytokine HMGB1 in prediction of human ischemic stroke outcome.
Ischemic Stroke
Correlation between the -1562C/T polymorphism in the matrix metalloproteinase-9 gene and hemorrhagic transformation of ischemic stroke.
Ischemic Stroke
Curcumin prevents reperfusion injury following ischemic stroke in rats via inhibition of NF??B, ICAM-1, MMP-9 and caspase-3 expression.
Ischemic Stroke
Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke.
Ischemic Stroke
Discovery of 7-aminophenanthridin-6-one as a new scaffold for matrix metalloproteinase inhibitors with multitarget neuroprotective activity.
Ischemic Stroke
DL-3n-Butylphthalide Improves Blood-Brain Barrier Integrity in Rat After Middle Cerebral Artery Occlusion.
Ischemic Stroke
Do extracellular-matrix-regulating enzymes play a role in cervical artery dissection?
Ischemic Stroke
Dynamic change of MMP-9 in diabetic stroke visualized by optical imaging and treated with CD28 superagonist.
Ischemic Stroke
Early upregulation of matrix metalloproteinases following reperfusion triggers neuroinflammatory mediators in brain ischemia in rat.
Ischemic Stroke
Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.
Ischemic Stroke
Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model.
Ischemic Stroke
Effects of Edaravone, a Free Radical Scavenger, on Serum Levels of Inflammatory Biomarkers in Acute Brain Infarction.
Ischemic Stroke
Exploring molecular mechanism underlying Chinese medicine syndrome: A study on correlation between Chinese medicine syndrome and biomarkers for ischemic stroke.
Ischemic Stroke
Fluid-attenuated inversion recovery hyperintensity correlates with matrix metalloproteinase-9 level and hemorrhagic transformation in acute ischemic stroke.
Ischemic Stroke
Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke.
Ischemic Stroke
Genetic Deletion or Pharmacological Inhibition of Cyclooxygenase-2 Reduces Blood-Brain Barrier Damage in Experimental Ischemic Stroke.
Ischemic Stroke
High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia.
Ischemic Stroke
Human cerebral microvessel endothelial cell culture as a model system to study the blood-brain interface in ischemic/hypoxic conditions.
Ischemic Stroke
Hypoxia Response Element-Regulated MMP-9 Promotes Neurological Recovery via Glial Scar Degradation and Angiogenesis in Delayed Stroke.
Ischemic Stroke
Hypoxia-controlled matrix metalloproteinase-9 hyperexpression promotes behavioral recovery after ischemia.
Ischemic Stroke
Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke.
Ischemic Stroke
Inflammatory marker expression and its implication in Korean ischemic stroke patients.
Ischemic Stroke
Influence of the Matrix Metalloproteinase 9 Gene rs3918242 Polymorphism on Development of Ischemic Stroke: a Meta-analysis.
Ischemic Stroke
Intraarterial administration of norcantharidin attenuates ischemic stroke damage in rodents when given at the time of reperfusion: novel uses of endovascular capabilities.
Ischemic Stroke
Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound.
Ischemic Stroke
Involvement of Matrix Metalloproteinase 9 in Vertebral Arterial Dissection With Posterior Circulation Ischemic Stroke.
Ischemic Stroke
Limited clinical value of multiple blood markers in the diagnosis of ischemic stroke.
Ischemic Stroke
Matrix metallopeptidase 9 and placental growth factor may correlate with collateral status based on whole-brain perfusion combined with multiphase computed tomography angiography.
Ischemic Stroke
Matrix Metalloproteinase-9 and Monocyte Chemoattractant Protein-1 Are Associated With Collateral Status in Acute Ischemic Stroke With Large Vessel Occlusion.
Ischemic Stroke
Matrix Metalloproteinase-9 as a Marker for Acute Ischemic Stroke: A Systematic Review.
Ischemic Stroke
Matrix metalloproteinase-9 as a messenger in the crosstalk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review.
Ischemic Stroke
Matrix metalloproteinase-9 contributes to the increase of tau protein in serum during acute ischemic stroke.
Ischemic Stroke
Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke.
Ischemic Stroke
Matrix metalloproteinase-9 gene polymorphisms are associated with ischemic stroke severity and early neurologic deterioration in patients with atrial fibrillation.
Ischemic Stroke
Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke.
Ischemic Stroke
Matrix Metalloproteinase-9 Relationship With Infarct Growth and Hemorrhagic Transformation in the Era of Thrombectomy.
Ischemic Stroke
Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats.
Ischemic Stroke
Melatonin inhibits postischemic matrix metalloproteinase-9 (MMP-9) activation via dual modulation of plasminogen/plasmin system and endogenous MMP inhibitor in mice subjected to transient focal cerebral ischemia.
Ischemic Stroke
MicroRNA-132 attenuates cerebral injury by protecting blood-brain-barrier in MCAO mice.
Ischemic Stroke
MicroRNA-212 promotes the recovery function and vascular regeneration of endothelial progenitor cells in mice with ischemic stroke through inactivation of the notch signaling pathway via downregulating MMP9 expression.
Ischemic Stroke
MMP-9 and/or TIMP as predictors of ischaemic stroke in patients with symptomatic and asymptomatic atherosclerotic stenosis of carotid artery treated by stenting or endarterectomy - A review.
Ischemic Stroke
MMP-9 gene rs3918242 polymorphism increases risk of stroke: A meta-analysis.
Ischemic Stroke
MMP-9, Vertebrobasilar Ectasia and Vertebral Artery Dominance in Vertigo or Dizziness Patients With Vascular Risk Factors.
Ischemic Stroke
Multiple biomarkers covering several pathways for the prediction of depression after ischemic stroke.
Ischemic Stroke
Multiple biomarkers covering several pathways improve predictive ability for cognitive impairment among ischemic stroke patients with elevated blood pressure.
Ischemic Stroke
Neuroprotection from Tissue Inhibitor of Metalloproteinase-1 and its nanoparticles.
Ischemic Stroke
Neuroprotective effect of bicyclol in rat ischemic stroke: Down-regulates TLR4, TLR9, TRAF6, NF-?B, MMP-9 and up-regulates claudin-5 expression.
Ischemic Stroke
New insights into mechanism for the effect of resveratrol preconditioning against cerebral ischemic stroke: Possible role of matrix metalloprotease-9.
Ischemic Stroke
Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke.
Ischemic Stroke
Normobaric hyperoxia protects the blood brain barrier through inhibiting Nox2 containing NADPH oxidase in ischemic stroke.
Ischemic Stroke
Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study.
Ischemic Stroke
Predictive value of plasma matrix metalloproteinase-9 concentrations for spontaneous haemorrhagic transformation in patients with acute ischaemic stroke: A cohort study in Chinese patients.
Ischemic Stroke
Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies.
Ischemic Stroke
Prognostic Metrics Associated with Inflammation and Atherosclerosis Signaling Evaluate the Burden of Adverse Clinical Outcomes in Ischemic Stroke Patients.
Ischemic Stroke
Protective effect of ginsenoside Rb1 on integrity of blood-brain barrier following cerebral ischemia.
Ischemic Stroke
Protective effect of naringenin in experimental ischemic stroke: down-regulated NOD2, RIP2, NF-?B, MMP-9 and up-regulated claudin-5 expression.
Ischemic Stroke
Protective effect of shikonin in experimental ischemic stroke: attenuated TLR4, p-p38MAPK, NF-?B, TNF-? and MMP-9 expression, up-regulated claudin-5 expression, ameliorated BBB permeability.
Ischemic Stroke
Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke.
Ischemic Stroke
Relationship between matrix metalloproteinase-9 and common carotid artery intima media thickness.
Ischemic Stroke
Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke.
Ischemic Stroke
Relationship between the matrix metalloproteinase-9 gene polymorphisms and ischemic stroke.
Ischemic Stroke
Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice.
Ischemic Stroke
Rutin improves functional outcome via reducing the elevated matrix metalloproteinase-9 level in a photothrombotic focal ischemic model of rats.
Ischemic Stroke
Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.
Ischemic Stroke
Serum Matrix Metalloproteinase-9 and Cognitive Impairment After Acute Ischemic Stroke.
Ischemic Stroke
Serum Matrix Metalloproteinase-9 Is Associated With Depression After Acute Ischemic Stroke.
Ischemic Stroke
Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke.
Ischemic Stroke
Simvastatin pretreatment ameliorates t-PA-induced hemorrhage transformation and MMP-9/TIMP-1 imbalance in thromboembolic cerebral ischemic rats.
Ischemic Stroke
Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage.
Ischemic Stroke
Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice.
Ischemic Stroke
SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells.
Ischemic Stroke
Systematic studies on the in vivo substance basis and the pharmacological mechanism of Acanthopanax Senticosus Harms leaves by UPLC-Q-TOF-MS coupled with a target-network method.
Ischemic Stroke
The Accuracy of Serum Matrix Metalloproteinase-9 for Predicting Hemorrhagic Transformation After Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Ischemic Stroke
The Alteration of Plasma Matrix Metalloproteinase-9 Level after the Addition of Bromelin 500 mg to Standard Therapy of Acute Ischemic Stroke and Its Correlation with Outcome.
Ischemic Stroke
The effects of memantine on the serum concentrations of matrix metalloproteinases and neurologic function of patients with ischemic stroke.
Ischemic Stroke
The effects of previous statin treatment on plasma matrix metalloproteinase-9 level in chinese stroke patients undergoing thrombolysis.
Ischemic Stroke
The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke.
Ischemic Stroke
The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.
Ischemic Stroke
Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release.
Ischemic Stroke
Variants in matrix metalloproteinase-9 gene are associated with hemorrhagic transformation in acute ischemic stroke patients with atherothrombosis, small artery disease, and cardioembolic stroke.
Ischemic Stroke
[An effect of perindopril on the level of tumor necrosis factor-alpha and matrix metalloproteinase-9 in peripheral blood in the acute period of atherothrombotic ischemic stroke and myocardial infarction]
Ischemic Stroke
[Study on relationship between constitution and syndrome of MMP-9, IL-6 and MTHFR gene in patients with ischemic stroke].
Ischemic Stroke
[The effects of combination anti-inflammatory and anti-oxidation drugs in acute stroke.]
Jaw Cysts
Identification and characterization of gelatinases/type IV collagenases in jaw cysts.
Jaw Cysts
Interleukin-1alpha-dependent regulation of matrix metalloproteinase-9(MMP-9) secretion and activation in the epithelial cells of odontogenic jaw cysts.
Joint Diseases
Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
Joint Diseases
Expression of matrix metalloproteinase-9 (gelatinase B) in gouty arthritis and stimulation of MMP-9 by urate crystals in macrophages.
Joint Diseases
Gelatinase B in chronic synovitis: immunolocalization with a monoclonal antibody.
Joint Diseases
Increased matrix metalloproteinases as possible cause of osseoarticular tissue destruction in long-term haemodialysis and beta 2-microglobulin amyloidosis.
Joint Diseases
Inhibitory effects of sodium pentosan polysulfate on formation and function of osteoclasts derived from canine bone marrow.
Joint Diseases
Matrix metalloproteinase, vitamin A and methylprednisolone effects on experimentally induced amyloid arthropathy.
Joint Diseases
Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade.
Joint Diseases
The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis.
Keloid
Growth Differentiation Factor-9 Promotes Fibroblast Proliferation and Migration in Keloids through the Smad2/3 Pathway.
Keloid
Localization of MMP-9 in multinuclear giant cells in keloids after treatment with 5-fluorouracil with or without combination of cryotherapy and cryotherapy alone.
Keloid
Thalidomide inhibits fibronectin production in TGF-ß1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway.
Keloid
Tissue-remodelling M2 Macrophages Recruits Matrix Metallo-proteinase-9 for Cryotherapy-induced Fibrotic Resolution during Keloid Treatment.
Keratitis
Bilateral Increase of the Matrix Metalloproteinase-9 Expression in Tears After the Unilateral Decrease of Corneal Sensitivity.
Keratitis
Biofilm microenvironment activated supramolecular nanoparticles for enhanced photodynamic therapy of bacterial keratitis.
Keratitis
Constitutively active NF-kappaB triggers systemic TNFalpha-dependent inflammation and localized TNFalpha-independent inflammatory disease.
Keratitis
Corneal Cross-Linking Has No Effect on Matrix Metalloproteinase 9 and 13 Levels During Fungal Keratitis on the Early Stage.
Keratitis
Evaluation of matrix metalloproteinase concentrations in precorneal tear film from dogs with Pseudomonas aeruginosa-associated keratitis.
Keratitis
Expression of matrix metalloproteinases 2 and 9 in experimental corneal injury and fungal keratitis.
Keratitis
Expression of matrix metalloproteinases during experimental Candida albicans keratitis.
Keratitis
Immunohistochemical study of matrix metalloproteinases-2 and -9, macrophage inflammatory protein-2 and tissue inhibitors of matrix metalloproteinases-1 and -2 in normal, purulonecrotic and fungal infected equine corneas.
Keratitis
Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
Keratitis
Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.
Keratitis
Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis.
Keratitis
Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus.
Keratitis
Tissue Inhibitor of Metalloproteinase (TIMP) Peptidomimetic as an Adjunctive Therapy for Infectious Keratitis.
Keratitis
[The roles of gelatinases in pathological changes of fungal keratitis in experimental rabbits]
Keratitis, Herpetic
Active form of gelatinases in tear fluidin patients with corneal ulcer or ocular burn.
Keratitis, Herpetic
In vivo kinetics of GITR and GITR ligand expression and their functional significance in regulating viral immunopathology.
Keratitis, Herpetic
[Amniotic membrane transplantation improves experimental herpetic keratitis. Modulation of matrix metalloproteinase-9]
Keratoacanthoma
Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9.
Keratoacanthoma
Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas.
Keratoconjunctivitis
Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome.
Keratoconjunctivitis
Metalloproteinases in canine experimental traumatic keratoconjunctivitis.
Keratoconjunctivitis Sicca
Constitutively active NF-kappaB triggers systemic TNFalpha-dependent inflammation and localized TNFalpha-independent inflammatory disease.
Keratoconus
A NEW APPROACH TO KERATOCONUS DIAGNOSTICS USING MATRIX METALLOPROTEINASE-9 MARKER.
Keratoconus
Altered gelatinolytic activities in an apparent unilateral keratoconus patient. A case report.
Keratoconus
Changes in tear biomarker levels in keratoconus after corneal collagen crosslinking.
Keratoconus
Correlation between the COL4A3, MMP-9, and TIMP-1 polymorphisms and risk of keratoconus.
Keratoconus
Elevated expression of matrix metalloproteinase-9 and inflammatory cytokines in keratoconus patients is inhibited by cyclosporine A.
Keratoconus
Keratoconus Progression in Patients With Allergy and Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test.
Keratoconus
Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis.
Keratoconus
Relationship between tear eotaxin-2 and MMP-9 with ocular allergy and corneal topography in keratoconus patients.
Keratoconus
The expression of human corneal MMP-2, MMP-9, proMMP-13 and TIMP-1 in bullous keratopathy and keratoconus.
Keratosis
Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions.
Keratosis, Actinic
Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
Keratosis, Actinic
[Immunohistochemical study of the specific features of expression of matrix metalloproteinases 1, 9 in the photoaged skin, the foci of actinic keratosis and basal cell carcinoma].
Kidney Diseases
Exploration of association of 1,25-OH2D3 with augmentation index, a composite measure of arterial stiffness.
Kidney Failure, Chronic
25-hydroxyvitamin D concentration is inversely associated with serum MMP-9 in a cross-sectional study of African American ESRD patients.
Kidney Failure, Chronic
Are there any new reliable markers to detect renal injury in obese children?
Kidney Failure, Chronic
Association of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 With Endothelial Dysfunction, Cardiovascular Disease Risk Factors and thrombotic events in Children With End-stage Renal Disease.
Kidney Failure, Chronic
Cubilin Single Nucleotide Polymorphism Variants are Associated with Macroangiopathy While a Matrix Metalloproteinase-9 Single Nucleotide Polymorphism Flip-Flop may Indicate Susceptibility of Diabetic Nephropathy in Type-2 Diabetic Patients.
Kidney Failure, Chronic
Evaluation of genetic variation and association in the matrix metalloproteinase 9 (MMP9) gene in ESRD patients.
Kidney Failure, Chronic
Metalloproteinase-9 mRNA expression in monocytes from patients with chronic renal failure.
Kidney Failure, Chronic
Protective effect of exogenous matrix metalloproteinase-9 on chronic renal failure.
Kidney Failure, Chronic
Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality.
Kidney Failure, Chronic
Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
Kidney Failure, Chronic
Serum Resistin, Adenylate Cyclase-Associated Protein 1 Gene Expression, and Carotid Intima-Media Thickness in Patients with End-Stage Renal Disease and Healthy Controls.
Kidney Neoplasms
Anticancer effect of lysine, proline, arginine, ascorbic acid and green tea extract on human renal adenocarcinoma line 786-0.
Kidney Neoplasms
Influence of osteopontin short hairpin RNA on the proliferation and invasion of human renal cancer cells.
Kidney Neoplasms
Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression.
Kidney Neoplasms
MTA2 as a Potential Biomarker and Its Involvement in Metastatic Progression of Human Renal Cancer by miR-133b Targeting MMP-9.
Kidney Neoplasms
[mRNA expression analysis of metastatic markers in clear-cell renal cell carcinoma]
Klatskin Tumor
Down-regulation of Gab1 inhibits cell proliferation and migration in hilar cholangiocarcinoma.
Klatskin Tumor
Expression of RECK gene and MMP-9 in hilar cholangiocarcinoma and its clinical significance.
Klatskin Tumor
High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinoma.
Klatskin Tumor
Relationship between serum MMP-9 level and prognosis after radical resection for Hilar cholangiocarcinoma patients.
Krukenberg Tumor
Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor.
Labyrinth Diseases
The Balance of Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Autoimmune Inner Ear Disease Patients.
Lacrimal Duct Obstruction
Matrix Metalloproteinase-9 Point-of-Care Immunoassay after Dacryocystorhinostomy in Patients with Nasolacrimal Duct Obstruction.
Laryngeal Neoplasms
Activity of matrix metalloproteinases-2 and -9 in advanced laryngeal cancer.
Laryngeal Neoplasms
Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma.
Laryngeal Neoplasms
Expression of matrix metalloproteinase-9 (MMP-9) and blood vessel density in laryngeal squamous cell carcinomas.
Laryngeal Neoplasms
Inhibition of laryngeal cancer cell invasion and growth with lentiviral-vector delivered short hairpin RNA targeting human MMP-9 gene.
Laryngeal Neoplasms
Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma.
Laryngeal Neoplasms
NOB1 silencing inhibits the growth and metastasis of laryngeal cancer cells through the regulation of JNK signaling pathway.
Laryngeal Neoplasms
Pituitary tumor-transforming 1 expression in laryngeal cancer and its association with prognosis.
Laryngeal Neoplasms
[The experimental investigation of laryngeal cancer growth in vive by recombinant lentivirus of small interference RNA (siRNA) targeting MMP-9]
Laryngeal Neoplasms
[The experimental investigation of the invasion and growth of laryngeal cancer by matrix metalloproteinase-2 and matrix metalloproteinase-9 gene silence together]
Laryngitis
[Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance]
Leg Ulcer
Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
Leg Ulcer
Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers.
Leg Ulcer
The direct inhibition of MMP-2 and MMP-9 by an enzyme alginogel: a possible mechanism of healing support for venous leg ulcers.
Leg Ulcer
Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9.
Leiomyoma
Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium.
Leiomyoma
Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression.
Leiomyoma
Expression of vascular endothelial factor-A, gelatinases (MMP-2, MMP-9) and TIMP-1 in uterine leiomyomas.
Leiomyoma
Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
Leiomyoma
MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma.
Leiomyoma
Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells.
Leiomyoma
Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp.
Leiomyoma
[Expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in ectopic and eutopic endometrium]
Leiomyoma
[Role of single-nucleotide polymorphism C-1562? of the matrix metaloprote?naza-9 gene in the development of leiomyoma in women with cervical pathology].
Leiomyosarcoma
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines.
Leishmaniasis
Canine cerebral leishmaniasis: Potential role of matrix metalloproteinase-2 in the development of neurological disease.
Leishmaniasis
Levels of Matrix Metalloproteinase-2 and -9 in the Cerebrospinal Fluid of Dogs with Visceral Leishmaniasis.
Leishmaniasis
MMP-9 activity is induced by Leishmania braziliensis infection and correlates with mucosal leishmaniasis.
Leishmaniasis, Cutaneous
Matrix metalloproteinase 9 production by monocytes is enhanced by TNF and participates in the pathology of human cutaneous Leishmaniasis.
Leishmaniasis, Visceral
115kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-? induced down-regulation of TNF-? mediated MMP-9 activity.
Leishmaniasis, Visceral
Canine cerebral leishmaniasis: Potential role of matrix metalloproteinase-2 in the development of neurological disease.
Leishmaniasis, Visceral
Expression of matrix metalloproteinase-2 and metalloproteinase-9 in the skin of dogs with visceral leishmaniasis.
Leishmaniasis, Visceral
High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis.
Lentivirus Infections
LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p/PPP2R2A axis.
Lentivirus Infections
Potential suppression of the high glucose and insulin-induced retinal neovascularization by Sirtuin 3 in the human retinal endothelial cells.
Leprosy
Expression of metalloproteinases (MMP-2, MMP-9, and TACE) and TNF-alpha in the nerves of leprosy patients.
Leprosy
High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions.
Leptospirosis
Leptospira interrogans interaction with human proteolytic systems enhances dissemination through endothelial cells and protease levels.
Leukemia
A novel small-form NEDD4 regulates cell invasiveness and apoptosis to promote tumor metastasis.
Leukemia
A possible role of 92 kDa type IV collagenase in the extramedullary tumor formation in leukemia.
Leukemia
Amsacrine suppresses matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in human leukemia cells.
Leukemia
Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-alpha (TNF-alpha) in NB4 leukemic cells: specific involvement of TNF receptor type 1.
Leukemia
Bone marrow niche-derived extracellular matrix-degrading enzymes influence the progression of B-cell acute lymphoblastic leukemia.
Leukemia
Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca(2+)/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway.
Leukemia
Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features.
Leukemia
CIL-102 induces matrix metalloproteinase-2 (MMP-2)/MMP-9 down-regulation via simultaneous suppression of genetic transcription and mRNA stability.
Leukemia
Contribution of Matrix Metalloproteinase-9 rs3918242 Genotypes to Childhood Leukemia Risk.
Leukemia
Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices.
Leukemia
Early Diagnosis of Delayed Cerebral Ischemia: Possible Relevance for Inflammatory Biomarkers in Routine Clinical Practice?
Leukemia
Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.
Leukemia
Effects of para-nonylphenol on 92 kDa gelatinase secretion by human peripheral lymphocytes and U937 cells in vitro.
Leukemia
Epigallocatechin-3-gallate Inhibits Tax-dependent Activation of Nuclear Factor Kappa B and of Matrix Metalloproteinase 9 in Human T-cell Lymphotropic Virus-1 Positive Leukemia Cells.
Leukemia
Expression and survival significance of B-cell-specific Moloney murine leukemia virus integration site 1 and matrix metalloproteinase-9 in non-small-cell lung cancer.
Leukemia
Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement.
Leukemia
Gallic acid downregulates matrix metalloproteinase-2 (MMP-2) and MMP-9 in human leukemia cells with expressed Bcr/Abl.
Leukemia
Glycogen synthase kinase 3? inhibition reduces mitochondrial oxidative stress in chronic myocardial ischemia.
Leukemia
High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis.
Leukemia
HL-60 leukemia cells produce an autocatalytically truncated form of matrix metalloproteinase-9 with impaired sensitivity to inhibition by tissue inhibitors of metalloproteinases.
Leukemia
Infiltrative capacity of T leukemia cell lines: a distinct functional property coupled to expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1).
Leukemia
Inhibition of matrix metalloproteinases expression in human dental pulp cells by all-trans retinoic acid.
Leukemia
Modulation of autocrine TNF-alpha-stimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells.
Leukemia
Morus alba Stem Extract Suppresses Matrix Metalloproteinases (MMP)-1, MMP-9, and Tissue Inhibitors of Metalloproteinase (TIMP)-1 Expression via Inhibition of I?B? Degradation Induced by Porphyromonas gingivalis LPS Signal in THP-1 Cells.
Leukemia
NF?B- and AP-1-mediated DNA looping regulates matrix metalloproteinase-9 transcription in TNF-?-treated human leukemia U937 cells.
Leukemia
Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach.
Leukemia
Optofluidic Platform for Real-Time Monitoring of Live Cell Secretory Activities Using Fano Resonance in Gold Nanoslits.
Leukemia
Ornithine decarboxylase interferes with macrophage-like differentiation and matrix metalloproteinase-9 expression by tumor necrosis factor alpha via NF-kappaB.
Leukemia
Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
Leukemia
Procyanidin oligomers from Japanese quince (Chaenomeles japonica) fruit inhibit activity of MMP-2 and MMP-9 metalloproteinases.
Leukemia
Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells.
Leukemia
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Leukemia
Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion.
Leukemia
Regulation of gelatinase B in human monocytic and endothelial cells by PECAM-1 ligation and its modulation by interferon-beta.
Leukemia
Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells.
Leukemia
Role of intrauterine administration of transfected peripheral blood mononuclear cells by GM-CSF on embryo implantation and pregnancy rate in mice.
Leukemia
Role of sialic acid-containing glycans of matrix metalloproteinase-9 (MMP-9) in the interaction between MMP-9 and staphylococcal superantigen-like protein 5.
Leukemia
Simvastatin induces NF?B/p65 down-regulation and JNK1/c-Jun/ATF-2 activation, leading to matrix metalloproteinase-9 (MMP-9) but not MMP-2 down-regulation in human leukemia cells.
Leukemia
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.
Leukemia
The prognostic significance of serum and cerebrospinal fluid MMP-9, CCL2 and sVCAM-1 in leukemia CNS metastasis.
Leukemia
Tumor necrosis factor alpha and lymphotoxin stimulate human myeloblastic leukemia cell (ML-1) invasion through a reconstituted basement membrane (Matrigel) with concomitant induction of 92 kDa gelatinase secretion.
Leukemia
[Acetyl-11-keto-beta-boswellic acid and arsenic trioxide regulate the productions and activities of matrix metalloproteinases in human skin fibroblasts and human leukemia cell line THP-1].
Leukemia
[Effect of SHIP-1 on Invasion, Migration and PI3K-AKT Signaling Pathway of Leukemic Cells].
Leukemia
[Expression of gelatinase A and B in cord blood CD34+ cells and leukemic cell lines]
Leukemia
[Expression of nuclear factor-kappaB in bone marrow cells from patients with acute leukemia and its relationship with P21, MMP-2 and MMP-9]
Leukemia
[High tumorigenicity of human acute monocytic leukemic cell Line SHI-1 in nude mice and its mechanism]
Leukemia
[Inhibition effect of short hairpin RNA on VEGF receptor flt-1 gene expression in leukemia cell line k562]
Leukemia, Erythroblastic, Acute
[Regulation of Ruxolitinib on matrix metalloproteinase in JAK2V617F positive myeloroliferative neoplasms cells].
Leukemia, Lymphocytic, Chronic, B-Cell
A 17-residue Sequence from the Matrix Metalloproteinase-9 (MMP-9) Hemopexin Domain Binds ?4?1 Integrin and Inhibits MMP-9-induced Functions in Chronic Lymphocytic Leukemia B Cells.
Leukemia, Lymphocytic, Chronic, B-Cell
A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells.
Leukemia, Lymphocytic, Chronic, B-Cell
CD38 signals up-regulate expression and functions of matrix metalloproteinase-9 in chronic lymphocytic leukemia cells.
Leukemia, Lymphocytic, Chronic, B-Cell
Comparative effects of interferon-gamma and all- trans retinoic acid on secreted and surface-associated matrix metalloproteinase-9 expression of human monocytes.
Leukemia, Lymphocytic, Chronic, B-Cell
Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9.
Leukemia, Lymphocytic, Chronic, B-Cell
Matrix metalloproteinase-9 induces a pro-angiogenic profile in chronic lymphocytic leukemia cells.
Leukemia, Lymphocytic, Chronic, B-Cell
Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide.
Leukemia, Lymphocytic, Chronic, B-Cell
Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration.
Leukemia, Lymphocytic, Chronic, B-Cell
Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain.
Leukemia, Lymphocytic, Chronic, B-Cell
MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest.
Leukemia, Lymphocytic, Chronic, B-Cell
MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration.
Leukemia, Lymphocytic, Chronic, B-Cell
Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP-9) and tumour protein 73 (TP73) interact with Epstein Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph.
Leukemia, Lymphocytic, Chronic, B-Cell
VEGF/VEGFR2 interaction down-regulates matrix metalloproteinase-9 via STAT1 activation and inhibits B chronic lymphocytic leukemia cell migration.
Leukemia, Lymphoid
Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia.
Leukemia, Monocytic, Acute
Optofluidic Platform for Real-Time Monitoring of Live Cell Secretory Activities Using Fano Resonance in Gold Nanoslits.
Leukemia, Monocytic, Acute
[Acetyl-11-keto-beta-boswellic acid and arsenic trioxide regulate the productions and activities of matrix metalloproteinases in human skin fibroblasts and human leukemia cell line THP-1].
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Clinical implications of angiogenic factors in patients with acute or chronic leukemia: Hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cells.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Matrix metalloproteinase-9 was involved in the immuno-modulatory defect of mesenchymal stem cell from chronic myeloid leukemia patients.
Leukemia, Myeloid
Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3.
Leukemia, Myeloid
Culture of K562 human myeloid leukemia cells in presence of fibronectin expresses and secretes MMP-9 in serum-free culture medium.
Leukemia, Myeloid
Fibronectin-mediated cell adhesion is required for induction of 92-kDa type IV collagenase/gelatinase (MMP-9) gene expression during macrophage differentiation. The signaling role of protein kinase C-beta.
Leukemia, Myeloid
Hemoglobin induces the production and release of matrix metalloproteinase-9 from human malignant cells.
Leukemia, Myeloid
IL-18 increases invasiveness of HL-60 myeloid leukemia cells: up-regulation of matrix metalloproteinases-9 (MMP-9) expression.
Leukemia, Myeloid
Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg.
Leukemia, Myeloid
Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
Leukemia, Myeloid, Acute
Blockade of CD82 by a monoclonal antibody potentiates anti-leukemia effects of AraC in vivo.
Leukemia, Myeloid, Acute
Clinical implications of angiogenic factors in patients with acute or chronic leukemia: Hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia.
Leukemia, Myeloid, Acute
Effects of azacitidine on matrix metalloproteinase-9 in acute myeloid leukemia and myelodysplasia.
Leukemia, Myeloid, Acute
Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells.
Leukemia, Myeloid, Acute
Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion.
Leukemia, Myeloid, Acute
[Activity of matrix metalloproteinases MMP-2 and MMP-9 in bone marrow plasma of patients with acute myeloid leukemia].
Leukemia, Myeloid, Acute
[Matrix metalloproteinase-9 in plasma of bone marrow aspirates of patients with acute myeloid leukemia and myelodysplastic syndrome].
Leukemia, Myeloid, Acute
[Relationship between VEGF and MMP-2, MMP-9 in 82 Patients with Acute Myeloid Leukemia.]
Leukemia, Promyelocytic, Acute
Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-alpha (TNF-alpha) in NB4 leukemic cells: specific involvement of TNF receptor type 1.
Leukemia, T-Cell
Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness.
Leukemia, T-Cell
Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice.
Leukemia-Lymphoma, Adult T-Cell
Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness.
Leukocytosis
Cerebrospinal fluid u-plasminogen activator and matrix metalloproteinase-9 levels in human eosinophilic meningitis associated with angiostrongyliasis.
Leukocytosis
Effects of Toll-like receptor 2 agonist Pam(3)CysSK(4) on inflammation and brain damage in experimental pneumococcal meningitis.
Leukocytosis
Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis.
Leukocytosis
Neutrophil gelatinase B and chemokines in leukocytosis and stem cell mobilization.
Leukocytosis
New insights in the regulation of leukocytosis and the role played by leukocytes in septic shock.
Leukocytosis
Production and characterization of recombinant active mouse gelatinase B from eukaryotic cells and in vivo effects after intravenous administration.
Leukoencephalopathies
Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy.
Leukoencephalopathy, Progressive Multifocal
Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy.
Leukopenia
Production and characterization of recombinant active mouse gelatinase B from eukaryotic cells and in vivo effects after intravenous administration.
Leukoplakia
Expression of matrix metalloproteinase-9 in oral potentially malignant disorders: A systematic review.
Leukoplakia
Matrix metalloproteinase-2 matrix metalloproteinase-9 and inducible nitric oxide synthase in oral leukoplakia: immunohistochemistry and RT-PCR analysis.
Leukoplakia, Oral
Immunohistochemical analysis of neutrophils, interleukin-17, matrix metalloproteinase-9, and neoformed vessels in oral squamous cell carcinoma.
Leukoplakia, Oral
Matrix metalloproteinase-2 matrix metalloproteinase-9 and inducible nitric oxide synthase in oral leukoplakia: immunohistochemistry and RT-PCR analysis.
Lichen Planus
Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Lichen Planus, Oral
CD4+CD25+ T regulatory cells and MMP-9 as diagnostic salivary biomarkers in oral lichen planus.
Lichen Planus, Oral
Effect of a structured plaque control on MMP-1 and MMP-9 crevicular levels in patients with desquamative gingivitis associated with oral lichen planus.
Lichen Planus, Oral
Expression of matrix metalloproteinase 9 in patients with oral lichen planus.
Lichen Planus, Oral
Expression of matrix metalloproteinase-9 in oral potentially malignant disorders: A systematic review.
Lichen Planus, Oral
MMP-1, MMP-9, and TIMP-1 levels in oral lichen planus patients with gingivitis or periodontitis.
Lichen Planus, Oral
MMPs, TIMP-2, and TGF-beta1 in the cancerization of oral lichen planus.
Lichen Planus, Oral
[Effect of hypoxia on the proliferation and expressions of hypoxia-inducible factor-1?, vascular endothelial growth factor and matrix metalloproteinase-9 in keratinocytes obtained from oral lichen planus lesions].
Lichen Sclerosus et Atrophicus
The molecular basis of lipoid proteinosis: mutations in extracellular matrix protein 1.
Limbic Encephalitis
Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in non-herpetic acute limbic encephalitis.
Liposarcoma
In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
Liposarcoma
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines.
Listeriosis
Matrix metalloproteinase expression in sheep with listerial meningoencephalitis.
Liver Cirrhosis
A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen.
Liver Cirrhosis
Activity of MMP-2, MMP-8 and MMP-9 in serum as a marker of progression of alcoholic liver disease in people from Lublin Region, eastern Poland.
Liver Cirrhosis
Administration of fibroblast growth factor 2 in combination with bone marrow transplantation synergistically improves carbon-tetrachloride-induced liver fibrosis in mice.
Liver Cirrhosis
Advanced therapies using autologous bone marrow cells for chronic liver disease.
Liver Cirrhosis
Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Liver Cirrhosis
Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases.
Liver Cirrhosis
Characterization of metalloproteinases, oxidative status and inflammation levels in the different stages of fibrosis in HCV patients.
Liver Cirrhosis
Deficiency of inducible nitric oxide synthase exacerbates hepatic fibrosis in mice fed high-fat diet.
Liver Cirrhosis
Development of cell therapy using autologous bone marrow cells for liver cirrhosis.
Liver Cirrhosis
Differences in circulating MMP-9 levels with regard to viral load and AST:ALT ratio between chronic hepatitis B and C patients.
Liver Cirrhosis
Disruption of tissue-type plasminogen activator gene in mice aggravated liver fibrosis.
Liver Cirrhosis
Fraxinus rhynchophylla ethanol extract attenuates carbon tetrachloride-induced liver fibrosis in rats via down-regulating the expressions of uPA, MMP-2, MMP-9 and TIMP-1.
Liver Cirrhosis
Growth Arrest-Specific Transcript 5 (GAS5) Exerts Important Roles on the Treatment of BM45 Cells of Liver Cirrhosis.
Liver Cirrhosis
Heparanase expression during normal liver development and following partial hepatectomy.
Liver Cirrhosis
HIF-1 ? as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats.
Liver Cirrhosis
Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF-alpha-stimulated human hepatic stellate cells.
Liver Cirrhosis
Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow.
Liver Cirrhosis
Increased urinary lipocalin-2 reflects matrix metalloproteinase-9 activity in chronic hepatitis C with hepatic fibrosis.
Liver Cirrhosis
Kupffer-derived matrix metalloproteinase-9 contributes to liver fibrosis resolution.
Liver Cirrhosis
Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients.
Liver Cirrhosis
Matrix Metalloproteinase-13 Promotes Recovery from Experimental Liver Cirrhosis in Rats.
Liver Cirrhosis
Matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 in plasma of patients co-infected with HCV and HIV.
Liver Cirrhosis
Matrix metalloproteinases and their tissue inhibitors in children with chronic hepatitis B treated with lamivudine.
Liver Cirrhosis
Mechanism and Efficacy of Mobilization of Granulocyte Colony-Stimulating Factor in the Treatment of Chronic Hepatic Failure.
Liver Cirrhosis
MMP mediated degradation of type VI collagen is highly associated with liver fibrosis--identification and validation of a novel biochemical marker assay.
Liver Cirrhosis
Molecular mechanism of miR-154 targeting MMP-9 by regulating Wnt/?-catenin pathway in liver fibrosis.
Liver Cirrhosis
Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression.
Liver Cirrhosis
Novel findings for the development of drug therapy for various liver diseases:current state and future prospects for our liver regeneration therapy using autologous bone marrow cells for decompensated liver cirrhosis patients.
Liver Cirrhosis
OK-432 treatment increases matrix metalloproteinase-9 production and improves dimethylnitrosamine-induced liver cirrhosis in rats.
Liver Cirrhosis
Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model.
Liver Cirrhosis
Pigment epithelium-derived factor and matrix metalloproteinase-9 in liver cirrhosis.
Liver Cirrhosis
Plasma levels of matrix metalloproteinase-2 and -9 in male and female patients with cirrhosis of different aetiologies.
Liver Cirrhosis
Role of MMP-2 and MMP-9 and their natural inhibitors in liver fibrosis, chronic pancreatitis and non-specific inflammatory bowel diseases.
Liver Cirrhosis
Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients.
Liver Cirrhosis
The effect of Ras inhibition on the proliferation, apoptosis and matrix metalloproteases activity in rat hepatic stellate cells.
Liver Cirrhosis
Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion.
Liver Cirrhosis
[ASSESSMENT OF MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS FOR NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE].
Liver Cirrhosis
[Expression of matrix metalloproteinase 2 and 9 in liver tissue of patients with schistosomiasis japonica]
Liver Cirrhosis
[Protein expression profiles in a rat cirrhotic model induced by thioacetamide.]
Liver Cirrhosis
[Studies on synthesis and degradation of collagen at transcription level in liver fibrosis of rabbits with schistosomiasis japonica]
Liver Cirrhosis, Alcoholic
Activity of MMP-2, MMP-8 and MMP-9 in serum as a marker of progression of alcoholic liver disease in people from Lublin Region, eastern Poland.
Liver Cirrhosis, Alcoholic
The decrease of serum MMP-2 activity corresponds to alcoholic cirrhosis stage.
Liver Diseases
A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis.
Liver Diseases
Analysis of cytotoxic T-lymphocyte-associated antigen-4 and MMP-9 genes' methylation and their expression profiles with risk of non-alcoholic fatty liver disease.
Liver Diseases
Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma.
Liver Diseases
Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Liver Diseases
Differences in circulating MMP-9 levels with regard to viral load and AST:ALT ratio between chronic hepatitis B and C patients.
Liver Diseases
Differential expression of matrix metalloproteinases in viral and non-viral chronic liver diseases.
Liver Diseases
Effects of ezetimibe and anticoagulant combined therapy on progressing stroke: a randomized, placebo-controlled study.
Liver Diseases
Elevated circulating osteoprotegerin and reduced matrix-metalloprotease-9 in post-menopausal women with chronic Hepatitis C virus infection.
Liver Diseases
Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C.
Liver Diseases
Expression of matrix metalloproteinases and their inhibitors in the woodchuck model of hepatocellular carcinoma.
Liver Diseases
Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins.
Liver Diseases
Matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 in plasma of patients co-infected with HCV and HIV.
Liver Diseases
Plasma Levels of Matrix Metalloproteinase (MMP)-2, MMP-9 and Tumor Necrosis Factor-? in Chronic Hepatitis C Virus Patients.
Liver Diseases
Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients.
Liver Diseases
Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers.
Liver Diseases
TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
Liver Diseases, Alcoholic
Activity of MMP-2, MMP-8 and MMP-9 in serum as a marker of progression of alcoholic liver disease in people from Lublin Region, eastern Poland.
Liver Diseases, Alcoholic
[Dynamic change and expression of matrix metalloproteinase-2, -9 in alcoholic liver disease in rats]
Liver Failure
Interleukin-1alpha-induced proteolytic activation of metalloproteinase-9 by human skin.
Liver Failure, Acute
Contribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure.
Liver Failure, Acute
Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice.
Liver Failure, Acute
Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice.
Liver Failure, Acute
TGF?1 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5.
Liver Neoplasms
A self-assembly nanodrug delivery system based on amphiphilic low generations of PAMAM dendrimers-ursolic acid conjugate modified by lactobionic acid for HCC targeting therapy.
Liver Neoplasms
Angiogenesis in residual cancer and roles of HIF-1?, VEGF, and MMP-9 in the development of residual cancer after radiofrequency ablation and surgical resection in rabbits with liver cancer.
Liver Neoplasms
Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
Liver Neoplasms
Atractylon induces apoptosis and suppresses metastasis in hepatic cancer cells and inhibits growth in vivo.
Liver Neoplasms
Contribution of Nitric Oxide and Epidermal Growth Factor Receptor in Anti-Metastatic Potential of Paclitaxel in Human Liver Cancer Cell (HebG2).
Liver Neoplasms
Effects of Ad-p27mt gene transfer on the expression of Bax, Bcl-2, VEGF and MMP-9 in the transplanted liver tumors in nude mice.
Liver Neoplasms
Effects of lamivudine on cell proliferation of liver cancer and expressions of HBsAg, HBeAg, and MMP-9 in patients.
Liver Neoplasms
Effects of siRNA-targeting BMP-2 on the abilities of migration and invasion of human liver cancer SMMC7721 cells and its mechanism.
Liver Neoplasms
Ellagic acid normalizes mitochondrial outer membrane permeabilization and attenuates inflammation-mediated cell proliferation in experimental liver cancer.
Liver Neoplasms
Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis.
Liver Neoplasms
Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase-9 through modulation of NF-?B and AP-1 activity in human liver cancer cells lines.
Liver Neoplasms
Identification of the fatty acid synthase interaction network via iTRAQ-based proteomics indicates the potential molecular mechanisms of liver cancer metastasis.
Liver Neoplasms
Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells.
Liver Neoplasms
Inhibition of PI3K/Akt and ERK signaling decreases visfatin-induced invasion in liver cancer cells.
Liver Neoplasms
Inhibitory effect of bufalin combined with Hedgehog signaling pathway inhibitors on proliferation and invasion and metastasis of liver cancer cells.
Liver Neoplasms
Natural triterpenoid saponin Momordin Ic suppresses HepG2 cell invasion via COX-2 inhibition and PPAR? activation.
Liver Neoplasms
Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours.
Liver Neoplasms
Silencing of WWP2 inhibits adhesion, invasion, and migration in liver cancer cells.
Liver Neoplasms
Silymarin attenuated mast cell recruitment thereby decreased the expressions of matrix metalloproteinases-2 and 9 in rat liver carcinogenesis.
Liver Neoplasms
Sonic Hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer.
Liver Neoplasms
TO901317 inhibits the development of hepatocellular carcinoma by LXR?/Glut1 decreasing glycometabolism.
Low Tension Glaucoma
The Association of Single-Nucleotide Polymorphisms in the MMP-9 Gene with Normal Tension Glaucoma and Primary Open-Angle Glaucoma.
Lung Diseases
All trans-retinoic acid selectively down-regulates matrix metalloproteinase-9 (MMP-9) and up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) in human bronchoalveolar lavage cells.
Lung Diseases
All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema.
Lung Diseases
Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels: implications for antenatal origins of chronic lung disease.
Lung Diseases
Detection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technology.
Lung Diseases
Expression and significance of MMP-9 and MDM2 in the oncogenesis of lung cancer in rats.
Lung Diseases
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Lung Diseases
Functional and inflammatory alterations in the lung following exposure of rats to nitrogen mustard.
Lung Diseases
Human Neutrophil Elastase-Mediated Cleavage Sites of MMP-9 and TIMP-1: Implications to Cystic Fibrosis Proteolytic Dysfunction.
Lung Diseases
Implications for matrix metalloproteinases as modulators of pediatric lung disease.
Lung Diseases
Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas.
Lung Diseases
Inducible expression of tissue inhibitor of metalloproteinases-resistant matrix metalloproteinase-9 on the cell surface of neutrophils.
Lung Diseases
Laser capture microdissection reveals dose-response of gene expression in situ consequent to asbestos exposure.
Lung Diseases
Maternal Serum Interleukin-6, C-Reactive Protein, and Matrix Metalloproteinase-9 Concentrations as Risk Factors for Preterm Birth <32 Weeks and Adverse Neonatal Outcomes.
Lung Diseases
Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha.
Lung Diseases
Matrix metalloproteinase-9 (MMP-9) elevated in serum but not in bronchial lavage fluid in patients with lung cancer.
Lung Diseases
Matrix Metalloproteinase-9 Deficiency Worsens Lung Injury in a Model of Bronchopulmonary Dysplasia.
Lung Diseases
Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation.
Lung Diseases
S-nitrosothiols inhibit cytokine-mediated induction of matrix metalloproteinase-9 in airway epithelial cells.
Lung Diseases
Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS.
Lung Diseases
The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer.
Lung Diseases
[Expressions of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 and their correlation with metastasis and prognosis in lung cancer.]
Lung Diseases
[Overexpression of IL-8 and MMP-9 confer high malignant phenotype in patients with non-small cell lung cancer]
Lung Diseases
[Regulatory effects of inhaled steroids on expression of matrix metalloproteinase-9 and its inhibitor in asthmatic rats]
Lung Diseases
[The expression and its clinical significance of MMP-2 and MMP-9 in non-small cell lung cancer.]
Lung Diseases, Interstitial
Extracellular matrix metalloproteinase inducer in interstitial pneumonias.
Lung Diseases, Interstitial
N-acetylcysteine inhibits IL-8 and MMP-9 release and ICAM-1 expression by bronchoalveolar cells from interstitial lung disease patients.
Lung Diseases, Interstitial
[The serum levels of cytokines in patients with rheumatoid arthritis associated interstitial lung disease and their clinical significance]
Lung Injury
Acidic Preconditioning Protects Against Ischemia-Reperfusion Lung Injury Via Inhibiting the Expression of Matrix Metalloproteinase 9.
Lung Injury
Activity of lung neutrophils and matrix metalloproteinases in cyclophosphamide-treated mice with experimental sepsis.
Lung Injury
Augmented metalloproteinase activity and acute lung injury in copper-deficient rats.
Lung Injury
Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice.
Lung Injury
Chronic Alcohol Ingestion Impairs Rat Alveolar Macrophage Phagocytosis via Disruption of RAGE Signaling.
Lung Injury
Contrary regulation of TIMP-1 and MMP-9 by hepatocyte growth factor antibody after lung injury.
Lung Injury
Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus.
Lung Injury
Effect of siRNA against NF-?B on sepsis?induced acute lung injury in a mouse model.
Lung Injury
Effects of hypoxia-inducible factor-1? and matrix metalloproteinase-9 on alveolar-capillary barrier disruption and lung edema in rat models of severe acute pancreatitis-associated lung injury.
Lung Injury
Erythropoietin attenuates ischemia-reperfusion induced lung injury by inhibiting tumor necrosis factor-alpha and matrix metalloproteinase-9 expression.
Lung Injury
Evidence of increased matrix metalloproteinase-9 concentration in patients following cardiopulmonary bypass.
Lung Injury
Human amniotic mesenchymal stem cells alleviate lung injury induced by ischemia and reperfusion after cardiopulmonary bypass in dogs.
Lung Injury
Hydrogen Attenuates Endotoxin-Induced Lung Injury by Activating Thioredoxin 1 and Decreasing Tissue Factor Expression.
Lung Injury
Increased matrix metalloproteinase-9 activity and mRNA expression in lung injury following cardiopulmonary bypass.
Lung Injury
Inhibition of activin receptor-like kinase 5 induces matrix metallopeptidase 9 expression and aggravates lipopolysaccharide-induced pulmonary injury in mice.
Lung Injury
Inhibition of matrix metalloproteinase-9 with doxycycline reduces pancreatitis-associated lung injury.
Lung Injury
Inspiratory resistive breathing induces MMP-9 and MMP-12 expression in the lung.
Lung Injury
Kinetics and Role of Plasma Matrix Metalloproteinase-9 Expression in Acute Lung Injury and the Acute Respiratory Distress Syndrome.
Lung Injury
LPS-induced lung injury in neonatal rats: changes in gelatinase activities and consequences on lung growth.
Lung Injury
Matrix Metalloproteinase-9 Deficiency Worsens Lung Injury in a Model of Bronchopulmonary Dysplasia.
Lung Injury
Matrix metalloproteinase-9 expression in congenital diaphragmatic hernia during mechanical ventilation.
Lung Injury
Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat.
Lung Injury
Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Lung Injury
Mechanisms of inflammatory lung injury in the neonate: lessons from a transgenic mouse model of bronchopulmonary dysplasia.
Lung Injury
Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats.
Lung Injury
Modulation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in RAW264.7 cells by irradiation.
Lung Injury
Pentoxifylline attenuates lung injury and modulates transcription factor activity in hemorrhagic shock.
Lung Injury
Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis.
Lung Injury
Potentiated interaction between ineffective doses of budesonide and formoterol to control the inhaled cadmium-induced up-regulation of metalloproteinases and acute pulmonary inflammation in rats.
Lung Injury
Preactivated and Disaggregated Shape-Changed Platelets Protected Against Acute Respiratory Distress Syndrome Complicated by Sepsis Through Inflammation Suppression.
Lung Injury
Protective effects of S-nitrosoalbumin on lung injury induced by hypoxia-reoxygenation in mouse model of sickle cell disease.
Lung Injury
Salidroside protects against ventilation-induced lung injury by inhibiting the expression of matrix metalloproteinase-9.
Lung Injury
TGF-betal transgenic mouse model of thoracic irradiation: modulation of MMP-2 and MMP-9 in the lung tissue.
Lung Injury
The impact of sodium aescinate on acute lung injury induced by oleic acid in rats.
Lung Injury
Time course of lung parenchyma remodeling in pulmonary and extrapulmonary acute lung injury.
Lung Injury
Time-dependent inhibition of immune complex-induced lung injury by catalase: relationship to alterations in macrophage and neutrophil matrix metalloproteinase elaboration.
Lung Injury
Unexpected smoking-linked high MMP-9 in induced sputum of hazardous dust-exposed workers.
Lung Injury
[Comparison of matrix metalloproteinase-9 between Wistar rat and spontaneously hypertensive rat in pulmonary injury model].
Lung Injury
[Effect of SiO2 on the expression of MMP-9 and TIMP-1 in human alveolar macrophages in vitro]
Lung Injury
[Effects of phosphorylated mitogen-activated protein kinases on phosgene inhalation-induced lung injury in rats and its relationship with matrix metalloproteinase].
Lung Injury
[Expression of various matrix metalloproteinases in mice with hyperoxia induced acute lung injury.]
Lung Injury
[Protective role of MMP-9 inhibitor batimastat in acute lung injury after cardiopulmonary bypass.]
Lung Injury
[Retinoic acid diminished the expression of lung tissue matrix metalloproteinase-2 and matrix metalloproteinase-9 in hyperoxia-exposed premature rats through regulating mitogen-activated protein kinases]
Lung Neoplasms
A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers.
Lung Neoplasms
A Fra-1-dependent, matrix metalloproteinase driven EGFR activation promotes human lung epithelial cell motility and invasion.
Lung Neoplasms
A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude mice.
Lung Neoplasms
Activity of type IV collagenases (MMP-2 and MMP-9) in primary pulmonary carcinomas: a quantitative analysis.
Lung Neoplasms
AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model.
Lung Neoplasms
Andrographolide inhibits the activation of NF-?B and MMP-9 activity in H3255 lung cancer cells.
Lung Neoplasms
Angelica sinensis suppresses human lung adenocarcinoma A549 cell metastasis by regulating MMPs/TIMPs and TGF-?1.
Lung Neoplasms
Anticancer Effects of Valproic Acid via Regulation of Epigenetic Mechanisms in Non-small-cell Lung Cancer A549 Cell Line.
Lung Neoplasms
Aquaporin 1 promotes the proliferation and migration of lung cancer cell in vitro.
Lung Neoplasms
Association of MMP9-1562C/T and MMP13-77A/G Polymorphisms with Non-Small Cell Lung Cancer in Southern Chinese Population.
Lung Neoplasms
Ataxia-telangiectasia group D complementing gene (ATDC) upregulates matrix metalloproteinase 9 (MMP-9) to promote lung cancer cell invasion by activating ERK and JNK pathways.
Lung Neoplasms
Basigin-2 upregulated by receptor activator of NF-?B ligand enhances lung cancer-induced osteolytic lesions.
Lung Neoplasms
Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer.
Lung Neoplasms
Bisphenol A stimulates human lung cancer cell migration via upregulation of matrix metalloproteinases by GPER/EGFR/ERK1/2 signal pathway.
Lung Neoplasms
Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
Lung Neoplasms
Clinical Significance of Circulating Osteopontin Levels in Patients With Lung Cancer and Correlation With VEGF and MMP-9.
Lung Neoplasms
Comparison of the effects of sevoflurane and propofol anesthesia on pulmonary function, MMP-9 and postoperative cognition in patients receiving lung cancer resection.
Lung Neoplasms
Correction to: a facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers.
Lung Neoplasms
Correlation between matrix metalloproteinase 9 and 18F-2-fluoro-2-deoxyglucose-positron emission tomography as diagnostic markers of lung cancer.
Lung Neoplasms
Correlation of MMP-9 and p53 protein expression with prognosis in metastatic spinal tumor of lung cancer.
Lung Neoplasms
Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway.
Lung Neoplasms
Cytochrome P450 ?-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.
Lung Neoplasms
Dehydrocostus Lactone Enhances Chemotherapeutic Potential of Doxorubicin in Lung Cancer by Inducing Cell Death and Limiting Metastasis.
Lung Neoplasms
Delta-tocotrienol inhibits non-small-cell lung cancer cell invasion via the inhibition of NF-?B, uPA activator, and MMP-9.
Lung Neoplasms
Derlin-1 Is Overexpressed in Non-Small Cell Lung Cancer and Promotes Cancer Cell Invasion via EGFR-ERK-Mediated Up-Regulation of MMP-2 and MMP-9.
Lung Neoplasms
Detection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technology.
Lung Neoplasms
Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment.
Lung Neoplasms
Dietary flavonoid myricetin inhibits invasion and migration of radioresistant lung cancer cells (A549-IR) by suppressing MMP-2 and MMP-9 expressions through inhibition of the FAK-ERK signaling pathway.
Lung Neoplasms
Differential diagnosis of lung cancer, its metastasis and chronic obstructive pulmonary disease based on serum Vegf, Il-8 and MMP-9.
Lung Neoplasms
Differential Expressions Of Matrix Metalloproteinases, A Disintegrin And Metalloproteinases, And A Disintegrin And Metalloproteinases With Thrombospondin Motifs And Their Endogenous Inhibitors Among Histologic Subtypes Of Lung Cancers.
Lung Neoplasms
Downregulation of cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9.
Lung Neoplasms
Effect of lentivirus-mediated integrin ?V?3-shRNA on tumor growth of mice with lung cancer xenografts.
Lung Neoplasms
Effect of Osimertinib on the expression of serum mmp-7 and mmp-9 in patients with non-small cell lung cancer.
Lung Neoplasms
Effects of sevoflurane inhalation anesthesia on IL-6, TNF-? and MMP-9 expression and hemodynamics in elderly patients undergoing lobectomy for lung cancer.
Lung Neoplasms
Efficacy of hypofractionated radiotherapy combined with docetaxel in middle and advanced non-small cell lung cancer and its effects on serum MMP-9 and VEGF expressions.
Lung Neoplasms
Efficacy of radiotherapy on intermediate and advanced lung cancer and its effect on dynamic changes of serum vascular endothelial growth factor and matrix metalloproteinase-9.
Lung Neoplasms
Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer.
Lung Neoplasms
Elevated levels of circulating matrix metalloproteinase-9 in non-small cell lung cancer patients.
Lung Neoplasms
Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
Lung Neoplasms
Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer.
Lung Neoplasms
Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells.
Lung Neoplasms
Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination.
Lung Neoplasms
Exosomal miR-106b serves as a novel marker for lung cancer and promotes cancer metastasis via targeting PTEN.
Lung Neoplasms
Expression and significance of MMP-9 and MDM2 in the oncogenesis of lung cancer in rats.
Lung Neoplasms
Expression and survival significance of B-cell-specific Moloney murine leukemia virus integration site 1 and matrix metalloproteinase-9 in non-small-cell lung cancer.
Lung Neoplasms
Expression and the potential functions of TRIM32 in lung cancer tumorigenesis.
Lung Neoplasms
Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer.
Lung Neoplasms
Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC).
Lung Neoplasms
Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
Lung Neoplasms
Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.
Lung Neoplasms
Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer Relation to clinicopathological factors, beta-catenin and prognosis.
Lung Neoplasms
Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Lung Neoplasms
Expression of metastasis-associated molecules in non-small cell lung cancer and their prognostic significance.
Lung Neoplasms
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Lung Neoplasms
Expression of SHP2 and Related Markers in Non-Small Cell Lung Cancer: A Tissue Microarray Study of 80 Cases.
Lung Neoplasms
Feruloyl-L-arabinose attenuates migration, invasion and production of reactive oxygen species in H1299 lung cancer cells.
Lung Neoplasms
Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer.
Lung Neoplasms
Gelatin-degrading type IV collagenase isolated from human small cell lung cancer.
Lung Neoplasms
GMI, a Ganoderma Immunomodulatory Protein, Down-regulates Tumor Necrosis Factor ?-Induced Expression of Matrix Metalloproteinase 9 via NF-?B Pathway in Human Alveolar Epithelial A549 Cells.
Lung Neoplasms
GOLPH3 Overexpression is Closely Correlated with Poor Prognosis in Human Non-Small Cell Lung Cancer and Mediates its Metastasis Through Upregulating MMP-2 and MMP-9.
Lung Neoplasms
Growth factor-enhanced expression and activity of matrix metalloproteases in human non-small cell lung cancer cell lines.
Lung Neoplasms
HMGB1-Mediated MMP-9 Expression in Non-Small Cell Lung Cancer Contributes to Tumor Cell Invasiveness.
Lung Neoplasms
Human papillomavirus up-regulates MMP-2 and MMP-9 expression and activity by inducing interleukin-8 in lung adenocarcinomas.
Lung Neoplasms
ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB.
Lung Neoplasms
Identification and Validation of SAA as a Potential Lung Cancer Biomarker and its Involvement in Metastatic Pathogenesis of Lung Cancer.
Lung Neoplasms
IL-17A/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via p38 MAPK signaling pathway in non-small cell lung cancer.
Lung Neoplasms
Increased plasma levels of urokinase plasminogen activator and matrix metalloproteinase-9 in nonsmall cell lung cancer patients.
Lung Neoplasms
Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
Lung Neoplasms
Inhibition of cell proliferation, migration and invasion by DNAzyme targeting MMP-9 in A549 cells.
Lung Neoplasms
Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.
Lung Neoplasms
Integrin ?v?6 Promotes Lung Cancer Proliferation and Metastasis through Upregulation of IL-8-Mediated MAPK/ERK Signaling.
Lung Neoplasms
Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis.
Lung Neoplasms
Linarin inhibits radiation-induced cancer invasion by downregulating MMP-9 expression via the suppression of NF-?B activation in human non-small-cell lung cancer A549.
Lung Neoplasms
Liver X receptors agonist T0901317 downregulates matrix metalloproteinase-9 expression in non-small-cell lung cancer by repressing nuclear factor-?B.
Lung Neoplasms
Lung CSC-derived exosomal miR-210-3p contributes to a pro-metastatic phenotype in lung cancer by targeting FGFRL1.
Lung Neoplasms
M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.
Lung Neoplasms
Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.
Lung Neoplasms
Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer.
Lung Neoplasms
Matrix metalloproteinase-9 (MMP-9) elevated in serum but not in bronchial lavage fluid in patients with lung cancer.
Lung Neoplasms
Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer.
Lung Neoplasms
Matrix metalloproteinase-9 expression in lung cancer patients and its relation to serum mmp-9 activity, pathologic type, and prognosis.
Lung Neoplasms
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.
Lung Neoplasms
Matrix metalloproteinase-9 in broncho-alveolar lavage fluid of patients with non-small cell lung cancer.
Lung Neoplasms
Mesenchymal stem cells promote metastasis through activation of an ABL-MMP9 signaling axis in lung cancer cells.
Lung Neoplasms
Metastatic potential of mouse Lewis lung cancer cells is regulated via ganglioside GM1 by modulating the matrix metalloprotease-9 localization in lipid rafts.
Lung Neoplasms
MicroRNA-145 replacement effect on growth and migration inhibition in lung cancer cell line.
Lung Neoplasms
MiR-26a-5p potentiates metastasis of human lung cancer cells by regulating ITG?8- JAK2/STAT3 axis.
Lung Neoplasms
MiR-451 suppresses cell proliferation and metastasis in A549 lung cancer cells.
Lung Neoplasms
MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription.
Lung Neoplasms
MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer.
Lung Neoplasms
Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines.
Lung Neoplasms
Modulatory effect of hesperidin on benzo(a)pyrene induced experimental lung carcinogenesis with reference to COX-2, MMP-2 and MMP-9.
Lung Neoplasms
Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung.
Lung Neoplasms
Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells.
Lung Neoplasms
Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms.
Lung Neoplasms
New Insights on Old Biomarkers Involved in Tumor Microenvironment Changes and Their Diagnostic Relevance in Non-Small Cell Lung Carcinoma.
Lung Neoplasms
Non-invasive profiling of protease-specific elastin turnover in lung cancer: biomarker potential.
Lung Neoplasms
Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-?B-mediated matrix metalloproteinase-9 expression.
Lung Neoplasms
Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression.
Lung Neoplasms
Overexpression of CXCR4 promotes invasion and migration of non-small cell lung cancer via EGFR and MMP-9.
Lung Neoplasms
Overexpression of integrin-linked kinase promotes lung cancer cell migration and invasion via NF-?B-mediated upregulation of matrix metalloproteinase-9.
Lung Neoplasms
Peonidin 3-glucoside inhibits lung cancer metastasis by downregulation of proteinases activities and MAPK pathway.
Lung Neoplasms
Percutaneous microwave ablation (MWA) increased the serum levels of VEGF and MMP-9 in Stage I non-small cell lung cancer (NSCLC).
Lung Neoplasms
Pipoxolan inhibits CL1-5 lung cancer cells migration and invasion through inhibition of MMP-9 and MMP-2.
Lung Neoplasms
Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients.
Lung Neoplasms
Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer.
Lung Neoplasms
Predicting non-small cell lung cancer expression of epidermal growth factor receptor and matrix metalloproteinase 9 from immunohistochemical staining of diagnostic biopsy samples.
Lung Neoplasms
Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer.
Lung Neoplasms
Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC).
Lung Neoplasms
Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
Lung Neoplasms
Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study.
Lung Neoplasms
Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer.
Lung Neoplasms
Prognostic impact of MMP-2 and MMP-9 expression in pathologic stage IA non-small cell lung cancer.
Lung Neoplasms
Prognostic impact of serum and tissue MMP-9 in non-small cell lung cancer: a systematic review and meta-analysis.
Lung Neoplasms
Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma.
Lung Neoplasms
Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer.
Lung Neoplasms
Protease-Mediated Release of Chemotherapeutics from Mesoporous Silica Nanoparticles to ex Vivo Human and Mouse Lung Tumors.
Lung Neoplasms
Re: Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer (Respir Med 2001; 95: 1-4).
Lung Neoplasms
Regulatory effects of ?FosB on proliferation and apoptosis of MCF-7 breast cancer cells.
Lung Neoplasms
Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases.
Lung Neoplasms
RNA interference-mediated knockdown of RhoGDI2 induces the migration and invasion of human lung cancer A549 cells via activating the PI3K/Akt pathway.
Lung Neoplasms
Salinomycin suppresses TGF-?1-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK/SIRT1 pathway in non-small cell lung cancer.
Lung Neoplasms
Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer.
Lung Neoplasms
Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Lung Neoplasms
Simvastatin inhibits proliferation and induces apoptosis in human lung cancer cells.
Lung Neoplasms
Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells.
Lung Neoplasms
Social defeat stress promotes tumor growth and angiogenesis by upregulating vascular endothelial growth factor/extracellular signal-regulated kinase/matrix metalloproteinase signaling in a mouse model of lung carcinoma.
Lung Neoplasms
Sodium Danshensu inhibits the progression of lung cancer by regulating PI3K/Akt signaling pathway.
Lung Neoplasms
Sodium hydrogen exchanger and phospholipase D are required for alpha1-adrenergic receptor stimulation of metalloproteinase-9 and cellular invasion in CCL39 fibroblasts.
Lung Neoplasms
Steroidal Saponins from Paris polyphylla Suppress Adhesion, Migration and Invasion of Human Lung Cancer A549 Cells Via Down-Regulating MMP-2 and MMP-9.
Lung Neoplasms
Studies on the relationship between P13K/AKT signal pathway-mediated MMP-9 gene and lung cancer.
Lung Neoplasms
Study on the expression of p53 and MMP-2 in patients with lung cancer after interventional therapy.
Lung Neoplasms
Suppressing migration and invasion of H1299 lung cancer cells by honokiol through disrupting expression of an HDAC6-mediated matrix metalloproteinase 9.
Lung Neoplasms
Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1.
Lung Neoplasms
Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells.
Lung Neoplasms
The association of MMP-9 enzyme activity, MMP-9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 gene expression in lung cancer.
Lung Neoplasms
The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
Lung Neoplasms
The Combination of CD147 and MMP-9 Serum Levels Is Identified as Novel Chemotherapy Response Markers of Advanced Non-Small-Cell Lung Cancer.
Lung Neoplasms
The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer.
Lung Neoplasms
The effects of cordycepin on the cell proliferation, migration and apoptosis in human lung cancer cell lines A549 and NCI-H460.
Lung Neoplasms
The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo.
Lung Neoplasms
The LncRNA H19/microRNA-29b-3p/HMGB1 signaling axis contributes to the regulation of lung cancer cell growth.
Lung Neoplasms
The role of serum vascular endothelial growth factor and matrix metalloproteinase-9 in predicting response to chemotherapy in patients with advanced nonsmall cell lung cancer.
Lung Neoplasms
The significance of serum active matrix metalloproteinase-9 in patients with non-small cell lung cancer.
Lung Neoplasms
The value of MMP-9 for breast and non-small cell lung cancer patients' survival.
Lung Neoplasms
Thromboxane A2 receptor-mediated release of matrix metalloproteinase-1 (MMP-1) induces expression of monocyte chemoattractant protein-1 (MCP-1) by activation of protease-activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cells.
Lung Neoplasms
Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1/2, Src/FAK and ?-catenin signaling pathways.
Lung Neoplasms
Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
Lung Neoplasms
TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-?-catenin signaling.
Lung Neoplasms
Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin.
Lung Neoplasms
Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables.
Lung Neoplasms
Tumour-associated neutrophils and loss of epithelial PTEN can promote corticosteroid-insensitive MMP-9 expression in the chronically inflamed lung microenvironment.
Lung Neoplasms
Two serine residues of non-metastasis protein 23-H1 are critical in inhibiting signal transducer and activator of transcription 3 activity in human lung cancer cells.
Lung Neoplasms
Update analysis of studies on the MMP-9 -1562 C>T polymorphism and cancer risk.
Lung Neoplasms
Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion.
Lung Neoplasms
[Clinical and prognostic significance of serum MMP-9, endostatin and VEGF in patients with advanced non-small cell lung cancer.]
Lung Neoplasms
[Clinical research of perioperative serum VEGF and MMP-9 levels in patients with non-small cell lung cancer.]
Lung Neoplasms
[Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer]
Lung Neoplasms
[Detection of serum total MMP-9 and its clinical significance for lung neoplasms].
Lung Neoplasms
[Effect of cisplatin on expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and their correlations in Lewis lung cancer in mice.]
Lung Neoplasms
[Effect of Src tyrosine kinase inhibition on secretion of MMP-2 and MMP-9 by non-small cell lung cancer cells].
Lung Neoplasms
[Expression and pathological mechanism of MMP-9 and HIF-2? in CD133(+) lung cancer stem cells].
Lung Neoplasms
[Expression and significance of matrix metalloproteinases and their tissue inhibitors in the infiltration and metastasis of lung cancer.]
Lung Neoplasms
[Expression of adiponectin in non-small cell lung cancer and its relationship with MMP-9 and angiogenesis].
Lung Neoplasms
[Expression of AKT2, Cyclin D1, and MMP-9 and Their Correlations to Clinicopathologic Features of Non-small Cell Lung Cancer.]
Lung Neoplasms
[Expression of MMP-2 and MMP-9 in non-small-cell lung cancer and their prognostic value.]
Lung Neoplasms
[Expressions of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 and their correlation with metastasis and prognosis in lung cancer.]
Lung Neoplasms
[Joint serum tumor markers serve as survival predictive model of erlotinib in the treatment of recurrent non-small cell lung cancer].
Lung Neoplasms
[Mechanisms for quercetin in prevention of lung cancer cell growth and metastasis].
Lung Neoplasms
[Overexpression of IL-8 and MMP-9 confer high malignant phenotype in patients with non-small cell lung cancer]
Lung Neoplasms
[Plasma level and prognostic significance of VEGF, bFGF and MMP-9 in patients with advanced non-small-cell lung cancer]
Lung Neoplasms
[Preliminary study for the roles and mechanisms of 20(R)-ginsenoside Rg3 and PEG-PLGA-Rg3 nanoparticles in the Lewis lung cancer mice].
Lung Neoplasms
[Prognostic impact of matrix metalloproteinases 2,9, and 11 in stromal cells stage I non-small cell lung cancer]
Lung Neoplasms
[Significance of expression of chemokine receptor and matrix metalloproteinase in small cell lung cancer].
Lung Neoplasms
[The expression and its clinical significance of MMP-2 and MMP-9 in non-small cell lung cancer.]
Lung Neoplasms
[The serum concentration of metalloproteinase 9 and 2 in non-small cell lung cancer patients]
Lupus Erythematosus, Systemic
Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Circulating Matrix Metalloproteinase-9 Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis.
Lupus Erythematosus, Systemic
Concentrations of circulating matrix metalloproteinase 9 inversely correlate with autoimmune antibodies to double stranded DNA: implications for monitoring disease activity in systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Deficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune disease.
Lupus Erythematosus, Systemic
EDTA/gelatin zymography method to identify C1s versus activated MMP-9 in plasma and immune complexes of patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Expression of reversion-inducing cysteine-rich protein with Kazal motifs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus: links to disease activity, damage accrual and matrix metalloproteinase 9 secretion.
Lupus Erythematosus, Systemic
Expression of the matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 in systemic lupus erythematosus patients.
Lupus Erythematosus, Systemic
Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Lupus Erythematosus, Systemic
Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
Lupus Erythematosus, Systemic
Matrix metalloproteinase-9 and its natural inhibitor TIMP-1 expressed or secreted by peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Matrix metalloproteinase-9 promoter polymorphisms in Korean patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Role of polymorphisms in MMP-9 and TIMP-1 as biomarkers for susceptibility to systemic lupus erythematosus patients.
Lupus Erythematosus, Systemic
Roles of CD147 on T lymphocytes activation and MMP-9 secretion in systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Serum Levels of MDC and MMP-9 and the Relationship Between Serum Levels and Disease Activity in the Patients with Systemic Lupus Erythematosus.
Lupus Erythematosus, Systemic
[Relationship of serum levels of HGF and MMP-9 with disease activity of patients with systemic lupus erythematosus]
Lupus Nephritis
Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis.
Lupus Nephritis
Glomerular expression of matrix metalloproteinases in systemic lupus erythematosus in association with activity index and renal function.
Lupus Nephritis
Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis.
Lyme Disease
?-Glucuronidase, a Regulator of Lyme Arthritis Severity, Modulates Lysosomal Trafficking and MMP-9 Secretion in Response to Inflammatory Stimuli.
Lyme Disease
Borrelia burgdorferi-induced monocyte chemoattractant protein-1 production in vivo and in vitro.
Lyme Disease
Borrelia spirochetes upregulate release and activation of matrix metalloproteinase gelatinase B (MMP-9) and collagenase 1 (MMP-1) in human cells.
Lyme Disease
CD14 mediates cross talk between mononuclear cells and fibroblasts for upregulation of matrix metalloproteinase 9 by Borrelia burgdorferi.
Lyme Disease
CD14 signaling reciprocally controls collagen deposition and turnover to regulate the development of lyme arthritis.
Lyme Disease
Matrix metalloproteinase-9 plays a key role in Lyme arthritis but not dissemination of Borrelia burgdorferi.
Lyme Disease
Selective up-regulation of matrix metalloproteinase-9 expression in human erythema migrans skin lesions of acute lyme disease.
Lyme Disease
[Usefulness of examinations of serum levels of matrix metalloproteinases 1, MMP-3, MMP-9, tissue inhibitor of metalloproteinases 1, hyaluronic acid and antibodies against cyclic citrullinated peptide in Lyme arthritis, rheumatoid arthritis and patients with arthritic complaints].
Lyme Neuroborreliosis
Upregulation of matrix metalloproteinase-9 in the cerebrospinal fluid of patients with acute Lyme neuroborreliosis.
Lymphadenopathy
Deficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune disease.
Lymphadenopathy
Expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in tissues with a diagnosis of childhood lymphoma.
Lymphangioleiomyomatosis
Doxycycline use in patients with lymphangioleiomyomatosis: biomarkers and pulmonary function response.
Lymphangioleiomyomatosis
Doxycycline use in patients with lymphangioleiomyomatosis: safety and efficacy in metalloproteinase blockade.
Lymphangioleiomyomatosis
Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).
Lymphatic Metastasis
A circular RNA derived from MMP9 facilitates oral squamous cell carcinoma metastasis through regulation of MMP9 mRNA stability.
Lymphatic Metastasis
Aberrant expression of Kiss-1 and matrix metalloproteinase-9 are closely linked to lymph node metastasis of gastric cancer.
Lymphatic Metastasis
Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.
Lymphatic Metastasis
Absent expression of FLNA is correlated with poor prognosis of nasopharyngeal cancer.
Lymphatic Metastasis
Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
Lymphatic Metastasis
Active and inactive forms of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
Lymphatic Metastasis
ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.
Lymphatic Metastasis
An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.
Lymphatic Metastasis
Areca quid chewing enhances the expression of salivary matrix metalloproteinase-9.
Lymphatic Metastasis
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Lymphatic Metastasis
Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.
Lymphatic Metastasis
BTG1 expression correlates with the pathogenesis and progression of breast carcinomas.
Lymphatic Metastasis
Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
Lymphatic Metastasis
Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer.
Lymphatic Metastasis
Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma.
Lymphatic Metastasis
Clinicopathological correlation of keratinocyte growth factor and matrix metalloproteinase-9 expression in human gastric cancer.
Lymphatic Metastasis
Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma.
Lymphatic Metastasis
Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors.
Lymphatic Metastasis
Detection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technology.
Lymphatic Metastasis
Detection of serum VEGF and MMP-9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma.
Lymphatic Metastasis
Determining the levels of matrix metalloproteinase-9 in portal and peripheral blood is useful for predicting liver metastasis of colorectal cancer.
Lymphatic Metastasis
Down-regulation of Gab1 inhibits cell proliferation and migration in hilar cholangiocarcinoma.
Lymphatic Metastasis
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer.
Lymphatic Metastasis
E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: Analysis of 125 patients.
Lymphatic Metastasis
Effects of various treatment approaches for treatment efficacy for late stage breast cancer and expression level of TIMP-1 and MMP-9.
Lymphatic Metastasis
Enhanced production of matrix metalloproteinase-2 in human head and neck carcinomas is correlated with lymph node metastasis.
Lymphatic Metastasis
Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction.
Lymphatic Metastasis
Expression and clinical significance of ARTN and MMP-9 in endometrial carcinoma.
Lymphatic Metastasis
Expression and clinical significance of CD74 and MMP-9 in colon adenocarcinomas.
Lymphatic Metastasis
Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
Lymphatic Metastasis
Expression levels of matrix metalloproteinase-9 in human gastric carcinoma.
Lymphatic Metastasis
Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis.
Lymphatic Metastasis
Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis.
Lymphatic Metastasis
Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
Lymphatic Metastasis
Expression of matrix metalloproteinase-9 and bombesin/gastrin-releasing peptide in human prostate cancers and their lymph node metastases.
Lymphatic Metastasis
Expression of matrix metalloproteinase-9 in surgically resected intrahepatic cholangiocarcinoma.
Lymphatic Metastasis
Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer.
Lymphatic Metastasis
Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Lymphatic Metastasis
Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Lymphatic Metastasis
Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Lymphatic Metastasis
Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue.
Lymphatic Metastasis
Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
Lymphatic Metastasis
Expression of SHP2 and Related Markers in Non-Small Cell Lung Cancer: A Tissue Microarray Study of 80 Cases.
Lymphatic Metastasis
Expression of TGF-?1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.
Lymphatic Metastasis
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
Lymphatic Metastasis
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Lymphatic Metastasis
Expression of Twist protein in colorectal carcinoma and its effect on proliferation and invasion of colorectal cancer cells.
Lymphatic Metastasis
Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer.
Lymphatic Metastasis
Expressions of CD147, MMP-2 and MMP-9 in Laryngeal Carcinoma and its Correlation with Poor Prognosis.
Lymphatic Metastasis
Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma.
Lymphatic Metastasis
Filamin A regulates MMP-9 expression and suppresses prostate cancer cell migration and invasion.
Lymphatic Metastasis
Gab1 regulates proliferation and migration through the PI3K/Akt signaling pathway in intrahepatic cholangiocarcinoma.
Lymphatic Metastasis
GABRA3 promotes lymphatic metastasis in lung adenocarcinoma by mediating upregulation of matrix metalloproteinases.
Lymphatic Metastasis
HAND2-AS1 inhibits invasion and metastasis of cervical cancer cells via microRNA-330-5p-mediated LDOC1.
Lymphatic Metastasis
High infiltration of CD68-tumor associated macrophages, predict poor prognosis in Kazakh esophageal cancer patients.
Lymphatic Metastasis
HMGA2 gene silencing reduces epithelial-mesenchymal transition and lymph node metastasis in cervical cancer through inhibiting the ATR/Chk1 signaling pathway.
Lymphatic Metastasis
Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Lymphatic Metastasis
Immunohistochemical analysis of matrix metalloproteinase-9 predicts papillary thyroid carcinoma prognosis.
Lymphatic Metastasis
Immunohistochemical analysis of neutrophils, interleukin-17, matrix metalloproteinase-9, and neoformed vessels in oral squamous cell carcinoma.
Lymphatic Metastasis
Immunohistochemical expression of Notch1, Jagged1, NF-?B and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
Lymphatic Metastasis
Immunohistochemical studies on matrix metalloproteinase-9 (MMP-9) and type-IV collagen in endometrial carcinoma.
Lymphatic Metastasis
Immunohistochemical study of KiSS1 and KiSS1R expression in human primary breast cancer: Association with breast cancer receptor status, proliferation markers and clinicopathological features.
Lymphatic Metastasis
Impact of Histological and Molecular Parameters on Prognosis of Oral Squamous Cell Carcinoma: Analysis of 290 Cases.
Lymphatic Metastasis
Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer.
Lymphatic Metastasis
Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases.
Lymphatic Metastasis
Influence of VEGF, COX-2, and MMP-9 expression on the molybdenum-targeted X-ray in breast cancer.
Lymphatic Metastasis
Interactions between filamin A and MMP-9 regulate proliferation and invasion in renal cell carcinoma.
Lymphatic Metastasis
Intratumoral macrophage counts correlate with tumor progression in colorectal cancer.
Lymphatic Metastasis
LABAZ1: A metastatic tumor model for renal cell carcinoma expressing the carbonic anhydrase type 9 tumor antigen.
Lymphatic Metastasis
LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
Lymphatic Metastasis
Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.
Lymphatic Metastasis
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.
Lymphatic Metastasis
Matrix Metalloproteinase-9 Expression and Status of Cervical Lymph Nodes in Patients with Nasopharyngeal Carcinoma.
Lymphatic Metastasis
Matrix metalloproteinase-9 is a prognostic marker for patients with cervical cancer.
Lymphatic Metastasis
Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer.
Lymphatic Metastasis
Matrix Metalloproteinase-9 Is Associated with Relapse and Prognosis of Patients with Colorectal Cancer.
Lymphatic Metastasis
Matrix metalloproteinases 2 and 9 in situ mRNA expression in colorectal tumors from Iraqi patients.
Lymphatic Metastasis
Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-?B pathway, and MMP-9 expression.
Lymphatic Metastasis
MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma.
Lymphatic Metastasis
MMP-9 -1562 Promoter Polymorphism Associated with Gastric Cancer Risk in Females.
Lymphatic Metastasis
MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC).
Lymphatic Metastasis
MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases.
Lymphatic Metastasis
MMP-9 Knockdown Inhibits Oral Squamous Cell Carcinoma Lymph Node Metastasis in the Nude Mouse Tongue-Xenografted Model through the RhoC/Src Pathway.
Lymphatic Metastasis
MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
Lymphatic Metastasis
NDRG1 Controls Gastric Cancer Migration and Invasion through Regulating MMP-9.
Lymphatic Metastasis
No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Lymphatic Metastasis
Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell.
Lymphatic Metastasis
Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
Lymphatic Metastasis
Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Lymphatic Metastasis
Pituitary tumor-transforming 1 expression in laryngeal cancer and its association with prognosis.
Lymphatic Metastasis
Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
Lymphatic Metastasis
Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma.
Lymphatic Metastasis
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Lymphatic Metastasis
Prognostic roles of miR-124-3p and its target ANXA7 and their effects on cell migration and invasion in hepatocellular carcinoma.
Lymphatic Metastasis
Prognostic significance of CD44v6, p63, Podoplanin, and MMP-9 in oral squamous cell carcinomas.
Lymphatic Metastasis
Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
Lymphatic Metastasis
Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
Lymphatic Metastasis
Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Lymphatic Metastasis
Protein Expression and Significance of VEGF, EGFR and MMP-9 in Non-Small Cell Lung Carcinomas.
Lymphatic Metastasis
Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.
Lymphatic Metastasis
Relationship between preoperative staging by endoscopic ultrasonography and MMP-9 expression in gastric carcinoma.
Lymphatic Metastasis
Relationship between serum MMP-9 level and prognosis after radical resection for Hilar cholangiocarcinoma patients.
Lymphatic Metastasis
Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer.
Lymphatic Metastasis
Serum levels of matrix metalloproteinase-9 predict lymph node metastasis in breast cancer patients.
Lymphatic Metastasis
Serum Levels of S100A11 and MMP-9 in Patients with Epithelial Ovarian Cancer and Their Clinical Significance.
Lymphatic Metastasis
Serum melatonin is inversely associated with matrix metalloproteinase-9 in oral squamous cell carcinoma.
Lymphatic Metastasis
Significance of MMP-9 and VEGF-C expression in North Indian women with breast cancer diagnosis.
Lymphatic Metastasis
Silencing of LASS2/TMSG1 enhances invasion and metastasis capacity of prostate cancer cell.
Lymphatic Metastasis
Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling.
Lymphatic Metastasis
Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy.
Lymphatic Metastasis
The association of co-expression of CD44v4/MMP-9 with different nodal status in high-grade breast carcinoma patients.
Lymphatic Metastasis
The CCL21/CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase-9.
Lymphatic Metastasis
The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
Lymphatic Metastasis
The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis.
Lymphatic Metastasis
The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival.
Lymphatic Metastasis
The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery.
Lymphatic Metastasis
The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis.
Lymphatic Metastasis
The role of MMP-2 and MMP-9 in the metastasis and development of hypopharyngeal carcinoma.
Lymphatic Metastasis
Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (?35 Years).
Lymphatic Metastasis
Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.
Lymphatic Metastasis
Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors.
Lymphatic Metastasis
Values of ultrasound features and MMP-9 of papillary thyroid carcinoma in predicting cervical lymph node metastases.
Lymphatic Metastasis
[A multianalysis study on clinicopathologic factors related to lymph node metastasis in gastric cancer]
Lymphatic Metastasis
[Correlation between bacterial L-form infection, expression of HIF-1?/MMP-9 and vasculogenic mimicry in epithelial ovarian cancer].
Lymphatic Metastasis
[Correlation between expression of metastasis-associated gene 1 and matrix metalloproteinase 9 and invasion and metastasis of breast cancer]
Lymphatic Metastasis
[Correlations of serous levels of matrix metalloproteinases (MMP-2 and MMP-9) to invasion and metastasis of papillary thyroid carcinoma]
Lymphatic Metastasis
[Detection of serum total MMP-9 and its clinical significance for lung neoplasms].
Lymphatic Metastasis
[Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma]
Lymphatic Metastasis
[Expression and significance of CD44v6 and MMP-9 in laryngeal squamous cell carcinoma]
Lymphatic Metastasis
[Expression and significance of matrix metalloproteinases and their tissue inhibitors in the infiltration and metastasis of lung cancer.]
Lymphatic Metastasis
[Expression of adiponectin in non-small cell lung cancer and its relationship with MMP-9 and angiogenesis].
Lymphatic Metastasis
[Expression of AKT2, Cyclin D1, and MMP-9 and Their Correlations to Clinicopathologic Features of Non-small Cell Lung Cancer.]
Lymphatic Metastasis
[Expression of COX-2 and MMP-9 in cervical carcinoma and their clinical significance]
Lymphatic Metastasis
[Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour]
Lymphatic Metastasis
[Expression of matrix metalloproteinase 9 (MMP-9) and laminin-receptor in breast carcinoma and their correlation with tumor metastasis and prognosis]
Lymphatic Metastasis
[Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix]
Lymphatic Metastasis
[Expression of matrix metalloproteinase-2,9 in hypopharyngeal carcinoma and its relationship with lymphatic metastasis]
Lymphatic Metastasis
[Expression of matrix metaloproteinase and tissue inhibitors in ovarian tumors]
Lymphatic Metastasis
[Expression of MMP-2, MMP-9, TIMP-1 and their relationship with prognosis in NSCLC.]
Lymphatic Metastasis
[Expression of MMP-9 and TIMP-1 in nasopharyngeal carcinoma and its signification at Xi'an and Shenzhen]
Lymphatic Metastasis
[Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance]
Lymphatic Metastasis
[Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues]
Lymphatic Metastasis
[Matrix metalloproteinase 2 and 9 as the factor of head and neck tumor metastasis]
Lymphatic Metastasis
[Overexpression of IL-8 and MMP-9 confer high malignant phenotype in patients with non-small cell lung cancer]
Lymphatic Metastasis
[Relationship and clinical significance of KiSS-1, nuclear factor kappa B (NF-kappaB), p50, and matrix metalloproteinase 9 expression in breast cancer]
Lymphatic Metastasis
[Relationship between bFGF mRNA and MMP-9 mRNA expression in gastric carcinoma and their clinicopathological features as well as patients survival]
Lymphatic Metastasis
[Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix]
Lymphatic Metastasis
[Relationship between lymph node metastasis and the expressions of E-cadherin, N-cadherin, and matrix metalloproteinase in breast carcinoma]
Lymphatic Metastasis
[Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas]
Lymphatic Metastasis
[Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer.]
Lymphatic Metastasis
[Significance in gene expression of matrix metalloproteinase-9, urokinase-type plasminogen activator and tissue inhibitor of metalloproteinase for metastases of gastric and/or colo-rectal cancer]
Lymphatic Metastasis
[Study on expression of matrix metalloproteinases and their inhibitors in parotid gland tumors]
Lymphatic Metastasis
[The expression and its clinical significance of MMP-2 and MMP-9 in non-small cell lung cancer.]
Lymphatic Metastasis
[The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship]
Lymphatic Metastasis
[Treatment of lymph node metastasis from the viewpoint of surgical oncology]
Lymphedema
Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9.
Lymphoma
A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression.
Lymphoma
Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases.
Lymphoma
Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1.
Lymphoma
Biomarkers Reflecting The Destruction Of The Blood-Brain Barrier Are Valuable In Predicting The Risk Of Lymphomas With Central Nervous System Involvement.
Lymphoma
Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase.
Lymphoma
Correlations of mouse lymphoma xenografts with the expressions of MMP-9 and Bcl-2.
Lymphoma
Distinct Functionality of Tumor Cell-Derived Gelatinases during Formation of Liver Metastases.
Lymphoma
Effects of serum amyloid A on matrix metalloproteinase-9 production in feline lymphoma-derived cell lines.
Lymphoma
Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression.
Lymphoma
Expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in tissues with a diagnosis of childhood lymphoma.
Lymphoma
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells.
Lymphoma
Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas.
Lymphoma
Galectin-7 in lymphoma: elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model.
Lymphoma
Gelatinase B (MMP-9) production and expression by stromal cells in the normal and adult thymus and experimental thymic lymphoma.
Lymphoma
Gelatinase B (MMP-9), but not its inhibitor (TIMP-1), dictates the growth rate of experimental thymic lymphoma.
Lymphoma
Gelatinases (MMP-2 and MMP-9), TIMP-1 expression and the extent of neovascularization in aggressive non-Hodgkin's lymphomas.
Lymphoma
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice.
Lymphoma
Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas.
Lymphoma
Korean Red Ginseng Extract Enhances the Anticancer Effects of Imatinib Mesylate Through Abrogation p38 and STAT5 Activation in KBM-5 Cells.
Lymphoma
Lack of prognostic value of MMP-9 expression and immunohistochemically defined germinal center phenotype in patients with diffuse large B-cell lymphoma treated with modern chemotherapy with or without CD20 antibody.
Lymphoma
Matrix metalloproteinase-9 is upregulated in nucleophosmin-anaplastic lymphoma kinase-positive anaplastic lymphomas and activated at the cell surface by the chaperone heat shock protein 90 to promote cell invasion.
Lymphoma
Modulation of matrix metalloproteinase-9 activity by hyaluronan is dependent on NF-kappaB activity in lymphoma cell lines with dissimilar invasive behavior.
Lymphoma
Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases.
Lymphoma
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Positively Modulates Matrix Metalloproteinase-9 Production in Alveolar Macrophages upon Toll-Like Receptor 7 Signaling and Influenza Virus Infection.
Lymphoma
Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
Lymphoma
Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
Lymphoma
Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in Hodgkin's and non-Hodgkin's lymphoma.
Lymphoma
Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1.
Lymphoma
Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs.
Lymphoma
The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma.
Lymphoma
Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice.
Lymphoma
Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.
Lymphoma
YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma.
Lymphoma
[Expressions of matrix metalloproteinase 9 in mucosal natural killer/T cell and mature T cell lymphomas and its relation to Epstein-Barr virus infection]
Lymphoma
[Inhibition of TLR4 represses proliferation and invasion ability of Raji lymphoma cells].
Lymphoma
[mRNA and Protein Expression of AXIN,?-Catenin, MMP7 and MMP9 and Their Relationship in Lymphoma Cells].
Lymphoma, B-Cell
Chi-Ju-Di-Huang-Wan protects rats against retinal ischemia by downregulating matrix metalloproteinase-9 and inhibiting p38 mitogen-activated protein kinase.
Lymphoma, B-Cell
Evaluation of the antitumor activity of platinum nanoparticles in the treatment of hepatocellular carcinoma induced in rats.
Lymphoma, B-Cell
Functions of endothelin-1 in apoptosis and migration in hepatocellular carcinoma.
Lymphoma, B-Cell
Gelatinases (MMP-2 and MMP-9), TIMP-1 expression and the extent of neovascularization in aggressive non-Hodgkin's lymphomas.
Lymphoma, B-Cell
I157172, a novel inhibitor of cystathionine ?-lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3.
Lymphoma, B-Cell
Lack of prognostic value of MMP-9 expression and immunohistochemically defined germinal center phenotype in patients with diffuse large B-cell lymphoma treated with modern chemotherapy with or without CD20 antibody.
Lymphoma, B-Cell
Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells via up-regulation of MEST through NF-?B1.
Lymphoma, B-Cell
microRNA-613 exerts anti-angiogenic effect on nasopharyngeal carcinoma cells through inactivating the AKT signaling pathway by down-regulating FN1.
Lymphoma, B-Cell
miR-30d inhibits cell biological progression of Ewing's sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways
Lymphoma, B-Cell
Preconditioning with pitavastatin, an HMG-CoA reductase inhibitor, attenuates C-Jun N-terminal kinase activation in experimental subarachnoid hemorrhage-induced apoptosis.
Lymphoma, B-Cell
Puerarin 6?-O-xyloside possesses significant antitumor activities on colon cancer through inducing apoptosis.
Lymphoma, B-Cell
Trametes robiniophila may induce apoptosis and inhibit MMPs expression in the human gastric carcinoma cell line MKN-45.
Lymphoma, B-Cell
Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.
Lymphoma, B-Cell
[Expression and significance of MMP-26, TIMP-4 and MMP-9 in diffuse large B-cell lymphoma cells].
Lymphoma, B-Cell, Marginal Zone
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Positively Modulates Matrix Metalloproteinase-9 Production in Alveolar Macrophages upon Toll-Like Receptor 7 Signaling and Influenza Virus Infection.
Lymphoma, Follicular
Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
Lymphoma, Large B-Cell, Diffuse
Lack of prognostic value of MMP-9 expression and immunohistochemically defined germinal center phenotype in patients with diffuse large B-cell lymphoma treated with modern chemotherapy with or without CD20 antibody.
Lymphoma, Large B-Cell, Diffuse
[Expression and significance of MMP-26, TIMP-4 and MMP-9 in diffuse large B-cell lymphoma cells].
Lymphoma, Large-Cell, Immunoblastic
Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs.
Lymphoma, Non-Hodgkin
Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma.
Lymphoma, Non-Hodgkin
Expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in tissues with a diagnosis of childhood lymphoma.
Lymphoma, Non-Hodgkin
Galectin-7 in lymphoma: elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model.
Lymphoma, Non-Hodgkin
Plasma MMP-2-TIMP-2 complex levels measured during follow-up predict a risk of relapse in patients with malignant lymphoma.
Lymphoma, Non-Hodgkin
Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in Hodgkin's and non-Hodgkin's lymphoma.
Lymphoma, Non-Hodgkin
[Expression of CD147 and matrix metalloproteinase-9 in children with non-Hodgkin's lymphoma and its correlation with prognosis]
Lymphoma, T-Cell
Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis.
Lymphoma, T-Cell
Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model.
Lymphopenia
Recombinant mouse granulocyte chemotactic protein-2: production in bacteria, characterization, and systemic effects on leukocytes.
macrophage elastase deficiency
Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
Macular Degeneration
Amyloid-?-induced matrix metalloproteinase-9 secretion is associated with retinal pigment epithelial barrier disruption.
Macular Degeneration
Association analysis of genetic polymorphisms and expression levels of selected genes involved in extracellular matrix turnover and angiogenesis with the risk of age-related macular degeneration.
Macular Degeneration
Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
Macular Degeneration
Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation.
Macular Degeneration
Increased pro-MMP9 plasma levels are associated with neovascular age-related macular degeneration and with the risk allele of rs142450006 near MMP9.
Macular Degeneration
MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration.
Macular Degeneration
MMP9 gene polymorphism is not associated with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration in a Chinese Han population.
Macular Degeneration
Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular disorders.
Macular Degeneration
Sequential in-office vitreous aspirates demonstrate vitreous matrix metalloproteinase 9 levels correlate with the amount of subretinal fluid in eyes with wet age-related macular degeneration.
Macular Degeneration
Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration.
Macular Degeneration
SIRT1 negatively regulates amyloid-beta-induced inflammation via the NF-?B pathway.
Macular Degeneration
The Role of Matrix Metalloproteinases Polymorphisms in Age-Related Macular Degeneration.
Macular Edema
Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients.
Macular Edema
Role of matrix metalloproteinase 9 and its tissue inhibitor 1 in development and prognosis of diabetic retinopathy.
Macular Edema
The relationship between plasma MMP-9 and TIMP-2 levels and intraocular pressure elevation in diabetic patients after intravitreal triamcinolone injection.
Malaria
Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
Malaria
Genesis of placental sequestration in malaria and possible targets for drugs for placental malaria.
Malaria
Haemozoin induces early cytokine-mediated lysozyme release from human monocytes through p38 MAPK- and NF-kappaB-dependent mechanisms.
Malaria
Involvement of p38 MAPK in haemozoin-dependent MMP-9 enhancement in human monocytes.
Malaria
Matrix Metalloproteinase-9 and Haemozoin: Wedding Rings for Human Host and Plasmodium falciparum Parasite in Complicated Malaria.
Malaria
Matrix metalloproteinase-9 polymorphism 1562 C > T (rs3918242) associated with protection against placental malaria.
Malaria
Matrix Metalloproteinases and Their Tissue Inhibitors (TIMPs) in Plasmodium falciparum Malaria: Serum Levels of TIMP-1 Are Associated with Disease Severity.
Malaria
Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity.
Malaria
Natural haemozoin induces expression and release of human monocyte tissue inhibitor of metalloproteinase-1.
Malaria
Phagocytosis of hemozoin enhances matrix metalloproteinase-9 activity and TNF-alpha production in human monocytes: role of matrix metalloproteinases in the pathogenesis of falciparum malaria.
Malaria
Role of the NF-kappaB transcription pathway in the haemozoin- and 15-HETE-mediated activation of matrix metalloproteinase-9 in human adherent monocytes.
Malaria, Cerebral
Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
Malaria, Cerebral
Natural haemozoin induces expression and release of human monocyte tissue inhibitor of metalloproteinase-1.
Malaria, Cerebral
Phagocytosis of haemozoin (malarial pigment) enhances metalloproteinase-9 activity in human adherent monocytes: role of IL-1beta and 15-HETE.
Malformations of Cortical Development
Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Malformations of Cortical Development
Matrix metalloproteinase-9 (MMP-9) in human intractable epilepsy caused by focal cortical dysplasia.
Malnutrition
The expression of matrix metalloproteinases 8 and 9 by neutrophils of Wistar albino rats with severe qualitative and quantitative protein malnutrition.
Malocclusion
Using Salivary MMP-9 to Successfully Quantify Periodontal Inflammation during Orthodontic Treatment.
Mania
Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression.
Mania
The Clinical Effect of Electroconvulsive Therapy and Its Relationship with Serum Levels of MMP-9 and CXCL12 in Patients with Mania.
Marfan Syndrome
Gelatinolytic activity in gingival crevicular fluid and saliva of growing patients with Marfan syndrome: a case-control study.
Marfan Syndrome
Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome.
Masked Hypertension
Changes of Metalloproteinases Profile in Patients With Masked Hypertension.
Mastitis
Increase in milk metalloproteinase activity and vascular permeability in bovine endotoxin-induced and naturally occurring Escherichia coli mastitis.
Mastitis
The Effects of Matrix Metalloproteinase-9 on Dairy Goat Mastitis and Cell Survival of Goat Mammary Epithelial Cells.
Mastocytoma
Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain.
Medulloblastoma
Apoptosis Induced by Knockdown of uPAR and MMP-9 is Mediated by Inactivation of EGFR/STAT3 Signaling in Medulloblastoma.
Medulloblastoma
Blockade of tumor growth due to matrix metalloproteinase-9 inhibition is mediated by sequential activation of beta1-integrin, ERK, and NF-kappaB.
Medulloblastoma
Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.
Medulloblastoma
Gadd45a sensitizes medulloblastoma cells to irradiation and suppresses MMP-9-mediated EMT.
Medulloblastoma
Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells.
Medulloblastoma
MMP-9 short interfering RNA induced senescence resulting in inhibition of medulloblastoma growth via p16(INK4a) and mitogen-activated protein kinase pathway.
Medulloblastoma
MT1-MMP expression level status dictates the in vitro action of lupeol on inflammatory biomarkers MMP-9 and COX-2 in medulloblastoma cells.
Medulloblastoma
Pharmacological targeting of ?-adrenergic receptor functions abrogates NF-?B signaling and MMP-9 secretion in medulloblastoma cells.
Medulloblastoma
Retraction: siRNA-Mediated Downregulation of MMP-9 and uPAR in Combination with Radiation Induces G2-M Cell-Cycle Arrest in Medulloblastoma.
Medulloblastoma
siRNA-mediated downregulation of MMP-9 and uPAR in combination with radiation induces G2/M cell-cycle arrest in Medulloblastoma.
Medulloblastoma
Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype.
Meibomian Gland Dysfunction
Benign Reactive Lymphoid Hyperplasia of the Conjunctiva Treated With Cyclosporine.
Meibomian Gland Dysfunction
Changes in the expression of matrix metalloproteinase-9 after intense pulsed light therapy combined with meibomian gland expression in moderate and severe meibomian gland dysfunction.
Meibomian Gland Dysfunction
Clinical Outcomes of Lifitegrast 5% Ophthalmic Solution in the Treatment of Dry Eye Disease.
Meibomian Gland Dysfunction
Effect of Oral Re-esterified Omega-3 Nutritional Supplementation on Dry Eyes.
Meibomian Gland Dysfunction
Effect of thermal pulsation treatment on tear film parameters in dry eye disease patients.
Meibomian Gland Dysfunction
Effects of lid debris debridement combined with meibomian gland expression on the ocular surface MMP-9 levels and clinical outcomes in moderate and severe meibomian gland dysfunction.
Meibomian Gland Dysfunction
The non-antibiotic properties of tetracyclines: Clinical potential in ophthalmic disease.
Melanoma
'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression.
Melanoma
(-)-Oleocanthal exerts anti-melanoma activities and inhibits STAT3 signaling pathway.
Melanoma
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces matrix metalloproteinase (MMP) expression and invasion in A2058 melanoma cells.
Melanoma
22?-hydroxytingenone induces apoptosis and suppresses invasiveness of melanoma cells by inhibiting MMP-9 activity and MAPK signaling.
Melanoma
?-Elemene inhibits the metastasis of B16F10 melanoma cells by downregulation of the expression of uPA, uPAR, MMP-2, and MMP-9.
Melanoma
A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins.
Melanoma
A novel synthetic oleanane triterpenoid suppresses adhesion, migration, and invasion of highly metastatic melanoma cells by modulating gelatinase signaling axis.
Melanoma
A prognostic index in skin melanoma through the combination of matrix metalloproteinase-2, Ki67, and p53.
Melanoma
Acidic extracellular pH increases calcium influx-triggered phospholipase D activity along with acidic sphingomyelinase activation to induce matrix metalloproteinase-9 expression in mouse metastatic melanoma.
Melanoma
Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signaling.
Melanoma
Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice.
Melanoma
Active and inactive forms of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
Melanoma
Adhesive defect in extracellular matrix tenascin-X-null fibroblasts: a possible mechanism of tumor invasion.
Melanoma
Alterations in endothelial cell proteinase and inhibitor polarized secretion following treatment with interleukin-1, phorbol ester, and human melanoma cell conditioned medium.
Melanoma
Analysis of the application of MMP-9 inhibitor in skin melanoma: experimental study.
Melanoma
Anti-angiogenesis effect of essential oil from Curcuma zedoaria in vitro and in vivo.
Melanoma
Anti-metastatic Effects of Cationic KT2 Peptide (a Lysine/Tryptophan-rich Peptide) on Human Melanoma A375.S2 Cells.
Melanoma
Antimetastatic potential of vernolide-A, a sesquiterpenoid from Vernonia cinerea L.
Melanoma
AT1 receptors activation enhances the expression of MMP-2, MMP-13 and VEGF but not MMP-9 in B16F10 melanoma cells.
Melanoma
Attenuation of genotoxicity under adhesion-restrictive conditions through modulation of p53, gamma H2AX and nuclear DNA organization.
Melanoma
Augmented antitumor effects of combination therapy with VEGF antibody and cisplatin on murine B16F10 melanoma cells.
Melanoma
Bornyl cis-4-Hydroxycinnamate Suppresses Cell Metastasis of Melanoma through FAK/PI3K/Akt/mTOR and MAPK Signaling Pathways and Inhibition of the Epithelial-to-Mesenchymal Transition.
Melanoma
Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappa B and c-Jun.
Melanoma
Changes in the Levels of N-Cadherin and PCNA in Skin Melanoma Cells Are Mediated through Matrix Metalloproteinase 9.
Melanoma
Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
Melanoma
Constitutive production of 92-kDa gelatinase B can be suppressed by alterations in cell shape.
Melanoma
Coordinated targeting of MMP-2/MMP-9 by miR-296-3p/FOXCUT exerts tumor-suppressing effects in choroidal malignant melanoma.
Melanoma
Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis.
Melanoma
CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells.
Melanoma
Culture of human A375 melanoma cells in the presence of fibronectin causes expression of MMP-9 and activation of MMP-2 in culture supernatants.
Melanoma
Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo.
Melanoma
Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9.
Melanoma
Differential regulation of gelatinase B and tissue-type plasminogen activator expression in human Bowes melanoma cells.
Melanoma
Differential regulation of MMP-9 and TIMP-2 expression in malignant melanoma developed in metallothionein/RET transgenic mice.
Melanoma
Evaluation of heparanase and matrix metalloproteinase-9 in patients with cutaneous malignant melanoma.
Melanoma
Ex Vivo and In Vivo Imaging and Biodistribution of Aptamers Targeting the Human Matrix MetalloProtease-9 in Melanomas.
Melanoma
Expression and activation of pro-gelatinase A by human melanoma cell lines with different tumorigenic potential.
Melanoma
Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors.
Melanoma
Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin.
Melanoma
Expression of matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of MMP (TIMP)-1 in conjunctival melanomas and clinical implications.
Melanoma
Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
Melanoma
Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
Melanoma
Expression of vascular endothelial growth factor-A, matrix metalloproteinase-9, and extravascular matrix patterns and their correlations with clinicopathologic parameters in posterior uveal melanomas.
Melanoma
Fibronectin-integrin (alpha5beta1) modulates migration and invasion of murine melanoma cell line B16F10 by involving MMP-9.
Melanoma
Filamin A-mediated down-regulation of the exchange factor Ras-GRF1 correlates with decreased matrix metalloproteinase-9 expression in human melanoma cells.
Melanoma
Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
Melanoma
Ginkgo biloba Exocarp Extract Inhibits the Metastasis of B16-F10 Melanoma Involving PI3K/Akt/NF-?B/MMP-9 Signaling Pathway.
Melanoma
GM3 Upregulation of matrix metalloproteinase-9 possibly through PI3K, AKT, RICTOR, RHOGDI-2, and TNF-A pathways in mouse melanoma B16 cells.
Melanoma
Halogenated bis(methoxy-benzylidene)-4-piperidone curcuminoids with improved anticancer activity.
Melanoma
Hemoglobin induces the production and release of matrix metalloproteinase-9 from human malignant cells.
Melanoma
High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
Melanoma
Homophilic interactions of Tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways.
Melanoma
Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma.
Melanoma
Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis.
Melanoma
Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography.
Melanoma
Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Melanoma
In Vitro Methods to Study the Modulation of Migration and Invasion by Sphingosine-1-Phosphate.
Melanoma
Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines.
Melanoma
Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice.
Melanoma
Inhibition of tumor growth by ?-elemene through downregulation of the expression of uPA, uPAR, MMP-2, and MMP-9 in a murine intraocular melanoma model.
Melanoma
Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9.
Melanoma
Interleukin-33 is a Novel Immunosuppressor that Protects Cancer Cells from TIL Killing by a Macrophage-Mediated Shedding Mechanism.
Melanoma
Intertumor heterogeneity in vascularity and invasiveness of artificial melanoma brain metastases.
Melanoma
Invasion-associated MMP-2 and MMP-9 are up-regulated intracellularly in concert with apoptosis linked to melanoma cell detachment.
Melanoma
Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt-dependent matrix metalloproteinase-9 expression.
Melanoma
Laminin gamma 1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16-F10 mouse melanoma cells.
Melanoma
Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.
Melanoma
Long noncoding RNA CPS1-IT1 suppresses melanoma cell metastasis through inhibiting Cyr61 via competitively binding to BRG1.
Melanoma
Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.
Melanoma
Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway.
Melanoma
Lycorine inhibits melanoma cell migration and metastasis mainly through reducing intracellular levels of ?-catenin and matrix metallopeptidase 9.
Melanoma
Matrix metalloproteinase 9 targeting peptides: syntheses, 68Ga-labeling, and preliminary evaluation in a rat melanoma xenograft model.
Melanoma
Matrix metalloproteinase induction in the tumor stroma does not depend on CD147 expression in murine B16 melanoma.
Melanoma
Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma.
Melanoma
Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Melanoma
MED27 promotes melanoma growth by targeting AKT/MAPK and NF-?B/iNOS signaling pathways.
Melanoma
Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA.
Melanoma
Melanoma invasion in reconstructed human skin is influenced by skin cells--investigation of the role of proteolytic enzymes.
Melanoma
Merkel Cell Polyomavirus Small Tumor Antigen Activates Matrix Metallopeptidase-9 Gene Expression for Cell Migration and Invasion.
Melanoma
Micro-environmental cross-talk in an organotypic human melanoma-in-skin model directs M2-like monocyte differentiation via IL-10.
Melanoma
MicroRNA-183 inhibits A375 human melanoma cell migration and invasion by targeting Ezrin and MMP-9.
Melanoma
MicroRNA-330 inhibits growth and migration of melanoma A375 cells: In vitro study.
Melanoma
Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion.
Melanoma
MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAFV600E Mutation Detected in Circulating-Free DNA.
Melanoma
MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma.
Melanoma
MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma.
Melanoma
Modulation of MMP-2 and -9 secretion by cytokines, inducers and inhibitors in human melanoma A-2058 cells.
Melanoma
Monitoring mmp-9 gene expression in stromal cells using a novel transgenic mouse model.
Melanoma
Mycobacterium indicus pranii (Mw) inhibits invasion by reducing matrix metalloproteinase (MMP-9) via AKT/ERK-1/2 and PKC? signalling: a potential candidate in melanoma cancer therapy.
Melanoma
Neutralization of matrix metalloproteinase-9 potentially enhances oncolytic efficacy of tanapox virus for melanoma therapy.
Melanoma
Nuclear factor inducing kinase: A key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.
Melanoma
Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via ?9?1 integrin.
Melanoma
Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways.
Melanoma
Overexpression of Hsp27 affects the metastatic phenotype of human melanoma cells in vitro.
Melanoma
Oxalomalate suppresses metastatic melanoma through IDH-targeted stress response to ROS.
Melanoma
Penta-O-galloyl-beta-D-glucose inhibits the invasion of mouse melanoma by suppressing metalloproteinase-9 through down-regulation of activator protein-1.
Melanoma
Polysaccharide from Inonotus obliquus inhibits migration and invasion in B16-F10 cells by suppressing MMP?2 and MMP?9 via downregulation of NF-?B signaling pathway.
Melanoma
Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Melanoma
PSY-1, a Taxus chinensis var. mairei extract, inhibits cancer cell metastasis by interfering with MMPs.
Melanoma
Quercetin and sulforaphane in combination suppress the progression of melanoma through the down-regulation of matrix metalloproteinase-9.
Melanoma
Regulation of melanoma cell migration and invasion by laminin-5 and alpha3beta1 integrin (VLA-3).
Melanoma
RhoA mediates the expression of acidic extracellular pH-induced matrix metalloproteinase-9 mRNA through phospholipase D1 in mouse metastatic B16-BL6 melanoma cells.
Melanoma
RNAi-mediated MMP-9 silencing inhibits mouse melanoma cell invasion and migration in vitro and in vivo.
Melanoma
Role of poly(?-caprolactone) lipid-core nanocapsules on melanoma-neutrophil crosstalk.
Melanoma
Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells.
Melanoma
Silencing of astrocyte elevated gene-1 inhibits proliferation and migration of melanoma cells and induces apoptosis.
Melanoma
Silymarin Targets ?-Catenin Signaling in Blocking Migration/Invasion of Human Melanoma Cells.
Melanoma
Slow induction of gelatinase B mRNA by acidic culture conditions in mouse metastatic melanoma cells.
Melanoma
Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo.
Melanoma
Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGF? Inhibitor Sequencing in Melanoma.
Melanoma
Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1.
Melanoma
Synthesis and antimetastatic activity evaluation of cinnamic acid derivatives containing 1,2,3-triazolic portions.
Melanoma
Synthesis and exploration of a novel chlorobenzylated 2-aminothiazole-phenyltriazole hybrid as migratory inhibitor of B16F10 in melanoma cells.
Melanoma
Tetraspanin CD151 Stimulates Adhesion-dependent Activation of Ras, Rac, and Cdc42 by Facilitating Molecular Association between ?1 Integrins and Small GTPases.
Melanoma
Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells.
Melanoma
The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells.
Melanoma
The influence of different microenvironments on melanoma invasiveness and microcirculation patterns: an animal experiment study in the mouse model.
Melanoma
The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like Region.
Melanoma
The matrix metalloproteinase 9 (mmp-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist.
Melanoma
The tumour suppressor p33ING1 does not regulate migration and angiogenesis in melanoma cells.
Melanoma
Therapeutic intervention of proanthocyanidins on the migration capacity of melanoma cells is mediated through PGE2 receptors and ?-catenin signaling molecules.
Melanoma
TRIM59 loss in M2 macrophages promotes melanoma migration and invasion by upregulating MMP-9 and Madcam1.
Melanoma
Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells.
Melanoma
U0126, a mitogen-activated protein kinase kinase inhibitor, inhibits the invasion of human A375 melanoma cells.
Melanoma
Up-regulated expression of the beta3 integrin and the 92-kDa gelatinase in human HT-144 melanoma cell tumors grown in nude mice.
Melanoma
Up-regulating ribonuclease inhibitor inhibited epithelial-to-mesenchymal transition and metastasis in murine melanoma cells.
Melanoma
Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation.
Melanoma
Wild-type p53 gene transfer inhibits invasion and reduces matrix metalloproteinase-2 levels in p53-mutated human melanoma cells.
Melanoma
[Caspase-3 expression in the tissues of experimental melanoma and its metastases during matrix metalloproteinase-9 inhibition].
Melanoma
[Controlled expression of matrix metalloproteinase 9 promotes expression of invasive phenotype of human melanoma cells]
Melanoma
[Down-regulation of metastatic phenotype in human melanoma cells by controlled expression of anti-sense matrix metalloproteinase 9]
Melanoma
[Effects of CD147 on the production of matrix metalloproteinase-9 by fibroblasts and the invasion of melanoma cells]
Melanoma
[Inhibition of matrix metalloproteinases 9 and 13 affects the degree of lymphocytic infiltration and the expression levels of microRNA miR-21 and miR-let-7b in melanoma cells in vivo].
Melanoma
[Role of matrix metalloproteinases (MMPs) in tumor invasion and metastasis: serial studies on MMPs and TIMPs]
Melanoma
[The influence of different microenvironments on melanoma invasiveness and microcirculation patterns]
Melanoma
[The mechanisms of microenvironments influence on vasculogenic mimicry between introcular and subcutaneous melanoma]
Melanoma
[Zymographic analysis of MMPs in human carcinoma cell lines with different metastasis potential]
Melanoma, Amelanotic
A novel gelatinolytic enzyme secreted by amelanotic cells isolated from B16 melanoma cell line.
Melanoma, Experimental
A novel gelatinolytic enzyme secreted by amelanotic cells isolated from B16 melanoma cell line.
Melanoma, Experimental
Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo.
Melanoma, Experimental
Matrix metalloproteinase induction in the tumor stroma does not depend on CD147 expression in murine B16 melanoma.
Melanoma, Experimental
[Caspase-3 expression in the tissues of experimental melanoma and its metastases during matrix metalloproteinase-9 inhibition].
Melkersson-Rosenthal Syndrome
Expression of protease-activated receptor-1 and -2 in orofacial granulomatosis.
Memory Disorders
Betaine prevents homocysteine-induced memory impairment via matrix metalloproteinase-9 in the frontal cortex.
Meningioma
Clinicopathological characteristics, hormone receptor status and matrix metallo-proteinase-9 (MMP-9) immunohistochemical expression in spinal meningiomas.
Meningioma
Correlation of clinical and biological parameters with peritumoral edema in meningioma.
Meningioma
Deficiency of the protein-tyrosine phosphatase DEP-1/PTPRJ promotes matrix metalloproteinase-9 expression in meningioma cells.
Meningioma
Differential expression of extracellular matrix-related genes in rare variants of meningioma.
Meningioma
Ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas.
Meningioma
Evaluation of matrix metalloproteinase type IV-collagenases in serum of patients with tumors of the central nervous system.
Meningioma
Expression of extracellular matrix-degrading proteins in classic, atypical, and anaplastic meningiomas.
Meningioma
Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema.
Meningioma
Expression of matrix metalloproteinases and their inhibitors in human brain tumors.
Meningioma
Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas.
Meningioma
Expression of MMP-2 and MMP-9 in Benign Canine Rostrotentorial Meningiomas Is Not Correlated to the Extent of Peritumoral Edema.
Meningioma
Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema.
Meningioma
Gene Expression of Matrix Metalloproteinases and their Inhibitors (TIMPs) in Meningiomas of Dogs.
Meningioma
Increased co-expression of macrophage migration inhibitory factor and matrix metalloproteinase 9 is associated with tumor recurrence of meningioma.
Meningioma
Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and MMP-9.
Meningioma
Matrix metalloprotease-9 expresssion in meningioma: Correlation with growth fraction and role of gender. A pilot immunohistochemical study.
Meningioma
Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 expression in the biological behavior of Canine and Feline Meningioma.
Meningioma
Matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas.
Meningioma
Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
Meningioma
RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
Meningioma
RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis.
Meningioma
RNAi-mediated downregulation of radiation-induced MMP-9 leads to apoptosis via activation of ERK and Akt in IOMM-Lee cells.
Meningioma
Role of VEGF and matrix metalloproteinase-9 in peritumoral brain edema associated with supratentorial benign meningiomas.
Meningioma
Secretion of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by meningiomas detected by cell immunoblot analysis.
Meningioma
The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells.
Meningioma
The role of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in microcystic meningiomas.
Meningioma
uPAR and cathepsin B shRNA impedes TGF-?1-driven proliferation and invasion of meningioma cells in a XIAP-dependent pathway.
Meningitis
Angiostrongylus cantonensis infection induces MMP-9 and causes tight junction protein disruption associated with Purkinje cell degeneration.
Meningitis
Association of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinase-4 in cerebrospinal fluid with blood-brain barrier dysfunction in patients with eosinophilic meningitis caused by Angiostrongylus cantonensis.
Meningitis
Association of matrix metalloproteinase-9 in eosinophilic meningitis of BALB/c mice caused by Angiostrongylus cantonensis.
Meningitis
Association of plasminogen activators and matrix metalloproteinase-9 proteolytic cascade with blood-CNS barrier damage of angiostrongyliasis.
Meningitis
Biochemical and pathological evaluation of albendazole/thalidomide co-therapy against eosinophilic meningitis or meningoencephalitis induced by Angiostrongylus cantonensis.
Meningitis
Cerebrospinal fluid u-plasminogen activator and matrix metalloproteinase-9 levels in human eosinophilic meningitis associated with angiostrongyliasis.
Meningitis
Chemokines and matrix metalloproteinases in cerebrospinal fluid of patients with central nervous system complications caused by varicella-zoster virus.
Meningitis
Comparative efficacies of albendazole and the Chinese herbal medicine long-dan-xie-gan-tan, used alone or in combination, in the treatment of experimental eosinophilic meningitis induced by Angiostrongylus cantonensis.
Meningitis
Dexamethasone downregulates the expressions of MMP-9 and oxidative stress in mice with eosinophilic meningitis caused by Angiostrongylus cantonensis infection.
Meningitis
Differences of proteolytic enzymes and pathological changes in permissive and nonpermissive animal hosts for Angiostrongylus cantonensis infection.
Meningitis
Dynamic changes of matrix metalloproteinase-9 in patients with Klebsiella pneumoniae meningitis.
Meningitis
Effects of Toll-like receptor 2 agonist Pam(3)CysSK(4) on inflammation and brain damage in experimental pneumococcal meningitis.
Meningitis
Efficacy of albendazole-GM6001 co-therapy against Angiostrongylus cantonensis-induced meningitis in BALB/c mice.
Meningitis
Efficacy of curcumin therapy against Angiostrongylus cantonensis-induced eosinophilic meningitis.
Meningitis
Efficacy of GM6001 as an adjuvant to ceftriaxone in a neonatal rat model of Streptococcus pneumoniae meningitis.
Meningitis
Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of children with echovirus type 30 and mumps meningitis.
Meningitis
Endothelial cell/macrophage cocultures as a model to study Streptococcus suis-induced inflammatory responses.
Meningitis
Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with meningitis.
Meningitis
Gelatinase activity of matrix metalloproteinases in the cerebrospinal fluid of various patient populations.
Meningitis
Immunohistochemical analysis of MMP-9, MMP-2 and TIMP-1, TIMP-2 expression in the central nervous system following infection with viral and bacterial meningitis.
Meningitis
Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Meningitis
Induction of matrix metalloproteinase-9 in murine eosinophilic meningitis caused by Angiostrongylus cantonensis.
Meningitis
Levels of matrix metalloproteinase-9 within cerebrospinal fluid in a rabbit model of coccidioidal meningitis and vasculitis.
Meningitis
Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.
Meningitis
Matrix metalloprotease-9 in cerebrospinal fluid correlates with disease activity in lymphomatous meningitis.
Meningitis
Melatonin inhibits matrix metalloproteinase-9 (MMP-9) activation in the lipopolysaccharide (LPS)-stimulated RAW 264.7 and BV2 cells and a mouse model of meningitis.
Meningitis
The efficacy of therapy with albendazole in mice with parasitic meningitis caused by Angiostrongylus cantonensis.
Meningitis
Ultrastructural localization of matrix metalloproteinase-9 in eosinophils from the cerebrospinal fluid of mice with eosinophilic meningitis caused by Angiostrongylus cantonensis.
Meningitis
Upregulation of MMP-9/TIMP-1 enzymatic system in eosinophilic meningitis caused by Angiostrongylus cantonensis.
Meningitis
Zinc metalloproteinase ZmpC suppresses experimental pneumococcal meningitis by inhibiting bacterial invasion of central nervous systems.
Meningitis, Aseptic
Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with meningitis.
Meningitis, Aseptic
Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.
Meningitis, Aseptic
Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis.
Meningitis, Bacterial
Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
Meningitis, Bacterial
Changes in MMP-9 and TIMP-1 Concentrations in Cerebrospinal Fluid after 1 Week of Treatment of Childhood Bacterial Meningitis.
Meningitis, Bacterial
Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.
Meningitis, Bacterial
Differential expression of matrix metalloproteinases in bacterial meningitis.
Meningitis, Bacterial
Effects of B7-H3 on the Inflammatory Response and Expression of MMP-9 in Mice with Pneumococcal Meningitis.
Meningitis, Bacterial
Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion.
Meningitis, Bacterial
Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with meningitis.
Meningitis, Bacterial
Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children.
Meningitis, Bacterial
Immunohistochemical analysis of MMP-9, MMP-2 and TIMP-1, TIMP-2 expression in the central nervous system following infection with viral and bacterial meningitis.
Meningitis, Bacterial
Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
Meningitis, Bacterial
Matrix metalloproteinase-9 deficiency impairs host defense mechanisms against Streptococcus pneumoniae in a mouse model of bacterial meningitis.
Meningitis, Bacterial
Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway.
Meningitis, Bacterial
Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis.
Meningitis, Bacterial
Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.
Meningitis, Bacterial
Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis.
Meningitis, Bacterial
Predictive Value of Cerebrospinal Fluid Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Concentrations in Childhood Bacterial Meningitis.
Meningitis, Bacterial
The Potential Role of Matrix Metalloproteinases 8 and 9 and Myeloperoxidase in Predicting Outcomes of Bacterial Meningitis of Childhood.
Meningitis, Meningococcal
Differential expression of matrix metalloproteinases in bacterial meningitis.
Meningitis, Meningococcal
Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis.
Meningitis, Pneumococcal
Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.
Meningitis, Pneumococcal
Effects of B7-H3 on the Inflammatory Response and Expression of MMP-9 in Mice with Pneumococcal Meningitis.
Meningitis, Pneumococcal
Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion.
Meningitis, Pneumococcal
In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation.
Meningitis, Pneumococcal
Inhibition of matrix metalloproteinases-2 and -9 prevents cognitive impairment induced by pneumococcal meningitis in Wistar rats.
Meningitis, Pneumococcal
Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway.
Meningitis, Viral
Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of children with echovirus type 30 and mumps meningitis.
Meningitis, Viral
Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo.
Meningitis, Viral
Immunohistochemical analysis of MMP-9, MMP-2 and TIMP-1, TIMP-2 expression in the central nervous system following infection with viral and bacterial meningitis.
Meningitis, Viral
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid.
Meningoencephalitis
Differences of proteolytic enzymes and pathological changes in permissive and nonpermissive animal hosts for Angiostrongylus cantonensis infection.
Meningoencephalitis
Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.
Meningoencephalitis
Matrix metalloproteinase expression in sheep with listerial meningoencephalitis.
Meningoencephalitis
Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis.
Meningoencephalitis
Matrix metalloproteinase-9 leads to blood-brain barrier leakage in mice with eosinophilic meningoencephalitis caused by Angiostrongylus cantonensis.
Meningoencephalitis
Matrix Metalloproteinase-9 Leads to Claudin-5 Degradation via the NF-?B Pathway in BALB/c Mice with Eosinophilic Meningoencephalitis Caused by Angiostrongylus cantonensis.
Meningomyelocele
Histological response and expression of collagen, metalloproteinases MMP-1 and MMP-9 and tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 in fetal membranes following open intrauterine surgery: an experimental study.
Menorrhagia
Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-alpha in menstrual endometrium and effluent in women with menorrhagia.
Mesothelioma
Identifying Thoracic Malignancies Through Pleural Fluid Biomarkers: A Predictive Multivariate Model.
Mesothelioma
Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients.
Mesothelioma
Osteopontin is linked to p65 and MMP-9 expression in pulmonary adenocarcinoma but not in malignant pleural mesothelioma.
Mesothelioma, Malignant
Evaluation of Matrix Metalloproteinase 9 Serum Concentration as a Biomarker in Malignant Mesothelioma.
Mesothelioma, Malignant
Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines.
Mesothelioma, Malignant
Osteopontin is linked to p65 and MMP-9 expression in pulmonary adenocarcinoma but not in malignant pleural mesothelioma.
Mesothelioma, Malignant
Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors.
Metabolic Diseases
Serum haptoglobin-matrix metalloproteinase 9 (Hp-MMP 9) complex as a biomarker of systemic inflammation in cattle.
Metabolic Syndrome
Adipose tissue is not an important source for matrix metalloproteinase-9 in the circulation.
Metabolic Syndrome
Altered matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 levels in children with primary hypertension.
Metabolic Syndrome
Association of MMP-9 to TIMP-1 ratio with long-term body weight and waist circumference after dietary weight reduction in men with metabolic syndrome.
Metabolic Syndrome
Chymase as an important target for preventing complications of metabolic syndrome.
Metabolic Syndrome
Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors.
Metabolic Syndrome
Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case-control study.
Metabolic Syndrome
Gelatinases and their tissue inhibitors in a group of subjects with metabolic syndrome.
Metabolic Syndrome
High serum level of matrix metalloproteinase 9 and promoter polymorphism - 1562 C:T as a new risk factor for metabolic syndrome.
Metabolic Syndrome
Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
Metabolic Syndrome
Influence of Malondialdehyde and Matrix Metalloproteinase-9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic Syndrome.
Metabolic Syndrome
Low intensity exercise in the prevention of cardiac insulin resistance-related inflammation and disturbances in NOS and MMP-9 regulation in fructose-fed ovariectomised rats.
Metabolic Syndrome
Matrix metalloproteinase-9 gene polymorphisms and their interaction with environment on subarachnoid hemorrhage risk.
Metabolic Syndrome
Metalloproteinases and leptin in vehicle drivers of public service with metabolic syndrome in Armenia, Quindío.
Metabolic Syndrome
Oestradiol Treatment Counteracts the Effect of Fructose-Rich Diet on Matrix Metalloproteinase 9 Expression and NF?B Activation.
Metabolic Syndrome
The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease.
Metabolic Syndrome
Vitamin D supplementation has no effect on matrix metalloproteinases-2, -9, and tissue inhibitor matrix metalloproteinase-1 in subjects with metabolic syndrome: A pilot study.
Metabolic Syndrome
[DYNAMIC OF CLINICAL, LABORATORY AND SONOGRAPHIC PARAMETERS AFTER SUCCESSFUL LITHOLITIC THERAPY AT PATIENTS WITH GALLSTONE DISEASE IN ASSOCIATION WITH METABOLIC SYNDROME].
Metabolic Syndrome
[Evaluation of prognostic factors for the development of cholelithiasis in patients with metabolic syndrome].
Metabolic Syndrome
[The participation of matrix metalloproteinases-9 and TIMP-1 in formation of atrial fibrillation paroxisms in patients with metabolic syndrome].
Metrorrhagia
Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel.
Microaneurysm
Blood Vessel Basement Membrane Alterations in Human Retinal Microaneurysms During Aging.
Microphthalmos
Rapamycin prevents spontaneous abortion by triggering decidual stromal cell autophagy-mediated NK cell residence.
Migraine Disorders
CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine.
Migraine Disorders
Different circulating metalloproteinases profiles in women with migraine with and without aura.
Migraine Disorders
Differential effects of corticosteroids on the expression of cyclooxygenase-2, tumour necrosis factor-alpha and matrix metalloproteinase-9 in an animal model of migraine.
Migraine Disorders
Effects of Ligusticum chuanxiong and Gastrodia elata on blood-brain barrier permeability in migraine rats.
Migraine Disorders
Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression.
Migraine Disorders
Matrix metalloproteinases during and outside of migraine attacks without aura.
Migraine Disorders
New implications of the proteolytic balance between matrix metalloproteinases and their tissue inhibitors in migraine with and without aura.
Migraine Disorders
Serum levels of matrix metalloproteinases: implications in clinical neurology.
Migraine Disorders
Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine.
Migraine without Aura
Matrix metalloproteinases during and outside of migraine attacks without aura.
Migraine without Aura
Serum levels of matrix metalloproteinases: implications in clinical neurology.
Mitral Valve Stenosis
Peripheral blood levels of matrix metalloproteinases in patients referred for percutaneous balloon mitral valve commissurotomy.
Motor Neuron Disease
Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis.
Mouth Neoplasms
A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma.
Mouth Neoplasms
A novel high-throughput screening system identifies a small molecule repressive for matrix metalloproteinase-9 expression.
Mouth Neoplasms
Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.
Mouth Neoplasms
Coexpression of growth differentiation factor 11 and reactive oxygen species in metastatic oral cancer and its role in inducing the epithelial to mesenchymal transition.
Mouth Neoplasms
Combined evaluation of matrix metalloproteinases and their inhibitors has better clinical utility in oral cancer.
Mouth Neoplasms
Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression.
Mouth Neoplasms
Curcumin Inhibits Invasiveness and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Through Reducing Matrix Metalloproteinase 2, 9 and Modulating p53-E-Cadherin Pathway.
Mouth Neoplasms
Elevated Matrix Metalloproteinase-9 Expression Correlates With Advanced Stages of Oral Cancer and Is Linked to Poor Clinical Outcomes.
Mouth Neoplasms
Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
Mouth Neoplasms
Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
Mouth Neoplasms
Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma.
Mouth Neoplasms
Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma.
Mouth Neoplasms
Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Mouth Neoplasms
Kalopanaxsaponin a inhibits the invasion of human oral squamous cell carcinoma by reducing metalloproteinase-9 mRNA stability and protein trafficking.
Mouth Neoplasms
KLF6 inhibited oral cancer migration and invasion via downregulation of mesenchymal markers and inhibition of MMP-9 activities.
Mouth Neoplasms
Matrix metalloproteinase 2 and matrix metalloproteinase 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: preliminary observations.
Mouth Neoplasms
Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer.
Mouth Neoplasms
Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation.
Mouth Neoplasms
MMP-9 as a?potential biomarker for carcinoma of oral cavity: a?study in?eastern India.
Mouth Neoplasms
NGAL is Downregulated in Oral Squamous Cell Carcinoma and Leads to Increased Survival, Proliferation, Migration and Chemoresistance.
Mouth Neoplasms
Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells.
Mouth Neoplasms
Overexpression of MMPs Functions as a Prognostic Biomarker for Oral Cancer Patients: A Systematic Review and Meta-analysis.
Mouth Neoplasms
Paclitaxel induces apoptosis and reduces proliferation by targeting epidermal growth factor receptor signaling pathway in oral cavity squamous cell carcinoma.
Mouth Neoplasms
PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma.
Mouth Neoplasms
Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling.
Mouth Neoplasms
Quercetin inhibits cell viability, migration and invasion by regulating miR-16/HOXA10 axis in oral cancer.
Mouth Neoplasms
Resveratrol suppresses TPA-induced matrix metalloproteinase-9 expression through the inhibition of MAPK pathways in oral cancer cells.
Mouth Neoplasms
RNAi targeting urokinase-type plasminogen activator receptor inhibits metastasis and progression of oral squamous cell carcinoma in vivo.
Mouth Neoplasms
Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer.
Mouth Neoplasms
Slug is a downstream mediator of transforming growth factor-beta1-induced matrix metalloproteinase-9 expression and invasion of oral cancer cells.
Mouth Neoplasms
The Response of the Tongue Epithelial on Cigarette Smoke Exposure as a Risk Factor for Oral Cancer Development.
Mouth Neoplasms
Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression.
Mouth Neoplasms
Tricetin suppresses human oral cancer cell migration by reducing matrix metalloproteinase-9 expression through the mitogen-activated protein kinase signaling pathway.
Mouth Neoplasms
[Effect of mi-138 targeting PLD2 gene on proliferation and migration of oral cancer cells].
Moyamoya Disease
Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease.
Moyamoya Disease
Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene.
Moyamoya Disease
Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease.
Moyamoya Disease
Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene.
Moyamoya Disease
MMP-9 as a Biomarker for Predicting Hemorrhagic Strokes in Moyamoya Disease.
Mucocele
Immunohistochemical expression of matrix metalloproteinase-1, matrix metalloproteinase-2 and matrix metalloproteinase-9, myofibroblasts and Ki-67 in actinic cheilitis and lip squamous cell carcinoma.
Mucocutaneous Lymph Node Syndrome
Cell distribution differences of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with kawasaki disease.
Mucocutaneous Lymph Node Syndrome
Effect of angiotensin-converting enzyme inhibitor on matrix metalloproteinase-9 activity in patients with Kawasaki disease.
Mucocutaneous Lymph Node Syndrome
Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease.
Mucocutaneous Lymph Node Syndrome
Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease.
Mucocutaneous Lymph Node Syndrome
Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease.
Mucocutaneous Lymph Node Syndrome
Evaluating the added predictive ability of MMP-9 in serum for Kawasaki disease with coronary artery lesions.
Mucocutaneous Lymph Node Syndrome
Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease.
Mucocutaneous Lymph Node Syndrome
IVIG inhibits TNF-?-induced MMP9 expression and activity in monocytes by suppressing NF-?B and P38 MAPK activation.
Mucocutaneous Lymph Node Syndrome
Matrix metalloproteinase 9 activity leads to elastin breakdown in an animal model of Kawasaki disease.
Mucocutaneous Lymph Node Syndrome
Matrix metalloproteinase-9 in vascular lesions and endothelial regulation in Kawasaki disease.
Mucocutaneous Lymph Node Syndrome
Salvianolic Acid B Down-regulates Matrix Metalloproteinase-9 Activity and Expression in Tumor Necrosis Factor-?-induced Human Coronary Artery Endothelial Cells.
Mucocutaneous Lymph Node Syndrome
Serum MMP-2 and MMP-9 in patients with Behçet's disease: Do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Mucocutaneous Lymph Node Syndrome
[Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease]
Mucocutaneous Lymph Node Syndrome
[Effect of small interfering RNA on matrix metalloproteinase-9 expression in vascular endothelial cells stimulated by serum from children with Kawasaki disease]
Mucocutaneous Lymph Node Syndrome
[Effects of intravenous immunoglobulin upon the overexpression and over-activation of nuclear factor-?B and matrix metalloproteinase-9 in murine model of Kawasaki disease].
Mucocutaneous Lymph Node Syndrome
[Roles of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase and hs-CRP in Kawasaki disease]
Mucolipidoses
Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9.
Mucositis
Correction: olmesartan decreased levels of IL-1? and TNF-?, down-regulated MMP-2, MMP-9, COX-2, RANK/RANKL and up-regulated SOCs-1 in an intestinal mucositis model.
Mucositis
Olmesartan decreased levels of IL-1? and TNF-?, down-regulated MMP-2, MMP-9, COX-2, RANK/RANKL and up-regulated SOCs-1 in an intestinal mucositis model.
Mucositis
The beneficial influence of rhubarb on 5-fluorouracil-induced ileal mucositis and the combined role of aquaporin-4, tumour necrosis factor-?, nuclear factor-kappa B & matrix metalloproteinase-9 in rat model: histological study.
Multiple Myeloma
Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor.
Multiple Myeloma
Cell-surface serglycin promotes adhesion of myeloma cells to collagen type I and affects the expression of matrix metalloproteinases.
Multiple Myeloma
Connective tissue growth factor is an indicator of bone involvement in multiple myeloma, but matrix metalloproteinase-9 is not.
Multiple Myeloma
Effect of wild type PTEN gene on proliferation and invasion of multiple myeloma.
Multiple Myeloma
Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma.
Multiple Myeloma
Histone deacetylases meet microRNA-associated MMP-9 expression regulation in glucocorticoid-sensitive and -resistant cell lines.
Multiple Myeloma
Increased expression of metalloproteinase-2 and -9 (MMP-2, MMP-9), tissue inhibitor of metalloproteinase-1 and -2 (TIMP-1, TIMP-2), and EMMPRIN (CD147) in multiple myeloma.
Multiple Myeloma
Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells.
Multiple Myeloma
Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression.
Multiple Myeloma
Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma.
Multiple Myeloma
Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease.
Multiple Myeloma
Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro.
Multiple Myeloma
Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma.
Multiple Myeloma
Upregulation of matrix metalloproteinase-9 in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cells.
Multiple Myeloma
[Brain-derived neurotrophic factor promotes the secretion of MMP-9 in human myeloma cell through modulation of nucleus factor-kappaB]
Multiple Myeloma
[Effects of Triptolide on MMP-9 Expression and Inducing Apoptosis of Multiple Myeloma Cells by Inhibiting SMYD3].
Multiple Sclerosis
A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders.
Multiple Sclerosis
A novel rationale for inhibition of gelatinase B in multiple sclerosis: MMP-9 destroys alpha B-crystallin and generates a promiscuous T cell epitope.
Multiple Sclerosis
A Randomized, Triple-blind Placebo-controlled Trial to Determine the Effect of Saffron on the Serum Levels of MMP-9 and TIMP-1 in Patients with Multiple Sclerosis.
Multiple Sclerosis
Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b.
Multiple Sclerosis
Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study.
Multiple Sclerosis
AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon ?.
Multiple Sclerosis
Atorvastatin does not alter interferon Beta-induced changes of serum matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in patients with multiple sclerosis.
Multiple Sclerosis
CCR2(+)CCR5(+) T cells produce matrix metalloproteinase-9 and osteopontin in the pathogenesis of multiple sclerosis.
Multiple Sclerosis
CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis.
Multiple Sclerosis
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
Multiple Sclerosis
Changes of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) after autologous hematopoietic stem cell transplantation in multiple sclerosis.
Multiple Sclerosis
Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis.
Multiple Sclerosis
Common genetic variants in the plasminogen activation pathway are not associated with multiple sclerosis.
Multiple Sclerosis
Decreased MMP-9 production in primary progressive multiple sclerosis patients.
Multiple Sclerosis
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients.
Multiple Sclerosis
Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients. One year follow-up results.
Multiple Sclerosis
Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of neuro-Behçet's disease.
Multiple Sclerosis
Elevated matrix metalloproteinase-9 and degradation of perineuronal nets in cerebrocortical multiple sclerosis plaques.
Multiple Sclerosis
Engineering autoactivating forms of matrix metalloproteinase-9 and expression of the active enzyme in cultured cells and transgenic mouse brain.
Multiple Sclerosis
Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions.
Multiple Sclerosis
Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).
Multiple Sclerosis
Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases.
Multiple Sclerosis
Evaluation of matrix metalloproteinase-9 plasma levels in untreated new Relapsing-remitting multiple sclerosis patients and their first-degree family.
Multiple Sclerosis
Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis.
Multiple Sclerosis
Functional MMP-9 polymorphisms modulate plasma MMP-9 levels in multiple sclerosis patients.
Multiple Sclerosis
Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis.
Multiple Sclerosis
Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis.
Multiple Sclerosis
Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis.
Multiple Sclerosis
Gelatinase B, PECAM-1 and MCP-3 gene polymorphisms in Belgian multiple sclerosis.
Multiple Sclerosis
Gelatinase B/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy.
Multiple Sclerosis
Gelatinases (MMP-2 and MMP-9) are preferentially expressed by Th1 vs. Th2 cells.
Multiple Sclerosis
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants.
Multiple Sclerosis
Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis.
Multiple Sclerosis
Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone.
Multiple Sclerosis
Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Multiple Sclerosis
Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients.
Multiple Sclerosis
Increased serum matrix metalloproteinase-9 in neuromyelitis optica: Implication of disruption of blood-brain barrier.
Multiple Sclerosis
Inhibitory Effect of Polyunsaturated Fatty Acids on MMP-9 Release from Microglial Cells-Implications for Complementary Multiple Sclerosis Treatment.
Multiple Sclerosis
Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatment.
Multiple Sclerosis
Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.
Multiple Sclerosis
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients.
Multiple Sclerosis
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis.
Multiple Sclerosis
Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein.
Multiple Sclerosis
Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy.
Multiple Sclerosis
Matrix metalloproteinase-7 and matrix metalloproteinase-9 in pediatric multiple sclerosis.
Multiple Sclerosis
Matrix metalloproteinase-7, matrix metalloproteinase-9, and disease activity in pediatric multiple sclerosis.
Multiple Sclerosis
Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.
Multiple Sclerosis
Matrix metalloproteinase-9 -1562 C/T gene polymorphism in Serbian patients with multiple sclerosis.
Multiple Sclerosis
Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
Multiple Sclerosis
Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis.
Multiple Sclerosis
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in multiple sclerosis.
Multiple Sclerosis
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in multiple sclerosis.
Multiple Sclerosis
Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease.
Multiple Sclerosis
Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis.
Multiple Sclerosis
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica.
Multiple Sclerosis
Migratory behavior of lymphocytes isolated from multiple sclerosis patients: effects of interferon beta-1b therapy.
Multiple Sclerosis
MMP-2 -1575G/A polymorphism modifies the onset of optic neuritis as a first presenting symptom in MS?
Multiple Sclerosis
MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a.
Multiple Sclerosis
Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity.
Multiple Sclerosis
MS susceptibility is not affected by single nucleotide polymorphisms in the MMP9 gene.
Multiple Sclerosis
Multiple sclerosis: Association of gelatinase B/matrix metalloproteinase-9 with risk and clinical course the disease.
Multiple Sclerosis
Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs.
Multiple Sclerosis
Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis.
Multiple Sclerosis
PECAM-1 and gelatinase B coexist in vascular cuffs of multiple sclerosis lesions.
Multiple Sclerosis
Peptide Cross-Linked Poly(2-oxazoline) as a Sensor Material for the Detection of Proteases with a Quartz Crystal Microbalance.
Multiple Sclerosis
Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis.
Multiple Sclerosis
Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study.
Multiple Sclerosis
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes.
Multiple Sclerosis
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis.
Multiple Sclerosis
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment.
Multiple Sclerosis
Single nucleotide polymorphism in the MMP-9 gene is associated with susceptibility to develop multiple sclerosis in an Italian case-control study.
Multiple Sclerosis
The effects of omega-3 Fatty acids on matrix metalloproteinase-9 production and cell migration in human immune cells: implications for multiple sclerosis.
Multiple Sclerosis
The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes.
Multiple Sclerosis
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis.
Multiple Sclerosis
Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha.
Multiple Sclerosis
[Homocysteine and markers of endothelial dysfunction in multiple sclerosis].
Multiple Sclerosis
[von Willebrand factor and adhesion molecules in patients with multiple sclerosis.]
Multiple Sclerosis, Chronic Progressive
Decreased MMP-9 production in primary progressive multiple sclerosis patients.
Multiple Sclerosis, Chronic Progressive
Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.
Multiple Sclerosis, Chronic Progressive
Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.
Multiple Sclerosis, Relapsing-Remitting
Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study.
Multiple Sclerosis, Relapsing-Remitting
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients.
Multiple Sclerosis, Relapsing-Remitting
Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients. One year follow-up results.
Multiple Sclerosis, Relapsing-Remitting
Evaluation of matrix metalloproteinase-9 plasma levels in untreated new Relapsing-remitting multiple sclerosis patients and their first-degree family.
Multiple Sclerosis, Relapsing-Remitting
IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis.
Multiple Sclerosis, Relapsing-Remitting
Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.
Multiple Sclerosis, Relapsing-Remitting
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis.
Multiple Sclerosis, Relapsing-Remitting
Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.
Multiple Sclerosis, Relapsing-Remitting
Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
Multiple Sclerosis, Relapsing-Remitting
Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis.
Multiple Sclerosis, Relapsing-Remitting
The Role of Matrix Metalloproteinase 3 and 9 in the Pathogenesis of Acute Neuroinflammation. Implications for Disease Modifying Therapy.
Mumps
Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of children with echovirus type 30 and mumps meningitis.
Muscular Diseases
Effects of increased matrix metalloproteinase-9 expression on skeletal muscle fibrosis in prolonged alcoholic myopathies of rats.
Muscular Diseases
Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
Muscular Diseases
Matrix Metalloproteinase-9 Inhibition Ameliorates Pathogenesis and Improves Skeletal Muscle Regeneration in Muscular Dystrophy.
Muscular Diseases
Matrix Metalloproteinase-9 Inhibition Improves Proliferation and Engraftment of Myogenic Cells in Dystrophic Muscle of mdx Mice.
Muscular Diseases
MMP-10 is required for efficient muscle regeneration in mouse models of injury and muscular dystrophy.
Muscular Diseases
Osteopontin-Stimulated Expression of Matrix Metalloproteinase-9 Causes Cardiomyopathy in the mdx Model of Duchenne Muscular Dystrophy.
Muscular Diseases
Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy.
Muscular Dystrophies
Matrix Metalloproteinase-9 Inhibition Ameliorates Pathogenesis and Improves Skeletal Muscle Regeneration in Muscular Dystrophy.
Muscular Dystrophies
Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexia.
Muscular Dystrophies
MMP-9 overexpression improves myogenic cell migration and engraftment.
Muscular Dystrophies
The enzymatic processing of ?-dystroglycan by MMP-2 is controlled by two anchoring sites distinct from the active site.
Muscular Dystrophies, Limb-Girdle
Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection.
Muscular Dystrophy, Duchenne
Differential roles of MMP-9 in early and late stages of dystrophic muscles in a mouse model of Duchenne muscular dystrophy.
Muscular Dystrophy, Duchenne
Evaluation of the serum matrix metalloproteinase-9 as a biomarker for monitoring disease progression in Duchenne muscular dystrophy.
Muscular Dystrophy, Duchenne
Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
Muscular Dystrophy, Duchenne
MMP-10 is required for efficient muscle regeneration in mouse models of injury and muscular dystrophy.
Muscular Dystrophy, Duchenne
Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection.
Muscular Dystrophy, Duchenne
Osteopontin-Stimulated Expression of Matrix Metalloproteinase-9 Causes Cardiomyopathy in the mdx Model of Duchenne Muscular Dystrophy.
Muscular Dystrophy, Duchenne
Response to: Evaluation of the serum matrix metalloproteinase-9 as a biomarker for monitoring disease progression in Duchenne muscular dystrophy.
Muscular Dystrophy, Duchenne
Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD).
Muscular Dystrophy, Duchenne
Serum Osteopontin as a Novel Biomarker for Muscle Regeneration in Duchenne Muscular Dystrophy.
Myalgia
Assessing the usefulness of acute physiological responses following resistance exercise: sensitivity, magnitude of change, and time course of measures.
Mycetoma
Active Matrix Metalloprotease-9 Is Associated with the Collagen Capsule Surrounding the Madurella mycetomatis Grain in Mycetoma.
Mycosis Fungoides
Immunohistochemical study of the expression of matrix metalloproteinase-9 in skin lesions of mycosis fungoides.
Mycosis Fungoides
Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression.
Myelitis, Transverse
Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis.
Myelodysplastic Syndromes
Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
Myelodysplastic Syndromes
Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularity.
Myelodysplastic Syndromes
[Matrix metalloproteinase-9 in plasma of bone marrow aspirates of patients with acute myeloid leukemia and myelodysplastic syndrome].
Myocardial Infarction
A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction.
Myocardial Infarction
Acrolein increases 5-lipoxygenase expression in murine macrophages through activation of ERK pathway.
Myocardial Infarction
Activation of the adenosine-A3 receptor stimulates matrix metalloproteinase-9 secretion by macrophages.
Myocardial Infarction
Apigenin attenuates acute myocardial infarction of rats via the inhibitions of matrix metalloprotease-9 and inflammatory reactions.
Myocardial Infarction
Association Between High Serum Matrix Metalloproteinase-9 and MMP-9 (-1562C>T) Polymorphism in Patients With ST-Elevation Acute Myocardial Infarction.
Myocardial Infarction
Association of Matrix Metalloproteinase 9 C-1562T Polymorphism with Genetic Susceptibility to Myocardial Infarction: A Meta-Analysis.
Myocardial Infarction
Association of matrix metalloproteinase-1, matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1, and interleukin-6 with epicardial and myocardial perfusion.
Myocardial Infarction
Association of R279Q and C1562T polymorphisms of matrix metalloproteinase 9 gene and increased risk for myocardial infarction in patients with premature coronary artery disease.
Myocardial Infarction
Cardioprotection and Matrix Metalloproteinase-9 Regulation of Salvianolic Acids on Myocardial Infarction in Rats.
Myocardial Infarction
Changes of Matrix Metalloproteinase-9 Level Is Associated With Left Ventricular Remodeling Following Acute Myocardial Infarction Among Patients Treated With Trandolapril, Valsartan or Both.
Myocardial Infarction
Clinical Relevance of Matrix Metalloproteinase 9 in Patients With Acute Coronary Syndrome.
Myocardial Infarction
Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris.
Myocardial Infarction
Correlation between acute myocardial infarction complicated with cerebral infarction and expression levels of MMP-2 and MMP-9.
Myocardial Infarction
CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction.
Myocardial Infarction
Danhong injection mobilizes endothelial progenitor cells to repair vascular endothelium injury via upregulating the expression of Akt, eNOS and MMP-9.
Myocardial Infarction
Dynamic expression of the main related indicators of thrombosis, inflammatory reaction and tissue damage in a rat model of myocardial infarction.
Myocardial Infarction
Early effect of pravastatin on serum soluble CD40L, matrix metalloproteinase-9, and C-reactive protein in patients with acute myocardial infarction.
Myocardial Infarction
Effect of exercise training on left ventricular remodeling in patients with myocardial infarction and possible mechanisms.
Myocardial Infarction
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Myocardial Infarction
Effect of typhaneoside on ventricular remodeling and regulation of PI3K/Akt/mTOR pathway.
Myocardial Infarction
Elevation of plasma matrix metalloproteinase-9 in the culprit coronary artery in patients with acute myocardial infarction: clinical evidence from distal protection.
Myocardial Infarction
EMMPRIN-Targeted Magnetic Nanoparticles for In Vivo Visualization and Regression of Acute Myocardial Infarction.
Myocardial Infarction
Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9.
Myocardial Infarction
Estrogen induces cardioprotection in male C57BL/6J mice after acute myocardial infarction via decreased activity of matrix metalloproteinase-9 and increased Akt-Bcl-2 anti-apoptotic signaling.
Myocardial Infarction
Expression level and diagnostic value of exosomal NEAT1/miR-204/MMP-9 in acute ST-segment elevation myocardial infarction.
Myocardial Infarction
High serum matrix metalloproteinase-9 level predict increased risk of in-hospital cardiac events in patients with type 2 diabetes and ST segment elevation myocardial infarction.
Myocardial Infarction
Immunoglobulin E and matrix metalloproteinase-9 in patients with different stages of coronary artery diseases.
Myocardial Infarction
In-Vivo Higher Plasma Levels of Platelet-Derived Growth Factor and Matrix Metalloproteinase-9 in Coronary Artery at the Very Onset of Myocardial Infarction with ST-Segment Elevation.
Myocardial Infarction
Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome.
Myocardial Infarction
Increased pericardial fluid level of matrix metalloproteinase-9 activity in patients with acute myocardial infarction: possible role in the development of cardiac rupture.
Myocardial Infarction
Increases in interleukin-6 and matrix metalloproteinase-9 in the infarct-related coronary artery of acute myocardial infarction.
Myocardial Infarction
Inhibition of human neutrophils NEP activity, CD11b/CD18 expression and elastase release by 3,4-dihydroxyphenylethanol-elenolic acid dialdehyde, oleacein.
Myocardial Infarction
Inhibition of matrix metalloproteinase-9 activity by lisinopril after myocardial infarction in hamsters.
Myocardial Infarction
Inhibitory profiles of captopril on matrix metalloproteinase-9 activity.
Myocardial Infarction
Interaction Between MMP-9 Gene Polymorphisms and Smoking in Relation to Myocardial Infarction in a Uighur Population.
Myocardial Infarction
Interleukin-33, matrix metalloproteinase-9, and tissue ?nhibitor of matrix metalloproteinase-1 in myocardial infarction.
Myocardial Infarction
Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme.
Myocardial Infarction
Local Matrix Metalloproteinase 9 Level Determines Early Clinical Presentation of ST-Segment-Elevation Myocardial Infarction.
Myocardial Infarction
Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction.
Myocardial Infarction
Low-level Transcutaneous Electrical Stimulation of the Auricular Branch of Vagus Nerve Ameliorates Left Ventricular Remodeling and Dysfunction By Down-regulation of Matrix Metalloproteinase 9 and Transforming Growth Factor ?1.
Myocardial Infarction
Lysophosphatidic Acid Is Associated with Atherosclerotic Plaque Instability by Regulating NF-?B Dependent Matrix Metalloproteinase-9 Expression via LPA2 in Macrophages.
Myocardial Infarction
Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction.
Myocardial Infarction
Matrix metalloproteinas-9 functional promoter polymorphism 1562C>T increased risk of early-onset coronary artery disease.
Myocardial Infarction
Matrix metalloproteinase -9 polymorphism and outcome after acute myocardial infarction.
Myocardial Infarction
Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?
Myocardial Infarction
Matrix Metalloproteinase-9 (MMP-9) and Myeloperoxidase (MPO) Levels in Patients with Nonobstructive Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography.
Myocardial Infarction
Matrix metalloproteinase-9 as a messenger in the crosstalk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review.
Myocardial Infarction
Matrix metalloproteinase-9 expression after myocardial infarction: physiological or pathological?
Myocardial Infarction
Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction.
Myocardial Infarction
Matrix Metalloproteinase-9 Is a Marker of Heart Failure After Acute Myocardial Infarction.
Myocardial Infarction
Matrix metalloproteinases in patients with myocardial infarction and percutaneous revascularization.
Myocardial Infarction
MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy.
Myocardial Infarction
MMP-9 signaling in the left ventricle following myocardial infarction.
Myocardial Infarction
MMP9 mediates acute hyperglycemia-induced human cardiac stem cell death by upregulating apoptosis and pyroptosis in vitro.
Myocardial Infarction
Molecular mechanism of imidapril for cardiovascular protection via inhibition of MMP-9.
Myocardial Infarction
Myocardial Infarction Superimposed on Aging: MMP-9 Deletion Promotes M2 Macrophage Polarization.
Myocardial Infarction
Myocardial Injury Promotes Matrix Metalloproteinase-9 Activity in the Renal Cortex in Preclinical Models of Acute Myocardial Infarction.
Myocardial Infarction
Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9.
Myocardial Infarction
Neuregulin-1 protects cardiac electrical conduction through downregulating matrix metalloproteinase-9 and upregulating connexin 43 in a rat myocardial infarction model.
Myocardial Infarction
Noninvasive Limb Ischemic Preconditioning Protects Against Myocardial I/R Injury in Rats.
Myocardial Infarction
Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction.
Myocardial Infarction
Overexpression of MMP-9 and its inhibitors in blood mononuclear cells after myocardial infarction--is it associated with depressive symptomatology?
Myocardial Infarction
Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes.
Myocardial Infarction
Plasma fractionation enriches post-myocardial infarction samples prior to proteomics analysis.
Myocardial Infarction
Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.
Myocardial Infarction
Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study.
Myocardial Infarction
Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Myocardial Infarction
Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction.
Myocardial Infarction
Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction.
Myocardial Infarction
Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up.
Myocardial Infarction
Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women.
Myocardial Infarction
Protective effect of lycopene on cardiac function and myocardial fibrosis after acute myocardial infarction in rats via the modulation of p38 and MMP-9.
Myocardial Infarction
Proteomic Analysis of the Left Ventricle Post-myocardial Infarction to Identify In Vivo Candidate Matrix Metalloproteinase Substrates.
Myocardial Infarction
Relation of nocturnal melatonin levels to serum matrix metalloproteinase-9 concentrations in patients with myocardial infarction.
Myocardial Infarction
Relationship among LRP1 expression, Pyk2 phosphorylation and MMP-9 activation in left ventricular remodelling after myocardial infarction.
Myocardial Infarction
Relationship of long-term prognosis to MMP and TIMP polymorphisms in patients after ST elevation myocardial infarction.
Myocardial Infarction
Role of annexin II in estrogen-induced macrophage matrix metalloproteinase-9 activity: the modulating effect of statins.
Myocardial Infarction
Role of proinflammatory alleles in longevity and atherosclerosis: results of studies performed on -1562C/T MMP-9 in centenarians and myocardial infarction patients from Sicily.
Myocardial Infarction
S100A8/A9 promotes MMP-9 expression in the fibroblasts from cardiac rupture after myocardial infarction by inducing macrophages secreting TNF?.
Myocardial Infarction
Screening and Identification of Potential Hub Genes in Myocardial Infarction Through Bioinformatics Analysis.
Myocardial Infarction
Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction.
Myocardial Infarction
Serum levels of matrix metalloproteinases 2 and 9 in patients with acute myocardial infarction.
Myocardial Infarction
Serum levels of the osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarction.
Myocardial Infarction
Serum matrix metalloproteinase-9 is elevated in men with a history of myocardial infarction.
Myocardial Infarction
Serum metalloproteinase 9 levels in patients with coronary artery disease: a novel marker of inflammation.
Myocardial Infarction
Serum MMP-9 activity as a diagnosing marker for the developing heart failure of post MI patients.
Myocardial Infarction
Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction.
Myocardial Infarction
Serum YKL-40 positively correlates with MMP-9 and CRP in patients with acute ST segment elevation myocardial infarction following emergency treatment.
Myocardial Infarction
Sesamol Attenuates Isoproterenol-induced Acute Myocardial Infarction via Inhibition of Matrix Metalloproteinase-2 and -9 Expression in Rats.
Myocardial Infarction
Significance of matrix metalloproteinase-9 in cardiac dysfunction during the very acute phase after myocardial infarction in hamsters.
Myocardial Infarction
Suppressed MMP-9 Activity in Myocardial Infarction-Related Cardiogenic Shock Implies Diminished Rage Degradation.
Myocardial Infarction
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.
Myocardial Infarction
The circular relationship between matrix metalloproteinase-9 and inflammation following myocardial infarction.
Myocardial Infarction
The long-term prognostic value of multiple biomarkers following a myocardial infarction.
Myocardial Infarction
The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina.
Myocardial Infarction
The prognostic value of elevated matrix metalloproteinase-9 in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A two-year prospective study.
Myocardial Infarction
The targeted regulation of miR-26a on PTEN-PI3K/AKT signaling pathway in myocardial fibrosis after myocardial infarction.
Myocardial Infarction
Time-dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction.
Myocardial Infarction
Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction.
Myocardial Infarction
Treatment of Cardiotonic Pills(®) after Ischemia-Reperfusion Ameliorates Myocardial Fibrosis in Rats.
Myocardial Infarction
Trimetazidine suppresses oxidative stress, inhibits MMP-2 and MMP-9 expression, and prevents cardiac rupture in mice with myocardial infarction.
Myocardial Infarction
Usefulness of Matrix Metalloproteinase-9 Plasma Levels to Identify Patients With Preserved Left Ventricular Systolic Function After Acute Myocardial Infarction Who Could Benefit from Eplerenone.
Myocardial Infarction
Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute myocardial infarction.
Myocardial Infarction
Usefulness of plasma matrix metalloproteinase-9 levels in prediction of in-hospital mortality in patients who received emergent percutaneous coronary artery intervention following myocardial infarction.
Myocardial Infarction
[An effect of perindopril on the level of tumor necrosis factor-alpha and matrix metalloproteinase-9 in peripheral blood in the acute period of atherothrombotic ischemic stroke and myocardial infarction]
Myocardial Infarction
[Analysis of the gene polymorphism of matrix metalloproteinase-2 and -9 in patients with coronary heart disease]
Myocardial Infarction
[Association of matrix metalloproteinase-9 and platelet membrane glycoprotein VI polymorphisms with acute coronary syndrome]
Myocardial Infarction
[Association of MMP9 gene -1562 C/T polymorphism with myocardial infarction in Uighur population of Xinjiang.]
Myocardial Infarction
[Chinese herbs for shen invigorating and blood activating activated MMP-9 signaling pathway to mobilize rats' bone marrow EPCs: a molecular mechanism research].
Myocardial Infarction
[Correlation between serum MMP-2 and MMP-9 in patients with acute myocardial infarction before and after PCI.]
Myocardial Infarction
[Evaluation of the myocardial systolic function and ventricular remodeling of rats with experimental myocardial infarction by strain/strain rate imaging and MMP-9].
Myocardial Infarction
[Values of matrix metalloproteinase-9 in early diagnosis and short-term prognosis of ST-segment elevation myocardial infarction].
Myocardial Ischemia
Can the expression of the metalloproteinase 9 gene and its inhibitor be considered as markers of heart failure?
Myocardial Ischemia
Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events.
Myocardial Ischemia
Dystrophin and metalloproteinase 9 in myocardial ischemia: A post-mortem immunohistochemical study.
Myocardial Ischemia
Enhancement of Matrix Metalloproteinase 2 and 9 Inhibitory Action of Minocycline by Aspirin: An Approach to Attenuate Outcome of Acute Myocardial Infarction in Diabetes.
Myocardial Ischemia
Plasma Brain Natriuretic Peptide, Endothelin-1, and Matrix Metalloproteinase 9 Expression and Significance in Type 2 Diabetes Mellitus Patients with Ischemic Heart Disease.
Myocardial Ischemia
Tumor necrosis factor-alpha G(-308)A promoter polymorphism, matrix metalloproteinase (MMP)-3 5A/6A gene variation, MMP-9 C(-1562)T promoter polymorphism and risk and extent of ischemic heart disease.
Myocardial Ischemia
White wine consumption influences inflammatory phase of repair following myocardial infarction in rats.
Myocardial Ischemia
[Correlation between serum MMP-2 and MMP-9 in patients with acute myocardial infarction before and after PCI.]
Myocardial Ischemia
[Role of MMP-9 and NF-kappaB expression by xuemaitong capsule preconditioning on rats of acute myocardial ischemia].
Myocarditis
Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice.
Myocarditis
Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice.
Myocarditis
Early treatment with clarithromycin attenuates rat autoimmune myocarditis via inhibition of matrix metalloproteinase activity.
Myocarditis
Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection.
Myocarditis
Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
Myocarditis
Letter by Pinto and Heymans regarding article, "Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice".
Myocarditis
[Effects of matrix metalloproteinase-9 inhibitor in Lewis rats with experimental autoimmune myocarditis.]
Myopia
Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients.
Myositis
Increased Serum Matrix Metalloproteinase-9 Levels are Associated with Anti-Jo1 but not Anti-MDA5 in Myositis Patients.
Myositis
Matrix metalloproteinase (MMP)-9: A realiable marker for inflammation in early human trichinellosis.
Myositis
Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers.
Myositis, Inclusion Body
Expression of specific matrix metalloproteinases in inflammatory myopathies.
Myringosclerosis
Expressions of TGF-?1 and MMP-9 in a guinea pig model of tympanosclerosis: Possible role in the pathogenesis of this disorder.
Myxoma
Expression of matrix metalloproteinases 2 and 9 in odontogenic myxoma in vivo and in vitro.
Myxoma
Expression of MMP-2 and MMP-9 in odontogenic myxoma in a child: report of a clinical case.
Myxoma
Immunohistochemical expression of matrix metalloproteinases 1, 2, and 9 in odontogenic myxoma and dental germ papilla.
Myxoma
Targeting gallbladder cancer: hyaluronan sensitizes cancer cells to chemo-therapeutics.
Myxoma
The expression of apoptotic proteins and matrix metalloproteinases in odontogenic myxomas.
Nasal Polyps
Double-stranded RNA poly(I:C) enhances matrix metalloproteinase mRNA expression in human nasal polyp epithelial cells.
Nasal Polyps
Effect of Acacia Honey on Transforming Growth Factor-Beta-1-Induced Myofibroblast Differentiation and Matrix Metalloproteinase-9 Production in Nasal Polyp Fibroblasts.
Nasal Polyps
Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1.
Nasal Polyps
Eosinophil-derived neurotoxin enhances airway remodeling in eosinophilic chronic rhinosinusitis and correlates with disease severity.
Nasal Polyps
Evaluation of MMP-9 and TIMP-1 Levels of the Patients with Nasal Polyposis After Corticosteroid Therapies.
Nasal Polyps
Expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in recurrent chronic rhinosinusitis with nasal polyposis.
Nasal Polyps
Involvement of the extracellular matrix proteins periostin and tenascin C in nasal polyp remodeling by regulating the expression of MMPs.
Nasal Polyps
Matrix metalloproteinases and their impact on sinusal extension in chronic rhinosinusitis with nasal polyps.
Nasal Polyps
Mucin 5AC is significantly upregulated in exosomes from the nasal lavage fluid and may promote the expression of COX-2, VEGF and MMP-9: an implication in nasal polyp pathogenesis.
Nasal Polyps
Nonasthmatic nasal polyposis patients with allergy exhibit greater epithelial MMP positivity.
Nasal Polyps
Polymorphisms in chronic rhinosinusitis with nasal polyps - a systematic review.
Nasal Polyps
Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps.
Nasal Polyps
Rhinovirus upregulates matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor expression in nasal polyp fibroblasts.
Nasal Polyps
Sirtuin-1 Controls Poly (I:C)-Dependent Matrix Metalloproteinase 9 Activation in Primary Human Nasal Epithelial Cells.
Nasal Polyps
The role of MMP-2, MMP-9, and TIMP-1 in the pathogenesis of nasal polyps: Immunohistochemical assessment at eight different levels in the epithelial, subepithelial, and deep layers of the mucosa.
Nasal Polyps
Vitamin D decreases the secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 in fibroblasts derived from Taiwanese patients with chronic rhinosinusitis with nasal polyposis.
Nasal Polyps
[Effect of TNF-alpha and MMP-9 in the infiltration of eosinophile granulocyte in nasal polyps].
Nasal Polyps
[Effects of double-stranded RNA poly(I:C) on matrix metalloproteinase mRNA expression in human nasal polyp epithelial cells]
Nasal Polyps
[The effect of the expression and influence of MMP-9 on prognosis of nasal polyps]
Nasal Polyps
[The protein expression difference of transforming growth factor beta1, matrix metalloproteinases 1,7,9 and tissue inhibitors of matrix metalloproteinases-1 between chronic rhinosinusitis, nasal polyps and normal mucosa tissues]
Nasopharyngeal Carcinoma
A cationic polymeric prodrug with chemotherapeutic self-sensibilization co-delivering MMP-9 shRNA plasmid for a combined therapy to nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Assessment and clinicopathological correlation of matrix metalloproteinase 9 expression in nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Caspase 12 degrades IkBa protein and enhances MMP-9 expression in human nasopharyngeal carcinoma cell invasion.
Nasopharyngeal Carcinoma
CD-PLLD co-delivering docetaxel and MMP-9 siRNA plasmid for nasopharyngeal carcinoma therapy in vivo.
Nasopharyngeal Carcinoma
Cisplatin combined with metformin inhibits migration and invasion of human nasopharyngeal carcinoma cells by regulating E-cadherin and MMP-9.
Nasopharyngeal Carcinoma
Concurrent alterations of RAGE, RECK, and MMP9 protein expression are relevant to Epstein-Barr virus infection, metastasis, and survival in nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activity.
Nasopharyngeal Carcinoma
Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
Nasopharyngeal Carcinoma
Expression of matrix metalloproteinase 9 in nasopharyngeal carcinoma and association with Epstein-Barr virus infection.
Nasopharyngeal Carcinoma
Folate-targeted star-shaped cationic copolymer co-delivering docetaxel and MMP-9 siRNA for nasopharyngeal carcinoma therapy.
Nasopharyngeal Carcinoma
Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
Nasopharyngeal Carcinoma
IL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients.
Nasopharyngeal Carcinoma
Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9.
Nasopharyngeal Carcinoma
Interplay of N-Cadherin and matrix metalloproteinase 9 enhances human nasopharyngeal carcinoma cell invasion.
Nasopharyngeal Carcinoma
Isoliquiritigenin suppresses the proliferation and induced apoptosis via miR-32/LATS2/Wnt in nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines.
Nasopharyngeal Carcinoma
Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
Nasopharyngeal Carcinoma
Matrix Metalloproteinase-9 Expression and Status of Cervical Lymph Nodes in Patients with Nasopharyngeal Carcinoma.
Nasopharyngeal Carcinoma
Melatonin suppresses TPA-induced metastasis by downregulating matrix metalloproteinase-9 expression through JNK/SP-1 signaling in nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
MMP-9 expression in peripheral blood mononuclear cells and the association with clinicopathological features and prognosis of nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea.
Nasopharyngeal Carcinoma
Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.
Nasopharyngeal Carcinoma
Pharmacophore-based screening targeted at upregulated FN1, MMP-9, APP reveals therapeutic compounds for nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Prognostic value of interleukin-8 and MMP-9 in nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Prognostic value of matrix metalloproteinase 9 in nasopharyngeal carcinoma: a meta-analysis.
Nasopharyngeal Carcinoma
Radiosensitizing Potential of Curcumin in Different Cancer Models.
Nasopharyngeal Carcinoma
SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
Nasopharyngeal Carcinoma
Selaginella tamariscina extract suppresses TPA-induced invasion and metastasis through inhibition of MMP-9 in human nasopharyngeal carcinoma HONE-1 cells.
Nasopharyngeal Carcinoma
The long noncoding RNA FOXCUT promotes proliferation and migration by targeting FOXC1 in nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Zoledronic acid inhibits proliferation and impairs migration and invasion through downregulating VEGF and MMPs expression in human nasopharyngeal carcinoma cells.
Nasopharyngeal Carcinoma
[Cross-talk between c-Jun/Ets1 involved in EB virus-encoded latent membrane protein 1 regulates expression of matrix metalloproteinase-9 in nasopharyngeal carcinoma]
Nasopharyngeal Carcinoma
[Expression of MMP-9 and TIMP-1 in nasopharyngeal carcinoma and its signification at Xi'an and Shenzhen]
Nasopharyngeal Carcinoma
[Expression of RECK, RAGE and MMP-9 in nasopharyngeal carcinoma and its significance].
Nasopharyngeal Carcinoma
[Expressions of matrix metalloproteinase-9 and interleukin-8 in nasopharygeal carcinoma and association with Epstein-Barr virus latent membrane protein-1]
Nasopharyngeal Carcinoma
[Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells]
Nasopharyngeal Carcinoma
[Study of the expression of nuclear factor-kappa B, matrix metalloproteinase-3, -9 on nasopharygeal carcinoma and their clinical significance].
Nasopharyngeal Neoplasms
A star-shaped porphyrin-arginine functionalized poly(l-lysine) copolymer for photo-enhanced drug and gene co-delivery.
Nasopharyngeal Neoplasms
Absent expression of FLNA is correlated with poor prognosis of nasopharyngeal cancer.
Nasopharyngeal Neoplasms
Dione-thiophene conjugate inhibits proliferation and metastasis of nasopharyngeal carcinoma cells through calcium binding protein-P down-regulation.
Nasopharyngeal Neoplasms
Hypericin photoactivation triggers down-regulation of matrix metalloproteinase-9 expression in well-differentiated human nasopharyngeal cancer cells.
Necrobiosis Lipoidica
Expression of interstitial collagenase, 92-kDa gelatinase, and tissue inhibitor of metalloproteinases-1 in granuloma annulare and necrobiosis lipoidica diabeticorum.
Neoplasm Metastasis
'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression.
Neoplasm Metastasis
(-)-Epigallocatechin-3-gallate blocks nicotine-induced matrix metalloproteinase-9 expression and invasiveness via suppression of NF-?B and AP-1 in endothelial cells.
Neoplasm Metastasis
(-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
Neoplasm Metastasis
(±)Equol inhibits invasion in prostate cancer DU145 cells possibly via down-regulation of matrix metalloproteinase-9, matrix metalloproteinase-2 and urokinase-type plasminogen activator by antioxidant activity.
Neoplasm Metastasis
2,2',4,4'-Tetrabromodiphenyl ether promotes human neuroblastoma SH-SY5Y cells migration via the GPER/PI3K/Akt signal pathway.
Neoplasm Metastasis
3,5-Dicaffeoyl-epi-quinic acid inhibits the PMA-stimulated activation and expression of MMP-9 but not MMP-2 via downregulation of MAPK pathway.
Neoplasm Metastasis
?-Elemene inhibits the metastasis of B16F10 melanoma cells by downregulation of the expression of uPA, uPAR, MMP-2, and MMP-9.
Neoplasm Metastasis
?-Lipoic acid inhibits the migration and invasion of breast cancer cells through inhibition of TGF? signaling.
Neoplasm Metastasis
?-Mangostin suppresses lipopolysaccharide-induced invasion by inhibiting matrix metalloproteinase-2/9 and increasing E-cadherin expression through extracellular signal-regulated kinase signaling in pancreatic cancer cells.
Neoplasm Metastasis
?9-tetrahydrocannabinol inhibits epithelial-mesenchymal transition and metastasis by targeting matrix metalloproteinase-9 in endometrial cancer.
Neoplasm Metastasis
A bi-specific inhibitor targeting IL-17A and MMP-9 reduces invasion and motility in MDA-MB-231 cells.
Neoplasm Metastasis
A chimera of green fluorescent protein with gelatinase binding and tumor targeting peptide.
Neoplasm Metastasis
A circular RNA derived from MMP9 facilitates oral squamous cell carcinoma metastasis through regulation of MMP9 mRNA stability.
Neoplasm Metastasis
A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins.
Neoplasm Metastasis
A functional comparison between the HER2high/HER3 and the HER2low/HER3 dimers on heregulin-?1-induced MMP-1 and MMP-9 expression in breast cancer cells.
Neoplasm Metastasis
A high HIF-1? expression genotype is associated with poor prognosis of upper aerodigestive tract carcinoma patients.
Neoplasm Metastasis
A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9).
Neoplasm Metastasis
A molecular basis for the synergy between 17?allylamino?17?demethoxy geldanamycin with Capecitabine and Irinotecan in human colorectal cancer cells through VEFG and MMP-9 gene expression.
Neoplasm Metastasis
A Multi-functional Vector for delivery of Genome Editing Plasmid Targeting ?-Catenin to Re-modulate Cancer Cell Properties.
Neoplasm Metastasis
A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer's Disease and Type 2 Diabetes Mellitus.
Neoplasm Metastasis
A new pseudo-peptide of Arg-Gly-Asp (RGD) inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma.
Neoplasm Metastasis
A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy.
Neoplasm Metastasis
A novel binding factor of 14-3-3beta functions as a transcriptional repressor and promotes anchorage-independent growth, tumorigenicity, and metastasis.
Neoplasm Metastasis
A novel bisindole-PBD conjugate inhibits angiogenesis by regulating STAT3 and VEGF in breast cancer cells.
Neoplasm Metastasis
A novel peptide that selectively binds highly metastatic hepatocellular carcinoma cell surface is related to invasion and metastasis.
Neoplasm Metastasis
A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis.
Neoplasm Metastasis
A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis.
Neoplasm Metastasis
A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer.
Neoplasm Metastasis
A review of the anti-tumor effect of the combined administration of a cyclooxygenase-2 selective inhibitor and a non-specific immunostimulant protein-bound polysaccharide on an advanced colon cancer model using colon cancer cell lines.
Neoplasm Metastasis
A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer.
Neoplasm Metastasis
A small compound that inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-9 upregulation.
Neoplasm Metastasis
A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells.
Neoplasm Metastasis
A Specific Mixture of Nutrients Suppresses Ovarian Cancer A-2780 Tumor Incidence, Growth, and Metastasis to Lungs.
Neoplasm Metastasis
A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
Neoplasm Metastasis
Aberrant expression of ALDH1, MMP9, Integrin ?v?3, and KiSS-1 in invasive ductal carcinoma and their clinical significance.
Neoplasm Metastasis
Aberrant expression of CXCR4 significantly contributes to metastasis and predicts poor clinical outcome in breast cancer.
Neoplasm Metastasis
Aberrant expression of Kiss-1 and matrix metalloproteinase-9 are closely linked to lymph node metastasis of gastric cancer.
Neoplasm Metastasis
Abiotic Mimic of Matrix Metalloproteinase-9 Inhibitor against Advanced Metastatic Cancer.
Neoplasm Metastasis
Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.
Neoplasm Metastasis
Absent expression of FLNA is correlated with poor prognosis of nasopharyngeal cancer.
Neoplasm Metastasis
Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosis.
Neoplasm Metastasis
Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice.
Neoplasm Metastasis
Actin cytoskeleton participation in the onset of IL-1beta induction of an invasive mesenchymal-like phenotype in epithelial MCF-7 cells.
Neoplasm Metastasis
Activation of matrix metalloproteinase-9 by TNF-alpha in human urinary bladder cancer HT1376 cells: The role of MAP kinase signaling pathways.
Neoplasm Metastasis
Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
Neoplasm Metastasis
Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasis.
Neoplasm Metastasis
Activation State of Stromal Inflammatory Cells in Murine Metastatic Pancreatic Adenocarcinoma.
Neoplasm Metastasis
Active and inactive forms of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
Neoplasm Metastasis
Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Neoplasm Metastasis
Activity of type IV collagenases (MMP-2 and MMP-9) in primary pulmonary carcinomas: a quantitative analysis.
Neoplasm Metastasis
ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.
Neoplasm Metastasis
Additive effects of EGF and IL-1? regulate tumor cell migration and invasion in gastric adenocarcinoma via activation of ERK1/2.
Neoplasm Metastasis
Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis.
Neoplasm Metastasis
Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice.
Neoplasm Metastasis
Adhesive defect in extracellular matrix tenascin-X-null fibroblasts: a possible mechanism of tumor invasion.
Neoplasm Metastasis
AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression.
Neoplasm Metastasis
Alpha-2 Heremans Schmid Glycoprotein (AHSG) modulates signaling pathways in head and neck squamous cell carcinoma cell line SQ20B.
Neoplasm Metastasis
Alpha-chaconine-reduced metastasis involves a PI3K/Akt signaling pathway with downregulation of NF-kappaB in human lung adenocarcinoma A549 cells.
Neoplasm Metastasis
alpha-Lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer cells.
Neoplasm Metastasis
Alpha-mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen expression through the JNK signaling pathway.
Neoplasm Metastasis
Alpha-Mangostin Suppresses the Metastasis of Human Renal Carcinoma Cells by Targeting MEK/ERK Expression and MMP-9 Transcription Activity.
Neoplasm Metastasis
Alterations in human breast cancer adhesion-motility in response to changes in cell surface glycoproteins displaying alpha-L-fucose moieties.
Neoplasm Metastasis
Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3.
Neoplasm Metastasis
Altered epidermal growth factor signal transduction in activated Ha-ras-transformed human keratinocytes.
Neoplasm Metastasis
Amentoflavone Inhibits Experimental Tumor Metastasis Through a Regulatory Mechanism Involving MMP-2, MMP-9, Prolyl Hydroxylase, Lysyl Oxidase, VEGF, ERK-1, ERK-2, STAT-1, nm23 and Cytokines in Lung Tissues of C57BL/6 Mice.
Neoplasm Metastasis
Amorphous calcium phosphate-mediated binding of matrix metalloproteinase-9 to fibrin is inhibited by pyrophosphate and bisphosphonate.
Neoplasm Metastasis
Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors.
Neoplasm Metastasis
An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.
Neoplasm Metastasis
An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells.
Neoplasm Metastasis
An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression.
Neoplasm Metastasis
An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
Neoplasm Metastasis
An Investigation on the Therapeutic Potential of Butein, A Tretrahydroxychalcone Against Human Oral Squamous Cell Carcinoma.
Neoplasm Metastasis
Andrographolide enhances the anti-metastatic effect of radiation in Ras-transformed cells via suppression of ERK-mediated MMP-2 activity.
Neoplasm Metastasis
Annexin A5 overexpression might suppress proliferation and metastasis of human uterine cervical carcinoma cells.
Neoplasm Metastasis
AnnexinA7 down-regulation might suppress the proliferation and metastasis of human hepatocellular carcinoma cells via MAPK/ ERK pathway.
Neoplasm Metastasis
ANP reduced Hedgehog signaling-mediated activation of matrix metalloproteinase-9 in gastric cancer cell line MGC-803.
Neoplasm Metastasis
Antagonistic Effects of Endogenous Nitric Oxide in a Glioblastoma Photodynamic Therapy Model.
Neoplasm Metastasis
Anthocyanins from Black Rice (Oryza sativa L.) Demonstrate Antimetastatic Properties by Reducing MMPs and NF-?B Expressions in Human Oral Cancer CAL 27 Cells.
Neoplasm Metastasis
Anti-cancer Activity of Centipeda minima Extract in Triple Negative Breast Cancer via Inhibition of AKT, NF-?B, and STAT3 Signaling Pathways.
Neoplasm Metastasis
Anti-cancer effect of metformin on the metastasis and invasion of primary breast cancer cells through mediating NF-kB activity.
Neoplasm Metastasis
Anti-CD146 monoclonal antibody AA98 inhibits angiogenesis via suppression of nuclear factor-kappaB activation.
Neoplasm Metastasis
Anti-endometriosis Mechanism of Jiawei Foshou San Based on Network Pharmacology.
Neoplasm Metastasis
Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
Neoplasm Metastasis
Anti-invasive activity of torilin, a sesquiterpene compound isolated from Torilis japonica.
Neoplasm Metastasis
Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer.
Neoplasm Metastasis
Anti-metastatic and pro-apoptotic effects elicited by combination photodynamic therapy with sonodynamic therapy on breast cancer both in vitro and in vivo.
Neoplasm Metastasis
Anti-Metastatic Effect of Supercritical Extracts from the Citrus hassaku Pericarp via Inhibition of C-X-C Chemokine Receptor Type 4 (CXCR4) and Matrix Metalloproteinase-9 (MMP-9).
Neoplasm Metastasis
Anti-metastatic Effects of Cationic KT2 Peptide (a Lysine/Tryptophan-rich Peptide) on Human Melanoma A375.S2 Cells.
Neoplasm Metastasis
Anticancer Effects of Valproic Acid via Regulation of Epigenetic Mechanisms in Non-small-cell Lung Cancer A549 Cell Line.
Neoplasm Metastasis
Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226.
Neoplasm Metastasis
Antimetastatic and anti-invasive ability of phospho-ascorbyl palmitate through intracellular ascorbate enrichment and the resultant antioxidant action.
Neoplasm Metastasis
Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9.
Neoplasm Metastasis
Antimetastatic Potentials of Phyllanthusurinaria L on A549 and Lewis Lung Carcinoma Cells via Repression of Matrix-Degrading Proteases.
Neoplasm Metastasis
Antineoplastic activity of Newcastle disease virus strain D90 in oral squamous cell carcinoma.
Neoplasm Metastasis
Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
Neoplasm Metastasis
Antitumor and antimetastatic effects of licochalcone A in mouse models.
Neoplasm Metastasis
Antitumor effects of the novel quinazolinone MJ-33: Inhibition of metastasis through the MAPK, AKT, NF-?B and AP-1 signaling pathways in DU145 human prostate cancer cells.
Neoplasm Metastasis
Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells.
Neoplasm Metastasis
Antitumor evaluation of carboxymethyl chitosan based norcantharidin conjugates against gastric cancer as novel polymer therapeutics.
Neoplasm Metastasis
Apigenin Attenuates Insulin-Like Growth Factor-I Signaling in an Autochthonous Mouse Prostate Cancer Model.
Neoplasm Metastasis
Apoptotic Induction and Anti-Migratory Effects of Rhazya Stricta Fruit Extracts on a Human Breast Cancer Cell Line.
Neoplasm Metastasis
Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery.
Neoplasm Metastasis
Aquaporin 1 promotes the proliferation and migration of lung cancer cell in vitro.
Neoplasm Metastasis
Areca quid chewing enhances the expression of salivary matrix metalloproteinase-9.
Neoplasm Metastasis
Arfaptin 1 inhibits ADP-ribosylation factor-dependent matrix metalloproteinase-9 secretion induced by phorbol ester in HT 1080 fibrosarcoma cells.
Neoplasm Metastasis
Arsenic trioxide reduces the invasive and metastatic properties of nasopharyngeal carcinoma cells in vitro.
Neoplasm Metastasis
Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
Neoplasm Metastasis
Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms.
Neoplasm Metastasis
Aspirin Inhibits IKK-?-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator.
Neoplasm Metastasis
Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression.
Neoplasm Metastasis
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
Neoplasm Metastasis
Assessment and clinicopathological correlation of matrix metalloproteinase 9 expression in nasopharyngeal carcinoma.
Neoplasm Metastasis
Assessment of the clinical significance of serum vascular endothelial growth factor and matrix metalloproteinase-9 in patients with hepatocellular carcinoma.
Neoplasm Metastasis
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Neoplasm Metastasis
Association between Expression of Tissue Inhibitors of Metalloproteinases-1, Matrix Metalloproteinase-2, and Matrix Metalloproteinase-9 Genes and Axillary Lymph Nodes Metastasis in Patients with Breast Cancer.
Neoplasm Metastasis
Association between Matrix Metallopeptidase 9 Polymorphism and Breast Cancer Risk.
Neoplasm Metastasis
Association of axon guidance factor Semaphorin 3A with poor outcome in pancreatic cancer.
Neoplasm Metastasis
Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma.
Neoplasm Metastasis
Association of matrix metalloproteinase (MMP)-2 and -9 expression with extra-gastrointestinal stromal tumor metastasis.
Neoplasm Metastasis
Association of matrix metalloproteinase-9 and decorin expression with the infiltration of cervical cancer.
Neoplasm Metastasis
Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk.
Neoplasm Metastasis
Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.
Neoplasm Metastasis
Astragaloside IV inhibits cell invasion and metastasis in vulvar squamous cell carcinoma through the TGF-?1/FAK/AKT signaling pathway.
Neoplasm Metastasis
Astrocytes directly influence tumor cell invasion and metastasis in vivo.
Neoplasm Metastasis
ATIQCTPC targeting MMP-9: a key step to slowing primary tumor growth and inhibiting metastasis of lewis lung carcinoma
Neoplasm Metastasis
Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.
Neoplasm Metastasis
Bacoside A downregulates matrix metalloproteinases 2 and 9 in DEN-induced hepatocellular carcinoma.
Neoplasm Metastasis
Baicalin Suppresses Migration, Invasion and Metastasis of Breast Cancer via p38MAPK Signaling Pathway.
Neoplasm Metastasis
Basigin-2 upregulated by receptor activator of NF-?B ligand enhances lung cancer-induced osteolytic lesions.
Neoplasm Metastasis
Bee venom suppresses PMA-mediated MMP-9 gene activation via JNK/p38 and NF-kappaB-dependent mechanisms.
Neoplasm Metastasis
Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway.
Neoplasm Metastasis
Berberine modulates Keratin 17 to inhibit cervical cancer cell viability and metastasis.
Neoplasm Metastasis
Berberine Suppresses the TPA-Induced MMP-1 and MMP-9 Expressions Through the Inhibition of PKC-? in Breast Cancer Cells.
Neoplasm Metastasis
Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells.
Neoplasm Metastasis
Betulinic acid induces apoptosis and suppresses metastasis in hepatocellular carcinoma cell lines in vitro and in vivo.
Neoplasm Metastasis
Biological evaluation of optically pure chiral binuclear copper(ii) complexes based on a rosin derivative as highly potential anticancer agents.
Neoplasm Metastasis
Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer.
Neoplasm Metastasis
Biphenyl substituted lysine derivatives as recognition elements for the matrix metalloproteinases MMP-2 and MMP-9.
Neoplasm Metastasis
Blockade of Rho/Rho-associated coiled coil-forming kinase signaling can prevent progression of hepatocellular carcinoma in matrix metalloproteinase-dependent manner.
Neoplasm Metastasis
BMP7 Expression in Esophageal Squamous Cell Carcinoma and Its Potential Role in Modulating Metastasis.
Neoplasm Metastasis
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy.
Neoplasm Metastasis
Bornyl cis-4-Hydroxycinnamate Suppresses Cell Metastasis of Melanoma through FAK/PI3K/Akt/mTOR and MAPK Signaling Pathways and Inhibition of the Epithelial-to-Mesenchymal Transition.
Neoplasm Metastasis
Bovine Hemoglobin Derived Peptide Asn-Phe-Gly-Lys Inhibits Pancreatic Cancer Cells Metastasis by Targeting Secreted Hsp90?.
Neoplasm Metastasis
Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice.
Neoplasm Metastasis
Breast Cancer Invasion and Metastasis by mPR? Through the PI3K/Akt Signaling Pathway.
Neoplasm Metastasis
Breast Cancer Recurrence Risk Assessment: Is Non-Invasive Monitoring an Option?
Neoplasm Metastasis
Brucine suppresses breast cancer metastasis via inhibiting epithelial mesenchymal transition and matrix metalloproteinases expressions.
Neoplasm Metastasis
BTG1 expression correlates with the pathogenesis and progression of breast carcinomas.
Neoplasm Metastasis
Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells.
Neoplasm Metastasis
By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis.
Neoplasm Metastasis
C-C Chemokine Ligand 2 (CCL2) Recruits Macrophage-Membrane-Camouflaged Hollow Bismuth Selenide Nanoparticles To Facilitate Photothermal Sensitivity and Inhibit Lung Metastasis of Breast Cancer.
Neoplasm Metastasis
C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9.
Neoplasm Metastasis
c-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer.
Neoplasm Metastasis
Cadmium induces matrix metalloproteinase-9 expression via ROS-dependent EGFR, NF-?B, and AP-1 pathways in human endothelial cells.
Neoplasm Metastasis
CADPE Inhibits PMA-Stimulated Gastric Carcinoma Cell Invasion and Matrix Metalloproteinase-9 Expression by FAK/MEK/ERK-Mediated AP-1 Activation.
Neoplasm Metastasis
Caffeic acid phenyl ester in propolis is a strong inhibitor of matrix metalloproteinase-9 and invasion inhibitor: isolation and identification.
Neoplasm Metastasis
Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity.
Neoplasm Metastasis
Calcitriol-Loaded Dual-pH-Sensitive Micelle Counteracts Pro-Metastasis Effect of Paclitaxel in Triple-Negative Breast Cancer Therapy.
Neoplasm Metastasis
Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3.
Neoplasm Metastasis
Carboxy derivatized glucosamine is a potent inhibitor of matrix metalloproteinase-9 in HT1080 cells.
Neoplasm Metastasis
Casticin inhibits breast cancer cell migration and invasion by down-regulation of PI3K/Akt signaling pathway.
Neoplasm Metastasis
Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway.
Neoplasm Metastasis
CCL3-CCR5 Axis Regulates Intratumoral Accumulation of Leukocytes and Fibroblasts and Promotes Angiogenesis in Murine Lung Metastasis Process.
Neoplasm Metastasis
CCN6-mediated MMP-9 activation enhances metastatic potential of human chondrosarcoma.
Neoplasm Metastasis
CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis.
Neoplasm Metastasis
Celastrol induces the apoptosis of breast cancer cells and inhibits their invasion via downregulation of MMP-9.
Neoplasm Metastasis
Chemical composition and pharmacological bio-efficacy of Parrotiopsis jacquemontiana (Decne) Rehder for anticancer activity.
Neoplasm Metastasis
Chemoinhibitory effect of mulberry anthocyanins on melanoma metastasis involved in the Ras/PI3K pathway.
Neoplasm Metastasis
Chemokine receptor 7 enhances cell chemotaxis and migration of metastatic squamous cell carcinoma of head and neck through activation of matrix metalloproteinase-9.
Neoplasm Metastasis
Cholic Acid Stimulates MMP-9 in Human Colon Cancer Cells via Activation of MAPK, AP-1, and NF-?B Activity.
Neoplasm Metastasis
Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
Neoplasm Metastasis
CircRNA SMARCC1 Sponges MiR-140-3p to Regulate Cell Progression in Colorectal Cancer.
Neoplasm Metastasis
Cis-guggulsterone inhibits the IKK/NF-?B pathway, whereas trans-guggulsterone inhibits MAPK/AP-1 in MCF?7 breast cancer cells: guggulsterone regulates MMP?9 expression in an isomer-specific manner.
Neoplasm Metastasis
Clinical implications of proteolytic activity imbalance in breast cancer diagnosis.
Neoplasm Metastasis
Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases.
Neoplasm Metastasis
Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma.
Neoplasm Metastasis
Clinical significance of levels of molecular biological markers in zones of invasive front-line of colorectal cancer.
Neoplasm Metastasis
Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer.
Neoplasm Metastasis
Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma.
Neoplasm Metastasis
Clinical significance of plasma MMP-2 and MMP-9 levels as biomarkers for tumor expression in breast cancer patients in Egypt.
Neoplasm Metastasis
Clinical significance of the content of biomolecular markers in invasive front of colon carcinomas.
Neoplasm Metastasis
Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: metalloproteinase-9 as an independent prognostic factor.
Neoplasm Metastasis
Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis.
Neoplasm Metastasis
Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis.
Neoplasm Metastasis
Clinicopathological correlation of keratinocyte growth factor and matrix metalloproteinase-9 expression in human gastric cancer.
Neoplasm Metastasis
Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
Neoplasm Metastasis
Clonorchis sinensis excretory-secretory products regulate migration and invasion in cholangiocarcinoma cells via extracellular signal-regulated kinase 1/2/nuclear factor-?B-dependent matrix metalloproteinase-9 expression.
Neoplasm Metastasis
Clusterin induced by N,N'-Dinitrosopiperazine is involved in nasopharyngeal carcinoma metastasis.
Neoplasm Metastasis
Clusterin induces the secretion of TNF-? and the chemotactic migration of macrophages.
Neoplasm Metastasis
Clusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF-?B-Dependent Mechanism.
Neoplasm Metastasis
Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma.
Neoplasm Metastasis
Combination of ACY-241 and JQ1 Synergistically Suppresses Metastasis of HNSCC via Regulation of MMP-2 and MMP-9.
Neoplasm Metastasis
Combination of metformin and 5-aminosalicylic acid cooperates to decrease proliferation and induce apoptosis in colorectal cancer cell lines.
Neoplasm Metastasis
Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma.
Neoplasm Metastasis
Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma.
Neoplasm Metastasis
Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines.
Neoplasm Metastasis
Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas.
Neoplasm Metastasis
Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors.
Neoplasm Metastasis
Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model.
Neoplasm Metastasis
Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract.
Neoplasm Metastasis
Contributions of lung tissue extracts to invasion and migration of human hepatocellular carcinoma cells with various metastatic potentials.
Neoplasm Metastasis
Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Neoplasm Metastasis
Cooperative Treatment of Metastatic Breast Cancer Using Host-Guest Nanoplatform Coloaded with Docetaxel and siRNA.
Neoplasm Metastasis
Coordinated targeting of MMP-2/MMP-9 by miR-296-3p/FOXCUT exerts tumor-suppressing effects in choroidal malignant melanoma.
Neoplasm Metastasis
Coronin 3 promotes gastric cancer metastasis via the up-regulation of MMP-9 and cathepsin K.
Neoplasm Metastasis
Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
Neoplasm Metastasis
Correlation between matrix metalloproteinase-9 and vascular endothelial growth factor expression in lung adenocarcinoma.
Neoplasm Metastasis
Correlation between protein expression of PTEN in human pancreatic cancer and the proliferation, infiltration, metastasis and prognosis.
Neoplasm Metastasis
Correlation Between the Expression of Matrix Metalloproteinase-9, Matrix Metalloproteinase-13, Tissue Inhibitor of Metalloproteinases-1, p16 and Differentiation of Head and Neck Squamous Cell Carcinoma: A Prospective Observational Study.
Neoplasm Metastasis
Correlation between the progression of cancer and the expression of matrix metalloproteinase-9 in metastatic spinal tumor.
Neoplasm Metastasis
Correlation of matrix metalloproteinase-2, -9, tissue inhibitor-1 of matrix metalloproteinase and CD44 variant 6 in head and neck cancer metastasis.
Neoplasm Metastasis
Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Neoplasm Metastasis
Correlation of survivin and MMP9 expressions with prognosis and clinicopathological parameters in surface epithelial ovarian carcinomas.
Neoplasm Metastasis
Correlative studies on bFGF mRNA and MMP-9 mRNA expressions with microvascular density, progression, and prognosis of gastric carcinomas.
Neoplasm Metastasis
Corrigendum to "Yokukansan Alleviates Cancer Pain by Suppressing Matrix Metalloproteinase-9 in a Mouse Bone Metastasis Model".
Neoplasm Metastasis
Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis.
Neoplasm Metastasis
CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Neoplasm Metastasis
Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity.
Neoplasm Metastasis
CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells.
Neoplasm Metastasis
Cucurbitacin B inhibits 12-O-tetradecanoylphorbol 13-acetate-induced invasion and migration of human hepatoma cells through inactivating mitogen-activated protein kinase and PI3K/Akt signal transduction pathways.
Neoplasm Metastasis
Curcumae Radix Extract Decreases Mammary Tumor-Derived Lung Metastasis via Suppression of C-C Chemokine Receptor Type 7 Expression.
Neoplasm Metastasis
Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
Neoplasm Metastasis
Curcumin and wikstroflavone B, a new biflavonoid isolated from Wikstroemia indica, synergistically suppress the proliferation and metastasis of nasopharyngeal carcinoma cells via blocking FAK/STAT3 signaling pathway.
Neoplasm Metastasis
Curcumin inhibits the metastasis of K1 papillary thyroid cancer cells via modulating E-cadherin and matrix metalloproteinase-9 expression
Neoplasm Metastasis
Curcumin inhibits the metastasis of K1 papillary thyroid cancer cells via modulating E-cadherin and matrix metalloproteinase-9 expression.
Neoplasm Metastasis
Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Neoplasm Metastasis
Curcumol inhibits lung adenocarcinoma growth and metastasis via inactivation of PI3K/AKT and Wnt/ß-catenin pathway.
Neoplasm Metastasis
Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-?B Signaling Pathways.
Neoplasm Metastasis
CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Neoplasm Metastasis
CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone.
Neoplasm Metastasis
CXCR4 silencing inhibits invasion and migration of human laryngeal cancer Hep-2 cells.
Neoplasm Metastasis
Cyanidin-3-O-sambubioside from Acanthopanax sessiliflorus fruit inhibits metastasis by downregulating MMP-9 in breast cancer cells MDA-MB-231.
Neoplasm Metastasis
Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells.
Neoplasm Metastasis
Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha.
Neoplasm Metastasis
Cytochrome P450 ?-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.
Neoplasm Metastasis
Cytokines, inducers and inhibitors modulate MMP-2 and MMP?9 secretion by human Fanconi anemia immortalized fibroblasts.
Neoplasm Metastasis
DEAD-box helicase DP103 defines metastatic potential of human breast cancers.
Neoplasm Metastasis
Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
Neoplasm Metastasis
Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells.
Neoplasm Metastasis
Delphinidin suppresses PMA-induced MMP-9 expression by blocking the NF-?B activation through MAPK signaling pathways in MCF-7 human breast carcinoma cells.
Neoplasm Metastasis
Delta-tocotrienol inhibits non-small-cell lung cancer cell invasion via the inhibition of NF-?B, uPA activator, and MMP-9.
Neoplasm Metastasis
Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).
Neoplasm Metastasis
Des-?-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway.
Neoplasm Metastasis
Design, synthesis and biological evaluation of a new thieno[2,3-d]pyrimidine-based urea derivative with potential antitumor activity against tamoxifen sensitive and resistant breast cancer cell lines.
Neoplasm Metastasis
Detection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technology.
Neoplasm Metastasis
Detection of endometrial cancer by determination of matrix metalloproteinases in the uterine cavity.
Neoplasm Metastasis
Detection of serum VEGF and MMP-9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma.
Neoplasm Metastasis
Determining the levels of matrix metalloproteinase-9 in portal and peripheral blood is useful for predicting liver metastasis of colorectal cancer.
Neoplasm Metastasis
DHA/EPA-Enriched Phosphatidylcholine Suppresses Tumor Growth and Metastasis via Activating Peroxisome Proliferator-Activated Receptor ? in Lewis Lung Cancer Mice.
Neoplasm Metastasis
Diagnostic power of VEGF, MMP-9 and TIMP-1 in patients with breast cancer. A multivariate statistical analysis with ROC curve.
Neoplasm Metastasis
Diallyl trisulfide increases the effectiveness of TRAIL and inhibits prostate cancer growth in an orthotopic model: molecular mechanisms.
Neoplasm Metastasis
Differential diagnosis of lung cancer, its metastasis and chronic obstructive pulmonary disease based on serum Vegf, Il-8 and MMP-9.
Neoplasm Metastasis
Differential role of psoriasin (S100A7) in estrogen receptor ? positive and negative breast cancer cells occur through actin remodeling.
Neoplasm Metastasis
Dihydroartemisinin Prevents Distant Metastasis of Laryngeal Carcinoma by Inactivating STAT3 in Cancer Stem Cells.
Neoplasm Metastasis
Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells.
Neoplasm Metastasis
Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis.
Neoplasm Metastasis
Distinct endobronchial expression of matrix-metalloproteinases (MMP) and their endogenous inhibitors in lung cancer.
Neoplasm Metastasis
Distinct Functionality of Tumor Cell-Derived Gelatinases during Formation of Liver Metastases.
Neoplasm Metastasis
Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.
Neoplasm Metastasis
DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis.
Neoplasm Metastasis
DNA ploidy analysis and expression of MMP-9, TIMP-2, and E-cadherin in gastric carcinoma.
Neoplasm Metastasis
Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells.
Neoplasm Metastasis
Docosahexaenoic Acid Modulates Invasion and Metastasis of Human Ovarian Cancer via Multiple Molecular Pathways.
Neoplasm Metastasis
Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis.
Neoplasm Metastasis
Down-regulation of Gab1 inhibits cell proliferation and migration in hilar cholangiocarcinoma.
Neoplasm Metastasis
Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells.
Neoplasm Metastasis
Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
Neoplasm Metastasis
Downregulation of cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9.
Neoplasm Metastasis
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer.
Neoplasm Metastasis
Downregulation of miR-1225-5p is pivotal for proliferation, invasion, and migration of HCC cells through NF?B regulation.
Neoplasm Metastasis
Downregulation of the GnT-V gene inhibits metastasis and invasion of BGC823 gastric cancer cells.
Neoplasm Metastasis
Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
Neoplasm Metastasis
Downregulations of AKT/mTOR Signaling Pathway for Salmonella-Mediated Suppression of Matrix Metalloproteinases-9 Expression in Mouse Tumor Models.
Neoplasm Metastasis
Ds-echinoside A, a new triterpene glycoside derived from sea cucumber, exhibits antimetastatic activity via the inhibition of NF-?B-dependent MMP-9 and VEGF expressions.
Neoplasm Metastasis
Dual ATP/reduction-responsive polyplex to achieve the co-delivery of doxorubicin and miR-23b for the cancer treatment.
Neoplasm Metastasis
E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: Analysis of 125 patients.
Neoplasm Metastasis
Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
Neoplasm Metastasis
eEF1A2 promotes cell migration, invasion and metastasis in pancreatic cancer by upregulating MMP-9 expression through Akt activation.
Neoplasm Metastasis
Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.
Neoplasm Metastasis
Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background.
Neoplasm Metastasis
Effect of curcumin and Meriva on the lung metastasis of murine mammary gland adenocarcinoma.
Neoplasm Metastasis
Effect of isofebrifugine on the proliferation and invasion of human gastric cancer cells via MMP.
Neoplasm Metastasis
Effect of microRNA-206 on cytoskeleton remodelling by downregulating Cdc42 in MDA-MB-231 cells.
Neoplasm Metastasis
Effect of resveratrol on the metastasis of 4T1 mouse breast cancer cells in vitro and in vivo.
Neoplasm Metastasis
Effect of verbascoside on apoptosis and metastasis in human oral squamous cell carcinoma.
Neoplasm Metastasis
Effects of Ad-p27mt gene transfer on the expression of Bax, Bcl-2, VEGF and MMP-9 in the transplanted liver tumors in nude mice.
Neoplasm Metastasis
Effects of baicalein on proliferation, apoptosis, migration and invasion of Ewing's sarcoma cells.
Neoplasm Metastasis
Effects of cigarette smoke condensate on oral squamous cell carcinoma cells.
Neoplasm Metastasis
Effects of hepatocyte growth factor/scatter factor on the invasion of colorectal cancer cells in vitro.
Neoplasm Metastasis
Effects of magnetic induction hyperthermia and radiotherapy alone or combined on a murine 4T1 metastatic breast cancer model.
Neoplasm Metastasis
Effects of nutrients on matrix metalloproteinases in human T-lymphotropic virus type 1 positive and negative malignant T-lymphocytes.
Neoplasm Metastasis
Effects of the combination of hyperbaric oxygen and 5-fluorouracil on proliferation and metastasis of human nasopharyngeal carcinoma CNE-2Z cells.
Neoplasm Metastasis
Effects of the regulation of polysialyltransferase ST8SiaII on the invasiveness and metastasis of small cell lung cancer cells.
Neoplasm Metastasis
Effects of various treatment approaches for treatment efficacy for late stage breast cancer and expression level of TIMP-1 and MMP-9.
Neoplasm Metastasis
Effects of VEGFR1+ hematopoietic progenitor cells on pre-metastatic niche formation and in vivo metastasis of breast cancer cells.
Neoplasm Metastasis
EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.
Neoplasm Metastasis
EGF stimulates glioblastoma metastasis by induction of matrix metalloproteinase-9 in an EGFR-dependent mechanism.
Neoplasm Metastasis
Electrical dual-sensing method for real-time quantitative monitoring of cell-secreted MMP-9 and cellular morphology during migration process.
Neoplasm Metastasis
Electrochemical immunoplatform to assist in the diagnosis and classification of breast cancer through the determination of matrix-metalloproteinase-9.
Neoplasm Metastasis
Elevated AEG-1 expression in macrophages promotes hypopharyngeal cancer invasion through the STAT3-MMP-9 signaling pathway.
Neoplasm Metastasis
Elevated levels of circulating matrix metalloproteinase-9 in non-small cell lung cancer patients.
Neoplasm Metastasis
Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
Neoplasm Metastasis
Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma.
Neoplasm Metastasis
Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
Neoplasm Metastasis
Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals.
Neoplasm Metastasis
Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9.
Neoplasm Metastasis
Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis.
Neoplasm Metastasis
Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells.
Neoplasm Metastasis
Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence.
Neoplasm Metastasis
Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.
Neoplasm Metastasis
Enhanced production of matrix metalloproteinase-2 in human head and neck carcinomas is correlated with lymph node metastasis.
Neoplasm Metastasis
Environmental endocrine disruptors promote invasion and metastasis of SK-N-SH human neuroblastoma cells.
Neoplasm Metastasis
Epidermal growth factor receptor-mediated regulation of matrix metalloproteinase-2 and matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Neoplasm Metastasis
Epigallocatechin-3-gallate inhibits bladder cancer cell invasion via suppression of NF-?B?mediated matrix metalloproteinase-9 expression.
Neoplasm Metastasis
Epigallocatechin-3-gallate inhibits photocarcinogenesis through inhibition of angiogenic factors and activation of CD8+ T cells in tumors.
Neoplasm Metastasis
Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
Neoplasm Metastasis
Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis.
Neoplasm Metastasis
ESM-1 Overexpression is Involved in Increased Tumorigenesis of Radiotherapy-Resistant Breast Cancer Cells.
Neoplasm Metastasis
Esophageal cancer stem cells express PLGF to increase cancer invasion through MMP9 activation.
Neoplasm Metastasis
Estrogen Induces Metastatic Potential of Papillary Thyroid Cancer Cells through Estrogen Receptor ? and ?.
Neoplasm Metastasis
Ethanol Extract of Lycopus lucidus Turcz. ex Benth Inhibits Metastasis by Downregulation of Runx-2 in Mouse Colon Cancer Cells.
Neoplasm Metastasis
Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity.
Neoplasm Metastasis
ETS-1 regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell SKOV-3.
Neoplasm Metastasis
Eugenol with antioxidant activity inhibits MMP-9 related to metastasis in human fibrosarcoma cells.
Neoplasm Metastasis
Euphorbia humifusa Willd exerts inhibition of breast cancer cell invasion and metastasis through inhibition of TNF?-induced MMP-9 expression.
Neoplasm Metastasis
Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction.
Neoplasm Metastasis
Evaluation of Serum Levels of HER2, MMP-9, Nitric Oxide, and Total Antioxidant Capacity in Egyptian Breast Cancer Patients: Correlation with Clinico-Pathological Parameters.
Neoplasm Metastasis
Evaluation on biological compatibility of carboxymethyl chitosan as biomaterials for antitumor drug delivery.
Neoplasm Metastasis
Ex Vivo and In Vivo Imaging and Biodistribution of Aptamers Targeting the Human Matrix MetalloProtease-9 in Melanomas.
Neoplasm Metastasis
Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.
Neoplasm Metastasis
Exogenous prostaglandin E2 inhibits TPA induced matrix metalloproteinase-9 production in MCF-7 cells.
Neoplasm Metastasis
Exosome EpCAM promotes the metastasis of glioma by targeting the CD44 signaling molecule on the surface of glioma cells.
Neoplasm Metastasis
Exploring the action of RGDV-gemcitabine on tumor metastasis, tumor growth and possible action pathway.
Neoplasm Metastasis
Exploring the Mechanism of Flaccidoxide-13-Acetate in Suppressing Cell Metastasis of Hepatocellular Carcinoma.
Neoplasm Metastasis
Expression and biological relationship of vascular endothelial growth factor-a and matrix metalloproteinase-9 in gastric carcinoma.
Neoplasm Metastasis
Expression and clinical significance of ARTN and MMP-9 in endometrial carcinoma.
Neoplasm Metastasis
Expression and clinical significance of CD74 and MMP-9 in colon adenocarcinomas.
Neoplasm Metastasis
Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
Neoplasm Metastasis
Expression and clinical significance of matrix metalloproteinase-9 in lymphatic invasiveness and metastasis of breast cancer.
Neoplasm Metastasis
Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer.
Neoplasm Metastasis
Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors.
Neoplasm Metastasis
Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression.
Neoplasm Metastasis
Expression and significance of MMP-9 and MDM2 in the oncogenesis of lung cancer in rats.
Neoplasm Metastasis
Expression and the molecular forms of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase 9 in canine mammary tumours.
Neoplasm Metastasis
Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.
Neoplasm Metastasis
Expression levels of matrix metalloproteinase-9 in human gastric carcinoma.
Neoplasm Metastasis
Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma.
Neoplasm Metastasis
Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors.
Neoplasm Metastasis
Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis.
Neoplasm Metastasis
Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis.
Neoplasm Metastasis
Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis.
Neoplasm Metastasis
Expression of gelatinase-A (MMP-2) in human colon cancer and normal colon mucosa.
Neoplasm Metastasis
Expression of KiSS-1 gene and its role in invasion and metastasis of human hepatocellular carcinoma.
Neoplasm Metastasis
Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
Neoplasm Metastasis
Expression of matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of MMP (TIMP)-1 in conjunctival melanomas and clinical implications.
Neoplasm Metastasis
Expression of matrix metalloproteinase 9 in pancreatic ductal carcinoma is associated with tumor metastasis formation.
Neoplasm Metastasis
Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential.
Neoplasm Metastasis
Expression of matrix metalloproteinase-2 and prostate-specific antigen in localized and metastatic prostate cancer.
Neoplasm Metastasis
Expression of matrix metalloproteinase-9 (MMP-9) and blood vessel density in laryngeal squamous cell carcinomas.
Neoplasm Metastasis
Expression of matrix metalloproteinase-9 and bombesin/gastrin-releasing peptide in human prostate cancers and their lymph node metastases.
Neoplasm Metastasis
Expression of matrix metalloproteinase-9 correlates with poor prognosis in human malignant fibrous histiocytoma.
Neoplasm Metastasis
Expression of matrix metalloproteinase-9 in surgically resected intrahepatic cholangiocarcinoma.
Neoplasm Metastasis
Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in gastric cancer.
Neoplasm Metastasis
Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer.
Neoplasm Metastasis
Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Neoplasm Metastasis
Expression of matrix metalloproteinase-9, cyclooxygenase-2 and vascular endothelial growth factor are increased in gastrointestinal stromal tumors.
Neoplasm Metastasis
Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Neoplasm Metastasis
Expression of Matrix Metalloproteinases (MMPs) in Primary Human Breast Cancer: MMP-9 as a Potential Biomarker for Cancer Invasion and Metastasis.
Neoplasm Metastasis
Expression of Matrix Metalloproteinases and Its Inhibitor in Gastric Adenocarcinoma.
Neoplasm Metastasis
Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Neoplasm Metastasis
Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
Neoplasm Metastasis
Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and their relation to claudin-4 expression.
Neoplasm Metastasis
Expression of MMP-2, MMP-9, and urokinase-type plasminogen activator in cervical intraepithelial neoplasia.
Neoplasm Metastasis
Expression of MMP-9 and WAVE3 in colorectal cancer and its relationship to clinicopathological features.
Neoplasm Metastasis
Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue.
Neoplasm Metastasis
Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication.
Neoplasm Metastasis
Expression of molecular factors correlated with metastasis in small cell lung cancer and their significance.
Neoplasm Metastasis
Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis.
Neoplasm Metastasis
Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells.
Neoplasm Metastasis
Expression of RECK gene and MMP-9 in hilar cholangiocarcinoma and its clinical significance.
Neoplasm Metastasis
Expression of reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase 9 in middle ear squamous cell carcinoma.
Neoplasm Metastasis
Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
Neoplasm Metastasis
Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC.
Neoplasm Metastasis
Expression of SHP2 and Related Markers in Non-Small Cell Lung Cancer: A Tissue Microarray Study of 80 Cases.
Neoplasm Metastasis
Expression of TGF-?1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.
Neoplasm Metastasis
Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status.
Neoplasm Metastasis
Expression of the reversion-inducing cysteine-rich protein with Kazal motifs and matrix metalloproteinase-14 in neuroblastoma and the role in tumour metastasis.
Neoplasm Metastasis
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
Neoplasm Metastasis
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Neoplasm Metastasis
Expression of Twist protein in colorectal carcinoma and its effect on proliferation and invasion of colorectal cancer cells.
Neoplasm Metastasis
Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
Neoplasm Metastasis
Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer.
Neoplasm Metastasis
Expression of vascular endothelial growth factor-A, matrix metalloproteinase-9, and extravascular matrix patterns and their correlations with clinicopathologic parameters in posterior uveal melanomas.
Neoplasm Metastasis
Expression, subcellular distribution and plasma membrane binding of cathepsin B and gelatinases in bone metastatic tissue.
Neoplasm Metastasis
Expressions of CD147, MMP-2 and MMP-9 in Laryngeal Carcinoma and its Correlation with Poor Prognosis.
Neoplasm Metastasis
Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma.
Neoplasm Metastasis
Expressions of Inhibitors of DNA Binding-1 and Matrix Metalloproteinase-9 in Colorectal Adenocarcinoma Tissues and Their Correlations with Microvessel Density.
Neoplasm Metastasis
Expressions of Matrix Metalloproteinase-7 and -9 and their Prognostic Significances in Rectal Cancer.
Neoplasm Metastasis
Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.
Neoplasm Metastasis
Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma.
Neoplasm Metastasis
Failure of matrix metalloproteinase-9 dimer induction by phorbol 12-myristate 13-acetate in normal human cell lines.
Neoplasm Metastasis
FAK is involved in invasion and metastasis of hepatocellular carcinoma.
Neoplasm Metastasis
Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules.
Neoplasm Metastasis
Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome.
Neoplasm Metastasis
FGF-1-induced matrix metalloproteinase-9 expression in breast cancer cells is mediated by increased activities of NF-kappaB and activating protein-1.
Neoplasm Metastasis
Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production.
Neoplasm Metastasis
Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells.
Neoplasm Metastasis
Fibronectin induces matrix metalloproteinase-9 (MMP-9) in human laryngeal carcinoma cells by involving multiple signaling pathways.
Neoplasm Metastasis
Fibronectin-integrin (alpha5beta1) modulates migration and invasion of murine melanoma cell line B16F10 by involving MMP-9.
Neoplasm Metastasis
Filamin A regulates MMP-9 expression and suppresses prostate cancer cell migration and invasion.
Neoplasm Metastasis
Fine particulate matter PM2.5 generated by building demolition increases the malignancy of breast cancer MDA-MB-231 cells.
Neoplasm Metastasis
Flavokawain B inhibits growth of human squamous carcinoma cells: Involvement of apoptosis and cell cycle dysregulation in vitro and in vivo.
Neoplasm Metastasis
Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.
Neoplasm Metastasis
Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma.
Neoplasm Metastasis
Folate-decorated arginine-based poly(ester urea urethane) nanoparticles as carriers for gambogic acid and effect on cancer cells.
Neoplasm Metastasis
Folate-targeted paclitaxel-conjugated polymeric micelles inhibits pulmonary metastatic hepatoma in experimental murine H22 metastasis models.
Neoplasm Metastasis
Formal model of the interplay between TGF?1 and MMP-9 and their dynamics in hepatocellular carcinoma.
Neoplasm Metastasis
FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibition.
Neoplasm Metastasis
Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
Neoplasm Metastasis
Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-?B and AP-1 signaling in human breast cancer cells.
Neoplasm Metastasis
Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB.
Neoplasm Metastasis
Functional expression of CXC chemokine recepter-4 mediates the secretion of matrix metalloproteinases from mouse hepatocarcinoma cell lines with different lymphatic metastasis ability.
Neoplasm Metastasis
Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cells.
Neoplasm Metastasis
Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.
Neoplasm Metastasis
Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer.
Neoplasm Metastasis
Functional proteomics study reveals that N-Acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1.
Neoplasm Metastasis
Functional roles of tumor necrosis factor-related apoptosis-inducing ligand-DR5 interaction in B16F10 cells by activating the nuclear factor-?B pathway to induce metastatic potential.
Neoplasm Metastasis
Furanodiene, a natural small molecule suppresses metastatic breast cancer cell migration and invasion in vitro.
Neoplasm Metastasis
Fuzheng Yiliu Formula Regulates Tumor Invasion and Metastasis through Inhibition of WAVE3 Expression.
Neoplasm Metastasis
Gab1 regulates proliferation and migration through the PI3K/Akt signaling pathway in intrahepatic cholangiocarcinoma.
Neoplasm Metastasis
Galectin-1 knockdown in carcinoma-associated fibroblasts inhibits migration and invasion of human MDA-MB-231 breast cancer cells by modulating MMP-9 expression.
Neoplasm Metastasis
Galectin-3 expressed on different lung compartments promotes organ specific metastasis by facilitating arrest, extravasation and organ colonization via high affinity ligands on melanoma cells.
Neoplasm Metastasis
Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Neoplasm Metastasis
Gallic acid-capped gold nanoparticles inhibit EGF-induced MMP-9 expression through suppression of p300 stabilization and NF?B/c-Jun activation in breast cancer MDA-MB-231 cells.
Neoplasm Metastasis
Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity.
Neoplasm Metastasis
Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression.
Neoplasm Metastasis
Gastrokine-2 is downregulated in gastric cancer and its restoration suppresses gastric tumorigenesis and cancer metastasis.
Neoplasm Metastasis
Gelatinases A and B expression in human colorectal cancer in upper Egypt: a clinicopathological study.
Neoplasm Metastasis
Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1.
Neoplasm Metastasis
Ginkgo biloba Exocarp Extract Inhibits the Metastasis of B16-F10 Melanoma Involving PI3K/Akt/NF-?B/MMP-9 Signaling Pathway.
Neoplasm Metastasis
Ginkgolic acids inhibit migration in breast cancer cells by inhibition of NEMO sumoylation and NF-?B activity.
Neoplasm Metastasis
Glaucine inhibits breast cancer cell migration and invasion by inhibiting MMP-9 gene expression through the suppression of NF-?B activation.
Neoplasm Metastasis
Golgi phosphoprotein 3 regulates metastasis of prostate cancer via matrix metalloproteinase 9.
Neoplasm Metastasis
GOLPH3 Overexpression is Closely Correlated with Poor Prognosis in Human Non-Small Cell Lung Cancer and Mediates its Metastasis Through Upregulating MMP-2 and MMP-9.
Neoplasm Metastasis
Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9.
Neoplasm Metastasis
Hairy/enhancer-of-split related with YRPW motif protein 1 promotes osteosarcoma metastasis via matrix metallopeptidase 9 expression.
Neoplasm Metastasis
Halofuginone induces the apoptosis of breast cancer cells and inhibits migration via downregulation of matrix metalloproteinase-9.
Neoplasm Metastasis
Halting colorectal cancer metastasis via novel dual nanomolar MMP-9/MAO-A quinoxaline-based inhibitors; design, synthesis, and evaluation.
Neoplasm Metastasis
HAND2-AS1 inhibits invasion and metastasis of cervical cancer cells via microRNA-330-5p-mediated LDOC1.
Neoplasm Metastasis
Helicobacter pylori promotes invasion and metastasis of gastric cancer cells through activation of AP-1 and up-regulation of CACUL1.
Neoplasm Metastasis
HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
Neoplasm Metastasis
Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells.
Neoplasm Metastasis
Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells.
Neoplasm Metastasis
High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients.
Neoplasm Metastasis
High Expression of GRP78 Promotes Invasion and Metastases in Patients with Esophageal Squamous Cell Carcinoma.
Neoplasm Metastasis
High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
Neoplasm Metastasis
High infiltration of CD68-tumor associated macrophages, predict poor prognosis in Kazakh esophageal cancer patients.
Neoplasm Metastasis
High level of ?B-crystallin contributes to the progression of osteosarcoma.
Neoplasm Metastasis
High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
Neoplasm Metastasis
High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
Neoplasm Metastasis
High-throughput functional profiling of single adherent cells via hydrogel drop-screen.
Neoplasm Metastasis
Hispolon suppresses SK-Hep1 human hepatoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen activator through the PI3K/Akt and ERK signaling pathways.
Neoplasm Metastasis
Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer.
Neoplasm Metastasis
Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/?-catenin signaling.
Neoplasm Metastasis
HMGA2 gene silencing reduces epithelial-mesenchymal transition and lymph node metastasis in cervical cancer through inhibiting the ATR/Chk1 signaling pathway.
Neoplasm Metastasis
HMGB1-Mediated MMP-9 Expression in Non-Small Cell Lung Cancer Contributes to Tumor Cell Invasiveness.
Neoplasm Metastasis
Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE?-mediated activation of ?-catenin signaling.
Neoplasm Metastasis
Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasis.
Neoplasm Metastasis
Host response to short-term, single-agent chemotherapy induces matrix metalloproteinase-9 expression and accelerates metastasis in mice.
Neoplasm Metastasis
Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met.
Neoplasm Metastasis
Human leucine zipper protein sLZIP induces migration and invasion of cervical cancer cells via expression of matrix metalloproteinase-9.
Neoplasm Metastasis
Human tongue carcinoma growth is inhibited by selective antigelatinolytic peptides.
Neoplasm Metastasis
Hydrogen peroxide inducible clone-5 sustains NADPH oxidase-dependent reactive oxygen species-c-jun N-terminal kinase signaling in hepatocellular carcinoma.
Neoplasm Metastasis
Hypoxia activates heparanase expression in an NF-kappaB dependent manner.
Neoplasm Metastasis
Hypoxia enhances gene expression of inducible nitric oxide synthase and matrix metalloproteinase-9 in ras/myc-transformed serum-free mouse embryo cells under simulated inflammatory and infectious conditions.
Neoplasm Metastasis
Identification of a Potent Oridonin Analogue for Treatment of Triple-Negative Breast Cancer.
Neoplasm Metastasis
Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
Neoplasm Metastasis
IL-10 inhibition of human prostate PC-3 ML cell metastases in SCID mice: IL-10 stimulation of TIMP-1 and inhibition of MMP-2/MMP-9 expression.
Neoplasm Metastasis
IL-17RB enhances thyroid cancer cell invasion and metastasis via ERK1/2 pathway-mediated MMP-9 expression.
Neoplasm Metastasis
IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
Neoplasm Metastasis
Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Neoplasm Metastasis
Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma.
Neoplasm Metastasis
Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue.
Neoplasm Metastasis
Immunoexpression of ROCK-1 and MMP-9 as prognostic markers in breast cancer.
Neoplasm Metastasis
Immunohistochemical analysis of matrix metalloproteinase-9 predicts papillary thyroid carcinoma prognosis.
Neoplasm Metastasis
Immunohistochemical analysis of neutrophils, interleukin-17, matrix metalloproteinase-9, and neoformed vessels in oral squamous cell carcinoma.
Neoplasm Metastasis
Immunohistochemical evaluation of MMP-2, MMP-9 and CD31/microvascular density in squamous cell carcinomas of the floor of the mouth.
Neoplasm Metastasis
Immunohistochemical expression of matrix metalloproteinases 1, 2, 9, and 14 in dermatofibrosarcoma protuberans and common fibrous histiocytoma (dermatofibroma).
Neoplasm Metastasis
Immunohistochemical expression of MMP-9 and VEGF in squamous cell carcinoma of the tongue.
Neoplasm Metastasis
Immunohistochemical expression of Notch1, Jagged1, NF-?B and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
Neoplasm Metastasis
Immunohistochemical studies on matrix metalloproteinase-9 (MMP-9) and type-IV collagen in endometrial carcinoma.
Neoplasm Metastasis
Immunohistochemical study of KiSS1 and KiSS1R expression in human primary breast cancer: Association with breast cancer receptor status, proliferation markers and clinicopathological features.
Neoplasm Metastasis
Immunoinformatics design of multiepitopes peptide-based universal cancer vaccine using matrix metalloproteinase-9 protein as a target.
Neoplasm Metastasis
Immunoregulatory Monocyte Subset Promotes Metastasis Associated With Therapeutic Intervention for Primary Tumor.
Neoplasm Metastasis
Impact of Histological and Molecular Parameters on Prognosis of Oral Squamous Cell Carcinoma: Analysis of 290 Cases.
Neoplasm Metastasis
In situ localization of gelatinolytic activity in the extracellular matrix of metastases of colon cancer in rat liver using quenched fluorogenic DQ-gelatin.
Neoplasm Metastasis
In vitro and in vivo matrix metalloproteinase production by pancreatic cancer cells and by distant organs.
Neoplasm Metastasis
In vitro determination of basement membrane invasion predicts liver metastases in human gastrointestinal carcinoma.
Neoplasm Metastasis
In vitro evaluation of the cytotoxic, anti-proliferative and anti-oxidant properties of pterostilbene isolated from Pterocarpus marsupium.
Neoplasm Metastasis
In vitro inhibition of invasion and metastasis in colon cancer cells by TanIIA.
Neoplasm Metastasis
In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors.
Neoplasm Metastasis
In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
Neoplasm Metastasis
Inactivation of the Akt/FOXM1 Signaling Pathway by Panobinostat Suppresses the Proliferation and Metastasis of Gastric Cancer Cells.
Neoplasm Metastasis
Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model.
Neoplasm Metastasis
Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer.
Neoplasm Metastasis
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
Neoplasm Metastasis
Increased metastases are associated with inflammation and matrix metalloproteinase-9 activity at incision sites in a murine model of peritoneal dissemination of colorectal cancer.
Neoplasm Metastasis
Increased plasma levels of urokinase plasminogen activator and matrix metalloproteinase-9 in nonsmall cell lung cancer patients.
Neoplasm Metastasis
Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases.
Neoplasm Metastasis
Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.
Neoplasm Metastasis
Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: Decreased tumor metastasis in a breast cancer model.
Neoplasm Metastasis
Influence of VEGF, COX-2, and MMP-9 expression on the molybdenum-targeted X-ray in breast cancer.
Neoplasm Metastasis
Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
Neoplasm Metastasis
Inhibition of Breast Cancer Metastasis by Pluronic Copolymers with Moderate Hydrophilic-Lipophilic Balance.
Neoplasm Metastasis
Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells.
Neoplasm Metastasis
Inhibition of cell proliferation, migration and invasion by DNAzyme targeting MMP-9 in A549 cells.
Neoplasm Metastasis
Inhibition of collagenases from mouse lung carcinoma cells by green tea catechins and black tea theaflavins.
Neoplasm Metastasis
Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro.
Neoplasm Metastasis
Inhibition of FoxO1 nuclear exclusion prevents metastasis of glioblastoma.
Neoplasm Metastasis
Inhibition of invasion and metastasis of MHCC97H cells by expression of snake venom cystatin through reduction of proteinases activity and epithelial-mesenchymal transition.
Neoplasm Metastasis
Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.
Neoplasm Metastasis
Inhibition of Late and Early Phases of Cancer Metastasis by the NF-?B Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review.
Neoplasm Metastasis
Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system.
Neoplasm Metastasis
Inhibition of matrix metalloproteinase-9 expression by docosahexaenoic acid mediated by heme oxygenase 1 in 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 human breast cancer cells.
Neoplasm Metastasis
Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice.
Neoplasm Metastasis
Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.
Neoplasm Metastasis
Inhibition of miR-574-5p suppresses cell growth and metastasis and enhances chemosensitivity by targeting RNA binding protein QKI in cervical cancer cells.
Neoplasm Metastasis
Inhibition of MMP-9 transcription and suppression of tumor metastasis by pyrrole-imidazole polyamide.
Neoplasm Metastasis
Inhibition of spontaneous rat osteosarcoma lung metastasis by 3S-[4-(N-hydroxyamino)-2R-isobutylsuccinyl]amino-1-methoxy-3,4-dihydroc arbostyril, a novel matrix metalloproteinase inhibitor.
Neoplasm Metastasis
Inhibitory effect of chitooligosaccharides on matrix metalloproteinase-9 in human fibrosarcoma cells (HT1080).
Neoplasm Metastasis
Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo.
Neoplasm Metastasis
Inhibitory effect of methanol extract of Euonymus alatus on matrix metalloproteinase-9.
Neoplasm Metastasis
Inhibitory effect of phytoglycoprotein (38 kDa) on expression of matrix metalloproteinase-9 in 12-O-tetradecanoylphorbol-13-acetate-treated HepG2cells.
Neoplasm Metastasis
Inhibitory effects of butein on cancer metastasis and bioenergetic modulation.
Neoplasm Metastasis
Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9.
Neoplasm Metastasis
Inhibitory effects of tanshinone II-A on invasion and metastasis of human colon carcinoma cells.
Neoplasm Metastasis
Inhibitory effects of tetrandrine on epidermal growth factor-induced invasion and migration in HT29 human colorectal adenocarcinoma cells.
Neoplasm Metastasis
Inositol Hexaphosphate and Inositol Inhibit Colorectal Cancer Metastasis to the Liver in BALB/c Mice.
Neoplasm Metastasis
Insulin-like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcoma.
Neoplasm Metastasis
Interactions between filamin A and MMP-9 regulate proliferation and invasion in renal cell carcinoma.
Neoplasm Metastasis
Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression.
Neoplasm Metastasis
Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
Neoplasm Metastasis
Interleukin-1? activates focal adhesion kinase and Src to induce matrix metalloproteinase-9 production and invasion of MCF-7 breast cancer cells.
Neoplasm Metastasis
Interleukin-1alpha-induced proteolytic activation of metalloproteinase-9 by human skin.
Neoplasm Metastasis
Interplay of N-Cadherin and matrix metalloproteinase 9 enhances human nasopharyngeal carcinoma cell invasion.
Neoplasm Metastasis
Intrabronchial orthotopic propagation of human lung adenocarcinoma--characterizations of tumorigenicity, invasion and metastasis.
Neoplasm Metastasis
Intrahepatic metastasis by orthotopic implantation of a fragment of murine hepatoma and its related molecules.
Neoplasm Metastasis
Intratumoral macrophage counts correlate with tumor progression in colorectal cancer.
Neoplasm Metastasis
Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis.
Neoplasm Metastasis
Involvement of osteopontin in the matrix-degrading and proangiogenic changes mediated by nicotine in pancreatic cancer cells.
Neoplasm Metastasis
Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9.
Neoplasm Metastasis
Involvement of protease-activated receptor 4 in over-expression of matrix metalloproteinase 9 induced by Porphyromonas gingivalis.
Neoplasm Metastasis
Iron increases MMP-9 expression through activation of AP-1 via ERK/Akt pathway in human head and neck squamous carcinoma cells.
Neoplasm Metastasis
Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts.
Neoplasm Metastasis
Ischemia reperfusion-induced metastasis is resistant to PPAR? agonist pioglitazone in a murine model of colon cancer.
Neoplasm Metastasis
Isothiocyanates inhibit the invasion and migration of C6 glioma cells by blocking FAK/JNK-mediated MMP-9 expression.
Neoplasm Metastasis
Isothiocyanates suppress the invasion and metastasis of tumors by targeting FAK/MMP-9 activity.
Neoplasm Metastasis
Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.
Neoplasm Metastasis
KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line.
Neoplasm Metastasis
Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer.
Neoplasm Metastasis
Kiss-1 suppresses MMP-9 expression by activating p38 MAP kinase in human stomach cancer.
Neoplasm Metastasis
KISS1 Associates with Better Outcome via Inhibiting Matrix Metalloproteinase-9 in Colorectal Liver Metastasis.
Neoplasm Metastasis
Knockdown of Angiopoietin-2 Suppresses Metastasis in Human Pancreatic Carcinoma by Reduced Matrix Metalloproteinase-2.
Neoplasm Metastasis
Knockdown of Matrix Metallopeptidase 9 Inhibits Metastasis of Oral Squamous Cell Carcinoma Cells in a Zebrafish Xenograft Model.
Neoplasm Metastasis
Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Neoplasm Metastasis
Korean Red Ginseng water extract arrests growth of xenografted lymphoma cells.
Neoplasm Metastasis
L-carnosine inhibits metastasis of SK-Hep-1 cells by inhibition of matrix metaoproteinase-9 expression and induction of an antimetastatic gene, nm23-H1.
Neoplasm Metastasis
Laminin gamma 1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16-F10 mouse melanoma cells.
Neoplasm Metastasis
Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression.
Neoplasm Metastasis
Laser-induced hyperthermia in rat prostate cancer: role of site of tumor implantation.
Neoplasm Metastasis
Liver-specific overexpression of matrix metalloproteinase 9 (MMP-9) in transgenic mice accelerates development of hepatocellular carcinoma.
Neoplasm Metastasis
LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
Neoplasm Metastasis
LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis.
Neoplasm Metastasis
Long non-coding RNA HOTAIR is associated with human cervical cancer progression.
Neoplasm Metastasis
Long Non-Coding RNA LOC648987 Promotes Proliferation and Metastasis of Renal Cell Carcinoma by Regulating Epithelial-Mesenchymal Transition.
Neoplasm Metastasis
Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion.
Neoplasm Metastasis
Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Neoplasm Metastasis
Long noncoding RNA CPS1-IT1 suppresses melanoma cell metastasis through inhibiting Cyr61 via competitively binding to BRG1.
Neoplasm Metastasis
Long noncoding RNA DANCR aggravates retinoblastoma through miR-34c and miR-613 by targeting MMP-9.
Neoplasm Metastasis
Long Noncoding RNA Highly Up-regulated in Liver Cancer Predicts Unfavorable Outcome and Regulates Metastasis by MMPs in Triple-negative Breast Cancer.
Neoplasm Metastasis
Long noncoding RNA LINC00460 targets miR-539/MMP-9 to promote meningioma progression and metastasis.
Neoplasm Metastasis
Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis.
Neoplasm Metastasis
Low concentrations of the recombinant toxin protein rLj-RGD3 suppress TNF-?-induced human renal carcinoma cell invasion.
Neoplasm Metastasis
Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
Neoplasm Metastasis
Lower Serum Matrix Metalloproteinase?9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis.
Neoplasm Metastasis
Luteolin inhibits the proliferation, adhesion, migration and invasion of choroidal melanoma cells in vitro.
Neoplasm Metastasis
Lycorine inhibits melanoma cell migration and metastasis mainly through reducing intracellular levels of ?-catenin and matrix metallopeptidase 9.
Neoplasm Metastasis
Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
Neoplasm Metastasis
MAGP2, a Component of Extracellular Matrix, Is Upregulated in Colorectal Cancer and Negatively Modulated by miR-200b-3p.
Neoplasm Metastasis
Manipulation of prostate cancer metastasis by locus-specific modification of the CRMP4 promoter region using chimeric TALE DNA methyltransferase and demethylase.
Neoplasm Metastasis
Matrine suppresses lung metastasis of human hepatocellular carcinoma by directly targeting matrix metalloproteinase-9.
Neoplasm Metastasis
Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis.
Neoplasm Metastasis
Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.
Neoplasm Metastasis
Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling.
Neoplasm Metastasis
Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.
Neoplasm Metastasis
Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.
Neoplasm Metastasis
Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer.
Neoplasm Metastasis
Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.
Neoplasm Metastasis
Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system.
Neoplasm Metastasis
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.
Neoplasm Metastasis
Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances.
Neoplasm Metastasis
Matrix metalloproteinase-9 (MMP-9) elevated in serum but not in bronchial lavage fluid in patients with lung cancer.
Neoplasm Metastasis
Matrix metalloproteinase-9 (MMP-9) expression in childhood osseous osteosarcoma.
Neoplasm Metastasis
Matrix metalloproteinase-9 as a prognostic factor in gastric cancer: a meta-analysis.
Neoplasm Metastasis
Matrix Metalloproteinase-9 Expression and Status of Cervical Lymph Nodes in Patients with Nasopharyngeal Carcinoma.
Neoplasm Metastasis
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.
Neoplasm Metastasis
Matrix metalloproteinase-9 gene polymorphism in hepatocellular carcinoma patients with hepatitis B and C viruses.
Neoplasm Metastasis
Matrix metalloproteinase-9 is a prognostic marker for patients with cervical cancer.
Neoplasm Metastasis
Matrix metalloproteinase-9 is a prognostic marker to predict survival of patients who underwent surgery due to rectal carcinoma.
Neoplasm Metastasis
Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer.
Neoplasm Metastasis
Matrix Metalloproteinase-9 Is Associated with Relapse and Prognosis of Patients with Colorectal Cancer.
Neoplasm Metastasis
Matrix metalloproteinase-9 is required for tubular network formation and migration of resistant breast cancer cells MCF-7 through PKC and ERK1/2 signalling pathways.
Neoplasm Metastasis
Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival.
Neoplasm Metastasis
Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer.
Neoplasm Metastasis
Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population.
Neoplasm Metastasis
Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1.
Neoplasm Metastasis
Matrix metalloproteinase-9 silencing by RNA interference promotes the adhesive-invasive switch in HT1080 human fibrosarcoma cells.
Neoplasm Metastasis
Matrix metalloproteinase-9: a deleterious link between hepatic ischemia-reperfusion and colorectal cancer.
Neoplasm Metastasis
Matrix metalloproteinases 2 and 9 in situ mRNA expression in colorectal tumors from Iraqi patients.
Neoplasm Metastasis
Matrix metalloproteinases and their inhibitors in correlation to proliferative and classical tumour markers during surgical therapy of colorectal liver metastases.
Neoplasm Metastasis
Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer.
Neoplasm Metastasis
Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Neoplasm Metastasis
Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas.
Neoplasm Metastasis
Matrix proteases, green tea, and St. John's wort: biomedical research catches up with folk medicine.
Neoplasm Metastasis
MDM2 promotes invasion and metastasis in invasive ductal breast carcinoma by inducing matrix metalloproteinase-9.
Neoplasm Metastasis
Mechanism of metastasis inhibition by cartilage polysaccharide in breast cancer cells.
Neoplasm Metastasis
Melanoma differentiation-associated gene-7 suppresses human gastric cancer cell invasion and migration.
Neoplasm Metastasis
Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.
Neoplasm Metastasis
Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-?B DNA-binding activity.
Neoplasm Metastasis
Melatonin Inhibits TE-1 Esophageal Cancer Cells Metastasis by Suppressing the NF-?B Signaling Pathway and Decreasing MMP-9.
Neoplasm Metastasis
Melatonin maximizes the therapeutic potential of non-preconditioned MSCs in a DEN-induced rat model of HCC.
Neoplasm Metastasis
Melatonin suppresses TPA-induced metastasis by downregulating matrix metalloproteinase-9 expression through JNK/SP-1 signaling in nasopharyngeal carcinoma.
Neoplasm Metastasis
Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression.
Neoplasm Metastasis
Merkel Cell Polyomavirus Small Tumor Antigen Activates Matrix Metallopeptidase-9 Gene Expression for Cell Migration and Invasion.
Neoplasm Metastasis
Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma.
Neoplasm Metastasis
Metallopeptidase, neurolysin, as a novel molecular tool for analysis of properties of cancer-producing matrix metalloproteinases-2 and -9.
Neoplasm Metastasis
Metalloproteinases and their inhibitors: Influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas.
Neoplasm Metastasis
Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-?B pathway, and MMP-9 expression.
Neoplasm Metastasis
Metastatic Inhibitory and Radical Scavenging Efficacies of Saponins Extracted from the Brittle Star (Ophiocoma erinaceus).
Neoplasm Metastasis
Metastatic potential in MDA-MB-231 human breast cancer cells is inhibited by proton beam irradiation via the Akt/nuclear factor-?B signaling pathway.
Neoplasm Metastasis
Metformin Inhibited Growth, Invasion and Metastasis of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo.
Neoplasm Metastasis
Methionine deprivation suppresses triple-negative breast cancer metastasis in vitro and in vivo.
Neoplasm Metastasis
Microarray analysis of anti-cancer effects of docosahexaenoic acid on human colon cancer model in nude mice.
Neoplasm Metastasis
Microcystin-LR promotes melanoma cell invasion and enhances matrix metalloproteinase-2/-9 expression mediated by NF-?B activation.
Neoplasm Metastasis
MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer.
Neoplasm Metastasis
MicroRNA-429 inhibits bone metastasis in breast cancer by regulating CrkL and MMP-9.
Neoplasm Metastasis
MicroRNA-708 activation by glucocorticoid receptor agonists regulate breast cancer tumorigenesis and metastasis via downregulation of NF-?B signaling.
Neoplasm Metastasis
miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway.
Neoplasm Metastasis
MiR-451 suppresses cell proliferation and metastasis in A549 lung cancer cells.
Neoplasm Metastasis
MiR-95-5p involves in the migration and invasion of trophoblast cells by targeting low density lipoprotein receptor-related protein 6.
Neoplasm Metastasis
miRNA-143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitro.
Neoplasm Metastasis
MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma.
Neoplasm Metastasis
MMI-166, a selective matrix metalloproteinase inhibitor, promotes apoptosis in human pancreatic cancer.
Neoplasm Metastasis
MMP-2 and MMP-9 gene polymorphisms associated with cervical cancer risk.
Neoplasm Metastasis
MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.
Neoplasm Metastasis
MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma.
Neoplasm Metastasis
MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.
Neoplasm Metastasis
MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients.
Neoplasm Metastasis
MMP-9 -1562 Promoter Polymorphism Associated with Gastric Cancer Risk in Females.
Neoplasm Metastasis
MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC).
Neoplasm Metastasis
MMP-9 directed shRNAs as relevant inhibitors of matrix metalloproteinase 9 activity and signaling.
Neoplasm Metastasis
MMP-9 expression varies according to molecular subtypes of breast cancer.
Neoplasm Metastasis
MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis.
Neoplasm Metastasis
MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors.
Neoplasm Metastasis
MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases.
Neoplasm Metastasis
MMP-9 Knockdown Inhibits Oral Squamous Cell Carcinoma Lymph Node Metastasis in the Nude Mouse Tongue-Xenografted Model through the RhoC/Src Pathway.
Neoplasm Metastasis
MMP-9 secreted by tumor associated macrophages promoted gastric cancer metastasis through a PI3K/AKT/Snail pathway.
Neoplasm Metastasis
MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice.
Neoplasm Metastasis
MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
Neoplasm Metastasis
MMP-9-hemopexin domain hampers adhesion and migration of colorectal cancer cells.
Neoplasm Metastasis
MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer.
Neoplasm Metastasis
MMP9 gene expression regulation by intragenic epigenetic modifications in breast cancer.
Neoplasm Metastasis
Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines.
Neoplasm Metastasis
Molecular basis of the effect of MMP-9 on the prostate bone metastasis: A review.
Neoplasm Metastasis
Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases.
Neoplasm Metastasis
Molecular mechanisms of action of Trehalose in cancer: A comprehensive review.
Neoplasm Metastasis
Molecular mechanisms of nitric oxide-dependent inhibition of TPA-induced matrix metalloproteinase-9 (MMP-9) in MCF-7 cells.
Neoplasm Metastasis
Monocyte chemoattractant protein-1 modulates invasion and apoptosis of PC-3M prostate cancer cells via regulating expression of VEGF, MMP9 and caspase-3.
Neoplasm Metastasis
MPPa-PDT suppresses breast tumor migration/invasion by inhibiting Akt-NF-?B-dependent MMP-9 expression via ROS.
Neoplasm Metastasis
MSH6 Aggravates the Hypoxic Microenvironment via Regulating HIF1A to Promote the Metastasis of Glioblastoma Multiforme.
Neoplasm Metastasis
MTA2 as a Potential Biomarker and Its Involvement in Metastatic Progression of Human Renal Cancer by miR-133b Targeting MMP-9.
Neoplasm Metastasis
MTP18 overexpression contributes to tumor growth and metastasis and associates with poor survival in hepatocellular carcinoma.
Neoplasm Metastasis
MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.
Neoplasm Metastasis
Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells.
Neoplasm Metastasis
N-Glycosylation pattern of the zymogenic form of human matrix metalloproteinase-9.
Neoplasm Metastasis
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.
Neoplasm Metastasis
Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition.
Neoplasm Metastasis
Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics.
Neoplasm Metastasis
Naringin suppresses cell metastasis and the expression of matrix metalloproteinases (MMP-2 and MMP-9) via the inhibition of ERK-P38-JNK signaling pathway in human glioblastoma.
Neoplasm Metastasis
NDRG1 Controls Gastric Cancer Migration and Invasion through Regulating MMP-9.
Neoplasm Metastasis
Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines.
Neoplasm Metastasis
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinoma.
Neoplasm Metastasis
New clinical scoring system for prognosis of early recurrence of colorectal liver metastases after surgical treatment.
Neoplasm Metastasis
NF-kappa BP65 Promotes Invasion and Metastasis of Esophageal Squamous Cell Cancer by Regulating Matrix Metalloproteinase-9 and Epithelial-to-Mesenchymal Transition.
Neoplasm Metastasis
NIK- and IKK?-binding protein promotes colon cancer metastasis by activating the classical NF-?B pathway and MMPs.
Neoplasm Metastasis
Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process.
Neoplasm Metastasis
Nitric oxide-releasing micelles with intelligent targeting for enhanced anti-tumor effect of cisplatin in hypoxia.
Neoplasm Metastasis
Notch1 and PI3K/Akt signaling blockers DAPT and LY294002 coordinately inhibit metastasis of gastric cancer through mutual enhancement.
Neoplasm Metastasis
Notch1 signaling pathway participates in cancer invasion by regulating MMPs in lingual squamous cell carcinoma.
Neoplasm Metastasis
Novel Antitumor Invasive Actions of p-Cymene by Decreasing MMP-9/TIMP-1 Expression Ratio in Human Fibrosarcoma HT-1080 Cells.
Neoplasm Metastasis
Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells.
Neoplasm Metastasis
Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach.
Neoplasm Metastasis
Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells.
Neoplasm Metastasis
Oleic acid-induced NOX4 is dependent on ANGPTL4 expression to promote human colorectal cancer metastasis.
Neoplasm Metastasis
On-line chromatographic screening of matrix metalloproteinase inhibitors using immobilized MMP-9 enzyme reactor.
Neoplasm Metastasis
On-line screening of matrix metalloproteinase inhibitors by capillary electrophoresis coupled to ESI mass spectrometry.
Neoplasm Metastasis
Oncogene-mediated downregulation of RECK, a novel transformation suppressor gene.
Neoplasm Metastasis
Oral Administration of Apigenin Inhibits Metastasis through AKT/P70S6K1/MMP-9 Pathway in Orthotopic Ovarian Tumor Model.
Neoplasm Metastasis
Orally administered green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors.
Neoplasm Metastasis
Organ heterogeneity of host-derived matrix metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines.
Neoplasm Metastasis
Orphan nuclear receptor Nur77 promotes colorectal cancer invasion and metastasis by regulating MMP-9 and E-cadherin.
Neoplasm Metastasis
Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.
Neoplasm Metastasis
Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis.
Neoplasm Metastasis
Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways.
Neoplasm Metastasis
Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-?B-mediated matrix metalloproteinase-9 expression.
Neoplasm Metastasis
Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells.
Neoplasm Metastasis
Over-expression of mir-124 inhibits MMP-9 expression and decreases invasion of renal cell carcinoma cells.
Neoplasm Metastasis
Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression.
Neoplasm Metastasis
Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)?2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway.
Neoplasm Metastasis
Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells.
Neoplasm Metastasis
Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell.
Neoplasm Metastasis
Overexpression of eIF4E in colorectal cancer patients is associated with liver metastasis.
Neoplasm Metastasis
Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis.
Neoplasm Metastasis
Overexpression of KiSS-1 reduces colorectal cancer cell invasion by downregulating MMP-9 via blocking PI3K/Akt/NF-?B signal pathway.
Neoplasm Metastasis
Overexpression of matrix metalloproteinase 9 in tumor epithelial cells correlates with colorectal cancer metastasis.
Neoplasm Metastasis
Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
Neoplasm Metastasis
Overexpression of MMP-3 and uPA with Diminished PAI-1 Related to Metastasis in Ductal Breast Cancer Patients Attending a Public Hospital in Mexico City.
Neoplasm Metastasis
Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
Neoplasm Metastasis
Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Neoplasm Metastasis
Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
Neoplasm Metastasis
Oxalomalate suppresses metastatic melanoma through IDH-targeted stress response to ROS.
Neoplasm Metastasis
Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours.
Neoplasm Metastasis
Penta-O-galloyl-?-D-glucose suppresses EGF-induced eIF3i expression through inhibition of the PI3K/AKT/mTOR pathway in prostate cancer cells.
Neoplasm Metastasis
Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression.
Neoplasm Metastasis
Peroxisome proliferator activated receptor-? agonists suppress transforming growth factor-?-induced matrix metalloproteinase-9 expression in human keratinocytes.
Neoplasm Metastasis
Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1).
Neoplasm Metastasis
Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer.
Neoplasm Metastasis
Piceatannol-3-O-?-D-glucopyranoside (PG) exhibits in vitro anti-metastatic and anti-angiogenic activities in HT1080 malignant fibrosarcoma cells.
Neoplasm Metastasis
Pituitary tumor-transforming 1 expression in laryngeal cancer and its association with prognosis.
Neoplasm Metastasis
Piwil2 modulates the invasion and metastasis of prostate cancer by regulating the expression of matrix metalloproteinase-9 and epithelial-mesenchymal transitions.
Neoplasm Metastasis
Piwil2 modulates the proliferation and metastasis of colon cancer via regulation of matrix metallopeptidase 9 transcriptional activity.
Neoplasm Metastasis
Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2.
Neoplasm Metastasis
Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
Neoplasm Metastasis
PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
Neoplasm Metastasis
Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia.
Neoplasm Metastasis
Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Neoplasm Metastasis
Poor early growth and excessive adult calorie intake independently and additively affect mitogenic signaling and increase mammary tumor susceptibility.
Neoplasm Metastasis
Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation.
Neoplasm Metastasis
Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation.
Neoplasm Metastasis
Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.
Neoplasm Metastasis
Prediction of metastasis in oral squamous cell carcinoma through phenotypic evaluation and gene expression of E-cadherin, ?-catenin, matrix metalloproteinase-2, and matrix metalloproteinase-9 biomarkers with clinical correlation.
Neoplasm Metastasis
Prediction of MMP-9 inhibitory activity of N-hydroxy-?-phenylsulfonylacetamide derivatives by pharmacophore based modeling and 3-D QSAR studies.
Neoplasm Metastasis
Preliminary evaluation of inhibition of matrix-metalloprotease MMP-2 and MMP-9 by Passiflora edulis and P foetida aqueous extracts.
Neoplasm Metastasis
Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.
Neoplasm Metastasis
Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma.
Neoplasm Metastasis
Preventive effect of phytoglycoprotein (38?kDa) on expression of alpha-fetoprotein and matrix metalloproteinase-9 in diethylnitrosamine-treated ICR mice.
Neoplasm Metastasis
Primary renal neuroblastoma with metastasis and matrix metalloproteinase-14 expression.
Neoplasm Metastasis
Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells.
Neoplasm Metastasis
Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
Neoplasm Metastasis
Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin ?1 complex in the progression of hepatocellular carcinoma.
Neoplasm Metastasis
Prognosis of metastasis based on age and serum analytes after follow-up of non-metastatic lung cancer patients.
Neoplasm Metastasis
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Neoplasm Metastasis
Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study.
Neoplasm Metastasis
Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer.
Neoplasm Metastasis
Prognostic impact of serum and tissue MMP-9 in non-small cell lung cancer: a systematic review and meta-analysis.
Neoplasm Metastasis
Prognostic significance of CD44v6, p63, Podoplanin, and MMP-9 in oral squamous cell carcinomas.
Neoplasm Metastasis
Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
Neoplasm Metastasis
Prognostic significance of matrix metalloproteinase 9 expression in osteosarcoma: A meta-analysis of 16 studies.
Neoplasm Metastasis
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer.
Neoplasm Metastasis
Prognostic significance of matrix metalloproteinases 2 and 9 in bladder cancer.
Neoplasm Metastasis
Prognostic significance of matrix metalloproteinases-2 activation ratio in renal cell carcinoma.
Neoplasm Metastasis
Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
Neoplasm Metastasis
Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Neoplasm Metastasis
Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis.
Neoplasm Metastasis
Prognostic value of matrix metalloproteinase 9 in nasopharyngeal carcinoma: a meta-analysis.
Neoplasm Metastasis
Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma.
Neoplasm Metastasis
Prognostic Value of Tumor-Related Molecular Expression in Gastric Carcinoma.
Neoplasm Metastasis
Prostate-specific membrane antigen can promote in vivo osseous metastasis of prostate cancer cells in mice.
Neoplasm Metastasis
Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression.
Neoplasm Metastasis
Protein disulfide isomerase-mediated disulfide bonds regulate the gelatinolytic activity and secretion of matrix metalloproteinase-9.
Neoplasm Metastasis
Protein Expression and Significance of VEGF, EGFR and MMP-9 in Non-Small Cell Lung Carcinomas.
Neoplasm Metastasis
Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.
Neoplasm Metastasis
Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients.
Neoplasm Metastasis
PTX3 gene activation in EGF-induced head and neck cancer cell metastasis.
Neoplasm Metastasis
Qi Ling decoction reduces gastric cancer cell metastasis by inhibiting MMP-9 through the PI3K/Akt signaling pathway.
Neoplasm Metastasis
Quercetin and sulforaphane in combination suppress the progression of melanoma through the down-regulation of matrix metalloproteinase-9.
Neoplasm Metastasis
RABEX-5 overexpression in gastric cancer is correlated with elevated MMP-9 level.
Neoplasm Metastasis
Raf kinase inhibitor protein inhibits cholangiocarcinoma cell metastasis by downregulating matrix metalloproteinase 9 and upregulating tissue inhibitor of metalloproteinase 4 expression.
Neoplasm Metastasis
Ras-induced invasion and metastasis are regulated by a leukotriene B4 receptor BLT2-linked pathway.
Neoplasm Metastasis
RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines.
Neoplasm Metastasis
Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.
Neoplasm Metastasis
Recurrence or metastasis of HCC:predictors, early detection and experimental antiangiogenic therapy.
Neoplasm Metastasis
Red ginseng extract reduced metastasis of colon cancer cells in vitro and in vivo.
Neoplasm Metastasis
Reduced expression of tissue inhibitor of metalloproteinase in nodal metastasis of stomach cancer.
Neoplasm Metastasis
Reduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma.
Neoplasm Metastasis
Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway.
Neoplasm Metastasis
Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion.
Neoplasm Metastasis
Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1.
Neoplasm Metastasis
Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK.
Neoplasm Metastasis
Regulation of MMP-9 (gelatinase B) in activated human monocyte/macrophages by two different types of bisphosphonates.
Neoplasm Metastasis
Regulation of VEGF, MMP-9, and metastasis by CXCR4 in a prostate cancer cell line.
Neoplasm Metastasis
Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells.
Neoplasm Metastasis
Relationship between preoperative staging by endoscopic ultrasonography and MMP-9 expression in gastric carcinoma.
Neoplasm Metastasis
Relationship between serum MMP-9 level and prognosis after radical resection for Hilar cholangiocarcinoma patients.
Neoplasm Metastasis
Relationships between clinical behavior of laryngeal squamous cell carcinomas and expression of VEGF, MMP-9 and E-cadherin.
Neoplasm Metastasis
Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer.
Neoplasm Metastasis
Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma.
Neoplasm Metastasis
Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay.
Neoplasm Metastasis
Resident stromal cell-derived MMP-9 promotes the growth of colorectal metastases in the liver microenvironment.
Neoplasm Metastasis
Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells.
Neoplasm Metastasis
Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector.
Neoplasm Metastasis
Ricinus communis Butanol Fraction Inhibits MCF-7 Breast Cancer Cell Migration, Adhesion, and Invasiveness.
Neoplasm Metastasis
RNA interference targeting CD147 inhibits metastasis and invasion of human breast cancer MCF-7 cells by downregulating MMP-9/VEGF expression.
Neoplasm Metastasis
RNAi targeting urokinase-type plasminogen activator receptor inhibits metastasis and progression of oral squamous cell carcinoma in vivo.
Neoplasm Metastasis
RNAi-mediated MMP-9 silencing inhibits mouse melanoma cell invasion and migration in vitro and in vivo.
Neoplasm Metastasis
ROC1 promotes the malignant progression of bladder cancer by regulating p-I?B?/NF-?B signaling.
Neoplasm Metastasis
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.
Neoplasm Metastasis
Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3.
Neoplasm Metastasis
Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer.
Neoplasm Metastasis
Role of matrix metalloproteinase-9 in in vitro invasion of esophageal carcinoma cells.
Neoplasm Metastasis
Role of matrix metalloproteinase-9 in transforming growth factor-?1-induced epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Neoplasm Metastasis
Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression.
Neoplasm Metastasis
Role of serum matrix metalloproteinase-2 and -9 to predict breast cancer progression.
Neoplasm Metastasis
Role of serum-derived hyaluronan-associated protein-hyaluronan complex in ovarian cancer.
Neoplasm Metastasis
Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor metastasis.
Neoplasm Metastasis
Roles of microsomal prostaglandin E synthase-1 in lung metastasis formation in prostate cancer RM9 cells.
Neoplasm Metastasis
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy.
Neoplasm Metastasis
RUNX3 Inhibits the Invasion and Metastasis of Human Colon Cancer HT-29 Cells by Upregulating MMP-2/9.
Neoplasm Metastasis
Ruscogenin suppressed the hepatocellular carcinoma metastasis via PI3K/Akt/mTOR signaling pathway.
Neoplasm Metastasis
S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.
Neoplasm Metastasis
S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-?B-dependent MMP-9 signal.
Neoplasm Metastasis
Saussurea lappa Clarke-Derived Costunolide Prevents TNF ? -Induced Breast Cancer Cell Migration and Invasion by Inhibiting NF- ? B Activity.
Neoplasm Metastasis
Scabraside D Derived from Sea Cucumber Induces Apoptosis and Inhibits Metastasis via iNOS and STAT-3 Expression in Human Cholangiocarcinoma Xenografts.
Neoplasm Metastasis
Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Neoplasm Metastasis
Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells.
Neoplasm Metastasis
Selaginella tamariscina extract suppresses TPA-induced invasion and metastasis through inhibition of MMP-9 in human nasopharyngeal carcinoma HONE-1 cells.
Neoplasm Metastasis
Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer.
Neoplasm Metastasis
SERPINA3 Silencing Inhibits the Migration, Invasion, and Liver Metastasis of Colon Cancer Cells.
Neoplasm Metastasis
Serum levels of endostatin and matrix metalloproteinase-9 associated with high stage and grade primary transitional cell carcinoma of the bladder.
Neoplasm Metastasis
Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers.
Neoplasm Metastasis
Serum levels of matrix metalloproteinase-9 predict lymph node metastasis in breast cancer patients.
Neoplasm Metastasis
Serum Levels of S100A11 and MMP-9 in Patients with Epithelial Ovarian Cancer and Their Clinical Significance.
Neoplasm Metastasis
Serum Matrix metalloproteinase-9 (MMP-9) can help identify patients with papillary thyroid cancer at high risk of persistent disease: Value and limitations of a potential marker of neoplasia.
Neoplasm Metastasis
Serum matrix metalloproteinase-9 level associated with stromal reaction in patients with gastric cancer.
Neoplasm Metastasis
Serum melatonin is inversely associated with matrix metalloproteinase-9 in oral squamous cell carcinoma.
Neoplasm Metastasis
Serum TIMP1 and TIMP2 concentration in patients with different grades of meningioma.
Neoplasm Metastasis
Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Neoplasm Metastasis
Shortening of microsatellite deoxy(CA) repeats involved in GL331-induced down-regulation of matrix metalloproteinase-9 gene expression.
Neoplasm Metastasis
SHP-2 promoting migration and metastasis of MCF-7 with loss of E-cadherin, dephosphorylation of FAK and secretion of MMP-9 induced by IL-1beta in vivo and in vitro.
Neoplasm Metastasis
Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
Neoplasm Metastasis
Significance of Matrix Metalloproteinase 9 Expression as Supporting Marker to Cytokeratin 19 mRNA in Sentinel Lymph Nodes in Breast Cancer Patients.
Neoplasm Metastasis
Significance of MMP-9 and VEGF-C expression in North Indian women with breast cancer diagnosis.
Neoplasm Metastasis
Silencing expression of the NANOG gene and changes in migration and metastasis of urinary bladder cancer cells.
Neoplasm Metastasis
Silencing of bach1 gene by small interfering RNA-mediation regulates invasive and expression level of miR-203, miR-145, matrix metalloproteinase-9, and CXCR4 receptor in MDA-MB-468 breast cancer cells.
Neoplasm Metastasis
Silencing of LASS2/TMSG1 enhances invasion and metastasis capacity of prostate cancer cell.
Neoplasm Metastasis
Silencing of TGF-?1 in tumor cells impacts MMP-9 in tumor microenvironment.
Neoplasm Metastasis
Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-?2 expression.
Neoplasm Metastasis
Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells.
Neoplasm Metastasis
Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells.
Neoplasm Metastasis
Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells.
Neoplasm Metastasis
Single treatment with cisplatin or UFT, but not their combination treatment enhances the metastatic capacity of mouse fibrosarcoma cells.
Neoplasm Metastasis
Sinulariolide Suppresses Human Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 through MAPKs and PI3K/Akt Signaling Pathways.
Neoplasm Metastasis
Slow induction of gelatinase B mRNA by acidic culture conditions in mouse metastatic melanoma cells.
Neoplasm Metastasis
Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling.
Neoplasm Metastasis
Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9.
Neoplasm Metastasis
Smoking-induced changes in cancer-related factors in patients with upper tract urothelial cancer.
Neoplasm Metastasis
Social defeat stress promotes tumor growth and angiogenesis by upregulating vascular endothelial growth factor/extracellular signal-regulated kinase/matrix metalloproteinase signaling in a mouse model of lung carcinoma.
Neoplasm Metastasis
Sodium hydrogen exchanger and phospholipase D are required for alpha1-adrenergic receptor stimulation of metalloproteinase-9 and cellular invasion in CCL39 fibroblasts.
Neoplasm Metastasis
Solanine induces mitochondria-mediated apoptosis in human pancreatic cancer cells.
Neoplasm Metastasis
Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer.
Neoplasm Metastasis
Sonic hedgehog signaling may promote invasion and metastasis of oral squamous cell carcinoma by activating MMP-9 and E-cadherin expression.
Neoplasm Metastasis
Soybean saponin inhibits tumor cell metastasis by modulating expressions of MMP-2, MMP-9 and TIMP- 2.
Neoplasm Metastasis
Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors.
Neoplasm Metastasis
Stable knockdown of clusterin by vectorbased RNA interference in a human breast cancer cell line inhibits tumour cell invasion and metastasis.
Neoplasm Metastasis
Stage-specific expression analysis ofMMP-2 & MMP-9 in laryngeal carcinoma.
Neoplasm Metastasis
Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells.
Neoplasm Metastasis
Stimulation of matrix metalloproteinase-9 expression in human fibrosarcoma cells by synthetic matrix metalloproteinase inhibitors.
Neoplasm Metastasis
Stimulation of MMP-9 of oral epithelial cells by areca nut extract is related to TGF-?/Smad2-dependent and -independent pathways and prevented by betel leaf extract, hydroxychavicol and melatonin.
Neoplasm Metastasis
Stimuli-Responsive Nanodiamond-Based Biosensor for Enhanced Metastatic Tumor Site Detection.
Neoplasm Metastasis
Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy.
Neoplasm Metastasis
Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect.
Neoplasm Metastasis
Stromal reaction in cancer tissue: pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions.
Neoplasm Metastasis
Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2.
Neoplasm Metastasis
Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo.
Neoplasm Metastasis
Strong significant correlation between MMP-9 and systemic symptoms in patients with localized renal cell carcinoma.
Neoplasm Metastasis
Structural characterisation of inhibitory and non-inhibitory MMP-9-TIMP-1 complexes and implications for regulatory mechanisms of MMP-9.
Neoplasm Metastasis
Study of matrix metalloproteinases and their inhibitors in breast cancer.
Neoplasm Metastasis
Sulforaphene Interferes with Human Breast Cancer Cell Migration and Invasion through Inhibition of Hedgehog Signaling.
Neoplasm Metastasis
Suppression by nimesulide of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats.
Neoplasm Metastasis
Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1.
Neoplasm Metastasis
Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2.
Neoplasm Metastasis
Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-?B/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells.
Neoplasm Metastasis
Suppression of PMA-induced tumor cell invasion and metastasis by aqueous extract isolated from Prunella vulgaris via the inhibition of NF-kappaB-dependent MMP-9 expression.
Neoplasm Metastasis
Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression.
Neoplasm Metastasis
Suppression of type IV collagenase in MDA-MB-435 human breast cancer cells by eicosapentaenoic acid in vitro and in vivo.
Neoplasm Metastasis
Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Neoplasm Metastasis
Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells via the Inhibition of STAT3 Signaling and Down-regulation of Inflammatory Cytokine Expressions.
Neoplasm Metastasis
Surfactin from Bacillus subtilis attenuates ambient air particulate matter-promoted human oral cancer cells metastatic potential.
Neoplasm Metastasis
Surgical excision promotes tumor growth and metastasis by promoting expression of MMP-9 and VEGF in a breast cancer model.
Neoplasm Metastasis
Sustained inhibition of PKC? reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model.
Neoplasm Metastasis
Synergism from the combination of ulinastatin and curcumin offers greater inhibition against colorectal cancer liver metastases via modulating matrix metalloproteinase-9 and E-cadherin expression.
Neoplasm Metastasis
Synergistic anticancer effects of timosaponin AIII and ginsenosides in MG63 human osteosarcoma cells.
Neoplasm Metastasis
Synthesis and evaluation of myxochelin analogues as antimetastatic agents.
Neoplasm Metastasis
Synthesized tetrahydroisoquinoline alkaloid exerts anticancer effects at least in part by suppressing NF??B?regulated proteins in A549 human lung cancer cells.
Neoplasm Metastasis
Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis.
Neoplasm Metastasis
Systemic Ablation of MMP9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL-6 Expression in the Bone Marrow.
Neoplasm Metastasis
TAK1 is required for TGF-beta 1-mediated regulation of matrix metalloproteinase-9 and metastasis.
Neoplasm Metastasis
TAK1-TAB2 Signaling Contributes to Bone Destruction by Breast Carcinoma Cells.
Neoplasm Metastasis
Talin2 mediates secretion and trafficking of matrix metallopeptidase 9 during invadopodium formation.
Neoplasm Metastasis
Tangeretin, a citrus pentamethoxyflavone, exerts cytostatic effect via p53/p21 up-regulation and suppresses metastasis in 7,12-dimethylbenz(?)anthracene-induced rat mammary carcinoma.
Neoplasm Metastasis
Targeting angiogenic pathway for chemoprevention of experimental colon cancer using C-phycocyanin as cyclooxygenase-2 inhibitor.
Neoplasm Metastasis
Targeting filamin B induces tumor growth and metastasis via enhanced activity of matrix metalloproteinase-9 and secretion of VEGF-A.
Neoplasm Metastasis
Targeting Notch1 inhibits invasion and angiogenesis of human breast cancer cells via inhibition Nuclear Factor-?B signaling.
Neoplasm Metastasis
Targeting of colorectal cancer growth, metastasis, and anti-apoptosis in BALB/c nude mice via APRIL siRNA.
Neoplasm Metastasis
Targeting of Survivin Pathways by YM155 Inhibits Cell Death and Invasion in Oral Squamous Cell Carcinoma Cells.
Neoplasm Metastasis
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-?B and AP-1 Activity.
Neoplasm Metastasis
Testes-specific protease 50 promotes cell invasion and metastasis by increasing NF-kappaB-dependent matrix metalloproteinase-9 expression.
Neoplasm Metastasis
Tetrabromobisphenol A Induces MMP-9 Expression via NADPH Oxidase and the activation of ROS, MAPK, and Akt Pathways in Human Breast Cancer MCF-7 Cells.
Neoplasm Metastasis
TFAP4 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating the PI3K/AKT Signaling Pathway.
Neoplasm Metastasis
The a3 Isoform Vacuolar Type H+-ATPase Promotes Distant Metastasis in the Mouse B16 Melanoma Cells.
Neoplasm Metastasis
The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity.
Neoplasm Metastasis
The Anti-tumoral Effect of ?-D-Mannuronic Acid (M2000) as a Novel NSAID on Treg Cells Frequency and MMP-2, MMP-9, CCL22 and TGF?1 Gene Expression in Pre-surgical Breast Cancer Patients.
Neoplasm Metastasis
The assessment of serum and diagnostic peritoneal lavage concentration of matrix metalloproteinase-2, matrix metalloproteinase-9, carbohydrate antigen 19-9, and carcinoembryonic antigen in patients with pancreatic cancer and chronic pancreatitis.
Neoplasm Metastasis
The association between the serum levels of matrix metalloproteinase 9 and colorectal cancer.
Neoplasm Metastasis
The association of co-expression of CD44v4/MMP-9 with different nodal status in high-grade breast carcinoma patients.
Neoplasm Metastasis
The C3G/Rap1 pathway promotes secretion of MMP-2 and MMP-9 and is involved in serous ovarian cancer metastasis.
Neoplasm Metastasis
The CCL21/CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase-9.
Neoplasm Metastasis
The co-expression of MMP-9 and Tenascin-C is significantly associated with the progression and prognosis of pancreatic cancer.
Neoplasm Metastasis
The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
Neoplasm Metastasis
The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.
Neoplasm Metastasis
The Distribution, Clearance, and Safety of an Anti-MMP-9 DNAzyme in Normal and MMTV-PyMT Transgenic Mice.
Neoplasm Metastasis
The effect of a DNA repair gene on cellular invasiveness: XRCC3 over-expression in breast cancer cells.
Neoplasm Metastasis
The effect of E1A transfection on MMP-9 expression and metastatic potential.
Neoplasm Metastasis
The effects of microRNA-183 promots cell proliferation and invasion by targeting MMP-9 in endometrial cancer.
Neoplasm Metastasis
The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis.
Neoplasm Metastasis
The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival.
Neoplasm Metastasis
The Expression of S100A4 Protein in Human Intrahepatic Cholangiocarcinoma: Clinicopathologic Significance and Prognostic Value.
Neoplasm Metastasis
The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process.
Neoplasm Metastasis
The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibody.
Neoplasm Metastasis
The interferon-gamma-induced GTPase, mGBP-2, inhibits tumor necrosis factor alpha (TNF-alpha) induction of matrix metalloproteinase-9 (MMP-9) by inhibiting NF-kappaB and Rac protein.
Neoplasm Metastasis
The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.
Neoplasm Metastasis
The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo.
Neoplasm Metastasis
The localization of thrombospondin-1 (TSP-1), cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) TSP receptor, and matrix metalloproteinase-9 (MMP-9) in colorectal cancer.
Neoplasm Metastasis
The marine compound spongistatin 1 targets pancreatic tumour progression and metastasis.
Neoplasm Metastasis
The matrix metalloproteinase 9 (mmp-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist.
Neoplasm Metastasis
The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion.
Neoplasm Metastasis
The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis.
Neoplasm Metastasis
The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells.
Neoplasm Metastasis
The p75(NTR) metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells.
Neoplasm Metastasis
The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery.
Neoplasm Metastasis
The prognostic significance of serum and cerebrospinal fluid MMP-9, CCL2 and sVCAM-1 in leukemia CNS metastasis.
Neoplasm Metastasis
The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis.
Neoplasm Metastasis
The role of ?-catenin in the initiation and metastasis of TA2 mice spontaneous breast cancer.
Neoplasm Metastasis
The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells.
Neoplasm Metastasis
The role of CD44 and matrix metalloproteinase-9 expression in predicting neck metastasis of supraglottic laryngeal carcinoma.
Neoplasm Metastasis
The role of gelatinases in colorectal cancer progression and metastasis.
Neoplasm Metastasis
The Role of Matrix Metalloproteinase-9 (MMP-9) as a Prognostic Factor in Epithelial and Lymphatic Neoplasia.
Neoplasm Metastasis
The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer.
Neoplasm Metastasis
The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.
Neoplasm Metastasis
The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis.
Neoplasm Metastasis
The role of MMP-2 and MMP-9 as prognostic markers in the early stages of tongue squamous cell carcinoma.
Neoplasm Metastasis
The role of MMP-2 and MMP-9 in the metastasis and development of hypopharyngeal carcinoma.
Neoplasm Metastasis
The Role of sLZIP in Transcriptional Regulation of c-Jun and Involvement in Migration and Invasion of Cervical Cancer Cells.
Neoplasm Metastasis
The role of Twist1 in hepatocellular carcinoma angiogenesis: a clinical study.
Neoplasm Metastasis
The roles of ARHGAP10 in the proliferation, migration and invasion of lung cancer cells.
Neoplasm Metastasis
The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
Neoplasm Metastasis
The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9.
Neoplasm Metastasis
The significance of serum active matrix metalloproteinase-9 in patients with non-small cell lung cancer.
Neoplasm Metastasis
The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells.
Neoplasm Metastasis
Therapeutic and analysis model of intrahepatic metastasis reflects clinical behavior of hepatocellular carcinoma.
Neoplasm Metastasis
Therapeutic effect of combined hyperbaric oxygen and radiation therapy for single brain metastasis and its influence on osteopontin and MMP-9.
Neoplasm Metastasis
Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer.
Neoplasm Metastasis
Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model.
Neoplasm Metastasis
Thermochemotherapy effect of nanosized As2O3/Fe3O4 complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9.
Neoplasm Metastasis
Thrombospondin-2 stimulates MMP-9 production and promotes osteosarcoma metastasis via the PLC, PKC, c-Src and NF-?B activation.
Neoplasm Metastasis
TIMP-2 inhibits metastasis and predicts prognosis of colorectal cancer via regulating MMP-9.
Neoplasm Metastasis
TIPE-mediated up-regulation of MMP-9 promotes colorectal cancer invasion and metastasis through MKK-3/p38/NF-?B pro-oncogenic signaling pathway.
Neoplasm Metastasis
Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) and IL-23 Induced by Polysaccharide of the Black Hoof Medicinal Mushroom, Phellinus linteus (Agaricomycetes).
Neoplasm Metastasis
Tissue invasion and metastasis: Molecular, biological and clinical perspectives.
Neoplasm Metastasis
Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma.
Neoplasm Metastasis
Tissue-engineered nanoclay-based 3D in vitro breast cancer model for studying breast cancer metastasis to bone.
Neoplasm Metastasis
TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo.
Neoplasm Metastasis
Tomatidine inhibits cell invasion through the negative modulation of gelatinase and inactivation of p38 and ERK.
Neoplasm Metastasis
Transcription factor Egr-1 is essential for maximal matrix metalloproteinase-9 transcription by tumor necrosis factor alpha.
Neoplasm Metastasis
Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line.
Neoplasm Metastasis
Transcutaneous carbon dioxide induces mitochondrial apoptosis and suppresses metastasis of oral squamous cell carcinoma in vivo.
Neoplasm Metastasis
Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro.
Neoplasm Metastasis
Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Neoplasm Metastasis
Trefoil Factor 1 Suppresses Epithelial-mesenchymal Transition through Inhibition of TGF-beta Signaling in Gastric Cancer Cells.
Neoplasm Metastasis
Tricetin inhibits human osteosarcoma cells metastasis by transcriptionally repressing MMP-9 via p38 and Akt pathways.
Neoplasm Metastasis
TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-?-catenin signaling.
Neoplasm Metastasis
Trimeric Tn Antigen on Syndecan 1 Produced by ppGalNAc-T13 Enhances Cancer Metastasis via a Complex Formation with Integrin ?5?1 and Matrix Metalloproteinase 9.
Neoplasm Metastasis
Triptolide inhibits matrix metalloproteinase-9 expression and invasion of breast cancer cells through the inhibition of NF-?B and AP-1 signaling pathways.
Neoplasm Metastasis
Tspan9 inhibits the proliferation, migration and invasion of human gastric cancer SGC7901 cells via the ERK1/2 pathway.
Neoplasm Metastasis
Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.
Neoplasm Metastasis
Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
Neoplasm Metastasis
Tumor metastasis in an orthotopic murine model of head and neck cancer: possible role of TGF-beta 1 secreted by the tumor cells.
Neoplasm Metastasis
Tumor promoter TPA stimulates MMP-9 secretion from human keratinocytes by activation of superoxide-producing NADPH oxidase.
Neoplasm Metastasis
Tumor-Recruited Neutrophils and Neutrophil TIMP-Free MMP-9 Regulate Coordinately the Levels of Tumor Angiogenesis and Efficiency of Malignant Cell Intravasation.
Neoplasm Metastasis
Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
Neoplasm Metastasis
Tumour cell and stromal features in metastatic and non-metastatic non-small cell lung carcinomas.
Neoplasm Metastasis
TWIST expression in hypopharyngeal cancer and the mechanism of TWIST-induced promotion of metastasis.
Neoplasm Metastasis
Type I collagen-induced pro-MMP-2 activation is differentially regulated by H-Ras and N-Ras in human breast epithelial cells.
Neoplasm Metastasis
Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
Neoplasm Metastasis
Ulinastatin reduces cancer recurrence after resection of hepatic metastases from colon cancer by inhibiting MMP-9 activation via the antifibrinolytic pathway.
Neoplasm Metastasis
Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention.
Neoplasm Metastasis
Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination.
Neoplasm Metastasis
Unique activation of matrix metalloproteinase-9 within human liver metastasis from colorectal cancer.
Neoplasm Metastasis
Up-regulated expression of the beta3 integrin and the 92-kDa gelatinase in human HT-144 melanoma cell tumors grown in nude mice.
Neoplasm Metastasis
Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor.
Neoplasm Metastasis
Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.
Neoplasm Metastasis
Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis.
Neoplasm Metastasis
URGCP promotes non-small cell lung cancer invasiveness by activating the NF-?B-MMP-9 pathway.
Neoplasm Metastasis
Urinary trypsin inhibitor suppresses surgical stress-facilitated lung metastasis of murine colon 26-L5 carcinoma cells.
Neoplasm Metastasis
Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients.
Neoplasm Metastasis
Uterine cervical carcinoma: Role of matrix metalloproteinases (Review).
Neoplasm Metastasis
Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors.
Neoplasm Metastasis
Values of ultrasound features and MMP-9 of papillary thyroid carcinoma in predicting cervical lymph node metastases.
Neoplasm Metastasis
Verapamil inhibits tumor protease production, local invasion and metastasis development in murine carcinoma cells.
Neoplasm Metastasis
Vinorelbine cationic liposomes modified with wheat germ agglutinin for inhibiting tumor metastasis in treatment of brain glioma.
Neoplasm Metastasis
Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis.
Neoplasm Metastasis
WIP1 stimulates migration and invasion of salivary adenoid cystic carcinoma by inducing MMP-9 and VEGF-C.
Neoplasm Metastasis
Wnt signaling pathway inhibitors as promising diagnostic serum markers of osteolytic bone metastasis.
Neoplasm Metastasis
Wogonin Suppresses the Activity of Matrix Metalloproteinase-9 and Inhibits Migration and Invasion in Human Hepatocellular Carcinoma.
Neoplasm Metastasis
Wortmannin Reduces Metastasis and Angiogenesis of Human Breast Cancer Cells via Nuclear Factor- B-dependent Matrix Metalloproteinase-9 and Interleukin-8 Pathways.
Neoplasm Metastasis
XRCC1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis through suppressing MMP-2 and MMP-9.
Neoplasm Metastasis
Yokukansan Alleviates Cancer Pain by Suppressing Matrix Metalloproteinase-9 in a Mouse Bone Metastasis Model.
Neoplasm Metastasis
Zinc dependent endopeptidases of matrix metalloproteinases-9 expressions is associated with tumor metastases of oral squamous cell carcinoma in Chinese population: a meta-analysis.
Neoplasm Metastasis
Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.
Neoplasm Metastasis
Zymographic analysis of circulating and tissue forms of colon carcinoma gelatinase A (MMP-2) and B (MMP-9) separated by mono- and two-dimensional electrophoresis.
Neoplasm Metastasis
[A multianalysis study on clinicopathologic factors related to lymph node metastasis in gastric cancer]
Neoplasm Metastasis
[Antimetastatic effects of genistein on salivary adenoid cystic carcinoma in vivo.]
Neoplasm Metastasis
[Caspase-3 expression in the tissues of experimental melanoma and its metastases during matrix metalloproteinase-9 inhibition].
Neoplasm Metastasis
[CCL21 promotes the metastasis of human pancreatic cancer Panc-1 cells via epithelial- mesenchymal transition].
Neoplasm Metastasis
[Chemokine receptor 7 induces metastasis of NSCLC via upregulating MMP-9 expression].
Neoplasm Metastasis
[Controlled expression of matrix metalloproteinase 9 promotes expression of invasive phenotype of human melanoma cells]
Neoplasm Metastasis
[Correlation between bacterial L-form infection, expression of HIF-1?/MMP-9 and vasculogenic mimicry in epithelial ovarian cancer].
Neoplasm Metastasis
[Correlation between expression of metastasis-associated gene 1 and matrix metalloproteinase 9 and invasion and metastasis of breast cancer]
Neoplasm Metastasis
[Correlation between expression of MMP-2, MMP-9, TIMP-2, TIMP-1 and metastasis of neuroblastoma]
Neoplasm Metastasis
[Correlation study between OPN, CD44v6, MMP-9 and distant metastasis in laryngeal squamous cell carcinoma].
Neoplasm Metastasis
[Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer]
Neoplasm Metastasis
[Correlations of serous levels of matrix metalloproteinases (MMP-2 and MMP-9) to invasion and metastasis of papillary thyroid carcinoma]
Neoplasm Metastasis
[Detection of serum levels of MMP-9 and VEGF in patients with bladder cancer]
Neoplasm Metastasis
[Detection of serum total MMP-9 and its clinical significance for lung neoplasms].
Neoplasm Metastasis
[Down-regulation of metastatic phenotype in human melanoma cells by controlled expression of anti-sense matrix metalloproteinase 9]
Neoplasm Metastasis
[Effect of cisplatin on expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and their correlations in Lewis lung cancer in mice.]
Neoplasm Metastasis
[Effect of long noncoding RNA SPRY4-IT1 on proliferation and metastasis of medulloblastoma].
Neoplasm Metastasis
[Effect of macrophage migration inhibitory factor (MIF) on expression of MMP-2,MMP-9,and IL-8 in nasopharyngeal carcinoma cell strains]
Neoplasm Metastasis
[Effect of mechanical stimulation on the invasion in salivary adenoid cystic carcinoma]
Neoplasm Metastasis
[Effect of ray cartilage glycosaminoglycans (RCG) on the expression of MMP-9 in Lewis lung carcinoma]
Neoplasm Metastasis
[Effect of the combination of hyperbaric oxygen and 5-fluorouracil on the proliferation and metastasis of nasopharyngea carcinoma CNE-2Z cell line]
Neoplasm Metastasis
[Effect of tumor-associated macrophages on invasion and metastasis of gastric cancer cells].
Neoplasm Metastasis
[Effects of Epstein-Barr virus latent membrane protein 1(EBV-LMP1) on related factors of metastasis of nasopharyngeal carcinoma cell line CNE1]
Neoplasm Metastasis
[Effects of matrine on invasion and metastasis of leukemia cell line Jurkat]
Neoplasm Metastasis
[Effects of matrix metalloproteinase-9 antisense oligonucleotide on the apoptosis and metastasis of the human lung adenocarcinoma cell.]
Neoplasm Metastasis
[Enhancement effects of hypoxia on invasion and metastasis of K562 cells]
Neoplasm Metastasis
[Expression and clinical significance of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinomas]
Neoplasm Metastasis
[Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma]
Neoplasm Metastasis
[Expression and clinical value of eukaryotic initiation factor4E and matrix metalloproteinase-9 in supraglottic and hypopharyngeal carcinoma and metastasic lymph]
Neoplasm Metastasis
[Expression and pathological mechanism of MMP-9 and HIF-2? in CD133(+) lung cancer stem cells].
Neoplasm Metastasis
[Expression and significance of CD44v6 and MMP-9 in laryngeal squamous cell carcinoma]
Neoplasm Metastasis
[Expression and significance of matrix metalloproteinases and their tissue inhibitors in the infiltration and metastasis of lung cancer.]
Neoplasm Metastasis
[Expression and significance of MTDH and MMP-9 in laryngeal squamous cell carcinoma].
Neoplasm Metastasis
[Expression of adiponectin in non-small cell lung cancer and its relationship with MMP-9 and angiogenesis].
Neoplasm Metastasis
[Expression of AKT2, Cyclin D1, and MMP-9 and Their Correlations to Clinicopathologic Features of Non-small Cell Lung Cancer.]
Neoplasm Metastasis
[Expression of CD147, matrix metalloproteinases and transforming growth factor beta1 in breast cancer]
Neoplasm Metastasis
[Expression of COX-2 and MMP-9 in cervical carcinoma and their clinical significance]
Neoplasm Metastasis
[Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour]
Neoplasm Metastasis
[Expression of matrix metalloproteinase 9 (MMP-9) and laminin-receptor in breast carcinoma and their correlation with tumor metastasis and prognosis]
Neoplasm Metastasis
[Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix]
Neoplasm Metastasis
[Expression of matrix metalloproteinase-2,9 in hypopharyngeal carcinoma and its relationship with lymphatic metastasis]
Neoplasm Metastasis
[Expression of matrix metalloproteinase-2,matrix metalloproteinase-9 and vascular endothdial growth factor in retinoblastoma and its clinical significance.]
Neoplasm Metastasis
[Expression of matrix metalloproteinase-9 and its complex in the urine of breast cancer patients]
Neoplasm Metastasis
[Expression of matrix metaloproteinase and tissue inhibitors in ovarian tumors]
Neoplasm Metastasis
[Expression of MMP-2, MMP-9, TIMP-1 and their relationship with prognosis in NSCLC.]
Neoplasm Metastasis
[Expression of MMP-9 and MMP-9 mRNA in gastric carcinoma and its correlation with angiogenesis]
Neoplasm Metastasis
[Expression of MMP-9 and TIMP-1 in nasopharyngeal carcinoma and its signification at Xi'an and Shenzhen]
Neoplasm Metastasis
[Expression of TGF-beta1 and the mechanism of invasiveness and metastasis induced by TGF-beta1 in breast cancer]
Neoplasm Metastasis
[Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance]
Neoplasm Metastasis
[Expressions of CD44s, MMP-9, and Ki-67: possible association with invasion, metastasis, and recurrence of osteosarcoma]
Neoplasm Metastasis
[Expressions of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 and their correlation with metastasis and prognosis in lung cancer.]
Neoplasm Metastasis
[Expressions of matrix metalloproteinase-9 and interleukin-8 in nasopharygeal carcinoma and association with Epstein-Barr virus latent membrane protein-1]
Neoplasm Metastasis
[Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues]
Neoplasm Metastasis
[FABP5 promotes cell growth, invasion and metastasis in cervical cancer].
Neoplasm Metastasis
[Implication of VEGF and MMPs in hepatic metastasis of human colon cancer]
Neoplasm Metastasis
[Influence of suppression of Epstein-Barr Virus-encoded latent membrane protein 1 by rAAV vector mediated RNA interference on metastatic ability of nasopharyngeal cancer cells in vivo]
Neoplasm Metastasis
[Inhibitory effects of antisense MMP-9 oligodeoxynucleotides on invasiveness and adherence of ovarian]
Neoplasm Metastasis
[Inhibitory effects of matrix metalloproteinase (MMP) inhibitor LY52 on expression of MMP-2 and MMP-9 and invasive ability of human ovarian carcinoma cell line SKOV3]
Neoplasm Metastasis
[Matrix metalloproteinase 2 and 9 as the factor of head and neck tumor metastasis]
Neoplasm Metastasis
[Matrix metalloproteinase 9 (92kDa gelatinase/type IV collagenase) is implicated in liver metastasis in colorectal cancers: preliminary report]
Neoplasm Metastasis
[Matrix metalloproteinase-2 concentrations in squamous cell carcinoma of the head and neck and its clinical significance]
Neoplasm Metastasis
[Mechanisms for quercetin in prevention of lung cancer cell growth and metastasis].
Neoplasm Metastasis
[MiR-373-3p Promotes Invasion and Metastasis of Lung Adenocarcinoma Cells].
Neoplasm Metastasis
[Molecular biology studies on metalloproteinase and tissue inhibitor of metalloproteinase expression in salivary adenoid cystic carcinoma]
Neoplasm Metastasis
[mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR]
Neoplasm Metastasis
[Osteopontin expression and its relation to invasion and metastases in gastric cancer]
Neoplasm Metastasis
[Overexpression of IL-8 and MMP-9 confer high malignant phenotype in patients with non-small cell lung cancer]
Neoplasm Metastasis
[Plasma level and prognostic significance of VEGF, bFGF and MMP-9 in patients with advanced non-small-cell lung cancer]
Neoplasm Metastasis
[Progress of clinical pathology and application of PET-CT on thyroid carcinoma]
Neoplasm Metastasis
[Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells]
Neoplasm Metastasis
[Relationship and clinical significance of KiSS-1, nuclear factor kappa B (NF-kappaB), p50, and matrix metalloproteinase 9 expression in breast cancer]
Neoplasm Metastasis
[Relationship between bFGF mRNA and MMP-9 mRNA expression in gastric carcinoma and their clinicopathological features as well as patients survival]
Neoplasm Metastasis
[Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix]
Neoplasm Metastasis
[Relationship between expression of matrix metalloproteinase-9 (MMP-9) and angiogenesis in renal cell carcinoma]
Neoplasm Metastasis
[Relationship between lymph node metastasis and the expressions of E-cadherin, N-cadherin, and matrix metalloproteinase in breast carcinoma]
Neoplasm Metastasis
[Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas]
Neoplasm Metastasis
[Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer.]
Neoplasm Metastasis
[Role of matrix metalloproteinases (MMPs) in tumor invasion and metastasis: serial studies on MMPs and TIMPs]
Neoplasm Metastasis
[Role of vascular endothelial growth factor receptor 1-positive hematopoietic progenitor cell clusters in human colorectal carcinoma metastasis]
Neoplasm Metastasis
[Short hairpin RNA-mediated suvivin gene silencing inhibits invasion and metastasis of human colon carcinoma cell line SW480 in vitro]
Neoplasm Metastasis
[Significance in gene expression of matrix metalloproteinase-9, urokinase-type plasminogen activator and tissue inhibitor of metalloproteinase for metastases of gastric and/or colo-rectal cancer]
Neoplasm Metastasis
[Significance of expression of chemokine receptor and matrix metalloproteinase in small cell lung cancer].
Neoplasm Metastasis
[Significance of MMP-9 and TIMP-1 production during liver metastasis in colorectal cancer]
Neoplasm Metastasis
[Study of matrix metalloproteinase-2 and -9 in thyroid papillary cancer]
Neoplasm Metastasis
[Study on differentially expressed molecules influencing the metastatic potential between highly and poorly metastatic human lung giant cell carcinoma]
Neoplasm Metastasis
[Study on expression of matrix metalloproteinases and their inhibitors in parotid gland tumors]
Neoplasm Metastasis
[The expression and its clinical significance of MMP-2 and MMP-9 in non-small cell lung cancer.]
Neoplasm Metastasis
[The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship]
Neoplasm Metastasis
[The expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in transplanted tumor of salivary adenoid cystic carcinoma cell lines]
Neoplasm Metastasis
[The mechanisms of microenvironments influence on vasculogenic mimicry between introcular and subcutaneous melanoma]
Neoplasm Metastasis
[The serum concentration of metalloproteinase 9 and 2 in non-small cell lung cancer patients]
Neoplasm Metastasis
[The utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignancies].
Neoplasm Metastasis
[Treatment of lymph node metastasis from the viewpoint of surgical oncology]
Neoplasm Micrometastasis
14,15-EET induces the infiltration and tumor-promoting function of neutrophils to trigger the growth of minimal dormant metastases.
Neoplasm Micrometastasis
A third-generation matrix metalloproteinase (MMP) inhibitor (ONO-4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP-expressing tumor cells in nude mice.
Neoplasm Micrometastasis
Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma.
Neoplasm Micrometastasis
Is copper chelation an effective anti-angiogenic strategy for cancer treatment?
Neoplasm Micrometastasis
Warm hepatic ischemia-reperfusion promotes growth of colorectal carcinoma micrometastases in mouse liver via matrix metalloproteinase-9 induction.
Neoplasm Micrometastasis
[Expression and clinical significance of certain apoptosis and angiogenesis factors in hepatocellular carcinoma]
Neoplasm Micrometastasis
[Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma]
Neoplasm, Residual
Angiogenesis in residual cancer and roles of HIF-1?, VEGF, and MMP-9 in the development of residual cancer after radiofrequency ablation and surgical resection in rabbits with liver cancer.
Neoplasm, Residual
Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation.
Neoplasm, Residual
Over-expression of VEGF and MMP-9 in residual tumor cells of hepatocellular carcinoma after embolization with lipidol.
Neoplasm, Residual
Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients.
Neoplasm, Residual
The expression and activity of MMPs are increased in residual tumor tissues after the termination of immunotherapy.
Neoplasms
'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression.
Neoplasms
(-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells.
Neoplasms
(18)F-Fluorodeoxyglucose positron emission tomography and serum cytokines and matrix metalloproteinases in the assessment of disease activity in Takayasu's arteritis.
Neoplasms
(99m)Tc-MAG3-aptamer for imaging human tumors associated with high level of matrix metalloprotease-9.
Neoplasms
1-furan-2-yl-3-pyridin-2-yl-propenone inhibits the invasion and migration of HT1080 human fibrosarcoma cells through the inhibition of proMMP-2 activation and down regulation of MMP-9 and MT1-MMP.
Neoplasms
1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-yl) Urea Protects the Blood-Brain Barrier Against Ischemic Injury by Upregulating Tight Junction Protein Expression, Mitigating Apoptosis and Inflammation InVivo and In Vitro Model.
Neoplasms
18?-Glycyrrhetinic acid suppresses TNF-? induced matrix metalloproteinase-9 and vascular endothelial growth factor by suppressing the Akt-dependent NF-?B pathway.
Neoplasms
2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9.
Neoplasms
2-Hydroxy-3,4-naphthochalcone (2H-NC) inhibits TNF?-induced tumor invasion through the downregulation of NF-?B-mediated MMP-9 gene expression.
Neoplasms
2-[5-Selenocyanato-pentyl]-6-amino-benzo[de]isoquinoline-1,3-dione inhibits angiogenesis, induces p53 dependent mitochondrial apoptosis and enhances therapeutic efficacy of cyclophosphamide.
Neoplasms
3,4,5-trihydroxybenzaldehyde from Geum japonicum has dual inhibitory effect on matrix metalloproteinase 9; inhibition of gelatinoytic activity as well as MMP-9 expression in TNF-alpha induced HASMC.
Neoplasms
3,5-Dicaffeoyl-epi-quinic acid inhibits the PMA-stimulated activation and expression of MMP-9 but not MMP-2 via downregulation of MAPK pathway.
Neoplasms
3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea inhibits tumor cell invasion by regulating protein kinase C-delta-dependent matrix metalloproteinase-9 expression.
Neoplasms
3-deoxysappanchalcone inhibits tumor necrosis factor-?-induced matrix metalloproteinase-9 expression in human keratinocytes through activated protein-1 inhibition and nuclear factor-kappa B DNA binding activity.
Neoplasms
4-XL-PPD, a novel ginsenoside derivative, as potential therapeutic agents for gastric cancer shows anti-cancer activity via inducing cell apoptosis medicated generation of reactive oxygen species and inhibiting migratory and invasive.
Neoplasms
5'-adenosine monophosphate-induced hypothermia attenuates brain ischemia/reperfusion injury in a rat model by inhibiting the inflammatory response.
Neoplasms
5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix metalloproteinase 9.
Neoplasms
92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer.
Neoplasms
?-Solanine inhibits human melanoma cell migration and invasion by reducing matrix metalloproteinase-2/9 activities.
Neoplasms
?-Tocotrienol suppresses growth and sensitises human colorectal tumours to capecitabine in a nude mouse xenograft model by down-regulating multiple molecules.
Neoplasms
?3GnT8 Regulates Laryngeal Carcinoma Cell Proliferation Via Targeting MMPs/TIMPs and TGF-?1.
Neoplasms
A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9.
Neoplasms
A bi-specific inhibitor targeting IL-17A and MMP-9 reduces invasion and motility in MDA-MB-231 cells.
Neoplasms
A catalytic role for proangiogenic marrow-derived cells in tumor neovascularization.
Neoplasms
A chimera of green fluorescent protein with gelatinase binding and tumor targeting peptide.
Neoplasms
A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway.
Neoplasms
A chinese herbal formula ameliorates COPD by inhibiting the inflammatory response via downregulation of p65, JNK, and p38.
Neoplasms
A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile.
Neoplasms
A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins.
Neoplasms
A comparison of the biological features between prostate cancers arising in the transition and peripheral zones.
Neoplasms
A comparison of the expression of the malignant phenotype in two androgen-independent human prostate cancer cell lines after orthotopic implantation in nude mice.
Neoplasms
A DNA-directed covalent conjugation fluorescence probe for in vitro detection of functional matrix metalloproteinases.
Neoplasms
A Dual-Targeting Delivery System for Effective Genome Editing and In Situ Detecting Related Protein Expression in Edited Cells.
Neoplasms
A gelatin in situ-overlay technique localizes brain matrix metalloproteinase activity in experimental focal cerebral ischemia.
Neoplasms
A gold-selenium-bonded nanoprobe for real-time in situ imaging of the upstream and downstream relationship between uPA and MMP-9 in cancer cells.
Neoplasms
A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9).
Neoplasms
A lower admission level of interleukin-6 is associated with first-pass effect in ischemic stroke patients.
Neoplasms
A mitochondrial ROS pathway controls matrix metalloproteinase 9 levels and invasive properties in RAS-activated cancer cells.
Neoplasms
A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer.
Neoplasms
A Multi-functional Vector for delivery of Genome Editing Plasmid Targeting ?-Catenin to Re-modulate Cancer Cell Properties.
Neoplasms
A murine model of myeloma that allows genetic manipulation of the host microenvironment.
Neoplasms
A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis.
Neoplasms
A New Paradigm for the Treatment of Alzheimer's Disease: Targeting Vascular Activation.
Neoplasms
A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer's Disease and Type 2 Diabetes Mellitus.
Neoplasms
A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes.
Neoplasms
A new pseudo-peptide of Arg-Gly-Asp (RGD) inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma.
Neoplasms
A nitric oxide-releasing salbutamol elicits potent relaxant and anti-inflammatory activities.
Neoplasms
A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
Neoplasms
A novel herbal medicine, KIOM-C, induces autophagic and apoptotic cell death mediated by activation of JNK and reactive oxygen species in HT1080 human fibrosarcoma cells.
Neoplasms
A novel hydroxamic acid derivative, MHY218, induces apoptosis and cell cycle arrest through downregulation of NF-?B in HCT116 human colon cancer cells.
Neoplasms
A novel peptide that selectively binds highly metastatic hepatocellular carcinoma cell surface is related to invasion and metastasis.
Neoplasms
A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-?B and Nrf2-Keap1 signaling pathways.
Neoplasms
A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis.
Neoplasms
A plant-based medicinal food inhibits the growth of human gastric carcinoma by reversing epithelial-mesenchymal transition via the canonical Wnt/?-catenin signaling pathway.
Neoplasms
A possible role of 92 kDa type IV collagenase in the extramedullary tumor formation in leukemia.
Neoplasms
A prospective study to assess the value of MMP-9 in improving the appropriateness of urgent referrals for colorectal cancer.
Neoplasms
A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis.
Neoplasms
A randomised clinical trial of high-intensity focused ultrasound ablation for the treatment of patients with localised breast cancer.
Neoplasms
A randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: study design and protocol.
Neoplasms
A rare case of double recurrent choroidal melanoma, with distinctive immunohistochemical features.
Neoplasms
A reporter system evaluates tumorigenesis, metastasis, ?-catenin/MMP regulation, and druggability.
Neoplasms
A role for AP-1 in matrix metalloproteinase production and invadopodia formation of v-Crk-transformed cells.
Neoplasms
A role for focal adhesion kinase signaling in tumor necrosis factor-alpha-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1.
Neoplasms
A role for p53 in the regulation of extracellular matrix metalloproteinase inducer in human cancer cells.
Neoplasms
A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
Neoplasms
A significant elevation of plasma level of matrix metalloproteinase-9 in patients with high-grade intraepithelial neoplasia and early squamous cell carcinoma of the uterine cervix.
Neoplasms
A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells.
Neoplasms
A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer.
Neoplasms
A small compound that inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-9 upregulation.
Neoplasms
A Specific Mixture of Nutrients Suppresses Ovarian Cancer A-2780 Tumor Incidence, Growth, and Metastasis to Lungs.
Neoplasms
A star-shaped porphyrin-arginine functionalized poly(l-lysine) copolymer for photo-enhanced drug and gene co-delivery.
Neoplasms
A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
Neoplasms
Aberrant cytokeratin expression during arsenic-induced acquired malignant phenotype in human HaCaT keratinocytes consistent with epidermal carcinogenesis.
Neoplasms
Aberrant expression of ALDH1, MMP9, Integrin ?v?3, and KiSS-1 in invasive ductal carcinoma and their clinical significance.
Neoplasms
Aberrant expression of CXCR4 significantly contributes to metastasis and predicts poor clinical outcome in breast cancer.
Neoplasms
Abiotic Mimic of Matrix Metalloproteinase-9 Inhibitor against Advanced Metastatic Cancer.
Neoplasms
Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.
Neoplasms
Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosis.
Neoplasms
Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages.
Neoplasms
Activation of ?2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.
Neoplasms
Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Neoplasms
Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice.
Neoplasms
Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase.
Neoplasms
Activation of Large form Galanin-LI by Extracellular Processing in Small Cell Lung Carcinoma Tissue.
Neoplasms
Activation of matrix metalloproteinase (MMP)-2 by membrane type 1-MMP and abnormal immunolocalization of the basement membrane components laminin and type IV collagen in canine spontaneous hemangiosarcomas.
Neoplasms
Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion.
Neoplasms
Activation of matrix metalloproteinase-9 by TNF-alpha in human urinary bladder cancer HT1376 cells: The role of MAP kinase signaling pathways.
Neoplasms
Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasis.
Neoplasms
Activation of phosphatidylinositol 3-kinase is required for tumor necrosis factor-alpha-induced upregulation of matrix metalloproteinase-9: its direct inhibition by quercetin.
Neoplasms
Activation of Poly(ADP-Ribose) Polymerase-1 Delays Wound Healing by Regulating Keratinocyte Migration and Production of Inflammatory Mediators.
Neoplasms
Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells.
Neoplasms
Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases.
Neoplasms
Activation of Rho and ROCK by GPR54 and KiSS1 Metastasis Suppressor Gene Product Induces Changes of Cell Morphology and Contributes to Apoptosis.
Neoplasms
Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factor-alpha signaling.
Neoplasms
Activation State of Stromal Inflammatory Cells in Murine Metastatic Pancreatic Adenocarcinoma.
Neoplasms
Activator Protein-2? Promotes Tumor Growth and Predicts Poor Prognosis in Breast Cancer.
Neoplasms
Active and inactive forms of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
Neoplasms
Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
Neoplasms
Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9.
Neoplasms
Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Neoplasms
Activity of biphenyl matrix metalloproteinase inhibitor BAY 12-9566 in a human breast cancer orthotopic model.
Neoplasms
Activity of the matrix metalloproteinase-9 promoter in human normal and tumor cells.
Neoplasms
Activity of type IV collagenases (MMP-2 and MMP-9) in primary pulmonary carcinomas: a quantitative analysis.
Neoplasms
Acupuncture-mediated inhibition of inflammation facilitates significant functional recovery after spinal cord injury.
Neoplasms
Acute and chronic neuroinflammation is triggered by diabetic ketoacidosis in a rat model.
Neoplasms
Acute elevation of interleukin 6 and matrix metalloproteinase 9 during the onset of pituitary apoplexy in Cushing's disease.
Neoplasms
Acute Inflammatory Responses to Exercise in Patients with Abdominal Aortic Aneurysm.
Neoplasms
ADAM17 silencing in mouse colon carcinoma cells: the effect on tumoricidal cytokines and angiogenesis.
Neoplasms
ADAMTS-5 Decreases in Aortas and Plasma From Aortic Dissection Patients and Alleviates Angiotensin II-Induced Smooth Muscle-Cell Apoptosis.
Neoplasms
Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer.
Neoplasms
Additive Influence of Extracellular pH, Oxygen Tension, and Pressure on Invasiveness and Survival of Human Osteosarcoma Cells.
Neoplasms
Adenosine dialdehyde suppresses MMP-9-mediated invasion of cancer cells by blocking the Ras/Raf-1/ERK/AP-1 signaling pathway.
Neoplasms
Adenosine Inhibits Ovarian Cancer Growth Through Regulating RhoGDI2 Protein Expression.
Neoplasms
Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion.
Neoplasms
Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis.
Neoplasms
Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis.
Neoplasms
Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice.
Neoplasms
Adhesive defect in extracellular matrix tenascin-X-null fibroblasts: a possible mechanism of tumor invasion.
Neoplasms
Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice.
Neoplasms
Adipose tissue is not an important source for matrix metalloproteinase-9 in the circulation.
Neoplasms
Administration of granulocyte colony-stimulating factor with radiotherapy promotes tumor growth by stimulating vascularization in tumor-bearing mice.
Neoplasms
Adrenomedullin production is increased in colorectal adenocarcinomas; its relation to matrix metalloproteinase-9.
Neoplasms
AEG-1 knockdown in colon cancer cell lines inhibits radiation-enhanced migration and invasion in vitro and in a novel in vivo zebrafish model.
Neoplasms
Age-related changes in matrix metalloproteinase-9 regulation in cultured mouse aortic smooth muscle cells.
Neoplasms
Age-related leukocyte and cytokine patterns in community-acquired bronchopneumonia.
Neoplasms
Aging attenuates radiation-induced expression of pro-inflammatory mediators in rat brain.
Neoplasms
Aging-related early changes in markers of ventricular and matrix remodeling after reperfused ST-segment elevation myocardial infarction in the canine model: effect of early therapy with an angiotensin II type 1 receptor blocker.
Neoplasms
AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
Neoplasms
Albumin-encapsulated Nanoparticles of Naproxen Platinum(IV) Complexes with Inflammation Inhibitory Competence Displaying Effective Antitumor Activities in vitro and in vivo.
Neoplasms
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain.
Neoplasms
ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells.
Neoplasms
alpha-Lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer cells.
Neoplasms
alpha2beta1 integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid-dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity.
Neoplasms
AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients.
Neoplasms
Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer.
Neoplasms
Alterations in human breast cancer adhesion-motility in response to changes in cell surface glycoproteins displaying alpha-L-fucose moieties.
Neoplasms
Altered Gene and Protein Expressions in Torn Rotator Cuff Tendon Tissues in Diabetic Patients.
Neoplasms
Alternagin-C binding to ?2?1 integrin controls matrix metalloprotease-9 and matrix metalloprotease-2 in breast tumor cells and endothelial cells.
Neoplasms
Ameliorating the effects of Adalimumab on rabbits with experimental cerebral vasospasm after subarachnoid hemorrhage.
Neoplasms
Ameloblastic neoplasia spectrum: a cross-sectional study of MMPS expression and proliferative activity.
Neoplasms
Amentoflavone Inhibits Experimental Tumor Metastasis Through a Regulatory Mechanism Involving MMP-2, MMP-9, Prolyl Hydroxylase, Lysyl Oxidase, VEGF, ERK-1, ERK-2, STAT-1, nm23 and Cytokines in Lung Tissues of C57BL/6 Mice.
Neoplasms
Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma.
Neoplasms
Amorphous calcium phosphate-mediated binding of matrix metalloproteinase-9 to fibrin is inhibited by pyrophosphate and bisphosphonate.
Neoplasms
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.
Neoplasms
An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors.
Neoplasms
An Aqueous Extract of a Bifidobacterium Species Induces Apoptosis and Inhibits Invasiveness of Non-Small Cell Lung Cancer Cells.
Neoplasms
An epitope-specific novel anti-EMMPRIN polyclonal antibody inhibits tumor progression.
Neoplasms
An immortalization-dependent switch in integrin function up-regulates MMP-9 to enhance tumor cell invasion.
Neoplasms
An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression.
Neoplasms
An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily.
Neoplasms
An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
Neoplasms
An orthotopic floor-of-mouth cancer model allows quantification of tumor invasion.
Neoplasms
Analysis of KRT1, KRT10, KRT19, TP53 and MMP9 expression in pediatric and adult cholesteatoma.
Neoplasms
Analysis of matrix metalloproteinase mRNAs expressed in hepatocellular carcinoma cell lines.
Neoplasms
Analysis of matrix metalloproteinases and related tissue inhibitors in cystic fluids of ovarian tumors.
Neoplasms
Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives.
Neoplasms
Analysis of the application of MMP-9 inhibitor in skin melanoma: experimental study.
Neoplasms
Analysis of the Gene Expression Profile of Stromal Pro-Tumor Factors in Cancer-Associated Fibroblasts from Luminal Breast Carcinomas.
Neoplasms
Analysis of vascular-associated factors and the prognosis of poorly differentiated hypopharyngeal carcinoma.
Neoplasms
Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression.
Neoplasms
Andrographolide enhances the anti-metastatic effect of radiation in Ras-transformed cells via suppression of ERK-mediated MMP-2 activity.
Neoplasms
Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia.
Neoplasms
Angiogenesis for tumor vascular normalization of Endostar on hepatoma 22 tumor-bearing mice is involved in the immune response.
Neoplasms
Angiogenesis in residual cancer and roles of HIF-1?, VEGF, and MMP-9 in the development of residual cancer after radiofrequency ablation and surgical resection in rabbits with liver cancer.
Neoplasms
Angiogenesis in vestibular schwannomas: expression of extracellular matrix factors MMP-2, MMP-9, and TIMP-1.
Neoplasms
Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice.
Neoplasms
Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.
Neoplasms
Ankle loading ameliorates bone loss from breast cancer-associated bone metastasis.
Neoplasms
Anthocyanins from the Fruit of Vitis Coignetiae Pulliat Inhibit TNF-Augmented Cancer Proliferation, Migration, and Invasion in A549 Cells
Neoplasms
Anti-Cancer Effect of Ginsenoside F2 against Glioblastoma Multiforme in Xenograft Model in SD Rats.
Neoplasms
Anti-CD146 monoclonal antibody AA98 inhibits angiogenesis via suppression of nuclear factor-kappaB activation.
Neoplasms
Anti-inflammatory activities of Physalis alkekengi var. franchetii extract through the inhibition of MMP-9 and AP-1 activation.
Neoplasms
Anti-Inflammatory Effects of Naringin in Chronic Pulmonary Neutrophilic Inflammation in Cigarette Smoke-Exposed Rats.
Neoplasms
Anti-inflammatory property of quercetin through downregulation of ICAM-1 and MMP-9 in TNF-?-activated retinal pigment epithelial cells.
Neoplasms
Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma--in vitro and in vivo studies.
Neoplasms
Anti-invasive activity of anthocyanins isolated from Vitis coignetiae in human hepatocarcinoma cells.
Neoplasms
Anti-invasive activity of torilin, a sesquiterpene compound isolated from Torilis japonica.
Neoplasms
Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
Neoplasms
Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer.
Neoplasms
Anti-metastatic and pro-apoptotic effects elicited by combination photodynamic therapy with sonodynamic therapy on breast cancer both in vitro and in vivo.
Neoplasms
Anti-Proliferation Effect of Theasaponin E? on the ALDH-Positive Ovarian Cancer Stem-Like Cells.
Neoplasms
Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study.
Neoplasms
Anti-tubulin agent vinorelbine inhibits metastasis of cancer cells by regulating epithelial-mesenchymal transition.
Neoplasms
Anti-tumor effects of progesterone in human glioblastoma multiforme: Role of PI3K/Akt/mTOR signaling.
Neoplasms
Antiangiogenic therapy effects on age-associated matrix metalloproteinase-9 (MMP-9) and insulin-like growth factor receptor-1 (IGFR-1) responses: a comparative study of prostate disorders in aged and TRAMP mice.
Neoplasms
Antibody microarray profiling of osteosarcoma cell serum for identifying potential biomarkers.
Neoplasms
Anticancer activities of an anthocyanin-rich extract from black rice against breast cancer cells in vitro and in vivo.
Neoplasms
Anticancer and antimetastatic effects of cordycepin, an active component of Cordyceps sinensis.
Neoplasms
Anticancer potential of Euphorbia helioscopia L extracts against human cancer cells.
Neoplasms
Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease.
Neoplasms
Antifibrogenic effect of IFN-alpha2b on hepatic stellate cell activation by human hepatocytes.
Neoplasms
Antihypertensive and Antifibrosis Effects of Acupuncture at PC6 Acupoints in Spontaneously Hypertensive Rats and the Underlying Mechanisms.
Neoplasms
Antimetastatic activity of pinosylvin, a natural stilbenoid, is associated with the suppression of matrix metalloproteinases.
Neoplasms
Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9.
Neoplasms
Antimetastatic effects of gambogic acid are mediated via the actin cytoskeleton and NF-?B pathways in SK-HEP1 cells.
Neoplasms
Antimetastatic Potentials of Phyllanthusurinaria L on A549 and Lewis Lung Carcinoma Cells via Repression of Matrix-Degrading Proteases.
Neoplasms
Antinociceptive effect of isoorientin against neuropathic pain induced by the chronic constriction injury of the sciatic nerve in mice.
Neoplasms
Antioxidant and anti-inflammatory potential of curcumin accelerated the cutaneous wound healing in streptozotocin-induced diabetic rats.
Neoplasms
Antioxidants inhibit TNFalpha-induced motility and invasion of human osteosarcoma cells: possible involvement of NFkappaB activation.
Neoplasms
Antioxidative, anti-inflammatory, and matrix metalloproteinase inhibitory activities of 20(S)-ginsenoside Rg3 in cultured mammalian cell lines.
Neoplasms
Antiproliferative Activity of Triterpene Glycoside Nutrient from Monk Fruit in Colorectal Cancer and Throat Cancer.
Neoplasms
Antiproliferative and antimetastatic effects of emodin on human pancreatic cancer.
Neoplasms
Antitumor activity of targeting SRC kinases in endothelial and myeloid cell compartments of the tumor microenvironment.
Neoplasms
Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
Neoplasms
Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer.
Neoplasms
Antitumor evaluation of carboxymethyl chitosan based norcantharidin conjugates against gastric cancer as novel polymer therapeutics.
Neoplasms
Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor kappaB pathway.
Neoplasms
AP-1 and ERK1 but not p38 nor JNK is required for CRPV early protein 2-dependent MMP-9 promoter activation in rabbit epithelial cells.
Neoplasms
AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon ?.
Neoplasms
Apigenin Attenuates Insulin-Like Growth Factor-I Signaling in an Autochthonous Mouse Prostate Cancer Model.
Neoplasms
Apomorphine suppresses TNF-?-induced MMP-9 expression and cell invasion through inhibition of ERK/AP-1 signaling pathway in MCF-7 cells.
Neoplasms
Apoptosis Induced by Knockdown of uPAR and MMP-9 is Mediated by Inactivation of EGFR/STAT3 Signaling in Medulloblastoma.
Neoplasms
Apoptosis induction and ERK/NF-?B inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo.
Neoplasms
Application of the nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate for the treatment of endometriosis: an in vitro study.
Neoplasms
Aqueous extract of Anisomeles indica and its purified compound exerts anti-metastatic activity through inhibition of NF-?B/AP-1-dependent MMP-9 activation in human breast cancer MCF-7 cells.
Neoplasms
Aqueous extract of Bambusae Caulis in Taeniam inhibits PMA-induced tumor cell invasion and pulmonary metastasis: suppression of NF-?B activation through ROS signaling.
Neoplasms
Aqueous Terminalia arjuna extract modulates expression of key atherosclerosis-related proteins in a hypercholesterolemic rabbit: A proteomic-based study.
Neoplasms
Areca quid chewing enhances the expression of salivary matrix metalloproteinase-9.
Neoplasms
Arfaptin 1 inhibits ADP-ribosylation factor-dependent matrix metalloproteinase-9 secretion induced by phorbol ester in HT 1080 fibrosarcoma cells.
Neoplasms
Aristolochic acid downregulates monocytic matrix metalloproteinase-9 by inhibiting nuclear factor-?B activation.
Neoplasms
Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
Neoplasms
Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB.
Neoplasms
Arylamine N-acetyltransferase 1 regulates expression of matrix metalloproteinase 9 in cancer cells: role of HIF1-?.
Neoplasms
Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
Neoplasms
Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms.
Neoplasms
Ascorbate supplementation inhibits growth and metastasis of B16FO melanoma and 4T1 breast cancer cells in vitamin C-deficient mice.
Neoplasms
Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression.
Neoplasms
Aspirin suppresses TNF-?-induced MMP-9 expression via NF-?B and MAPK signaling pathways in RAW264.7 cells.
Neoplasms
Assessing the value of matrix metalloproteinase 9 (MMP9) in improving the appropriateness of referrals for colorectal cancer.
Neoplasms
Assessment and clinicopathological correlation of matrix metalloproteinase 9 expression in nasopharyngeal carcinoma.
Neoplasms
Assessment of CMKLR1 level in colorectal cancer and its correlation with angiogenic markers.
Neoplasms
ASSESSMENT OF GELATINASE AND TUMOR NECROSIS FACTOR-? LEVEL IN THE VITREOUS AND SERUM OF PATIENTS WITH EALES DISEASE: Role of Inflammation-Mediated Angiogenesis in the Pathogenesis of Eales Disease.
Neoplasms
Assessment of the clinical significance of serum vascular endothelial growth factor and matrix metalloproteinase-9 in patients with hepatocellular carcinoma.
Neoplasms
Assessment of the Inhibitory Effects of Ficin-hydrolyzed Gelatin Derived from Squid (Uroteuthis duvauceli) on Breast Cancer Cell Lines and Animal Model.
Neoplasms
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Neoplasms
Association between focal adhesion kinase and matrix metalloproteinase-9 expression in prostate adenocarcinoma and their influence on the progression of prostatic adenocarcinoma.
Neoplasms
Association between Inflammatory Biomarkers and Progression of Intracranial Large Artery Stenosis after Ischemic Stroke.
Neoplasms
Association between Matrix Metallopeptidase 9 Polymorphism and Breast Cancer Risk.
Neoplasms
Association between matrix metalloproteinase-9 gene polymorphism and breast cancer in Brazilian women.
Neoplasms
Association between MMP-9 -1562 C/T polymorphism and susceptibility to digestive cancers: A meta-analysis.
Neoplasms
Association of bone loss with the upregulation of survival-related genes and concomitant downregulation of Mammalian target of rapamycin and osteoblast differentiation-related genes in the peripheral blood of late postmenopausal osteoporotic women.
Neoplasms
Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults.
Neoplasms
Association of fibrotic remodeling and cytokines/chemokines content in epicardial adipose tissue with atrial myocardial fibrosis in patients with atrial fibrillation.
Neoplasms
Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas.
Neoplasms
Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma.
Neoplasms
Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Neoplasms
Association of matrix metalloproteinase (MMP)-2 and -9 expression with extra-gastrointestinal stromal tumor metastasis.
Neoplasms
Association of matrix metalloproteinase-9 and decorin expression with the infiltration of cervical cancer.
Neoplasms
Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk.
Neoplasms
Association of matrix metalloproteinases 1, 7, and 9 gene polymorphisms with genetic susceptibility to colorectal carcinoma in a Han Chinese population.
Neoplasms
Association of Oxytocin with Glucose Intolerance and Inflammation Biomarkers in Metabolic Syndrome Patients with and without Prediabetes.
Neoplasms
Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells.
Neoplasms
Association of tumor necrosis factor-? (G-308A) genetic variant with matrix metalloproteinase-9 activity and joint destruction in early rheumatoid arthritis.
Neoplasms
Association of type II apoptosis and 92-kDa type IV collagenase expression in human amniochorion in prematurely ruptured membranes with tumor necrosis factor receptor-1 expression.
Neoplasms
Associations of markers of inflammation and coagulation with delirium during critical illness.
Neoplasms
Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.
Neoplasms
Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion.
Neoplasms
ATIQCTPC targeting MMP-9: a key step to slowing primary tumor growth and inhibiting metastasis of lewis lung carcinoma
Neoplasms
Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes.
Neoplasms
Attenuation of Remifentanil-Induced Hyperalgesia by Betulinic Acid Associates with Inhibiting Oxidative Stress and Inflammation in Spinal Dorsal Horn.
Neoplasms
Autocrine regulation of macrophage differentiation and 92-kDa gelatinase production by tumor necrosis factor-alpha via alpha5 beta1 integrin in HL-60 cells.
Neoplasms
Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-alpha (TNF-alpha) in NB4 leukemic cells: specific involvement of TNF receptor type 1.
Neoplasms
Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo.
Neoplasms
Autologous Bone Marrow Mononuclear Cell Transplantation Delays Progression of Carotid Atherosclerosis in Rabbits.
Neoplasms
Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappaB and Brg-1.
Neoplasms
Bacoside A downregulates matrix metalloproteinases 2 and 9 in DEN-induced hepatocellular carcinoma.
Neoplasms
Baicalein inhibits pulmonary carcinogenesis-associated inflammation and interferes with COX-2, MMP-2 and MMP-9 expressions in-vivo.
Neoplasms
Baicalin Ameliorates Collagen-Induced Arthritis Through the Suppression of Janus Kinase 1 (JAK1)/Signal Transducer and Activator of Transcription 3 (STAT3) Signaling in Mice.
Neoplasms
Baincalein alleviates early brain injury after experimental subarachnoid hemorrhage in rats: possible involvement of TLR4/NF-?B-mediated inflammatory pathway.
Neoplasms
Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer.
Neoplasms
Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis.
Neoplasms
Bee venom suppresses PMA-mediated MMP-9 gene activation via JNK/p38 and NF-kappaB-dependent mechanisms.
Neoplasms
Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression.
Neoplasms
Benzo[a]pyrene Potentiates the Pathogenesis of Abdominal Aortic Aneurysms in Apolipoprotein E Knockout Mice.
Neoplasms
Berberine Suppresses the TPA-Induced MMP-1 and MMP-9 Expressions Through the Inhibition of PKC-? in Breast Cancer Cells.
Neoplasms
Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells.
Neoplasms
Beta-endorphin ameliorates synovial cell hyperfunction in the collagen-induced arthritis rat model by specific downregulation of NF-kappa B activity.
Neoplasms
Beta-endorphin prevents collagen induced arthritis by neuroimmuno-regulation pathway.
Neoplasms
Betulinic acid attenuates renal oxidative stress and inflammation in experimental model of murine polymicrobial sepsis.
Neoplasms
Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization.
Neoplasms
Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species.
Neoplasms
Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.
Neoplasms
Biochemical and pathological evaluation of albendazole/thalidomide co-therapy against eosinophilic meningitis or meningoencephalitis induced by Angiostrongylus cantonensis.
Neoplasms
Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
Neoplasms
Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment.
Neoplasms
Biomarkers of inflammation and hemostasis associated with left ventricular mass: The Multiethnic Study of Atherosclerosis (MESA).
Neoplasms
Bioprotective potential of bacteriocinogenic Enterococcus gallinarum strains isolated from some Nigerian fermented foods, and of their bacteriocins.
Neoplasms
Biphenyl substituted lysine derivatives as recognition elements for the matrix metalloproteinases MMP-2 and MMP-9.
Neoplasms
Black tea theaflavins attenuate Porphyromonas gingivalis virulence properties, modulate gingival keratinocyte tight junction integrity and exert anti-inflammatory activity.
Neoplasms
BLCA-4 expression is related to MMP-9, VEGF, IL-1? and IL-8 in bladder cancer but not to PEDF, TNF-? or angiogenesis.
Neoplasms
Blockade of NF-?B nuclear translocation results in the inhibition of the invasiveness of human gastric cancer cells.
Neoplasms
Blockade of Rho/Rho-associated coiled coil-forming kinase signaling can prevent progression of hepatocellular carcinoma in matrix metalloproteinase-dependent manner.
Neoplasms
Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators.
Neoplasms
Blockade of tumor growth due to matrix metalloproteinase-9 inhibition is mediated by sequential activation of beta1-integrin, ERK, and NF-kappaB.
Neoplasms
Blocking mouse MMP-9 production in tumor cells and mouse cornea by short hairpin (sh) RNA encoding plasmids.
Neoplasms
Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model.
Neoplasms
Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood.
Neoplasms
Bone marrow niche-derived extracellular matrix-degrading enzymes influence the progression of B-cell acute lymphoblastic leukemia.
Neoplasms
Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-?1, IL-13 and oxidative stress.
Neoplasms
Bone morphogenetic protein 4 (BMP-4) and epidermal growth factor (EGF) inhibit metalloproteinase-9 (MMP-9) expression in cancer cells.
Neoplasms
Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model.
Neoplasms
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy.
Neoplasms
Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells.
Neoplasms
Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.
Neoplasms
BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53/MDM2-mediated HIF-1? proteasomal degradation.
Neoplasms
Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-alpha, releasing matrix metalloproteinase-9 and migrating in vitro.
Neoplasms
Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta.
Neoplasms
Breast Cancer Invasion and Metastasis by mPR? Through the PI3K/Akt Signaling Pathway.
Neoplasms
Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression.
Neoplasms
Brefeldin a effectively inhibits cancer stem cell-like properties and mmp-9 activity in human colorectal cancer colo 205 cells.
Neoplasms
Broccoli and watercress suppress matrix metalloproteinase-9 activity and invasiveness of human MDA-MB-231 breast cancer cells.
Neoplasms
Bromoenol Lactone Attenuates Nicotine-Induced Breast Cancer Cell Proliferation and Migration.
Neoplasms
Bruton's Tyrosine Kinase (BTK) Inhibitor (Ibrutinib)?-Suppressed Migration and Invasion of Prostate Cancer.
Neoplasms
BubR1 Acts as a Promoter in Cellular Motility of Human Oral Squamous Cancer Cells through Regulating MMP-2 and MMP-9.
Neoplasms
Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells.
Neoplasms
C-FLIP promotes the motility of cancer cells by activating FAK and ERK, and increasing MMP-9 expression.
Neoplasms
c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumor model.
Neoplasms
C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: Implications for the destabilization of atherosclerotic plaque.
Neoplasms
c-Src-dependent transactivation of PDGFR contributes to TNF-?-induced MMP-9 expression and functional impairment in osteoblasts.
Neoplasms
Cadmium induces matrix metalloproteinase-9 expression via ROS-dependent EGFR, NF-?B, and AP-1 pathways in human endothelial cells.
Neoplasms
Cadmium malignantly transforms normal human breast epithelial cells into a basal-like phenotype.
Neoplasms
CADPE Inhibits PMA-Stimulated Gastric Carcinoma Cell Invasion and Matrix Metalloproteinase-9 Expression by FAK/MEK/ERK-Mediated AP-1 Activation.
Neoplasms
Caffeic acid phenethyl ester alleviates asthma by regulating the airway microenvironment via the ROS-responsive MAPK/Akt pathway.
Neoplasms
Caffeic acid phenethyl ester inhibits invasion and expression of matrix metalloproteinase in SK-Hep1 human hepatocellular carcinoma cells by targeting nuclear factor kappa B.
Neoplasms
Caffeic acid phenyl ester in propolis is a strong inhibitor of matrix metalloproteinase-9 and invasion inhibitor: isolation and identification.
Neoplasms
Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppression of matrix metalloproteinase activity.
Neoplasms
Calcitriol-Loaded Dual-pH-Sensitive Micelle Counteracts Pro-Metastasis Effect of Paclitaxel in Triple-Negative Breast Cancer Therapy.
Neoplasms
Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by ERK1/2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma.
Neoplasms
Camptothecin suppresses expression of matrix metalloproteinase-9 and vascular endothelial growth factor in DU145 cells through PI3K/Akt-mediated inhibition of NF-?B activity and Nrf2-dependent induction of HO-1 expression.
Neoplasms
Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?
Neoplasms
Can serum matrix metalloproteinase-9 and SMAD-2 levels predict lamina propria invasion in bladder urothelial carcinoma?
Neoplasms
Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3.
Neoplasms
Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke.
Neoplasms
Capturing Changes in the Brain Microenvironment during Initial Steps of Breast Cancer Brain Metastasis.
Neoplasms
Carbohydrate source influences gelatinase production by mouse astrocytes in vitro.
Neoplasms
Carboxy derivatized glucosamine is a potent inhibitor of matrix metalloproteinase-9 in HT1080 cells.
Neoplasms
Carboxylated chitooligosaccharides (CCOS) inhibit MMP-9 expression in human fibrosarcoma cells via down-regulation of AP-1.
Neoplasms
Carcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR.
Neoplasms
Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism.
Neoplasms
Cardiotrophin-1 promotes a high survival rate in rabbits with lethal fulminant hepatitis of viral origin.
Neoplasms
Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis.
Neoplasms
Case of primary malignant hemangiopericytoma of the heart expressing basement membrane-degradable enzymes.
Neoplasms
Caspase-10, matrix metalloproteinase-9 and total laminin are correlated with the tumor malignancy of clear cell renal cell carcinoma.
Neoplasms
Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-?B in esophageal squamous cell carcinoma cells.
Neoplasms
Cathepsin S Alters the Expression of Pro-Inflammatory Cytokines and MMP-9, Partially through Protease-Activated Receptor-2, in Human Corneal Epithelial Cells.
Neoplasms
CCR5 facilitates endothelial progenitor cell recruitment and promotes the stabilization of atherosclerotic plaques in ApoE-/- mice.
Neoplasms
CD-PLLD co-delivering docetaxel and MMP-9 siRNA plasmid for nasopharyngeal carcinoma therapy in vivo.
Neoplasms
CD133+ cancer stem-like cells promote migration and invasion of salivary adenoid cystic carcinoma by inducing vasculogenic mimicry formation.
Neoplasms
CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.
Neoplasms
CD147, MMP-2, MMP-9 and MVD-CD34 are Significant Predictors of Recurrence After Liver Transplantation in Hepatocellular Carcinoma Patients.
Neoplasms
CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis.
Neoplasms
CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
Neoplasms
CD44+/CD133+ immunophenotype and matrix metalloproteinase-9: Influence on prognosis in early-stage oral squamous cell carcinoma.
Neoplasms
CD44-expressing undifferentiated carcinoma with rhabdoid features of the pancreas: Molecular analysis of aggressive invasion and metastasis.
Neoplasms
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Neoplasms
CDX1 Expression Induced by CagA-Expressing Helicobacter pylori Promotes Gastric Tumorigenesis.
Neoplasms
Celastrol induces the apoptosis of breast cancer cells and inhibits their invasion via downregulation of MMP-9.
Neoplasms
Celastrol inhibit the proliferation, invasion and migration of human cervical HeLa cancer cells through down-regulation of MMP-2 and MMP-9.
Neoplasms
Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats.
Neoplasms
Celecoxib inhibits cell growth and modulates the expression of matrix metalloproteinases in human osteosarcoma MG-63 cell line.
Neoplasms
Cell mediated immune responses through TLR4 prevents DMBA-induced mammary carcinogenesis in mice.
Neoplasms
Cell surface associated alpha-L: -fucose moieties modulate human breast cancer neoplastic progression.
Neoplasms
Cell surface immunophenotype and gelatinase activity of the human breast carcinoma cell line (MCF-7/6) with functionally defective E-cadherin.
Neoplasms
Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.
Neoplasms
Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features.
Neoplasms
Cellular distribution of 92-kd type IV collagenase/gelatinase B in human hepatocellular carcinoma.
Neoplasms
Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
Neoplasms
Cepharanthin, a biscoclaurine alkaloid, prevents destruction of acinar tissues in murine Sjögren's syndrome.
Neoplasms
Cerebrospinal fluid and plasma concentrations of proinflammatory mediators in human immunodeficiency virus-infected children.
Neoplasms
Cervical cancer cell-derived interleukin-6 impairs CCR7-dependent migration of MMP-9-expressing dendritic cells.
Neoplasms
Changes in biologic characteristics of breast cancer treated with high-intensity focused ultrasound.
Neoplasms
Changes in Expressions of HSP27, HSP70, and Soluble Glycoprotein in Heart Failure Rats Complicated with Pulmonary Edema and Correlations with Cardiopulmonary Functions.
Neoplasms
Changes in expressions of miR-22-3p and MMP-9 in rats with thoracic aortic aneurysm and their significance.
Neoplasms
Changes in extracellular matrix in different stages of colorectal cancer and their effects on proliferation of cancer cells.
Neoplasms
Changes in mitochondrial DNA alter expression of nuclear encoded genes associated with tumorigenesis.
Neoplasms
Changes in MMP-2, MMP-9, inflammation, blood coagulation and intestinal mucosal permeability in patients with active ulcerative colitis.
Neoplasms
Changes in the gene expression of co-cultured human fibroblast cells and osteosarcoma cells: the role of microenvironment.
Neoplasms
Changes in the Levels of N-Cadherin and PCNA in Skin Melanoma Cells Are Mediated through Matrix Metalloproteinase 9.
Neoplasms
Changes of synovial fluid biomarker levels after opening wedge high tibial osteotomy in patients with knee osteoarthritis.
Neoplasms
Characterization of promoter activities of four different Japanese flounder promoters in transgenic zebrafish.
Neoplasms
Characterization of Tear Immunoglobulins in a Small-Cohort of Keratoconus Patients.
Neoplasms
Characterizing the effect of substrate stiffness on the extravasation potential of breast cancer cells using a 3D microfluidic model.
Neoplasms
Chelerythrine suppresses proliferation and metastasis of human prostate cancer cells via modulating MMP/TIMP/NF-?B system.
Neoplasms
Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma.
Neoplasms
Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer.
Neoplasms
Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype.
Neoplasms
Chlorogenic Acid Decreases Malignant Characteristics of Hepatocellular Carcinoma Cells by Inhibiting DNMT1 Expression.
Neoplasms
Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines.
Neoplasms
Cholic Acid Stimulates MMP-9 in Human Colon Cancer Cells via Activation of MAPK, AP-1, and NF-?B Activity.
Neoplasms
Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
Neoplasms
Chronic cadmium exposure in vitro causes acquisition of multiple tumor cell characteristics in human pancreatic epithelial cells.
Neoplasms
Chronic Exposure of Renal Stem Cells to Inorganic Arsenic Induces a Cancer Phenotype.
Neoplasms
Chronic exposure to microcystin-LR increases the risk of prostate cancer and induces malignant transformation of human prostate epithelial cells.
Neoplasms
Chronic liver injury promotes hepatocarcinoma cell seeding and growth, associated with infiltration by macrophages.
Neoplasms
Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade.
Neoplasms
Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2.
Neoplasms
Chrysanthemum indicum ethanolic extract inhibits invasion of hepatocellular carcinoma via regulation of MMP/TIMP balance as therapeutic target.
Neoplasms
Chrysin inhibits tumor promoter-induced MMP-9 expression by blocking AP-1 via suppression of ERK and JNK pathways in gastric cancer cells.
Neoplasms
Chungtaejeon, a Korean Fermented Tea, Scavenges Oxidation and Inhibits Cytokine Induced Proliferation and Migration of Human Aortic Smooth Muscle Cells.
Neoplasms
Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery.
Neoplasms
Circulating gelatinases are not prognostic of treatment response and survival in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy.
Neoplasms
Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.
Neoplasms
Circulating tumor cells and serum levels of MMP-2, MMP-9 and VEGF as markers of the metastatic process in patients with high risk of metastatic progression.
Neoplasms
Cis-guggulsterone inhibits the IKK/NF-?B pathway, whereas trans-guggulsterone inhibits MAPK/AP-1 in MCF?7 breast cancer cells: guggulsterone regulates MMP?9 expression in an isomer-specific manner.
Neoplasms
cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.
Neoplasms
Clarification of the active gelatinolytic sites in human ovarian neoplasms using in situ zymography.
Neoplasms
Classical and Alternative Activation of Cyanobacterium Oscillatoria sp. Lipopolysaccharide-Treated Rat Microglia in vitro.
Neoplasms
Classical and Alternative Activation of Rat Microglia Treated with Ultrapure Porphyromonas gingivalis Lipopolysaccharide In Vitro.
Neoplasms
Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer.
Neoplasms
Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer.
Neoplasms
Clinical implications of angiogenic factors in patients with acute or chronic leukemia: Hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia.
Neoplasms
Clinical implications of proteolytic activity imbalance in breast cancer diagnosis.
Neoplasms
Clinical Significance and Roles in Angiogenesis of Circulating Microparticles in Oral Cancer.
Neoplasms
Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma.
Neoplasms
Clinical Significance of Circulating Osteopontin Levels in Patients With Lung Cancer and Correlation With VEGF and MMP-9.
Neoplasms
Clinical significance of levels of molecular biological markers in zones of invasive front-line of colorectal cancer.
Neoplasms
Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma.
Neoplasms
Clinical significance of plasma MMP-2 and MMP-9 levels as biomarkers for tumor expression in breast cancer patients in Egypt.
Neoplasms
Clinical Significance of Serum IL-12 Level in Patients with Early Breast Carcinoma and Its Correlation with Other Tumor Markers.
Neoplasms
Clinical significance of the content of biomolecular markers in invasive front of colon carcinomas.
Neoplasms
Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: metalloproteinase-9 as an independent prognostic factor.
Neoplasms
Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer.
Neoplasms
Clinical study of systemic chemotherapy combined with bronchoscopic interventional cryotherapy in the treatment of lung cancer.
Neoplasms
Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma.
Neoplasms
Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNF?-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase.
Neoplasms
Clinicohistopathological implications of MMP/VEGF expression in retinoblastoma: a combined meta-analysis and bioinformatics analysis.
Neoplasms
Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis.
Neoplasms
Clinicopathological analysis of invading muscularis propria (T2) cancers < or =20 mm in diameter.
Neoplasms
Clinicopathological characteristics, hormone receptor status and matrix metallo-proteinase-9 (MMP-9) immunohistochemical expression in spinal meningiomas.
Neoplasms
Clinicopathological correlation of keratinocyte growth factor and matrix metalloproteinase-9 expression in human gastric cancer.
Neoplasms
Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
Neoplasms
Clonorchis sinensis excretory-secretory products regulate migration and invasion in cholangiocarcinoma cells via extracellular signal-regulated kinase 1/2/nuclear factor-?B-dependent matrix metalloproteinase-9 expression.
Neoplasms
Clusterin induced by N,N'-Dinitrosopiperazine is involved in nasopharyngeal carcinoma metastasis.
Neoplasms
Clusterin induces matrix metalloproteinase-9 expression via ERK1/2 and PI3K/Akt/NF-{kappa}B pathways in monocytes/macrophages.
Neoplasms
Clusterin induces the secretion of TNF-? and the chemotactic migration of macrophages.
Neoplasms
Co-evolution of cancer microenvironment reveals distinctive patterns of gastric cancer invasion: laboratory evidence and clinical significance.
Neoplasms
Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion.
Neoplasms
Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells.
Neoplasms
Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma.
Neoplasms
Cold-inducible RNA-binding protein plays a central role in the pathogenesis of abdominal aortic aneurysm in a murine experimental model.
Neoplasms
Collagenase-1, stromelysin-1 and 92 kDa gelatinase are associated with tumor necrosis factor-alpha induced morphological change of human endothelial cells in vitro.
Neoplasms
Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer.
Neoplasms
Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells.
Neoplasms
Colorectal Cancer and Mitochondrial Dysfunctions of the Adjunct Adipose Tissues: A Case Study.
Neoplasms
Colorectal cancer detection by biomarker quantification in noninvasively collected colorectal mucus: preliminary comparison of 24 protein biomarkers.
Neoplasms
Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.
Neoplasms
Combination of Potassium Pentagamavunon-0 and Doxorubicin Induces Apoptosis and Cell Cycle Arrest and Inhibits Metastasis in Breast Cancer Cells.
Neoplasms
Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma.
Neoplasms
Combination therapy with tumor-lysate pulsed dendritic cells and antiangiogenic drug TNP-470 for mouse pancreatic cancer.
Neoplasms
Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix.
Neoplasms
Combined effect of substance P and curcumin on cutaneous wound healing in diabetic rats.
Neoplasms
Combined evaluation of matrix metalloproteinases and their inhibitors has better clinical utility in oral cancer.
Neoplasms
Combined PGE2 with TNF-? promotes laryngeal carcinoma progression by enhancing GRK2 and TRAF2 interaction.
Neoplasms
Comparative analysis of the expression of metalloproteases (MMP-2, MMP-9, MMP-11 and MMP-13) and the tissue inhibitor of metalloprotease 3 (TIMP-3) between previous negative biopsies and radical prostatectomies.
Neoplasms
Comparative analysis of the immunohistochemical expression of collagen IV, MMP-9, and TIMP-2 in odontogenic cysts and tumors.
Neoplasms
Comparative analysis of the immunohistochemical expression of vascular endothelial growth factor and matrix metalloproteinase-9 in keratocystic odontogenic tumor, dentigerous cyst and radicular cyst.
Neoplasms
Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines.
Neoplasms
Comparative effects of interferon-gamma and all- trans retinoic acid on secreted and surface-associated matrix metalloproteinase-9 expression of human monocytes.
Neoplasms
Comparative expression of matrix metalloproteinases in internal malignancies and paired cutaneous metastatic lesions.
Neoplasms
Comparative gene expression profiling of normal and degenerative discs: analysis of a rabbit annular laceration model.
Neoplasms
Comparative proteomics and molecular mechanical analysis in CDA-II induced therapy of LCI-D20 hepatocellular carcinoma model.
Neoplasms
Comparison of circulating MMP-9, TIMP-1 and CA19-9 in the detection of pancreatic cancer.
Neoplasms
Comparison of Early Changes in Ocular Surface and Inflammatory Mediators between Femtosecond Lenticule Extraction and Small-Incision Lenticule Extraction.
Neoplasms
Comparison of early changes in ocular surface markers and tear inflammatory mediators after femtosecond lenticule extraction and FS-LASIK.
Neoplasms
Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas.
Neoplasms
Comparison of the effect of ticagrelor combined with tirofiban versus clopidogrel combined with tirofiban on inflammation response and prognosis of patients with unstable angina pectoris in long term follow-up.
Neoplasms
Comparison of the levels of human herpesvirus 6 (HHV-6) DNA and cytokines in the cerebrospinal fluid and serum of children with HHV-6 encephalopathy.
Neoplasms
Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors.
Neoplasms
Compensatory Growth Factor and Cytokine Response in Tears After Subconjunctival Bevacizumab Injection.
Neoplasms
Composites of yeast glucan particles and curcumin lead to improvement of dextran sulfate sodium-induced acute bowel inflammation in rats.
Neoplasms
Concomitant consumption of lycopene and fish oil inhibits tumor growth and progression in a mouse xenograft model of colon cancer.
Neoplasms
Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model.
Neoplasms
Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
Neoplasms
Conjunctival expression of matrix metalloproteinase and pro-inflammatory cytokine genes following trichiasis surgery.
Neoplasms
Constitutive production of 92-kDa gelatinase B can be suppressed by alterations in cell shape.
Neoplasms
Constructing and Validating 3D-pharmacophore Models to a Set of MMP-9 Inhibitors for Designing Novel Anti-melanoma Agents.
Neoplasms
Construction and antitumor properties of a targeted nano-drug carrier system responsive to the tumor microenvironment.
Neoplasms
Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes.
Neoplasms
Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice.
Neoplasms
Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).
Neoplasms
Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Neoplasms
Converting a broad matrix metalloproteinase family inhibitor into a specific inhibitor of MMP-9 and MMP-14.
Neoplasms
Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness.
Neoplasms
Cooperative Treatment of Metastatic Breast Cancer Using Host-Guest Nanoplatform Coloaded with Docetaxel and siRNA.
Neoplasms
Coordinated targeting of MMP-2/MMP-9 by miR-296-3p/FOXCUT exerts tumor-suppressing effects in choroidal malignant melanoma.
Neoplasms
Coronin 3 promotes gastric cancer metastasis via the up-regulation of MMP-9 and cathepsin K.
Neoplasms
Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
Neoplasms
Correlation Between Placental Matrix Metalloproteinase 9 and Tumor Necrosis Factor-? Protein Expression Throughout Gestation in Normal Human Pregnancy.
Neoplasms
Correlation between serum biomarkers and BODE index in patients with stable COPD.
Neoplasms
Correlation Between the Expression of Matrix Metalloproteinase-9, Matrix Metalloproteinase-13, Tissue Inhibitor of Metalloproteinases-1, p16 and Differentiation of Head and Neck Squamous Cell Carcinoma: A Prospective Observational Study.
Neoplasms
Correlation between the progression of cancer and the expression of matrix metalloproteinase-9 in metastatic spinal tumor.
Neoplasms
Correlation of Clinical and Biomechanical Outcomes of Accelerated Crosslinking (9 mW/cm(2) in 10 minutes) in Keratoconus with Molecular Expression of Ectasia-Related Genes.
Neoplasms
Correlation of expression of Ki-67, EGFR, c-erbB-2, MMP-9, p53, bcl-2, CD34 and cell cycle analysis with survival in head and neck squamous cell cancer.
Neoplasms
Correlation of hypoxia as measured by fluorine-18 fluoroerythronitroimidazole (18F-FETNIM) PET/CT and overall survival in glioma patients.
Neoplasms
Correlation of matrix metalloproteinase-2, -9, tissue inhibitor-1 of matrix metalloproteinase and CD44 variant 6 in head and neck cancer metastasis.
Neoplasms
Correlation of matrix metalloproteinase-9 expression with morphometric analysis of mucosal vasculature in oral squamous cell carcinoma, oral epithelial dysplasia, and normal oral mucosa.
Neoplasms
Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Neoplasms
Correlation of matrix metalloproteinases-2 and -9 with proinflammatory cytokines in Guillain-Barré syndrome.
Neoplasms
Correlation of MMP-9 and p53 protein expression with prognosis in metastatic spinal tumor of lung cancer.
Neoplasms
Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer.
Neoplasms
Correlation of Serum Biomarkers in Adults with Single Ventricles with Strain and Strain Rate Using 2D Speckle Tracking.
Neoplasms
Correlation of survivin and MMP9 expressions with prognosis and clinicopathological parameters in surface epithelial ovarian carcinomas.
Neoplasms
Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma.
Neoplasms
Correlation of TNFAIP8 overexpression with the proliferation, metastasis, and disease-free survival in endometrial cancer.
Neoplasms
Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
Neoplasms
Correlation of Vascular Endothelial Growth Factor Expression With Tumor Recurrence and Poor Prognosis in Patients With pN0 Gastric Cancer.
Neoplasms
Correlations of mouse lymphoma xenografts with the expressions of MMP-9 and Bcl-2.
Neoplasms
Correlative studies on bFGF mRNA and MMP-9 mRNA expressions with microvascular density, progression, and prognosis of gastric carcinomas.
Neoplasms
Corrigendum to "Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor" [Gene 711 (2019) 143952].
Neoplasms
Corrigendum to "Yokukansan Alleviates Cancer Pain by Suppressing Matrix Metalloproteinase-9 in a Mouse Bone Metastasis Model".
Neoplasms
Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.
Neoplasms
Corydalis hendersonii Hemsl. protects against myocardial injury by attenuating inflammation and fibrosis via NF-?B and JAK2-STAT3 signaling pathways.
Neoplasms
Cox-2 expression, PGE(2) and cytokines production are inhibited by endogenously synthesized n-3 PUFAs in inflamed colon of fat-1 mice.
Neoplasms
COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung. A study of 117 patients from Brazil.
Neoplasms
Cratoxy formosum leaf extract inhibits proliferation and migration of human breast cancer MCF-7 cells.
Neoplasms
Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis.
Neoplasms
Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation.
Neoplasms
CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Neoplasms
Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice.
Neoplasms
Cryptotanshinone from Salvia miltiorrhiza BUNGE has an inhibitory effect on TNF-alpha-induced matrix metalloproteinase-9 production and HASMC migration via down-regulated NF-kappaB and AP-1.
Neoplasms
Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity.
Neoplasms
CSF lipocalin-2 increases early in subarachnoid hemorrhage are associated with neuroinflammation and unfavorable outcome.
Neoplasms
Curcumin arrests endometriosis by downregulation of matrix metalloproteinase-9 activity.
Neoplasms
Curcumin Inhibits Carcinogen and Nicotine-induced Mammalian Target of Rapamycin Pathway Activation in Head and Neck Squamous Cell Carcinoma.
Neoplasms
Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells.
Neoplasms
Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer.
Neoplasms
Curcumin prevents human aortic smooth muscle cells migration by inhibiting of MMP-9 expression.
Neoplasms
Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis.
Neoplasms
Curcumin suppresses the TPA-induced invasion through inhibition of PKC?-dependent MMP-expression in MCF-7 human breast cancer cells.
Neoplasms
Curcumin targets fibroblast-tumor cell interactions in oral squamous cell carcinoma.
Neoplasms
Curcumin-targeting Pericellular Serine Protease Matriptase Role in Suppression of Prostate Cancer Cell Invasion, Tumor Growth and Metastasis.
Neoplasms
Curcumol inhibits lung adenocarcinoma growth and metastasis via inactivation of PI3K/AKT and Wnt/ß-catenin pathway.
Neoplasms
Cutaneous adverse drug reaction in patients with epilepsy after acute encephalitis.
Neoplasms
Cutaneous wound healing of chronically stressed mice is improved through catecholamines blockade.
Neoplasms
CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Neoplasms
CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone.
Neoplasms
CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation.
Neoplasms
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Neoplasms
CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.
Neoplasms
Cyanobacterial Microcystis aeruginosa lipopolysaccharide elicits release of superoxide anion, thromboxane B2, cytokines, chemokines, and matrix metalloproteinase-9 by rat microglia.
Neoplasms
Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells.
Neoplasms
Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9.
Neoplasms
Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha.
Neoplasms
Cypermethrin Induces the Activation of Rat Primary Microglia and Expression of Inflammatory Proteins.
Neoplasms
Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood-brain barrier.
Neoplasms
Cysteinyl leukotrienes enhance tumour necrosis factor-alpha-induced matrix metalloproteinase-9 in human monocytes/macrophages.
Neoplasms
Cytochrome P450 ?-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.
Neoplasms
Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
Neoplasms
Cytokine and matrix metalloproteinase expression in pigmented villonodular synovitis may mediate bone and cartilage destruction.
Neoplasms
Cytokine inducible matrix metalloproteinase expression in immortalized rat chondrocytes is independent of nitric oxide stimulation.
Neoplasms
Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts.
Neoplasms
Cytokines, inducers and inhibitors modulate MMP-2 and MMP?9 secretion by human Fanconi anemia immortalized fibroblasts.
Neoplasms
Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients.
Neoplasms
Cytotoxic Fusicoccane-Type Diterpenoids from Streptomyces violascens Isolated from Ailuropoda melanoleuca Feces.
Neoplasms
DAPT suppresses proliferation and migration of hepatocellular carcinoma by regulating the extracellular matrix and inhibiting the Hes1/PTEN/AKT/mTOR signaling pathway.
Neoplasms
DC-SIGN and Toll-like receptor 4 mediate oxidized low-density lipoprotein-induced inflammatory responses in macrophages.
Neoplasms
DDR1 may play a key role in destruction of the blood-brain barrier after cerebral ischemia-reperfusion.
Neoplasms
Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad.
Neoplasms
Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma.
Neoplasms
Decreased CUL4B expression inhibits malignant proliferation of glioma in vitro and in vivo.
Neoplasms
Decreased expression of protein tyrosine kinase 6 contributes to tumor progression and metastasis in laryngeal squamous cell carcinoma.
Neoplasms
Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events.
Neoplasms
Decursin prevents TPA-induced invasion through suppression of PKC?/p38/NF-?B-dependent MMP-9 expression in MCF-7 human breast carcinoma cells.
Neoplasms
Deferoxamine modulates cytokines and growth factors to accelerate cutaneous wound healing in diabetic rats.
Neoplasms
Deficiency of interleukin-1 receptor antagonist promotes spontaneous femoral artery aneurysm formation in mice.
Neoplasms
Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models.
Neoplasms
Deguelin targets multiple oncogenic signaling pathways to combat human malignancies.
Neoplasms
Deletion of peroxiredoxin 6 is protective in lipopolysaccharide-induced acute lung injury in mice*
Neoplasms
Delivering minocycline into brain endothelial cells with liposome-based technology.
Neoplasms
Delphinidin suppresses PMA-induced MMP-9 expression by blocking the NF-?B activation through MAPK signaling pathways in MCF-7 human breast carcinoma cells.
Neoplasms
Delta-tocotrienol inhibits non-small-cell lung cancer cell invasion via the inhibition of NF-?B, uPA activator, and MMP-9.
Neoplasms
Density-dependent induction of 92-kd type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells.
Neoplasms
Deoxyelephantopin, a novel multifunctional agent, suppresses mammary tumour growth and lung metastasis and doubles survival time in mice.
Neoplasms
Deoxypodophyllotoxin, flavolignan, from Anthriscus sylvestris Hoffm. inhibits migration and MMP-9 via MAPK pathways in TNF-alpha-induced HASMC.
Neoplasms
Depletion of cell surface CD44 in nonmelanoma skin tumours is associated with increased expression of matrix metalloproteinase 7.
Neoplasms
Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).
Neoplasms
Derlin-1 Is Overexpressed in Non-Small Cell Lung Cancer and Promotes Cancer Cell Invasion via EGFR-ERK-Mediated Up-Regulation of MMP-2 and MMP-9.
Neoplasms
Des-?-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway.
Neoplasms
Design of radiolabeled gelatinase inhibitor peptide ((99m)Tc-CLP) and evaluation in rats.
Neoplasms
Design, synthesis and biological evaluation of N-anthraniloyl tryptamine derivatives as pleiotropic molecules for the therapy of malignant glioma.
Neoplasms
Detection and Molecular Staging of Bladder Cancer Using Real-Time RT-PCR for Gelatinases (MMP-2, MMP-9) and TIMP-2 in Peripheral Blood.
Neoplasms
Detection of matrix metalloproteinases in canine mammary tumours: analysis by immunohistochemistry and zymography.
Neoplasms
Detection of MMP-2 and MMP-9 Activity in Vivo with a Triple-Helical Peptide Optical Probe.
Neoplasms
Detection of serum VEGF and MMP-9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma.
Neoplasms
Determination of imbalance between MMP-2 and TIMP-2 in human neuroblastoma by reverse-transcription polymerase chain reaction and its correlation with tumor progression.
Neoplasms
Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment.
Neoplasms
Determining the levels of matrix metalloproteinase-9 in portal and peripheral blood is useful for predicting liver metastasis of colorectal cancer.
Neoplasms
Development of an ex vivo cellular model of rheumatoid arthritis: critical role of CD14-positive monocyte/macrophages in the development of pannus tissue.
Neoplasms
Development of Postoperative Pain in Patients with End-Stage Knee Osteoarthritis Is Associated with Upregulation of Genes Related to Extracellular Matrix Degradation, Inflammation, and Apoptosis Measured in the Peripheral Blood before Knee Surgery.
Neoplasms
Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium.
Neoplasms
Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum.
Neoplasms
Diagnostic and prognostic ability of salivary MMP-9 for oral squamous cell carcinoma: A pre-/post-surgery case and matched control study.
Neoplasms
Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
Neoplasms
Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia.
Neoplasms
Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue.
Neoplasms
Different patterns of expression of cell cycle control and local invasion-related proteins in oral squamous cell carcinoma affecting young patients.
Neoplasms
Different patterns of gelatinolytic activity in pituitary macro- and microadenomas.
Neoplasms
Differential effect of p47phox and gp91phox deficiency on the course of Pneumococcal Meningitis.
Neoplasms
Differential effects of corticosteroids on the expression of cyclooxygenase-2, tumour necrosis factor-alpha and matrix metalloproteinase-9 in an animal model of migraine.
Neoplasms
Differential Effects of Domoic Acid and E. coli Lipopolysaccharide on Tumor Necrosis Factor-alpha, Transforming Growth Factor-beta1 and Matrix Metalloproteinase-9 Release by Rat Neonatal Microglia: Evaluation of the Direct Activation Hypothesis.
Neoplasms
Differential effects of estradiol on carotid artery inflammation when administered early versus late after surgical menopause.
Neoplasms
Differential effects of luteolin and its glycosides on invasion and apoptosis in MDA-MB-231 triple-negative breast cancer cells.
Neoplasms
Differential expression and activity status of MMP-1, MMP-2 and MMP-9 in tumor and stromal cells of squamous cell carcinomas of the lung.
Neoplasms
Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs.
Neoplasms
Differential expression of extracellular matrix-related genes in rare variants of meningioma.
Neoplasms
Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions.
Neoplasms
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
Neoplasms
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
Neoplasms
Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.
Neoplasms
Differential expression of matrix metalloproteinases 2 and 9 by glial Müller cells: response to soluble and extracellular matrix-bound tumor necrosis factor-alpha.
Neoplasms
Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder.
Neoplasms
Differential gene expression in human abdominal aorta: aneurysmal versus occlusive disease.
Neoplasms
Differential gene expression in pristane-induced arthritis susceptible DA versus resistant E3 rats.
Neoplasms
Differential inductions of matrix metalloproteinase-2 and -9 in host tissues during the growth of ascitic sarcoma 180 cells in mice.
Neoplasms
Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study.
Neoplasms
Differential inhibition of gelatinase activity in human colon adenocarcinoma cells by Aloe vera and Aloe arborescens extracts.
Neoplasms
Differential modulatory effects of clarithromycin on the production of cytokines by a tumor.
Neoplasms
Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
Neoplasms
Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: relevance to inflammation in rheumatoid arthritis.
Neoplasms
Differential regulation of MMP-9 and TIMP-2 expression in malignant melanoma developed in metallothionein/RET transgenic mice.
Neoplasms
Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated locoregionally at a single institution.
Neoplasms
Dihydroartemisinin Prevents Distant Metastasis of Laryngeal Carcinoma by Inactivating STAT3 in Cancer Stem Cells.
Neoplasms
Diosgenin ameliorates cellular and molecular changes in multiple sclerosis in C57BL/6 mice.
Neoplasms
Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours.
Neoplasms
Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells.
Neoplasms
Discovery of the possible mechanisms in kouyanqing granule for treatment of oral ulcers based on network pharmacology.
Neoplasms
Disease- and cell-type-specific transcriptional targeting of vectors for osteoarthritis gene therapy: further development of a clinical canine model.
Neoplasms
Disruption of Nrf2 enhances the upregulation of nuclear factor-kappab activity, tumor necrosis factor-?, and matrix metalloproteinase-9 after spinal cord injury in mice.
Neoplasms
Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis.
Neoplasms
Disseminated tumor cells in bone marrow of gastric cancer patients: correlation with tumor hypoxia and clinical relevance.
Neoplasms
Dissociation of the Inflammatory Reaction following PCI for Acute Myocardial Infarction.
Neoplasms
Distinct endobronchial expression of matrix-metalloproteinases (MMP) and their endogenous inhibitors in lung cancer.
Neoplasms
Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors.
Neoplasms
Distinct Functionality of Tumor Cell-Derived Gelatinases during Formation of Liver Metastases.
Neoplasms
Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.
Neoplasms
Distinct patterns of matrix metalloproteinase-2 and -9 expression in normal human cell lines.
Neoplasms
Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion.
Neoplasms
Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma.
Neoplasms
Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression.
Neoplasms
Dithiolethiones inhibit NF-?B activity via covalent modification in human estrogen receptor-negative breast cancer.
Neoplasms
Diuretic response to cyclophosphamide in rats bearing a matrix metalloproteinase-9-producing tumour.
Neoplasms
Divergent regulation of 92-kDa gelatinase and TIMP-1 by HBECs in response to IL-1beta and TNF-alpha.
Neoplasms
Diverse role of MMP-2 and MMP-9 in the clinicopathological behavior of Hodgkin's lymphoma.
Neoplasms
DN-R175H p53 mutation is more effective than p53 interference in inducing epithelial disorganization and activation of proliferation signals in human carcinoma cells: role of E-cadherin.
Neoplasms
DNA ploidy analysis and expression of MMP-9, TIMP-2, and E-cadherin in gastric carcinoma.
Neoplasms
Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells.
Neoplasms
Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes.
Neoplasms
Double-Stranded RNA Induces MMP-9 Gene Expression in HaCaT Keratinocytes by Tumor Necrosis Factor-?
Neoplasms
Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis.
Neoplasms
Down-regulation of Gab1 inhibits cell proliferation and migration in hilar cholangiocarcinoma.
Neoplasms
Down-regulation of long non-coding RNA HOTAIR inhibits invasion and migration of oesophageal cancer cells via up-regulation of microRNA-204.
Neoplasms
Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells.
Neoplasms
Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
Neoplasms
Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an anti-metastatic ruthenium complex.
Neoplasms
Down-regulation of uPA and uPAR by 3,3'-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells.
Neoplasms
Downregulation of angiogenic factors in Ewing tumor xenografts by the combination of human interferon-alpha or interferon-beta with ifosfamide.
Neoplasms
Downregulation of FOXP3 inhibits invasion and immune escape in cholangiocarcinoma.
Neoplasms
Downregulation of G3BPs inhibits the growth, migration and invasion of human lung carcinoma H1299 cells by suppressing the Src/FAK-associated signaling pathway.
Neoplasms
Downregulation of inflammatory mediators and pro-inflammatory cytokines by alkaloids of Jeevaneeya rasayana in adjuvant-induced arthritis.
Neoplasms
Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis.
Neoplasms
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer.
Neoplasms
Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.
Neoplasms
Downregulation of PART1 Inhibits Proliferation and Differentiation of Hep3B Cells by Targeting hsa-miR-3529-3p/FOXC2 Axis.
Neoplasms
Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2.
Neoplasms
Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer.
Neoplasms
Downregulation of the GnT-V gene inhibits metastasis and invasion of BGC823 gastric cancer cells.
Neoplasms
Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
Neoplasms
Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth.
Neoplasms
Downregulations of AKT/mTOR Signaling Pathway for Salmonella-Mediated Suppression of Matrix Metalloproteinases-9 Expression in Mouse Tumor Models.
Neoplasms
Ds-echinoside A, a new triterpene glycoside derived from sea cucumber, exhibits antimetastatic activity via the inhibition of NF-?B-dependent MMP-9 and VEGF expressions.
Neoplasms
Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
Neoplasms
Dual ATP/reduction-responsive polyplex to achieve the co-delivery of doxorubicin and miR-23b for the cancer treatment.
Neoplasms
Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
Neoplasms
Dual Enzymatic Reaction-Assisted Gemcitabine Delivery Systems for Programmed Pancreatic Cancer Therapy.
Neoplasms
Dulcitol suppresses proliferation and migration of hepatocellular carcinoma via regulating SIRT1/p53 pathway.
Neoplasms
Dynamic changes of innate lymphoid cells in acute ST-segment elevation myocardial infarction and its association with clinical outcomes.
Neoplasms
E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: Analysis of 125 patients.
Neoplasms
Early changes in the apparent diffusion coefficient and MMP-9 expression of a cervical carcinoma U14 allograft model following irradiation.
Neoplasms
Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats.
Neoplasms
Early laminar events involving endothelial activation in horses with black walnut- induced laminitis.
Neoplasms
Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection.
Neoplasms
Editorial: pro-matrix metalloproteinase-9 in tumor B lymphocytes: balancing migration and homing.
Neoplasms
Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.
Neoplasms
Effect of a short-term in vitro exposure to the marine toxin domoic acid on viability, tumor necrosis factor-alpha, matrix metalloproteinase-9 and superoxide anion release by rat neonatal microglia.
Neoplasms
Effect of an antimicrobial agent on atherosclerotic plaques: assessment of metalloproteinase activity by molecular imaging.
Neoplasms
Effect of arginine on angiogenesis induced by human colon cancer: in vitro and in vivo studies.
Neoplasms
Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia.
Neoplasms
Effect of Conjugated Linoleic Acid Supplementation on Inflammatory Factors and Matrix Metalloproteinase Enzymes in Rectal Cancer Patients Undergoing Chemoradiotherapy.
Neoplasms
Effect of continuous traditional Chinese medicine nursing on patients with coronary heart disease.
Neoplasms
Effect of curcumin on permeability of coronary artery and expression of related proteins in rat coronary atherosclerosis heart disease model.
Neoplasms
Effect of Cyclic Stretch on Vascular Endothelial Cells and Abdominal Aortic Aneurysm (AAA): Role in the Inflammatory Response.
Neoplasms
Effect of cyclosporin A intervention on the immunological mechanisms of coronary heart disease and restenosis.
Neoplasms
Effect of Dexamethasone Administered With Magnesium Sulfate on Inflammation-Mediated Degradation of the Blood-Brain Barrier Using an In Vitro Model.
Neoplasms
Effect of ethanol extract from Lactobacillus plantarum TWK10-fermented soymilk on wound healing in streptozotocin-induced diabetic rat.
Neoplasms
Effect of folic acid combined with pravastatin on arteriosclerosis in elderly hypertensive patients with lacunar infarction.
Neoplasms
Effect of hGC-MSCs from human gastric cancer tissue on cell proliferation, invasion and epithelial-mesenchymal transition in tumor tissue of gastric cancer tumor-bearing mice.
Neoplasms
Effect of isofebrifugine on the proliferation and invasion of human gastric cancer cells via MMP.
Neoplasms
Effect of lentivirus-mediated integrin ?V?3-shRNA on tumor growth of mice with lung cancer xenografts.
Neoplasms
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Neoplasms
Effect of proinflammatory cytokines, tumor necrosis factor-alpha and interferon-gamma on epithelial barrier function and matrix metalloproteinase-9 in Madin Darby canine kidney cells.
Neoplasms
Effect of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cells.
Neoplasms
Effect of resveratrol on the metastasis of 4T1 mouse breast cancer cells in vitro and in vivo.
Neoplasms
Effect of Rosemarinus officinalis L. on MMP-9, MCP-1 Levels, and Cell Migration in RAW 264.7 and Smooth Muscle Cells.
Neoplasms
Effect of selective small molecule inhibitors on MMP-9 and VEGFR-1 expression in p16-positive and -negative squamous cell carcinoma.
Neoplasms
Effect of smoking cessation on chronic waterpipe smoke inhalation-induced airway hyperresponsiveness, inflammation, and oxidative stress.
Neoplasms
Effect of sodium butyrate on pro-matrix metalloproteinase-9 and -2 differential secretion in pediatric tumors and cell lines.
Neoplasms
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD.
Neoplasms
Effect of typhaneoside on ventricular remodeling and regulation of PI3K/Akt/mTOR pathway.
Neoplasms
Effect of verbascoside on apoptosis and metastasis in human oral squamous cell carcinoma.
Neoplasms
Effect of weight loss on proinflammatory state of mononuclear cells in obese women.
Neoplasms
Effects and Mechanism of Noninvasive Positive-Pressure Ventilation in a Rat Model of Heart Failure Due to Myocardial Infarction.
Neoplasms
Effects of 9cis,11trans and 10trans,12cis CLA on osteoclast formation and activity from human CD14+ monocytes.
Neoplasms
Effects of a High-Fat or High-Sucrose Diet on Ultraviolet B Irradiation-Induced Carcinogenesis and Tumor Growth in Melanin-Possessing Hairless Mice.
Neoplasms
Effects of Ad-p27mt gene transfer on the expression of Bax, Bcl-2, VEGF and MMP-9 in the transplanted liver tumors in nude mice.
Neoplasms
Effects of All-Trans Retinoic Acid on Lipopolysaccharide-Induced Synovial Explant.
Neoplasms
Effects of atorvastatin on plasma matrix metalloproteinase-9 concentration after glial tumor resection; a randomized, double blind, placebo controlled trial.
Neoplasms
Effects of chlorella on activities of protein tyrosine phosphatases, matrix metalloproteinases, caspases, cytokine release, B and T cell proliferations, and phorbol ester receptor binding.
Neoplasms
Effects of Chronic Intractable Insomnia on Inflammatory Cytokines, Blood Pressure Characteristics, and Antihypertensive Efficacy in Hypertensive Patients.
Neoplasms
Effects of DNMT and MEK inhibitors on the expression of RECK, MMP-9, -2, uPA and VEGF in response to arsenite stimulation in human uroepithelial cells.
Neoplasms
Effects of Edaravone, a Free Radical Scavenger, on Serum Levels of Inflammatory Biomarkers in Acute Brain Infarction.
Neoplasms
Effects of genistein and 2-methoxyestradiol on matrix metalloproteinases and their inhibitors secreted by Ehrlich ascites tumor cells.
Neoplasms
Effects of HMGA2 siRNA and doxorubicin dual delivery by chitosan nanoparticles on cytotoxicity and gene expression of HT-29 colorectal cancer cell line.
Neoplasms
Effects of lamivudine on cell proliferation of liver cancer and expressions of HBsAg, HBeAg, and MMP-9 in patients.
Neoplasms
Effects of linoleic acid and gamma-linolenic acid on the growth and metastasis of a human breast cancer cell line in nude mice and on its growth and invasive capacity in vitro.
Neoplasms
Effects of LY294002 on the invasiveness of human gastric cancer in vivo in nude mice.
Neoplasms
Effects of magnetic induction hyperthermia and radiotherapy alone or combined on a murine 4T1 metastatic breast cancer model.
Neoplasms
Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCI-D20.
Neoplasms
Effects of micro-amounts of Porphyromonas gingivalis lipopolysaccharide on rabbit inflammatory immune response and development of atherosclerosis.
Neoplasms
Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis.
Neoplasms
Effects of nutrients on matrix metalloproteinases in human T-lymphotropic virus type 1 positive and negative malignant T-lymphocytes.
Neoplasms
Effects of rambutan (Nephelium lappaceum) peel phenolics and Leu-Ser-Gly-Tyr-Gly-Pro on hairless mice skin photoaging induced by ultraviolet irradiation.
Neoplasms
Effects of the beta-amyloid and carboxyl-terminal fragment of Alzheimer's amyloid precursor protein on the production of the tumor necrosis factor-alpha and matrix metalloproteinase-9 by human monocytic THP-1.
Neoplasms
Effects of the Tight Junction Protein CLDN6 on Cell Migration and Invasion in High-Grade Meningioma.
Neoplasms
Effects of tumor necrosis factor-alpha and interferon-gamma on expressions of matrix metalloproteinase-2 and -9 in human bladder cancer cells.
Neoplasms
Effects of ulinastatin and cyclophosphamide on the growth of xenograft breast cancer and expression of CXC chemokine receptor 4 and matrix metalloproteinase-9 in cancers.
Neoplasms
Effects of various treatment approaches for treatment efficacy for late stage breast cancer and expression level of TIMP-1 and MMP-9.
Neoplasms
Effects of xuelian injection on cerebral TNF-?, IL-1? and MMP-9 in rats experienced focal cerebral ischemia/reperfusion.
Neoplasms
Efficacy of autologous platelet-rich plasma gel in the treatment of refractory pressure injuries and its effect on wound healing time and patient quality of life.
Neoplasms
EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells.
Neoplasms
EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-?B and MMP-9.
Neoplasms
EGCG inhibited bladder cancer T24 and 5637 cell proliferation and migration via PI3K/AKT pathway.
Neoplasms
EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.
Neoplasms
EGF stimulates glioblastoma metastasis by induction of matrix metalloproteinase-9 in an EGFR-dependent mechanism.
Neoplasms
EGFR regulates the development and microarchitecture of intratumoral angiogenic vasculature capable of sustaining cancer cell intravasation.
Neoplasms
Electrical dual-sensing method for real-time quantitative monitoring of cell-secreted MMP-9 and cellular morphology during migration process.
Neoplasms
Electroacupuncture preconditioning and postconditioning inhibit apoptosis and neuroinflammation induced by spinal cord ischemia reperfusion injury through enhancing autophagy in rats.
Neoplasms
Electrochemical immunoplatform to assist in the diagnosis and classification of breast cancer through the determination of matrix-metalloproteinase-9.
Neoplasms
Elevated AEG-1 expression in macrophages promotes hypopharyngeal cancer invasion through the STAT3-MMP-9 signaling pathway.
Neoplasms
Elevated expression levels of androgen receptors and matrix metalloproteinase-2 and -9 in 30 cases of hepatocellular carcinoma compared with adjacent tissues as predictors of cancer invasion and staging.
Neoplasms
Elevated expression of matrix metalloproteinase-9 is associated with bladder cancer pathogenesis.
Neoplasms
Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer.
Neoplasms
Elevated levels of angiostatin in effusions from patients with malignant disease.
Neoplasms
Elevated levels of circulating matrix metalloproteinase-9 in non-small cell lung cancer patients.
Neoplasms
Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients.
Neoplasms
Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer.
Neoplasms
Elevated levels of serum metalloproteinase 9 in patients with esophageal squamous cell carcinoma.
Neoplasms
Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma.
Neoplasms
Elevated Matrix Metalloproteinase-9 Expression Correlates With Advanced Stages of Oral Cancer and Is Linked to Poor Clinical Outcomes.
Neoplasms
Elevated matrix metalloproteinase-9 expression may contribute to the pathogenesis of bladder cancer.
Neoplasms
Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
Neoplasms
Elevated Serum and Cerebrospinal Fluid CD138 in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.
Neoplasms
Elevated serum levels of human matrix metalloproteinase-9 (MMP-9) during the induction of peripheral blood stem cell mobilization by granulocyte colony-stimulating factor (G-CSF).
Neoplasms
Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients.
Neoplasms
Elevated serum matrix metalloproteinase 9 concentration predicts the presence of colorectal neoplasia in symptomatic patients.
Neoplasms
Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction.
Neoplasms
Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals.
Neoplasms
EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
Neoplasms
EMMPRIN contributes to the in vitro invasion of human salivary adenoid cystic carcinoma cells.
Neoplasms
EMMPRIN silencing inhibits proliferation and perineural invasion of human salivary adenoid cystic carcinoma cells in vitro and in vivo.
Neoplasms
Emodin inhibits tumor necrosis factor-?-induced migration and inflammatory responses in rat aortic smooth muscle cells.
Neoplasms
Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9.
Neoplasms
Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions.
Neoplasms
Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease.
Neoplasms
Endothelial cell culture of intramuscular venous malformation and its invasive behavior related to matrix metalloproteinase-9.
Neoplasms
Endothelial Progenitor Cells Attenuate Ventilator-Induced Lung Injury with Large-Volume Ventilation.
Neoplasms
Endothelial TRPV4 channels prevent tumor growth and metastasis via modulation of tumor angiogenesis and vascular integrity.
Neoplasms
Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats.
Neoplasms
Endurance Training Depletes Antioxidant System but Does Not Affect Endothelial Functions in Women with Abdominal Obesity: A Randomized Trial with a Comparison to Endurance-Strength Training.
Neoplasms
Engineered hypoxia-responding Escherichia coli carrying cardiac peptide genes, suppresses tumor growth, angiogenesis and metastasis in vivo.
Neoplasms
Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis.
Neoplasms
Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential.
Neoplasms
Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.
Neoplasms
Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases.
Neoplasms
Enhanced production of matrix metalloproteinase-2 in human head and neck carcinomas is correlated with lymph node metastasis.
Neoplasms
Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
Neoplasms
Enhanced stability and efficacy of GEM-TOS prodrug by co-assembly with antimetastatic shell LMWH-TOS.
Neoplasms
Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers.
Neoplasms
Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor.
Neoplasms
Enzyme-responsive multifunctional peptide coating of gold nanorods improves tumor targeting and photothermal therapy efficacy.
Neoplasms
Epidermal growth factor receptor-mediated regulation of matrix metalloproteinase-2 and matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Neoplasms
Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells.
Neoplasms
Epidermal growth factor stimulates matrix metalloproteinase-9 expression and invasion in human follicular thyroid carcinoma cells through Focal adhesion kinase.
Neoplasms
Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis via up-regulation of fibronectin.
Neoplasms
Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
Neoplasms
Epigallocatechin-3 Gallate Inhibits Invasion, Epithelial-Mesenchymal Transition, and Tumor Growth in Oral Cancer Cells.
Neoplasms
Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor ?5?1 in the process.
Neoplasms
Epigallocatechin-3-gallate inhibits photocarcinogenesis through inhibition of angiogenic factors and activation of CD8+ T cells in tumors.
Neoplasms
Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
Neoplasms
Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation.
Neoplasms
Epigenetic DNA-methylation regulation of genes coding for lipid raft-associated components: a role for raft proteins in cell transformation and cancer progression (review).
Neoplasms
Epimedium koreanum Nakai inhibits PMA-induced cancer cell migration and invasion by modulating NF-?B/MMP-9 signaling in monomorphic malignant human glioma cells.
Neoplasms
Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis.
Neoplasms
Epithelial carcinogenesis: dynamic interplay between neoplastic cells and their microenvironment.
Neoplasms
Epithelial cells up-regulate matrix metalloproteinases in cells within the same mammary carcinoma that have undergone an epithelial-mesenchymal transition.
Neoplasms
Epithelial lining fluid neutrophil-gelatinase-associated lipocalin levels in premature newborns with bronchopulmonary dysplasia and patency of ductus arteriosus.
Neoplasms
Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.
Neoplasms
Epstein-Barr virus Rta promotes invasion of bystander tumor cells through paracrine of matrix metalloproteinase 9.
Neoplasms
ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway.
Neoplasms
Erythropoietin attenuates ischemia-reperfusion induced lung injury by inhibiting tumor necrosis factor-alpha and matrix metalloproteinase-9 expression.
Neoplasms
Escherichia coli lipopolysaccharide potentiation and inhibition of rat neonatal microglia superoxide anion generation: correlation with prior lactic dehydrogenase, nitric oxide, tumor necrosis factor-alpha, thromboxane B2, and metalloprotease release.
Neoplasms
Esculentoside H inhibits colon cancer cell migration and growth through suppression of MMP-9 gene expression via NF-kB signaling pathway.
Neoplasms
ESM-1 Overexpression is Involved in Increased Tumorigenesis of Radiotherapy-Resistant Breast Cancer Cells.
Neoplasms
Essential oils purified from Schisandrae semen inhibits tumor necrosis factor-¿-induced matrix metalloproteinase-9 activation and migration of human aortic smooth muscle cells.
Neoplasms
Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells.
Neoplasms
Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo.
Neoplasms
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells.
Neoplasms
Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-alpha-308GG genotype.
Neoplasms
Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt-NF-?B signaling.
Neoplasms
Euodia pasteuriana Methanol Extract Exerts Anti-Inflammatory Effects by Targeting TAK1 in the AP-1 Signaling Pathway.
Neoplasms
Evaluation of a Schiff base copper complex compound as potent anticancer molecule with multiple targets of action.
Neoplasms
Evaluation of a Sesquiterpene as Possible Drug Lead Against Gelatinases via Molecular Dynamics Simulations.
Neoplasms
Evaluation of Local Injection of Bevacizumab against Triple-Negative Breast Cancer Xenograft Tumors.
Neoplasms
Evaluation of matrix metalloproteinase type IV-collagenases in serum of patients with tumors of the central nervous system.
Neoplasms
Evaluation of matrix metalloproteinases (MMP)-2 and MMP-9 activity in serum and biochemical and hematological parameters in spontaneous canine cutaneous tumors before and after surgical treatment.
Neoplasms
Evaluation of MMP-1, MMP-8, MMP-9 serum levels in patients with adrenal tumors prior to and after surgery.
Neoplasms
Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in sera and urine of patients with kidney tumors.
Neoplasms
Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination.
Neoplasms
Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population.
Neoplasms
Evaluation of the antitumor activity of platinum nanoparticles in the treatment of hepatocellular carcinoma induced in rats.
Neoplasms
Evaluation of the post-treatment anti-inflammatory capacity of osteoarthritic chondrocytes: An in vitro study using baicalein.
Neoplasms
Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer.
Neoplasms
Evaluation on biological compatibility of carboxymethyl chitosan as biomaterials for antitumor drug delivery.
Neoplasms
Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression.
Neoplasms
Evidence of an immunosuppressive effect of progesterone upon in vitro secretion of proinflammatory and prodegradative factors in a model of choriodecidual infection.
Neoplasms
Evidence that blood-CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen.
Neoplasms
Ex Vivo and In Vivo Imaging and Biodistribution of Aptamers Targeting the Human Matrix MetalloProtease-9 in Melanomas.
Neoplasms
Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma.
Neoplasms
Exercise pre-conditioning reduces brain inflammation in stroke via tumor necrosis factor-alpha, extracellular signal-regulated kinase 1/2 and matrix metalloproteinase-9 activity.
Neoplasms
Exogenous heat shock cognate protein 70 pretreatment attenuates cardiac and hepatic dysfunction with associated anti-inflammatory responses in experimental septic shock.
Neoplasms
Exosomes Derived from miR-143-Overexpressing MSCs Inhibit Cell Migration and Invasion in Human Prostate Cancer by Downregulating TFF3.
Neoplasms
Exosomes of Mesenchymal Stem Cells as a Proper Vehicle for Transfecting miR-145 into the Breast Cancer Cell Line and Its Effect on Metastasis.
Neoplasms
Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model.
Neoplasms
Exploring the action of RGDV-gemcitabine on tumor metastasis, tumor growth and possible action pathway.
Neoplasms
Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors.
Neoplasms
Exposure to environmental concentrations of hexachlorobenzene induces alterations associated with endometriosis progression in a rat model.
Neoplasms
Expression Analysis of the Mediators of Epithelial to Mesenchymal Transition and Early Risk Assessment of Therapeutic Failure in Laryngeal Carcinoma.
Neoplasms
Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients.
Neoplasms
Expression and biological relationship of vascular endothelial growth factor-a and matrix metalloproteinase-9 in gastric carcinoma.
Neoplasms
Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer.
Neoplasms
Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
Neoplasms
Expression and clinical significance of matrix metalloproteinase-9 in lymphatic invasiveness and metastasis of breast cancer.
Neoplasms
Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma.
Neoplasms
Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer.
Neoplasms
Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
Neoplasms
Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas.
Neoplasms
Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas.
Neoplasms
Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors.
Neoplasms
Expression and the molecular forms of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase 9 in canine mammary tumours.
Neoplasms
Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression.
Neoplasms
Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.
Neoplasms
Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma.
Neoplasms
Expression of 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma.
Neoplasms
Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumors.
Neoplasms
Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors.
Neoplasms
Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis.
Neoplasms
Expression of Cytokeratin Subtypes: MMP-9, p53, and ?SMA to Differentiate Basaloid Squamous Cell Carcinoma From Other Basaloid Tumors of the Oral Cavity.
Neoplasms
Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis.
Neoplasms
Expression of epidermal growth-factor (EGF), matrix metalloproteinase-9 (mmp-9) and proliferating cell nuclear antigen (pcna) in esophageal cancer.
Neoplasms
Expression of extracellular matrix metalloproteinase (MMP-9), E-cadherin and proliferation-associated antigen Ki-67 and their reciprocal correlation in canine mammary adenocarcinomas.
Neoplasms
Expression of extracellular matrix-degrading proteins in classic, atypical, and anaplastic meningiomas.
Neoplasms
Expression of Ezrin, Mmp-9 and Cox-2 in 50 Chordoma Specimens: A Clinical and Immunohistochemical Analysis.
Neoplasms
Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma.
Neoplasms
Expression of gelatinase-A (MMP-2) in human colon cancer and normal colon mucosa.
Neoplasms
Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells.
Neoplasms
Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases.
Neoplasms
Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer.
Neoplasms
Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Neoplasms
Expression of inflammation-associated genes in circulating leukocytes collected from horses with gastrointestinal tract disease.
Neoplasms
Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
Neoplasms
Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
Neoplasms
Expression of LGR8 and related biomarkers in hepatocellular carcinoma: correlation with clinicopathological parameters.
Neoplasms
Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer.
Neoplasms
Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Neoplasms
Expression of matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of MMP (TIMP)-1 in conjunctival melanomas and clinical implications.
Neoplasms
Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice.
Neoplasms
Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
Neoplasms
Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.
Neoplasms
Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
Neoplasms
Expression of matrix metalloproteinase 2 and 9 in breast cancer and breast fibroadenoma: a randomized, double-blind study.
Neoplasms
Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor alpha correlates with metastatic ability in a human osteosarcoma cell line.
Neoplasms
Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells - Associations with histopathology and patients outcome.
Neoplasms
Expression of matrix metalloproteinase 9 (MMP-9/gelatinase B) in adenocarcinomas strongly correlated with expression of immune response genes.
Neoplasms
Expression of matrix metalloproteinase 9 in pancreatic ductal carcinoma is associated with tumor metastasis formation.
Neoplasms
Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
Neoplasms
Expression of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in intraductal and nonintraductal growth type of cholangiocarcinoma.
Neoplasms
Expression of matrix metalloproteinase-2 and -9 in human ligamentum flavum cells treated with tumor necrosis factor-? and interleukin-1?.
Neoplasms
Expression of matrix metalloproteinase-2 and prostate-specific antigen in localized and metastatic prostate cancer.
Neoplasms
Expression of matrix metalloproteinase-9 (MMP-9) and blood vessel density in laryngeal squamous cell carcinomas.
Neoplasms
Expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in tissues with a diagnosis of childhood lymphoma.
Neoplasms
Expression of matrix metalloproteinase-9 and bombesin/gastrin-releasing peptide in human prostate cancers and their lymph node metastases.
Neoplasms
Expression of matrix metalloproteinase-9 and tumour necrosis factor-alpha in the synovial cells of patients with meniscus tears.
Neoplasms
Expression of matrix metalloproteinase-9 correlates with poor prognosis in human malignant fibrous histiocytoma.
Neoplasms
Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis.
Neoplasms
Expression of matrix metalloproteinase-9 in high-grade salivary gland carcinomas is associated with their metastatic potential.
Neoplasms
Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.
Neoplasms
Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
Neoplasms
Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.
Neoplasms
Expression of matrix metalloproteinase-9 in surgically resected intrahepatic cholangiocarcinoma.
Neoplasms
Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in gastric cancer.
Neoplasms
Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer.
Neoplasms
Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Neoplasms
Expression of matrix metalloproteinase-9, cyclooxygenase-2 and vascular endothelial growth factor are increased in gastrointestinal stromal tumors.
Neoplasms
Expression of Matrix Metalloproteinase-9, Pituitary Tumor Transforming Gene, High Mobility Group A 2, and Ki-67 in Adrenocorticotropic Hormone-Secreting Pituitary Tumors and Their Association with Tumor Recurrence.
Neoplasms
Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue.
Neoplasms
Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Neoplasms
Expression of Matrix Metalloproteinases (MMPs) in Primary Human Breast Cancer: MMP-9 as a Potential Biomarker for Cancer Invasion and Metastasis.
Neoplasms
Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas.
Neoplasms
Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitor-1 in cartilage-forming osteal tumors.
Neoplasms
Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis.
Neoplasms
Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema.
Neoplasms
Expression of matrix metalloproteinases 2, 7 and 9 in patients with colorectal cancer.
Neoplasms
Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer Relation to clinicopathological factors, beta-catenin and prognosis.
Neoplasms
Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.
Neoplasms
Expression of matrix metalloproteinases and their inhibitors in human brain tumors.
Neoplasms
Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
Neoplasms
Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Neoplasms
Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in laryngeal and pharyngeal squamous cell carcinoma: A quantitative analysis.
Neoplasms
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Neoplasms
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells.
Neoplasms
Expression of matrix metalloproteinases in gallbladder carcinoma and their significance in carcinogenesis.
Neoplasms
Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Neoplasms
Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
Neoplasms
Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas.
Neoplasms
Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland.
Neoplasms
Expression of matrix metalloproteinases, cytokines, and connexins in diabetic and nondiabetic human keratinocytes before and after transplantation into an ex vivo wound-healing model.
Neoplasms
Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas.
Neoplasms
Expression of Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases and Vascular Endothelial Growth Factor in Canine Mast Cell Tumours.
Neoplasms
Expression of Matrix Metalloproteinases-2/-9 is Associated With Microvessel Density in Pancreatic Cancer.
Neoplasms
Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma.
Neoplasms
Expression of metalloproteases and their inhibitors in primary tumors and in local recurrences after mastectomy for breast cancer.
Neoplasms
Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma.
Neoplasms
Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
Neoplasms
Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix.
Neoplasms
Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas.
Neoplasms
Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis.
Neoplasms
Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis.
Neoplasms
Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer.
Neoplasms
Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors.
Neoplasms
Expression of MMP-2 and MMP-9 in Benign Canine Rostrotentorial Meningiomas Is Not Correlated to the Extent of Peritumoral Edema.
Neoplasms
Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
Neoplasms
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Neoplasms
Expression of MMP-2, MMP-9, and urokinase-type plasminogen activator in cervical intraepithelial neoplasia.
Neoplasms
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Neoplasms
Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema.
Neoplasms
Expression of MMP-9 in different degrees of chronic hepatitis B and its correlation with inflammation.
Neoplasms
Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue.
Neoplasms
Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication.
Neoplasms
Expression of MMPs and TIMPs genes in human breast cancer epithelial cells depends on cell culture conditions and is associated with their invasive potential.
Neoplasms
Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.
Neoplasms
Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.
Neoplasms
Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis.
Neoplasms
Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis.
Neoplasms
Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines.
Neoplasms
Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells.
Neoplasms
Expression of reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase 9 in middle ear squamous cell carcinoma.
Neoplasms
Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
Neoplasms
Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
Neoplasms
Expression of SKA1 and MMP-9 in primary salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis.
Neoplasms
Expression of TGF-?1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.
Neoplasms
Expression of the active form of MMP-2 on the surface of leukemic cells accounts for their in vitro invasion.
Neoplasms
Expression of the Annexin A1 and its correlation with matrix metalloproteinases and the receptor for formylated peptide-2 in diffuse astrocytic tumors.
Neoplasms
Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status.
Neoplasms
Expression of the miR200 family of microRNAs in mesothelial cells suppresses the dissemination of ovarian cancer cells.
Neoplasms
Expression of the reversion-inducing cysteine-rich protein with Kazal motifs and matrix metalloproteinase-14 in neuroblastoma and the role in tumour metastasis.
Neoplasms
Expression of thrombospondin-1 in human pancreatic adenocarcinomas: role in matrix metalloproteinase-9 production.
Neoplasms
Expression of tissue inhibitor of metalloproteinase-3 (TIMP-3) and its prognostic significance in resected non-small cell lung cancer.
Neoplasms
Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage.
Neoplasms
Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
Neoplasms
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Neoplasms
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma.
Neoplasms
Expression of toll-like receptor 4, tumor necrosis factor- alpha, matrix metalloproteinase-9 and effects of benazepril in patients with acute coronary syndromes.
Neoplasms
Expression of tumor antigens and heat-shock protein 70 in breast cancer cells after high-intensity focused ultrasound ablation.
Neoplasms
Expression of tumor necrosis factor alpha and matrix metalloproteinase-9 in surgically induced necrotizing scleritis.
Neoplasms
Expression of Twist protein in colorectal carcinoma and its effect on proliferation and invasion of colorectal cancer cells.
Neoplasms
Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung.
Neoplasms
Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status.
Neoplasms
Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
Neoplasms
Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer.
Neoplasms
Expression of vascular endothelial growth factor-A, matrix metalloproteinase-9, and extravascular matrix patterns and their correlations with clinicopathologic parameters in posterior uveal melanomas.
Neoplasms
Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions.
Neoplasms
Expression pattern and circulating levels of endostatin in patients with pancreas cancer.
Neoplasms
Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.
Neoplasms
Expression profile of NF-?B regulated genes in sporadic colorectal cancer patients.
Neoplasms
Expression profiling using a cDNA array and immunohistochemistry for the extracellular matrix genes FN-1, ITGA-3, ITGB-5, MMP-2, and MMP-9 in colorectal carcinoma progression and dissemination.
Neoplasms
Expression, Regulation, and Effects of Interleukin-17f in the Human Ocular Surface.
Neoplasms
Expressions of CD147, MMP-2 and MMP-9 in Laryngeal Carcinoma and its Correlation with Poor Prognosis.
Neoplasms
Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma.
Neoplasms
Expressions of Matrix Metalloproteinase-7 and -9 and their Prognostic Significances in Rectal Cancer.
Neoplasms
Expressions of matrix metalloproteinase-9 (MMP-9), dentin sialophosphoprotein (DSPP), and osteopontin (OPN) at histologically negative surgical margins may predict recurrence of oral squamous cell carcinoma.
Neoplasms
Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma.
Neoplasms
Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.
Neoplasms
Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma.
Neoplasms
Extended-access methamphetamine self-administration elicits neuroinflammatory response along with blood-brain barrier breakdown.
Neoplasms
Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
Neoplasms
Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor-signaling.
Neoplasms
Extracellular vesicles secreted from cancer cell lines stimulate secretion of MMP-9, IL-6, TGF-?1 and EMMPRIN.
Neoplasms
Extracts of Cordyceps sinensis inhibit breast cancer cell metastasis via down-regulation of metastasis-related cytokines expression.
Neoplasms
Extraorbital lacrimal gland excision: a reproducible model of severe aqueous tear-deficient dry eye disease.
Neoplasms
Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model.
Neoplasms
Fabrication of In Vitro Cancer Microtissue Array on Fibroblast-Layered Nanofibrous Membrane by Inkjet Printing.
Neoplasms
Failure of antioxidants to protect against angiotensin II-induced aortic rupture in aged apolipoprotein(E)-deficient mice.
Neoplasms
Failure of matrix metalloproteinase-9 dimer induction by phorbol 12-myristate 13-acetate in normal human cell lines.
Neoplasms
FAK signaling in neoplastic disorders: a linkage between inflammation and cancer.
Neoplasms
Farnesyltransferase inhibitor effects on prostate tumor micro-environment and radiation survival.
Neoplasms
Febuxostat attenuates vascular calcification induced by vitamin D3 plus nicotine in rats.
Neoplasms
Fentanyl inhibits the progression of human gastric carcinoma MGC-803 cells by modulating NF-?B-dependent gene expression in vivo.
Neoplasms
Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes.
Neoplasms
FGF-1-induced matrix metalloproteinase-9 expression in breast cancer cells is mediated by increased activities of NF-kappaB and activating protein-1.
Neoplasms
Fibroblast activation protein-? promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions.
Neoplasms
Fibroblast-directed expression and localization of 92-kDa type IV collagenase along the tumor-stroma interface in an in vitro three-dimensional model of human squamous cell carcinoma.
Neoplasms
Fibroblasts and extracellular matrix differently modulate MMP activation by primary and metastatic head and neck cancer cells.
Neoplasms
Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production.
Neoplasms
Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells.
Neoplasms
Fibronectin induces matrix metalloproteinase-9 (MMP-9) in human laryngeal carcinoma cells by involving multiple signaling pathways.
Neoplasms
Fibronectin-alpha4beta1 integrin interactions regulate metalloproteinase-9 expression in steatotic liver ischemia and reperfusion injury.
Neoplasms
Fibronectin-integrin (alpha5beta1) modulates migration and invasion of murine melanoma cell line B16F10 by involving MMP-9.
Neoplasms
First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome.
Neoplasms
Fisetin regulates TPA-induced breast cell invasion by suppressing matrix metalloproteinase-9 activation via the PKC/ROS/MAPK pathways.
Neoplasms
Fisetin, a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma.
Neoplasms
Flavocoxid Ameliorates Aortic Calcification Induced by Hypervitaminosis D3 and Nicotine in Rats Via Targeting TNF-?, IL-1?, iNOS, and Osteogenic Runx2.
Neoplasms
Flavokawain B inhibits growth of human squamous carcinoma cells: Involvement of apoptosis and cell cycle dysregulation in vitro and in vivo.
Neoplasms
Flavonoid components in Scutellaria baicalensis inhibit nicotine-induced proliferation, metastasis and lung cancer-associated inflammation in vitro.
Neoplasms
Flavonoids from Citrus unshiu Marc. inhibit cancer cell adhesion to endothelial cells by selective inhibition of VCAM-1.
Neoplasms
FlexPro MD®, a Combination of Krill Oil, Astaxanthin and Hyaluronic Acid, Reduces Pain Behavior and Inhibits Inflammatory Response in Monosodium Iodoacetate-Induced Osteoarthritis in Rats.
Neoplasms
Flow cytometric analysis of gelatinase B (MMP-9) activity using immobilized fluorescent substrate on microspheres.
Neoplasms
Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.
Neoplasms
Fluorescent polymer dots and graphene oxide based nanocomplexes for "off-on" detection of metalloproteinase-9.
Neoplasms
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.
Neoplasms
Folate-decorated arginine-based poly(ester urea urethane) nanoparticles as carriers for gambogic acid and effect on cancer cells.
Neoplasms
Folate-targeting redox hyperbranched poly(amido amine)s delivering MMP-9 siRNA for cancer therapy.
Neoplasms
Formal model of the interplay between TGF?1 and MMP-9 and their dynamics in hepatocellular carcinoma.
Neoplasms
FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness.
Neoplasms
FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases.
Neoplasms
FoxO4 regulates tumor necrosis factor alpha-directed smooth muscle cell migration by activating matrix metalloproteinase 9 gene transcription.
Neoplasms
Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
Neoplasms
Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-?B and AP-1 signaling in human breast cancer cells.
Neoplasms
FSTL3 Induces Lipid Accumulation and Inflammatory Response in Macrophages and Associates With Atherosclerosis.
Neoplasms
Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB.
Neoplasms
Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Neoplasms
Functional analysis of matrix metalloproteinases and tissue inhibitors of metalloproteinases differentially expressed by variants of human HT-1080 fibrosarcoma exhibiting high and low levels of intravasation and metastasis.
Neoplasms
Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cells.
Neoplasms
Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.
Neoplasms
Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients.
Neoplasms
Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene in alcohol dependence: family and case control study.
Neoplasms
Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia.
Neoplasms
Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer.
Neoplasms
Functional proteomics study reveals that N-Acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1.
Neoplasms
Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells.
Neoplasms
Functional Significance of MMP-9 in Tumor Necrosis Factor-Induced Proliferation and Branching Morphogenesis of Mammary Epithelial Cells.
Neoplasms
Gab1 regulates proliferation and migration through the PI3K/Akt signaling pathway in intrahepatic cholangiocarcinoma.
Neoplasms
Gadd45a sensitizes medulloblastoma cells to irradiation and suppresses MMP-9-mediated EMT.
Neoplasms
Galectin-7 in lymphoma: elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model.
Neoplasms
Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Neoplasms
Gallic acid-capped gold nanoparticles inhibit EGF-induced MMP-9 expression through suppression of p300 stabilization and NF?B/c-Jun activation in breast cancer MDA-MB-231 cells.
Neoplasms
Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity.
Neoplasms
Gambogic acid regulates the migration and invasion of colorectal cancer via microRNA-21-mediated activation of phosphatase and tensin homolog.
Neoplasms
Ganoderic acid T inhibits tumor invasion in vitro and in vivo through inhibition of MMP expression.
Neoplasms
Gas6/Axl mediates tumor cell apoptosis, migration and invasion and predicts the clinical outcome of osteosarcoma patients.
Neoplasms
Gastrin-stimulated gastric epithelial cell invasion: the role and mechanism of increased matrix metalloproteinase 9 expression.
Neoplasms
Gastrokine-2 is downregulated in gastric cancer and its restoration suppresses gastric tumorigenesis and cancer metastasis.
Neoplasms
GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors.
Neoplasms
Gd@C82(OH)22 nanoparticles constrain macrophages migration into tumor tissue to prevent metastasis.
Neoplasms
Gelatinase B (-1562C/T) polymorphism in tumor progression and invasion of breast cancer.
Neoplasms
Gelatinase B (MMP-9) production and expression by stromal cells in the normal and adult thymus and experimental thymic lymphoma.
Neoplasms
Gelatinase B (MMP-9), but not its inhibitor (TIMP-1), dictates the growth rate of experimental thymic lymphoma.
Neoplasms
Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
Neoplasms
Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.
Neoplasms
Gelatinase B/matrix metalloproteinase-9 contributes to cellular infiltration in a murine model of zymosan peritonitis.
Neoplasms
Gelatinolytic activities (matrix metalloproteinase-2 and -9) and soluble extracellular domain of Her-2/neu in pleural effusions.
Neoplasms
Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells.
Neoplasms
Gene Expression of Matrix Metalloproteinases and their Inhibitors (TIMPs) in Meningiomas of Dogs.
Neoplasms
Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
Neoplasms
Generation of antitumor peptides by connection of matrix metalloproteinase-9 peptide inhibitor to an endostatin fragment.
Neoplasms
Genes associated with inflammation and the cell cycle may serve as biomarkers for the diagnosis and prognosis of acute myocardial infarction in a Chinese population.
Neoplasms
Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1.
Neoplasms
Genome-wide analysis of gene-expression profiles in chronic myeloid leukemia cells using a cDNA microarray.
Neoplasms
GHRH antagonist inhibits focal adhesion kinase (FAK) and decreases expression of vascular endothelial growth factor (VEGF) in human lung cancer cells in vitro.
Neoplasms
Ginkgo biloba Exocarp Extract Inhibits the Metastasis of B16-F10 Melanoma Involving PI3K/Akt/NF-?B/MMP-9 Signaling Pathway.
Neoplasms
GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer.
Neoplasms
Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells.
Neoplasms
Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE?cadherin/EphA2/MMP9/MMP2 expression.
Neoplasms
Glaucine inhibits breast cancer cell migration and invasion by inhibiting MMP-9 gene expression through the suppression of NF-?B activation.
Neoplasms
Gleditsia sinensis Thorn Extract Inhibits Proliferation and TNF-?-Induced MMP-9 Expression in Vascular Smooth Muscle Cells.
Neoplasms
Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9.
Neoplasms
Glioma cell activation by Alzheimer's peptide Abeta1-42, alpha1-antichymotrypsin, and their mixture.
Neoplasms
Glucocorticoid-induced tumour necrosis factor receptor family related protein (GITR) mediates inflammatory activation of macrophages that can destabilize atherosclerotic plaques.
Neoplasms
Glycogen synthase kinase-3? mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion.
Neoplasms
Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin.
Neoplasms
GMI, a Ganoderma Immunomodulatory Protein, Down-regulates Tumor Necrosis Factor ?-Induced Expression of Matrix Metalloproteinase 9 via NF-?B Pathway in Human Alveolar Epithelial A549 Cells.
Neoplasms
Grape seed extract suppresses MDA-MB231 breast cancer cell migration and invasion.
Neoplasms
Growth factor stimulation of matrix metalloproteinase expression and myoblast migration and invasion in vitro.
Neoplasms
Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9.
Neoplasms
Halofuginone induces the apoptosis of breast cancer cells and inhibits migration via downregulation of matrix metalloproteinase-9.
Neoplasms
Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition.
Neoplasms
Haloperidol Abrogates Matrix Metalloproteinase-9 Expression by Inhibition of NF-?B Activation in Stimulated Human Monocytic Cells.
Neoplasms
HDAC inhibitor trichostatin A suppresses esophageal squamous cell carcinoma metastasis through HADC2 reduced MMP-2/9.
Neoplasms
Helicobacter pylori promotes invasion and metastasis of gastric cancer cells through activation of AP-1 and up-regulation of CACUL1.
Neoplasms
Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9.
Neoplasms
Heme oxygenase-1 inhibits progression and destabilization of vulnerable plaques in a rabbit model of atherosclerosis.
Neoplasms
Hemoglobin induces the production and release of matrix metalloproteinase-9 from human malignant cells.
Neoplasms
Heparan sulfate proteoglycans and their modification as promising anticancer targets in hepatocellular carcinoma.
Neoplasms
Heparanase-driven sequential released nanoparticles for ferroptosis and tumor microenvironment modulations synergism in breast cancer therapy.
Neoplasms
Hepatic ischemia/reperfusion injury is prevented by a novel matrix metalloproteinase inhibitor, ONO-4817.
Neoplasms
Hepatitis C virus NS3 protein enhances cancer cell invasion by activating matrix metalloproteinase-9 and cyclooxygenase-2 through ERK/p38/NF-?B signal cascade.
Neoplasms
Hepatocellular carcinoma with osteoclast-like giant cells: possibility of osteoclastogenesis by hepatocyte-derived cells.
Neoplasms
Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers.
Neoplasms
Hepatoprotective effect and mechanistic insights of deoxyelephantopin, a phyto-sesquiterpene lactone, against fulminant hepatitis.
Neoplasms
Hepatoprotective effect of forsythiaside a against acetaminophen-induced liver injury in zebrafish: Coupling network pharmacology with biochemical pharmacology.
Neoplasms
HER-2-induced PI3K signaling pathway was involved in the pathogenesis of gastric cancer.
Neoplasms
Herbal mixtures consisting of puerarin and either polyenylphosphatidylcholine or curcumin provide comprehensive protection against alcohol-related disorders in P rats receiving free choice water and 15% ethanol in pure water.
Neoplasms
Hesperidin Prevents Nitric Oxide Deficiency-Induced Cardiovascular Remodeling in Rats via Suppressing TGF-?1 and MMPs Protein Expression.
Neoplasms
Heterogeneous microenvironmental stiffness regulates pro-metastatic functions of breast cancer cells.
Neoplasms
Hibiscus sabdariffa Leaf Extract Inhibits Human Prostate Cancer Cell Invasion via Down-Regulation of Akt/NF-kB/MMP-9 Pathway.
Neoplasms
HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion.
Neoplasms
High expression level of MMP9 is associated with poor prognosis in patients with clear cell renal carcinoma.
Neoplasms
High expression of 92 kDa type IV collagenase (matrix metalloproteinase-9) in canine mammary adenocarcinoma.
Neoplasms
High expression of matrix metalloproteinase-9 indicates poor prognosis in human hilar cholangiocarcinoma.
Neoplasms
High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
Neoplasms
High expression of MMP-9 is associated with better prognosis in extrahepatic bile duct cancer patients.
Neoplasms
High expression of MMP-9 is associated with better prognosis in extrahepatic bile duct cancer.
Neoplasms
High expression of RELM-? correlates with poor prognosis and promotes angiogenesis in gastric cancer.
Neoplasms
High glucose increases RAW 264.7 macrophages activation by lipoteichoic acid from Staphylococcus aureus.
Neoplasms
High infiltration of CD68-tumor associated macrophages, predict poor prognosis in Kazakh esophageal cancer patients.
Neoplasms
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.
Neoplasms
High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma.
Neoplasms
High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.
Neoplasms
High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions.
Neoplasms
High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis.
Neoplasms
High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer: Gene set enrichment analysis and validation in large-scale cohorts.
Neoplasms
High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia.
Neoplasms
High-throughput functional profiling of single adherent cells via hydrogel drop-screen.
Neoplasms
Highly conserved surface proteins of oral spirochetes as adhesins and potent inducers of proinflammatory and osteoclastogenic factors.
Neoplasms
Hirsutenone inhibits phorbol ester-induced upregulation of COX-2 and MMP-9 in cultured human mammary epithelial cells: NF-kappaB as a potential molecular target.
Neoplasms
Histochemical evidence of osteoclastic degradation of extracellular matrix in osteolytic metastasis originating from human lung small carcinoma (SBC-5) cells.
Neoplasms
Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer.
Neoplasms
Histone deacetylases meet microRNA-associated MMP-9 expression regulation in glucocorticoid-sensitive and -resistant cell lines.
Neoplasms
HMG-CoA reductase inhibitors reduce matrix metalloproteinase-9 activity in human varicose veins.
Neoplasms
HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma.
Neoplasms
HMGB1-Mediated MMP-9 Expression in Non-Small Cell Lung Cancer Contributes to Tumor Cell Invasiveness.
Neoplasms
Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE?-mediated activation of ?-catenin signaling.
Neoplasms
Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts.
Neoplasms
Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasis.
Neoplasms
Host response to short-term, single-agent chemotherapy induces matrix metalloproteinase-9 expression and accelerates metastasis in mice.
Neoplasms
HOXB13 regulates the prostate-derived Ets factor: implications for prostate cancer cell invasion.
Neoplasms
HPV16 infection promotes an M2 macrophage phenotype to promote the invasion and metastasis of esophageal squamous cell carcinoma.
Neoplasms
HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema.
Neoplasms
Human ?-defensin 3 inhibits periodontitis development by suppressing inflammatory responses in macrophages.
Neoplasms
Human breast adenocarcinoma (MDA-231) and human lung squamous cell carcinoma (Hara) do not have the ability to cause bone resorption by themselves during the establishment of bone metastasis.
Neoplasms
Human CD133-positive hematopoietic progenitor cells initiate growth and metastasis of colorectal cancer cells.
Neoplasms
Human chorionic gonadotropin prevents Sjögren's syndrome-like exocrinopathy in mice.
Neoplasms
Human cytomegalovirus infection is correlated with atherosclerotic plaque vulnerability in carotid artery.
Neoplasms
Human matrix metalloproteinase-9: activation by limited trypsin treatment and generation of monoclonal antibodies specific for the activated form.
Neoplasms
Human monocyte-derived dendritic cells produce bioactive gelatinase B: inhibition by IFN-beta.
Neoplasms
Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis.
Neoplasms
Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis.
Neoplasms
Hydrogen sulfide stabilizes atherosclerotic plaques in apolipoprotein E knockout mice.
Neoplasms
Hydroxysafflor Yellow A of Carthamus Tinctorius L., Represses the Malignant Development of Esophageal Cancer Cells via Regulating NF-?B Signaling Pathway.
Neoplasms
Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation.
Neoplasms
Hyperglycemia Suppresses Calcium Phosphate-Induced Aneurysm Formation Through Inhibition of Macrophage Activation.
Neoplasms
Hypertensive disorders in pregnancy: Screening by biophysical and biochemical markers at 11-13 weeks.
Neoplasms
Hypertonic Saline Attenuates the Pro-metastatic Effects of LPS by Reducing Tumor Cell Migration, Proliferation and MMP-9 Expression.
Neoplasms
Hypoxia enhances gene expression of inducible nitric oxide synthase and matrix metalloproteinase-9 in ras/myc-transformed serum-free mouse embryo cells under simulated inflammatory and infectious conditions.
Neoplasms
Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma.
Neoplasms
Hypoxia level and matrix metalloproteinases-2 and -9 activity in Lewis lung carcinoma: correlation with metastasis.
Neoplasms
Hypoxia reduces the output of matrix metalloproteinase-9 (MMP-9) in monocytes by inhibiting its secretion and elevating membranal association.
Neoplasms
Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis.
Neoplasms
Hypoxia-induced endogenous prostaglandin E2 negatively regulates hypoxia-enhanced aberrant overgrowth of rheumatoid synovial tissue.
Neoplasms
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice.
Neoplasms
Ibudilast inhibits cerebral aneurysms by down-regulating inflammation-related molecules in the vascular wall of rats.
Neoplasms
Id-1 and the p65 subunit of NF-?B promote migration of nasopharyngeal carcinoma cells and are correlated with poor prognosis.
Neoplasms
Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1.
Neoplasms
Identification of Candidate Susceptibility and Resistance Genes of Mice Infected with Streptococcus suis Type 2.
Neoplasms
Identification of Caspase-6 as a New Regulator of Alternatively Activated Macrophages.
Neoplasms
Identification of clustered cells in human hair follicle responsible for MMP-9 gelatinolytic activity: consequences for the regulation of hair growth.
Neoplasms
Identification of gene expression profiles correlated to tumor progression in a preclinical model of colon carcinogenesis.
Neoplasms
Identification of matrix metalloproteinases in canine cutaneous mast cell tumors.
Neoplasms
Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
Neoplasms
Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study.
Neoplasms
Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
Neoplasms
Identifying the regulative role of NF-?B binding sites within promoter region of human matrix metalloproteinase 9 (mmp-9) by TNF-? induction.
Neoplasms
IFT80 Improves Invasion Ability in Gastric Cancer Cell Line via ift80/p75NGFR/MMP9 Signaling.
Neoplasms
IgE-mediated basophil tumour necrosis factor alpha induces matrix metalloproteinase-9 from monocytes.
Neoplasms
IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages.
Neoplasms
Imaging the rapid yet transient accumulation of regulatory lipids, lipid kinases, and protein kinases during membrane fusion, at sites of exocytosis of MMP-9 in MCF-7 cells.
Neoplasms
Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Neoplasms
Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma.
Neoplasms
Imbalance of MMP-2 and MMP-9 expression versus TIMP-1 and TIMP-2 reflects increased invasiveness of human testicular germ cell tumours.
Neoplasms
Immunocharacterization of matrix metalloproteinase-2 and matrix metalloproteinase-9 in canine transmissible venereal tumors.
Neoplasms
Immunoexpression of MMPs-1, -2, and -9 in ameloblastoma and odontogenic adenomatoid tumor.
Neoplasms
Immunogenicity moderation effect of interleukin-24 on myelogenous leukemia cells.
Neoplasms
Immunohistochemical analysis of matrix metalloproteinase-9 predicts papillary thyroid carcinoma prognosis.
Neoplasms
Immunohistochemical analysis of neutrophils, interleukin-17, matrix metalloproteinase-9, and neoformed vessels in oral squamous cell carcinoma.
Neoplasms
Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
Neoplasms
Immunohistochemical Demonstration of Membrane-bound Prostaglandin E(2) Synthase-1 in Papillary Thyroid Carcinoma.
Neoplasms
Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas.
Neoplasms
Immunohistochemical detection of the 150-kDa oxygen-regulated protein in bladder cancer.
Neoplasms
Immunohistochemical expression of epidermal growth factor receptor, E-cadherin, and matrix metalloproteinase-9 in ovarian epithelial cancer and relation to patient deaths.
Neoplasms
Immunohistochemical expression of matrix metalloproteinase-9 and inhibitor of matrix metalloproteinase-1 in prostate adenocarcinoma.
Neoplasms
Immunohistochemical expression of matrix metalloproteinases 1, 2, 9, and 14 in dermatofibrosarcoma protuberans and common fibrous histiocytoma (dermatofibroma).
Neoplasms
Immunohistochemical expression of matrix metalloproteinases in ameloblastomas and pericoronal follicles.
Neoplasms
Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: association with tumor progression and clinical outcome.
Neoplasms
Immunohistochemical expression of MMP-9 and VEGF in squamous cell carcinoma of the tongue.
Neoplasms
Immunohistochemical expression of MMP-9, TIMP-2, E-cadherin and vimentin in ameloblastomas and their implication in the local aggressive behavior of these tumors.
Neoplasms
Immunohistochemical expression of Notch1, Jagged1, NF-?B and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
Neoplasms
Immunohistochemical expression of osteonectin, matrix metalloproteinases-9 and Ki-67 in ameloblastoma.
Neoplasms
Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Neoplasms
Immunohistochemical Expression Profiles of Cell Adhesion Molecules, Matrix Metalloproteinases and their Tissue Inhibitors in Central and Peripheral Neoplastic Foci of Feline Mammary Carcinoma.
Neoplasms
Immunohistochemical studies on matrix metalloproteinase-9 (MMP-9) and type-IV collagen in endometrial carcinoma.
Neoplasms
Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
Neoplasms
Immunohistochemical study of the expression of matrix metalloproteinase-9 in skin lesions of mycosis fungoides.
Neoplasms
Immunoinformatics design of multiepitopes peptide-based universal cancer vaccine using matrix metalloproteinase-9 protein as a target.
Neoplasms
Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.
Neoplasms
Immunological and microbiological periodontal profiles in isolated growth hormone deficiency.
Neoplasms
Immunotherapy Using Oxygenated Water and Tumor-Derived Exosomes Potentiates Antitumor Immune Response and Attenuates Malignancy Tendency in Mice Model of Breast Cancer.
Neoplasms
Impact of a chronic smoking habit on the osteo-immunoinflammatory mediators in the peri-implant fluid of clinically healthy dental implants.
Neoplasms
Impact of atrial fibrillation on inflammatory and fibrinolytic variables in the elderly.
Neoplasms
Impact of Histological and Molecular Parameters on Prognosis of Oral Squamous Cell Carcinoma: Analysis of 290 Cases.
Neoplasms
Impact of MMP-2 and MMP-9 enzyme activity on wound healing, tumor growth and RACPP cleavage.
Neoplasms
Impact of p27mt gene on transplantation model of human colorectal cancer in nude mice.
Neoplasms
Impact of the biophysical features of a 3D gelatin microenvironment on glioblastoma malignancy.
Neoplasms
Impaired lung repair during neutropenia can be reverted by matrix metalloproteinase-9.
Neoplasms
Impairment of the Gn?11-controlled expression of claudin-1 and MMP-9 and collective migration of human breast cancer MCF-7 cells by DHEAS.
Neoplasms
In situ detection of matrix metalloproteinase-9 (MMP-9) in gingival epithelium in human periodontal disease.
Neoplasms
In situ localization of gelatinolytic activity in the extracellular matrix of metastases of colon cancer in rat liver using quenched fluorogenic DQ-gelatin.
Neoplasms
In vitro and in vivo evaluation of doxorubicin conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin alphavbeta3.
Neoplasms
In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models.
Neoplasms
In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer.
Neoplasms
In Vitro and In Vivo Study on the Toxic Effects of Propiconazole Fungicide in the Pathogenesis of Liver Fibrosis.
Neoplasms
In vitro cellular aging is associated with enhanced proliferative capacity, G1 cell cycle modulation, and matrix metalloproteinase-9 regulation in mouse aortic smooth muscle cells.
Neoplasms
In vitro effects of meloxicam on metabolism in articular chondrocytes from dogs with naturally occurring osteoarthritis.
Neoplasms
In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
Neoplasms
In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors.
Neoplasms
In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
Neoplasms
In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on human fibrosarcoma cells HT-1080.
Neoplasms
In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human colon cancer cell HCT 116 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry.
Neoplasms
In vivo imaging and characterization of hypoxia-induced neovascularization and tumor invasion.
Neoplasms
In-capillary screening of matrix metalloproteinase inhibitors by electrophoretically mediated microanalysis with fluorescence detection.
Neoplasms
In-vivo and in-silico studies of Eucalyptus kino polyphenolics: outstanding activity in quenching solid liver tumors through inhibition of MMP-9 and TGF-? gene expression.
Neoplasms
Increase in IL-6, TNF-?, and MMP-9, but not sICAM-1, concentrations depends on exercise duration.
Neoplasms
Increase of tumor necrosis factor-alpha in the blood induces early activation of matrix metalloproteinase-9 in the brain.
Neoplasms
Increased co-expression of macrophage migration inhibitory factor and matrix metalloproteinase 9 is associated with tumor recurrence of meningioma.
Neoplasms
Increased endostatin generation and decreased angiogenesis via MMP-9 by tamoxifen in hormone dependent ovarian cancer.
Neoplasms
Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and MMP-9.
Neoplasms
Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors.
Neoplasms
Increased expression of matrix metalloproteinase-9 in neutrophils in glycogen-induced peritoneal inflammation of guinea pigs.
Neoplasms
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
Neoplasms
Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence.
Neoplasms
Increased expression of tissue inhibitor of metalloproteinase-2 in clear cell carcinoma of the ovary.
Neoplasms
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization.
Neoplasms
Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone.
Neoplasms
Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma.
Neoplasms
Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells.
Neoplasms
Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapy.
Neoplasms
Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer.
Neoplasms
Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukaemia.
Neoplasms
Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression.
Neoplasms
Increased Six1 expression in macrophages promotes hepatocellular carcinoma growth and invasion by regulating MMP-9.
Neoplasms
Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions.
Neoplasms
Increased urinary lipocalin-2 reflects matrix metalloproteinase-9 activity in chronic hepatitis C with hepatic fibrosis.
Neoplasms
Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Neoplasms
Incretin treatment and atherosclerotic plaque stability: Role of adiponectin/APPL1 signaling pathway.
Neoplasms
Indacaterol inhibits tumor cell invasiveness and MMP-9 expression by suppressing IKK/NF-?B activation.
Neoplasms
Induced sputum markers of fibrosis and decline in pulmonary function in asbestosis and silicosis: a pilot study.
Neoplasms
Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells.
Neoplasms
Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases.
Neoplasms
Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.
Neoplasms
Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts.
Neoplasms
Induction of matrix metalloproteinase gene expression in an endothelial cell line by direct interaction with malignant cells.
Neoplasms
Induction of matrix metalloproteinase-9 by galectin-7 through p38 MAPK signaling in HeLa human cervical epithelial adenocarcinoma cells.
Neoplasms
Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway.
Neoplasms
Induction of p97MAPK expression regulates collagen mediated inhibition of proliferation and migration in human squamous cell carcinoma lines.
Neoplasms
Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: Decreased tumor metastasis in a breast cancer model.
Neoplasms
Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines.
Neoplasms
Infiltration of blood outgrowth endothelial cells into tumor spheroids: role of matrix metalloproteinases and irradiation.
Neoplasms
Infiltration of T cells promotes the metastasis of ovarian cancer cells via the modulation of metastasis-related genes and PD-L1 expression.
Neoplasms
Inflammation Induced by MMP-9 Enhances Tumor Regression of Experimental Breast Cancer.
Neoplasms
Inflammation suppression by dexamethasone via inhibition of CD147-mediated NF-?B pathway in collagen-induced arthritis rats.
Neoplasms
Inflammations mediators and circulating levels of matrix metalloproteinases: Biomarkers of diabetes in Tunisians metabolic syndrome patients.
Neoplasms
Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD.
Neoplasms
Inflammatory cytokine modulation of matrix metalloproteinase expression and invasiveness of glioma cells in a 3-dimensional collagen matrix.
Neoplasms
Inflammatory Cytokines and Matrix Metalloproteinases in the Synovial Fluid After Intra-articular Ankle Fracture.
Neoplasms
Inflammatory cytokines and matrix metalloproteinases in the synovial fluid after intra-articular elbow fracture.
Neoplasms
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.
Neoplasms
Inflammatory responses of a macrophage/epithelial cell co-culture model to mono and mixed infections with Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia.
Neoplasms
Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: experimental models and clinical perspectives.
Neoplasms
Influence of hydrogencalcium salts of oxidized cellulose on MMP-2, MMP-9 and TNF-? production and wound healing in non-healing wounds.
Neoplasms
Influence of lymphatic endothelial cells on proliferation and invasiveness of esophageal carcinoma cells in vitro and lymphangiogenesis in vivo.
Neoplasms
Influence of matrix metalloproteinase 9 (MMP-9) on the metastatic behavior of oropharyngeal cancer.
Neoplasms
Influence of microenvironments on microcirculation patterns and tumor invasion-related protein expression in melanoma.
Neoplasms
Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
Neoplasms
Influence of organosulphur compounds from garlic on the secretion of matrix metalloproteinases and their inhibitor TIMP-1 by cultured HUVEC cells.
Neoplasms
Influence of surgical decompression on the expression of inflammatory and tissue repair biomarkers in periapical cysts.
Neoplasms
Influences of neoadjuvant chemotherapy on clinical indicators, prognosis and neutrophil/lymphocyte ratio of stage IB2-IIB cervical cancer.
Neoplasms
Inhibiting Cell Viability and Motility by Layer-by-Layer Assembly and Biomineralization.
Neoplasms
Inhibition activity of sulfated polysaccharide of Sepiella maindroni ink on matrix metalloproteinase (MMP)-2.
Neoplasms
Inhibition of arachidonic acid metabolism decreases tumor cell invasion and matrix metalloproteinase expression.
Neoplasms
Inhibition of Caco-2 colon, MCF-7 and Hs578T breast, and DU 145 prostatic cancer cell proliferation by water-soluble black bean condensed tannins.
Neoplasms
Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells.
Neoplasms
Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
Neoplasms
Inhibition of cell proliferation, migration and invasion by DNAzyme targeting MMP-9 in A549 cells.
Neoplasms
Inhibition of collagenases from mouse lung carcinoma cells by green tea catechins and black tea theaflavins.
Neoplasms
Inhibition of endothelial cell migration through the down?regulation of MMP-9 by A-kinase anchoring protein 12.
Neoplasms
Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice.
Neoplasms
Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD-HepII polypeptide of fibronectin.
Neoplasms
Inhibition of histone deacetylase activity down-regulates urokinase plasminogen activator and matrix metalloproteinase-9 expression in gastric cancer.
Neoplasms
Inhibition of Histone Deacetylase Attenuates Hypoxia-Induced Migration and Invasion of Cancer Cells via the Restoration of RECK Expression.
Neoplasms
Inhibition of human preadipocyte proteasomal activity by HIV protease inhibitors or specific inhibitor lactacystin leads to a defect in adipogenesis, which involves matrix metalloproteinase-9.
Neoplasms
Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.
Neoplasms
Inhibition of laryngeal cancer cell invasion and growth with lentiviral-vector delivered short hairpin RNA targeting human MMP-9 gene.
Neoplasms
Inhibition of lethal endotoxin shock with an L-pyridylalanine containing metalloproteinase inhibitor selected by high-throughput screening of a new peptide library.
Neoplasms
Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment.
Neoplasms
Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells.
Neoplasms
Inhibition of matrix metalloproteinase-9 expression by docosahexaenoic acid mediated by heme oxygenase 1 in 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 human breast cancer cells.
Neoplasms
Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells.
Neoplasms
Inhibition of matrix metalloproteinase-9 secretion by dimethyl sulfoxide and cyclic adenosine monophosphate in human monocytes.
Neoplasms
Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
Neoplasms
Inhibition of matrix metalloproteinases expression in human dental pulp cells by all-trans retinoic acid.
Neoplasms
Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.
Neoplasms
Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility.
Neoplasms
Inhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cells.
Neoplasms
Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells.
Neoplasms
Inhibition of MMP-9 transcription and suppression of tumor metastasis by pyrrole-imidazole polyamide.
Neoplasms
Inhibition of nuclear factor erythroid 2-related factor 2 exacerbates HIV-1 gp120-induced oxidative and inflammatory response: role in HIV associated neurocognitive disorder.
Neoplasms
Inhibition of SPHK1 suppresses phorbol 12-myristate 13-acetate-induced metastatic phenotype in colorectal cancer HT-29 cells.
Neoplasms
Inhibition of Stat3 Signaling Pathway by Natural Product Pectolinarigenin Attenuates Breast Cancer Metastasis.
Neoplasms
Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion.
Neoplasms
Inhibition of the pro-inflammatory mediators in rat neutrophils by shanzhiside methyl ester and its acetyl derivative isolated from Barleria prionitis.
Neoplasms
Inhibition of tumor growth and metastasis by EMMPRIN multiple antigenic peptide (MAP) vaccination is mediated by immune modulation.
Neoplasms
Inhibition of tumor growth by ?-elemene through downregulation of the expression of uPA, uPAR, MMP-2, and MMP-9 in a murine intraocular melanoma model.
Neoplasms
Inhibition of tumor progression by oral piceatannol in mouse 4T1 mammary cancer is associated with decreased angiogenesis and macrophage infiltration.
Neoplasms
Inhibition of UVB-Induced Inflammation by Laminaria japonica Extract via Regulation of nc886-PKR Pathway.
Neoplasms
Inhibition on angiotensin-converting enzyme exerts beneficial effects on trabecular bone in orchidectomized mice.
Neoplasms
Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis.
Neoplasms
Inhibitory effect of acetylsalicylic acid on metalloproteinase activity in human lung adenocarcinoma at different stages of differentiation.
Neoplasms
Inhibitory effect of aminoethyl-chitooligosaccharides on invasion of human fibrosarcoma cells.
Neoplasms
Inhibitory effect of chitooligosaccharides on matrix metalloproteinase-9 in human fibrosarcoma cells (HT1080).
Neoplasms
Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB.
Neoplasms
Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. Invasiveness in vitro.
Neoplasms
Inhibitory effect of methanol extract of Euonymus alatus on matrix metalloproteinase-9.
Neoplasms
Inhibitory effect of phytoglycoprotein (38 kDa) on expression of matrix metalloproteinase-9 in 12-O-tetradecanoylphorbol-13-acetate-treated HepG2cells.
Neoplasms
Inhibitory effects of a nutrient mixture on human testicular cancer cell line NT 2/DT matrigel invasion and MMP activity.
Neoplasms
Inhibitory effects of calcitonin gene-related peptides on experimental vein graft disease.
Neoplasms
Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
Neoplasms
Inhibitory effects of GL-V9 on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-2/9.
Neoplasms
Inhibitory Effects of Gyeji-Tang on MMP-9 Activity and the Expression of Adhesion Molecules in IL-4- and TNF-?-Stimulated BEAS-2B Cells.
Neoplasms
Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9.
Neoplasms
Inhibitory effects of oleic and docosahexaenoic acids on lung metastasis by colon-carcinoma-26 cells are associated with reduced matrix metalloproteinase-2 and -9 activities.
Neoplasms
Inhibitory Effects of Pectic Polysaccharide Isolated from Diospyros kaki Leaves on Tumor Cell Angiogenesis via VEGF and MMP-9 Regulation.
Neoplasms
Inhibitory effects of polysaccharide extract from Spirulina platensis on corneal neovascularization.
Neoplasms
Inhibitory effects of the ethanol extract of Gleditsia sinensis thorns on human colon cancer HCT116 cells in vitro and in vivo.
Neoplasms
Inhibitory effects of wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9.
Neoplasms
Innovative immunohistochemistry identifies MMP-9 expressing macrophages at the invasive front of murine HCC.
Neoplasms
Inorganic arsenite-induced malignant transformation of human prostate epithelial cells.
Neoplasms
Inorganic sulfur reduces the motility and invasion of MDA-MB-231 human breast cancer cells.
Neoplasms
Inositol Hexaphosphate and Inositol Inhibit Colorectal Cancer Metastasis to the Liver in BALB/c Mice.
Neoplasms
Insight into the structural requirement of aryl sulphonamide based gelatinases (MMP-2 and MMP-9) inhibitors - Part I: 2D-QSAR, 3D-QSAR topomer CoMFA and Naïve Bayes studies - First report of 3D-QSAR Topomer CoMFA analysis for MMP-9 inhibitors and jointly inhibitors of gelatinases together.
Neoplasms
Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9/gelatinase B.
Neoplasms
Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment.
Neoplasms
Intake of grape-derived polyphenols reduces C26 tumor growth by inhibiting angiogenesis and inducing apoptosis.
Neoplasms
Integrating macrophages into organotypic co-cultures: a 3D in vitro model to study tumor-associated macrophages.
Neoplasms
Integrin ?9?1-mediated cell migration in glioblastoma via SSAT and Kir4.2 potassium channel pathway.
Neoplasms
Integrin ?v?6 sustains and promotes tumor invasive growth in colon cancer progression.
Neoplasms
Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver.
Neoplasms
Integrin and matrix metalloprotease dual-targeting with an MMP substrate-RGD conjugate.
Neoplasms
Integrin-linked kinase regulates cell proliferation and tumour growth in murine colitis-associated carcinogenesis.
Neoplasms
Interaction between angiotensin II and relaxin 2 in the progress of growth and spread of prostate cancer cells.
Neoplasms
Interaction between pathogenic bacteria and intrauterine leukocytes triggers alternative molecular signaling cascades leading to labor in women.
Neoplasms
Interactions between filamin A and MMP-9 regulate proliferation and invasion in renal cell carcinoma.
Neoplasms
Interferon-? and celecoxib inhibit lung-tumor growth through modulating M2/M1 macrophage ratio in the tumor microenvironment.
Neoplasms
Interferon-? protects first-trimester decidual cells against aberrant matrix metalloproteinases 1, 3, and 9 expression in preeclampsia.
Neoplasms
Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.
Neoplasms
Interferon-gamma and lipopolysaccharide stimulation increases matrix metalloproteinase-9 expression and enhances invasion activity in ras/myc-transformed serum-free mouse embryo cells.
Neoplasms
Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8.
Neoplasms
Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response.
Neoplasms
Interferons inhibit tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 activation via interferon regulatory factor-1 binding competition with NF-kappa B.
Neoplasms
Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion.
Neoplasms
Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
Neoplasms
Interleukin-12 deficiency is permissive for angiogenesis in UV radiation-induced skin tumors.
Neoplasms
Interleukin-1? activates focal adhesion kinase and Src to induce matrix metalloproteinase-9 production and invasion of MCF-7 breast cancer cells.
Neoplasms
Interleukin-1alpha-induced proteolytic activation of metalloproteinase-9 by human skin.
Neoplasms
Interleukin-1beta upregulates MMP-9 expression in stromal cells of human giant cell tumor of bone.
Neoplasms
Interleukin-22 Mediates the Chemotactic Migration of Breast Cancer Cells and Macrophage Infiltration of the Bone Microenvironment by Potentiating S1P/SIPR Signaling.
Neoplasms
Interleukin-33 is a Novel Immunosuppressor that Protects Cancer Cells from TIL Killing by a Macrophage-Mediated Shedding Mechanism.
Neoplasms
Interleukin-6 expression by interactions between gynecologic cancer cells and human mesenchymal stem cells promotes epithelial-mesenchymal transition.
Neoplasms
Interleukins, Laminin and Epstein-Barr virus Latent Membrane Protein 1 (EBV LMP1) Promote Metastatic Phenotype in Nasopharyngeal Carcinoma.
Neoplasms
Interplay Between MMP-9 and TIMP-2 Regulates Ameloblastoma Behavior and Tooth Morphogenesis.
Neoplasms
Interplay of N-Cadherin and matrix metalloproteinase 9 enhances human nasopharyngeal carcinoma cell invasion.
Neoplasms
Interpretation of immunohistochemistry data of tumor should consider microenvironmental factors.
Neoplasms
Intervention of human breast cell carcinogenesis chronically induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Neoplasms
Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma.
Neoplasms
Intracerebral administration of ultrasound-induced dissolution of lipid-coated GDNF microbubbles provides neuroprotection in a rat model of Parkinson's disease.
Neoplasms
Intrahepatic metastasis by orthotopic implantation of a fragment of murine hepatoma and its related molecules.
Neoplasms
Intraoperative dexmedetomidine for prevention of postoperative delirium in elderly patients with mild cognitive impairment.
Neoplasms
Intrathecal transplantation of bone marrow stromal cells attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia-reperfusion injury in rabbits.
Neoplasms
Intratumoral macrophage counts correlate with tumor progression in colorectal cancer.
Neoplasms
Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment.
Neoplasms
Intravenous gamma globulin inhibits the production of matrix metalloproteinase-9 in macrophages.
Neoplasms
Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease.
Neoplasms
Intravenous superoxide dismutase as a protective agent to prevent impairment of lung function induced by high tidal volume ventilation.
Neoplasms
Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-?B signaling via initiation of HSP70.
Neoplasms
Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression.
Neoplasms
Investigating Prescriptions and Mechanisms of Acupuncture for Chronic Stable Angina Pectoris: An Association Rule Mining and Network Analysis Study.
Neoplasms
Investigating the anti-inflammatory effects of high molecular weight secretions from Limosilactobacillus reuteri PTCC 1655 on LPS-stimulated PMA-differentiated THP-1 cells.
Neoplasms
Investigation of potential early Histologic markers of pediatric inflammatory bowel disease.
Neoplasms
Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9.
Neoplasms
Involvement of plasmin-mediated extracellular activation of progalanin in angiogenesis.
Neoplasms
Involvement of protease-activated receptor 4 in over-expression of matrix metalloproteinase 9 induced by Porphyromonas gingivalis.
Neoplasms
Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNgamma-based cancer therapy in mice.
Neoplasms
Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A.
Neoplasms
Involvement of TNF-alpha in enhancement of invasion and metastasis of colon 26-L5 carcinoma cells in mice by social isolation stress.
Neoplasms
Involvement of transforming growth factor beta1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells.
Neoplasms
Iptakalim protects against ischemic injury by improving neurovascular unit function in the mouse brain.
Neoplasms
Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells.
Neoplasms
Ischemic Preconditioning Protects against Spinal Cord Ischemia-Reperfusion Injury in Rabbits by Attenuating Blood Spinal Cord Barrier Disruption.
Neoplasms
Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase/Akt-dependent matrix metalloproteinase-9 expression.
Neoplasms
Isolation and characterization of novel RECK tumor suppressor gene splice variants.
Neoplasms
Isothiocyanates inhibit the invasion and migration of C6 glioma cells by blocking FAK/JNK-mediated MMP-9 expression.
Neoplasms
Isothiocyanates suppress the invasion and metastasis of tumors by targeting FAK/MMP-9 activity.
Neoplasms
iTRAQ-Based Proteomics Screen identifies LIPOCALIN-2 (LCN-2) as a potential biomarker for colonic lateral-spreading tumors.
Neoplasms
iTRAQ-based quantitative proteomic analysis provides insight for molecular mechanism of neuroticism.
Neoplasms
Jaceosidin, a pharmacologically active flavone derived from Artemisia argyi, inhibits phorbol-ester-induced upregulation of COX-2 and MMP-9 by blocking phosphorylation of ERK-1 and -2 in cultured human mammary epithelial cells.
Neoplasms
JNK Suppression is Essential for 17beta-Estradiol Inhibits Prostaglandin E2-Induced uPA and MMP-9 Expressions and Cell Migration in Human LoVo Colon Cancer Cells.
Neoplasms
JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation.
Neoplasms
Joint Tumor Bud-MMP/TIMP Count at the Invasive Front Improves the Prognostic Evaluation of Invasive Breast Carcinoma.
Neoplasms
Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression.
Neoplasms
JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma.
Neoplasms
KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line.
Neoplasms
Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKC{delta}-mediated signaling in MCF-7 human breast cancer cells.
Neoplasms
Kalopanaxsaponin a inhibits the invasion of human oral squamous cell carcinoma by reducing metalloproteinase-9 mRNA stability and protein trafficking.
Neoplasms
Ketogenic Diet Elicits Antitumor Properties through Inducing Oxidative Stress, Inhibiting MMP-9 Expression, and Rebalancing M1/M2 Tumor-Associated Macrophage Phenotype in a Mouse Model of Colon Cancer.
Neoplasms
KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation.
Neoplasms
Kiss-1 suppresses MMP-9 expression by activating p38 MAP kinase in human stomach cancer.
Neoplasms
KISS1 Associates with Better Outcome via Inhibiting Matrix Metalloproteinase-9 in Colorectal Liver Metastasis.
Neoplasms
Knockdown of Lymphoid Enhancer factor 1 Inhibits Colon Cancer Progression In Vitro and In Vivo.
Neoplasms
Knockdown of Matrix Metallopeptidase 9 Inhibits Metastasis of Oral Squamous Cell Carcinoma Cells in a Zebrafish Xenograft Model.
Neoplasms
Knockdown of the inflammatory factor pentraxin-3 suppresses growth and invasion of lung adenocarcinoma through the AKT and NF-kappa B pathways.
Neoplasms
Kupffer cell-derived 95-kd type IV collagenase/gelatinase B: characterization and expression in cultured cells.
Neoplasms
L-3-n-butylphthalide attenuates inflammation response and brain edema in rat intracerebral hemorrhage model.
Neoplasms
L-carnosine inhibits metastasis of SK-Hep-1 cells by inhibition of matrix metaoproteinase-9 expression and induction of an antimetastatic gene, nm23-H1.
Neoplasms
LABAZ1: A metastatic tumor model for renal cell carcinoma expressing the carbonic anhydrase type 9 tumor antigen.
Neoplasms
Lacidipine [correction of Lalsoacidipine] modulates the secretion of matrix metalloproteinase-9 by human macrophages.
Neoplasms
Laminin signals initiate the reciprocal loop that informs breast-specific gene expression and homeostasis by activating NO, p53 and microRNAs.
Neoplasms
Large-scale and effective screening of Korean medicinal plants for inhibitory activity on matrix metalloproteinase-9.
Neoplasms
Laser-induced hyperthermia in rat prostate cancer: role of site of tumor implantation.
Neoplasms
Late ischemic preconditioning of the myocardium alters the expression of genes involved in inflammatory response.
Neoplasms
Legume seeds and colorectal cancer revisited: Protease inhibitors reduce MMP-9 activity and colon cancer cell migration.
Neoplasms
Lentivirus-mediated estrogen receptor ? overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Neoplasms
Leptomycin B reduces matrix metalloproteinase-9 expression and suppresses cutaneous inflammation.
Neoplasms
Leukocyte-mimicking Pluronic-lipid nanovesicle hybrids inhibit the growth and metastasis of breast cancer.
Neoplasms
Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.
Neoplasms
Licochalcone A attenuates abdominal aortic aneurysm induced by angiotensin II via regulating the miR-181b/SIRT1/HO-1 signaling.
Neoplasms
LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro-inflammatory cytokines and MMP-9 in macrophages.
Neoplasms
Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Neoplasms
LINC00963 affects the development of colorectal cancer via MiR-532-3p/HMGA2 axis.
Neoplasms
LINC01534 Promotes the Aberrant Metabolic Dysfunction and Inflammation in IL-1?-Simulated Osteoarthritic Chondrocytes by Targeting miR-140-5p.
Neoplasms
Lipocalin2 enhances the matrix metalloproteinase-9 activity and invasion of extravillous trophoblasts under hypoxia.
Neoplasms
Lipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma.
Neoplasms
Lipoic Acid-Modified Oligoethyleneimine-Mediated miR-34a Delivery to Achieve the Anti-Tumor Efficacy.
Neoplasms
Liposome-mediated amplified detection of cell-secreted matrix metalloproteinase-9.
Neoplasms
Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages.
Neoplasms
Liver-specific overexpression of matrix metalloproteinase 9 (MMP-9) in transgenic mice accelerates development of hepatocellular carcinoma.
Neoplasms
LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
Neoplasms
Local influence of high molecular polyethylene particles on heterotopic ossification.
Neoplasms
Localization of 92-kDa type IV collagenase in human skin tumors: comparison with normal human fetal and adult skin.
Neoplasms
Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.
Neoplasms
Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas.
Neoplasms
Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells.
Neoplasms
Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?
Neoplasms
Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway.
Neoplasms
Long non-coding RNA H19 regulates viability and metastasis, and is upregulated in retinoblastoma.
Neoplasms
Long Noncoding RNA HOTAIR Contributes to Progression in Hepatocellular Carcinoma by Sponging miR-217-5p.
Neoplasms
Long Noncoding RNA LINC003121 Inhibits Proliferation and Invasion of Thyroid Cancer Cells by Suppression of the Phosphatidylinositol-3-Kinase (PI3K)/Akt Signaling Pathway.
Neoplasms
Long noncoding RNA LINC00460 targets miR-539/MMP-9 to promote meningioma progression and metastasis.
Neoplasms
Lonicera japonica THUNB. Extract Inhibits Lipopolysaccharide-Stimulated Inflammatory Responses by Suppressing NF-?B Signaling in BV-2 Microglial Cells.
Neoplasms
Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9.
Neoplasms
Loss of Inhibitor of Growth (ING-4) Is Implicated in the Pathogenesis and Progression of Human Astrocytomas.
Neoplasms
Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
Neoplasms
Loss of Suppressors of Cytokine Signaling 3 Promotes Aggressiveness in Hepatocellular Carcinoma.
Neoplasms
Loss of TIMP-1 immune expression and tumor recurrence in localized prostate cancer.
Neoplasms
Low concentrations of the recombinant toxin protein rLj-RGD3 suppress TNF-?-induced human renal carcinoma cell invasion.
Neoplasms
Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
Neoplasms
Low intensity exercise in the prevention of cardiac insulin resistance-related inflammation and disturbances in NOS and MMP-9 regulation in fructose-fed ovariectomised rats.
Neoplasms
Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.
Neoplasms
Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma.
Neoplasms
Low-density lipoprotein receptor-related protein contributes to the antiangiogenic activity of thrombospondin-2 in a murine glioma model.
Neoplasms
LOX inhibition downregulates MMP-2 and MMP-9 in gastric cancer tissues and cells.
Neoplasms
LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1.
Neoplasms
Lung resided monocytic myeloid-derived suppressor cells contribute to premetastatic niche formation by enhancing MMP-9 expression.
Neoplasms
Lung transplant ischemia reperfusion injury: metalloprotease inhibition down-regulates exposure of type V collagen, growth-related oncogene-induced neutrophil chemotaxis, and tumor necrosis factor-alpha expression.
Neoplasms
Lupeol induces apoptosis and inhibits invasion in gallbladder carcinoma GBC-SD cells by suppression of EGFR/MMP-9 signaling pathway.
Neoplasms
Lutein Treatment Effects on the Redox Status and Metalloproteinase-9 (MMP-9) in Oral Cancer Squamous Cells-Are There Therapeutical Hopes?
Neoplasms
Luteolin 8-C-?-fucopyranoside downregulates IL-6 expression by inhibiting MAPKs and the NF-?B signaling pathway in human monocytic cells.
Neoplasms
Luteolin 8-C-?-fucopyranoside inhibits invasion and suppresses TPA-induced MMP-9 and IL-8 via ERK/AP-1 and ERK/NF-?B signaling in MCF-7 breast cancer cells.
Neoplasms
Luteolin inhibits the proliferation, adhesion, migration and invasion of choroidal melanoma cells in vitro.
Neoplasms
Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques.
Neoplasms
LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression.
Neoplasms
M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.
Neoplasms
M2 macrophage-derived exosomes facilitate hepatocarcinoma metastasis by transferring ?M ?2 integrin to tumor cells.
Neoplasms
Macrophage tolerance response to Aggregatibacter actinomycetemcomitans lipopolysaccharide induces differential regulation of tumor necrosis factor-alpha, interleukin-1 beta and matrix metalloproteinase 9 secretion.
Neoplasms
Macrophages of M1 phenotype have properties that influence lung cancer cell progression.
Neoplasms
Macrophages-Triggered Sequential Remodeling of Endothelium-Interstitial Matrix to Form Pre-Metastatic Niche in Microfluidic Tumor Microenvironment.
Neoplasms
Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-?B signaling pathway.
Neoplasms
Major surface protein complex of Treponema denticola induces the production of tumor necrosis factor alpha, interleukin-1beta, interleukin-6 and matrix metalloproteinase 9 by primary human peripheral blood monocytes.
Neoplasms
Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.
Neoplasms
Mangiferin attenuates DSS colitis in mice: Molecular docking and in vivo approach.
Neoplasms
Mangiferin inhibits tumor necrosis factor-?-induced matrix metalloproteinase-9 expression and cellular invasion by suppressing nuclear factor-?B activity.
Neoplasms
Marked induction of gelatinases, especially type B, in host fibroblasts by human ovarian cancer cells in athymic mice.
Neoplasms
Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers.
Neoplasms
Matricellular proteins and matrix metalloproteinases mark the inflammatory and fibrotic response in human cardiac allograft rejection.
Neoplasms
Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
Neoplasms
Matrix metallopeptidase 9 targeted by hsa-miR-494 promotes silybin-inhibited osteosarcoma.
Neoplasms
Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer.
Neoplasms
Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer.
Neoplasms
Matrix metalloproteinase (MMP)-1 and MMP-3 induce macrophage MMP-9: evidence for the role of TNF-alpha and cyclooxygenase-2.
Neoplasms
Matrix metalloproteinase (MMP)-2 and MMP-9 Expression in Tumor Infiltrating CD3 Lymphocytes From Women With Endometrial Cancer.
Neoplasms
Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
Neoplasms
Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts (CAFs) is suppressed by omega-3 polyunsaturated fatty acids in vitro and in vivo.
Neoplasms
Matrix metalloproteinase (MMP-2 and MMP-9) and steroid receptor expressions in feline mammary tumors.
Neoplasms
Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
Neoplasms
Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis.
Neoplasms
Matrix metalloproteinase 2 and matrix metalloproteinase 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: preliminary observations.
Neoplasms
Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.
Neoplasms
Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity.
Neoplasms
Matrix metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells.
Neoplasms
Matrix metalloproteinase 9 activity leads to elastin breakdown in an animal model of Kawasaki disease.
Neoplasms
Matrix metalloproteinase 9 and prostate-cancer risk : a meta-analysis of 1,059 participants.
Neoplasms
Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.
Neoplasms
Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis.
Neoplasms
Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.
Neoplasms
Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling.
Neoplasms
Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.
Neoplasms
Matrix metalloproteinase 9 is associated with Gleason score in prostate cancer but not with prognosis.
Neoplasms
Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression.
Neoplasms
Matrix metalloproteinase 9 targeting peptides: syntheses, 68Ga-labeling, and preliminary evaluation in a rat melanoma xenograft model.
Neoplasms
Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: An overview.
Neoplasms
Matrix metalloproteinase expression in normal skin associated with basal cell carcinoma and in distal skin from the same patients.
Neoplasms
Matrix metalloproteinase induction in the tumor stroma does not depend on CD147 expression in murine B16 melanoma.
Neoplasms
Matrix metalloproteinase inhibition improves survival in an orthotopic model of human pancreatic cancer.
Neoplasms
Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study.
Neoplasms
Matrix metalloproteinase inhibitor MMI-166 inhibits lymphogenous metastasis in an orthotopically implanted model of lung cancer.
Neoplasms
Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Neoplasms
Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha.
Neoplasms
MATRIX METALLOPROTEINASE- 9 POLYMORPHISMS IN THE DIAGNOSIS OF PROSTATE CANCER. A PRELIMINARY EXPERIENCE.
Neoplasms
Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.
Neoplasms
Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients.
Neoplasms
Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours.
Neoplasms
Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.
Neoplasms
Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system.
Neoplasms
Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 expression in the biological behavior of Canine and Feline Meningioma.
Neoplasms
Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer.
Neoplasms
Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients.
Neoplasms
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.
Neoplasms
Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.
Neoplasms
Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion.
Neoplasms
Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances.
Neoplasms
Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer.
Neoplasms
Matrix metalloproteinase-9 (MMP-9) elevated in serum but not in bronchial lavage fluid in patients with lung cancer.
Neoplasms
Matrix metalloproteinase-9 (MMP-9) Expression in Non-Small Cell Lung Carcinoma and Its Association with Clinicopathologic Factors.
Neoplasms
Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy.
Neoplasms
Matrix metalloproteinase-9 (MMP-9) immunoreactive protein in urinary bladder cancer: a marker of favorable prognosis.
Neoplasms
Matrix metalloproteinase-9 (MMP9) is involved in the TNF-?-induced fusion of human M13SV1-Cre breast epithelial cells and human MDA-MB-435-pFDR1 cancer cells.
Neoplasms
Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders.
Neoplasms
Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.
Neoplasms
Matrix metalloproteinase-9 and the cu/zn ratio as ancillary diagnostic tools in distinguishing between the classical and follicular variants of papillary thyroid carcinoma.
Neoplasms
Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse.
Neoplasms
Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition.
Neoplasms
Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy.
Neoplasms
Matrix metalloproteinase-9 expression in lung cancer patients and its relation to serum mmp-9 activity, pathologic type, and prognosis.
Neoplasms
Matrix metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factors and patient outcome.
Neoplasms
Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.
Neoplasms
Matrix Metalloproteinase-9 Expression is Increased in Astrocytic Glioma and Associated with Prognosis of Patients.
Neoplasms
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.
Neoplasms
Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer.
Neoplasms
Matrix metalloproteinase-9 gene polymorphism in hepatocellular carcinoma patients with hepatitis B and C viruses.
Neoplasms
Matrix metalloproteinase-9 in broncho-alveolar lavage fluid of patients with non-small cell lung cancer.
Neoplasms
Matrix metalloproteinase-9 in vascular lesions and endothelial regulation in Kawasaki disease.
Neoplasms
Matrix metalloproteinase-9 induces a pro-angiogenic profile in chronic lymphocytic leukemia cells.
Neoplasms
Matrix Metalloproteinase-9 Is a Marker of Heart Failure After Acute Myocardial Infarction.
Neoplasms
Matrix metalloproteinase-9 is a prognostic marker for patients with cervical cancer.
Neoplasms
Matrix metalloproteinase-9 is a prognostic marker to predict survival of patients who underwent surgery due to rectal carcinoma.
Neoplasms
Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer.
Neoplasms
Matrix Metalloproteinase-9 Is Associated with Relapse and Prognosis of Patients with Colorectal Cancer.
Neoplasms
Matrix metalloproteinase-9 is required for tubular network formation and migration of resistant breast cancer cells MCF-7 through PKC and ERK1/2 signalling pathways.
Neoplasms
Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells.
Neoplasms
Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.
Neoplasms
Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival.
Neoplasms
Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer.
Neoplasms
Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population.
Neoplasms
Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat.
Neoplasms
Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1.
Neoplasms
Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis.
Neoplasms
Matrix metalloproteinase-9 silencing by RNA interference promotes the adhesive-invasive switch in HT1080 human fibrosarcoma cells.
Neoplasms
Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.
Neoplasms
Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
Neoplasms
Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and tumour necrosis factor alpha release during cardiopulmonary bypass.
Neoplasms
Matrix metalloproteinase-9, transforming growth factor-?1, and tumor necrosis factor-? plasma levels in chronic pancreatitis.
Neoplasms
Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
Neoplasms
Matrix Metalloproteinase-9-Responsive Surface Charge-Reversible Nanocarrier to Enhance Endocytosis as Efficient Targeted Delivery System for Cancer Diagnosis and Therapy.
Neoplasms
Matrix metalloproteinase-9: a deleterious link between hepatic ischemia-reperfusion and colorectal cancer.
Neoplasms
Matrix metalloproteinases 2 and 9 and their tissue inhibitors in low malignant potential ovarian tumors.
Neoplasms
Matrix metalloproteinases 2 and 9 immunoexpression in prostate carcinoma at the positive margin of radical prostatectomy specimens.
Neoplasms
Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.
Neoplasms
Matrix metalloproteinases 2 and 9 in situ mRNA expression in colorectal tumors from Iraqi patients.
Neoplasms
Matrix metalloproteinases 2, 7, and 9 in tumors and sera of patients with breast cancer.
Neoplasms
Matrix metalloproteinases and E-cadherin immunoreactivity in different basal cell carcinoma histological types.
Neoplasms
Matrix metalloproteinases and their tissue inhibitors - expression, role and regulation in human malignant non-Hodgkin's lymphomas.
Neoplasms
Matrix Metalloproteinases and Their Tissue Inhibitors in Blood Serum of Patients with Endometrial Cancer: Clinical and Morphological Correlations.
Neoplasms
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Neoplasms
Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Neoplasms
Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
Neoplasms
Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
Neoplasms
Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.
Neoplasms
Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.
Neoplasms
Matrix metalloproteinases-2 and -9 in cervical cancer: different roles in tumor progression.
Neoplasms
Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation.
Neoplasms
Matrix metalloproteinases-7, -8, -9 and TIMP-1 in the follow-up of diisocyanate-induced asthma.
Neoplasms
Matrix proteases, green tea, and St. John's wort: biomedical research catches up with folk medicine.
Neoplasms
Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma.
Neoplasms
MDM2 Overexpression Modulates the Angiogenesis-Related Gene Expression Profile of Prostate Cancer Cells.
Neoplasms
MDM2 promotes invasion and metastasis in invasive ductal breast carcinoma by inducing matrix metalloproteinase-9.
Neoplasms
Mechanisms by which thiazolidinediones induce anti-cancer effects in cancers in digestive organs.
Neoplasms
Mechanisms involved in the differential bone marrow homing of CD45 subsets in 5T murine models of myeloma.
Neoplasms
MED27 promotes melanoma growth by targeting AKT/MAPK and NF-?B/iNOS signaling pathways.
Neoplasms
Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
Neoplasms
Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: A potentially protective mechanism in atherosclerotic vascular disease and cancer.
Neoplasms
Melatonin improves periodontitis-induced kidney damages by decreasing inflammatory stress and apoptosis in rats.
Neoplasms
Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.
Neoplasms
Melatonin protects circulatory death heart from ischemia/reperfusion injury via the JAK2/STAT3 signalling pathway.
Neoplasms
Melatonin suppresses TPA-induced metastasis by downregulating matrix metalloproteinase-9 expression through JNK/SP-1 signaling in nasopharyngeal carcinoma.
Neoplasms
Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression.
Neoplasms
Mercaptoethanol Protects the Aorta from Dissection by Inhibiting Oxidative Stress, Inflammation, and Extracellular Matrix Degeneration in a Mouse Model.
Neoplasms
Merkel Cell Polyomavirus Small Tumor Antigen Activates Matrix Metallopeptidase-9 Gene Expression for Cell Migration and Invasion.
Neoplasms
Mesenchymal stem cells induce a fibrolytic phenotype by regulating mmu-miR-6769b-5p expression in macrophages.
Neoplasms
Mesenchymal Stem Cells Promote Tumor Progression via Inducing Stroma Remodeling on Rabbit VX2 Bladder Tumor Model.
Neoplasms
Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients.
Neoplasms
Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma.
Neoplasms
Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome.
Neoplasms
Metallopeptidase, neurolysin, as a novel molecular tool for analysis of properties of cancer-producing matrix metalloproteinases-2 and -9.
Neoplasms
Metalloprotease-specific poly(ethylene glycol) methyl ether-peptide-doxorubicin conjugate for targeting anticancer drug delivery based on angiogenesis.
Neoplasms
Metalloproteinase and TIMP expression by the human breast carcinoma cell line 8701-BC.
Neoplasms
Metalloproteinase- and gamma-secretase-mediated cleavage of protein-tyrosine phosphatase receptor type Z.
Neoplasms
Metalloproteinases and their inhibitors in squamous cell carcinoma of the hypopharynx: indicators of individual tumor aggressiveness.
Neoplasms
Metalloproteinases and their inhibitors: Influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas.
Neoplasms
Metalloproteinases TACE and MMP-9 Differentially Regulate Death Factors on Adult and Neonatal Monocytes After Infection with Escherichia coli.
Neoplasms
METALLOPROTEINS DURING DEVELOPMENT OF WALKER-256 CARCINOSARCOMA RESISTANT PHENOTYPE.
Neoplasms
Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo.
Neoplasms
Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-?B pathway, and MMP-9 expression.
Neoplasms
Metastatic Inhibitory and Radical Scavenging Efficacies of Saponins Extracted from the Brittle Star (Ophiocoma erinaceus).
Neoplasms
Metastatic potential in MDA-MB-231 human breast cancer cells is inhibited by proton beam irradiation via the Akt/nuclear factor-?B signaling pathway.
Neoplasms
Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Calpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activator protein-1.
Neoplasms
Methanol extract of Codium fragile inhibits tumor necrosis factor-?-induced matrix metalloproteinase-9 and invasiveness of MDA-MB-231 cells by suppressing nuclear factor-?B activation.
Neoplasms
Methanol extract of Elaeagnus glabra, a Korean medicinal plant, inhibits HT1080 tumor cell invasion.
Neoplasms
Methanol extract of Hydroclathrus clathratus suppresses matrix metalloproteinase-9 in T24 bladder carcinoma cells by suppressing the NF-?B and MAPK pathways.
Neoplasms
Methotrexate gamma-hydroxamate derivatives as potential dual target antitumor drugs.
Neoplasms
Microarray analysis of anti-cancer effects of docosahexaenoic acid on human colon cancer model in nude mice.
Neoplasms
Microcystin-LR promotes melanoma cell invasion and enhances matrix metalloproteinase-2/-9 expression mediated by NF-?B activation.
Neoplasms
Microdermabrasion with and without aluminum oxide crystal abrasion: a comparative molecular analysis of dermal remodeling.
Neoplasms
Microenvironment effects on promoting upregulation of matrix metalloproteinases in Bcl-2-overexpressing renal cell carcinoma as a response to doxorubicin treatment inducing the production of metastasis.
Neoplasms
Microglial SMAD4 regulated by microRNA-146a promotes migration of microglia which support tumor progression in a glioma environment.
Neoplasms
Microglial stress inducible protein 1 promotes proliferation and migration in human glioblastoma cells.
Neoplasms
Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression.
Neoplasms
MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer.
Neoplasms
MicroRNA-183 inhibits A375 human melanoma cell migration and invasion by targeting Ezrin and MMP-9.
Neoplasms
microRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer.
Neoplasms
microRNA-340 Suppresses Tumorigenic Potential of Prostate Cancer Cells by Targeting High-Mobility Group Nucleosome-Binding Domain 5.
Neoplasms
microRNA-451a prevents activation of matrix metalloproteinases 2 and 9 in human cardiomyocytes during pathological stress stimulation.
Neoplasms
MicroRNA-495 attenuates proliferation and inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes through attenuating ?-catenin pathway.
Neoplasms
MicroRNA-520a-3p suppresses non-small-cell lung carcinoma by inhibition of High Mobility Group Box 1 (HMGB1).
Neoplasms
MicroRNA-708 activation by glucocorticoid receptor agonists regulate breast cancer tumorigenesis and metastasis via downregulation of NF-?B signaling.
Neoplasms
MicroRNA-mediated extracellular matrix remodeling in squamous cell carcinoma of the oral cavity.
Neoplasms
Mid-trimester amniotic fluid pro-inflammatory biomarkers predict the risk of spontaneous preterm delivery in twins: a retrospective cohort study.
Neoplasms
Mifepristone alleviates cerebral ischemia-reperfusion injury in rats by stimulating PPAR ?.
Neoplasms
miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway.
Neoplasms
miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3.
Neoplasms
miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases.
Neoplasms
miR-618: possible control over TIMP-1 and its expression in localized prostate cancer.
Neoplasms
miR-768-3p is involved in the proliferation, invasion and migration of non-small cell lung carcinomas.
Neoplasms
miR-9 functions as a tumor inhibitor of cell proliferation in epithelial ovarian cancer through targeting the SDF-1/CXCR4 pathway.
Neoplasms
miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancer.
Neoplasms
miRNA-143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitro.
Neoplasms
MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma.
Neoplasms
Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells.
Neoplasms
Mitomycin C modulates intracellular matrix metalloproteinase-9 expression and affects corneal fibroblast migration.
Neoplasms
Mitotic arrest induced in human DU145 prostate cancer cells in response to KHC-4 treatment.
Neoplasms
MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription.
Neoplasms
MMI-166, a selective matrix metalloproteinase inhibitor, promotes apoptosis in human pancreatic cancer.
Neoplasms
MMP-2 activation and stepwise progression of pulmonary adenocarcinoma: analysis of MMP-2 and MMP-9 with gelatin zymography.
Neoplasms
MMP-2 and MMP-9 as prognostic markers for the early detection of urinary bladder cancer.
Neoplasms
MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions.
Neoplasms
MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients.
Neoplasms
MMP-2 expression associates with CA 125 and clinical course in endometrial carcinoma.
Neoplasms
MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not.
Neoplasms
MMP-2 mRNA Expression in Ovarian Cancer Tissues Predicts Patients' Response to Platinum-Taxane Chemotherapy.
Neoplasms
MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.
Neoplasms
MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients.
Neoplasms
MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells.
Neoplasms
MMP-9 activity in urine from patients with various tumors, as measured by a novel MMP activity assay using modified urokinase as a substrate.
Neoplasms
MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC).
Neoplasms
MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors.
Neoplasms
MMP-9 as a?potential biomarker for carcinoma of oral cavity: a?study in?eastern India.
Neoplasms
MMP-9 Deletion Attenuates Arteriovenous Fistula Neointima through Reduced Perioperative Vascular Inflammation.
Neoplasms
MMP-9 directed shRNAs as relevant inhibitors of matrix metalloproteinase 9 activity and signaling.
Neoplasms
MMP-9 Expression after Metallic Stent Placement in Patients with Colorectal Cancer: Association with In-Stent Restenosis.
Neoplasms
MMP-9 expression in peripheral blood mononuclear cells and the association with clinicopathological features and prognosis of nasopharyngeal carcinoma.
Neoplasms
MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis.
Neoplasms
MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration.
Neoplasms
MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells.
Neoplasms
MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors.
Neoplasms
MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model.
Neoplasms
MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases.
Neoplasms
MMP-9 is increased in the pathogenesis of gastric cancer by the mediation of HER2.
Neoplasms
MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma.
Neoplasms
MMP-9 Knockdown Inhibits Oral Squamous Cell Carcinoma Lymph Node Metastasis in the Nude Mouse Tongue-Xenografted Model through the RhoC/Src Pathway.
Neoplasms
MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma.
Neoplasms
MMP-9 polymorphisms are related to serum lipids levels but not associated with colorectal cancer susceptibility in Chinese population.
Neoplasms
Mmp-9 responsive PEG cleavable nanovesicles for efficient delivery of chemotherapeutics to pancreatic cancer.
Neoplasms
MMP-9 secreted by tumor associated macrophages promoted gastric cancer metastasis through a PI3K/AKT/Snail pathway.
Neoplasms
MMP-9 silencing regulates hTERT expression via ?1 integrin-mediated FAK signaling and induces senescence in glioma xenograft cells.
Neoplasms
MMP-9 triggered self-assembly of doxorubicin nanofiber depots halts tumor growth.
Neoplasms
MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice.
Neoplasms
MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
Neoplasms
MMP-9/RECK Imbalance: A Mechanism Associated with High-Grade Cervical Lesions and Genital Infection by Human Papillomavirus and Chlamydia trachomatis.
Neoplasms
MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer.
Neoplasms
MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy.
Neoplasms
MMP9 Promoter Polymorphism (-1562 C/T) Does not Affect the Serum Levels of Soluble MICB and MICA in Breast Cancer.
Neoplasms
Modulation of autocrine TNF-alpha-stimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells.
Neoplasms
Modulation of metastasis phenotypes of non-small cell lung cancer cells by 17-allylamino 17-demethoxy geldanamycin.
Neoplasms
Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines.
Neoplasms
Modulation of MMP-2 and MMP-9 secretion by cytokines, inducers and inhibitors in human glioblastoma T-98G cells.
Neoplasms
Modulation of p75 neurotrophin receptor under hypoxic conditions induces migration and invasion of C6 glioma cells.
Neoplasms
Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
Neoplasms
Molecular basis for the involvement of thymidine phosphorylase in cancer invasion.
Neoplasms
Molecular characterization and in-silico analysis of the tissue inhibitor of metalloproteinases-3 (TIMP-3) gene of canine mammary tumor.
Neoplasms
Molecular Decision Tree Algorithms Predict Individual Recurrence Pattern for Locally Advanced Nasopharyngeal Carcinoma.
Neoplasms
Molecular evaluation of chronic restrain stress in mice model of non metastatic fibrosarcoma.
Neoplasms
Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice.
Neoplasms
Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice.
Neoplasms
Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter.
Neoplasms
Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases.
Neoplasms
Molecular mechanisms of anticancer activity of deoxyelephantopin in cancer cells.
Neoplasms
Molecular pathobiology of human cervical high-grade lesions: paracrine STAT3 activation in tumor-instructed myeloid cells drives local MMP-9 expression.
Neoplasms
Molecular prognostic markers in recurrent and in non-recurrent epithelial ovarian cancer.
Neoplasms
Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage.
Neoplasms
Monascus purpureus-fermented rice inhibits tumor necrosis factor-?-induced upregulation of matrix metalloproteinase 2 and 9 in human aortic smooth muscle cells.
Neoplasms
Monitoring mmp-9 gene expression in stromal cells using a novel transgenic mouse model.
Neoplasms
Monitoring multiple angiogenesis-related molecules in the blood of cancer patients shows a correlation between VEGF-A and MMP-9 levels before treatment and divergent changes after surgical vs. conservative therapy.
Neoplasms
Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity.
Neoplasms
Monocyte Chemoattractant Protein-1 promotes cancer cell migration via c-Raf/MAPK/AP-1 pathway and MMP-9 production in osteosarcoma.
Neoplasms
Monocyte differentiation induced by co-culture with tumor cells involves RGD-dependent cell adhesion to extracellular matrix.
Neoplasms
Monomeric ?-synuclein induces blood-brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro.
Neoplasms
Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity.
Neoplasms
Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung.
Neoplasms
Mouse trophoblastic cells exhibit a dominant invasiveness phenotype over cancer cells.
Neoplasms
mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas.
Neoplasms
MSH6 Aggravates the Hypoxic Microenvironment via Regulating HIF1A to Promote the Metastasis of Glioblastoma Multiforme.
Neoplasms
MUC1- and Survivin-based DNA Vaccine Combining Immunoadjuvants CpG and interleukin-2 in a Bicistronic Expression Plasmid Generates Specific Immune Responses and Antitumour Effects in a Murine Colorectal Carcinoma Model.
Neoplasms
MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.
Neoplasms
Multi-analyte profiling in human carotid atherosclerosis uncovers pro-inflammatory macrophage programming in plaques.
Neoplasms
Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products.
Neoplasms
Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells.
Neoplasms
Mutation analysis of tumor suppressor gene PTEN in patients with gastric carcinomas and its impact on PI3K/AKT pathway.
Neoplasms
Mycobacterium indicus pranii (Mw) inhibits invasion by reducing matrix metalloproteinase (MMP-9) via AKT/ERK-1/2 and PKC? signalling: a potential candidate in melanoma cancer therapy.
Neoplasms
Mycobacterium indicus pranii downregulates MMP-9 and iNOS through COX-2 dependent and TNF-? independent pathway in mouse peritoneal macrophages in vitro.
Neoplasms
Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept.
Neoplasms
Myeloperoxidase Is an Early Biomarker of Inflammation and Cardiovascular Risk in Prepubertal Obese Children.
Neoplasms
N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation.
Neoplasms
N-Glycosylation pattern of the zymogenic form of human matrix metalloproteinase-9.
Neoplasms
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.
Neoplasms
Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo.
Neoplasms
Naringin inhibits matrix metalloproteinase-9 expression and AKT phosphorylation in tumor necrosis factor-alpha-induced vascular smooth muscle cells.
Neoplasms
Near-infrared triple-helical peptide with quenched fluorophores for optical imaging of MMP-2 and MMP-9 proteolytic activity in vivo.
Neoplasms
Necroptosis triggered by ROS accumulation and Ca2+ overload, partly explains the inflammatory responses and anti-cancer effects associated with 1Hz, 100 mT ELF-MF in vivo.
Neoplasms
Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-? signaling pathway.
Neoplasms
Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines.
Neoplasms
Neuroprotective effects of hypothermia in inflammatory-sensitized hypoxic-ischemic encephalopathy.
Neoplasms
Neutralization of matrix metalloproteinase-9 potentially enhances oncolytic efficacy of tanapox virus for melanoma therapy.
Neoplasms
Neutrophil elastase ameliorates matrix metalloproteinase-9 to promote lipopolysaccharide-induced acute lung injury in mice 1.
Neoplasms
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinoma.
Neoplasms
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma.
Neoplasms
Neutrophil gelatinase-associated lipocalin (NGAL) expression dependent on the tumor-associated sigma-2 receptor S2RPgrmc1.
Neoplasms
Neutrophils in Biomaterial-Guided Tissue Regeneration: Matrix Reprogramming for Angiogenesis.
Neoplasms
New clinical scoring system for prognosis of early recurrence of colorectal liver metastases after surgical treatment.
Neoplasms
New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: Outside-in signaling and relationship to tumor progression.
Neoplasms
New inhibitors of matrix metalloproteinases 9 (MMP-9): Lignans from Selaginella moellendorffii.
Neoplasms
New Insights on Old Biomarkers Involved in Tumor Microenvironment Changes and Their Diagnostic Relevance in Non-Small Cell Lung Carcinoma.
Neoplasms
New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells.
Neoplasms
New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents.
Neoplasms
NF-kappa BP65 Promotes Invasion and Metastasis of Esophageal Squamous Cell Cancer by Regulating Matrix Metalloproteinase-9 and Epithelial-to-Mesenchymal Transition.
Neoplasms
NF-kappaB blockade upregulates Bax, TSP-1, and TSP-2 expression in rat granulation tissue.
Neoplasms
NF-kappaB-dependent regulation of matrix metalloproteinase-9 gene expression by lipopolysaccharide in a macrophage cell line RAW 264.7.
Neoplasms
NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes.
Neoplasms
NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells.
Neoplasms
NGAL knockdown by siRNA in human cholangiocarcinoma cells suppressed invasion by reducing NGAL/MMP-9 complex formation.
Neoplasms
Niacin action in the atherogenic mixed dyslipidemia of metabolic syndrome: Insights from metabolic biomarker profiling and network analysis.
Neoplasms
Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model.
Neoplasms
NIK- and IKK?-binding protein promotes colon cancer metastasis by activating the classical NF-?B pathway and MMPs.
Neoplasms
Nitric Oxide Involvement in TNF-alpha and IL-1beta-Mediated Changes in Human Mesangial Cell MMP-9 and TIMP-1.
Neoplasms
Nitric oxide-matrix metaloproteinase-9 interactions: Biological and pharmacological significance: NO and MMP-9 interactions.
Neoplasms
Nitric oxide-releasing micelles with intelligent targeting for enhanced anti-tumor effect of cisplatin in hypoxia.
Neoplasms
Nitrogen mustard exposure of murine skin induces DNA damage, oxidative stress and activation of MAPK/Akt-AP1 pathway leading to induction of inflammatory and proteolytic mediators.
Neoplasms
No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Neoplasms
Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.
Neoplasms
Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol.
Neoplasms
Notch1 Regulates the Effects of Matrix Metalloproteinase-9 on Colitis-Associated Cancer in Mice.
Neoplasms
Novel Antitumor Invasive Actions of p-Cymene by Decreasing MMP-9/TIMP-1 Expression Ratio in Human Fibrosarcoma HT-1080 Cells.
Neoplasms
Novel biomarkers assessing renal function in heart failure: relation to inflammatory status and cardiac remodelling.
Neoplasms
Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells.
Neoplasms
Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach.
Neoplasms
Novel roles of androgen receptor, epidermal growth factor receptor, TP53, regulatory RNAs, NF-kappa-B, chromosomal translocations, neutrophil associated gelatinase, and matrix metalloproteinase-9 in prostate cancer and prostate cancer stem cells.
Neoplasms
Novel self-nanoemulsifying formulation of quercetin: Implications of pro-oxidant activity on the anticancer efficacy.
Neoplasms
Novel Suppressive Effects of Ketotifen on Migration and Invasion of MDA-MB-231 and HT-1080 Cancer Cells.
Neoplasms
Nuclear factor ?B activity correlates with the progression and prognosis of pancreatic cancer in a mouse model.
Neoplasms
Nuclear factor E2-related factor 2 knockdown enhances glucose uptake and alters glucose metabolism in AML12 hepatocytes.
Neoplasms
Nuclear factor inducing kinase: A key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.
Neoplasms
Nuclear factor-?B plays an important role in Tamarixetin-mediated inhibition of matrix metalloproteinase-9 expression.
Neoplasms
Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
Neoplasms
Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression.
Neoplasms
Nuclear-targeted inhibition of NF-kappaB on MMP-9 production by N-2-(4-bromophenyl) ethyl caffeamide in human monocytic cells.
Neoplasms
O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: implications for the domain organization of the enzyme.
Neoplasms
Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells.
Neoplasms
Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases.
Neoplasms
Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells.
Neoplasms
Olea europaea leaf extract and bevacizumab synergistically exhibit beneficial efficacy upon human glioblastoma cancer stem cells through reducing angiogenesis and invasion in vitro.
Neoplasms
Oleic acid-induced NOX4 is dependent on ANGPTL4 expression to promote human colorectal cancer metastasis.
Neoplasms
Olive Leaf Extract and Its Main Component Oleuropein Prevent Chronic Ultraviolet B Radiation-Induced Skin Damage and Carcinogenesis in Hairless Mice.
Neoplasms
Olive oil phenols modulate the expression of metalloproteinase 9 in THP-1 cells by acting on nuclear factor-kappaB signaling.
Neoplasms
Olmesartan decreases IL-1? and TNF-? levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis.
Neoplasms
Omega 3 Polyunsaturated Fatty Acids Suppress the Development of Aortic Aneurysms Through the Inhibition of Macrophage-Mediated Inflammation.
Neoplasms
On-line chromatographic screening of matrix metalloproteinase inhibitors using immobilized MMP-9 enzyme reactor.
Neoplasms
On-line screening of matrix metalloproteinase inhibitors by capillary electrophoresis coupled to ESI mass spectrometry.
Neoplasms
Oncogene-mediated downregulation of RECK, a novel transformation suppressor gene.
Neoplasms
Oncogenic transformation of human benign prostate hyperplasia with chronic cadmium exposure.
Neoplasms
Opioids and matrix metalloproteinases: the influence of morphine on MMP-9 production and cancer progression.
Neoplasms
Opposite Roles of CCR2 and CX3CR1 Macrophages in Alkali-Induced Corneal Neovascularization.
Neoplasms
Oral Administration of Apigenin Inhibits Metastasis through AKT/P70S6K1/MMP-9 Pathway in Orthotopic Ovarian Tumor Model.
Neoplasms
Oral and Extraoral Intermediate Tumors: Are MMP-9 and Ki-67 Biomarkers Correlated to Their High Recurrence Rates?
Neoplasms
Orally administered green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors.
Neoplasms
Organ heterogeneity of host-derived matrix metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines.
Neoplasms
Ornithine decarboxylase interferes with macrophage-like differentiation and matrix metalloproteinase-9 expression by tumor necrosis factor alpha via NF-kappaB.
Neoplasms
Oroxylin A inhibits invasion and migration through suppressing ERK/GSK-3? signaling in snail-expressing non-small-cell lung cancer cells.
Neoplasms
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.
Neoplasms
Osteoclast precursors acquire sensitivity to breast cancer derived factors early in differentiation.
Neoplasms
Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.
Neoplasms
Osteoclast-derived matrix metalloproteinase-9 directly affects angiogenesis in the prostate tumor-bone microenvironment.
Neoplasms
Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice.
Neoplasms
Osteopontin is linked to p65 and MMP-9 expression in pulmonary adenocarcinoma but not in malignant pleural mesothelioma.
Neoplasms
Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via ?9?1 integrin.
Neoplasms
Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways.
Neoplasms
Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells.
Neoplasms
Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels.
Neoplasms
Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment.
Neoplasms
Ovatodiolide of Anisomeles indica Exerts the Anticancer Potential on Pancreatic Cancer Cell Lines through STAT3 and NF-?B Regulation.
Neoplasms
Over-expression of mir-124 inhibits MMP-9 expression and decreases invasion of renal cell carcinoma cells.
Neoplasms
Over-expression of VEGF and MMP-9 in residual tumor cells of hepatocellular carcinoma after embolization with lipidol.
Neoplasms
Overabundance of putative cancer stem cells in human skin keratinocyte cells malignantly transformed by arsenic.
Neoplasms
Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer.
Neoplasms
Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis.
Neoplasms
Overexpression of CXCR4 promotes invasion and migration of non-small cell lung cancer via EGFR and MMP-9.
Neoplasms
Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis.
Neoplasms
Overexpression of matrix metalloproteinase 9 in tumor epithelial cells correlates with colorectal cancer metastasis.
Neoplasms
Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer.
Neoplasms
Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: Correlation with a favorable clinical outcome.
Neoplasms
Overexpression of matrix metalloproteinase-9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta/SMAD signalling.
Neoplasms
Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients.
Neoplasms
Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.
Neoplasms
Overexpression of MMP-9 and HIF-1? in Breast Cancer Cells under Hypoxic Conditions.
Neoplasms
Overexpression of MMP-9 Contributes to Invasiveness of Prostate Cancer Cell Line LNCaP.
Neoplasms
Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion.
Neoplasms
Overexpression of PRDX4 Modulates Tumor Microenvironment and Promotes Urethane-Induced Lung Tumorigenesis.
Neoplasms
Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Neoplasms
Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
Neoplasms
Overexpression of VEGF-C and MMP-9 predicts poor prognosis in Kazakh patients with esophageal squamous cell carcinoma.
Neoplasms
Oxalomalate suppresses metastatic melanoma through IDH-targeted stress response to ROS.
Neoplasms
Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated monocytes.
Neoplasms
Oxymatrine alleviates periodontitis in rats by inhibiting inflammatory factor secretion and regulating MMPs/TIMP protein expression1.
Neoplasms
p16(INK4A) Represses the paracrine tumor-promoting effects of breast stromal fibroblasts.
Neoplasms
P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor ? expression and enhanced matrix metalloproteinase 9 secretion.
Neoplasms
P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer.
Neoplasms
p38 MAP kinase regulates rapid matrix metalloproteinase-9 release from eosinophils.
Neoplasms
P53 stratification reveals the prognostic utility of matrix metalloproteinase-9 protein expression in glioblastoma.
Neoplasms
Paeoniflorin Prevents Intestinal Barrier Disruption and Inhibits Lipopolysaccharide (LPS)-Induced Inflammation in Caco-2 Cell Monolayers.
Neoplasms
Panax Notoginseng Saponins Inhibits Ventricular Remodeling after Myocardial Infarction in Rats Through Regulating ATF3/MAP2K3/p38 MAPK and NF ? B Pathway.
Neoplasms
Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway.
Neoplasms
Paracrine communication between malignant and non-malignant prostate epithelial cells in culture alters growth rate, matrix protease secretion and in vitro invasion.
Neoplasms
Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures.
Neoplasms
Parathyroid Hormone-related Protein Drives a CD11b+Gr1+ cell-mediated Positive Feedback Loop to Support Prostate Cancer Growth.
Neoplasms
Parecoxib exhibits anti-inflammatory and neuroprotective effects in a rat model of transient global cerebral ischemia.
Neoplasms
Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours.
Neoplasms
Pattern of collagen fibers and localization of matrix metalloproteinase 2 and 9 during breast cancer invasion.
Neoplasms
Pattern of expression of inflammatory markers in adipose tissue of untreated hypertensive patients.
Neoplasms
Patterns of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironment.
Neoplasms
Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
Neoplasms
PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma.
Neoplasms
PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.
Neoplasms
PEG10 plays a crucial role in human lung cancer proliferation, progression, prognosis and metastasis.
Neoplasms
Peptide inhibition of catalytic and noncatalytic activities of matrix metalloproteinase-9 blocks tumor cell migration and invasion.
Neoplasms
Peptidoglycan from sterile human spleen induces T-cell proliferation and inflammatory mediators in rheumatoid arthritis patients and healthy subjects.
Neoplasms
Performance of Nano-Hydroxyapatite/Beta-Tricalcium Phosphate and Xenogenic Hydroxyapatite on Bone Regeneration in Rat Calvarial Defects: Histomorphometric, Immunohistochemical and Ultrastructural Analysis.
Neoplasms
Perineural expression of high-mobility group box-1 contributes to long-lasting mechanical hypersensitivity via matrix metalloproteinase-9 upregulation in mice with painful peripheral neuropathy.
Neoplasms
Peritumoral Clefting and Expression of MMP-2 and MMP-9 in Basal Cell Carcinoma of the Skin.
Neoplasms
Peroxisome proliferator activated receptor-? agonists suppress transforming growth factor-?-induced matrix metalloproteinase-9 expression in human keratinocytes.
Neoplasms
Peroxisome Proliferator-Activated Receptor-gamma1 Gene Therapy Attenuates Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice.
Neoplasms
Pharmacologic induction of heme oxygenase 1 reduces acute inflammatory arthritis in mice.
Neoplasms
Pharmacological hypothermia induced neurovascular protection after severe stroke of transient middle cerebral artery occlusion in mice.
Neoplasms
Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies.
Neoplasms
Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas.
Neoplasms
Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1).
Neoplasms
Phenotypic characterization of a human synovial sarcoma cell line, SW982, and its response to dexamethasone.
Neoplasms
Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells.
Neoplasms
Phosphatidic acid as a regulator of matrix metalloproteinase-9 expression via the TNF-alpha signaling pathway.
Neoplasms
Phosphorylation of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase and nuclear translocation of nuclear factor-kappaB are involved in upregulation of matrix metalloproteinase-9 by tumour necrosis factor-alpha.
Neoplasms
Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin.
Neoplasms
Piceatannol inhibits MMP-9-dependent invasion of tumor necrosis factor-?-stimulated DU145 cells by suppressing the Akt-mediated nuclear factor-?B pathway.
Neoplasms
Piceatannol-3-O-?-D-glucopyranoside (PG) exhibits in vitro anti-metastatic and anti-angiogenic activities in HT1080 malignant fibrosarcoma cells.
Neoplasms
Picroside II, an iridoid glycoside from Picrorhiza kurroa, suppresses tumor migration, invasion, and angiogenesis in vitro and in vivo.
Neoplasms
Pigment epithelium-derived factor expression is down-regulated in bladder tumors and correlates with vascular endothelial growth factor and matrix metalloproteinase-9.
Neoplasms
Pimaric acid from Aralia cordata has an inhibitory effect on TNF-?-induced MMP-9 production and HASMC migration via down-regulated NF-?B and AP-1.
Neoplasms
Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR.
Neoplasms
Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway.
Neoplasms
Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer.
Neoplasms
Plasma concentrations of interleukin-6, C-reactive protein, tumor necrosis factor-? and matrix metalloproteinase-9 in aortic dissection.
Neoplasms
Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer.
Neoplasms
Plasma levels and diagnostic utility of macrophage-colony stimulating factor, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 as tumor markers in cervical cancer patients.
Neoplasms
Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer.
Neoplasms
Plasma Levels of Matrix Metalloproteinase (MMP)-2, MMP-9 and Tumor Necrosis Factor-? in Chronic Hepatitis C Virus Patients.
Neoplasms
Plasma levels of matrix metalloproteinases 2 and 9 correlate with histological grade in breast cancer patients.
Neoplasms
Plasma matrix metalloproteinase 9 as an early surrogate biomarker of advanced colorectal neoplasia.
Neoplasms
Plasma matrix metalloproteinase 9 as biomarker of prostate cancer progression in Dunning (Copenhagen) rats.
Neoplasms
Plasma matrix metalloproteinase-9 (gelatinase B) in patients with hepatocellular carcinoma.
Neoplasms
Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
Neoplasms
Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease.
Neoplasms
Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients.
Neoplasms
Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b(+)/F4/80(+) myeloid cell recruitment.
Neoplasms
Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer.
Neoplasms
Plasmodium infection inhibits tumor angiogenesis through effects on tumor-associated macrophages in a murine implanted hepatoma model.
Neoplasms
Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response.
Neoplasms
Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas.
Neoplasms
Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity.
Neoplasms
Podoplanin promotes cell migration via the EGF-Src-Cas pathway in oral squamous cell carcinoma cell lines.
Neoplasms
Poly(lactic-co-glycolic acid) nanoparticle-mediated interleukin-12 delivery for the treatment of diabetic retinopathy.
Neoplasms
Polymorphism of MMP-9 gene is not associated with the risk of urinary cancers: Evidence from an updated meta-analysis.
Neoplasms
Polymorphisms in the matrix metalloproteinase-9 promoters and susceptibility to glial tumors in Turkey.
Neoplasms
Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Neoplasms
Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Neoplasms
Polyphenols Extracted from Artemisia annua L. Exhibit Anti-Cancer Effects on Radio-Resistant MDA-MB-231 Human Breast Cancer Cells by Suppressing Stem Cell Phenotype, ?-Catenin, and MMP-9.
Neoplasms
Polyphenols from Artemisia annua L Inhibit Adhesion and EMT of Highly Metastatic Breast Cancer Cells MDA-MB-231.
Neoplasms
Polyphenols prevent cell shedding from mouse mammary cancer spheroids and inhibit cancer cell invasion in confrontation cultures derived from embryonic stem cells.
Neoplasms
Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation.
Neoplasms
Positive correlation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues.
Neoplasms
Possible role of matrix metalloproteinases (MMPs) in hyperostosis of intracranial meningiomas.
Neoplasms
Potent delivery of an MMP inhibitor to the tumor microenvironment with thermosensitive liposomes for the suppression of metastasis and angiogenesis.
Neoplasms
Potential role of matrix metalloproteinase-2,-9 and tissue inhibitors of metalloproteinase-1,-2 in exudative pleural effusions.
Neoplasms
Potentiation of scutellarin on human tongue carcinoma xenograft by low-intensity ultrasound.
Neoplasms
PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse.
Neoplasms
PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway.
Neoplasms
PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.
Neoplasms
Predictive role of nuclear factor-kappaB activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester.
Neoplasms
Predictive value of markers of inflammation in the postthrombotic syndrome: a systematic review: inflammatory biomarkers and PTS.
Neoplasms
Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E.
Neoplasms
Preischemic induction of TNF-alpha by physical exercise reduces blood-brain barrier dysfunction in stroke.
Neoplasms
Preliminary assessment of differential expression of candidate genes associated with atherosclerosis.
Neoplasms
Preliminary evaluation of inhibition of matrix-metalloprotease MMP-2 and MMP-9 by Passiflora edulis and P foetida aqueous extracts.
Neoplasms
Preoperative levels of matrix metalloproteinase-7 and -9 and tissue inhibitor of matrix metalloproteinase-1 relation to pathologic parameters in bladder carcinoma patients.
Neoplasms
Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.
Neoplasms
Preparation and characterization of a novel chimeric protein VEGI-CTT in Escherichia coli.
Neoplasms
Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Neoplasms
Presence of insulin-like growth factor binding proteins correlates with tumor-promoting effects of matrix metalloproteinase 9 in breast cancer.
Neoplasms
Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma.
Neoplasms
Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer.
Neoplasms
Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.
Neoplasms
Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.
Neoplasms
Prevention of elastase-induced emphysema in placenta growth factor knock-out mice.
Neoplasms
Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model.
Neoplasms
Prevention of tumor spread by matrix metalloproteinase-9 inhibition: old drugs, new concept.
Neoplasms
Preventive effect of phytoglycoprotein (38?kDa) on expression of alpha-fetoprotein and matrix metalloproteinase-9 in diethylnitrosamine-treated ICR mice.
Neoplasms
Preventive effects of curcumin and dexamethasone on lung transplantation-associated lung injury in rats.
Neoplasms
Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
Neoplasms
Pro-inflammatory effects of e-cigarette vapour condensate on human alveolar macrophages.
Neoplasms
Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells.
Neoplasms
Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome.
Neoplasms
Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKKalpha/NF-kappaB pathway.
Neoplasms
Production of matrix metalloproteinase-9 in CaCO-2 cells in response to inflammatory stimuli.
Neoplasms
Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
Neoplasms
Production of matrix metalloproteinases in specific subpopulations of human-patient breast cancer invading in three dimensional culture system.
Neoplasms
Progesterone alters human cervical epithelial and stromal cell transition and migration: Implications in cervical remodeling during pregnancy and parturition.
Neoplasms
Progesterone and 1,25-dihydroxyvitamin D? inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F.
Neoplasms
Progesterone Receptor Membrane Component 1 as the Mediator of the Inhibitory Effect of Progestins on Cytokine-Induced Matrix Metalloproteinase 9 Activity In Vitro.
Neoplasms
Progestins Inhibit Tumor Necrosis Factor ?-Induced Matrix Metalloproteinase 9 Activity via the Glucocorticoid Receptor in Primary Amnion Epithelial Cells.
Neoplasms
Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Neoplasms
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Neoplasms
Prognostic and diagnostic implications of MMP-2, MMP-9, and VEGF-? expressions in colorectal cancer.
Neoplasms
Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
Neoplasms
Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study.
Neoplasms
Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer.
Neoplasms
Prognostic impact of serum and tissue MMP-9 in non-small cell lung cancer: a systematic review and meta-analysis.
Neoplasms
Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma.
Neoplasms
Prognostic Role of Matrix Metalloproteinases 2, 7, 8, 9 and Their Type 1 Tissue Inhibitor in Blood Serum of Patients with Kidney Cancer.
Neoplasms
Prognostic roles of miR-124-3p and its target ANXA7 and their effects on cell migration and invasion in hepatocellular carcinoma.
Neoplasms
Prognostic significance of CD44v6, p63, Podoplanin, and MMP-9 in oral squamous cell carcinomas.
Neoplasms
Prognostic significance of expression of matrix metalloproteinase in colorectal adenocarcinomas and their metastases.
Neoplasms
Prognostic significance of matrix metalloproteinase 9 expression in osteosarcoma: A meta-analysis of 16 studies.
Neoplasms
Prognostic significance of matrix metalloproteinase-2 in gynecological cancer: a systemic review of the literature and meta-analysis.
Neoplasms
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer.
Neoplasms
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma.
Neoplasms
Prognostic significance of matrix metalloproteinases 2 and 9 in endometrial cancer.
Neoplasms
Prognostic significance of matrix metalloproteinases-2 activation ratio in renal cell carcinoma.
Neoplasms
Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
Neoplasms
Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Neoplasms
Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
Neoplasms
Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis.
Neoplasms
Prognostic value of matrix metalloproteinase 9 in nasopharyngeal carcinoma: a meta-analysis.
Neoplasms
Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients.
Neoplasms
Prognostic value of matrix metalloproteinase-9 (gelatinase-B) expression in epithelial ovarian tumors.
Neoplasms
Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma.
Neoplasms
Prognostic value of microvessel density, matrix metalloproteinase-9 and p53 protein expression in esophageal cancer.
Neoplasms
Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.
Neoplasms
Prognostic values of ETS-1, MMP-2 and MMP-9 expression and co-expression in breast cancer patients.
Neoplasms
Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9.
Neoplasms
Prolonged Treatment with Inhaled Corticosteroids does not Normalize High Activity of Matrix Metalloproteinase-9 in Exhaled Breath Condensates of Children with Asthma.
Neoplasms
Prominent expression of metalloproteinases in early stages of ovarian tumorigenesis.
Neoplasms
Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia.
Neoplasms
Propolis ameliorates restenosis in hypercholesterolemia rabbits with carotid balloon injury by inhibiting lipid accumulation, oxidative stress, and TLR4/NF-?B pathway.
Neoplasms
Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity.
Neoplasms
Protease-Activated Ratiometric Fluorescent Probe for pH Mapping of Malignant Tumors.
Neoplasms
Protease-Mediated Release of Chemotherapeutics from Mesoporous Silica Nanoparticles to ex Vivo Human and Mouse Lung Tumors.
Neoplasms
Proteasome activity as a target of hormone replacement therapy-dependent plaque stabilization in postmenopausal women.
Neoplasms
Protective effect of pravastatin on lipopolysaccharide-induced acute lung injury during neutropenia recovery in mice.
Neoplasms
Protective effects and mechanisms of high-dose vitamin C on sepsis-associated cognitive impairment in rats.
Neoplasms
Protective effects of fermented rice vinegar sediment (Kurozu moromimatsu) in a diethylnitrosamine-induced hepatocellular carcinoma animal model.
Neoplasms
Protein disulfide isomerase-mediated disulfide bonds regulate the gelatinolytic activity and secretion of matrix metalloproteinase-9.
Neoplasms
Protein Expression and Significance of VEGF, EGFR and MMP-9 in Non-Small Cell Lung Carcinomas.
Neoplasms
Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.
Neoplasms
Protein inhibitor of activated STAT-1 is downregulated in gastric cancer tissue and involved in cell metastasis.
Neoplasms
Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B.
Neoplasms
Protein kinase D1 inhibits cell proliferation through matrix metalloproteinase-2 and matrix metalloproteinase-9 secretion in prostate cancer.
Neoplasms
Protein tyrosine kinase and p38 MAP kinase pathways are involved in stimulation of matrix metalloproteinase-9 by TNF-alpha in human monocytes.
Neoplasms
Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs.
Neoplasms
Proteins in Soy Might Have a Higher Role in Cancer Prevention than Previously Expected: Soybean Protein Fractions Are More Effective MMP-9 Inhibitors Than Non-Protein Fractions, Even in Cooked Seeds.
Neoplasms
Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains.
Neoplasms
Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by alpha-1-antichymotrypsin.
Neoplasms
Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression.
Neoplasms
Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients.
Neoplasms
Proteomic profile of patients with atrial fibrillation undergoing cardiac surgery.
Neoplasms
Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats.
Neoplasms
Protosappanin A protects against atherosclerosis via anti- hyperlipidemia, anti-inflammation and NF-?B signaling pathway in hyperlipidemic rabbits.
Neoplasms
PSY-1, a Taxus chinensis var. mairei extract, inhibits cancer cell metastasis by interfering with MMPs.
Neoplasms
PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation.
Neoplasms
Puerarin alleviates coronary heart disease via suppressing inflammation in a rat model.
Neoplasms
Puerarin inhibits titanium particle-induced osteolysis and RANKL-induced osteoclastogenesis via suppression of the NF-?B signaling pathway.
Neoplasms
Pulp Inflammation Diagnosis from Clinical to Inflammatory Mediators: A Systematic Review.
Neoplasms
Purification and characterization of recombinant full-length and protease domain of murine MMP-9 expressed in Drosophila S2 cells.
Neoplasms
Quantification of matrix metalloproteinase activity in plasma of patients enrolled in a BAY 12-9566 phase I study.
Neoplasms
Quantitative Assessment of Invasion of High-Grade Gliomas Using Diffusion Tensor Magnetic Resonance Imaging.
Neoplasms
Quantitative MRI study of the permeability of peritumoral brain edema in lung cancer patients with brain metastases.
Neoplasms
Quercetin and sulforaphane in combination suppress the progression of melanoma through the down-regulation of matrix metalloproteinase-9.
Neoplasms
Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells.
Neoplasms
Quercetin Inhibits the Production of IL-1?-Induced Inflammatory Cytokines and Chemokines in ARPE-19 Cells via the MAPK and NF-?B Signaling Pathways.
Neoplasms
Quercetin Suppresses the Migration and Invasion in Human Colon Cancer Caco-2 Cells Through Regulating Toll-like Receptor 4/Nuclear Factor-kappa B Pathway.
Neoplasms
Quiescin sulfhydryl oxidase 1 promotes invasion of pancreatic tumor cells mediated by matrix metalloproteinases.
Neoplasms
RABEX-5 overexpression in gastric cancer is correlated with elevated MMP-9 level.
Neoplasms
Racial disparity in membrane response to infectious stimuli: a possible explanation for observed differences in the incidence of prematurity. Community Award Paper.
Neoplasms
Radiation-induced lipoprotein-associated phospholipase A2 increases lysophosphatidylcholine and induces endothelial cell damage.
Neoplasms
Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide.
Neoplasms
Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor.
Neoplasms
Rapid xenograft tumor progression in beta-arrestin1 transgenic mice due to enhanced tumor angiogenesis.
Neoplasms
Ras/myc-transformed serum-free mouse embryo cells under simulated inflammatory and infectious conditions increase levels of nitric oxide and matrix metalloproteinase-9 without a direct association between them.
Neoplasms
Recent progress in the strategic incorporation of fluorine into medicinally active compounds.
Neoplasms
RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines.
Neoplasms
Recombinant CBD-HepII polypeptide of fibronectin inhibits alphavbeta3 signaling and hematogenous metastasis of tumor.
Neoplasms
Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.
Neoplasms
Recruited leukocytes and local synthesis account for increased matrix metalloproteinase-9 activity in cerebrospinal fluid of dogs with central nervous system neoplasm.
Neoplasms
Recruitment of Matrix Metalloproteinase-9 (MMP-9) to the Fibroblast Cell Surface by Lysyl Hydroxylase 3 (LH3) Triggers Transforming Growth Factor-? (TGF-?) Activation and Fibroblast Differentiation.
Neoplasms
Recurrence or metastasis of HCC:predictors, early detection and experimental antiangiogenic therapy.
Neoplasms
Red ginseng extract reduced metastasis of colon cancer cells in vitro and in vivo.
Neoplasms
Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications.
Neoplasms
Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA.
Neoplasms
Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-alpha and interleukin-10.
Neoplasms
Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-alpha in menstrual endometrium and effluent in women with menorrhagia.
Neoplasms
Reduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma.
Neoplasms
Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion.
Neoplasms
Reduction of metastatic and angiogenic potency of malignant cancer by Eupatorium fortunei via suppression of MMP-9 activity and VEGF production.
Neoplasms
Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study.
Neoplasms
Regional specificity of matrix metalloproteinase-9 expression in the brain: voxel-level mapping in primary glioblastomas.
Neoplasms
Regorafenib diminishes the expression and secretion of angiogenesis and metastasis associated proteins and inhibits cell invasion via NF-?B inactivation in SK-Hep1 cells.
Neoplasms
Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion.
Neoplasms
Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1beta and tumor necrosis factor-alpha.
Neoplasms
Regulation of gelatinases in human airway smooth muscle cells: mechanism of progelatinase A activation.
Neoplasms
Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein.
Neoplasms
Regulation of human monocyte proMMP-9 production by fetuin, an endogenous TGF-beta antagonist.
Neoplasms
Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?
Neoplasms
Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons.
Neoplasms
Regulation of matrix metalloproteinase-9 (MMP-9) by translational efficiency in murine prostate carcinoma cells.
Neoplasms
Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release.
Neoplasms
Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK.
Neoplasms
Regulation of matrix metalloproteinase-9 expression between gingival fibroblast cells from old and young rats.
Neoplasms
Regulation of matrix metalloproteinase-9 gene expression and cell migration by NF-kappaB in response to CpG-oligodeoxynucleotides in RAW 264.7 cells.
Neoplasms
Regulation of matrix metalloproteinase-9 transcription in squamous cell carcinoma of uterine cervix: the role of human papillomavirus gene E2 expression and activation of transcription factor NF-kappaB.
Neoplasms
Regulation of matrix metalloproteinases - their role in tumor invasion and metastasis.
Neoplasms
Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone.
Neoplasms
Regulation of MMP-9 (gelatinase B) in activated human monocyte/macrophages by two different types of bisphosphonates.
Neoplasms
Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases.
Neoplasms
Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells.
Neoplasms
Regulation of TIMP-1 phenotypic expression in Epstein--Barr virus-immortalized B lymphocytes.
Neoplasms
Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience.
Neoplasms
Regulation of VEGF, MMP-9, and metastasis by CXCR4 in a prostate cancer cell line.
Neoplasms
Regulatory effects of ?FosB on proliferation and apoptosis of MCF-7 breast cancer cells.
Neoplasms
Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.
Neoplasms
Relation of Matrix Metalloproteinase-9 to Different Stages of Tumors in the Serum of Gastric Cancer.
Neoplasms
Relationship among expression of basic-fibroblast growth factor, MTDH/Astrocyte elevated gene-1, adenomatous polyposis coli, matrix metalloproteinase 9,and COX-2 markers with prognostic factors in prostate carcinomas.
Neoplasms
Relationship between clinicopathological features and HIF-2? in gastric adenocarcinoma.
Neoplasms
Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells.
Neoplasms
Relationship between matrix metalloproteinase-9 and some clinicopathological prognostic factors of breast carcinoma.
Neoplasms
Relationship between NF-?B, MMP-9, and MICA expression in pituitary adenomas reveals a new mechanism of pituitary adenomas immune escape.
Neoplasms
Relationship of 99mTc-HYNIC annexin V uptake to microvessel density, FasL and MMP-9 expression, and the number of tumour-infiltrating lymphocytes in head and neck carcinoma.
Neoplasms
Relationships between clinical behavior of laryngeal squamous cell carcinomas and expression of VEGF, MMP-9 and E-cadherin.
Neoplasms
Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer.
Neoplasms
Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer.
Neoplasms
Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers.
Neoplasms
Reoxygenation using a novel CO2 therapy decreases the metastatic potential of osteosarcoma cells.
Neoplasms
Repeated Administration of Kupffer Cells-Targeting Nanoantioxidant Ameliorates Liver Fibrosis in an Experimental Mouse Model.
Neoplasms
Repressions of MMP-9 expression and NF-kappa B localization are involved in inhibition of lung carcinoma 95-D cell invasion by (-)-epigallocatechin-3-gallate.
Neoplasms
Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma.
Neoplasms
Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay.
Neoplasms
Resident stromal cell-derived MMP-9 promotes the growth of colorectal metastases in the liver microenvironment.
Neoplasms
Response of neuroblastoma cells to ionizing radiation: modulation of in vitro invasiveness and angiogenesis of human microvascular endothelial cells.
Neoplasms
Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls.
Neoplasms
Resveratrol downregulates the constitutional activation of nuclear factor-kappaB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis.
Neoplasms
Resveratrol downregulates the TLR4 signaling pathway to reduce brain damage in a rat model of focal cerebral ischemia.
Neoplasms
Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction.
Neoplasms
Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells.
Neoplasms
Resveratrol relieves Angiostrongylus cantonensis - Induced meningoencephalitis by activating sirtuin-1.
Neoplasms
Retinoic acid stimulates meningioma cell adhesion to the extracellular matrix and inhibits invasion.
Neoplasms
Retraction: Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
Neoplasms
Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector.
Neoplasms
Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion.
Neoplasms
Reversing the polarization of tumor-associated macrophages inhibits tumor metastasis.
Neoplasms
Reversion-inducing-cysteine-rich protein with Kazal motif is involved in intimal hyperplasia in carotid arteries: a new insight in the prevention of restenosis after vascular angioplasty.
Neoplasms
RHCG suppresses cervical cancer progression through inhibiting migration and inducing apoptosis regulated by TGF-?1.
Neoplasms
Rhein inhibits invasion and migration of human nasopharyngeal carcinoma cells in vitro by down-regulation of matrix metalloproteinases-9 and vascular endothelial growth factor.
Neoplasms
RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.
Neoplasms
RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion.
Neoplasms
Riboflavin Reduces Pro-Inflammatory Activation of Adipocyte-Macrophage Co-culture. Potential Application of Vitamin B2 Enrichment for Attenuation of Insulin Resistance and Metabolic Syndrome Development.
Neoplasms
Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
Neoplasms
Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.
Neoplasms
RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
Neoplasms
RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis.
Neoplasms
RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.
Neoplasms
RNAi-mediated MMP-9 silencing inhibits mouse melanoma cell invasion and migration in vitro and in vivo.
Neoplasms
Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity.
Neoplasms
Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice.
Neoplasms
Role of Daucosterol Linoleate on Breast Cancer: Studies on Apoptosis and Metastasis.
Neoplasms
Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular disorders.
Neoplasms
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.
Neoplasms
Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3.
Neoplasms
Role of IKK and oscillatory NFkappaB kinetics in MMP-9 gene expression and chemoresistance to 5-fluorouracil in RKO colorectal cancer cells.
Neoplasms
Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer.
Neoplasms
Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas.
Neoplasms
Role of matrix metalloproteinases 2 and 9 in determination of invasive potential of pancreatic tumors.
Neoplasms
Role of MMP-3 and MMP-9 and their haplotypes in risk of bladder cancer in North Indian cohort.
Neoplasms
Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma: findings in 42 patients followed for 1-16 years.
Neoplasms
Role of Peroxisome Proliferator-Activated Receptor ?/? and B-Cell Lymphoma-6 in Regulation of Genes Involved in Metastasis and Migration in Pancreatic Cancer Cells.
Neoplasms
Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression.
Neoplasms
Role of serum matrix metalloproteinase-2 and -9 to predict breast cancer progression.
Neoplasms
Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer.
Neoplasms
Role of serum-derived hyaluronan-associated protein-hyaluronan complex in ovarian cancer.
Neoplasms
Role of the conserved histidine and aspartic acid residues in activity and stabilization of human gelatinase B: an example of matrix metalloproteinases.
Neoplasms
Role of tumor necrosis factor-alpha and matrix metalloproteinase-9 in blood-brain barrier disruption after peripheral thermal injury in rats.
Neoplasms
Role of tumor necrosis factor-alpha in the premature rupture of membranes and preterm labor pathways.
Neoplasms
Role of tumor-derived granulocyte-macrophage colony-stimulating factor in mice bearing a highly invasive and metastatic mammary carcinoma.
Neoplasms
Role of VEGF and matrix metalloproteinase-9 in peritumoral brain edema associated with supratentorial benign meningiomas.
Neoplasms
Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor metastasis.
Neoplasms
Roles of galectin-7 and S100A9 in cervical squamous carcinoma: Clinicopathological and in vitro evidence.
Neoplasms
Roles of microsomal prostaglandin E synthase-1 in lung metastasis formation in prostate cancer RM9 cells.
Neoplasms
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy.
Neoplasms
RON-regulated innate immunity is protective in an animal model of multiple sclerosis.
Neoplasms
ROR2 promotes the epithelial-mesenchymal transition by regulating MAPK/p38 signaling pathway in breast cancer.
Neoplasms
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
Neoplasms
RPN2 promotes metastasis of hepatocellular carcinoma cell and inhibits autophagy via STAT3 and NF-?B pathways.
Neoplasms
rs3918242 variant genotype frequency and increased TIMP-2 and MMP-9 expression are positively correlated with cancer invasion in urinary bladder cancer.
Neoplasms
Russian study of morphological prognostic factors characterization in BRAF-mutant cutaneous melanoma.
Neoplasms
S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-?B-dependent MMP-9 signal.
Neoplasms
S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-?B signaling.
Neoplasms
Safety and effectiveness of localized lung resection combined with neoadjuvant chemotherapy in the treatment of stage I-II non-small cell lung cancer.
Neoplasms
Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.
Neoplasms
Safety and tolerability of PCK3145, a synthetic peptide derived from prostate secretory protein 94 (PSP94) in metastatic hormone-refractory prostate cancer.
Neoplasms
Salvia miltiorrhiza extract inhibits TPA-induced MMP-9 expression and invasion through the MAPK/AP-1 signaling pathway in human breast cancer MCF-7 cells.
Neoplasms
Salvianolic Acid B Down-regulates Matrix Metalloproteinase-9 Activity and Expression in Tumor Necrosis Factor-?-induced Human Coronary Artery Endothelial Cells.
Neoplasms
Salvianolic acid B protects from pulmonary microcirculation disturbance induced by lipopolysaccharide in rat.
Neoplasms
SANT,a novel Chinese herbal monomer combination,decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer.
Neoplasms
Saponins derived from the roots of Platycodon grandiflorum inhibit HT-1080 cell invasion and MMPs activities: regulation of NF-kappaB activation via ROS signal pathway.
Neoplasms
Saussurea lappa extract suppresses TPA-induced cell invasion via inhibition of NF-?B-dependent MMP-9 expression in MCF-7 breast cancer cells.
Neoplasms
Saxatilin, a snake venom disintegrin, suppresses TNF-alpha-induced ovarian cancer cell invasion.
Neoplasms
SB203580, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis by down-regulating proinflammatory cytokines and proteolytic factors in a mouse model.
Neoplasms
Scabraside D Derived from Sea Cucumber Induces Apoptosis and Inhibits Metastasis via iNOS and STAT-3 Expression in Human Cholangiocarcinoma Xenografts.
Neoplasms
Schisandrin B synergizes docetaxel-induced restriction of growth and invasion of cervical cancer cells in vitro and in vivo.
Neoplasms
Screening for the selective inhibitors of MMP-9 from natural products based on pharmacophore modeling and molecular docking in combination with bioassay experiment, hybrid QM/MM calculation, and MD simulation.
Neoplasms
Scrophularia buergeriana attenuates allergic inflammation by reducing NF-?B activation.
Neoplasms
SCUBE3 is an endogenous TGF-? receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer.
Neoplasms
Secondary malignant giant-cell tumour of bone: molecular abnormalities of p53 and H-ras gene correlated with malignant transformation.
Neoplasms
Secretion of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by meningiomas detected by cell immunoblot analysis.
Neoplasms
Secretion of matrix metalloproteinase-9 by macrophages, in vitro, in response to Helicobacter pylori.
Neoplasms
Secretion of Matrix Metalloproteinase-9 from Astrocytes by Inhibition of Tonic P2Y(14)-Receptor-Mediated Signal(s).
Neoplasms
Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment.
Neoplasms
Secretion of urokinase and metalloproteinase-9 induced by staurosporine is dependent on a tyrosine kinase pathway in mammary tumor cells.
Neoplasms
Secretions of MMP-9 by soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) mediated by protein kinase C (PKC)delta and phospholipase D (PLD) in murine macrophage.
Neoplasms
Selected gene profiles of stressed NSC-34 cells and rat spinal cord following peripheral nerve reconstruction and minocycline treatment.
Neoplasms
Selection of a histidine-containing inhibitor of gelatinases through deconvolution of combinatorial tetrapeptide libraries.
Neoplasms
Selective amplification of glucocorticoid anti-inflammatory activity through synergistic multi-target action of a combination drug.
Neoplasms
Selective degradation of BET proteins with dBET1, a proteolysis-targeting chimera, potently reduces pro-inflammatory responses in lipopolysaccharide-activated microglia.
Neoplasms
Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells.
Neoplasms
Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells.
Neoplasms
Self-sensibilized polymeric prodrug co-delivering MMP-9 shRNA plasmid for combined treatment of tumors.
Neoplasms
SEMA4D Knockdown Attenuates ?-Catenin-Dependent Tumor Progression in Colorectal Cancer.
Neoplasms
Semaphorin7A promotes tumor growth and exerts a pro-angiogenic effect in macrophages of mammary tumor-bearing mice.
Neoplasms
Sensitizing effects of an organovanadium compound during adjuvant therapy with cyclophosphamide in a murine tumor model.
Neoplasms
Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer.
Neoplasms
Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression.
Neoplasms
Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression.
Neoplasms
Serum biomarkers for personalization of nanotherapeutics-based therapy in different tumor and organ microenvironments.
Neoplasms
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients.
Neoplasms
Serum inflammatory mediators in pregnancy: changes after periodontal treatment and association with pregnancy outcomes.
Neoplasms
Serum Level of Matrix Metalloproteinase-9 in Patients with Head and Neck Squamous Cell Carcinoma.
Neoplasms
Serum levels of endostatin and matrix metalloproteinase-9 associated with high stage and grade primary transitional cell carcinoma of the bladder.
Neoplasms
Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers.
Neoplasms
Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma.
Neoplasms
Serum levels of matrix metalloproteinase-9 predict lymph node metastasis in breast cancer patients.
Neoplasms
Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their tissue natural inhibitors in breast tumors.
Neoplasms
Serum Levels of S100A11 and MMP-9 in Patients with Epithelial Ovarian Cancer and Their Clinical Significance.
Neoplasms
Serum levels of the proinflammatory cytokine interleukin-6 vary based on diagnoses in individuals with lumbar intervertebral disc diseases.
Neoplasms
Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test.
Neoplasms
Serum matrix metalloproteinase 9 as a marker for the assessment of severe acute pancreatitis.
Neoplasms
Serum Matrix metalloproteinase-9 (MMP-9) can help identify patients with papillary thyroid cancer at high risk of persistent disease: Value and limitations of a potential marker of neoplasia.
Neoplasms
Serum matrix metalloproteinase-9 in children exposed to arsenic from playground dust at elementary schools in Hermosillo, Sonora, Mexico.
Neoplasms
Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening.
Neoplasms
Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker.
Neoplasms
Serum matrix metalloproteinase-9 level associated with stromal reaction in patients with gastric cancer.
Neoplasms
Serum melatonin is inversely associated with matrix metalloproteinase-9 in oral squamous cell carcinoma.
Neoplasms
Serum MMP-9 Level Associated With Progression of Breast Cancer in Iranian Population.
Neoplasms
Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases?
Neoplasms
Serum TIMP1 and TIMP2 concentration in patients with different grades of meningioma.
Neoplasms
Sesamin Inhibits Macrophage-Induced Vascular Endothelial Growth Factor and Matrix Metalloproteinase-9 Expression and Proangiogenic Activity in Breast Cancer Cells.
Neoplasms
Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products.
Neoplasms
Seven days' around the clock exhaustive physical exertion combined with energy depletion and sleep deprivation primes circulating leukocytes.
Neoplasms
Shikonin inhibits tumor invasion via down-regulation of NF-?B-mediated MMP-9 expression in human ACC-M cells.
Neoplasms
Short hairpin RNA targeting autotaxin reduces human gastric carcinoma AGS cell proliferative, migratory and invasive capabilities in vitro and causes tumor regression in vivo.
Neoplasms
Shortening of microsatellite deoxy(CA) repeats involved in GL331-induced down-regulation of matrix metalloproteinase-9 gene expression.
Neoplasms
ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
Neoplasms
Signaling pathway for TNF-alpha-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells.
Neoplasms
Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma.
Neoplasms
Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
Neoplasms
Significance of MMP-9 and VEGF-C expression in North Indian women with breast cancer diagnosis.
Neoplasms
Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
Neoplasms
Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis.
Neoplasms
Sildenafil protects against bile duct ligation induced hepatic fibrosis in rats: Potential role for silent information regulator 1 (SIRT1).
Neoplasms
Silence of Stomatin-Like Protein 2 Represses Migration and Invasion Ability of Human Liver Cancer Cells via Inhibiting the Nuclear Factor Kappa B (NF-?B) Pathway.
Neoplasms
Silencing of bach1 gene by small interfering RNA-mediation regulates invasive and expression level of miR-203, miR-145, matrix metalloproteinase-9, and CXCR4 receptor in MDA-MB-468 breast cancer cells.
Neoplasms
Silencing of EphA2 inhibits invasion of human gastric cancer SGC-7901 cells in vitro and in vivo.
Neoplasms
Silencing of estrogen receptor ? promotes the invasion and migration of osteosarcoma cells through activating Wnt signaling pathway.
Neoplasms
Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Neoplasms
Silencing of LINC00461 enhances radiosensitivity of lung adenocarcinoma cells by down-regulating HOXA10 via microRNA-195.
Neoplasms
Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
Neoplasms
Silencing RhoA inhibits migration and invasion through Wnt/?-catenin pathway and growth through cell cycle regulation in human tongue cancer.
Neoplasms
Silencing the hsp25 gene eliminates migration capability of the highly metastatic murine 4T1 breast adenocarcinoma cell.
Neoplasms
Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells.
Neoplasms
Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells.
Neoplasms
Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas.
Neoplasms
Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.
Neoplasms
Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing mice.
Neoplasms
Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms.
Neoplasms
Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products.
Neoplasms
Simvastatin Suppresses Human Breast Cancer Cell Invasion by Decreasing the Expression of Pituitary Tumor-Transforming Gene 1.
Neoplasms
Sine oculis homeobox homolog 1 promotes ?5?1-mediated invasive migration and metastasis of cervical cancer cells.
Neoplasms
Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells.
Neoplasms
Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP-9) and tumour protein 73 (TP73) interact with Epstein Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph.
Neoplasms
siRNA-mediated downregulation of MMP-9 and uPAR in combination with radiation induces G2/M cell-cycle arrest in Medulloblastoma.
Neoplasms
Six cases of perforating pilomatricoma: Anetodermic changes with expression of matrix metalloproteinases.
Neoplasms
Size-adaptable and ligand (biotin)-sheddable nanocarriers equipped with avidin scavenging technology for deep tumor penetration and reduced toxicity.
Neoplasms
SKI-606 (Bosutinib) Blocks Prostate Cancer Invasion, Growth, and Metastasis In vitro and In vivo through Regulation of Genes Involved in Cancer Growth and Skeletal Metastasis.
Neoplasms
Slow induction of gelatinase B mRNA by acidic culture conditions in mouse metastatic melanoma cells.
Neoplasms
Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling.
Neoplasms
Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers.
Neoplasms
Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9.
Neoplasms
SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.
Neoplasms
Snail-1 Silencing by siRNA Inhibits Migration of TE-8 Esophageal Cancer Cells Through Downregulation of Metastasis-Related Genes.
Neoplasms
Social defeat stress promotes tumor growth and angiogenesis by upregulating vascular endothelial growth factor/extracellular signal-regulated kinase/matrix metalloproteinase signaling in a mouse model of lung carcinoma.
Neoplasms
Sodium hydrogen exchanger and phospholipase D are required for alpha1-adrenergic receptor stimulation of metalloproteinase-9 and cellular invasion in CCL39 fibroblasts.
Neoplasms
Solanine induces mitochondria-mediated apoptosis in human pancreatic cancer cells.
Neoplasms
Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid.
Neoplasms
Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling.
Neoplasms
Soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) increased MMP-9 activity in murine macrophage.
Neoplasms
Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.
Neoplasms
Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy.
Neoplasms
Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer.
Neoplasms
Sonic hedgehog signaling may promote invasion and metastasis of oral squamous cell carcinoma by activating MMP-9 and E-cadherin expression.
Neoplasms
Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.
Neoplasms
Soybean saponin inhibits tumor cell metastasis by modulating expressions of MMP-2, MMP-9 and TIMP- 2.
Neoplasms
SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.
Neoplasms
Spatiotemporal expression profile of proteases and immunological, angiogenic, hormonal and apoptotic mediators in rat placenta before and during intrauterine trophoblast migration.
Neoplasms
Spatiotemporal organization and protein dynamics involved in regulated exocytosis of MMP-9 in breast cancer cells.
Neoplasms
Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down-regulation of matrix metalloproteinase-3/-9/-14 and CD44.
Neoplasms
Specific inflammatory microenvironments in the zones of the fetal membranes at term delivery.
Neoplasms
Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
Neoplasms
Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
Neoplasms
Sphingosine-1-phosphate mediates a reciprocal signaling pathway between stellate cells and cancer cells that promotes pancreatic cancer growth.
Neoplasms
Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors.
Neoplasms
Sputum and salivary protein biomarkers and point-of-care biosensors for the management of COPD.
Neoplasms
Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10.
Neoplasms
Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
Neoplasms
Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metalloproteinase-2 and -9 expression.
Neoplasms
Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells.
Neoplasms
SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis.
Neoplasms
Stability of matrix metalloproteinase-9 as biological marker in colorectal cancer.
Neoplasms
Stable expression of ?1-antitrypsin Portland in MDA-MB-231 cells increased MT1-MMP and MMP-9 levels, but reduced tumour progression.
Neoplasms
Stage-IIB osteosarcomas around the knee. A study of MMP-9 in surviving tumour cells.
Neoplasms
Standardized Salvia miltiorrhiza extract suppresses hepatic stellate cell activation and attenuates steatohepatitis induced by a methionine-choline deficient diet in mice.
Neoplasms
Staphylococcal SSL5-induced platelet microparticles provoke proinflammatory responses via the CD40/TRAF6/NF?B signalling pathway in monocytes.
Neoplasms
Star-Shaped Amphiphilic Hyperbranched Polyglycerol Conjugated with Dendritic Poly(l-lysine) for the Codelivery of Docetaxel and MMP-9 siRNA in Cancer Therapy.
Neoplasms
Star-shaped cyclodextrin-poly(l-lysine) derivative co-delivering docetaxel and MMP-9 siRNA plasmid in cancer therapy.
Neoplasms
Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-?B pathways.
Neoplasms
Stimulation of matrix metalloproteinase-9 expression in human fibrosarcoma cells by synthetic matrix metalloproteinase inhibitors.
Neoplasms
Stimulation of MMP-9 of oral epithelial cells by areca nut extract is related to TGF-?/Smad2-dependent and -independent pathways and prevented by betel leaf extract, hydroxychavicol and melatonin.
Neoplasms
Stimulation of nuclear receptor REV-ERBs suppresses production of pronociceptive molecules in cultured spinal astrocytes and ameliorates mechanical hypersensitivity of inflammatory and neuropathic pain of mice.
Neoplasms
Stimulation of Peritoneal Mesothelial Cells to Secrete Matrix Metalloproteinase-9 (MMP-9) by TNF-?: A Role in the Invasion of Gastric Carcinoma Cells.
Neoplasms
Stomach Cancer: Interconnection between the Redox State, Activity of MMP-2, MMP-9 and Stage of Tumor Growth.
Neoplasms
Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductase.
Neoplasms
Stratifying fascin and cortactin function in invadopodium formation using inhibitory nanobodies and targeted subcellular delocalization.
Neoplasms
Stress-activated protein kinase signaling pathways in dry eye and ocular surface disease.
Neoplasms
Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy.
Neoplasms
Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect.
Neoplasms
Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGF? Inhibitor Sequencing in Melanoma.
Neoplasms
Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment.
Neoplasms
Stromal metalloproteinase-9 is essential to angiogenesis and progressive growth of orthotopic human pancreatic cancer in parabiont nude mice.
Neoplasms
Stromal versus tumoral inflammation differentially contribute to metastasis and poor survival in laryngeal squamous cell carcinoma.
Neoplasms
Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo.
Neoplasms
Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors.
Neoplasms
Strong significant correlation between MMP-9 and systemic symptoms in patients with localized renal cell carcinoma.
Neoplasms
Structural characterisation of inhibitory and non-inhibitory MMP-9-TIMP-1 complexes and implications for regulatory mechanisms of MMP-9.
Neoplasms
Structural characterization of the catalytic active site in the latent and active natural gelatinase B from human neutrophils.
Neoplasms
Studies on anti-metastatic and anti-invasive effects of harmine using highly metastatic murine B16F-10 melanoma cells.
Neoplasms
Study on the expression of p53 and MMP-2 in patients with lung cancer after interventional therapy.
Neoplasms
Substitution at carbon 2 of 19-nor-1?,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells.
Neoplasms
Substrate-zymography: a still worthwhile method for gelatinases analysis in biological samples.
Neoplasms
Successful Treatment of MMP-9-Expressing Angiosarcoma with Low-Dose Docetaxel and Bisphosphonate.
Neoplasms
Sulforaphane controls TPA-induced MMP-9 expression through the NF-?B signaling pathway, but not AP-1, in MCF-7 breast cancer cells.
Neoplasms
Superoxide- and NO-dependent mechanisms of antitumor and antimetastatic effect of L-arginine hydrochloride and coenzyme Q10.
Neoplasms
Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
Neoplasms
Suppression by nimesulide of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats.
Neoplasms
Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha.
Neoplasms
Suppression of chronic streptococcal cell wall-induced arthritis in Lewis rats by liposomal clodronate.
Neoplasms
Suppression of coronary atherosclerosis by helix B surface Peptide, a nonerythropoietic, tissue-protective compound derived from erythropoietin.
Neoplasms
Suppression of EGF-induced tumor cell migration and matrix metalloproteinase-9 expression by capsaicin via the inhibition of EGFR-mediated FAK/Akt, PKC/Raf/ERK, p38 MAPK, and AP-1 signaling.
Neoplasms
Suppression of ERK/NF-?B Activation Is Associated With Amentoflavone-Inhibited Osteosarcoma Progression In Vivo.
Neoplasms
Suppression of matrix metalloproteinase-9 expression by andrographolide in human monocytic THP-1 cells via inhibition of NF-?B activation.
Neoplasms
Suppression of matrix metalloproteinase-9 expression by RNA interference inhibits SGC7901 gastric adenocarcinoma cell growth and invasion in vitro and in vivo.
Neoplasms
Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-?B/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells.
Neoplasms
Suppression of nucleosome-binding protein 1 by miR-326 impedes cell proliferation and invasion in non-small cell lung cancer cells.
Neoplasms
Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by apigenin via the inhibition of p38 mitogen-activated protein kinase-dependent matrix metalloproteinase-9 expression.
Neoplasms
Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cdelta/p38 mitogen-activated protein kinase and JNK/nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression.
Neoplasms
Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKC?/ERK1/2-dependent matrix metalloproteinase-9 expression.
Neoplasms
Suppression of PMA-induced tumor cell invasion and metastasis by aqueous extract isolated from Prunella vulgaris via the inhibition of NF-kappaB-dependent MMP-9 expression.
Neoplasms
Suppression of PMA-induced tumor cell invasion and migration by ginsenoside Rg1 via the inhibition of NF-?B-dependent MMP-9 expression.
Neoplasms
Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression.
Neoplasms
Suppression of the invasive potential of highly malignant tumor cells by KIOM-C, a novel herbal medicine, via inhibition of NF-?B activation and MMP-9 expression.
Neoplasms
Suppression of TPA-induced cancer cell invasion by Peucedanum japonicum Thunb. extract through the inhibition of PKC?/NF-?B-dependent MMP-9 expression in MCF-7 cells.
Neoplasms
Suppression of TPA-induced tumor cell invasion by sulfuretin via inhibition of NF-?B-dependent MMP-9 expression.
Neoplasms
Suppression of tumor cell invasiveness by hydrolyzable tannins (plant polyphenols) via the inhibition of matrix metalloproteinase-2/-9 activity.
Neoplasms
Suppression of tumor necrosis factor alpha-induced matrix metalloproteinase 9 production by the introduction of a super-repressor form of inhibitor of nuclear factor kappaBalpha complementary DNA into immortalized human salivary gland acinar cells. Prevention of the destruction of the acinar structure in Sjögren's syndrome salivary glands.
Neoplasms
Suppression of tumor necrosis factor alpha-induced matrix metalloproteinase 9 production in human salivary gland acinar cells by cepharanthine occurs via down-regulation of nuclear factor kappaB: a possible therapeutic agent for preventing the destruction of the acinar structure in the salivary glands of Sjögren's syndrome patients.
Neoplasms
Suppression of type IV collagenase in MDA-MB-435 human breast cancer cells by eicosapentaenoic acid in vitro and in vivo.
Neoplasms
Suppressions of Migration and Invasion by Cantharidin in TSGH-8301 Human Bladder Carcinoma Cells through the Inhibitions of Matrix Metalloproteinase-2/-9 Signaling.
Neoplasms
Suppressive effect of calcipotriol on the induction of matrix metalloproteinase (MMP)-9 and MMP-13 in a human squamous cell carcinoma cell line.
Neoplasms
Suppressive effects of an ethanol extract of Gleditsia sinensis thorns on human SNU-5 gastric cancer cells.
Neoplasms
Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells via the Inhibition of STAT3 Signaling and Down-regulation of Inflammatory Cytokine Expressions.
Neoplasms
Supramolecular Aggregate as a High-Efficiency Gene Carrier Mediated with Optimized Assembly Structure.
Neoplasms
Surface modified PAMAM dendrimers with gallic acid inhibit, cell proliferation, cell migration and inflammatory response to augment apoptotic cell death in human colon carcinoma cells.
Neoplasms
Surfactin from Bacillus subtilis attenuates ambient air particulate matter-promoted human oral cancer cells metastatic potential.
Neoplasms
Surgical excision promotes tumor growth and metastasis by promoting expression of MMP-9 and VEGF in a breast cancer model.
Neoplasms
Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways.
Neoplasms
Sustained inhibition of PKC? reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model.
Neoplasms
Synergism from the combination of ulinastatin and curcumin offers greater inhibition against colorectal cancer liver metastases via modulating matrix metalloproteinase-9 and E-cadherin expression.
Neoplasms
Synergistic and protective effect of atorvastatin and amygdalin against histopathological and biochemical alterations in Sprague-Dawley rats with experimental endometriosis.
Neoplasms
Synergistic anticancer effects of timosaponin AIII and ginsenosides in MG63 human osteosarcoma cells.
Neoplasms
Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
Neoplasms
Synergistic effect of l-ascorbic acid and hyaluronic acid on the expressions of matrix metalloproteinase-3 and -9 in human chondrocytes.
Neoplasms
Synergistic enhancement of matrix metalloproteinase-9 expression and pro-inflammatory cytokines by influenza virus infection and oxidized-LDL treatment in human endothelial cells.
Neoplasms
Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B.
Neoplasms
Synthesis and anti-metastasis activities of norcantharidin-conjugated carboxymethyl chitosan as a novel drug delivery system.
Neoplasms
Synthesis and characterization of a PDMS-PMOXA based polymersomes sensitive to MMP-9 for application in breast cancer.
Neoplasms
Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
Neoplasms
Synthesis, Kinetic Characterization and Metabolism of Diastereomeric 2-(1-(4-Phenoxyphenylsulfonyl)ethyl)thiiranes as Potent Gelatinase and MT1-MMP Inhibitors.
Neoplasms
Synthesized tetrahydroisoquinoline alkaloid exerts anticancer effects at least in part by suppressing NF??B?regulated proteins in A549 human lung cancer cells.
Neoplasms
Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis.
Neoplasms
Systemic Ablation of MMP9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL-6 Expression in the Bone Marrow.
Neoplasms
Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer.
Neoplasms
Systemic administration of autologous adipose-derived mesenchymal stem cells alleviates hepatic ischemia-reperfusion injury in rats.
Neoplasms
Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer.
Neoplasms
Systemic Th17-like cytokine pattern in gangrenous appendicitis but not in phlegmonous appendicitis.
Neoplasms
Tacrolimus downregulates inflammation by regulating pro?/anti?inflammatory responses in LPS?induced keratitis.
Neoplasms
TAK1 is required for TGF-beta 1-mediated regulation of matrix metalloproteinase-9 and metastasis.
Neoplasms
Tangeretin, a citrus pentamethoxyflavone, exerts cytostatic effect via p53/p21 up-regulation and suppresses metastasis in 7,12-dimethylbenz(?)anthracene-induced rat mammary carcinoma.
Neoplasms
Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction.
Neoplasms
Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer.
Neoplasms
Targeting colon cancer cell NF-?B promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis.
Neoplasms
Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.
Neoplasms
Targeting Epirubicin Plus Quinacrine Liposomes Modified with DSPE-PEG2000-C(RGDfK) Conjugate for Eliminating Invasive Breast Cancer.
Neoplasms
Targeting filamin B induces tumor growth and metastasis via enhanced activity of matrix metalloproteinase-9 and secretion of VEGF-A.
Neoplasms
Targeting L1 cell adhesion molecule expression using liposome-encapsulated siRNA suppresses prostate cancer bone metastasis and growth.
Neoplasms
Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock.
Neoplasms
Targeting Notch1 inhibits invasion and angiogenesis of human breast cancer cells via inhibition Nuclear Factor-?B signaling.
Neoplasms
Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions.
Neoplasms
Targeting the Temporal Dynamics of Hypoxia-Induced Tumor-Secreted Factors Halts Tumor Migration.
Neoplasms
Targeting tumor-associated macrophages as a novel strategy against breast cancer.
Neoplasms
Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease.
Neoplasms
Temozolomide does not influence the transcription or activity of matrix metalloproteinases 9 and 2 in glioma cell lines.
Neoplasms
Temporal profiles of age-dependent changes in cytokine mRNA expression and glial cell activation after status epilepticus in postnatal rat hippocampus.
Neoplasms
Testis peritubular myoid cells increase their motility and express matrix-metalloproteinase 9 (MMP-9) after interaction with embryonal carcinoma cells.
Neoplasms
Tetrabromobisphenol A Induces MMP-9 Expression via NADPH Oxidase and the activation of ROS, MAPK, and Akt Pathways in Human Breast Cancer MCF-7 Cells.
Neoplasms
Tetramethylpyrazine Preserves the Integrity of Blood-Brain Barrier Associated With Upregulation of MCPIP1 in a Murine Model of Focal Ischemic Stroke.
Neoplasms
Tetrandrine Attenuates Cartilage Degeneration, Osteoclast Proliferation, and Macrophage Transformation through Inhibiting P65 Phosphorylation in Ovariectomy-induced Osteoporosis.
Neoplasms
Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells.
Neoplasms
TGF-?1 facilitates MT1-MMP-mediated proMMP-9 activation and invasion in oral squamous cell carcinoma cells.
Neoplasms
Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma.
Neoplasms
The a3 Isoform Vacuolar Type H+-ATPase Promotes Distant Metastasis in the Mouse B16 Melanoma Cells.
Neoplasms
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques.
Neoplasms
The alpha v beta 6 integrin induces gelatinase B secretion in colon cancer cells.
Neoplasms
The alphaVbeta6 integrin regulates its own expression with cell crowding: implications for tumour progression.
Neoplasms
The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness.
Neoplasms
The analysis of the levels of plasma inflammation-related cytokines and endotoxins in patients with acute aortic dissection.
Neoplasms
The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus.
Neoplasms
The angiostatic molecule Multimerin 2 is processed by MMP-9 to allow sprouting angiogenesis.
Neoplasms
The anti-invasive role of novel synthesized pyridazine hydrazide appended phenoxy acetic acid against neoplastic development targeting matrix metallo proteases.
Neoplasms
The antitumor and antimetastatic effects of N-trimethyl chitosan-encapsulated camptothecin on ovarian cancer with minimal side effects.
Neoplasms
The assessment of matrix metalloproteinase-9 expression and angiogenesis in colorectal cancer.
Neoplasms
The assessment of serum and diagnostic peritoneal lavage concentration of matrix metalloproteinase-2, matrix metalloproteinase-9, carbohydrate antigen 19-9, and carcinoembryonic antigen in patients with pancreatic cancer and chronic pancreatitis.
Neoplasms
The association between the preoperative serum levels of lipocalin-2 and matrix metalloproteinase-9 (MMP-9) and prognosis of breast cancer.
Neoplasms
The association of co-expression of CD44v4/MMP-9 with different nodal status in high-grade breast carcinoma patients.
Neoplasms
The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients.
Neoplasms
The association of transforming growth factor-beta 1 with myometrial invasion of endometrial carcinomas through effects on matrix metalloproteinase.
Neoplasms
The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer.
Neoplasms
The behavior of MMP-2, MMP-7, MMP-9 and their inhibitors TIMP-1, TIMP-2 in adenoma-colorectal cancer sequence.
Neoplasms
The beneficial influence of rhubarb on 5-fluorouracil-induced ileal mucositis and the combined role of aquaporin-4, tumour necrosis factor-?, nuclear factor-kappa B & matrix metalloproteinase-9 in rat model: histological study.
Neoplasms
The C3G/Rap1 pathway promotes secretion of MMP-2 and MMP-9 and is involved in serous ovarian cancer metastasis.
Neoplasms
The Cadin-2-en-1?-ol-1?-D-glucuronopyranoside Suppresses TPA-Mediated Matrix Metalloproteinase-9 Expression Through the ERK Signaling Pathway in MCF-7 Human Breast Adenocarcinoma Cells.
Neoplasms
The catalytically defective receptor protein tyrosine kinase EphA10 promotes tumorigenesis in pancreatic cancer cells.
Neoplasms
The CCL21/CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase-9.
Neoplasms
The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer.
Neoplasms
The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma.
Neoplasms
The co-expression of MMP-9 and Tenascin-C is significantly associated with the progression and prognosis of pancreatic cancer.
Neoplasms
The combined effects of celecoxib and minocycline hydrochloride on inhibiting the osseous metastasis of breast cancer in nude mice.
Neoplasms
The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent.
Neoplasms
The curcumin derivative WZ35 activates ROS-dependent JNK to suppress hepatocellular carcinoma metastasis.
Neoplasms
The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.
Neoplasms
The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
Neoplasms
The diet-derived sulforaphane inhibits matrix metalloproteinase-9-activated human brain microvascular endothelial cell migration and tubulogenesis.
Neoplasms
The Distribution, Clearance, and Safety of an Anti-MMP-9 DNAzyme in Normal and MMTV-PyMT Transgenic Mice.
Neoplasms
The effect of hypoxic microenvironment on matrix metalloproteinase expression in xenografts of human oral squamous cell carcinoma.
Neoplasms
The effect of intravascular interventional embolization and craniotomy on MMP-2, MMP-9 and caspase3 in serum of intracranial aneurysm patients.
Neoplasms
The Effect of Neddylation Inhibition on Inflammation-Induced MMP9 Gene Expression in Esophageal Squamous Cell Carcinoma.
Neoplasms
The effect of probiotic yoghurt consumption on oxidative stress and inflammatory factors in young females after exhaustive exercise.
Neoplasms
The Effect of Progestins on Tumor Necrosis Factor ?-Induced Matrix Metalloproteinase-9 Activity and Gene Expression in Human Primary Amnion and Chorion Cells In Vitro.
Neoplasms
The Effect of Rice Bran Extract on Arterial Blood Pressure, Hepatic Steatosis, and Inflammation in Mice Fed with a High-Fat Diet.
Neoplasms
The effect of vascular endothelial growth factor (VEGF) on mouse condylar articular cartilage cultured in vitro.
Neoplasms
The effects of chitosan-based materials on glioma: Recent advances in its applications for diagnosis and treatment.
Neoplasms
The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Neoplasms
The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo.
Neoplasms
The effects of high-dose vitamin E supplementation on biomarkers of kidney injury, inflammation, and oxidative stress in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.
Neoplasms
The Effects of Xanthine Oxidoreductase Inhibitors on Oxidative Stress Markers following Global Brain Ischemia Reperfusion Injury in C57BL/6 Mice.
Neoplasms
The enzymatic processing of ?-dystroglycan by MMP-2 is controlled by two anchoring sites distinct from the active site.
Neoplasms
The estimation of metaloproteinases and their inhibitors blood levels in patients with pancreatic tumors.
Neoplasms
The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome.
Neoplasms
The evaluation of inhibitive effectiveness of the tumour necrosis factor-? converting enzyme selective inhibitors by HPLC.
Neoplasms
The expression and activity of MMPs are increased in residual tumor tissues after the termination of immunotherapy.
Neoplasms
The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer.
Neoplasms
The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival.
Neoplasms
The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades.
Neoplasms
The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Neoplasms
The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness.
Neoplasms
The Gastrprotective Effect of N- acetylcysteine and Genistein in Indomethacin-Induced Gastric Injury in Rats.
Neoplasms
The hemopexin domain of MMP-9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude mice.
Neoplasms
The IGF-I Receptor Can Alter the Matrix Metalloproteinase Repertoire of Tumor Cells through Transcriptional Regulation of PKC-{alpha}
Neoplasms
The Immunomodulatory Effects of Macrolides-A Systematic Review of the Underlying Mechanisms.
Neoplasms
The in vitro and in vivo anti-metastatic efficacy of oxythiamine and the possible mechanisms of action.
Neoplasms
The induction of heme oxygenase-1 suppresses heat shock protein 90 and the proliferation of human breast cancer cells through its byproduct carbon monoxide.
Neoplasms
The Induction of Metformin Inhibitory Effects on Tumor Cell Growth in Hypoxic Condition.
Neoplasms
The influence of functional polymorphisms in matrix metalloproteinase 9 on survival of breast cancer patients in a Chinese population.
Neoplasms
The influence of opioid peptides on matrix metalloproteinase-9 and urokinase plasminogen activator expression in three cancer cell lines.
Neoplasms
The influence of platelets on the promotion of invasion by tumor cells and inhibition by antiplatelet agents.
Neoplasms
The influence of simvastatin on selected inflammatory markers in patients with chronic obstructive pulmonary disease.
Neoplasms
The influence of transforming growth factor-?, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
Neoplasms
The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-alpha in human keratinocytes.
Neoplasms
The inhibitory effects of immunosuppressive factors, dexamethasone and interleukin-4, on NF-kappaB-mediated protease production by oral cancer.
Neoplasms
The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions.
Neoplasms
The integrin cytoplasmic-tail motif EKQKVDLSTDC is sufficient to promote tumor cell invasion mediated by matrix metalloproteinase (MMP)-2 or MMP-9.
Neoplasms
The interaction between aromatase, metalloproteinase 2,9 and cd44 in breast cancer.
Neoplasms
The interferon-gamma-induced GTPase, mGBP-2, inhibits tumor necrosis factor alpha (TNF-alpha) induction of matrix metalloproteinase-9 (MMP-9) by inhibiting NF-kappaB and Rac protein.
Neoplasms
The interferon-stimulated gene factor 3 complex mediates the inhibitory effect of interferon-beta on matrix metalloproteinase-9 expression.
Neoplasms
The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.
Neoplasms
The interplay of collagen IV, tumor necrosis factor-alpha, gelatinase B (matrix metalloprotease-9), and tissue inhibitor of metalloproteases-1 in the basal lamina regulates Sertoli cell-tight junction dynamics in the rat testis.
Neoplasms
The investigation of the relationships of demodex density with inflammatory response and oxidative stress in rosacea.
Neoplasms
The localization of thrombospondin-1 (TSP-1), cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) TSP receptor, and matrix metalloproteinase-9 (MMP-9) in colorectal cancer.
Neoplasms
The marine compound spongistatin 1 targets pancreatic tumour progression and metastasis.
Neoplasms
The matrix metalloproteinase 9 (mmp-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist.
Neoplasms
The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model.
Neoplasms
The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients.
Neoplasms
The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis.
Neoplasms
The MMP-2 and MMP-9 promoter polymorphisms and susceptibility to salivary gland cancer.
Neoplasms
The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Neoplasms
The MyD88 inhibitor TJ-M2010-2 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88/GSK-3? and MyD88/NF-?B signalling pathways.
Neoplasms
The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy.
Neoplasms
The non-antibiotic properties of tetracyclines: Clinical potential in ophthalmic disease.
Neoplasms
The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation.
Neoplasms
The Pathological Significance and Prognostic Roles of Thrombospondin-1, and -2, and 4N1K-peptide in Bladder Cancer.
Neoplasms
The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
Neoplasms
The phosphoinositide-binding protein ZF21 regulates ECM degradation by invadopodia.
Neoplasms
The possible role of heat shock protein-70 induction in collagen-induced arthritis in rats.
Neoplasms
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.
Neoplasms
The prediction of malignant cerebral infarction by molecular brain barrier disruption markers.
Neoplasms
The predictive potential and oncogenic effects of HOXC8 expression on osteosarcoma.
Neoplasms
The Preventative Role of Curcumin on the Lung Inflammatory Response Induced by Cardiopulmonary Bypass in Rats.
Neoplasms
The preventive and curative effects of melatonin against abdominal aortic aneurysm in rats.
Neoplasms
The prognostic significance of serum and cerebrospinal fluid MMP-9, CCL2 and sVCAM-1 in leukemia CNS metastasis.
Neoplasms
The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma.
Neoplasms
The protective effect of zeranol in cerebral ischemia reperfusion via p-CREB overexpression.
Neoplasms
The protective mechanism of progesterone on blood-brain barrier in cerebral ischemia in rats.
Neoplasms
The Protein Extract of Chlorella minutissima Inhibits The Expression of MMP-1, MMP-2 and MMP-9 in Cancer Cells through Upregulation of TIMP-3 and Down Regulation of c-Jun.
Neoplasms
The regulating role of mutant IkappaBalpha in expression of TIMP-2 and MMP-9 in human glioblastoma multiform.
Neoplasms
The Relationship between Corneal Nerve Morphology and Inflammatory Mediators and Neuropeptides in Healthy Individuals.
Neoplasms
The Relationship Between Maximal Exercise-Induced Increases in Serum IL-6, MPO and MMP-9 Concentrations.
Neoplasms
The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis.
Neoplasms
The Relationship Between Phospho-p38, Matrix Metalloproteinase 9, and Major Histocompatibility Complex Class I Chain-Related Molecule A Expression in Pituitary Adenomas Demonstrates a New Mechanism of Pituitary Adenoma Immune Escape.
Neoplasms
The role of ?-catenin in the initiation and metastasis of TA2 mice spontaneous breast cancer.
Neoplasms
The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells.
Neoplasms
The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease.
Neoplasms
The role of CD44 and matrix metalloproteinase-9 expression in predicting neck metastasis of supraglottic laryngeal carcinoma.
Neoplasms
The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression.
Neoplasms
The Role of Matrix Metalloproteinase-9 (MMP-9) as a Prognostic Factor in Epithelial and Lymphatic Neoplasia.
Neoplasms
The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer.
Neoplasms
The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer.
Neoplasms
The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis.
Neoplasms
The role of MMP-2 and MMP-9 as prognostic markers in the early stages of tongue squamous cell carcinoma.
Neoplasms
The role of MMP-2 and MMP-9 in the metastasis and development of hypopharyngeal carcinoma.
Neoplasms
The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine.
Neoplasms
The Role of Oxidative Stress Markers in Predicting Acute Thrombotic Occlusion of Haemodialysis Vascular Access and Progressive Stenotic Dysfunction Demanding Angioplasty.
Neoplasms
The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression.
Neoplasms
THE ROLE OF SERUM CK-18, MMP-9 AND TIPM-1 LEVELS IN PREDICTING R0 RESECTION IN PATIENTS WITH GASTRIC CANCER.
Neoplasms
The Role of Serum CK18, TIMP1, and MMP-9 Levels in Predicting R0 Resection in Patients with Gastric Cancer.
Neoplasms
The role of serum response factor in hepatocellular carcinoma: An association with matrix metalloproteinase.
Neoplasms
The Role of sLZIP in Transcriptional Regulation of c-Jun and Involvement in Migration and Invasion of Cervical Cancer Cells.
Neoplasms
The Role of Urokinase, Tumor Necrosis Factor, and Matrix Metalloproteinase-9 in Monocyte Activation.
Neoplasms
The Root Extract of Gentiana macrophylla Pall. Alleviates B19-NS1-Exacerbated Liver Injuries in NZB/W F1 Mice.
Neoplasms
The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.
Neoplasms
The secreted Ly6/uPAR-related protein-1 suppresses neutrophil binding, chemotaxis, and transmigration through human umbilical vein endothelial cells.
Neoplasms
The selective phosphodiesterase 4 inhibitor RP 73-401 reduced matrix metalloproteinase 9 activity and transforming growth factor-beta release during acute lung injury in mice: the role of the balance between Tumor necrosis factor-alpha and interleukin-10.
Neoplasms
The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
Neoplasms
The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9.
Neoplasms
The Significance of MMP-9 Over MMP-2 in HCC Invasiveness and Recurrence of Hepatocellular Carcinoma After Curative Resection.
Neoplasms
The significance of serum active matrix metalloproteinase-9 in patients with non-small cell lung cancer.
Neoplasms
The silencing of ApoC3 suppresses oxidative stress and inflammatory responses in placenta cells from mice with preeclampsia via inhibition of the NF-?B signaling pathway.
Neoplasms
The SOX2OT/miR-194-5p axis regulates cell proliferation and mobility of gastric cancer through suppressing epithelial-mesenchymal transition.
Neoplasms
The stem cell gene "inhibitor of differentiation 1" (ID1) is frequently expressed in non-small cell lung cancer.
Neoplasms
The Synthetic Triterpenoid CDDO-Methyl Ester Delays Estrogen Receptor-Negative Mammary Carcinogenesis in Polyoma Middle T Mice.
Neoplasms
The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells.
Neoplasms
The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.
Neoplasms
The tyrosine kinase inhibitor E-3810 combined with paclitaxel inhibits the growth of advanced-stage triple-negative breast cancer xenografts.
Neoplasms
The upregulated ?-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
Neoplasms
The upregulated scavenger receptor CD36 is associated with the progression of nontarget lesions after stent implantation in atherosclerotic rabbits.
Neoplasms
The Use of Conjunctival Staining to Measure Ocular Surface Inflammation in Patients With Dry Eye.
Neoplasms
Theophylline-Based KMUP-1 Improves Steatohepatitis via MMP-9/IL-10 and Lipolysis via HSL/p-HSL in Obese Mice.
Neoplasms
Therapeutic effect of Cryptotanshinone on collagen-induced arthritis in rats via inhibiting nuclear factor kappa B signaling pathway.
Neoplasms
Therapeutic effect of topical 5-fluorouracil in conjunctival squamous carcinoma is associated with changes in matrix metalloproteinases and tissue inhibitor of metalloproteinases expression.
Neoplasms
Therapeutic effects of nonerythropoietic erythropoietin analog ARA290 in experimental autoimmune encephalomyelitis rat.
Neoplasms
Therapeutic Effects of Three Human-derived Materials in a Mouse Corneal Alkali Burn Model.
Neoplasms
Therapeutic Effects of Topical Doxycycline in a Benzalkonium Chloride-Induced Mouse Dry Eye Model.
Neoplasms
Therapeutic potential of siRNA-mediated targeting of urokinase plasminogen activator, its receptor, and matrix metalloproteinases.
Neoplasms
Therapeutic Targeting of Vasculature in the Premetastatic and Metastatic Niches Reduces Lung Metastasis.
Neoplasms
Thermochemotherapy effect of nanosized As2O3/Fe3O4 complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9.
Neoplasms
Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.
Neoplasms
Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta1-integrin on the cell surface.
Neoplasms
Thrombin-induced Migration and Matrix Metalloproteinase-9 Expression Are Regulated by MAPK and PI3K Pathways in C6 Glioma Cells.
Neoplasms
Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor.
Neoplasms
Thrombospondin-1-derived 4N1K peptide expression is negatively associated with malignant aggressiveness and prognosis in urothelial carcinoma of the upper urinary tract.
Neoplasms
Thrombospondin-2 inhibits tumor cell invasion through the modulation of MMP-9 and uPA in pancreatic cancer cells.
Neoplasms
Thrombospondins, metallo proteases and thrombospondin receptors messenger RNA and protein expression in different tumour sublines of the Dunning prostate cancer model.
Neoplasms
Tianeptine sodium salt suppresses TNF-?-induced expression of matrix metalloproteinase-9 in human carcinoma cells via suppression of the PI3K/Akt-mediated NF-?B pathway.
Neoplasms
Tiaobu Feishen therapy inhibits inflammation induced by cigarette smoke extracts in a human monocyte/macrophage cell line.
Neoplasms
Time-dependent inhibition of immune complex-induced lung injury by catalase: relationship to alterations in macrophage and neutrophil matrix metalloproteinase elaboration.
Neoplasms
TIMP-1 expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells.
Neoplasms
TIMP-2 inhibits metastasis and predicts prognosis of colorectal cancer via regulating MMP-9.
Neoplasms
Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
Neoplasms
Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) and IL-23 Induced by Polysaccharide of the Black Hoof Medicinal Mushroom, Phellinus linteus (Agaricomycetes).
Neoplasms
Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: An independent predictor of mortality.
Neoplasms
Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model.
Neoplasms
Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma.
Neoplasms
Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
Neoplasms
Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion.
Neoplasms
Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.
Neoplasms
TLR4-mediated hippocampal MMP/TIMP imbalance contributes to the aggravation of perioperative neurocognitive disorder in db/db mice.
Neoplasms
TMEFF2 inhibits pancreatic cancer cells proliferation, migration, and invasion by suppressing phosphorylation of the MAPK signaling pathway.
Neoplasms
TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice.
Neoplasms
TNF-? induces phenotypic modulation in cerebral vascular smooth muscle cells: implications for cerebral aneurysm pathology.
Neoplasms
TNF-? May Exert Different Antitumor Effects in Response to Radioactive Iodine Therapy in Papillary Thyroid Cancer with/without Autoimmune Thyroiditis.
Neoplasms
TNF-?-Induced VEGF and MMP-9 Expression Promotes Hemorrhagic Transformation in Pituitary Adenomas.
Neoplasms
TNF-alpha regulates epithelial expression of MMP-9 and integrin alphavbeta6 during tumour promotion. A role for TNF-alpha in keratinocyte migration?
Neoplasms
TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve.
Neoplasms
Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction.
Neoplasms
Topical tretinoin in chronic rhinosinusitis with nasal polyps: a randomized clinical trial.
Neoplasms
Toward Point-of-Care Diagnostics to Monitor MMP-9 and TNF-? Levels in Inflammatory Bowel Disease.
Neoplasms
Towards a Better Understanding of the Relationships between Galectin-7, p53 and MMP-9 during Cancer Progression.
Neoplasms
Trans-4,4'-dihydroxystilbene ameliorates cigarette smoke-induced progression of chronic obstructive pulmonary disease via inhibiting oxidative stress and inflammatory response.
Neoplasms
Trans-chalcone added in topical formulation inhibits skin inflammation and oxidative stress in a model of ultraviolet B radiation skin damage in hairless mice.
Neoplasms
Transcription factor Egr-1 is essential for maximal matrix metalloproteinase-9 transcription by tumor necrosis factor alpha.
Neoplasms
Transcriptional Activation of Human Matrix Metalloproteinase-9 Gene Expression by Multiple Co-activators.
Neoplasms
Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line.
Neoplasms
Transcriptional Factors for Epithelial-Mesenchymal Transition Are Associated with Mesenchymal Differentiation in Gliosarcoma.
Neoplasms
Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma.
Neoplasms
Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion.
Neoplasms
Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha.
Neoplasms
Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha.
Neoplasms
Transcutaneous carbon dioxide induces mitochondrial apoptosis and suppresses metastasis of oral squamous cell carcinoma in vivo.
Neoplasms
Transcutaneous electrical acupoint stimulation for prevention of postoperative delirium in geriatric patients with silent lacunar infarction: a preliminary study.
Neoplasms
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women.
Neoplasms
Transfer of mesenchymal stem cells and cyclosporine A on alkali-injured rabbit cornea using nanofiber scaffolds strongly reduces corneal neovascularization and scar formation.
Neoplasms
Transferrin-functionalized chitosan-graft-poly(l-lysine) dendrons as a high-efficiency gene delivery carrier for nasopharyngeal carcinoma therapy.
Neoplasms
Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas.
Neoplasms
Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
Neoplasms
Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells.
Neoplasms
Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro.
Neoplasms
Transforming growth factor-β and matrix metalloproteinase secretion in cell culture from ex-vivo pbmc after exposure to uv radiation.
Neoplasms
Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin.
Neoplasms
Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression.
Neoplasms
Transforming growth factor-beta facilitates breast carcinoma metastasis by promoting tumor cell survival.
Neoplasms
Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes.
Neoplasms
Transforming growth factor-beta1 modulates metalloproteinase-2 and -9, nitric oxide, RhoA and alpha-smooth muscle actin expression in colon adenocarcinoma cells.
Neoplasms
Transforming growth factor-beta2 suppresses collagen cleavage in cultured human osteoarthritic cartilage, reduces expression of genes associated with chondrocyte hypertrophy and degradation, and increases prostaglandin E(2) production.
Neoplasms
Transgenesis-mediated reproductive dysfunction and tumorigenesis: effects of immunological neutralization.
Neoplasms
Transglutaminase 2 silencing reduced the beta-amyloid-effects on the activation of human THP-1 cells.
Neoplasms
Transglutaminase-2 Is Involved in All-Trans Retinoic Acid-Induced Invasion and Matrix Metalloproteinases Expression of SH-SY5Y Neuroblastoma Cells via NF-?B Pathway.
Neoplasms
Treatment of 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 inhibits TNF-alpha-mediated expression of MMP-9 protein and cell invasion through the suppression of JNK pathway and microRNA 221 in human pancreatic adenocarcinoma cancer cells.
Neoplasms
Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells.
Neoplasms
Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo.
Neoplasms
Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Neoplasms
Trefoil Factor 1 Suppresses Epithelial-mesenchymal Transition through Inhibition of TGF-beta Signaling in Gastric Cancer Cells.
Neoplasms
Tricolor imaging of MMPs to investigate the promoting roles of inflammation on invasion and migration of tumor cells.
Neoplasms
Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice.
Neoplasms
Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes ?v?3-mediated adhesion and invasive migration.
Neoplasms
Trimeric Tn Antigen on Syndecan 1 Produced by ppGalNAc-T13 Enhances Cancer Metastasis via a Complex Formation with Integrin ?5?1 and Matrix Metalloproteinase 9.
Neoplasms
TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling.
Neoplasms
Tristetraprolin: A novel target of diallyl disulfide that inhibits the progression of breast cancer.
Neoplasms
TSG101, a tumor susceptibility gene, bidirectionally modulates cell invasion through regulating MMP-9 mRNA expression.
Neoplasms
Tspan9 inhibits the proliferation, migration and invasion of human gastric cancer SGC7901 cells via the ERK1/2 pathway.
Neoplasms
Tubular network formation by adriamycin-resistant MCF-7 breast cancer cells is closely linked to MMP-9 and VEGFR-2/VEGFR-3 over-expressions.
Neoplasms
Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle.
Neoplasms
Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat.
Neoplasms
Tumor Cell-Derived Exosomes from the Prostate Cancer Cell Line TRAMP-C1 Impair Osteoclast Formation and Differentiation.
Neoplasms
Tumor Cell-educated Periprostatic Adipose Tissue Acquires an Aggressive Cancer-promoting Secretory Profile.
Neoplasms
Tumor cell-macrophage interactions increase angiogenesis through secretion of EMMPRIN.
Neoplasms
Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.
Neoplasms
Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
Neoplasms
Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate.
Neoplasms
Tumor immunobiological differences in prostate cancer between African-American and European-American men.
Neoplasms
Tumor M2-Pyruvate Kinase, Matrix Carbonic Anhydrase IX, and Metalloproteinase 9 - Novel Prognostic Markers of Renal Cell Carcinoma.
Neoplasms
Tumor metastasis in an orthotopic murine model of head and neck cancer: possible role of TGF-beta 1 secreted by the tumor cells.
Neoplasms
Tumor necrosis factor alpha (TNFalpha) induces pro-matrix metalloproteinase 9 production in human uterine cervical fibroblasts but interleukin 1alpha antagonizes the inductive effect of TNFalpha.
Neoplasms
Tumor necrosis factor alpha and lymphotoxin stimulate human myeloblastic leukemia cell (ML-1) invasion through a reconstituted basement membrane (Matrigel) with concomitant induction of 92 kDa gelatinase secretion.
Neoplasms
Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin.
Neoplasms
Tumor necrosis factor stimulates matrix metalloproteinase 9 secretion from cultured human chorionic trophoblast cells through TNF receptor 1 signaling to IKBKB-NFKB and MAPK1/3 pathway.
Neoplasms
Tumor necrosis factor-? disruption of brain endothelial cell barrier is mediated through matrix metalloproteinase-9.
Neoplasms
Tumor necrosis factor-alpha and not interleukin-1alpha is the dominant inducer of matrix metalloproteinase-9 synthesis in human corneal cells.
Neoplasms
Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway.
Neoplasms
Tumor necrosis factor-alpha G(-308)A promoter polymorphism, matrix metalloproteinase (MMP)-3 5A/6A gene variation, MMP-9 C(-1562)T promoter polymorphism and risk and extent of ischemic heart disease.
Neoplasms
Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated kinase-1.
Neoplasms
Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells.
Neoplasms
Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia.
Neoplasms
Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window.
Neoplasms
Tumor necrosis factor-alpha-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase.
Neoplasms
Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy.
Neoplasms
Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
Neoplasms
Tumor promoter TPA stimulates MMP-9 secretion from human keratinocytes by activation of superoxide-producing NADPH oxidase.
Neoplasms
Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor.
Neoplasms
Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin.
Neoplasms
Tumor-Recruited Neutrophils and Neutrophil TIMP-Free MMP-9 Regulate Coordinately the Levels of Tumor Angiogenesis and Efficiency of Malignant Cell Intravasation.
Neoplasms
Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species.
Neoplasms
Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.
Neoplasms
Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells.
Neoplasms
Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
Neoplasms
Tumorigenic Development of Induced Pluripotent Stem Cells in Ischemic Mouse Brain.
Neoplasms
Tumour cell and stromal features in metastatic and non-metastatic non-small cell lung carcinomas.
Neoplasms
Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway.
Neoplasms
Tumour-associated macrophages mediate the invasion and metastasis of bladder cancer cells through CXCL8.
Neoplasms
Tumour-associated neutrophils and loss of epithelial PTEN can promote corticosteroid-insensitive MMP-9 expression in the chronically inflamed lung microenvironment.
Neoplasms
Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth.
Neoplasms
TWIST expression in hypopharyngeal cancer and the mechanism of TWIST-induced promotion of metastasis.
Neoplasms
Type I collagen induces tissue factor expression and matrix metalloproteinase 9 production in human primary monocytes through a redox-sensitive pathway.
Neoplasms
Type I collagen-induced pro-MMP-2 activation is differentially regulated by H-Ras and N-Ras in human breast epithelial cells.
Neoplasms
Type IV collagen ?1-chain noncollagenous domain blocks MMP-2 activation both in-vitro and in-vivo.
Neoplasms
Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas.
Neoplasms
Ulinastatin improves myocardial ischemia-reperfusion injury in rats through endoplasmic reticulum stress-induced apoptosis pathway.
Neoplasms
Ulinastatin reduces cancer recurrence after resection of hepatic metastases from colon cancer by inhibiting MMP-9 activation via the antifibrinolytic pathway.
Neoplasms
Ultrasound enhanced matrix metalloproteinase-9 triggered release of contents from echogenic liposomes.
Neoplasms
Uncovering the hidden potential of intravenous immunoglobulin as an anticancer therapy.
Neoplasms
Up-regulated expression of the beta3 integrin and the 92-kDa gelatinase in human HT-144 melanoma cell tumors grown in nude mice.
Neoplasms
Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells.
Neoplasms
Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer.
Neoplasms
Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor.
Neoplasms
Up-regulation of miR-324-5p inhibits proliferation and invasion of colorectal cancer cells by targeting ELAVL1.
Neoplasms
Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.
Neoplasms
Upregulation of circulating cytokeratin 20, urokinase plasminogen activator and C-reactive protein is associated with poor prognosis in gastric cancer.
Neoplasms
Upregulation of matrix metalloproteinase-9 in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cells.
Neoplasms
Upregulation of miR-216a exerts neuroprotective effects against ischemic injury through negatively regulating JAK2/STAT3-involved apoptosis and inflammatory pathways.
Neoplasms
Upregulation of MMP-9 expression in MDA-MB231 tumor cells by platelet granular membrane.
Neoplasms
Upregulation of MMP-9 production by TNFalpha in keratinocytes and its attenuation by vitamin D.
Neoplasms
Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway.
Neoplasms
Urinary release of 72 and 92 kDa gelatinases, TIMPs, N-GAL and conventional prognostic factors in urothelial carcinomas.
Neoplasms
Urine phthalate metabolites are associated with urothelial cancer in chronic kidney disease patients.
Neoplasms
Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion.
Neoplasms
Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Neoplasms
Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells.
Neoplasms
Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-?B pathway in tumor-bearing nude mice.
Neoplasms
Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients.
Neoplasms
Usefulness of MMP-9/TIMP-1 in predicting tumor recurrence in patients undergoing curative surgical resection for gastric carcinoma.
Neoplasms
Using Serum Matrix Metalloproteinase-9 Levels in the Diagnosis of Functional Adrenal Tumors.
Neoplasms
v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines.
Neoplasms
Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors.
Neoplasms
Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats.
Neoplasms
Vanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells.
Neoplasms
Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas.
Neoplasms
Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma.
Neoplasms
Vasoactive intestinal peptide ameliorates synovial cell functions of collagen-induced arthritis rats by down-regulating NF-kappaB activity.
Neoplasms
VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis.
Neoplasms
VEGFR-2 expression in malignant tumours of the canine mammary gland: a prospective survival study.
Neoplasms
Verapamil inhibits tumor protease production, local invasion and metastasis development in murine carcinoma cells.
Neoplasms
Verbascoside Inhibits Glioblastoma Cell Proliferation, Migration and Invasion While Promoting Apoptosis Through Upregulation of Protein Tyrosine Phosphatase SHP-1 and Inhibition of STAT3 Phosphorylation.
Neoplasms
Vernolide-A inhibits radiation-induced hypoxia-mediated tumor angiogenesis by regulating HIF-1?, MMP-2, MMP-9, and VEGF.
Neoplasms
VILIP-1 expression in vivo results in decreased mouse skin keratinocyte proliferation and tumor development.
Neoplasms
Vinorelbine cationic liposomes modified with wheat germ agglutinin for inhibiting tumor metastasis in treatment of brain glioma.
Neoplasms
Vitamin D Inhibits Activities of Metalloproteinase-9/-13 in Articular Cartilage In Vivo and In Vitro.
Neoplasms
Vitamin D Receptor Genetic Variation and Cancer Biomarkers among Breast Cancer Patients Supplemented with Vitamin D3: A Single-Arm Non-Randomized Before and After Trial.
Neoplasms
Volatile Anesthetics Reduce Invasion of Colorectal Cancer Cells through Down-regulation of Matrix Metalloproteinase-9.
Neoplasms
Walker 256 cancer cells secrete tissue inhibitor of metalloproteinase-free metalloproteinase-9.
Neoplasms
Wikstromol from Wikstroemia indica induces apoptosis and suppresses migration of MDA-MB-231 cells via inhibiting PI3K/Akt pathway.
Neoplasms
Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis.
Neoplasms
Withdrawal: Blockade of tumor growth due to matrix metalloproteinase-9 inhibition is mediated by sequential activation of ?1-integrin, ERK, and NF-?B.
Neoplasms
Wnt signaling pathway inhibitors as promising diagnostic serum markers of osteolytic bone metastasis.
Neoplasms
Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer.
Neoplasms
Wogonin Suppresses the Activity of Matrix Metalloproteinase-9 and Inhibits Migration and Invasion in Human Hepatocellular Carcinoma.
Neoplasms
XBP1 induces MMP-9 expression to promote proliferation and invasion in human esophageal squamous cell carcinoma.
Neoplasms
Xiaoyaosan, a traditional Chinese medicine, inhibits the chronic restraint stress-induced liver metastasis of colon cancer in vivo.
Neoplasms
YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.
Neoplasms
YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma.
Neoplasms
YKL-40 promotes the progress of atherosclerosis independent of lipid metabolism in apolipoprotein E-/- mice fed a high-fat diet.
Neoplasms
Yokukansan Alleviates Cancer Pain by Suppressing Matrix Metalloproteinase-9 in a Mouse Bone Metastasis Model.
Neoplasms
ZHX2 inhibits proliferation and promotes apoptosis of human lung cancer cells through targeting p38MAPK pathway.
Neoplasms
Zinc dependent endopeptidases of matrix metalloproteinases-9 expressions is associated with tumor metastases of oral squamous cell carcinoma in Chinese population: a meta-analysis.
Neoplasms
Zingerone suppresses angiogenesis via inhibition of matrix metalloproteinases during tumor development.
Neoplasms
ZJ01, a Small Molecule Inhibitor of the Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction, Reduces Hyperoxic Acute Lung Injury in a Mouse Model.
Neoplasms
ZNF139 promotes tumor metastasis by increasing migration and invasion in human gastric cancer cells.
Neoplasms
Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.
Neoplasms
Zymographic analysis of circulating and tissue forms of colon carcinoma gelatinase A (MMP-2) and B (MMP-9) separated by mono- and two-dimensional electrophoresis.
Neoplasms
Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera.
Neoplasms
[(18)F-Fluorodeoxyglucose positron emission tomography and serum cytokines and matrix metalloproteinases in the assessment of disease activity in Takayasu's arteritis].
Neoplasms
[Activity of matrix metalloproteinases -2 and -9 (MMP-2 and MMP-9) and content of their tissue inhibitors in endometrial cancer--a preliminary study]
Neoplasms
[Adhesion induces matrix metalloproteinase-9 gene expression in ovarian cancer cells]
Neoplasms
[Alteration of ERalpha expression and tumor invasion by RNA interference against metastasis associated-1 gene in human breast cancer cells]
Neoplasms
[An effect of perindopril on the level of tumor necrosis factor-alpha and matrix metalloproteinase-9 in peripheral blood in the acute period of atherothrombotic ischemic stroke and myocardial infarction]
Neoplasms
[Anti-sense nucleic acid of CyclinD1 induces apoptosis of lung adenocarcinoma cancer cell A549.]
Neoplasms
[Assay of matrix metalloproteinase levels and their endogenous inhibitors in patients with laryngeal carcinoma]
Neoplasms
[CD147 increases invasiveness of U937 cells through regulation of matrix metalloproteinase activity]
Neoplasms
[Characteristics of immune response and inflammatory reaction in atherothrombotic stroke and myocardial infarction].
Neoplasms
[Clinical and prognostic significance of serum MMP-9, endostatin and VEGF in patients with advanced non-small cell lung cancer.]
Neoplasms
[Comparative study on effects of puerarin and granulocyte colony-stimulating factor in treating acute myocardial infarction]
Neoplasms
[Comparison of the pathogenesis of liver fibrosis induced by pig serum exposure and bile duct ligation in rats]
Neoplasms
[Controlled expression of matrix metalloproteinase 9 promotes expression of invasive phenotype of human melanoma cells]
Neoplasms
[Correlation between bacterial L-form infection, expression of HIF-1?/MMP-9 and vasculogenic mimicry in epithelial ovarian cancer].
Neoplasms
[Correlation between expression of MMP-2, MMP-9, TIMP-2, TIMP-1 and metastasis of neuroblastoma]
Neoplasms
[Correlation between expressions of matrix metalloproteinase-2 & 9 and vasculogenic mimicry in gastrointestinal stromal tumors]
Neoplasms
[Correlation of MUC1 expression to adhesion of breast cancer cell line MDA-MB-231.]
Neoplasms
[Correlations of serous levels of matrix metalloproteinases (MMP-2 and MMP-9) to invasion and metastasis of papillary thyroid carcinoma]
Neoplasms
[Detection of serum total MMP-9 and its clinical significance for lung neoplasms].
Neoplasms
[Diversity of invasiveness and matrix metalloproteinases expression profile of human gastric carcinoma xenografted in different tissue environments]
Neoplasms
[Down-regulation of metastatic phenotype in human melanoma cells by controlled expression of anti-sense matrix metalloproteinase 9]
Neoplasms
[Effect of As(2)O(3) on Expressions of COX-2 and Matrix Metalloproteinases in SGC7901 and K562 Cells.]
Neoplasms
[Effect of cisplatin on expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and their correlations in Lewis lung cancer in mice.]
Neoplasms
[Effect of epigallocatechin-3-gallate on the invasiveness of hepatocarcinoma cells in vitro]
Neoplasms
[Effect of human bone marrow mesenchymal stem cells on invasion of tongue squamous cell carcinoma cell line Cal-27].
Neoplasms
[Effect of hypoxia on production and secretion of matrix metalloproteinases in tumor cells]
Neoplasms
[Effect of mechanical stimulation on the invasion in salivary adenoid cystic carcinoma]
Neoplasms
[Effect of new qingkailing injection on cerebral edema following intracerebral hemorrhage in rats]
Neoplasms
[Effect of ray cartilage glycosaminoglycans (RCG) on the expression of MMP-9 in Lewis lung carcinoma]
Neoplasms
[Effect of recombinant human tumor necrosis factor alpha on activity of gelatinase B and migration of human umbilical cord blood mononuclear cells in vitro]
Neoplasms
[Effect of Shenxiong injection on inflammation injury of ischemia-reperfusion injury rats].
Neoplasms
[Effect of short-hairpin RNA expression vector-mediated osteopontin RNA interference on proliferation and invasion of prostate cancer PC-3 cells]
Neoplasms
[Effect of spearmint oil on lipopolysaccharide induced emphysema-like changes and expression of matrix metalloproteinase-9].
Neoplasms
[Effects of HSYA on expression of bFGF protein and MMP-9 in BGC-823 transplantation tumor of nude mice].
Neoplasms
[Effects of matrix metalloproteinase-9 antisense oligonucleotide on the apoptosis and metastasis of the human lung adenocarcinoma cell.]
Neoplasms
[Effects of periodontitis patient's own tissue nucleic acid on the mRNA expression of osteoclast-related factors in murine macrophages].
Neoplasms
[Effects of Runing Recipe medicated serum on expressions of genes in breast cancer cells.]
Neoplasms
[Effects of tumor necrosis factor-? on release of MMP-3, MMP-9, and interleukin-17 in mouse bone marrow-derived mast cells in vitro].
Neoplasms
[Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer]
Neoplasms
[Endotoxinemia and systemic inflammation in pathogenesis of chronic heart failure].
Neoplasms
[Experimental study of targeting MMP-9 deoxyribozyme role of adhesion and migration in human lung adenocarcinoma cancer cell.]
Neoplasms
[Exploratory study on influence of biopsy to biological behavior of Tca8113 transplanted tumor].
Neoplasms
[Expression and clinical significance of certain apoptosis and angiogenesis factors in hepatocellular carcinoma]
Neoplasms
[Expression and clinical significance of matrix metalloproteinase in gastric stromal tumor]
Neoplasms
[Expression and clinical significance of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinomas]
Neoplasms
[Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma]
Neoplasms
[Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma]
Neoplasms
[Expression and clinical value of eukaryotic initiation factor4E and matrix metalloproteinase-9 in supraglottic and hypopharyngeal carcinoma and metastasic lymph]
Neoplasms
[Expression and pathological mechanism of MMP-9 and HIF-2? in CD133(+) lung cancer stem cells].
Neoplasms
[Expression and significance of CD44v6 and MMP-9 in laryngeal squamous cell carcinoma]
Neoplasms
[Expression and significance of the matrix metalloprofeinase inhibitor RECK gene in prostate cell strains]
Neoplasms
[Expression of adiponectin in non-small cell lung cancer and its relationship with MMP-9 and angiogenesis].
Neoplasms
[Expression of CD147 and matrix metalloproteinase-9 in children with non-Hodgkin's lymphoma and its correlation with prognosis]
Neoplasms
[Expression of CD147, matrix metalloproteinases and transforming growth factor beta1 in breast cancer]
Neoplasms
[Expression of COX-2 and MMP-9 in cervical carcinoma and their clinical significance]
Neoplasms
[Expression of dishevelled-2 in cartilage of rheumatoid arthritis and its effect on cartilage destruction].
Neoplasms
[Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma]
Neoplasms
[Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour]
Neoplasms
[Expression of matrix metalloproteinase 9 (MMP-9) and laminin-receptor in breast carcinoma and their correlation with tumor metastasis and prognosis]
Neoplasms
[Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma]
Neoplasms
[Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix]
Neoplasms
[Expression of matrix metalloproteinase-2,matrix metalloproteinase-9 and vascular endothdial growth factor in retinoblastoma and its clinical significance.]
Neoplasms
[Expression of matrix metalloproteinase-9 and its complex in the urine of breast cancer patients]
Neoplasms
[Expression of matrix metalloproteinase-9 and tumor necrosis factor-alpha in the placenta of patients with pregnancy-induced hypertension]
Neoplasms
[Expression of matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in papillary thyroid cancer: an association with the clinical, morphological and ultrastructural characteristics of a tumor].
Neoplasms
[Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas]
Neoplasms
[Expression of matrix metalloproteinases in lung tissue and levels of some cytokines in bronchoalveolar lavage fluid in the obstructive emphysema rat models]
Neoplasms
[Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance]
Neoplasms
[Expression of MMP-2 and MMP-9 in non-small-cell lung cancer and their prognostic value.]
Neoplasms
[Expression of MMP-9 and MMP-9 mRNA in gastric carcinoma and its correlation with angiogenesis]
Neoplasms
[Expression of MMP-9 and VEGF in breast cancer: correlation with other prognostic indicators]
Neoplasms
[Expression of nuclear factor-kappaB, Ki-67 and matrix metalloproteinase-9 in calcifying odontogenic cyst]
Neoplasms
[Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma]
Neoplasms
[Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance]
Neoplasms
[Expressions of CD44s, MMP-9, and Ki-67: possible association with invasion, metastasis, and recurrence of osteosarcoma]
Neoplasms
[Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues]
Neoplasms
[Functions of neutrophil gelatinase-associated lipocalin in the esophageal carcinoma cell line SHEEC]
Neoplasms
[Gelatinases A and B and their endogenous regulators in the corpus uteri in squamous cell cervical carcinoma].
Neoplasms
[Growth inhibition of prostate cancer cells by epigallocatechin-3-gallate in the presence of Zn2+ in vitro]
Neoplasms
[High tumorigenicity of human acute monocytic leukemic cell Line SHI-1 in nude mice and its mechanism]
Neoplasms
[Immunohistochemistry of matrix metalloproteinases in different morphologic types of the lung cancer developed in the inhabitants of the Semipalatinsk Region]
Neoplasms
[Increased expression of gelatinases A and B, matrilysin and TIMP-1 genes in human malignant gliomas ]
Neoplasms
[Influence of nuclear factor erythoid 2-related factor 2 genotype on tumor necrosis factor-? and metalloproteinase-9 expression in spinal cord after spinal cord injury in mice].
Neoplasms
[Inhibition of matrix metalloproteinases 9 and 13 affects the degree of lymphocytic infiltration and the expression levels of microRNA miR-21 and miR-let-7b in melanoma cells in vivo].
Neoplasms
[Inhibitory effect of andrographolide on angiogenesis induced by the supernatant from cultured tumor cells].
Neoplasms
[Inhibitory effects of matrix metalloproteinase (MMP) inhibitor LY52 on expression of MMP-2 and MMP-9 and invasive ability of human ovarian carcinoma cell line SKOV3]
Neoplasms
[Interstitial collagenase, gelatinases A and B and their endogenous inhibitors in squamous cell cervical carcinomas].
Neoplasms
[Key enzymes of degradation and angiogenesis as a factors of tumor progression in squamous cell carcinoma of the cervix].
Neoplasms
[Ki-67 and matrix metalloproteinase-9 expression in the follicular cyst, keratocystic odontogenic tumor, and ameloblastoma].
Neoplasms
[Lentivirus media miR-1246 knockdown inhibits tumor growth and promotes apoptosis of SiHa cells].
Neoplasms
[Matrix metalloproteinase 2 and 9 as the factor of head and neck tumor metastasis]
Neoplasms
[Matrix metalloproteinase-2 concentrations in squamous cell carcinoma of the head and neck and its clinical significance]
Neoplasms
[Matrix metalloproteinases 2 and 9, their endogenous regulators, and angiotensin-converting enzyme in cervical squamous cell carcinoma].
Neoplasms
[Matrix metalloproteinases and their endogenous regulators in squamous cervical carcinoma (review of the own data)].
Neoplasms
[Matrix metalloproteinases and their tissue inhibitors in malignancies of the female genital tract]
Neoplasms
[Mechanism of EGFR Over-expression and Mutations Leading to ?Biological Characteristics Changes of Human Lung Adenocarcinoma Cells ?through CXCR4/CXCL12 Signaling Pathway].
Neoplasms
[Mechanisms for quercetin in prevention of lung cancer cell growth and metastasis].
Neoplasms
[mRNA expression analysis of metastatic markers in clear-cell renal cell carcinoma]
Neoplasms
[mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR]
Neoplasms
[Overexpression of IL-8 and MMP-9 confer high malignant phenotype in patients with non-small cell lung cancer]
Neoplasms
[Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid.]
Neoplasms
[Propofol suppresses invasion of human lung cancer A549 cells by down-regulating aquaporin-3 and matrix metalloproteinase-9].
Neoplasms
[Relationship and clinical significance of KiSS-1, nuclear factor kappa B (NF-kappaB), p50, and matrix metalloproteinase 9 expression in breast cancer]
Neoplasms
[Relationship between bFGF mRNA and MMP-9 mRNA expression in gastric carcinoma and their clinicopathological features as well as patients survival]
Neoplasms
[Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix]
Neoplasms
[Relationship between expression of matrix metalloproteinase-9 (MMP-9) and angiogenesis in renal cell carcinoma]
Neoplasms
[Relationship between levels of sex hormones and response to cardiac resynchronisation therapy in men].
Neoplasms
[RELATIONSHIP BETWEEN SMOKING AND INDICATORS OF SYSTEMIC INFLAMMATION IN PATIENTS WITH CORONARY HEART DISEASE].
Neoplasms
[Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas]
Neoplasms
[Relationship of the disturbed balance between matrix metalloproteinases and their tissue inhibitors and the invasion of malignant salivary gland tumours]
Neoplasms
[Review of correlation between human parvovirus B19 and autoimmune disease etiology].
Neoplasms
[RNA interference targeting c-Met inhibits proliferation of human laryngeal carcinoma Hep-2 cell line in vitro and in its xenografts in nude mice.]
Neoplasms
[RNAi-mediated Silencing of CXCR4 Inhibits the Adhesion, Invasion and Tumorigenicity of Acute Monocytic Leukemic Cell Line SHI-1].
Neoplasms
[Role and mechanism of the expression of matrix metalloproteinase 9 and tumor necrosis factor ? in upper and lower respiratory tract inflammation in rats].
Neoplasms
[Role of matrix metalloproteinase-9 in the pathogenesis of osteoporosis in patients with chronic obstructive pulmonary disease].
Neoplasms
[Role of matrix metalloproteinases (MMPs) in tumor invasion and metastasis: serial studies on MMPs and TIMPs]
Neoplasms
[Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior]
Neoplasms
[Role of vascular endothelial growth factor receptor 1-positive hematopoietic progenitor cell clusters in human colorectal carcinoma metastasis]
Neoplasms
[Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis]
Neoplasms
[Significance in gene expression of matrix metalloproteinase-9, urokinase-type plasminogen activator and tissue inhibitor of metalloproteinase for metastases of gastric and/or colo-rectal cancer]
Neoplasms
[Significance of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase and protein Ki-67 in prostate tumors].
Neoplasms
[Significance of MMP-9 and TIMP-1 production during liver metastasis in colorectal cancer]
Neoplasms
[Study on differentially expressed molecules influencing the metastatic potential between highly and poorly metastatic human lung giant cell carcinoma]
Neoplasms
[Study on expression of matrix metalloproteinases and their inhibitors in parotid gland tumors]
Neoplasms
[The activity of components of system of matrix metalloproteinase and tissue inhibitors of metalloproteinase on different stages of chronic cardiac failure].
Neoplasms
[The experimental investigation of laryngeal cancer growth in vive by recombinant lentivirus of small interference RNA (siRNA) targeting MMP-9]
Neoplasms
[The expression and its clinical significance of MMP-2 and MMP-9 in non-small cell lung cancer.]
Neoplasms
[The expression of a novel estrogen receptor, GPR30, in epithelial ovarian carcinoma and its correlation with MMP-9.]
Neoplasms
[The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship]
Neoplasms
[The expression of matrix metalloproteinase-9 and tumor necrosis factor-alpha in cholesteatoma]
Neoplasms
[The expression of matrix metalloproteinases and their tissue inhibitors in pleomorphic adenoma]
Neoplasms
[The expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in transplanted tumor of salivary adenoid cystic carcinoma cell lines]
Neoplasms
[The inhibitory effect of recombinant polypeptide CH50 of fibronectin on invasion and angiogenesis of tumors]
Neoplasms
[The mechanism and pulmonary-protective effects of endothelin-1 receptor antagonist in chronic obstructive pulmonary diseases rat model].
Neoplasms
[The mechanisms of microenvironments influence on vasculogenic mimicry between introcular and subcutaneous melanoma]
Neoplasms
[The plasma levels and diagnostic utility of matrix metalloproteinase-9 and CA 125 in cervical cancer patients].
Neoplasms
[The relationships between angiogenesis and matrix metalloproteinase-2, -9 in mice tumor intervened by feiyanning recipe's components].
Neoplasms
[The role of selected matrix metalloproteinases and their inhibitors in colorectal cancer development]
Neoplasms
[The role of stromal mast cells in the modification of CD4+CD25+Foxp³ regulatory T cells, Th17 lymphocytes and cytotoxic lymphocytes Tc1 in the development and progression of tumor].
Neoplasms
[The serum concentration of metalloproteinase 9 and 2 in non-small cell lung cancer patients]
Neoplasms
[The utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignancies].
Neoplasms
[Therapeutic effect of anti-nucleokine monoclonal antibody on ischemic brain infarction]
Neoplasms
[Tumor necrosis factor alpha-induced expression and activity of alveolar macrophages matrix metalloproteinase-9 in chronic obstructive pulmonary disease]
Neoplasms
[VALUE OF METALPROTEINASES OF BLOOD IN PATHOGENESIS OF EPITELIAL SKIN TUMORS AND THE POSSIBILITY OF THEIR SURGICAL CORRECTION].
Neoplasms
{gamma}-Tocotrienol Inhibits Pancreatic Tumors and Sensitizes Them to Gemcitabine Treatment by Modulating the Inflammatory Microenvironment.
Neoplasms, Germ Cell and Embryonal
Imbalance of MMP-2 and MMP-9 expression versus TIMP-1 and TIMP-2 reflects increased invasiveness of human testicular germ cell tumours.
Neoplasms, Glandular and Epithelial
Transcriptional Factors for Epithelial-Mesenchymal Transition Are Associated with Mesenchymal Differentiation in Gliosarcoma.
Neoplasms, Glandular and Epithelial
[Immunohistochemical study of the specific features of expression of matrix metalloproteinases 1, 9 in the photoaged skin, the foci of actinic keratosis and basal cell carcinoma].
Neoplasms, Radiation-Induced
Linarin inhibits radiation-induced cancer invasion by downregulating MMP-9 expression via the suppression of NF-?B activation in human non-small-cell lung cancer A549.
Neoplasms, Squamous Cell
Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by ERK1/2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma.
Neoplasms, Squamous Cell
Correlation of expression of Ki-67, EGFR, c-erbB-2, MMP-9, p53, bcl-2, CD34 and cell cycle analysis with survival in head and neck squamous cell cancer.
Neoplasms, Squamous Cell
Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer.
Neoplasms, Squamous Cell
NF-kappa BP65 Promotes Invasion and Metastasis of Esophageal Squamous Cell Cancer by Regulating Matrix Metalloproteinase-9 and Epithelial-to-Mesenchymal Transition.
Neoplasms, Squamous Cell
The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
Neoplasms, Squamous Cell
The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer.
Neoplastic Cells, Circulating
Circulating tumor cells and serum levels of MMP-2, MMP-9 and VEGF as markers of the metastatic process in patients with high risk of metastatic progression.
Neoplastic Cells, Circulating
MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy.
Nephritis
Altered expression of matrix-related molecules in the development of chronic Thy1.1 nephritis.
Nephritis
Cut-off values for serum matrix metalloproteinase-9: is there a threshold to predict renal involvement for Henoch-Schonlein purpura in children?
Nephritis
Differential glomerular immunoexpression of matrix metalloproteinases MMP-2 and MMP-9 in idiopathic IgA nephropathy and Schoenlein-Henoch nephritis.
Nephritis
Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis.
Nephritis
Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity.
Nephritis
Potential of Serum and Urinary Matrix Metalloproteinase-9 Levels for the Early Detection of Renal Involvement in Children With Henoch-Schönlein Purpura.
Nephritis, Hereditary
Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome.
Nephritis, Hereditary
Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS).
Nephrolithiasis
A polymorphism in the 3'-untranslated region of the matrix metallopeptidase 9 gene is associated with susceptibility to idiopathic calcium nephrolithiasis in the Chinese population.
Nephrosis, Lipoid
Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
Nephrotic Syndrome
Distinct metalloproteinase excretion patterns in focal segmental glomerulosclerosis.
Nephrotic Syndrome
Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy.
Nephrotic Syndrome
Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
Nervous System Diseases
Increase of tumor necrosis factor-alpha in the blood induces early activation of matrix metalloproteinase-9 in the brain.
Nervous System Diseases
Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count.
Nervous System Diseases
Matrix metalloproteinase-9 involvement in the structural plasticity of dendritic spines.
Nervous System Diseases
MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer's disease.
Nervous System Diseases
Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate.
Nervous System Diseases
Serum levels of matrix metalloproteinases: implications in clinical neurology.
Nervous System Diseases
The Perineuronal 'Safety' Net? Perineuronal Net Abnormalities in Neurological Disorders.
Nervous System Diseases
Upregulation of matrix metalloproteinase-9 in the cerebrospinal fluid of patients with acute Lyme neuroborreliosis.
Neuralgia
Acute morphine activates satellite glial cells and up-regulates IL-1? in dorsal root ganglia in mice via matrix metalloprotease-9.
Neuralgia
Acute morphine induces matrix metalloproteinase-9 up-regulation in primary sensory neurons to mask opioid-induced analgesia in mice.
Neuralgia
Biomarker Analysis of Orally Dosed, Dual Active, Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitor, AQU-118, in the Spinal Nerve Ligation (SNL) Rat Model of Neuropathic Pain.
Neuralgia
Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve.
Neuralgia
Different expression of tissue inhibitor of metalloproteinase family members in rat dorsal root ganglia and their changes after peripheral nerve injury.
Neuralgia
Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain.
Neuralgia
Effect of a Novel, Orally Active Matrix Metalloproteinase-2 and -9 Inhibitor in Spinal and Trigeminal Rat Models of Neuropathic Pain.
Neuralgia
Intrathecal CGS-26303 Pretreatment Attenuates Spinal Nerve Ligation-Induced Neuropathic Pain in the Spinal Cord.
Neuralgia
Matrix metalloproteinases in neuropathic pain and migraine: friends, enemies, and therapeutic targets.
Neuralgia
MMP-9 regulates CX3CL1/CX3CR1 in the early phase of neuropathic pain in chronic sciatic nerve constriction injury (CCI) rats.
Neuralgia
Naringenin ameliorates diabetic neuropathic pain by modulation of oxidative-nitrosative stress, cytokines and MMP-9 levels.
Neuralgia
Pretreatment with resveratrol ameliorate trigeminal neuralgia by suppressing matrix metalloproteinase-9/2 in trigeminal ganglion.
Neuralgia
Role of Matrix Metalloproteinases and Therapeutic Benefits of Their Inhibition in Spinal Cord Injury.
Neuralgia
Upregulation of inflammatory mediators in a model of chronic pain after spinal cord injury.
Neurilemmoma
Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.
Neurilemmoma
Expression of matrix metalloproteinases and their inhibitors in human brain tumors.
Neurilemmoma
Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
Neuritis
Administration of SB203580, a p38 MAPK Inhibitor, Reduced the Expression of MMP9, and Relieved Neurologic Severity in the Experimental Autoimmune Neuritis (EAN) in Rats.
Neuritis
Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
Neuritis, Autoimmune, Experimental
Administration of SB203580, a p38 MAPK Inhibitor, Reduced the Expression of MMP9, and Relieved Neurologic Severity in the Experimental Autoimmune Neuritis (EAN) in Rats.
Neuritis, Autoimmune, Experimental
Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
Neuroblastoma
2,2',4,4'-Tetrabromodiphenyl ether promotes human neuroblastoma SH-SY5Y cells migration via the GPER/PI3K/Akt signal pathway.
Neuroblastoma
All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma Cells.
Neuroblastoma
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastoma.
Neuroblastoma
Determination of imbalance between MMP-2 and TIMP-2 in human neuroblastoma by reverse-transcription polymerase chain reaction and its correlation with tumor progression.
Neuroblastoma
Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection.
Neuroblastoma
Environmental endocrine disruptors promote invasion and metastasis of SK-N-SH human neuroblastoma cells.
Neuroblastoma
Estrogen activates matrix metalloproteinases-2 and -9 to increase beta amyloid degradation.
Neuroblastoma
Galangin Inhibits Thrombin-Induced MMP-9 Expression in SK-N-SH Cells via Protein Kinase-Dependent NF-?B Phosphorylation.
Neuroblastoma
Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: association with tumor progression and clinical outcome.
Neuroblastoma
Induction of matrix metalloproteinase MMP-9 (92-kDa gelatinase) by retinoic acid in human neuroblastoma SKNBE cells: relevance to neuronal differentiation.
Neuroblastoma
Insights on ornithine decarboxylase silencing as a potential strategy for targeting retinoblastoma.
Neuroblastoma
KLF4 overexpression and apigenin treatment down regulated anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK-N-DZ and IMR-32 cells.
Neuroblastoma
Matrix Metalloproteinase-9 and Cell Division in Neuroblastoma Cells and Bone Marrow Macrophages.
Neuroblastoma
Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.
Neuroblastoma
MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression.
Neuroblastoma
Notch signaling regulates tumor-induced angiogenesis in SPARC-overexpressed neuroblastoma.
Neuroblastoma
Primary renal neuroblastoma with metastasis and matrix metalloproteinase-14 expression.
Neuroblastoma
Regulation of matrix metalloproteinase-9 gene expression in MPP+- or 6-OHDA-treated human neuroblastoma SK-N-BE(2)C cells.
Neuroblastoma
Response of neuroblastoma cells to ionizing radiation: modulation of in vitro invasiveness and angiogenesis of human microvascular endothelial cells.
Neuroblastoma
Role of estrogen receptor alpha in MEHP-induced proliferation and invasion of SH-SY5Y cells.
Neuroblastoma
Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment.
Neuroblastoma
The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent.
Neuroblastoma
The novel anti-neuroblastoma agent PF403, inhibits proliferation and invasion in vitro and in brain xenografts.
Neuroblastoma
Therapeutic Efficacy of Silibinin on Human Neuroblastoma Cells: Akt and NF-?B Expressions May Play an Important Role in Silibinin-Induced Response.
Neuroblastoma
Thymoquinone inhibits the migration of mouse neuroblastoma (Neuro-2a) cells by down-regulating MMP-2 and MMP-9.
Neuroblastoma
Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements.
Neuroblastoma
[Correlation between expression of MMP-2, MMP-9, TIMP-2, TIMP-1 and metastasis of neuroblastoma]
Neurocysticercosis
Association of MMP-2 and MMP-9 with clinical outcome of neurocysticercosis.
Neurocysticercosis
T1-Weighted Dynamic Contrast-Enhanced MR Evaluation of Different Stages of Neurocysticercosis and Its Relationship with Serum MMP-9 Expression.
Neurocysticercosis
Toll-like Receptor-4 Polymorphisms and Serum Matrix Metalloproteinase-9 in Newly Diagnosed Patients With Calcified Neurocysticercosis and Seizures.
Neurodegenerative Diseases
A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders.
Neurodegenerative Diseases
Astrocyte mediated MMP-9 activation in the synapse dysfunction: An implication in Alzheimer disease.
Neurodegenerative Diseases
ATP induced microglial cell migration through non-transcriptional activation of matrix metalloproteinase-9.
Neurodegenerative Diseases
AUF-1 mediates inhibition by nitric oxide of lipopolysaccharide-induced matrix metalloproteinase-9 expression in cultured astrocytes.
Neurodegenerative Diseases
Galangin Inhibits Thrombin-Induced MMP-9 Expression in SK-N-SH Cells via Protein Kinase-Dependent NF-?B Phosphorylation.
Neurodegenerative Diseases
Simvastatin Attenuates Hippocampal MMP-9 Expression in the Streptozotocin-Induced Cognitive Impairment
Neurodegenerative Diseases
Thrombin Enhanced Matrix Metalloproteinase-9 Expression and Migration of SK-N-SH Cells via PAR-1, c-Src, PYK2, EGFR, Erk1/2 and AP-1.
Neurodegenerative Diseases
TLR2 signaling directs NO-dependent MMP-9 induction in mouse microglia.
Neuroectodermal Tumors, Primitive
Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors.
Neurofibroma
Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression.
Neurofibroma
Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.
Neuroinflammatory Diseases
Acute morphine induces matrix metalloproteinase-9 up-regulation in primary sensory neurons to mask opioid-induced analgesia in mice.
Neuroinflammatory Diseases
Anxiogenic-like effect of chronic lipopolysaccharide is associated with increased expression of matrix metalloproteinase 9 in the rat amygdala.
Neuroinflammatory Diseases
AUF-1 mediates inhibition by nitric oxide of lipopolysaccharide-induced matrix metalloproteinase-9 expression in cultured astrocytes.
Neuroinflammatory Diseases
CD47 gene knockout protects against transient focal cerebral ischemia in mice.
Neuroinflammatory Diseases
Effect of Dexamethasone Administered With Magnesium Sulfate on Inflammation-Mediated Degradation of the Blood-Brain Barrier Using an In Vitro Model.
Neuroinflammatory Diseases
Elevated MMP-9 in the lumbar cord early after thoracic spinal cord injury impedes motor relearning in mice.
Neuroinflammatory Diseases
Endothelin-1 enhances cell migration via matrix metalloproteinase-9 up-regulation in brain astrocytes.
Neuroinflammatory Diseases
Evaluation of matrix metalloproteinase-9 plasma levels in untreated new Relapsing-remitting multiple sclerosis patients and their first-degree family.
Neuroinflammatory Diseases
HADC8 Inhibitor WK2-16 Therapeutically Targets Lipopolysaccharide-Induced Mouse Model of Neuroinflammation and Microglial Activation.
Neuroinflammatory Diseases
Hemorrhagic transformation after ischemic stroke in animals and humans.
Neuroinflammatory Diseases
High Estrogen Level Modifies Postoperative Hyperalgesia via GPR30 and MMP-9 in Dorsal Root Ganglia Neurons.
Neuroinflammatory Diseases
Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase-9 in the rat model of traumatic brain injury.
Neuroinflammatory Diseases
Increased serum matrix metalloproteinase-9 in neuromyelitis optica: Implication of disruption of blood-brain barrier.
Neuroinflammatory Diseases
Inhibitory mechanism of MMP-9 gene expression by ethyl pyruvate in lipopolysaccharide-stimulated BV2 microglial cells.
Neuroinflammatory Diseases
Inter-alpha Inhibitor Proteins Modulate Neuroinflammatory Biomarkers After Hypoxia-Ischemia in Neonatal Rats.
Neuroinflammatory Diseases
Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration.
Neuroinflammatory Diseases
Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development.
Neuroinflammatory Diseases
Matrix metalloproteinase-9 deficiency leads to prolonged foreign body response in the brain associated with increased IL-1beta levels and leakage of the blood-brain barrier.
Neuroinflammatory Diseases
Matrix metalloproteinase-9 may be a potential therapeutic target in epilepsy.
Neuroinflammatory Diseases
Melatonin protects blood-brain barrier integrity and permeability by inhibiting matrix metalloproteinase-9 via the NOTCH3/NF-?B pathway.
Neuroinflammatory Diseases
MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier.
Neuroinflammatory Diseases
MT1-MMP expression level status dictates the in vitro action of lupeol on inflammatory biomarkers MMP-9 and COX-2 in medulloblastoma cells.
Neuroinflammatory Diseases
N-acetyl-cysteine attenuates remifentanil-induced postoperative hyperalgesia via inhibiting matrix metalloproteinase-9 in dorsal root ganglia.
Neuroinflammatory Diseases
Natural haemozoin modulates matrix metalloproteinases and induces morphological changes in human microvascular endothelium.
Neuroinflammatory Diseases
Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer's Disease.
Neuroinflammatory Diseases
New in vivo compatible matrix metalloproteinase (MMP)-2 and MMP-9 inhibitors.
Neuroinflammatory Diseases
Protective effect of ginsenoside Rb1 on integrity of blood-brain barrier following cerebral ischemia.
Neuroinflammatory Diseases
Regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by alpha-synuclein in rat primary glial cells.
Neuroinflammatory Diseases
Relationship between Toxoplasma gondii seropositivity and schizophrenia in the Lebanese population: potential implication of genetic polymorphism of MMP-9.
Neuroinflammatory Diseases
Resveratrol decreases the insoluble A?1-42 level in hippocampus and protects the integrity of the blood-brain barrier in AD rats.
Neuroinflammatory Diseases
Resveratrol Targeting of Carcinogen-Induced Brain Endothelial Cell Inflammation Biomarkers MMP-9 and COX-2 is Sirt1-Independent.
Neuroinflammatory Diseases
Role of p38 MAPK on the down-regulation of matrix metalloproteinase-9 expression in rat astrocytes.
Neuroinflammatory Diseases
Suppression of MMP-9 Expression in Brain Microvascular Endothelial Cells (BMVEC) Using a Gold Nanorod (GNR)-siRNA Nanoplex.
Neuroinflammatory Diseases
The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes.
Neuroinflammatory Diseases
Thrombin/Matrix Metalloproteinase-9-Dependent SK-N-SH Cell Migration is Mediated Through a PLC/PKC/MAPKs/NF-?B Cascade.
Neuroinflammatory Diseases
TLR2 signaling directs NO-dependent MMP-9 induction in mouse microglia.
Neuroinflammatory Diseases
Ulinastatin decreases permeability of blood--brain barrier by inhibiting expression of MMP-9 and t-PA in postoperative aged rats.
Neurologic Manifestations
Correlative study between serum matrix metalloproteinase 9 values and neurologic deficit in acute, primary, supratentorial, intracerebral haemorrhage.
Neurologic Manifestations
Effect of genetic depletion of MMP-9 on neurological manifestations of hypertension-induced intracerebral hemorrhages in aged mice.
Neurologic Manifestations
Inhibition of prostaglandin E2 receptor EP3 mitigates thrombin-induced brain injury.
Neurologic Manifestations
Memantine protects blood-brain barrier integrity and attenuates neurological deficits through inhibiting nitric oxide synthase ser1412 phosphorylation in intracerebral hemorrhage rats: involvement of peroxynitrite-related matrix metalloproteinase-9/NLRP3 inflammasome activation.
Neurologic Manifestations
Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice.
Neurologic Manifestations
Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients.
Neurologic Manifestations
Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis.
Neurologic Manifestations
The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke.
Neurologic Manifestations
Thrombopoietin could protect cerebral tissue against ischemia-reperfusion injury by suppressing NF-?B and MMP-9 expression in rats.
Neurologic Manifestations
Thrombopoietin protects the brain and improves sensorimotor functions: reduction of stroke-induced MMP-9 upregulation and blood-brain barrier injury.
Neuroma, Acoustic
Angiogenesis in vestibular schwannomas: expression of extracellular matrix factors MMP-2, MMP-9, and TIMP-1.
Neuromyelitis Optica
Increased serum matrix metalloproteinase-9 in neuromyelitis optica: Implication of disruption of blood-brain barrier.
Neuromyelitis Optica
MMP-2 -1575G/A polymorphism modifies the onset of optic neuritis as a first presenting symptom in MS?
Neurosyphilis
Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with HIV-1 infection and syphilis or neurosyphilis.
Neutropenia
Granulocyte colony-stimulating factor (G-CSF) downregulates its receptor (CD114) on neutrophils and induces gelatinase B release in humans.
Neutropenia
Impaired lung repair during neutropenia can be reverted by matrix metalloproteinase-9.
neutrophil collagenase deficiency
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response.
Nevus
Active and inactive forms of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
Nevus
Evaluation of heparanase and matrix metalloproteinase-9 in patients with cutaneous malignant melanoma.
Nevus
Expression of matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor of MMP (TIMP)-1 in conjunctival melanomas and clinical implications.
Nevus
Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Nevus, Blue
Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin.
Nevus, Pigmented
Active and inactive forms of matrix metalloproteinases 2 and 9 in cutaneous melanoma.
Nevus, Pigmented
Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Nevus, Pigmented
Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
nitric-oxide synthase (nadph) deficiency
Inducible Nitric Oxide Synthase Deficiency Impairs Matrix Metalloproteinase-9 Activity and Disrupts Leukocyte Migration in Hepatic Ischemia/Reperfusion Injury.
Nodding Syndrome
Systemic and cerebrospinal fluid immune and complement activation in Ugandan children and adolescents with long-standing nodding syndrome: A case-control study.
Non-alcoholic Fatty Liver Disease
Analysis of cytotoxic T-lymphocyte-associated antigen-4 and MMP-9 genes' methylation and their expression profiles with risk of non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Changes in inflammatory factors and prognosis of patients complicated with non-alcoholic fatty liver disease undergoing coronary artery bypass grafting.
Non-alcoholic Fatty Liver Disease
Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Peripheral Blood Leukocytes and Plasma of Children with Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: association with liver histology.
Non-alcoholic Fatty Liver Disease
TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
Non-alcoholic Fatty Liver Disease
[ASSESSMENT OF MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS FOR NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE].
Non-alcoholic Fatty Liver Disease
[Study on the interaction between matrix metalloproteinases gene polymorphism and central obesity in nonalcoholic fatty liver disease].
Non-ST Elevated Myocardial Infarction
Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: correlations with serum troponin I.
Obesity
Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population.
Obesity
Cortisol/cortisone ratio and matrix metalloproteinase-9 activity are associated with pediatric primary hypertension.
Obesity
Crosstalk between obesity and MMP-9 in cardiac remodelling -a cross-sectional study in apparent treatment-resistant hypertension.
Obesity
Does metabolic status affect serum levels of BDNF and MMP-9 in patients with schizophrenia?
Obesity
Effect of obesity reduction on preservation of heart function and attenuation of left ventricular remodeling, oxidative stress and inflammation in obese mice.
Obesity
Effects of obesity on the association between common variations in the TBX5 gene and matrix metalloproteinase 9 levels in Taiwanese.
Obesity
Evaluation of plasmatic MMP-8, MMP-9, TIMP-1 and MPO levels in obese and lean women.
Obesity
Functional Polymorphism Located in MMP-9 Gene Promoter Is Strongly Associated with Obesity.
Obesity
Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans.
Obesity
Leptin Receptor Gene Variant rs11804091 Is Associated with BMI and Insulin Resistance in Spanish Female Obese Children: A Case-Control Study.
Obesity
Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children.
Obesity
Matrix metalloproteinase-9 increases and Interleukin-10 reduces with increase in body mass index in polycystic ovary syndrome: A cross-sectional study.
Obesity
MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients.
Obesity
Palmitate-Induced MMP-9 Expression in the Human Monocytic Cells is Mediated through the TLR4-MyD88 Dependent Mechanism.
Obesity
Plasma matrix metalloproteinase-9 levels, MMP-9 gene haplotypes, and cardiovascular risk in obese subjects.
Obesity
Prostate hyperplasia caused by long-term obesity is characterized by high deposition of extracellular matrix and increased content of MMP-9 and VEGF.
Obesity
Successful weight loss reduces endothelial activation in individuals with severe obesity participating in a multimodal weight loss program.
Obesity
[Selected matrix metalloproteinases (MMP-2, MMP-9) in obese children and adolescents]
Obesity, Abdominal
Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults.
Obesity, Abdominal
[Study on the interaction between matrix metalloproteinases gene polymorphism and central obesity in nonalcoholic fatty liver disease].
Obstetric Labor Complications
The expression of matrix metalloproteinases in placental tissue depends on the severity of undifferentiated connective tissue dysplasia.
Obstetric Labor, Premature
A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes.
Obstetric Labor, Premature
Amniotic fluid matrix metalloproteinase-9 levels in women with preterm labor and suspected intra-amniotic infection.
Obstetric Labor, Premature
Changes in matrix metalloproteinase (MMP)-2 and MMP-9 in the fetal amnion and chorion during gestation and at term and preterm labor.
Obstetric Labor, Premature
Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membrane.
Obstetric Labor, Premature
Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection.
Obstetric Labor, Premature
Expression of matrix metalloproteinase-9 (MMP-9) in human midpregnancy amniotic fluid and risk of preterm labor.
Obstetric Labor, Premature
Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes.
Obstetric Labor, Premature
Identification of matrix metalloproteinase-9 in amniotic fluid and amniochorion in spontaneous labor and after experimental intrauterine infection or interleukin-1 beta infusion in pregnant rhesus monkeys.
Obstetric Labor, Premature
Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor.
Obstetric Labor, Premature
Matrix metalloproteinase 9 activity in urine of patients at risk for premature delivery.
Obstetric Labor, Premature
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in plasma/serum and urine of women during term and threatened preterm labor: a clinical approach.
Obstetric Labor, Premature
Matrix metalloproteinases in the cervical mucus plug in relation to gestational age, plug compartment, and preterm labor.
Obstetric Labor, Premature
Matrix metalloproteinases-2 and -9 and their endogenous tissue inhibitors in tissue remodeling after sealing of the fetal membranes in a sheep model of fetoscopic surgery.
Obstetric Labor, Premature
Matrix metalloproteinases-9 in preterm and term human parturition.
Obstetric Labor, Premature
Predictive value of intra-amniotic and serum markers for inflammatory lesions of preterm placenta.
Obstetric Labor, Premature
Regulation of matrix metalloproteinases (type IV collagenases) and their inhibitors in the virgin, timed pregnant, and postpartum rat uterus and cervix by prostaglandin E(2)-cyclic adenosine monophosphate.
Obstetric Labor, Premature
The effect of magnesium sulfate on the activity of matrix metalloproteinase-9 in fetal cord plasma and human umbilical vein endothelial cells.
Obstetric Labor, Premature
The preterm cervix reveals a transcriptomic signature in the presence of premature prelabor rupture of membranes.
Ocular Hypertension
Aberrant Collagen Composition of the Trabecular Meshwork Results in Reduced Aqueous Humor Drainage and Elevated IOP in MMP-9 Null Mice.
Odontogenic Cyst, Calcifying
[Expression of nuclear factor-kappaB, Ki-67 and matrix metalloproteinase-9 in calcifying odontogenic cyst]
Odontogenic Cysts
Comparative analysis of the immunohistochemical expression of collagen IV, MMP-9, and TIMP-2 in odontogenic cysts and tumors.
Odontogenic Cysts
Discrimination of ameloblastomas from odontogenic keratocysts by cytokine levels and gelatinase species of the intracystic fluids.
Odontogenic Cysts
Immunohistochemical expression of nuclear factor ?B, matrix metalloproteinase 9, and endoglin (CD105) in odontogenic keratocysts, dentigerous cysts, and radicular cysts.
Odontogenic Cysts
Interleukin-1alpha-dependent regulation of matrix metalloproteinase-9(MMP-9) secretion and activation in the epithelial cells of odontogenic jaw cysts.
Odontogenic Cysts
[Ki-67 and matrix metalloproteinase-9 expression in the follicular cyst, keratocystic odontogenic tumor, and ameloblastoma].
Odontogenic Tumors
Comparative analysis of the immunohistochemical expression of vascular endothelial growth factor and matrix metalloproteinase-9 in keratocystic odontogenic tumor, dentigerous cyst and radicular cyst.
Odontogenic Tumors
Correlation between radiographic area and immunolocation of MMP-2 and MMP-9 in unilocular radiographic lesions.
Odontogenic Tumors
Podoplanin expression profiles characteristic of odontogenic tumor-specific tissue architectures.
Odontogenic Tumors
[Ki-67 and matrix metalloproteinase-9 expression in the follicular cyst, keratocystic odontogenic tumor, and ameloblastoma].
Oligodendroglioma
Expression of matrix metalloproteinases and their inhibitors in human brain tumors.
Oligodendroglioma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Oligospermia
Expression of matrix metalloproteinases (MMP-2, MMP-9) and their inhibitors (TIMP-1, TIMP-2) in canine testis, epididymis and semen.
Ophthalmia, Sympathetic
Expression of chemokines and gelatinase B in sympathetic ophthalmia.
Opportunistic Infections
Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Optic Nerve Glioma
Increased Tissue Stiffness in Tumors from Mice with Neurofibromatosis-1 Optic Glioma.
Optic Neuritis
Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases.
Optic Neuritis
Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis.
Optic Neuropathy, Ischemic
Matrix metalloproteinase-9 expression in retinal ganglion cell layer and effect of topically applied brimonidine tartrate 0.2% therapy on this expression in an endothelin-1-induced optic nerve ischemia model.
Oral Submucous Fibrosis
Matrix metalloproteinase (MMP)-2 and MMP-9 polymorphisms and haplotypes as disease biomarkers.
Oral Submucous Fibrosis
Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population.
Oral Ulcer
Discovery of the possible mechanisms in kouyanqing granule for treatment of oral ulcers based on network pharmacology.
Oropharyngeal Neoplasms
Influence of matrix metalloproteinase 9 (MMP-9) on the metastatic behavior of oropharyngeal cancer.
Osteitis
Increased nasal matrix metalloproteinase-1 and -9 expression in smokers with chronic rhinosinusitis and asthma.
Osteitis
Steroid-independent upregulation of matrix metalloproteinase 9 in chronic rhinosinusitis patients with radiographic evidence of osteitis.
Osteoarthritis
Association of (-1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms).
Osteoarthritis
Association of tumor necrosis factor-? (G-308A) genetic variant with matrix metalloproteinase-9 activity and joint destruction in early rheumatoid arthritis.
Osteoarthritis
Basic calcium phosphate crystals induce synthesis and secretion of 92 kDa gelatinase (gelatinase B/matrix metalloprotease 9) in human fibroblasts.
Osteoarthritis
Biomechanical regulation of matrix metalloproteinase-9 in cultured chondrocytes.
Osteoarthritis
CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.
Osteoarthritis
Changes in Synovial Fluid Biomarkers after Experimental Equine Osteoarthritis.
Osteoarthritis
Changes in the antiangiogenic properties of articular cartilage in osteoarthritis.
Osteoarthritis
Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis.
Osteoarthritis
Chicken collagen type II reduces articular cartilage destruction in a model of osteoarthritis in rats.
Osteoarthritis
Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis.
Osteoarthritis
Clinicopathological correlation of Krüppel-like factor 5 and matrix metalloproteinase-9 expression and cartilage degeneration in human osteoarthritis.
Osteoarthritis
Differential regulation of gelatinases by transforming growth factor beta-1 in normal equine chondrocytes.
Osteoarthritis
Elevation of activated protein C in synovial joints in rheumatoid arthritis and its correlation with matrix metalloproteinase 2.
Osteoarthritis
Ethanolic extracts of babandotan leaves (Ageratum conyzoides L.) prevents inflammation and proteoglycan degradation by inhibiting TNF-? and MMP-9 on osteoarthritis rats induced by monosodium iodoacetate.
Osteoarthritis
Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1.
Osteoarthritis
Expression of matrix metalloproteinase-9 (gelatinase B) in gouty arthritis and stimulation of MMP-9 by urate crystals in macrophages.
Osteoarthritis
Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis.
Osteoarthritis
Expression Pattern of iNOS, BCL-2 and MMP-9 in the Hip Synovium Tissue of Patients with Osteoarthritis.
Osteoarthritis
Histone Methylation and STAT-3 Differentially Regulate Interleukin-6-Induced Matrix Metalloproteinase Gene Activation in Rheumatoid Arthritis Synovial Fibroblasts.
Osteoarthritis
Interrelationship of MMP-9, Proteoglycan-4, and Inflammation in Osteoarthritis Patients Undergoing Total Hip Arthroplasty.
Osteoarthritis
Interrelationship of Osteopontin, MMP-9 and ADAMTS4 in Patients With Osteoarthritis Undergoing Total Joint Arthroplasty.
Osteoarthritis
Matrix Metalloproteinase-9 Production by Immortalized Human Chondrocyte Lines.
Osteoarthritis
Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis.
Osteoarthritis
Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9.
Osteoarthritis
NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes.
Osteoarthritis
Nicotine Attenuates Osteoarthritis Pain and Matrix Metalloproteinase-9 Expression via the ?7 Nicotinic Acetylcholine Receptor.
Osteoarthritis
Osteoarthritis: differential expression of matrix metalloproteinase-9 mRNA in nonfibrillated and fibrillated cartilage.
Osteoarthritis
Quercetin prevent proteoglycan destruction by inhibits matrix metalloproteinase-9, matrix metalloproteinase-13, a disintegrin and metalloproteinase with thrombospondin motifs-5 expressions on osteoarthritis model rats.
Osteoarthritis
Simvastatin, an HMG-CoA reductase inhibitor, reduced the expression of matrix metalloproteinase-9 (Gelatinase B) in osteoblastic cells and HT1080 fibrosarcoma cells.
Osteoarthritis
Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells.
Osteoarthritis
Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.
Osteoarthritis
Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.
Osteoarthritis
TNF-? increases the expression of inflammatory factors in synovial fibroblasts by inhibiting the PI3K/AKT pathway in a rat model of monosodium iodoacetate-induced osteoarthritis.
Osteoarthritis
Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
Osteoarthritis
[Effect of exogenous sodium hyaluronate on the level of MMP-9 in serum and joint synovia of patients with osteoarthritis]
Osteoarthritis, Knee
Association of (-1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms).
Osteoarthritis, Knee
Clinicopathological correlation of Krüppel-like factor 5 and matrix metalloproteinase-9 expression and cartilage degeneration in human osteoarthritis.
Osteoarthritis, Knee
Effect of total knee replacement combined with Yunnan Baiyao on the expression of serum IL-6, TNF-?, VCAM-1 and MMP-9 in patients with knee osteoarthritis.
Osteoarthritis, Knee
Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis.
Osteoarthritis, Knee
Preventive administration of juanbi capsules for knee osteoarthritis: effects on serum MMP-2 and MMP-9 levels and cartilage repair.
Osteochondrodysplasias
Expression of Genes Encoding Extracellular Matrix Macromolecules and Metalloproteinases in Avian Tibial Dyschondroplasia.
Osteolysis
CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone.
Osteolysis
Effect of cytosolic phospholipase A2 on proinflammatory cytokine-induced bone resorptive genes including receptor activator of nuclear factor kappa B ligand in human dental pulp cells.
Osteolysis
Inhibition of p38 Mitogen-Activated Protein Kinase Down-regulates the Inflammatory Osteolysis Response to Titanium Particles in a Murine Osteolysis Model.
Osteolysis
MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model.
Osteolysis
Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.
Osteolysis
Prostate Cancer Phenotype Influences Bone Mineralization at Metastasis: A Study Using an In Vitro Prostate Cancer Metastasis Testbed.
Osteolysis
Puerarin inhibits titanium particle-induced osteolysis and RANKL-induced osteoclastogenesis via suppression of the NF-?B signaling pathway.
Osteolysis
Suppression of puerarin on polymethylmethacrylate-induced lesion of peri-implant by inhibiting NF-?B activation in vitro and in vivo.
Osteolysis
[Influence and role of expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 9 in aseptic loosening of prosthesis].
Osteomyelitis
Angiogenic gene therapy as a potential therapeutic agent in chronic osteomyelitis.
Osteomyelitis
Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions.
Osteomyelitis
Regulation of monocyte chemokine and MMP-9 secretion by proinflammatory cytokines in tuberculous osteomyelitis.
Osteophyte
Comparative Studies of Different Extracts from Eucommia ulmoides Oliv. against Rheumatoid Arthritis in CIA Rats.
Osteoporosis
Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.
Osteoporosis
Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu Maxim.
Osteoporosis
Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9.
Osteoporosis
Dynamic expression of matrix metalloproteinases 2, 9 and 13 in ovariectomy-induced osteoporosis rats.
Osteoporosis
Effects of 12-Week Exercise Program on Enzyme Activity of Serum Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Female Patients with Postmenopausal Osteoporosis: A Randomized Control Study.
Osteoporosis
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells.
Osteoporosis
EVALUATION OF BONE RESORPTIVE POTENTIAL IN THE TREATMENT OF GENERALIZED PERIODONTITIS.
Osteoporosis
Interleukin-18 (IL-18) and matrix metalloproteinase-9 (MMP-9) in post-menopausal osteoporosis.
Osteoporosis
Interrelationship of Circulating Matrix Metalloproteinase-9, TNF-a, and OPG/RANK/RANKL Systems in COPD Patients with Osteoporosis.
Osteoporosis
Matrix metalloproteinase 9 a potential major player connecting atherosclerosis and osteoporosis in high fat diet fed rats.
Osteoporosis
Tetracycline Analogs Inhibit Osteoclast Differentiation by Suppressing MMP-9-Mediated Histone H3 Cleavage.
Osteoporosis
Tetrandrine Attenuates Cartilage Degeneration, Osteoclast Proliferation, and Macrophage Transformation through Inhibiting P65 Phosphorylation in Ovariectomy-induced Osteoporosis.
Osteoporosis
[Role of matrix metalloproteinase-9 in the pathogenesis of osteoporosis in patients with chronic obstructive pulmonary disease].
Osteoporosis, Postmenopausal
Effects of 12-Week Exercise Program on Enzyme Activity of Serum Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Female Patients with Postmenopausal Osteoporosis: A Randomized Control Study.
Osteoporosis, Postmenopausal
Interleukin-18 (IL-18) and matrix metalloproteinase-9 (MMP-9) in post-menopausal osteoporosis.
Osteosarcoma
A Single Nucleotide Polymorphism (rs1056629) in 3'-UTR of MMP-9 is Responsible for a Decreased Risk of Metastatic Osteosarcoma by Compromising its Interaction with microRNA-491-5p.
Osteosarcoma
A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
Osteosarcoma
Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway.
Osteosarcoma
Anti-Metastatic Properties of a Marine Bacterial Exopolysaccharide-Based Derivative Designed to Mimic Glycosaminoglycans.
Osteosarcoma
Antioxidants inhibit TNFalpha-induced motility and invasion of human osteosarcoma cells: possible involvement of NFkappaB activation.
Osteosarcoma
Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Osteosarcoma
Apatinib ameliorates doxorubicin-induced migration and cancer stemness of osteosarcoma cells by inhibiting Sox2 via STAT3 signalling.
Osteosarcoma
Circular RNA circ_001621 promotes osteosarcoma cells proliferation and migration by sponging miR-578 and regulating VEGF expression.
Osteosarcoma
Comments on Li H et al. "A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma".
Osteosarcoma
Compounds isolated from Ageratum houstonianum inhibit the activity of matrix metalloproteinases (MMP-2 and MMP-9): An oncoinformatics study.
Osteosarcoma
Delivery of inhibitor of growth 4 (ING4) gene significantly inhibits proliferation and invasion and promotes apoptosis of human osteosarcoma cells.
Osteosarcoma
Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression.
Osteosarcoma
Downregulation of 14-3-3? inhibits proliferation and migration in osteosarcoma cells.
Osteosarcoma
Downregulation of IDH2 exacerbates the malignant progression of osteosarcoma cells via increased NF-?B and MMP-9 activation.
Osteosarcoma
Downregulation of matrix metalloproteinase-9 mRNA by valproic acid plays a role in inhibiting the shedding of MHC class I-related molecules A and B on the surface of human osteosarcoma cells.
Osteosarcoma
Effect of human osteopontin on proliferation, transmigration and expression of MMP-2 and MMP-9 in osteosarcoma cells.
Osteosarcoma
Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kappaB in human osteosarcoma.
Osteosarcoma
Examination of the signal transduction pathways leading to activation of gelatinolytic activity by interleukin-1alpha and Porphyromonas gingivalis in human osteosarcoma cells.
Osteosarcoma
Exogenously added GPI-anchored tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) displays enhanced and novel biological activities.
Osteosarcoma
Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor alpha correlates with metastatic ability in a human osteosarcoma cell line.
Osteosarcoma
Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis.
Osteosarcoma
Functionalized curcumin analogs as potent modulators of the Wnt/?-catenin signaling pathway.
Osteosarcoma
Ganglioside GD1a suppresses TNFalpha expression via Pkn1 at the transcriptional level in mouse osteosarcoma-derived FBJ cells.
Osteosarcoma
Gas6/Axl mediates tumor cell apoptosis, migration and invasion and predicts the clinical outcome of osteosarcoma patients.
Osteosarcoma
Glucosamine sulfate suppresses the expression of matrix metalloproteinase-3 in osteosarcoma cells in vitro.
Osteosarcoma
Hairy/enhancer-of-split related with YRPW motif protein 1 promotes osteosarcoma metastasis via matrix metallopeptidase 9 expression.
Osteosarcoma
High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
Osteosarcoma
IKK? inibition by a glucosamine derivative enhances Maspin expression in osteosarcoma cell line.
Osteosarcoma
In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
Osteosarcoma
Inhibition of human osteosarcoma cell migration and invasion by a gene silencer, pyrrole-imidazole polyamide, targeted at the human MMP9 NF-?B binding site.
Osteosarcoma
Inhibition of spontaneous rat osteosarcoma lung metastasis by 3S-[4-(N-hydroxyamino)-2R-isobutylsuccinyl]amino-1-methoxy-3,4-dihydroc arbostyril, a novel matrix metalloproteinase inhibitor.
Osteosarcoma
Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis.
Osteosarcoma
Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.
Osteosarcoma
Isothiocyanates suppress the invasion and metastasis of tumors by targeting FAK/MMP-9 activity.
Osteosarcoma
Knockdown of autophagy-related protein 6, Beclin-1, decreases cell growth, invasion, and metastasis and has a positive effect on chemotherapy-induced cytotoxicity in osteosarcoma cells.
Osteosarcoma
Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Osteosarcoma
LINC00968 functions as an oncogene in osteosarcoma by activating the PI3K/AKT/mTOR signaling.
Osteosarcoma
Long non-coding RNA lncTCF7 predicts poor prognosis and promotes tumor metastasis in osteosarcoma.
Osteosarcoma
Matrix metallopeptidase 9 targeted by hsa-miR-494 promotes silybin-inhibited osteosarcoma.
Osteosarcoma
Matrix metalloproteinase 9 expression and survival of patients with osteosarcoma: a meta-analysis.
Osteosarcoma
Matrix metalloproteinase-9 (MMP-9) expression in childhood osseous osteosarcoma.
Osteosarcoma
Matrix metalloproteinases 2, 7, 9 and tissue inhibitor of matrix metalloproteinase-1 in the sera of patients with bone tumors.
Osteosarcoma
MicroRNA-194-3p inhibits the metastatic biological behaviors of spinal osteosarcoma cells by the repression of matrix metallopeptidase 9.
Osteosarcoma
MicroRNA-29b sensitizes osteosarcoma cells to doxorubicin by targeting matrix metalloproteinase 9 (MMP-9) in osteosarcoma.
Osteosarcoma
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in pediatric human sarcoma cell lines.
Osteosarcoma
Monocyte Chemoattractant Protein-1 promotes cancer cell migration via c-Raf/MAPK/AP-1 pathway and MMP-9 production in osteosarcoma.
Osteosarcoma
Nifuroxazide induces apoptosis, inhibits cell migration and invasion in osteosarcoma.
Osteosarcoma
Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression.
Osteosarcoma
Notoginsenoside R1 counteracts mesenchymal stem cell-evoked oncogenesis and doxorubicin resistance in osteosarcoma cells by blocking IL-6 secretion-induced JAK2/STAT3 signaling.
Osteosarcoma
Overexpression of matrix metalloproteinase (MMP)-9 correlates with metastatic potency of spontaneous and 4-hydroxyaminoquinoline 1-oxide (4-HAQO)-induced transplantable osteosarcomas in rats.
Osteosarcoma
Oxidative stress induced by low-dose doxorubicin promotes the invasiveness of osteosarcoma cell line U2OS in vitro.
Osteosarcoma
Prognostic significance of matrix metalloproteinase 9 expression in osteosarcoma: A meta-analysis of 16 studies.
Osteosarcoma
Promoter hypermethylation of the cysteine protease RECK may cause metastasis of osteosarcoma.
Osteosarcoma
Ras activation mediates WISP-1-induced increases in cell motility and matrix metalloproteinase expression in human osteosarcoma.
Osteosarcoma
Reoxygenation using a novel CO2 therapy decreases the metastatic potential of osteosarcoma cells.
Osteosarcoma
RNAi-mediated knockdown of relaxin decreases in vitro proliferation and invasiveness of osteosarcoma MG-63 cells by inhibition of MMP-9.
Osteosarcoma
Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma: findings in 42 patients followed for 1-16 years.
Osteosarcoma
Selaginella tamariscina (Beauv.) possesses antimetastatic effects on human osteosarcoma cells by decreasing MMP-2 and MMP-9 secretions via p38 and Akt signaling pathways.
Osteosarcoma
Simvastatin, an HMG-CoA reductase inhibitor, reduced the expression of matrix metalloproteinase-9 (Gelatinase B) in osteoblastic cells and HT1080 fibrosarcoma cells.
Osteosarcoma
Stage-IIB osteosarcomas around the knee. A study of MMP-9 in surviving tumour cells.
Osteosarcoma
Stimulation of gelatinase B and tissue inhibitors of metalloproteinase (TIMP) production in co-culture of human osteosarcoma cells and human fibroblasts: gelatinase B production was stimulated via up-regulation of fibroblast growth factor (FGF) receptor.
Osteosarcoma
Suppression of ERK/NF-?B Activation Is Associated With Amentoflavone-Inhibited Osteosarcoma Progression In Vivo.
Osteosarcoma
Ten-gene signature reveals the significance of clinical prognosis and immuno-correlation of osteosarcoma and study on novel skeleton inhibitors regarding MMP9.
Osteosarcoma
The Effect of Clown Intervention on Self-Report and Biomarker Measures of Stress and Fatigue in Pediatric Osteosarcoma Inpatients: A Pilot Study.
Osteosarcoma
The Effects of Interleukin-33 (IL-33) on Osteosarcoma Cell Viability, Apoptosis, and Epithelial-Mesenchymal Transition are Mediated Through the PI3K/AKT Pathway.
Osteosarcoma
The study of mechanism of miR-34c-5p targeting FLOT2 to regulate proliferation, migration and invasion of osteosarcoma cells.
Osteosarcoma
Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta1-integrin on the cell surface.
Osteosarcoma
Thrombospondin-2 stimulates MMP-9 production and promotes osteosarcoma metastasis via the PLC, PKC, c-Src and NF-?B activation.
Osteosarcoma
Tricetin inhibits human osteosarcoma cells metastasis by transcriptionally repressing MMP-9 via p38 and Akt pathways.
Osteosarcoma
Wogonin suppresses stem cell-like traits of CD133 positive osteosarcoma cell via inhibiting matrix metallopeptidase-9 expression.
Osteosarcoma
[Expressions of CD44s, MMP-9, and Ki-67: possible association with invasion, metastasis, and recurrence of osteosarcoma]
Otitis Media
Effect of CT manifestations of cholesteatoma on MMP-2, MMP-9 and IL-6 in the serum of patients.
Otitis Media
Expression of matrix metalloproteinase-9 and -2 in pediatric chronic otitis media with effusion.
Otitis Media
Lipoteichoic acid from Staphylococcus aureus induced expression of MMP-9 in human middle ear epithelial cells.
Otitis Media
Selected cytokines in hypertrophic adenoids in children suffering from otitis media with effusion.
Otitis Media
[The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma].
Otitis Media with Effusion
Expression of matrix metalloproteinase-9 and -2 in pediatric chronic otitis media with effusion.
Otitis Media with Effusion
Matrix metalloproteinases 2 and 9 in otitis media with effusion.
Otitis Media with Effusion
Selected cytokines in hypertrophic adenoids in children suffering from otitis media with effusion.
Ovarian Cysts
Difference in expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in patients with persistent ovarian cysts.
Ovarian Neoplasms
17 ?-Estradiol Reverses Leptin-Inducing Ovarian Cancer Cell Migration by the PI3K/Akt Signaling Pathway.
Ovarian Neoplasms
9-Hydroxycanthin-6-one isolated from stem bark of Ailanthus altissima induces ovarian cancer cell apoptosis and inhibits the activation of tumor-associated macrophages.
Ovarian Neoplasms
A Specific Mixture of Nutrients Suppresses Ovarian Cancer A-2780 Tumor Incidence, Growth, and Metastasis to Lungs.
Ovarian Neoplasms
Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells.
Ovarian Neoplasms
Adenosine Inhibits Ovarian Cancer Growth Through Regulating RhoGDI2 Protein Expression.
Ovarian Neoplasms
Anti-tumor and chemosensitization effects of Cryptotanshinone extracted from Salvia miltiorrhiza Bge. on ovarian cancer cells in vitro.
Ovarian Neoplasms
Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis.
Ovarian Neoplasms
Auraptene Inhibits Migration and Invasion of Cervical and Ovarian Cancer Cells by Repression of Matrix Metalloproteinasas 2 and 9 Activity.
Ovarian Neoplasms
Autocrine CCL5 Signaling Promotes Invasion and Migration of CD133+ Ovarian Cancer Stem-like Cells via NF-kappa B-Mediated MMP-9 Upregulation.
Ovarian Neoplasms
Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.
Ovarian Neoplasms
Bisphenol A induces ovarian cancer cell proliferation and metastasis through estrogen receptor-? pathways.
Ovarian Neoplasms
Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells.
Ovarian Neoplasms
CC Chemokine Ligand 7 Derived from Cancer-Stimulated Macrophages Promotes Ovarian Cancer Cell Invasion.
Ovarian Neoplasms
Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis.
Ovarian Neoplasms
Combined detection of serum matrix metalloproteinase 9, acetyl heparinase and cathepsin L in diagnosis of ovarian cancer.
Ovarian Neoplasms
Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice.
Ovarian Neoplasms
Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer.
Ovarian Neoplasms
ETS-1 regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell SKOV-3.
Ovarian Neoplasms
EV-Associated MMP9 in High-Grade Serous Ovarian Cancer Is Preferentially Localized to Annexin V-Binding EVs.
Ovarian Neoplasms
Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
Ovarian Neoplasms
Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
Ovarian Neoplasms
Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells.
Ovarian Neoplasms
Fibronectin secretion from human peritoneal tissue induces Mr 92,000 type IV collagenase expression and invasion in ovarian cancer cell lines.
Ovarian Neoplasms
Glycogen synthase kinase-3 beta (GSK3?)-mediated phosphorylation of ETS1 promotes progression of ovarian carcinoma.
Ovarian Neoplasms
Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Ovarian Neoplasms
Gonadotropins Induce Tumor Cell Migration and Invasion by Increasing Cyclooxygenases Expression and Prostaglandin E2 Production in Human Ovarian Cancer Cells.
Ovarian Neoplasms
Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer.
Ovarian Neoplasms
IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
Ovarian Neoplasms
In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors.
Ovarian Neoplasms
Increased endostatin generation and decreased angiogenesis via MMP-9 by tamoxifen in hormone dependent ovarian cancer.
Ovarian Neoplasms
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
Ovarian Neoplasms
Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue.
Ovarian Neoplasms
Integrin alphavbeta3-mediated transcriptional regulation of TIMP-1 in a human ovarian cancer cell line.
Ovarian Neoplasms
Invasiveness of Mouse Embryos to Human Ovarian Cancer Cells HO8910PM and the Role of MMP-9.
Ovarian Neoplasms
Lewis (y) Antigen Overexpression Increases the Expression of MMP-2 and MMP-9 and Invasion of Human Ovarian Cancer Cells.
Ovarian Neoplasms
Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells.
Ovarian Neoplasms
Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.
Ovarian Neoplasms
Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
Ovarian Neoplasms
MLK4? functions as a negative regulator of MAPK signaling and cell invasion.
Ovarian Neoplasms
MMP-2 mRNA Expression in Ovarian Cancer Tissues Predicts Patients' Response to Platinum-Taxane Chemotherapy.
Ovarian Neoplasms
Molecular prognostic markers in recurrent and in non-recurrent epithelial ovarian cancer.
Ovarian Neoplasms
Novel functions for 2-phenylbenzimidazole-5-sulphonic acid: Inhibition of ovarian cancer cell responses and tumour angiogenesis.
Ovarian Neoplasms
Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells.
Ovarian Neoplasms
Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer.
Ovarian Neoplasms
Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells.
Ovarian Neoplasms
Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells.
Ovarian Neoplasms
PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.
Ovarian Neoplasms
Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer.
Ovarian Neoplasms
Plasma-activated medium promotes autophagic cell death along with alteration of the mTOR pathway.
Ovarian Neoplasms
Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
Ovarian Neoplasms
Pre-Treatment of Platinum Resistant Ovarian Cancer Cells with an MMP-9/MMP-2 Inhibitor Prior to Cisplatin Enhances Cytotoxicity as Determined by High Content Screening.
Ovarian Neoplasms
Prognostic value of matrix metalloproteinase-9 (gelatinase-B) expression in epithelial ovarian tumors.
Ovarian Neoplasms
Quantity and clinical relevance of circulating endothelial progenitor cells in human ovarian cancer.
Ovarian Neoplasms
Regulation of monocyte MMP-9 production by TNF-alpha and a tumour-derived soluble factor (MMPSF).
Ovarian Neoplasms
Role of serum-derived hyaluronan-associated protein-hyaluronan complex in ovarian cancer.
Ovarian Neoplasms
Saxatilin, a snake venom disintegrin, suppresses TNF-alpha-induced ovarian cancer cell invasion.
Ovarian Neoplasms
SDF-1/CXCR7 axis enhances ovarian cancer cell invasion by MMP-9 expression through p38 MAPK pathway.
Ovarian Neoplasms
Selective mediation of ovarian cancer SKOV3 cells death by pristine carbon quantum dots/Cu2O composite through targeting matrix metalloproteinases, angiogenic cytokines and cytoskeleton.
Ovarian Neoplasms
Shed membrane fragment-associated markers for endometrial and ovarian cancers.
Ovarian Neoplasms
Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers.
Ovarian Neoplasms
Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2.
Ovarian Neoplasms
TGF-? Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment.
Ovarian Neoplasms
The anti-tumor effect and bioactive phytochemicals of Hedyotis diffusa willd on ovarian cancer cells.
Ovarian Neoplasms
The C3G/Rap1 pathway promotes secretion of MMP-2 and MMP-9 and is involved in serous ovarian cancer metastasis.
Ovarian Neoplasms
The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
Ovarian Neoplasms
The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells.
Ovarian Neoplasms
The synergistic effects of CXCR4 and EGFR on promoting EGF-mediated metastasis in ovarian cancer cells.
Ovarian Neoplasms
Tumor necrosis factor-alpha-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and cancer risk.
Ovarian Neoplasms
Tumor-associated macrophages promote invasion via Toll-like receptors signaling in patients with ovarian cancer.
Ovarian Neoplasms
Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels.
Ovarian Neoplasms
Vascular endothelial growth factor stimulates organ-specific host matrix metalloproteinase-9 expression and ovarian cancer invasion.
Ovarian Neoplasms
[Adhesion induces matrix metalloproteinase-9 gene expression in ovarian cancer cells]
Ovarian Neoplasms
[Assessment of prognostic factors in common ovarian tumors of varying malignancy]
Ovarian Neoplasms
[Correlation of vasculogenic mimicry with clinicopathologic features and prognosis of ovarian carcinoma]
Ovarian Neoplasms
[Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer]
Ovarian Neoplasms
[Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour]
Ovarian Neoplasms
[Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance]
Ovarian Neoplasms
[Expression of matrix metaloproteinase and tissue inhibitors in ovarian tumors]
Ovarian Neoplasms
[Inhibitory effects of antisense MMP-9 oligodeoxynucleotides on invasiveness and adherence of ovarian]
Ovarian Neoplasms
[Inhibitory effects of RNA interference on expression of matrix metalloproteinase-9 gene and invasiveness and adhesion in ovarian cancer cells]
Overnutrition
Postnatal early overnutrition dysregulates the intrarenal renin-angiotensin system and extracellular matrix-linked molecules in juvenile male rats.
Overweight
Level of Adiponectin, Leptin and Selected Matrix Metalloproteinases in Female Overweight Patients with Primary Gonarthrosis.
Overweight
MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration.
Overweight
The function of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in several clinical conditions: Results and analysis of our survey.
Pancreatic Neoplasms
?-Mangostin suppresses lipopolysaccharide-induced invasion by inhibiting matrix metalloproteinase-2/9 and increasing E-cadherin expression through extracellular signal-regulated kinase signaling in pancreatic cancer cells.
Pancreatic Neoplasms
?2-AR-HIF-1?: a novel regulatory axis for stress-induced pancreatic tumor growth and angiogenesis.
Pancreatic Neoplasms
Allergen?removed Rhus verniciflua Stokes suppresses invasion and migration of pancreatic cancer cells through downregulation of the JAK/STAT and Src/FAK signaling pathways.
Pancreatic Neoplasms
Anti-inflammatory macrophages activate invasion in pancreatic adenocarcinoma by increasing the MMP9 and ADAM8 expression.
Pancreatic Neoplasms
Antiproliferative and antimetastatic effects of emodin on human pancreatic cancer.
Pancreatic Neoplasms
Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-?B signaling by 6-shogaol.
Pancreatic Neoplasms
Association of axon guidance factor Semaphorin 3A with poor outcome in pancreatic cancer.
Pancreatic Neoplasms
Bovine Hemoglobin Derived Peptide Asn-Phe-Gly-Lys Inhibits Pancreatic Cancer Cells Metastasis by Targeting Secreted Hsp90?.
Pancreatic Neoplasms
Cholecystokinin regulates the invasiveness of human pancreatic cancer cell lines via protein kinase C pathway.
Pancreatic Neoplasms
Chronic cadmium exposure in vitro causes acquisition of multiple tumor cell characteristics in human pancreatic epithelial cells.
Pancreatic Neoplasms
Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: metalloproteinase-9 as an independent prognostic factor.
Pancreatic Neoplasms
Comparison of circulating MMP-9, TIMP-1 and CA19-9 in the detection of pancreatic cancer.
Pancreatic Neoplasms
Correlation between protein expression of PTEN in human pancreatic cancer and the proliferation, infiltration, metastasis and prognosis.
Pancreatic Neoplasms
Corrigendum: The assessment of serum and diagnostic peritoneal lavage concentration of matrix metalloproteinase-2, matrix metalloproteinase-9, carbohydrate antigen 19-9, and carcinoembryonic antigen in patients with pancreatic cancer and chronic pancreatitis, Journal of Physiology and Pharmacology 2020 Oct; 71(5): 689.
Pancreatic Neoplasms
Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK/NF-?B pathway.
Pancreatic Neoplasms
Detection of matrix metalloproteinase activity in human pancreatic cancer.
Pancreatic Neoplasms
Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells.
Pancreatic Neoplasms
Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Pancreatic Neoplasms
Downregulation of miR-21 inhibits the malignant phenotype of pancreatic cancer cells by targeting VHL.
Pancreatic Neoplasms
eEF1A2 promotes cell migration, invasion and metastasis in pancreatic cancer by upregulating MMP-9 expression through Akt activation.
Pancreatic Neoplasms
Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction.
Pancreatic Neoplasms
Epidermal growth factor promotes invasiveness of pancreatic cancer cells through NF-kappaB-mediated proteinase productions.
Pancreatic Neoplasms
Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer.
Pancreatic Neoplasms
Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination.
Pancreatic Neoplasms
Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer.
Pancreatic Neoplasms
Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
Pancreatic Neoplasms
Expression of Matrix Metalloproteinases-2/-9 is Associated With Microvessel Density in Pancreatic Cancer.
Pancreatic Neoplasms
Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells.
Pancreatic Neoplasms
Expression of thrombospondin-1 in human pancreatic adenocarcinomas: role in matrix metalloproteinase-9 production.
Pancreatic Neoplasms
Extraction of type-IV collagenase/gelatinase from plasma membranes of human cancer cells.
Pancreatic Neoplasms
Gene Expression Profiles in Chemokine (C-C Motif) Ligand 21-Overexpressing Pancreatic Cancer Cells.
Pancreatic Neoplasms
Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE?cadherin/EphA2/MMP9/MMP2 expression.
Pancreatic Neoplasms
Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation.
Pancreatic Neoplasms
Glial cell-derived neurotrophic factor upregulates the expression and activation of matrix metalloproteinase-9 in human pancreatic cancer.
Pancreatic Neoplasms
GPC-1 may serve as a predictor of perineural invasion and a prognosticator of survival in pancreatic cancer.
Pancreatic Neoplasms
HIF1 Contributes to Hypoxia-Induced Pancreatic Cancer Cells Invasion via Promoting QSOX1 Expression.
Pancreatic Neoplasms
Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer.
Pancreatic Neoplasms
In vitro and in vivo matrix metalloproteinase production by pancreatic cancer cells and by distant organs.
Pancreatic Neoplasms
Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells.
Pancreatic Neoplasms
Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
Pancreatic Neoplasms
Investigation of juglone effects on metastasis and angiogenesis in pancreatic cancer cells.
Pancreatic Neoplasms
Involvement of COX-2/PGE(2) Pathway in the Upregulation of MMP-9 Expression in Pancreatic Cancer.
Pancreatic Neoplasms
Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer.
Pancreatic Neoplasms
Macrophage inflammatory protein-3alpha promotes pancreatic cancer cell invasion.
Pancreatic Neoplasms
Matrine inhibiting pancreatic cells epithelial-mesenchymal transition and invasion through ROS/NF-?B/MMPs pathway.
Pancreatic Neoplasms
Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer.
Pancreatic Neoplasms
Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer.
Pancreatic Neoplasms
Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials.
Pancreatic Neoplasms
miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases.
Pancreatic Neoplasms
Mmp-9 responsive PEG cleavable nanovesicles for efficient delivery of chemotherapeutics to pancreatic cancer.
Pancreatic Neoplasms
Neurotensin receptor 1 signaling promotes pancreatic cancer progression.
Pancreatic Neoplasms
Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma.
Pancreatic Neoplasms
Nuclear factor ?B activity correlates with the progression and prognosis of pancreatic cancer in a mouse model.
Pancreatic Neoplasms
Overexpression and biological function of MEF2D in human pancreatic cancer.
Pancreatic Neoplasms
Paeoniflorin inhibits human pancreatic cancer cell apoptosis via suppression of MMP-9 and ERK signaling.
Pancreatic Neoplasms
Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Pancreatic Neoplasms
PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer.
Pancreatic Neoplasms
Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway.
Pancreatic Neoplasms
Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
Pancreatic Neoplasms
Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression.
Pancreatic Neoplasms
Ratiometric Activatable Cell-Penetrating Peptides Label Pancreatic Cancer, Enabling Fluorescence-Guided Surgery, Which Reduces Metastases and Recurrence in Orthotopic Mouse Models.
Pancreatic Neoplasms
REG4 contributes to the invasiveness of pancreatic cancer by upregulating MMP-7 and MMP-9.
Pancreatic Neoplasms
Retraction. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling.
Pancreatic Neoplasms
Retraction: Down-regulation of Notch-1 Inhibits Invasion by Inactivation of Nuclear Factor-?B, Vascular Endothelial Growth Factor, and Matrix Metalloproteinase-9 in Pancreatic Cancer Cells.
Pancreatic Neoplasms
Role of Peroxisome Proliferator-Activated Receptor ?/? and B-Cell Lymphoma-6 in Regulation of Genes Involved in Metastasis and Migration in Pancreatic Cancer Cells.
Pancreatic Neoplasms
SDF-1? upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines.
Pancreatic Neoplasms
Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling.
Pancreatic Neoplasms
Sphingosine-1-phosphate mediates a reciprocal signaling pathway between stellate cells and cancer cells that promotes pancreatic cancer growth.
Pancreatic Neoplasms
Stromal metalloproteinase-9 is essential to angiogenesis and progressive growth of orthotopic human pancreatic cancer in parabiont nude mice.
Pancreatic Neoplasms
SUMO-specific protease 1 regulates pancreatic cancer cell proliferation and invasion by targeting MMP-9.
Pancreatic Neoplasms
The assessment of serum and diagnostic peritoneal lavage concentration of matrix metalloproteinase-2, matrix metalloproteinase-9, carbohydrate antigen 19-9, and carcinoembryonic antigen in patients with pancreatic cancer and chronic pancreatitis.
Pancreatic Neoplasms
The co-expression of MMP-9 and Tenascin-C is significantly associated with the progression and prognosis of pancreatic cancer.
Pancreatic Neoplasms
The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibody.
Pancreatic Neoplasms
The potential molecular mechanism of overexpression of uPA, IL-8, MMP-7 and MMP-9 induced by TRAIL in pancreatic cancer cell.
Pancreatic Neoplasms
Thrombospondin-2 inhibits tumor cell invasion through the modulation of MMP-9 and uPA in pancreatic cancer cells.
Pancreatic Neoplasms
TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo.
Pancreatic Neoplasms
Traditional Chinese medicine Astragalus polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on proliferation, invasiveness, and apoptosis.
Pancreatic Neoplasms
Transcriptomic Analyses and Potential Therapeutic Targets of Pancreatic Cancer With Concomitant Diabetes.
Pancreatic Neoplasms
Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
Pancreatic Neoplasms
TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer.
Pancreatic Neoplasms
Ukrain Affects Pancreas Cancer Cell Phenotype in vitro by Targeting MMP-9 and Intra-/Extracellular SPARC Expression.
Pancreatic Neoplasms
ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts.
Pancreatic Neoplasms
Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.
Pancreatic Neoplasms
[CCL21 promotes the metastasis of human pancreatic cancer Panc-1 cells via epithelial- mesenchymal transition].
Pancreatic Neoplasms
[Effect of hypoxia on production and secretion of matrix metalloproteinases in tumor cells]
Pancreatic Neoplasms
[The role of Gli1 in the invasion and migration of pancreatic cancer cells].
Pancreatitis
Associations of MMP-2 and MMP-9 gene polymorphism with ulinastatin efficacy in patients with severe acute pancreatitis.
Pancreatitis
Captopril, an Angiotensin-converting enzyme inhibitor, attenuates the severity of acute pancreatitis in rats by reducing expression of matrix metalloproteinase 9.
Pancreatitis
Gelatinase B is diabetogenic in acute and chronic pancreatitis by cleaving insulin.
Pancreatitis
Hypertonic Saline Reduces Metalloproteinase Expression In Liver During Pancreatitis.
Pancreatitis
Increased gelatinase B/matrix metalloproteinase 9 (MMP-9) activity in a murine model of acute coxsackievirus B4-induced pancreatitis.
Pancreatitis
Increased matrix metalloproteinase expression and activation following experimental acute pancreatitis.
Pancreatitis
Inhibition of Matrix Metalloproteinase with BB-94 Protects against Caerulein-Induced Pancreatitis via Modulating Neutrophil and Macrophage Activation.
Pancreatitis
Inhibition of matrix metalloproteinase-9 with doxycycline reduces pancreatitis-associated lung injury.
Pancreatitis
Matrix Metalloproteinase 9 and Vasodilator-Stimulated Phosphoprotein Related to Acute Kidney Injury in Severe Acute Pancreatitis Rats.
Pancreatitis
Matrix metalloproteinase levels in acute aortic dissection, acute pancreatitis and other abdominal pain.
Pancreatitis
Matrix metalloproteinase-9 derived from polymorphonuclear neutrophils increases gut barrier dysfunction and bacterial translocation in rat severe acute pancreatitis.
Pancreatitis
Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat.
Pancreatitis
MMP-2 and MMP-9 gene polymorphisms act as biological indicators for ulinastatin efficacy in patients with severe acute pancreatitis.
Pancreatitis
MMP-9 in serum correlates with the development of pulmonary complications in experimental acute pancreatitis.
Pancreatitis
Neutrophil-derived matrix metalloproteinase-9 is a potent activator of trypsinogen in acinar cells in acute pancreatitis.
Pancreatitis
Pancreatic stellate cell activation and MMP production in experimental pancreatic fibrosis.
Pancreatitis
Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetes.
Pancreatitis
Serum matrix metalloproteinase 9 as a marker for the assessment of severe acute pancreatitis.
Pancreatitis
Serum Matrix Metalloproteinase-9 is an Early Marker of Pancreatic Necrosis in Patients with Severe Acute Pancreatitis.
Pancreatitis
The effect of Chaiqin Chengqi Decoction () on modulating serum matrix metalloproteinase 9 in patients with severe acute pancreatitis.
Pancreatitis
The imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in acute pancreatitis.
Pancreatitis
The influence of transforming growth factor beta 1 on the expression of genes coding for matrix metalloproteinases and tissue inhibitors of metalloproteinases during regeneration from cerulein-induced pancreatitis.
Pancreatitis
[The matrix metalloproteinase 9 (MMP-9) and TIMP-1 activities in patients with chronic and recurrent pancreatitis].
Pancreatitis, Acute Necrotizing
Serum Matrix Metalloproteinase-9 is an Early Marker of Pancreatic Necrosis in Patients with Severe Acute Pancreatitis.
Pancreatitis, Chronic
Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: metalloproteinase-9 as an independent prognostic factor.
Pancreatitis, Chronic
Corrigendum: The assessment of serum and diagnostic peritoneal lavage concentration of matrix metalloproteinase-2, matrix metalloproteinase-9, carbohydrate antigen 19-9, and carcinoembryonic antigen in patients with pancreatic cancer and chronic pancreatitis, Journal of Physiology and Pharmacology 2020 Oct; 71(5): 689.
Pancreatitis, Chronic
Gelatinase B is diabetogenic in acute and chronic pancreatitis by cleaving insulin.
Pancreatitis, Chronic
In vivo activation of gelatinase B/MMP-9 by trypsin in acute pancreatitis is a permissive factor in streptozotocin-induced diabetes.
Pancreatitis, Chronic
Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma.
Pancreatitis, Chronic
Matrix metalloproteinase-9, transforming growth factor-?1, and tumor necrosis factor-? plasma levels in chronic pancreatitis.
Pancreatitis, Chronic
Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
Pancreatitis, Chronic
Role of MMP-2 and MMP-9 and their natural inhibitors in liver fibrosis, chronic pancreatitis and non-specific inflammatory bowel diseases.
Pancreatitis, Chronic
Role of Plasma MMP 9 levels in the Pathogenesis of Chronic Pancreatitis.
Pancreatitis, Chronic
The assessment of serum and diagnostic peritoneal lavage concentration of matrix metalloproteinase-2, matrix metalloproteinase-9, carbohydrate antigen 19-9, and carcinoembryonic antigen in patients with pancreatic cancer and chronic pancreatitis.
Papilledema
Truncated netrin-1 contributes to pathological vascular permeability in diabetic retinopathy.
Papilloma
Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice.
Papilloma
Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions.
Papilloma
Expression of matrix metalloproteinases (MMP-2 and MMP-9) in recurrent respiratory papillomas and laryngeal carcinoma: clinical and morphological parallels.
Papilloma
Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway.
Papilloma
[Expression and clinical significance of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinomas]
Papilloma, Inverted
Overexpression of Neutrophil MMP-9 and HIF-1? May Contribute to the Finger-Like Projections Formation and Histo-Pathogenesis in Nasal Inverted Papilloma.
Papillomavirus Infections
Persistent Oral Human Papillomavirus (HPV) Infection is Associated with Low Salivary Levels of Matrix Metalloproteinase 8 (MMP-8).
Papillomavirus Infections
Schisandrin B synergizes docetaxel-induced restriction of growth and invasion of cervical cancer cells in vitro and in vivo.
Paracoccidioidomycosis
Matrix metalloproteinases with gelatinolytic activity induced by Paracoccidioides brasiliensis infection.
Parakeratosis
[Ki-67 and matrix metalloproteinase-9 expression in the follicular cyst, keratocystic odontogenic tumor, and ameloblastoma].
Paralysis
Minocycline prevents dynorphin-induced neurotoxicity during neuropathic pain in rats.
Paralysis
Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures.
Paralysis
Toll-like Receptor-4 Polymorphisms and Serum Matrix Metalloproteinase-9 in Newly Diagnosed Patients With Calcified Neurocysticercosis and Seizures.
Paraparesis, Spastic
Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Paraparesis, Spastic
Selective matrix metalloproteinase inhibitor, N-biphenyl sulfonyl phenylalanine hydroxamic acid, inhibits the migration of CD4+ T lymphocytes in patients with HTLV-I-associated myelopathy.
Paraparesis, Tropical Spastic
Gelatinase activity of matrix metalloproteinases in the cerebrospinal fluid of various patient populations.
Paraparesis, Tropical Spastic
Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV-1 infected patients with tropical spastic paraparesis.
Paraparesis, Tropical Spastic
Selective matrix metalloproteinase inhibitor, N-biphenyl sulfonyl phenylalanine hydroxamic acid, inhibits the migration of CD4+ T lymphocytes in patients with HTLV-I-associated myelopathy.
Paraparesis, Tropical Spastic
[Increased activity of metalloproteinases and their inhibitors in cerebrospinal fluid of patients with tropical spastic paraparesis]
Parasitic Diseases
SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.
Paresis
Role of Brain-Derived Neurotrophic Factor in Beneficial Effects of Repetitive Transcranial Magnetic Stimulation for Upper Limb Hemiparesis after Stroke.
Parkinson Disease
Association studies of mmp-9 in Parkinson's disease and amyotrophic lateral sclerosis.
Parkinson Disease
Associations of Matrix Metalloproteinase-9 and Tissue Inhibitory Factor-1 Polymorphisms With Parkinson Disease in Taiwan.
Parkinson Disease
Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease.
Parkinson Disease
Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
Parkinson Disease
MMP-9 Inhibitor GM6001 Prevents the Development of ssTBI-Induced Parkinson's Disease via the Autophagy Pathway.
Parkinson Disease
Regulation of matrix metalloproteinase-9 gene expression in MPP+- or 6-OHDA-treated human neuroblastoma SK-N-BE(2)C cells.
Parkinsonian Disorders
Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
Parkinsonian Disorders
Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism.
Parotitis
Decreased salivary matrix metalloproteinase-8 reflecting a defensive potential in juvenile parotitis.
Pasteurellosis, Pneumonic
Potential involvement of gelatinases and their inhibitors in Mannheimia haemolytica pneumonia in cattle.
Pediatric Obesity
Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents.
Pediatric Obesity
Identification of key genes and pathways associated with obesity in children.
Pelvic Inflammatory Disease
Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease.
Pelvic Inflammatory Disease
Significant elevation of plasma matrix metalloproteinase-9 level and its ratio to matrix metalloproteinase-2 in patients with pelvic inflammatory disease.
Pemphigoid, Bullous
Bullous pemphigoid outcome is associated with CXCL10-induced MMP-9 secretion from monocytes and neutrophils but not lymphocytes.
Pemphigoid, Bullous
Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Pemphigoid, Bullous
Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid.
Pemphigoid, Bullous
Interleukin-1alpha-induced proteolytic activation of metalloproteinase-9 by human skin.
Pemphigoid, Bullous
Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
Pemphigus
Defining the involvement of proteinases in pemphigus vulgaris: evidence of matrix metalloproteinase-9 overexpression in experimental models of disease.
Penile Neoplasms
E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: Analysis of 125 patients.
Penile Neoplasms
The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery.
Peptic Ulcer
Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels.
Peptic Ulcer
Functionally significant polymorphisms of the MMP-9 gene are associated with peptic ulcer disease in the Caucasian population of Central Russia.
Peptic Ulcer
[Role of Allelic Genes of Matrix Metalloproteinases and Their Tissue Inhibitors in the Peptic Ulcer Disease Development].
Peri-Implantitis
aMMP-8 Point-of-Care/Chairside Oral Fluid Technology as a Rapid, Non-Invasive Tool for Periodontitis and Peri-Implantitis Screening in a Medical Care Setting.
Peri-Implantitis
Assessment of matrix metalloproteinase-8 and -9 levels in the peri-implant sulcular fluid among waterpipe (narghile) smokers and never-smokers with peri-implantitis.
Peri-Implantitis
LOX-1 is involved in IL-1? production and extracellular matrix breakdown in dental peri-implantitis.
Peri-Implantitis
Matrix metalloproteinase 9 is regulated by LOX-1 and erk1/2 pathway in dental peri-implantitis.
Peri-Implantitis
Microbiological Profile and Human Immune Response Associated with Peri-Implantitis: A Systematic Review.
Peri-Implantitis
Tenascin-C and Matrix Metalloproteinase-9 Levels in Crevicular Fluid of Teeth and Implants.
Periapical Abscess
Comparative Metabolomics Reveals the Microenvironment of Common T-Helper Cells and Differential Immune Cells Linked to Unique Periapical Lesions.
Periapical Granuloma
Comparative Metabolomics Reveals the Microenvironment of Common T-Helper Cells and Differential Immune Cells Linked to Unique Periapical Lesions.
Periapical Granuloma
Immunohistochemical expression of TGF-?1 and MMP-9 in periapical lesions.
Periapical Periodontitis
Expression analysis of matrix metalloproteinase-9 in epithelialized and nonepithelialized apical periodontitis lesions.
Periapical Periodontitis
Expression of Inflammatory Markers RANK, MMP-9 and PTHrP in Chronic Apical Periodontitis from People Living with HIV Undergoing Antiretroviral Therapy.
Periapical Periodontitis
Expression of Matrix Metalloproteinases and Tissue Inhibitor of Matrix Metalloproteinases during Apical Periodontitis Development.
Periapical Periodontitis
Immunoexpression of bone resorption biomarkers in apical periodontitis in diabetics and normoglycaemics.
Periapical Periodontitis
Osteoclast formation, inflammation, and matrix metalloproteinase-9 are downregulated in bone repair following root canal treatment in dogs teeth.
Periapical Periodontitis
The virulence factor GroEL promotes gelatinase secretion from cells in the osteoblast lineage: Implication for direct crosstalk between bacteria and adult cells.
Periodontal Diseases
Application of quantitative proteomic analysis using tandem mass tags for discovery and identification of novel biomarkers in periodontal disease.
Periodontal Diseases
Association between isotretinoin (Roaccutanne) use and changes in periodontal clinical parameters and MMP-8 and MMP-9 salivary levels.
Periodontal Diseases
Cimetidine Reduces Interleukin-6, Matrix Metalloproteinases-1 and -9 Immunoexpression in the Gingival Mucosa of Rat Molars With Induced Periodontal Disease.
Periodontal Diseases
Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy.
Periodontal Diseases
Compartment differences of inflammatory activity in chronic obstructive pulmonary disease.
Periodontal Diseases
Cyclooxygenase-2 and matrix metalloproteinase-9 expressions correlate with tissue inflammation degree in periodontal disease.
Periodontal Diseases
Effects of therapy with two combinations of antibiotics on the imbalance of MMP-2÷TIMP-2 in chronic periodontitis.
Periodontal Diseases
Impact of Matrix Metalloproteinase-9 during Periodontitis and Cardiovascular Diseases.
Periodontal Diseases
In situ detection of matrix metalloproteinase-9 (MMP-9) in gingival epithelium in human periodontal disease.
Periodontal Diseases
Inhibitory activities of selected Sudanese medicinal plants on Porphyromonas gingivalis and matrix metalloproteinase-9 and isolation of bioactive compounds from Combretum hartmannianum (Schweinf) bark.
Periodontal Diseases
Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts.
Periodontal Diseases
Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue?
Periodontal Diseases
Levels of matrix metalloproteinases-8 and -9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase-9 and cholesterol in blood.
Periodontal Diseases
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis.
Periodontal Diseases
Relationship between TNF-?, MMP-8, and MMP-9 levels in gingival crevicular fluid and the subgingival microbiota in periodontal disease.
Periodontal Diseases
Targeted proteomics guided by label-free global proteome analysis in saliva reveal transition signatures from health to periodontal disease.
Periodontal Diseases
The influence of type I diabetes mellitus on the expression and activity of gelatinases (matrix metalloproteinases-2 and -9) in induced periodontal disease.
Periodontal Diseases
Up-regulation of osteolytic mediators in human osteosarcoma cells stimulated with nicotine.
Periodontal Diseases
[The relationship between chronic periodontitis and the instability of carotid atherosclerotic plaque by serum level of MMP-9, MCP-1 and MMP-7].
Periodontitis
Ability of S100 proteins and matrix metalloproteinase-9 to identify periodontitis in a ligature-induced periodontitis dog model.
Periodontitis
An aMMP-8 Point-of-Care and Questionnaire Based Real-Time Diagnostic Toolkit for Medical Practitioners.
Periodontitis
Assessment of VEGF and MMP-9 in the Periodontium of Rats Treated with Atorvastatin.
Periodontitis
Association between isotretinoin (Roaccutanne) use and changes in periodontal clinical parameters and MMP-8 and MMP-9 salivary levels.
Periodontitis
Association of matrix metalloproteinase (MMP-1, MMP-3 and MMP-9) and cyclooxygenase-2 gene polymorphisms and their proteins with chronic periodontitis.
Periodontitis
Automatic text-mining as an unbiased approach to uncover molecular associations between periodontitis and coronary artery disease.
Periodontitis
Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model.
Periodontitis
Carvedilol decrease IL-1? and TNF-?, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis.
Periodontitis
Changes in Inflammatory Cytokines in Saliva after Non-Surgical Periodontal Therapy: A Systematic Review and Meta-Analysis.
Periodontitis
Characteristics of neutrophil extracellular traps in patients with periodontitis and gingivitis.
Periodontitis
Comparative evaluation of inhibitory effect of curcumin and doxycycline on matrix metalloproteinase-9 activity in chronic periodontitis.
Periodontitis
Content of matrix metalloproteinase-8 and matrix metalloproteinase-9 in oral fluid of patients with chronic generalized periodontitis.
Periodontitis
Correlation of expression and activity of matrix metalloproteinase-9 and -2 in human gingival cells of periodontitis patients.
Periodontitis
Cyclooxygenase-2 and matrix metalloproteinase-9 expressions correlate with tissue inflammation degree in periodontal disease.
Periodontitis
Diagnostic Ability of Salivary Matrix Metalloproteinase-9 Lateral-Flow-Test Point-of-Care Test for Periodontitis.
Periodontitis
Diagnostic and Prognostic ability of salivary MMP-9 and S100A8 for periodontitis.
Periodontitis
Effect of Locally Delivered Melatonin as an Adjunct to Nonsurgical Therapy on GCF Antioxidant Capacity and MMP-9 in Stage II Periodontitis Patients: A Randomized Controlled Clinical Trial.
Periodontitis
Effect of Subantimicrobial Dose Doxycycline Treatment on Gingival Crevicular Fluid Levels of MMP-9 and MMP-13 in Periodontitis Stage 2, Grade B in Subjects with Type 2 Diabetes Mellitus.
Periodontitis
Effect of telmisartan on levels of IL-1, TNF-?, down-regulated COX-2, MMP-2, MMP-9 and RANKL/RANK in an experimental periodontitis model.
Periodontitis
Effects of Low Dose Doxycycline and Bisphosphonate Clodronate on Gingival Levels of Matrix Metalloproteinase -9, Interleukin -1B and Alveolar Bone Loss in Diabetic Rats. A Histomorphometric and Immunohistochemical Study.
Periodontitis
Elastase and metalloproteinase-9 concentrations in saliva in patients with chronic periodontitis.
Periodontitis
Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications.
Periodontitis
EVALUATION OF BONE RESORPTIVE POTENTIAL IN THE TREATMENT OF GENERALIZED PERIODONTITIS.
Periodontitis
Evidence for polymorphonuclear leukocyte collagenase and 92-kilodalton gelatinase in gingival crevicular fluid.
Periodontitis
Examination of the signal transduction pathways leading to activation of gelatinolytic activity by interleukin-1alpha and Porphyromonas gingivalis in human osteosarcoma cells.
Periodontitis
Exenatide and Sitagliptin Decrease Interleukin 1?, Matrix Metalloproteinase 9, and Nitric Oxide Synthase 2 Gene Expression But Does Not Reduce Alveolar Bone Loss in Rats With Periodontitis.
Periodontitis
Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva.
Periodontitis
Expression of matrix metalloproteinases-2, -9 and reversion-inducing cysteine-rich protein with Kazal motifs in gingiva in periodontal health and disease.
Periodontitis
Expression profile of lipoxygenases in gingival tissues of human periodontitis.
Periodontitis
Genetic Factors and the Risk of Periodontitis Development: Findings from a Systematic Review Composed of 13 Studies of Meta-Analysis with 71,531 Participants.
Periodontitis
Human ?-defensin 3 inhibits periodontitis development by suppressing inflammatory responses in macrophages.
Periodontitis
Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis.
Periodontitis
Impact of Matrix Metalloproteinase-9 during Periodontitis and Cardiovascular Diseases.
Periodontitis
Incipient periodontitis and salivary molecules among Korean adults: association and screening ability.
Periodontitis
Inflammatory responses of a macrophage/epithelial cell co-culture model to mono and mixed infections with Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia.
Periodontitis
Is the progression rate of periodontitis related to subgingival biofilm composition or gingival crevicular fluid IL-1? and MMP-8 concentrations?
Periodontitis
Levels of metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-1 in gingival crevicular fluid of patients with periodontitis, gingivitis, and healthy gingiva.
Periodontitis
Levels of Myeloperoxidase and Metalloproteinase-9 in Gingival Crevicular Fluid from Diabetic Subjects with and without Stage 2, Grade B Periodontitis.
Periodontitis
Loss of alveolar bone density in postmenopausal, osteopenic women is associated with circulating levels of gelatinases.
Periodontitis
Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status.
Periodontitis
Matrix metalloproteinases and inflammatory cytokines in oral fluid of patients with chronic generalized periodontitis and various construction materials.
Periodontitis
Matrix metalloproteinases and inflammatory cytokines in the oral fluid of patients with chronic generalized periodontitis various structural materials restoration of teeth and dentition.
Periodontitis
Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients.
Periodontitis
Melatonin improves periodontitis-induced kidney damages by decreasing inflammatory stress and apoptosis in rats.
Periodontitis
Membrane type (MT) 1-matrix metalloproteinase (MMP) and MMP-2 expression in ligature-induced periodontitis in the rat.
Periodontitis
Meta-analysis of the association between serum and gingival crevicular fluid matrix metalloproteinase-9 and periodontitis.
Periodontitis
MiRNA-218 regulates osteoclast differentiation and inflammation response in periodontitis rats through Mmp9.
Periodontitis
MMP-1, MMP-9, and TIMP-1 levels in oral lichen planus patients with gingivitis or periodontitis.
Periodontitis
MMP-2, MMP-9 and TIMP-2 gene polymorphisms in Chinese patients with generalized aggressive periodontitis.
Periodontitis
Modulation of host matrix metalloproteinases by bacterial virulence factors relevant in human periodontal diseases.
Periodontitis
Multiple forms of gelatinases/type IV collagenases in saliva and gingival crevicular fluid of periodontitis patients.
Periodontitis
Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: A mechanistic link between local and systemic inflammation.
Periodontitis
Olmesartan decreases IL-1? and TNF-? levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis.
Periodontitis
Parathyroid hormone administration may modulate periodontal tissue levels of interleukin-6, matrix metalloproteinase-2 and matrix metalloproteinase-9 in experimental periodontitis.
Periodontitis
Possible relationship between periodontitis and dementia in a North Indian old age population: a pilot study.
Periodontitis
Presence of mast cells and the expression of metalloproteinase 9 in the gingiva of ovariectomized rats with periodontal disease.
Periodontitis
Protective effects of desipramine on alveolar bone in experimental periodontitis.
Periodontitis
Salivary biomarker combination prediction model for the diagnosis of periodontitis in a Taiwanese population.
Periodontitis
Salivary MMP-13 gender differences in periodontitis: A cross-sectional study from Sweden.
Periodontitis
Significance of circulating and crevicular matrix metalloproteinase-9 in rheumatoid arthritis-chronic periodontitis association.
Periodontitis
Simvastatin modulates gingival cytokine and MMP production in a rat model of ligature-induced periodontitis.
Periodontitis
Simvastatin, an HMG-CoA reductase inhibitor, reduced the expression of matrix metalloproteinase-9 (Gelatinase B) in osteoblastic cells and HT1080 fibrosarcoma cells.
Periodontitis
The associations between gingival crevice fluid matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and periodontitis in human immunodeficiency virus-positive patients.
Periodontitis
The effect of smoking on the mRNA expression of MMPs and TIMP-1 in untreated chronic periodontitis patients: a cross-sectional study.
Periodontitis
The effects of periodontitis associated microbiota on the development of oral squamous cell carcinoma.
Periodontitis
The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis.
Periodontitis
Toll-like receptor (TLR) and matrix metalloproteinase (MMP) polymorphisms and periodontitis susceptibility: a meta-analysis.
Periodontitis
[Correlation of matrix metalloproteinase-9 polymorphisms with chronic periodontitis in Uygur adults].
Periodontitis
[Effect of smokers'sera on Porphyromonas gingivalis internalizing KB cells and the expression of matrix metalloproteinase-1, -9 and tissue inhibitor of metalloproteinase-1].
Periodontitis
[Effects of periodontitis patient's own tissue nucleic acid on the mRNA expression of osteoclast-related factors in murine macrophages].
Periodontitis
[Protective effect of baicalin on experimental periodontitis in rats and its possible mechanisms]
Periodontitis
[The relationship between chronic periodontitis and the instability of carotid atherosclerotic plaque by serum level of MMP-9, MCP-1 and MMP-7].
Peripheral Arterial Disease
Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease.
Peripheral Nerve Injuries
Acute- and late-phase matrix metalloproteinase (MMP)-9 activity is comparable in female and male rats after peripheral nerve injury.
Peripheral Nerve Injuries
Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve.
Peripheral Nerve Injuries
Different expression of tissue inhibitor of metalloproteinase family members in rat dorsal root ganglia and their changes after peripheral nerve injury.
Peripheral Nerve Injuries
Role of Matrix Metalloproteinases and Therapeutic Benefits of Their Inhibition in Spinal Cord Injury.
Peripheral Nervous System Diseases
Acute- and late-phase matrix metalloproteinase (MMP)-9 activity is comparable in female and male rats after peripheral nerve injury.
Peripheral Nervous System Diseases
High mobility group box-1-toll-like receptor 4-phosphatidylinositol 3-kinase/protein kinase B-mediated generation of matrix metalloproteinase-9 in the dorsal root ganglion promotes chemotherapy-induced peripheral neuropathy.
Peripheral Nervous System Diseases
Matrix metalloproteinases-9 and -2 in secondary vasculitic neuropathies.
Peripheral Nervous System Diseases
Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice.
Peripheral Nervous System Diseases
Perineural expression of high-mobility group box-1 contributes to long-lasting mechanical hypersensitivity via matrix metalloproteinase-9 upregulation in mice with painful peripheral neuropathy.
Peripheral Vascular Diseases
Peroxisome proliferator-activated receptor-{delta} activates endothelial progenitor cells to induce angio-myogenesis through matrix metallo-proteinase-9-mediated insulin-like growth factor-1 paracrine networks.
Peritoneal Fibrosis
Pioglitazone reduces peritoneal fibrosis via inhibition of TGF-?, MMP-2, and MMP-9 in a model of encapsulating peritoneal sclerosis.
Peritoneal Neoplasms
DJ-1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway.
Peritonitis
Enhanced early vascular permeability in gelatinase B (MMP-9)-deficient mice: putative contribution of COX-1-derived PGE2 of macrophage origin.
Peritonitis
Expression profiles of matrix metalloproteinase 9 in teleost fish provide evidence for its active role in initiation and resolution of inflammation.
Peritonitis
Gelatinase B/matrix metalloproteinase-9 contributes to cellular infiltration in a murine model of zymosan peritonitis.
Peritonitis
Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phase-specific and cell-specific production by mast cells, macrophages and neutrophils.
Peritonitis
In vivo processing of CXCL5 (LIX) by matrix metalloproteinase (MMP)-2 and MMP-9 promotes early neutrophil recruitment in IL-1?-induced peritonitis.
Peritonitis
Increased cyclooxygenase activity impairs apoptosis of inflammatory neutrophils in mice lacking gelatinase B/matrix metalloproteinase-9.
Peritonitis
Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice.
Peritonitis
Involvement of the Commensal Organism Bacillus subtilis in the Pathogenesis of Anastomotic Leak.
Peritonitis
Lp(a)/apo(a) Modulate MMP-9 Activation and Neutrophil Cytokines in Vivo in Inflammation to Regulate Leukocyte Recruitment.
Peritonitis
Matrix Metalloproteinase-9 Deficiency Impairs Host Defense against Abdominal Sepsis.
Peritonitis
Neutrophil elastase activity compensates for a genetic lack of matrix metalloproteinase-9 (MMP-9) in leukocyte infiltration in a model of experimental peritonitis.
Peritonitis
Peritonitis increases MMP-9 activity in peritoneal effluent from CAPD patients.
Peritonitis
Rapid, simple, and reliable method for the diagnosis of CAPD peritonitis using the new MMP-9 test kit.
Peritonitis
Resident peritoneal leukocytes are important sources of MMP-9 during zymosan peritonitis: Superior contribution of macrophages over mast cells.
Peritonitis
Resolvin D3 multi-level proresolving actions are host protective during infection.
Peritonitis
The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
Persistent Infection
Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice.
Persistent Infection
Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN/JAK/STAT Signaling.
Photosensitivity Disorders
[Expressions of fibrillin-1, elastin and matrix metalloproteinase-1 and -9 in chronic actinic dermatitis in elderly patients]
Pituitary ACTH Hypersecretion
Acute elevation of interleukin 6 and matrix metalloproteinase 9 during the onset of pituitary apoplexy in Cushing's disease.
Pituitary ACTH Hypersecretion
Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
Pituitary Apoplexy
Acute elevation of interleukin 6 and matrix metalloproteinase 9 during the onset of pituitary apoplexy in Cushing's disease.
Pituitary Neoplasms
Clinical features and immunohistochemical changes of pituitary apoplexy.
Pituitary Neoplasms
Different patterns of gelatinolytic activity in pituitary macro- and microadenomas.
Pituitary Neoplasms
Does MMP-9 Gene Polymorphism Play a Role in Pituitary Adenoma Development?
Pituitary Neoplasms
Effect of miR-106b on Invasiveness of Pituitary Adenoma via PTEN-PI3K/AKT.
Pituitary Neoplasms
Expression of Matrix Metalloproteinase-9, Pituitary Tumor Transforming Gene, High Mobility Group A 2, and Ki-67 in Adrenocorticotropic Hormone-Secreting Pituitary Tumors and Their Association with Tumor Recurrence.
Pituitary Neoplasms
Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
Pituitary Neoplasms
High levels of matrix metalloproteinases regulate proliferation and hormone secretion in pituitary cells.
Pituitary Neoplasms
Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space.
Pituitary Neoplasms
Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas.
Pituitary Neoplasms
Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials.
Pituitary Neoplasms
Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line.
Pituitary Neoplasms
Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis.
Pituitary Neoplasms
Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
Pituitary Neoplasms
Relationship between NF-?B, MMP-9, and MICA expression in pituitary adenomas reveals a new mechanism of pituitary adenomas immune escape.
Pituitary Neoplasms
siRNA-mediated silencing of bFGF gene inhibits the proliferation, migration, and invasion of human pituitary adenoma cells.
Pituitary Neoplasms
Suppression of estrogen-dependent MMP-9 expression by Edpm5, a genetic locus for pituitary tumor growth in rat.
Pituitary Neoplasms
The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas.
Pituitary Neoplasms
The Relationship Between Phospho-p38, Matrix Metalloproteinase 9, and Major Histocompatibility Complex Class I Chain-Related Molecule A Expression in Pituitary Adenomas Demonstrates a New Mechanism of Pituitary Adenoma Immune Escape.
Pituitary Neoplasms
TNF-?-Induced VEGF and MMP-9 Expression Promotes Hemorrhagic Transformation in Pituitary Adenomas.
Pituitary Neoplasms
Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas.
Pituitary Neoplasms
Up-regulation of the expressions of MiR-149-5p and MiR-99a-3p in exosome inhibits the progress of pituitary adenomas.
Pituitary Neoplasms
[Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior]
Pituitary Neoplasms
[The Role of Cancer-associated Fibroblasts in Invasive Behavior of Pituitary Adenoma].
Placenta Accreta
[Involvement of matrix metalloproteinase-2, -9, and tissue inhibitors of metalloproteinase-1, 2 in occurrence of the accrete placenta]
Placenta Previa
Placenta previa may acquire invasive nature by factors associated with epithelial-mesenchymal transition and matrix metalloproteinases.
Plague
Correlation analysis of levels of adiponectin and matrix metalloproteinase-9 with stability of coronary heart disease.
plasmin deficiency
Physiologic variations in blood plasminogen levels affect outcomes after acute cerebral thromboembolism in mice: a pathophysiologic role for microvascular thrombosis.
Pleural Diseases
High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation.
Pleural Effusion
ACE/ACE2 ratio and MMP-9 activity as potential biomarkers in tuberculous pleural effusions.
Pleural Effusion
Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.
Pleural Effusion
High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation.
Pleural Effusion
Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions.
Pleural Effusion
Matrix metalloproteinase-2 and matrix metalloproteinase-9 type IV collagenases in serum of patients with pleural effusions.
Pleural Effusion
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in diagnosis of pleural effusion of malignant origin.
Pleural Effusion
Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
Pleural Effusion
Potential role of matrix metalloproteinase-2,-9 and tissue inhibitors of metalloproteinase-1,-2 in exudative pleural effusions.
Pleural Effusion
Progelatinase B/matrix metalloproteinase-9 proenzyme as a marker of pleural inflammation.
Pleural Effusion
The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion.
Pleural Effusion
Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion.
Pleural Effusion
[Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion]
Pleural Effusion, Malignant
Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.
Pleurisy
Effect of matrix metalloproteinase-9 -1562C/T gene polymorphism on manifestations of pulmonary tuberculosis.
Pleurisy
Gelatinolytic activities (matrix metalloproteinase-2 and -9) and soluble extracellular domain of Her-2/neu in pleural effusions.
Pleurisy
Herbal mixtures consisting of puerarin and either polyenylphosphatidylcholine or curcumin provide comprehensive protection against alcohol-related disorders in P rats receiving free choice water and 15% ethanol in pure water.
Pleurisy
Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
Pleurisy
Potential role of matrix metalloproteinase-2,-9 and tissue inhibitors of metalloproteinase-1,-2 in exudative pleural effusions.
Pneumococcal Infections
Recognition of Streptococcus pneumoniae and muramyl dipeptide by NOD2 results in potent induction of MMP-9, which can be controlled by lipopolysaccharide stimulation.
Pneumoconiosis
Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
Pneumoconiosis
[Changes of serum matrix metaslloproteinases-9 and tissue inhibitors of metaslloproteinases-9 in coal workers' pneumoconiosis.]
Pneumoconiosis
[Serum levels of matrix metalloproteinase 9 and 19 in the patients with pneumoconiosis].
Pneumonia
A mucoactive drug carbocisteine ameliorates steroid resistance in rat COPD model.
Pneumonia
Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus.
Pneumonia
Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels: implications for antenatal origins of chronic lung disease.
Pneumonia
Circulating level of lipocalin 2 as a predictor of severity in patients with community-acquired pneumonia.
Pneumonia
Comparisons of acute inflammatory responses of nose-only inhalation and intratracheal instillation of ammonia in rats.
Pneumonia
CXCR4 inhibitor attenuates allergen-induced lung inflammation by down-regulating MMP-9 and ERK1/2.
Pneumonia
Diagnostic performance of serum interferon gamma, matrix metalloproteinases, and periostin measurements for pulmonary tuberculosis in Japanese patients with pneumonia.
Pneumonia
Effects of formoterol and ipratropium bromide on repeated cadmium inhalation-induced pulmonary inflammation and emphysema in rats.
Pneumonia
Effects of the serine protease inhibitor rBmTI-A in an experimental mouse model of chronic allergic pulmonary inflammation.
Pneumonia
Elevated plasma matrix metalloproteinase-9 protein and its gene polymorphism in patients with community-acquired pneumonia.
Pneumonia
Eucalyptol suppresses matrix metalloproteinase-9 expression through an extracellular signal-regulated kinase-dependent nuclear factor-kappa B pathway to exert anti-inflammatory effects in an acute lung inflammation model.
Pneumonia
Excessive matrix metalloproteinase-9 in the plasma of community-acquired pneumonia.
Pneumonia
Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis.
Pneumonia
Gelatinolytic matrix metalloproteinases-2 and -9 in tracheobronchial lavage fluid obtained from calves with concurrent infections of Pasteurella multocida and Mycoplasma bovirhinis.
Pneumonia
Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide.
Pneumonia
GMI, a Ganoderma Immunomodulatory Protein, Down-regulates Tumor Necrosis Factor ?-Induced Expression of Matrix Metalloproteinase 9 via NF-?B Pathway in Human Alveolar Epithelial A549 Cells.
Pneumonia
High-fat diet induces lung remodeling in ApoE-deficient mice: an association with an increase in circulatory and lung inflammatory factors.
Pneumonia
Hydrogen Sulfide Prevents and Partially Reverses Ozone-induced Feature of Lung Inflammation and Emphysema in Mice.
Pneumonia
Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia.
Pneumonia
Increased production of matrix metalloproteinase-2 in alveolar macrophages and regulation by interleukin-10 in patients with acute pulmonary sarcoidosis.
Pneumonia
Inflammation biomarkers associated with arsenic exposure by drinking water and respiratory outcomes in indigenous children from three Yaqui villages in southern Sonora, México.
Pneumonia
Intravenous superoxide dismutase as a protective agent to prevent impairment of lung function induced by high tidal volume ventilation.
Pneumonia
Kinetics and Role of Plasma Matrix Metalloproteinase-9 Expression in Acute Lung Injury and the Acute Respiratory Distress Syndrome.
Pneumonia
Matrix Metalloproteinase-9 Deficiency Worsens Lung Injury in a Model of Bronchopulmonary Dysplasia.
Pneumonia
Modificated Mahuang-Tang, a traditional herbal medicine suppresses inflammatory responses induced by cigarette smoke in human airway epithelial cell and mice.
Pneumonia
Mycoplasma pneumoniae in adult community-acquired pneumonia increases matrix metalloproteinase-9 serum level and induces its gene expression in peripheral blood mononuclear cells.
Pneumonia
Overexpression of Tumor Necrosis Factor-? in the Lungs Alters Immune Response, Matrix Remodeling, and Repair and Maintenance Pathways.
Pneumonia
Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors.
Pneumonia
Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia.
Pneumonia
Potentiated interaction between ineffective doses of budesonide and formoterol to control the inhaled cadmium-induced up-regulation of metalloproteinases and acute pulmonary inflammation in rats.
Pneumonia
Pulmonary matrix metalloproteinase-9 activity in mechanically ventilated children with respiratory syncytial virus.
Pneumonia
Regulation of MMP-9 by a WIN-binding site in the monocyte-macrophage system independent from cannabinoid receptors.
Pneumonia
Serum matrix metalloproteinase-9 in children exposed to arsenic from playground dust at elementary schools in Hermosillo, Sonora, Mexico.
Pneumonia
Serum MMP-9 and SAA in the Diagnosis of Severe Pneumonia Caused by Radiotherapy of Esophageal Cancer.
Pneumonia
Soluble CD200 Correlates With Interleukin-6 Levels in Sera of COPD Patients: Potential Implication of the CD200/CD200R Axis in the Disease Course.
Pneumonia
The circulating level of MMP-9 and its ratio to TIMP-1 as a predictor of severity in patients with community-acquired pneumonia.
Pneumonia
The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia.
Pneumonia
Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma.
Pneumonia
[Effects of Dureping Injection on the contents of MMP-g and TIMP-1 in the lung tissue of mice with pneumonia of influenza virus infection].
Pneumonia, Bacterial
[Study on inflammatory response and alteration of biochemical components in BALF from Pneumocystis carinii pneumonia]
Pneumonia, Pneumococcal
Lung dendritic cells facilitate extrapulmonary bacterial dissemination during pneumococcal pneumonia.
Pneumonia, Ventilator-Associated
Elevated Plasma Matrix Metalloproteinase-9 and Its Correlations with Severity of Disease in Patients with Ventilator-Associated Pneumonia.
Pneumoperitoneum
Major surgical trauma induces proteolysis of insulin-like growth factor binding protein-3 in transgenic mice and is associated with a rapid increase in circulating levels of matrix metalloproteinase-9.
Pneumoperitoneum
Study on the inhibition of hyperthermic CO2 pneumoperitoneum on the proliferation and migration of colon cancer cells and its mechanism.
Pneumothorax
Association of MMP-2 and MMP-9 expression with recurrences in primary spontaneous pneumothorax.
Pneumothorax
Overexpression of matrix metalloproteinase-9 in adolescents with primary spontaneous pneumothorax for surgical intervention.
Pneumothorax
TIMP-1 and MMP-9 expressions in COPD patients complicated with spontaneous pneumothorax and their correlations with treatment outcomes.
Polyarteritis Nodosa
Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy.
Polycystic Kidney Diseases
Matrix metalloproteinases synthesized in autosomal dominant polycystic kidney disease play a role in development of a concurrent abdominal aortic aneurysm.
Polycystic Kidney, Autosomal Dominant
Matrix metalloproteinases synthesized in autosomal dominant polycystic kidney disease play a role in development of a concurrent abdominal aortic aneurysm.
Polycystic Ovary Syndrome
Clomiphene citrate increases nitric oxide, interleukin-10 and reduces matrix metalloproteinase-9 in women with polycystic ovary syndrome.
Polycystic Ovary Syndrome
Gingival Inflammation and Salivary or Serum Granulocyte Secreted Enzymes in Patients With Polycystic Ovary Syndrome.
Polycystic Ovary Syndrome
Matrix metalloproteinase-9 increases and Interleukin-10 reduces with increase in body mass index in polycystic ovary syndrome: A cross-sectional study.
Polycystic Ovary Syndrome
Matrix metalloproteinases 2 and 9 and their tissue inhibitors in the follicular fluid of patients with polycystic ovaries undergoing in vitro fertilisation.
Polycystic Ovary Syndrome
Metformin treatment alleviates polycystic ovary syndrome by decreasing the expression of MMP-2 and MMP-9 via H19/miR-29b-3p and AKT/mTOR/autophagy signaling pathways.
Polycystic Ovary Syndrome
Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1.
Polycystic Ovary Syndrome
Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?
Polycystic Ovary Syndrome
Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome.
Polycythemia
Increased Pulmonary GM-CSF Causes Alveolar Macrophage Accumulation: Mechanistic Implications for Desquamative Interstitial Pneumonitis.
Polycythemia Vera
Importance of plasma matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinase (TIMP) in development of fibrosis in agnogenic myeloid metaplasia.
Polymyositis
Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Polymyositis
IL-15 up-regulates the MMP-9 expression levels and induces inflammatory infiltration of macrophages in polymyositis through regulating the NF-kB pathway.
Polyneuropathies
Expression pattern of matrix metalloproteinases-2 and -9 and their tissue inhibitors in patients with chronic inflammatory demyelinating polyneuropathy.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Expression pattern of matrix metalloproteinases-2 and -9 and their tissue inhibitors in patients with chronic inflammatory demyelinating polyneuropathy.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy.
Polyuria
Diuretic response to cyclophosphamide in rats bearing a matrix metalloproteinase-9-producing tumour.
Pouchitis
Faecal matrix metalloprotease-9 is a more sensitive marker for diagnosing pouchitis than faecal calprotectin: results from a pilot study.
Pouchitis
The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases.
Pre-Eclampsia
Altered Maternal Serum Matrix Metalloproteinases MMP-2, MMP-3, MMP-9, and MMP-13 in Severe Early- and Late-Onset Preeclampsia.
Pre-Eclampsia
AP-2? suppresses invasion in BeWo cells by repression of matrix metalloproteinase-2 and -9 and up-regulation of E-cadherin.
Pre-Eclampsia
AT2R -1332 G:A polymorphism and its interaction with AT1R 1166 A:C, ACE I/D and MMP-9 -1562 C:T polymorphisms: risk factors for susceptibility to preeclampsia.
Pre-Eclampsia
Celastrol attenuates symptoms of preeclampsia in rats by inhibiting matrix metalloproteinase-9.
Pre-Eclampsia
Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension.
Pre-Eclampsia
CXCR2 is decreased in preeclamptic placentas and promotes human trophoblast invasion through the Akt signaling pathway.
Pre-Eclampsia
Decreased expression of MMP-9 in CD8(+) cells in placenta with severe preeclampsia.
Pre-Eclampsia
Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.
Pre-Eclampsia
Down-Regulation of Neuropathy Target Esterase in Preeclampsia Placenta Inhibits Human Trophoblast Cell Invasion via Modulating MMP-9 Levels.
Pre-Eclampsia
Elevated expression of KiSS-1 in placenta of preeclampsia and its effect on trophoblast.
Pre-Eclampsia
Expressional and epigenetic alterations of placental matrix metalloproteinase 9 in preeclampsia.
Pre-Eclampsia
First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome.
Pre-Eclampsia
Gelatinase matrix metalloproteinase (MMP)-2 and MMP-9 of the umbilical cord blood in preeclampsia.
Pre-Eclampsia
Gene expression analysis of MMPs in women with preeclampsia using cell-free fetal RNA in maternal plasma.
Pre-Eclampsia
Increased urinary levels of podocyte glycoproteins, matrix metallopeptidases, inflammatory cytokines, and kidney injury biomarkers in women with preeclampsia.
Pre-Eclampsia
Interleukin-4 -590 (C>T), toll-like receptor-2 +2258 (G>A) and matrix metalloproteinase-9 -1562 (C>T) polymorphisms in pre-eclampsia.
Pre-Eclampsia
Investigation of the association between matrix metalloproteinase-9 genetic polymorphisms and development of pre-eclampsia in Chinese pregnant women.
Pre-Eclampsia
Lack of association between matrix metalloproteinase-9 gene-1562C/T polymorphism and preeclampsia: a meta-analysis.
Pre-Eclampsia
Maternal serum levels of Neutrophil Gelatinase-Associated Lipocalin (NGAL), Matrix Metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in pregnancies with preeclampsia and those with a small for gestational age neonate. A longitudinal study.
Pre-Eclampsia
Matrix metalloprotease-9, placental syncytiotrophoblast and the endothelial dysfunction of pre-eclampsia.
Pre-Eclampsia
Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension.
Pre-Eclampsia
Matrix metalloproteinase multiplex screening identifies increased MMP-2 urine concentrations in women predicted to develop preeclampsia.
Pre-Eclampsia
Matrix metalloproteinase-7 A-181G and its interaction with matrix metalloproteinase-9 C-1562T polymorphism in preeclamptic patients: association with malondialdehyde level and severe preeclampsia.
Pre-Eclampsia
Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction.
Pre-Eclampsia
Matrix metalloproteinase-9 gene -1562C/T polymorphism mitigates preeclampsia.
Pre-Eclampsia
Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Pre-Eclampsia
Matrix metalloproteinases MMP-2 and MMP-9 as markers for the prediction of preeclampsia in the first trimester.
Pre-Eclampsia
Matrix Metalloproteinases MMP-2 and MMP-9 Occupy a New Role in Severe Preeclampsia.
Pre-Eclampsia
Matrix metalloproteinases-2 (MMP-2) and matrix metalloproteinases -9 (MMP-9) are differentially expressed in different regions of normal and preeclampsia placentae.
Pre-Eclampsia
miR-183-5p suppressed the invasion and migration of HTR-8/SVneo trophoblast cells partly via targeting MMP-9 in preeclampsia.
Pre-Eclampsia
MMP-2 and MMP-9 Polymorphisms and Preeclampsia Risk in Tunisian Arabs: A Case-Control Study.
Pre-Eclampsia
MMP-2 levels are elevated in the plasma of women who subsequently develop preeclampsia.
Pre-Eclampsia
MMP-9 (-1562 C:T) polymorphism as a biomarker of susceptibility to severe pre-eclampsia.
Pre-Eclampsia
Non-association of MMP-9 -1562C/T polymorphism with preeclampsia risk: evidence from a meta-analysis.
Pre-Eclampsia
RNA interference-mediated silencing of laminin receptor 1 (LR1) suppresses migration and invasion and down-regulates matrix metalloproteinase (MMP)-2 and MMP-9 in trophoblast cells: implication in the pathogenesis of preeclampsia.
Pre-Eclampsia
Role of Gelatinases MMP-2 and MMP-9 in Healthy and Complicated Pregnancy and Their Future Potential as Preeclampsia Biomarkers.
Pre-Eclampsia
The activity of collagen-degrading enzymes of Wharton's jelly in EPH gestosis (pre-eclampsia).
Pre-Eclampsia
Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Pre-Eclampsia
Trisomy 21 is associated with variable defects in cytotrophoblast differentiation along the invasive pathway.
Pre-Eclampsia
[Clinical significance of KiSS-1 and matrix metalloproteinase-9 expression in trophoblasts of women with preeclampsia and their relation to perinatal outcome of neonates]
Pre-Eclampsia
[Differences between the expression of matrix metalloproteinase-2, 9 in preeclampsia and normal placental tissues]
Pre-Eclampsia
[Expression of KLF-8 and MMP-9 in placentas and their relationship with the pathogenesis of preeclampsia].
Pre-Eclampsia
[Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia]
Pre-Eclampsia
[Homocysteine decreases the invasion in cultured human trophoblasts: relationship between homocysteine and matrix metalloproteinase-2, -9 expression]
Pre-Eclampsia
[Inhibitory effects of soluble endoglin on invasive ability of cultured cytotrophoblasts of first trimester of pregnancy.]
Pre-Eclampsia
[The role of KiSS-1 and matrix metalloproteinase-9 in regulation of invasion of trophoblasts]
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Clinical implications of angiogenic factors in patients with acute or chronic leukemia: Hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Contribution of Matrix Metalloproteinase-9 rs3918242 Genotypes to Childhood Leukemia Risk.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
DNA methylation-mediated silencing of microRNA-204 enhances T cell acute lymphoblastic leukemia by up-regulating MMP-2 and MMP-9 via NF-?B.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Secretion of MMP-2 and MMP-9 induced by VEGF autocrine loop correlates with clinical features in childhood acute lymphoblastic leukemia.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
The Relationship Between MMP-2 -1306C>T and MMP-9 -1562C>T Polymorphisms and the Risk and Prognosis of T-Cell Acute Lymphoblastic Leukemia in a Chinese Population: A Case-Control Study.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
[Expression and clinical significance of MMP-2 and MMP-9 in B acute lymphoblastic leukemia].
Precursor Cell Lymphoblastic Leukemia-Lymphoma
[Plasma matrix metalloproteinases MMP-2 and MMP-9 and tissue inhibitors TIMP-1 and TIMP-2 in children treated for acute lymphoblastic leukemia]
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
DNA methylation-mediated silencing of microRNA-204 enhances T cell acute lymphoblastic leukemia by up-regulating MMP-2 and MMP-9 via NF-?B.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
miR-590 promotes cell proliferation and invasion in T-cell acute lymphoblastic leukaemia by inhibiting RB1.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
The Relationship Between MMP-2 -1306C>T and MMP-9 -1562C>T Polymorphisms and the Risk and Prognosis of T-Cell Acute Lymphoblastic Leukemia in a Chinese Population: A Case-Control Study.
Pregnancy Complications
PAPP-A2 deficiency does not exacerbate the phenotype of a mouse model of intrauterine growth restriction.
Pregnancy, Tubal
Differential Expression of EGFR-1, MMP-3, and MMP-9 in Spontaneous Abortions, Induced Abortions, and Tubal Pregnancies.
Premature Birth
Association of preterm birth with sustained postnatal inflammatory response.
Premature Birth
Class I to III Histone Deacetylases Differentially Regulate Inflammation-Induced Matrix Metalloproteinase 9 Expression in Primary Amnion Cells.
Premature Birth
Differential patterns of 27 cord blood immune biomarkers across gestational age.
Premature Birth
Evidence for participation of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 (NGALMMP-9) complex in the inflammatory response to infection in pregnancies complicated by preterm birth.
Premature Birth
Maternal Serum Interleukin-6, C-Reactive Protein, and Matrix Metalloproteinase-9 Concentrations as Risk Factors for Preterm Birth <32 Weeks and Adverse Neonatal Outcomes.
Premature Birth
Mid-trimester amniotic fluid pro-inflammatory biomarkers predict the risk of spontaneous preterm delivery in twins: a retrospective cohort study.
Premature Birth
Mid-trimester maternal plasma cytokines and CRP as predictors of spontaneous preterm birth.
Premature Birth
Prenatal plasma matrix metalloproteinase-9 levels to predict spontaneous preterm birth.
Premature Birth
Relationship between metalloproteinase-2 and -9 levels in plasma and vaginal secretion with preterm birth.
Premature Birth
The citrus flavone nobiletin reduces pro-inflammatory and pro-labour mediators in fetal membranes and myometrium: implications for preterm birth.
Premature Birth
The Preventive Effects of Quercetin on Preterm Birth Based on Network Pharmacology and Bioinformatics.
Premature Birth
Ureaplasma Infection Mediated Release of Matrix Metalloproteinase-9 and PGP - a Novel Mechanism of Preterm Rupture of Membranes and Chorioamnionitis.
Pressure Ulcer
Evaluation of physiological risk factors, oxidant-antioxidant imbalance, proteolytic and genetic variations of matrix metalloproteinase-9 in patients with pressure ulcer.
Pressure Ulcer
Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers.
Pressure Ulcer
Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids.
Pressure Ulcer
[Effects of smoking on the wound healing of stage 4 pressure ulcers in rats].
Pressure Ulcer
[Protein expressions of matrix metalloproteinase-9 and its inhibitor and their ratio changes in wound healing of patients with stages ? and ? pressure ulcers].
Primary Myelofibrosis
Elevated plasma levels of TIMP-1 correlate with plasma suPAR/uPA in patients with chronic myeloproliferative disorders.
Proctitis
Clinical significance of increased gelatinolytic activity in the rectal mucosa during external beam radiation therapy of prostate cancer.
Prolactinoma
Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
Prolactinoma
Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials.
Prolactinoma
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-2: Prognostic biological markers in invasive prolactinomas.
prostaglandin-d synthase deficiency
PGD2 deficiency exacerbates food antigen-induced mast cell hyperplasia.
Prostatic Diseases
Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions.
Prostatic Hyperplasia
Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.
Prostatic Hyperplasia
CD147, MMP-1, MMP-2 and MMP-9 Protein Expression as Significant Prognostic Factors in Human Prostate Cancer.
Prostatic Hyperplasia
Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions.
Prostatic Hyperplasia
Immunohistochemical expression of matrix metalloproteinase-9 and inhibitor of matrix metalloproteinase-1 in prostate adenocarcinoma.
Prostatic Hyperplasia
In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer.
Prostatic Hyperplasia
Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells.
Prostatic Hyperplasia
Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia.
Prostatic Hyperplasia
Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy.
Prostatic Hyperplasia
[Significance of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase and protein Ki-67 in prostate tumors].
Prostatic Intraepithelial Neoplasia
Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions.
Prostatic Intraepithelial Neoplasia
Expression of NGF, GDNF and MMP-9 in prostate carcinoma.
Prostatic Neoplasms
(±)Equol inhibits invasion in prostate cancer DU145 cells possibly via down-regulation of matrix metalloproteinase-9, matrix metalloproteinase-2 and urokinase-type plasminogen activator by antioxidant activity.
Prostatic Neoplasms
18?-glycyrrhetinic acid targets prostate cancer cells by down-regulating inflammation-related genes.
Prostatic Neoplasms
1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases.
Prostatic Neoplasms
A comparison of the expression of the malignant phenotype in two androgen-independent human prostate cancer cell lines after orthotopic implantation in nude mice.
Prostatic Neoplasms
A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
Prostatic Neoplasms
A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
Prostatic Neoplasms
Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells.
Prostatic Neoplasms
Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.
Prostatic Neoplasms
Activities and polymorphisms of MMP-2 and MMP-9, smoking, diabetes and risk of prostate cancer.
Prostatic Neoplasms
ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
Prostatic Neoplasms
Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors.
Prostatic Neoplasms
Anti-Tumor Effect of AlkB Homolog 3 Knockdown in Hormone- Independent Prostate Cancer Cells.
Prostatic Neoplasms
Aryl hydrocarbon exposure induces expression of MMP-9 in human prostate cancer cell lines.
Prostatic Neoplasms
Aspirin Inhibits IKK-?-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator.
Prostatic Neoplasms
Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood.
Prostatic Neoplasms
Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKC?/c-Src dependent signaling pathway.
Prostatic Neoplasms
Bruton's Tyrosine Kinase (BTK) Inhibitor (Ibrutinib)?-Suppressed Migration and Invasion of Prostate Cancer.
Prostatic Neoplasms
Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells.
Prostatic Neoplasms
CD147, MMP-1, MMP-2 and MMP-9 Protein Expression as Significant Prognostic Factors in Human Prostate Cancer.
Prostatic Neoplasms
Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer.
Prostatic Neoplasms
Clinical significance of increased gelatinolytic activity in the rectal mucosa during external beam radiation therapy of prostate cancer.
Prostatic Neoplasms
Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer.
Prostatic Neoplasms
Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model.
Prostatic Neoplasms
Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor.
Prostatic Neoplasms
CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Prostatic Neoplasms
CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone.
Prostatic Neoplasms
Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway.
Prostatic Neoplasms
Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue.
Prostatic Neoplasms
Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions.
Prostatic Neoplasms
Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells.
Prostatic Neoplasms
Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.
Prostatic Neoplasms
E2F5 promotes prostate cancer cell migration and invasion through regulation of TFPI2, MMP-2 and MMP-9.
Prostatic Neoplasms
Effect of 17beta-estradiol on apoptosis, IGF system components and gelatinases A and B in prostate cancer cells (PC-3).
Prostatic Neoplasms
Effect of quinolinyl acrylate derivatives on prostate cancer in vitro and in vivo.
Prostatic Neoplasms
Effectiveness of the Histone Deacetylase Inhibitor (S)-2 against LNCaP and PC3 Human Prostate Cancer Cells.
Prostatic Neoplasms
Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals.
Prostatic Neoplasms
Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Prostatic Neoplasms
Expression of matrix metalloproteinase-9 and bombesin/gastrin-releasing peptide in human prostate cancers and their lymph node metastases.
Prostatic Neoplasms
EXPRESSION OF MATRIX METALLOPROTEINASE-9 IN PROSTATE CANCER. PRELIMINARY EXPERIENCE.
Prostatic Neoplasms
Filamin A regulates MMP-9 expression and suppresses prostate cancer cell migration and invasion.
Prostatic Neoplasms
Fluorescent polymer dots and graphene oxide based nanocomplexes for "off-on" detection of metalloproteinase-9.
Prostatic Neoplasms
Gold nanoparticles regulate the antitumor secretome and have potent cytotoxic effects against prostate cancer cells.
Prostatic Neoplasms
Golgi phosphoprotein 3 regulates metastasis of prostate cancer via matrix metalloproteinase 9.
Prostatic Neoplasms
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity.
Prostatic Neoplasms
Heterogeneous activation of MMP-9 due to prostate cancer-bone interaction.
Prostatic Neoplasms
Host matrix metalloproteinase-9 contributes to tumor vascularization without affecting tumor growth in a model of prostate cancer bone metastasis.
Prostatic Neoplasms
Identification of sequence-specific interactions of the CD44-intracellular domain with RUNX2 in the transcription of matrix metalloprotease-9 in human prostate cancer cells.
Prostatic Neoplasms
Identification of TMPRSS2-ERG mechanisms in prostate cancer invasiveness: Involvement of MMP-9 and plexin B1.
Prostatic Neoplasms
In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer.
Prostatic Neoplasms
Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
Prostatic Neoplasms
Inhibition of the Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: potential therapeutic approaches for prostate cancer.
Prostatic Neoplasms
Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells.
Prostatic Neoplasms
Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
Prostatic Neoplasms
Kindlin-2 promotes invasiveness of prostate cancer cells via NF-?B-dependent upregulation of matrix metalloproteinases.
Prostatic Neoplasms
Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model.
Prostatic Neoplasms
Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9.
Prostatic Neoplasms
Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.
Prostatic Neoplasms
LOX-1 activation by oxLDL triggers an epithelial mesenchymal transition and promotes tumorigenic potential in prostate cancer cells.
Prostatic Neoplasms
Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
Prostatic Neoplasms
Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers.
Prostatic Neoplasms
Matrix metalloproteinase 9 and prostate-cancer risk : a meta-analysis of 1,059 participants.
Prostatic Neoplasms
Matrix metalloproteinase 9 is associated with Gleason score in prostate cancer but not with prognosis.
Prostatic Neoplasms
MATRIX METALLOPROTEINASE- 9 POLYMORPHISMS IN THE DIAGNOSIS OF PROSTATE CANCER. A PRELIMINARY EXPERIENCE.
Prostatic Neoplasms
Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1.
Prostatic Neoplasms
Matrix metalloproteinases 2 and 9 immunoexpression in prostate carcinoma at the positive margin of radical prostatectomy specimens.
Prostatic Neoplasms
Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer?
Prostatic Neoplasms
Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
Prostatic Neoplasms
MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion.
Prostatic Neoplasms
MiRNALet-7a mediates prostate cancer PC-3 cell invasion, migration by inducing epithelial-mesenchymal transition through CCR7/MAPK pathway.
Prostatic Neoplasms
MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.
Prostatic Neoplasms
MMP-9 overexpression due to TIMP-1 and RECK underexpression is associated with prognosis in prostate cancer.
Prostatic Neoplasms
Monocyte chemoattractant protein-1 modulates invasion and apoptosis of PC-3M prostate cancer cells via regulating expression of VEGF, MMP9 and caspase-3.
Prostatic Neoplasms
National Cancer Institute intramural approach to advanced prostate cancer.
Prostatic Neoplasms
Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines.
Prostatic Neoplasms
Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells.
Prostatic Neoplasms
Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach.
Prostatic Neoplasms
Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines.
Prostatic Neoplasms
Novel roles of androgen receptor, epidermal growth factor receptor, TP53, regulatory RNAs, NF-kappa-B, chromosomal translocations, neutrophil associated gelatinase, and matrix metalloproteinase-9 in prostate cancer and prostate cancer stem cells.
Prostatic Neoplasms
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion.
Prostatic Neoplasms
Overexpression of Fn14 Promotes Androgen Independent Prostate Cancer Progression through MMP-9 and Correlates with Poor Treatment Outcome.
Prostatic Neoplasms
Overexpression of MMP-9 Contributes to Invasiveness of Prostate Cancer Cell Line LNCaP.
Prostatic Neoplasms
Paracrine communication between malignant and non-malignant prostate epithelial cells in culture alters growth rate, matrix protease secretion and in vitro invasion.
Prostatic Neoplasms
Parathyroid Hormone-related Protein Drives a CD11b+Gr1+ cell-mediated Positive Feedback Loop to Support Prostate Cancer Growth.
Prostatic Neoplasms
Penta-O-galloyl-?-D-glucose suppresses EGF-induced eIF3i expression through inhibition of the PI3K/AKT/mTOR pathway in prostate cancer cells.
Prostatic Neoplasms
Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression.
Prostatic Neoplasms
Piceatannol inhibits MMP-9-dependent invasion of tumor necrosis factor-?-stimulated DU145 cells by suppressing the Akt-mediated nuclear factor-?B pathway.
Prostatic Neoplasms
Pinin promotes tumor progression via activating CREB through PI3K/AKT and ERK/MAPK pathway in prostate cancer.
Prostatic Neoplasms
Piwil2 modulates the invasion and metastasis of prostate cancer by regulating the expression of matrix metalloproteinase-9 and epithelial-mesenchymal transitions.
Prostatic Neoplasms
Plasma matrix metalloproteinase 9 as biomarker of prostate cancer progression in Dunning (Copenhagen) rats.
Prostatic Neoplasms
Platelet-type 12- lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/AKT/NF-?B.
Prostatic Neoplasms
Polymorphism of MMP-9 gene is not associated with the risk of urinary cancers: Evidence from an updated meta-analysis.
Prostatic Neoplasms
Proanthocyanidins from the American Cranberry (Vaccinium macrocarpon) inhibit matrix metalloproteinase-2 and matrix metalloproteinase-9 activity in human prostate cancer cells via alterations in multiple cellular signalling pathways.
Prostatic Neoplasms
Promising noninvasive cellular phenotype in prostate cancer cells knockdown of matrix metalloproteinase 9.
Prostatic Neoplasms
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors.
Prostatic Neoplasms
Protein kinase D1 inhibits cell proliferation through matrix metalloproteinase-2 and matrix metalloproteinase-9 secretion in prostate cancer.
Prostatic Neoplasms
Regulation of crosstalk between epithelial to mesenchymal transition molecules and MMP-9 mediates the antimetastatic activity of anethole in DU145 prostate cancer cells.
Prostatic Neoplasms
Regulation of VEGF, MMP-9, and metastasis by CXCR4 in a prostate cancer cell line.
Prostatic Neoplasms
Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma.
Prostatic Neoplasms
Retraction Note to: Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF.
Prostatic Neoplasms
Retraction: Inhibition of Angiogenesis and Invasion by 3,3'-Diindolylmethane Is Mediated by the Nuclear Factor-?B Downstream Target Genes MMP-9 and uPA that Regulated Bioavailability of Vascular Endothelial Growth Factor in Prostate Cancer.
Prostatic Neoplasms
Roles of microsomal prostaglandin E synthase-1 in lung metastasis formation in prostate cancer RM9 cells.
Prostatic Neoplasms
RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness.
Prostatic Neoplasms
S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.
Prostatic Neoplasms
Significance of MMP-9 expression and MMP-9 polymorphism in prostate cancer.
Prostatic Neoplasms
Silencing of LASS2/TMSG1 enhances invasion and metastasis capacity of prostate cancer cell.
Prostatic Neoplasms
SKI-606 (Bosutinib) Blocks Prostate Cancer Invasion, Growth, and Metastasis In vitro and In vivo through Regulation of Genes Involved in Cancer Growth and Skeletal Metastasis.
Prostatic Neoplasms
Skip Regulates TGF- ? 1-Induced Extracellular Matrix Degrading Proteases Expression in Human PC-3 Prostate Cancer Cells.
Prostatic Neoplasms
Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy.
Prostatic Neoplasms
Synthesis, crystal structure and effect of indeno[1,2-b]indole derivatives on prostate cancer in vitro. Potential effect against MMP-9.
Prostatic Neoplasms
Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer.
Prostatic Neoplasms
Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator.
Prostatic Neoplasms
Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.
Prostatic Neoplasms
TGF-beta1 and TGF-beta2 Strongly Enhance Secretion of Plasminogen Activator Inhibitor-1 and Matrix Metalloproteinase-9 of the Human Prostate Cancer Cell Line PC-3.
Prostatic Neoplasms
The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.
Prostatic Neoplasms
The p75(NTR) metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells.
Prostatic Neoplasms
The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells.
Prostatic Neoplasms
Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
Prostatic Neoplasms
Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
Prostatic Neoplasms
[Effects of FRZB on growth and metastasis of gastric cancer cell line SGC-7901]
Prostatic Neoplasms
[Inhibitory effect of 3-bromopyruvate on the proliferation, migration and invasive ability of prostate cancer PC-3 cells].
Prostatic Neoplasms
[P2Y purinergic receptor activated PI-3K/Akt signaling pathway in regulation of growth and invasion of prostatic cancer]
Prostatic Neoplasms
[Silencing of vacuolar ATPase c subunit ATP6V0C inhibits invasion of prostate cancer cells].
Prostatitis
Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions.
Prostatitis
Matrix metalloproteinases in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wistar rat.
protein-glutamine gamma-glutamyltransferase deficiency
Association between expression of MMP-2 and MMP-9 genes and pathogenesis of intracranial hemorrhage in severe coagulation factor XIII deficiency.
protein-glutamine gamma-glutamyltransferase deficiency
Expression and CpG island methylation pattern of MMP-2 and MMP-9 genes in patients with congenital factor XIII deficiency and intracranial hemorrhage.
protein-tyrosine-phosphatase deficiency
Deficiency of the protein-tyrosine phosphatase DEP-1/PTPRJ promotes matrix metalloproteinase-9 expression in meningioma cells.
Proteinuria
Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy.
Proteinuria
Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency.
Proteinuria
Cubilin Single Nucleotide Polymorphism Variants are Associated with Macroangiopathy While a Matrix Metalloproteinase-9 Single Nucleotide Polymorphism Flip-Flop may Indicate Susceptibility of Diabetic Nephropathy in Type-2 Diabetic Patients.
Proteinuria
High ambient glucose levels modulates the production of MMP-9 and alpha5(IV) collagen by cultured podocytes.
Proteinuria
IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
Proteinuria
Matrix metalloproteinase-9 expression in renal biopsies of patients with HIV-associated nephropathy.
Proteinuria
Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril.
Proteinuria
[Expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in IgA nephropathy]
Proteinuria
[Study on mechanism of Shenle and Fragmin in preventing and treating glomerulosclerosis in rats]
Pruritus
Evaluation of Association Between the Serum Levels of MMP-9 and MMP-9/TIMPs With Soluble Forms of Selectins and Itching Induced by Sulfur Mustard.
Pruritus
House Dust Mites Induce Production of Endothelin-1 and Matrix Metalloproteinase-9 in Keratinocytes via Proteinase-Activated Receptor-2 Activation.
Pseudoxanthoma Elasticum
Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential.
Pseudoxanthoma Elasticum
Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients.
Pseudoxanthoma Elasticum
Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles.
Psoriasis
Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.
Psoriasis
Effective Therapy with Anti-TNF-{alpha} in Patients with Psoriatic Arthritis Is Associated with Decreased Levels of Metalloproteinases and Angiogenic Cytokines in the Sera and Skin Lesions.
Psoriasis
Matrix metalloproteinase-9: a novel biomarker for monitoring disease activity in patients with chronic urticaria patients?
Psoriasis
Metalloelastase (MMP-12) and 92-kDa gelatinase (MMP-9) as well as their inhibitors, TIMP-1 and -3, are expressed in psoriatic lesions.
Psoriasis
MMP-9 gene polymorphisms (rs3918242, rs3918254 and rs4810482) and the risk of psoriasis vulgaris: No evidence for associations in a Chinese Han population.
Psoriasis
MMP-9 Mediates Cross-Talk between Neutrophils and Endothelial Cells in Psoriasis.
Psoriasis
Modification of osteopontin and MMP-9 levels in patients with psoriasis on anti-TNF-? therapy.
Psoriasis
Narrowband ultraviolet B light treatment changes plasma concentrations of MMP-3, MMP-9 and TIMP-3 in psoriatic patients.
Psoriasis
Neutrophils Enhance Cutaneous Vascular Dilation and Permeability to Aggravate Psoriasis by Releasing MMP-9.
Psoriasis
ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients.
Psoriasis
Serum of Patients with Psoriasis Modulates the Production of MMP-9 and TIMP-1 in Cells of Monocytic Lineage.
Psoriasis
Specific nature of changes in main immunohistochemical parameters of neoangiogenesis in patients with psoriasis.
Psoriasis
The Increased Expression of Matrix Metalloproteinase-9 Messenger RNA in the Non-lesional Skin of Patients with Large Plaque Psoriasis Vulgaris.
Pterygium
Continuous exposure of nicotine and cotinine retards human primary pterygium cell proliferation and migration.
Pterygium
Expression of gelatinase (MMP-2 and MMP-9) in pterygia and pterygium fibroblasts is increased with disease progression and activation of protein kinase C.
Pterygium
Posttranscriptional regulation of MMP-9 by HuR contributes to IL-1?-induced pterygium fibroblast migration and invasion.
Pterygium
Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells.
Pterygium
Relative gene expression analysis of human pterygium tissues and UV radiation-evoked gene expression patterns in corneal and conjunctival cells.
Pterygium
Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular disorders.
Pulmonary Arterial Hypertension
Baicalin Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension to Improve Hypoxic Cor Pulmonale by Reducing the Activity of the p38 MAPK Signaling Pathway and MMP-9.
Pulmonary Arterial Hypertension
MMP-2 and MMP-9 contribute to the angiogenic effect produced by hypoxia/15-HETE in pulmonary endothelial cells.
Pulmonary Arterial Hypertension
Transgenic expression of human matrix metalloproteinase-9 augments monocrotaline-induced pulmonary arterial hypertension in mice.
Pulmonary Atelectasis
Inhibition of matrix metalloproteinases in gerbil cholesteatoma: preliminary findings.
Pulmonary Disease, Chronic Obstructive
A mucoactive drug carbocisteine ameliorates steroid resistance in rat COPD model.
Pulmonary Disease, Chronic Obstructive
A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9.
Pulmonary Disease, Chronic Obstructive
A Regulatory Role of Chemokine Receptor CXCR3 in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Emphysema.
Pulmonary Disease, Chronic Obstructive
Activity of matrix metalloproteinase in airway epithelial cells of COPD patients.
Pulmonary Disease, Chronic Obstructive
Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection.
Pulmonary Disease, Chronic Obstructive
Adipokines NUCB2/nesfatin-1 and visfatin as novel inflammatory factors in chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Airway Remodeling in Chronic Obstructive Pulmonary Disease and Asthma: the Role of Matrix Metalloproteinase-9.
Pulmonary Disease, Chronic Obstructive
All trans-retinoic acid selectively down-regulates matrix metalloproteinase-9 (MMP-9) and up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) in human bronchoalveolar lavage cells.
Pulmonary Disease, Chronic Obstructive
Analysis of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients.
Pulmonary Disease, Chronic Obstructive
Chronic rhinosinusitis is associated with higher prevalence and severity of bronchiectasis in patients with COPD.
Pulmonary Disease, Chronic Obstructive
Cigarette smoke activates the proto-oncogene c-src to promote airway inflammation and lung tissue destruction.
Pulmonary Disease, Chronic Obstructive
Cigarette Smoke Induces Activation of Polymorphonuclear Leukocytes.
Pulmonary Disease, Chronic Obstructive
Cigarette smoke-induced epithelial expression of WNT-5B: implications for COPD.
Pulmonary Disease, Chronic Obstructive
Cigarette smoke-induced RANKL expression enhances MMP-9 production by alveolar macrophages.
Pulmonary Disease, Chronic Obstructive
Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Circulating monocytes from healthy individuals and COPD patients.
Pulmonary Disease, Chronic Obstructive
Comparison of arterial and venous blood biomarker levels in chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Compartment differences of inflammatory activity in chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
Pulmonary Disease, Chronic Obstructive
Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Correlation of Clinical Symptoms and Sputum Inflammatory Markers with Air Pollutants in Stable COPD Patients in Beijing Area.
Pulmonary Disease, Chronic Obstructive
Development of matrix metalloproteinase-targeted probes for lung inflammation detection with positron emission tomography.
Pulmonary Disease, Chronic Obstructive
Differential diagnosis of lung cancer, its metastasis and chronic obstructive pulmonary disease based on serum Vegf, Il-8 and MMP-9.
Pulmonary Disease, Chronic Obstructive
DNA sequence variations of metalloproteinases: their role in asthma and COPD.
Pulmonary Disease, Chronic Obstructive
E-Cigarette Use Causes a Unique Innate Immune Response in the Lung, Involving Increased Neutrophilic Activation and Altered Mucin Secretion.
Pulmonary Disease, Chronic Obstructive
Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs.
Pulmonary Disease, Chronic Obstructive
Effect of Liuweibuqi capsules on the balance between MMP-9 and TIMP1 and viability of alveolar macrophages in COPD.
Pulmonary Disease, Chronic Obstructive
Effect of the emphysema subtypes of patients with chronic obstructive pulmonary disease on airway inflammation and COTE index.
Pulmonary Disease, Chronic Obstructive
Effects of an oral MMP-9 and -12 inhibitor, AZD1236, on biomarkers in moderate/severe COPD: A randomised controlled trial.
Pulmonary Disease, Chronic Obstructive
Effects of Fengbaisan () on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung tissue of rats with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Elastin-Specific Autoimmunity in Smokers With Thoracic Aortic Aneurysm and Dissection is Independent of Chronic Obstructive Pulmonary Disease.
Pulmonary Disease, Chronic Obstructive
Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGene.
Pulmonary Disease, Chronic Obstructive
Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study.
Pulmonary Disease, Chronic Obstructive
EMMPRIN (CD147) REGULATION OF MMP-9 IN BRONCHIAL EPITHELIAL CELLS IN COPD.
Pulmonary Disease, Chronic Obstructive
Endothelin receptor-antagonists suppress lipopolysaccharide-induced cytokine release from alveolar macrophages of non-smokers, smokers and COPD subjects.
Pulmonary Disease, Chronic Obstructive
Enhanced Exhalation of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Patients with COPD Exacerbation: A Prospective Study.
Pulmonary Disease, Chronic Obstructive
Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease.
Pulmonary Disease, Chronic Obstructive
Expression of matrix metalloproteinases MMP-9 within the airways in asthma.
Pulmonary Disease, Chronic Obstructive
Expression of Toll-like Receptor 2 and 4 in Peripheral Blood Neutrophil Cells from Patients with Chronic Obstructive Pulmonary Disease.
Pulmonary Disease, Chronic Obstructive
Expressions of TOLL-like receptor 4 (TLR-4) and matrix metalloproteinase 9 (MMP-9)/Tissue inhibitor of metalloproteinase 1 (TIMP-1) in pulmonary blood vessels with chronic obstructive pulmonary diseases and their relationships with pulmonary vascular remodelling.
Pulmonary Disease, Chronic Obstructive
Gene-gene interactions between glutathione-s transferase M1 and matrix metalloproteinase 9 in the formation of hereditary predisposition to chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of south China.
Pulmonary Disease, Chronic Obstructive
Genetic polymorphisms of cytochrome p450 and matrix metalloproteinase in chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Genetic polymorphisms of matrix metalloproteinases and protein levels in chronic obstructive pulmonary disease in a Mexican population.
Pulmonary Disease, Chronic Obstructive
Genotypes in matrix metalloproteinase 9 are a risk factor for COPD.
Pulmonary Disease, Chronic Obstructive
Genotypes in matrix metalloproteinase 9 are risk factors for chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Glucocorticosteroids Differentially Regulate MMP-9 and Neutrophil Elastase in COPD.
Pulmonary Disease, Chronic Obstructive
GMI, a Ganoderma Immunomodulatory Protein, Down-regulates Tumor Necrosis Factor ?-Induced Expression of Matrix Metalloproteinase 9 via NF-?B Pathway in Human Alveolar Epithelial A549 Cells.
Pulmonary Disease, Chronic Obstructive
Identification of MMP-9 as a biomarker for detecting progression of chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
Pulmonary Disease, Chronic Obstructive
Impact of Matrix Metalloproteinase 9 on COPD Development in Polish Patients: Genetic Polymorphism, Protein Level, and Their Relationship with Lung Function.
Pulmonary Disease, Chronic Obstructive
Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD.
Pulmonary Disease, Chronic Obstructive
Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways.
Pulmonary Disease, Chronic Obstructive
Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients.
Pulmonary Disease, Chronic Obstructive
Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction.
Pulmonary Disease, Chronic Obstructive
Inflammatory mediators in exhaled breath condensate and peripheral blood of healthy donors and stable COPD patients.
Pulmonary Disease, Chronic Obstructive
Influence of age, past smoking, and disease severity on TLR2, neutrophilic inflammation, and MMP-9 levels in COPD.
Pulmonary Disease, Chronic Obstructive
Interrelationship of Circulating Matrix Metalloproteinase-9, TNF-a, and OPG/RANK/RANKL Systems in COPD Patients with Osteoporosis.
Pulmonary Disease, Chronic Obstructive
Localization of Matrix Metalloproteinase (MMP)-9 in Lung Tissue of a Murine Model of Allergic Asthma.
Pulmonary Disease, Chronic Obstructive
LPS-stimulated MUC5AC production involves Rac1-dependent MMP-9 secretion and activation in NCI-H292 cells.
Pulmonary Disease, Chronic Obstructive
Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow.
Pulmonary Disease, Chronic Obstructive
Matrix Metalloproteinase (MMP) 14 Mediates a Phenotypic Shift in the Airways to Increase Mucin Production.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase 9 in exhaled breath condensate in patients with stable chronic obstructive pulmonary disease: an observational study.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase 9 is involved in airway inflammation in cough variant asthma.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase gene polymorphisms: lack of association with chronic obstructive pulmonary disease in a Brazilian population.
Pulmonary Disease, Chronic Obstructive
Matrix Metalloproteinase-9 (279R/Q) Polymorphism is Associated with Clinical Severity and Airflow Limitation in Tunisian Patients with Chronic Obstructive Pulmonary Disease.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase-9 -1562C/T promoter polymorphism confers risk for COPD: a meta-analysis.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase-9 predicts pulmonary status declines in alpha1-antitrypsin deficiency.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase-9 release from human leukocytes.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinases -8 and -9 in the Airways, Blood and Urine During Exacerbations of COPD.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPD.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinases activity in COPD associated with wood smoke.
Pulmonary Disease, Chronic Obstructive
Matrix Metalloproteinases and Their Inhibitors in Chronic Obstructive Pulmonary Disease.
Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinases and TIMP-1 production by peripheral blood granulocytes from COPD patients and asthmatics.
Pulmonary Disease, Chronic Obstructive
MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
MMP-8, MMP-9 and Neutrophil Elastase in Peripheral Blood and Exhaled Breath Condensate in COPD.
Pulmonary Disease, Chronic Obstructive
MMP-9 as a marker of inflammation in tracheal epithelial lining fluid (TELF) and in bronchoalveolar fluid (BALF) of COPD horses.
Pulmonary Disease, Chronic Obstructive
MMP-9 genetic polymorphism may confer susceptibility to COPD.
Pulmonary Disease, Chronic Obstructive
MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
Pulmonary Disease, Chronic Obstructive
MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation.
Pulmonary Disease, Chronic Obstructive
MMP-9-C1562T polymorphism and susceptibility to chronic obstructive pulmonary disease: A meta-analysis.
Pulmonary Disease, Chronic Obstructive
Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
Pulmonary Disease, Chronic Obstructive
Peroxisome proliferator-activated receptor-? in induced sputum is correlated with MMP-9/TIMP-1 imbalance and formation of emphysema in COPD patients.
Pulmonary Disease, Chronic Obstructive
Platinum-based, leukocyte-depleting chemotherapy does not alter induced sputum markers of neutrophilic inflammation in COPD patients with unresectable non-small cell lung cancer.
Pulmonary Disease, Chronic Obstructive
Polymorphisms in Matrix Metalloproteinase-1, -9 and -12 Genes and the Risk of Chronic Obstructive Pulmonary Disease in a Korean Population.
Pulmonary Disease, Chronic Obstructive
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Pulmonary Disease, Chronic Obstructive
Proteolytic biomarkers are related to prognosis in COPD- report from a population-based cohort.
Pulmonary Disease, Chronic Obstructive
Prothymosin ? overexpression contributes to the development of pulmonary emphysema.
Pulmonary Disease, Chronic Obstructive
Relationship Between Circulating Serpina3g, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinase-1 and -2 with Chronic Obstructive Pulmonary Disease Severity.
Pulmonary Disease, Chronic Obstructive
Relationship between expression of matrix metalloproteinase-9 and adenylyl cyclase-associated protein 1 in chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.
Pulmonary Disease, Chronic Obstructive
Relationship between the thickness of bronchial wall layers, emphysema score, and markers of remodeling in bronchoalveolar lavage fluid in patients with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma.
Pulmonary Disease, Chronic Obstructive
Relationships of MMP-9 and TIMP-1 proteins with chronic obstructive pulmonary disease risk: A systematic review and meta-analysis.
Pulmonary Disease, Chronic Obstructive
Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Resveratrol Impairs the Release of Steroid-resistant Cytokines from Bacterial Endotoxin-Exposed Alveolar Macrophages in COPD.
Pulmonary Disease, Chronic Obstructive
Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Safety and tolerability of an oral MMP-9 and -12 inhibitor, AZD1236, in patients with moderate-to-severe COPD: A randomised controlled 6-week trial.
Pulmonary Disease, Chronic Obstructive
Serum angiopoietin-like 4 is over-expressed in COPD patients: association with pulmonary function and inflammation.
Pulmonary Disease, Chronic Obstructive
Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.
Pulmonary Disease, Chronic Obstructive
Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract.
Pulmonary Disease, Chronic Obstructive
SIRT1 redresses tissue inhibitor of matrix metalloproteinase-1/matrix metalloproteinase-9 imbalance in the development of mouse emphysema and human COPD.
Pulmonary Disease, Chronic Obstructive
Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7.
Pulmonary Disease, Chronic Obstructive
Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
Pulmonary Disease, Chronic Obstructive
Sputum matrix metalloproteinase-9 is associated with the degree of emphysema on computed tomography in COPD.
Pulmonary Disease, Chronic Obstructive
Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
Pulmonary Disease, Chronic Obstructive
Study on the expression of Toll-like receptor 4 and matrix metalloproteinase-9 in patients with chronic obstructive pulmonary disease and their clinical significance.
Pulmonary Disease, Chronic Obstructive
Systemic elastin degradation in chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
The BRD4 inhibitor JQ1 protects against chronic obstructive pulmonary disease in mice by suppressing NF-?B activation.
Pulmonary Disease, Chronic Obstructive
The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
The effect of phosphatidylinositol-3 kinase inhibition on matrix metalloproteinase-9 and reactive oxygen species release from chronic obstructive pulmonary disease neutrophils.
Pulmonary Disease, Chronic Obstructive
The Levels of Vitamin D, Metalloproteinase-9 and Tissue Inhibitor Metalloproteinase-1 in COPD Patients, Healthy Smokers and Non-Smokers of Indonesian Citizens.
Pulmonary Disease, Chronic Obstructive
The transcription factor Wilms tumor 1 regulates matrix metalloproteinase-9 through a nitric oxide-mediated pathway.
Pulmonary Disease, Chronic Obstructive
Therapy with plasma purified alpha1-antitrypsin (Prolastin®) induces time-dependent changes in plasma levels of MMP-9 and MPO.
Pulmonary Disease, Chronic Obstructive
TIMP-1 and MMP-9 expressions in COPD patients complicated with spontaneous pneumothorax and their correlations with treatment outcomes.
Pulmonary Disease, Chronic Obstructive
Tissue Inhibitor of Metalloproteinase-1 Promotes Polymorphonuclear Neutrophil (PMN) Pericellular Proteolysis by Anchoring Matrix Metalloproteinase-8 and -9 to PMN Surfaces.
Pulmonary Disease, Chronic Obstructive
TNF-alpha up-regulates matrix metalloproteinase-9 expression and activity in alveolar macrophages from patients with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Transient elevation of neutrophil proteinases in induced sputum during COPD exacerbation.
Pulmonary Disease, Chronic Obstructive
Tumour-associated neutrophils and loss of epithelial PTEN can promote corticosteroid-insensitive MMP-9 expression in the chronically inflamed lung microenvironment.
Pulmonary Disease, Chronic Obstructive
[Airway inflammation and macrophage inflammatory protein-1alpha, gelatinase B level in patients with COPD]
Pulmonary Disease, Chronic Obstructive
[Alveolar macrophage and airway inflammation in patients with chronic obstructive pulmonary disease]
Pulmonary Disease, Chronic Obstructive
[Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease].
Pulmonary Disease, Chronic Obstructive
[Effects of Shenqi Bufei Tang on expessions of NF-kappaB, MMP-9 and TIMP-1 in airway remodeling of COPD rat model with lung-Qi deficiency syndrome]
Pulmonary Disease, Chronic Obstructive
[Effects of shuxuening injection on the levels of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in acute exacerbated chronic obstructive pulmonary disease patients].
Pulmonary Disease, Chronic Obstructive
[Markers of airway remodeling in induced sputum from healthy smokers]
Pulmonary Disease, Chronic Obstructive
[Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation]
Pulmonary Disease, Chronic Obstructive
[MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma]
Pulmonary Disease, Chronic Obstructive
[Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease]
Pulmonary Disease, Chronic Obstructive
[Role of genetic factors in the development of COPD]
Pulmonary Disease, Chronic Obstructive
[Role of matrix metalloproteinase-9 in the pathogenesis of osteoporosis in patients with chronic obstructive pulmonary disease].
Pulmonary Disease, Chronic Obstructive
[The expressions of TNF-alpha and MMP-9 in serum and MMP-1 mRNA in the bone tissue in chronic obstructive pulmonary disease patients of cold dryness syndrome in northwest China].
Pulmonary Disease, Chronic Obstructive
[The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models]
Pulmonary Disease, Chronic Obstructive
[The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease]
Pulmonary Disease, Chronic Obstructive
[Tumor necrosis factor alpha-induced expression and activity of alveolar macrophages matrix metalloproteinase-9 in chronic obstructive pulmonary disease]
Pulmonary Edema
Caspase-1 Inhibitor Prevents Neurogenic Pulmonary Edema After Subarachnoid Hemorrhage in Mice.
Pulmonary Edema
Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome.
Pulmonary Edema
[Protective role of MMP-9 inhibitor batimastat in acute lung injury after cardiopulmonary bypass.]
Pulmonary Embolism
A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism.
Pulmonary Embolism
Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism.
Pulmonary Embolism
Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism.
Pulmonary Embolism
L-arginine attenuates acute pulmonary embolism-induced increases in lung matrix metalloproteinase-2 and matrix metalloproteinase-9.
Pulmonary Embolism
Limited value of novel pulmonary embolism biomarkers in patients with coronary atherosclerosis.
Pulmonary Embolism
Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism.
Pulmonary Embolism
Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9.
Pulmonary Embolism
Severity dependent increases in circulating cardiac troponin I and MMP-9 concentrations after experimental acute pulmonary thromboembolism.
Pulmonary Emphysema
Abnormal mouse lung alveolarization caused by Smad3 deficiency is a developmental antecedent of centrilobular emphysema.
Pulmonary Emphysema
Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis.
Pulmonary Emphysema
Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema.
Pulmonary Emphysema
Genetic polymorphism in matrix metalloproteinase-9 and transforming growth factor-?1 and susceptibility to combined pulmonary fibrosis and emphysema in a Chinese population.
Pulmonary Emphysema
Imbalance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 is associated with pulmonary emphysema in Klotho mice.
Pulmonary Emphysema
Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema.
Pulmonary Emphysema
Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema.
Pulmonary Emphysema
Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema.
Pulmonary Emphysema
RNA interference targeting carbohydrate sulfotransferase 3 diminishes macrophage accumulation, inhibits MMP-9 expression and promotes lung recovery in murine pulmonary emphysema.
Pulmonary Eosinophilia
Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation.
Pulmonary Fibrosis
A case of pulmonary capillary hemangiomatosis with pulmonary fibrosis associated with MMP-9 related pulmonary remodeling.
Pulmonary Fibrosis
Activity of matrix metalloproteinase in airway epithelial cells of COPD patients.
Pulmonary Fibrosis
Aesculin inhibits matrix metalloproteinase-9 expression via p38 mitogen activated protein kinase and activator protein 1 in lipopolysachride-induced RAW264.7 cells.
Pulmonary Fibrosis
Aliskiren attenuates bleomycin-induced pulmonary fibrosis in rats: focus on oxidative stress, advanced glycation end products, and matrix metalloproteinase-9.
Pulmonary Fibrosis
Amelioration of paraquat-induced pulmonary fibrosis in mice by regulating miR-140-5p expression with the fibrogenic inhibitor Xuebijing.
Pulmonary Fibrosis
C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
Pulmonary Fibrosis
Early and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary fibrosis.
Pulmonary Fibrosis
Effects of plant extracts and bioactive compounds on attenuation of bleomycin-induced pulmonary fibrosis.
Pulmonary Fibrosis
Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin.
Pulmonary Fibrosis
Genetic polymorphism in matrix metalloproteinase-9 and transforming growth factor-?1 and susceptibility to combined pulmonary fibrosis and emphysema in a Chinese population.
Pulmonary Fibrosis
Ginsenoside Rg1 Ameliorates Cigarette Smoke-Induced Airway Fibrosis by Suppressing the TGF-?1/Smad Pathway In Vivo and In Vitro.
Pulmonary Fibrosis
Iguratimod ameliorates bleomycin-induced alveolar inflammation and pulmonary fibrosis in mice by suppressing expression of matrix metalloproteinase-9.
Pulmonary Fibrosis
IL-33 Can Promote the Process of Pulmonary Fibrosis by Inducing the Imbalance Between MMP-9 and TIMP-1.
Pulmonary Fibrosis
Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Pulmonary Fibrosis
Inhibitory effects of total ginsenoside on bleomycin-induced pulmonary fibrosis in mice.
Pulmonary Fibrosis
Intranasal Curcumin Inhibits Pulmonary Fibrosis by Modulating Matrix Metalloproteinase-9 (MMP-9) in Ovalbumin-Induced Chronic Asthma.
Pulmonary Fibrosis
Matrix proteases, green tea, and St. John's wort: biomedical research catches up with folk medicine.
Pulmonary Fibrosis
Protective effects of naringin against paraquat-induced acute lung injury and pulmonary fibrosis in mice.
Pulmonary Fibrosis
Rac1-mediated mitochondrial H2O2 generation regulates MMP-9 gene expression in macrophages via inhibition of SP-1 and AP-1.
Pulmonary Fibrosis
The effects of taurochenodeoxycholic acid in preventing pulmonary fibrosis in mice.
Pulmonary Fibrosis
Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
Pulmonary Fibrosis
Transforming growth factor (TGF)-beta1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12.
Pulmonary Fibrosis
Unbalanced MMP/TIMP-1 expression during the development of experimental pulmonary fibrosis with acute paraquat poisoning.
Pulmonary Fibrosis
Upregulated miR-29c suppresses silica-induced lung fibrosis through the Wnt/?-catenin pathway in mice.
Pulmonary Fibrosis
[Changes of matrix metalloproteinases activities in pulmonary fibrosis rats]
Pulmonary Fibrosis
[Effect of atorvastatin on MMP-9 and TIMP-1 levels in bronchoalvcolar lavage fluid and serum of rats with bleomycin-induced pulmonary fibrosis].
Pulmonary Fibrosis
[The changes of expression level of matrix metalloprotease 9 and its inhibitor (TIMP-1) in murine pulmonary fibrosis model]
Pulmonary Fibrosis
[The effect of autologous bone marrow-derived cells mobilized by granulocyte colony stimulating factor on bleomycin-induced lung injury in mice.]
Pulmonary Heart Disease
Baicalin Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension to Improve Hypoxic Cor Pulmonale by Reducing the Activity of the p38 MAPK Signaling Pathway and MMP-9.
Pulmonary Sclerosing Hemangioma
Increased expression of matrix metalloproteinase 9 and tubulin-alpha in pulmonary sclerosing hemangioma.
Pulpitis
A connectivity mapping approach predicted acetylsalicylic acid (aspirin) to induce osteo/odontogenic differentiation of dental pulp cells.
Pulpitis
A first study on the usefulness of matrix metalloproteinase 9 from dentinal fluid to indicate pulp inflammation.
Pulpitis
A Prospective Clinical Pilot Study on the Level of Matrix Metalloproteinase-9 in Dental Pulpal Blood as a Marker for the State of Inflammation in the Pulp Tissue.
Pulpitis
Association between concentration of active MMP-9 in pulpal blood and pulpotomy outcome in permanent mature teeth with irreversible pulpitis - a preliminary study.
Pulpitis
Downregulation of microRNA-204 increases the expression of matrix metallopeptidase 9 in pediatric patients with pulpitis and Helicobacter pylori infection in the stomach.
Purpura
Association of matrix metalloproteinase-9 level with the risk of renal involvement for henoch-schönlein purpura in children.
Purpura
Association study between matrix metalloproteinase-9 gene (MMP9) polymorphisms and the risk of Henoch-Schönlein purpura in children.
Purpura
Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome.
Purpura
Potential of Serum and Urinary Matrix Metalloproteinase-9 Levels for the Early Detection of Renal Involvement in Children With Henoch-Schönlein Purpura.
Pyelonephritis
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in acute pyelonephritis and renal scarring.
Pyelonephritis
Mitochondria-Associated Matrix Metalloproteinases 2 and 9 in Acute Renal Pathologies.
Pyelonephritis
Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation.
Pyelonephritis
Urinary matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 biomarkers for predicting renal scar in children with urinary tract infection.
Pyoderma Gangrenosum
Expression of MMP-9, MMP-10 and TNF-alpha and lack of epithelial MMP-1 and MMP-26 characterize pyoderma gangrenosum.
Radicular Cyst
Association of Oxidative Stress and Production of Inflammatory Mediators Matrix Metalloproteinase-9 and Interleukin 6: Systemic Events in Radicular Cysts.
Radicular Cyst
Comparative analysis of the immunohistochemical expression of vascular endothelial growth factor and matrix metalloproteinase-9 in keratocystic odontogenic tumor, dentigerous cyst and radicular cyst.
Radicular Cyst
Comparative Metabolomics Reveals the Microenvironment of Common T-Helper Cells and Differential Immune Cells Linked to Unique Periapical Lesions.
Radicular Cyst
Correlation between radiographic area and immunolocation of MMP-2 and MMP-9 in unilocular radiographic lesions.
Radicular Cyst
High matrix metalloproteinase activity is a hallmark of periapical granulomas.
Radicular Cyst
Immunohistochemical expression of nuclear factor ?B, matrix metalloproteinase 9, and endoglin (CD105) in odontogenic keratocysts, dentigerous cysts, and radicular cysts.
Radicular Cyst
Immunohistochemical expression of vascular endothelial growth factor and matrix metalloproteinase-9 in radicular and residual radicular cysts.
Radicular Cyst
Influence of surgical decompression on the expression of inflammatory and tissue repair biomarkers in periapical cysts.
Radicular Cyst
Interleukin-1alpha-dependent regulation of matrix metalloproteinase-9(MMP-9) secretion and activation in the epithelial cells of odontogenic jaw cysts.
Raynaud Disease
Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus.
receptor protein-tyrosine kinase deficiency
Fibroblast growth factor receptor 1 regulates the differentiation and activation of osteoclasts through Erk1/2 pathway.
Rectal Neoplasms
Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9.
Rectal Neoplasms
Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Rectal Neoplasms
Clinical significance of the content of biomolecular markers in invasive front of colon carcinomas.
Rectal Neoplasms
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer.
Rectal Neoplasms
Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
Rectal Neoplasms
High formation of superoxide anion and nitric oxide, and matrix metalloproteinases activity in vascular wall of rectal carcinoma vessels.
Rectal Neoplasms
Immunohistochemical Markers as Predictors of Histopathologic Response and Prognosis in Rectal Cancer Treated with Preoperative Adjuvant Therapy: State of the Art.
Rectal Neoplasms
Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer.
Rectal Neoplasms
Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation.
Rectal Neoplasms
Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.
Rectal Neoplasms
Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy.
Rectal Neoplasms
Pretreatment Expression of 13 Molecular Markers as a Predictor of Tumor Responses After Neoadjuvant Chemoradiation in Rectal Cancer.
Rectal Neoplasms
The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis.
Renal Insufficiency
Adenylyl cyclase-associated protein-1/CAP1 as a biological target substrate of gelatinase B/MMP-9.
Renal Insufficiency, Chronic
Association between renal dysfunction and metalloproteinase (MMP)-9 activity in hypertensive patients.
Renal Insufficiency, Chronic
Cubilin Single Nucleotide Polymorphism Variants are Associated with Macroangiopathy While a Matrix Metalloproteinase-9 Single Nucleotide Polymorphism Flip-Flop may Indicate Susceptibility of Diabetic Nephropathy in Type-2 Diabetic Patients.
Renal Insufficiency, Chronic
Endocytosis of Albumin Induces Matrix Metalloproteinase-9 by Activating the ERK Signaling Pathway in Renal Tubule Epithelial Cells.
Renal Insufficiency, Chronic
Influence of Malondialdehyde and Matrix Metalloproteinase-9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic Syndrome.
Renal Insufficiency, Chronic
Matrix Metalloproteinase (MMP)-9 Levels in Children on Hemodialysis: Association with MMP-9 C(-1562)T Gene Polymorphism and Vitamin D Levels.
Renal Insufficiency, Chronic
Matrix metalloproteinase-9 gene polymorphisms and chronic kidney disease.
Renal Insufficiency, Chronic
Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases.
Renal Insufficiency, Chronic
MMP-9 Deletion Attenuates Arteriovenous Fistula Neointima through Reduced Perioperative Vascular Inflammation.
Renal Insufficiency, Chronic
Peripheral blood level alterations of MMP-2 and MMP-9 in patients with chronic kidney disease on conservative treatment and on hemodialysis.
Renal Insufficiency, Chronic
Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis.
Reperfusion Injury
?1 integrin-focal adhesion kinase (FAK) signaling modulates retinal ganglion cell (RGC) survival.
Reperfusion Injury
A Lipoxin A(4) Analog Ameliorates Blood-Brain Barrier Dysfunction and Reduces MMP-9 Expression in a Rat Model of Focal Cerebral Ischemia-Reperfusion Injury.
Reperfusion Injury
Absence of glutathione peroxidase-1 exacerbates cerebral ischemia-reperfusion injury by reducing post-ischemic microvascular perfusion.
Reperfusion Injury
Adeno-Associated Virus-Mediated Gene Transfer of Tissue Inhibitor of Metalloproteinases-1 Impairs Neutrophil Extracellular Trap Formation and Ameliorates Hepatic Ischemia and Reperfusion Injury.
Reperfusion Injury
Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats.
Reperfusion Injury
Curcumin prevents reperfusion injury following ischemic stroke in rats via inhibition of NF??B, ICAM-1, MMP-9 and caspase-3 expression.
Reperfusion Injury
Effect of cold ischemia/reperfusion injury and/or shear stress with portal hypertension on the expression of matrix metalloproteinase-9.
Reperfusion Injury
Fibronectin-?4?1 Interactions in Hepatic Cold Ischemia and Reperfusion Injury: Regulation of MMP-9 and MT1-MMP via the p38 MAPK Pathway.
Reperfusion Injury
Fullerenol Nanoparticles Decrease Blood-Brain Barrier Interruption and Brain Edema during Cerebral Ischemia-Reperfusion Injury Probably by Reduction of Interleukin-6 and Matrix Metalloproteinase-9 Transcription.
Reperfusion Injury
Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures.
Reperfusion Injury
Increased matrix metalloproteinase 9 activity and mRNA expression in lung ischemia-reperfusion injury.
Reperfusion Injury
Liver-selective mmp-9 inhibition in the rat eliminates ischemia-reperfusion injury and accelerates liver regeneration.
Reperfusion Injury
Matrix metalloprotease 9 promotes liver recovery from ischemia and reperfusion injury.
Reperfusion Injury
Matrix metalloproteinase inhibitor (ONO-4817) attenuates ischemia-reperfusion injury in rat lung.
Reperfusion Injury
Matrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic Ischemia and Reperfusion Injury in Mice.
Reperfusion Injury
MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury.
Reperfusion Injury
Neuroprotective effect of neuregulin-1? on spinal cord ischemia reperfusion injury.
Reperfusion Injury
Neuroprotective effects of oleanolic acid against cerebral ischemia-reperfusion injury in mice.
Reperfusion Injury
Propofol post-conditioning protects the blood brain barrier by decreasing matrix metalloproteinase-9 and aquaporin-4 expression and improves the neurobehavioral outcome in a rat model of focal cerebral ischemia-reperfusion injury.
Reperfusion Injury
Propofol vs desflurane on the cytokine, matrix metalloproteinase-9, and heme oxygenase-1 response during living donor liver transplantation: A pilot study.
Reperfusion Injury
Salvianolic acid A attenuates ischemia reperfusion induced rat brain damage by protecting the blood brain barrier through MMP-9 inhibition and anti-inflammation.
Reperfusion Injury
Serum matrix metalloproteinase MMP-2 and MMP-9 in the late phase of ischemia and reperfusion injury in human orthotopic liver transplantation.
Reperfusion Injury
Thrombopoietin could protect cerebral tissue against ischemia-reperfusion injury by suppressing NF-?B and MMP-9 expression in rats.
Reperfusion Injury
Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline.
Respiratory Distress Syndrome
Early increased levels of matrix metalloproteinase-9 in neonates recovering from respiratory distress syndrome.
Respiratory Distress Syndrome
Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome.
Respiratory Distress Syndrome
Kinetics and Role of Plasma Matrix Metalloproteinase-9 Expression in Acute Lung Injury and the Acute Respiratory Distress Syndrome.
Respiratory Distress Syndrome
Maternal Serum Interleukin-6, C-Reactive Protein, and Matrix Metalloproteinase-9 Concentrations as Risk Factors for Preterm Birth <32 Weeks and Adverse Neonatal Outcomes.
Respiratory Distress Syndrome
Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury.
Respiratory Distress Syndrome
Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome.
Respiratory Hypersensitivity
Protective effects of tiotropium alone or combined with budesonide against cadmium inhalation induced acute neutrophilic pulmonary inflammation in rats.
Respiratory Insufficiency
Azithromycin Treatment vs Placebo in Children With Respiratory Syncytial Virus-Induced Respiratory Failure: A Phase 2 Randomized Clinical Trial.
Respiratory Insufficiency
Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure.
Respiratory Insufficiency
Implications for matrix metalloproteinases as modulators of pediatric lung disease.
Respiratory Insufficiency
Inflammation and Coagulation during Critical Illness and Long-Term Cognitive Impairment and Disability.
Respiratory Insufficiency
Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling.
Respiratory Insufficiency
Pulmonary matrix metalloproteinase-9 activity in mechanically ventilated children with respiratory syncytial virus.
Respiratory Syncytial Virus Infections
Respiratory syncytial virus infection induces matrix metalloproteinase-9 expression in epithelial cells.
Respiratory Tract Diseases
Gelatinolytic matrix metalloproteinases-2 and -9 in tracheobronchial lavage fluid obtained from calves with concurrent infections of Pasteurella multocida and Mycoplasma bovirhinis.
Respiratory Tract Diseases
Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection.
Respiratory Tract Infections
Inflammation biomarkers associated with arsenic exposure by drinking water and respiratory outcomes in indigenous children from three Yaqui villages in southern Sonora, México.
Respiratory Tract Infections
Use of MMP-8 and MMP-9 to assess disease severity in children with viral lower respiratory tract infections.
Retinal Degeneration
Intravitreous injection of a membrane depolarization agent causes retinal degeneration via matrix metalloproteinase-9.
Retinal Degeneration
Kainic acid-mediated upregulation of matrix metalloproteinase-9 promotes retinal degeneration.
Retinal Degeneration
Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis-Case Series Report.
Retinal Degeneration
Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular disorders.
Retinal Detachment
A feasible tool to detect mRNA expression of matrix metalloproteinases and their tissue inhibitors in human Tenon's capsule.
Retinal Diseases
Matrix metalloproteinase-9 in spontaneously hypertensive hyperlipidemic rats.
Retinal Diseases
MMP-9 inhibition facilitates amacrine cell loss after ouabain-induced retinal damage.
Retinal Diseases
TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function.
Retinal Neovascularization
Angiopoietin/Tek interactions regulate mmp-9 expression and retinal neovascularization.
Retinal Neovascularization
Matrix metalloproteinase-9 and vascular endothelial growth factor expression change in experimental retinal neovascularization.
Retinal Perforations
Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGF?1 in diabetic eyes undergoing vitrectomy.
Retinal Perforations
Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy.
Retinal Perforations
Vitreous TIMP-1 levels associate with neovascularization and TGF-?2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy.
Retinal Vein Occlusion
High intravitreal TGF-?1 and MMP-9 levels in eyes with retinal vein occlusion.
Retinitis Pigmentosa
Inhibition of Matrix Metalloproteinase 9 Enhances Rod Survival in the S334ter-line3 Retinitis Pigmentosa Model.
Retinitis Pigmentosa
Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular disorders.
Retinoblastoma
Clinicohistopathological implications of MMP/VEGF expression in retinoblastoma: a combined meta-analysis and bioinformatics analysis.
Retinoblastoma
Curcumin suppressed proliferation and migration of human retinoblastoma cells through modulating NF-?B pathway.
Retinoblastoma
Differential roles of matrix metalloproteinase-9 and -2, depending on proliferation or differentiation of retinoblastoma cells.
Retinoblastoma
Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma.
Retinoblastoma
Long noncoding RNA DANCR aggravates retinoblastoma through miR-34c and miR-613 by targeting MMP-9.
Retinoblastoma
microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1.
Retinoblastoma
MiR-204, down-regulated in retinoblastoma, regulates proliferation and invasion of human retinoblastoma cells by targeting CyclinD2 and MMP-9.
Retinoblastoma
Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays.
Retinoblastoma
Suppressor of Zeste 12 homolog RNA interference inhibits retinoblastoma cell invasion.
Retinoblastoma
Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line.
Retinoblastoma
Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat.
Retinoblastoma
v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines.
Retinoblastoma
[Anti-sense nucleic acid of CyclinD1 induces apoptosis of lung adenocarcinoma cancer cell A549.]
Rhabdomyolysis
Mitochondria-Associated Matrix Metalloproteinases 2 and 9 in Acute Renal Pathologies.
Rhabdomyosarcoma
In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
Rhabdomyosarcoma
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in pediatric human sarcoma cell lines.
Rhabdomyosarcoma, Alveolar
Radiosensitizing Potential of Curcumin in Different Cancer Models.
Rheumatic Heart Disease
Matrix metalloproteinase-9 in pediatric rheumatic heart disease with and without heart failure.
Rhinitis, Allergic
Association of the MMP9 gene with childhood cedar pollen sensitization and pollinosis.
Rhinitis, Allergic
Remodelling of nasal mucosa in mild and severe persistent allergic rhinitis with special reference to the distribution of collagen, proteoglycans, and lymphatic vessels.
Rhinitis, Allergic
Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro.
Rhinitis, Allergic
Tissue-type plasminogen activator depletion affects the nasal mucosa matrix reconstruction in allergic rhinitis mice.
Rhinitis, Allergic
[Different intranasal corticosteroids effects on nasal airway remodeling of allergic rhinitis murine and matrix metalloproteinase-9].
Rhinitis, Allergic
[Role and mechanism of the expression of matrix metalloproteinase 9 and tumor necrosis factor ? in upper and lower respiratory tract inflammation in rats].
Rickets
Expression of chicken 75-kDa gelatinase B-like enzyme in perivascular chondrocytes suggests its role in vascularization of the growth plate.
Root Resorption
Comparison of expression patterns of cathepsin K and MMP-9 in odontoclasts and osteoclasts in physiological root resorption in the rat molar.
Root Resorption
Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
Root Resorption
Expression of matrix metalloproteinase-9 mRNA and protein during deciduous tooth resorption in bovine odontoclasts.
Root Resorption
Immunolocalization of vacuolar-type H+-ATPase, cathepsin K, matrix metalloproteinase-9, and receptor activator of NFkappaB ligand in odontoclasts during physiological root resorption of human deciduous teeth.
Rosacea
Effects of dextran sulfate, 4-t-butylcyclohexanol, pongamia oil and hesperidin methyl chalcone on inflammatory and vascular responses implicated in rosacea.
Rosacea
IL-1? and MMP-9 Tear Levels of Patients with Active Ocular Rosacea before and after Treatment with Systemic Azithromycin or Doxycycline.
Rosacea
Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea.
Salivary Gland Neoplasms
Expression of matrix metalloproteinase-9 in high-grade salivary gland carcinomas is associated with their metastatic potential.
Salivary Gland Neoplasms
The MMP-2 and MMP-9 promoter polymorphisms and susceptibility to salivary gland cancer.
Sarcoglycanopathies
Cleavage of ?-dystroglycan occurs in sarcoglycan-deficient skeletal muscle without MMP-2 and MMP-9.
Sarcoidosis
Comprehensive analysis of immune, extracellular matrices and pathogens profile in lung granulomatosis of unexplained etiology.
Sarcoidosis
Cytokine Signaling and Matrix Remodeling Pathways Associated with Cardiac Sarcoidosis Disease Activity Defined Using FDG PET Imaging.
Sarcoidosis
Involvement of discoidin domain receptor 1 in the deterioration of pulmonary sarcoidosis.
Sarcoidosis
Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.
Sarcoidosis
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF.
Sarcoidosis
Metalloproteinases MMP-9, MMP-2 and their tissue inhibitors TIMP-1, TIMP-2 in peripheral transbronchial lung biopsies of patients with sarcoidosis.
Sarcoidosis
N-acetylcysteine inhibits IL-8 and MMP-9 release and ICAM-1 expression by bronchoalveolar cells from interstitial lung disease patients.
Sarcoidosis, Pulmonary
Increased production of matrix metalloproteinase-2 in alveolar macrophages and regulation by interleukin-10 in patients with acute pulmonary sarcoidosis.
Sarcoma
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas.
Sarcoma
Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.
Sarcoma
Epigenetic DNA-methylation regulation of genes coding for lipid raft-associated components: a role for raft proteins in cell transformation and cancer progression (review).
Sarcoma
Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis.
Sarcoma
In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
Sarcoma
In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
Sarcoma
Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system.
Sarcoma
MicroRNA-429 inhibits bone metastasis in breast cancer by regulating CrkL and MMP-9.
Sarcoma
Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Sarcoma
Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis.
Sarcoma, Endometrial Stromal
Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis.
Sarcoma, Ewing
Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Sarcoma, Ewing
Beclin-1 knockdown decreases proliferation, invasion and migration of Ewing sarcoma SK-ES-1 cells via inhibition of MMP-9.
Sarcoma, Ewing
Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway.
Sarcoma, Ewing
Erratum: Beclin-1 knockdown decreases proliferation, invasion and migration of Ewing sarcoma SK-ES-1 cells via inhibition of MMP-9.
Sarcoma, Ewing
Matrix metalloproteinase-9 silencing by RNA interference triggers the migratory-adhesive switch in Ewing's sarcoma cells.
Sarcoma, Synovial
In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
Sarcoma, Synovial
Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines.
Schistosomiasis
Noninvasive Diagnosis of Bladder Cancer by Detection of Matrix Metalloproteinases (MMP-2 and MMP-9) and Their Inhibitor (TIMP-2) in Urine.
Schistosomiasis
[Expression of matrix metalloproteinase 2 and 9 in liver tissue of patients with schistosomiasis japonica]
Schistosomiasis japonica
[Expression of matrix metalloproteinase 2 and 9 in liver tissue of patients with schistosomiasis japonica]
Sciatica
Microarray analysis reveals an inflammatory transcriptomic signature in peripheral blood for sciatica.
Scleritis
Expression of tumor necrosis factor alpha and matrix metalloproteinase-9 in surgically induced necrotizing scleritis.
Scleritis
Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
Scleroderma, Diffuse
Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis.
Scleroderma, Diffuse
Expression of MMP-9 and TIMP-1 in lesions of systemic sclerosis and its implications.
Scleroderma, Localized
[Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin]
Scleroderma, Systemic
Analysis of matrix metalloproteinase-9 gene polymorphism -1562 C/T in patients suffering from systemic sclerosis with and without ulcers.
Scleroderma, Systemic
Bronchoalveolar matrix metalloproteinase 9 relates to restrictive lung function impairment in systemic sclerosis.
Scleroderma, Systemic
Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis.
Scleroderma, Systemic
Elevated matrix metalloproteinase-9 in patients with systemic sclerosis.
Scleroderma, Systemic
Expression of MMP-9 and TIMP-1 in lesions of systemic sclerosis and its implications.
Scoliosis
[Association of matrix metalloproteinase 9 polymorphisms with adolescent idiopathic scoliosis in Chinese Han female].
Seizures
Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus.
Seizures
Beta-dystroglycan as a target for MMP-9, in response to enhanced neuronal activity.
Seizures
Correlation of MMP-9 and HMGB1 expression with the cognitive function in patients with epilepsy and factors affecting the prognosis.
Seizures
Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels.
Seizures
Doxycycline could aggravate the absence-like epileptic seizures of WAG/Rij rats via matrix metalloproteinase inhibition.
Seizures
Dynamic contrast-enhanced (DCE) MRI derived kinetic perfusion indices may help predicting seizure control in single calcified neurocysticercosis.
Seizures
Increase in seizure susceptibility in sepsis like condition explained by spiking cytokines and altered adhesion molecules level with impaired blood brain barrier integrity in experimental model of rats treated with lipopolysaccharides.
Seizures
Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Seizures
Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development.
Seizures
Matrix metalloproteinase 9 regulates cell death following pilocarpine-induced seizures in the developing brain.
Seizures
Matrix metalloproteinase-9 activity increased by two different types of epileptic seizures that do not induce neuronal death: a possible role in homeostatic synaptic plasticity.
Seizures
Matrix metalloproteinase-9 contributes to kindled seizure development in pentylenetetrazole-treated mice by converting pro-BDNF to mature BDNF in the hippocampus.
Seizures
Myricetin attenuates the severity of seizures and neuroapoptosis in pentylenetetrazole kindled mice by regulating the of BDNF-TrkB signaling pathway and modulating matrix metalloproteinase-9 and GABAA.
Seizures
Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.
Seizures
Pro-inflammatory cytokines, but not brain- and extracellular matrix-derived proteins, are increased in the plasma following electrically induced kindling of seizures.
Seizures
Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration.
Seizures
Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures.
Seizures
The role of UCH-L1, MMP-9, and GFAP as peripheral markers of different susceptibility to seizure development in a preclinical model of epilepsy.
Seizures
Toll-like Receptor-4 Polymorphisms and Serum Matrix Metalloproteinase-9 in Newly Diagnosed Patients With Calcified Neurocysticercosis and Seizures.
Seizures, Febrile
Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy.
Seizures, Febrile
Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures.
Seizures, Febrile
Serum levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in human herpesvirus-6-infected infants with or without febrile seizures.
Seminoma
Imbalance of MMP-2 and MMP-9 expression versus TIMP-1 and TIMP-2 reflects increased invasiveness of human testicular germ cell tumours.
Sepsis
Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
Sepsis
Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the ED: an observational study.
Sepsis
Diagnostic Value of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis-Associated Acute Kidney Injury.
Sepsis
Differential release of matrix metalloproteinase-9 and nitric oxide following infusion of endotoxin to human volunteers.
Sepsis
Dynamic changes of matrix metalloproteinases and their tissue inhibitors in severe sepsis.
Sepsis
Effect of chemically modified tetracycline on transforming growth factor-beta1 and caspase-3 activation in liver of septic rats.
Sepsis
Elevated Plasma Levels of Matrix Metalloproteinase-3 and Tissue-Inhibitor of Matrix Metalloproteinases-1 Associate with Organ Dysfunction and Mortality in Sepsis.
Sepsis
Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid-Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding Protein.
Sepsis
Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators.
Sepsis
Identification of key pathogenic genes of sepsis based on the Gene Expression Omnibus database.
Sepsis
Increase of tumor necrosis factor-alpha in the blood induces early activation of matrix metalloproteinase-9 in the brain.
Sepsis
Maternal Serum Interleukin-6, C-Reactive Protein, and Matrix Metalloproteinase-9 Concentrations as Risk Factors for Preterm Birth <32 Weeks and Adverse Neonatal Outcomes.
Sepsis
Mathematical Modeling of the Biomarker Milieu to Characterize Preterm Birth and Predict Adverse Neonatal Outcomes.
Sepsis
Matrix Metalloproteinase-2 and Metalloproteinase-9 Activities are Associated with Blood-Brain Barrier Dysfunction in an Animal Model of Severe Sepsis.
Sepsis
Matrix metalloproteinase-9 -1562 C/T polymorphism is associated with the risk of sepsis in a Chinese population: A retrospective study.
Sepsis
Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery.
Sepsis
Matrix Metalloproteinase-9 Deficiency Impairs Host Defense against Abdominal Sepsis.
Sepsis
Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.
Sepsis
Matrix metalloproteinases -8 and -9 and tissue inhibitor of metalloproteinase-1 in burn patients. A prospective observational study.
Sepsis
Matrix- metalloproteinase -2, -8 and -9 in serum and skin blister fluid in patients with severe sepsis.
Sepsis
Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis.
Sepsis
MMP-9 Concentration in Peritoneal Fluid Is a Valuable Biomarker Associated with Endotoxemia in Equine Colic.
Sepsis
Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis.
Sepsis
Peptidoglycan of Staphylococcus aureus induces enhanced levels of matrix metalloproteinase-9 in human blood originating from neutrophils.
Sepsis
Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis.
Sepsis
Resveratrol reduces acute lung injury in a LPS?induced sepsis mouse model via activation of Sirt1.
Sepsis
Role of plasma matrix-metalloproteases (MMPs) and their polymorphisms (SNPs) in sepsis development and outcome in ICU patients.
Sepsis
Serum haptoglobin-matrix metalloproteinase 9 (Hp-MMP 9) complex as a biomarker of systemic inflammation in cattle.
Sepsis
Serum MMP-8, -9 and TIMP-1 in sepsis: High serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines.
Sepsis
The association between blood glucose levels and matrix-metalloproteinase-9 in early severe sepsis and septic shock.
Sepsis
The HIV protease inhibitor Saquinavir attenuates sepsis-induced acute lung injury and promotes M2 macrophage polarization via targeting matrix metalloproteinase-9.
Sepsis
The identification of neutrophils-mediated mechanisms and potential therapeutic targets for the management of sepsis-induced acute immunosuppression using bioinformatics.
Sepsis
Upregulation of Matrix Metalloproteinase-9 Protects against Sepsis-Induced Acute Lung Injury via Promoting the Release of Soluble Receptor for Advanced Glycation End Products.
Sepsis
[Clinical significance of soluble selectins and matrix metalloproteinases-9 in patients after successful cardiopulmonary resuscitation]
Severe Combined Immunodeficiency
Production of matrix metalloproteinases in response to mycobacterial infection.
Shock, Cardiogenic
High serum matrix metalloproteinase-9 level predict increased risk of in-hospital cardiac events in patients with type 2 diabetes and ST segment elevation myocardial infarction.
Shock, Cardiogenic
Ivabradine induces cardiac protection by preventing cardiogenic shock-induced extracellular matrix degradation.
Shock, Cardiogenic
Suppressed MMP-9 Activity in Myocardial Infarction-Related Cardiogenic Shock Implies Diminished Rage Degradation.
Shock, Septic
Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
Shock, Septic
Bivalent Inhibitor with Selectivity for Trimeric MMP-9 Amplifies Neutrophil Chemotaxis and Enables Functional Studies on MMP-9 Proteoforms.
Shock, Septic
Exogenous heat shock cognate protein 70 pretreatment attenuates cardiac and hepatic dysfunction with associated anti-inflammatory responses in experimental septic shock.
Shock, Septic
Inhibition of matrix metalloproteinases by chemically modified tetracyclines in sepsis.
Shock, Septic
Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: effect of fiber-immobilized polymyxin B treatment.
Shock, Septic
Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis.
Shock, Septic
Role of matrix metalloproteinases 2 and 9, toll-like receptor 4 and platelet-leukocyte aggregate formation in sepsis-associated thrombocytopenia.
Shock, Septic
The association between blood glucose levels and matrix-metalloproteinase-9 in early severe sepsis and septic shock.
Silicosis
Expression and localization of TIMP-1, TIMP-2, MMP-13, MMP-2, and MMP-9 in early and advanced experimental lung silicosis.
Silicosis
Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
Silicosis
[Changes of serum matrix metaslloproteinases-9 and tissue inhibitors of metaslloproteinases-9 in coal workers' pneumoconiosis.]
Silicosis
[The discriminant analysis of the silicosis's induction on cytokines in phlegm and combined multi-markers].
Sinus Thrombosis, Intracranial
Polymorphism in dural arteriovenous fistula: matrix metalloproteinase-2-1306 C/T as a potential risk factor for sinus thrombosis.
Sinusitis
BMP-7, MMP-9, and TGF-? tissue remodeling proteins and their correlations with interleukins 6 and 10 in chronic rhinosinusitis.
Sinusitis
Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis.
Sjogren's Syndrome
Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome.
Sjogren's Syndrome
Urinary matrix metalloproteinase-9 and interleukin-6 and renal manifestations of primary Sjogren's syndrome.
Sjogren's Syndrome
[Viral Tax protein expression in salivary glands of patients infected with human t-cell lymphotropic virus type I and Sicca Syndrome.]
Skin Diseases
Cytokine and Chemokine Profile in Amicrobial Pustulosis of the Folds: Evidence for Autoinflammation.
Skin Diseases
Histamine upregulates keratinocyte MMP-9 production via the histamine H1 receptor.
Skin Diseases
Peroxisome proliferator activated receptor-? agonists suppress transforming growth factor-?-induced matrix metalloproteinase-9 expression in human keratinocytes.
Skin Diseases
Suppression of TNF-alpha-induced MMP-9 expression by a cell-permeable superoxide dismutase in keratinocytes.
Skin Diseases
The influence of sun exposure on the DNA methylation status of MMP9, miR-137, KRT14 and KRT19 genes in human skin.
Skin Neoplasms
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
Skin Neoplasms
Evaluation of heparanase and matrix metalloproteinase-9 in patients with cutaneous malignant melanoma.
Skin Neoplasms
Merkel Cell Polyomavirus Small Tumor Antigen Activates Matrix Metallopeptidase-9 Gene Expression for Cell Migration and Invasion.
Skin Neoplasms
Plant derived coumestrol phytochemical targets human skin carcinoma cells by inducing mitochondrial-mediated apoptosis, cell cycle arrest, inhibition of cell migration and invasion and modulation of m-TOR/PI3K/AKT signalling pathway.
Skin Neoplasms
[VALUE OF METALPROTEINASES OF BLOOD IN PATHOGENESIS OF EPITELIAL SKIN TUMORS AND THE POSSIBILITY OF THEIR SURGICAL CORRECTION].
Skin Ulcer
Effect of insulin-like growth factor-1 on promoting healing of skin ulcers in diabetic rats.
Sleep Apnea Syndromes
Adiposity and low-grade systemic inflammation modulate matrix metalloproteinase-9 levels in Greek children with sleep apnea.
Sleep Apnea Syndromes
Matrix Metalloproteinase-9 Level and Gene Polymorphism in Sleep Disordered Breathing Patients with or without Cardiovascular Disorders.
Sleep Apnea, Obstructive
Activity of serum matrix metalloproteinase 9 in patients with obstructive sleep apnea.
Sleep Apnea, Obstructive
Adiposity and low-grade systemic inflammation modulate matrix metalloproteinase-9 levels in Greek children with sleep apnea.
Sleep Apnea, Obstructive
Effects of continuous positive airway pressure on resolvin and matrix metalloproteinase-9 in patients with obstructive sleep apnea.
Sleep Apnea, Obstructive
Functional polymorphisms in the promoter region of MMP-2 and MMP-9 and susceptibility to obstructive sleep apnea.
Sleep Apnea, Obstructive
Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome.
Sleep Apnea, Obstructive
Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome.
Sleep Apnea, Obstructive
Lack of association of matrix metalloproteinase-9 promoter gene polymorphism in obstructive sleep apnea syndrome.
Sleep Apnea, Obstructive
Matrix metalloproteinase 9 (MMP9) level and MMP9 -1562C>T in patients with obstructive sleep apnea: a systematic review and meta-analysis of case-control studies.
Sleep Apnea, Obstructive
Matrix metalloproteinase-9 as a messenger in the crosstalk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review.
Sleep Apnea, Obstructive
Matrix Metalloproteinase-9 Is a Predictive Factor for Systematic Hypertension and Heart Dysfunction in Patients with Obstructive Sleep Apnea Syndrome.
Sleep Apnea, Obstructive
[Research on the serum levels of matrix metalloproteinase-9 and free fatty acids in OSAHS cases].
Sleep Deprivation
Conditions that affect sleep alter the expression of molecules associated with synaptic plasticity.
Small Cell Lung Carcinoma
Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer.
Small Cell Lung Carcinoma
[Significance of expression of chemokine receptor and matrix metalloproteinase in small cell lung cancer].
Spasm
[Clinical significance of KiSS-1 and matrix metalloproteinase-9 expression in trophoblasts of women with preeclampsia and their relation to perinatal outcome of neonates]
Spasms, Infantile
Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures.
Spasms, Infantile
Serum matrix metallopeptidase-9 and tissue inhibitor of metalloproteinase-1 levels may predict response to adrenocorticotropic hormone therapy in patients with infantile spasms.
Spinal Cord Compression
The correlation between hypoxia-inducible factor-1?, matrix metalloproteinase-9 and functional recovery following chronic spinal cord compression.
Spinal Cord Diseases
Immunohistochemical Profile of NF-?B/p50, NF-?B/p65, MMP-9, MMP-2 and u-PA in Experimental Cervical Spondylotic Myelopathy.
Spinal Cord Injuries
17?-estradiol inhibits MMP-9 and SUR1/TrpM4 expression and activation and thereby attenuates BSCB disruption/hemorrhage after spinal cord injury in male rats.
Spinal Cord Injuries
A nutrient mixture reduces the expression of matrix metalloproteinases in an animal model of spinal cord injury by modulating matrix metalloproteinase-2 and matrix metalloproteinase-9 promoter activities.
Spinal Cord Injuries
Activation of matrix metalloproteinases-9 after photothrombotic spinal cord injury model in rats.
Spinal Cord Injuries
CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury.
Spinal Cord Injuries
CORRIGENDUM FOR "17?-Estradiol Inhibits MMP-9 and SUR1/TrpM4 Expression and Activation and Thereby Attenuates BSCB Disruption/Hemorrhage After Spinal Cord Injury in Male Rats".
Spinal Cord Injuries
Disruption of Nrf2 enhances the upregulation of nuclear factor-kappab activity, tumor necrosis factor-?, and matrix metalloproteinase-9 after spinal cord injury in mice.
Spinal Cord Injuries
Downregulation of Matrix Metalloproteinases 2 and 9 is Involved in the Protective Effect of Trehalose on Spinal Cord Injury.
Spinal Cord Injuries
Effect of rutin on spinal cord injury through inhibition of the expression of MIP-2 and activation of MMP-9, and downregulation of Akt phosphorylation.
Spinal Cord Injuries
Effects of hyperbaric oxygen on MMP-2 and MMP-9 expression and spinal cord edema after spinal cord injury.
Spinal Cord Injuries
Effects of hyperbaric oxygen on MMP-2 and MMP-9 expressions and spinal cord edema after spinal cord injury.
Spinal Cord Injuries
Efficacy of a metalloproteinase inhibitor in spinal cord injured dogs.
Spinal Cord Injuries
Elevated MMP-9 in the lumbar cord early after thoracic spinal cord injury impedes motor relearning in mice.
Spinal Cord Injuries
Exploratory study to suggest the possibility of MMP-8 and MMP-9 serum levels as early markers for remission after traumatic spinal cord injury.
Spinal Cord Injuries
Folic Acid Modulates Matrix Metalloproteinase-9 Expression Following Spinal Cord Injury.
Spinal Cord Injuries
Ghrelin inhibits BSCB disruption/hemorrhage by attenuating MMP-9 and SUR1/TrpM4 expression and activation after spinal cord injury.
Spinal Cord Injuries
Induction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injury.
Spinal Cord Injuries
Intrathecal transplantation of bone marrow stromal cells attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia-reperfusion injury in rabbits.
Spinal Cord Injuries
Jmjd3 mediates blood-spinal cord barrier disruption after spinal cord injury by regulating MMP-3 and MMP-9 expressions.
Spinal Cord Injuries
Matrix metalloprotease-9 activity in the cerebrospinal fluid and spinal injury severity in dogs with intervertebral disc herniation.
Spinal Cord Injuries
Matrix metalloproteinase-9 activity in the cerebrospinal fluid and serum of dogs with acute spinal cord trauma from intervertebral disk disease.
Spinal Cord Injuries
Matrix metalloproteinase-9 controls proliferation of NG2+ progenitor cells immediately after spinal cord injury.
Spinal Cord Injuries
Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord.
Spinal Cord Injuries
Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events.
Spinal Cord Injuries
Melatonin improves functional outcome via inhibition of matrix metalloproteinases-9 after photothrombotic spinal cord injury in rats.
Spinal Cord Injuries
Sulforaphane attenuates matrix metalloproteinase-9 expression following spinal cord injury in mice.
Spinal Cord Injuries
Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury.
Spinal Cord Injuries
[Influence of nuclear factor erythoid 2-related factor 2 genotype on tumor necrosis factor-? and metalloproteinase-9 expression in spinal cord after spinal cord injury in mice].
Spinocerebellar Ataxias
Laminin signals initiate the reciprocal loop that informs breast-specific gene expression and homeostasis by activating NO, p53 and microRNAs.
Squamous Cell Carcinoma of Head and Neck
A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9.
Squamous Cell Carcinoma of Head and Neck
A circular RNA derived from MMP9 facilitates oral squamous cell carcinoma metastasis through regulation of MMP9 mRNA stability.
Squamous Cell Carcinoma of Head and Neck
A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Alpha-2 Heremans Schmid Glycoprotein (AHSG) modulates signaling pathways in head and neck squamous cell carcinoma cell line SQ20B.
Squamous Cell Carcinoma of Head and Neck
Alpha-mangostin suppresses MMP-2 and MMP-9 expression in head and neck squamous carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
Apple- and Hop-Polyphenols Inhibit Porphyromonas gingivalis-Mediated Precursor of Matrix Metalloproteinase-9 Activation and Invasion of Oral Squamous Cell Carcinoma Cells.
Squamous Cell Carcinoma of Head and Neck
Areca quid chewing enhances the expression of salivary matrix metalloproteinase-9.
Squamous Cell Carcinoma of Head and Neck
Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by ERK1/2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Can MMP-9 be a Prognosticator Marker for Oral Squamous Cell Carcinoma?
Squamous Cell Carcinoma of Head and Neck
CD147 promotes invasion and MMP-9 expression through MEK signaling and predicts poor prognosis in hypopharyngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
CD44+/CD133+ immunophenotype and matrix metalloproteinase-9: Influence on prognosis in early-stage oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Combination of ACY-241 and JQ1 Synergistically Suppresses Metastasis of HNSCC via Regulation of MMP-2 and MMP-9.
Squamous Cell Carcinoma of Head and Neck
Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
Correlation Between the Expression of Matrix Metalloproteinase-9, Matrix Metalloproteinase-13, Tissue Inhibitor of Metalloproteinases-1, p16 and Differentiation of Head and Neck Squamous Cell Carcinoma: A Prospective Observational Study.
Squamous Cell Carcinoma of Head and Neck
Correlation of matrix metalloproteinase-2, -9, tissue inhibitor-1 of matrix metalloproteinase and CD44 variant 6 in head and neck cancer metastasis.
Squamous Cell Carcinoma of Head and Neck
Correlation of matrix metalloproteinase-9 expression with morphometric analysis of mucosal vasculature in oral squamous cell carcinoma, oral epithelial dysplasia, and normal oral mucosa.
Squamous Cell Carcinoma of Head and Neck
Curcumin Inhibits Carcinogen and Nicotine-induced Mammalian Target of Rapamycin Pathway Activation in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.
Squamous Cell Carcinoma of Head and Neck
CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
CYFRA 21-1 and MMP-9 as salivary biomarkers for the detection of oral squamous cell carcinoma: a systematic review of diagnostic test accuracy.
Squamous Cell Carcinoma of Head and Neck
Diagnostic and prognostic ability of salivary MMP-9 for oral squamous cell carcinoma: A pre-/post-surgery case and matched control study.
Squamous Cell Carcinoma of Head and Neck
Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs.
Squamous Cell Carcinoma of Head and Neck
Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
Squamous Cell Carcinoma of Head and Neck
Effect of selective small molecule inhibitors on MMP-9 and VEGFR-1 expression in p16-positive and -negative squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Effects of cigarette smoke condensate on oral squamous cell carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
ESE-1 inhibits the invasion of oral squamous cell carcinoma in conjunction with MMP-9 suppression.
Squamous Cell Carcinoma of Head and Neck
Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Expression of E-cadherin and matrix metalloproteinase-9 in oral squamous cell carcinoma and histologically negative surgical margins and association with clinicopathological parameters.
Squamous Cell Carcinoma of Head and Neck
Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.
Squamous Cell Carcinoma of Head and Neck
Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis.
Squamous Cell Carcinoma of Head and Neck
Expression of matrix metalloproteinase-9 in oral potentially malignant disorders: A systematic review.
Squamous Cell Carcinoma of Head and Neck
Expression of matrix metalloproteinase-9 in patients with squamous cell carcinoma of the larynx.
Squamous Cell Carcinoma of Head and Neck
Expression of matrix metalloproteinases (MMP-2 and MMP-9) in recurrent respiratory papillomas and laryngeal carcinoma: clinical and morphological parallels.
Squamous Cell Carcinoma of Head and Neck
Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.
Squamous Cell Carcinoma of Head and Neck
Expression of VEGF, HGF, IL-6, IL-8, MMP-9, Telomerase in Peripheral Blood of Patients with Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Expressions of matrix metalloproteinase-9 (MMP-9), dentin sialophosphoprotein (DSPP), and osteopontin (OPN) at histologically negative surgical margins may predict recurrence of oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo.
Squamous Cell Carcinoma of Head and Neck
Fibroblasts and extracellular matrix differently modulate MMP activation by primary and metastatic head and neck cancer cells.
Squamous Cell Carcinoma of Head and Neck
Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Squamous Cell Carcinoma of Head and Neck
Glycogen synthase kinase-3? mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion.
Squamous Cell Carcinoma of Head and Neck
Heparin-binding epidermal growth factor-like growth factor is a potent regulator of invasion activity in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Hypoxia-Induced Cleavage Of Soluble ephrinA1 From Cancer Cells Is Mediated By MMP-2 And Associates With Angiogenesis In Oral Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Identification of potential therapeutic target genes and mechanisms in head and neck squamous cell carcinoma by bioinformatics analysis.
Squamous Cell Carcinoma of Head and Neck
Imbalance between Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Promotes Invasion and Metastasis of Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Immunohistochemical analysis of neutrophils, interleukin-17, matrix metalloproteinase-9, and neoformed vessels in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Immunohistochemical Study of Laminin-332 ?2 Chain and MMP-9 in High Risk of Malignant Transformation Oral Lesions and OSCC.
Squamous Cell Carcinoma of Head and Neck
Increased VEGFR2 and MMP9 protein levels are associated with epithelial dysplasia grading.
Squamous Cell Carcinoma of Head and Neck
Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole.
Squamous Cell Carcinoma of Head and Neck
Inhibition of laryngeal cancer cell invasion and growth with lentiviral-vector delivered short hairpin RNA targeting human MMP-9 gene.
Squamous Cell Carcinoma of Head and Neck
Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma.
Squamous Cell Carcinoma of Head and Neck
Involvement of proteasomes in migration and matrix metalloproteinase-9 production of oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Iron increases MMP-9 expression through activation of AP-1 via ERK/Akt pathway in human head and neck squamous carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
Kalopanaxsaponin a inhibits the invasion of human oral squamous cell carcinoma by reducing metalloproteinase-9 mRNA stability and protein trafficking.
Squamous Cell Carcinoma of Head and Neck
Knockdown of Matrix Metallopeptidase 9 Inhibits Metastasis of Oral Squamous Cell Carcinoma Cells in a Zebrafish Xenograft Model.
Squamous Cell Carcinoma of Head and Neck
Leptin acts on neoplastic behavior and expression levels of genes related to hypoxia, angiogenesis, and invasiveness in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Matrix metalloproteinase (MMP)-2 and MMP-9 polymorphisms and haplotypes as disease biomarkers.
Squamous Cell Carcinoma of Head and Neck
Matrix metalloproteinase 2 and matrix metalloproteinase 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: preliminary observations.
Squamous Cell Carcinoma of Head and Neck
Matrix metalloproteinase 9 inhibits the motility of highly aggressive HSC-3 oral squamous cell carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer.
Squamous Cell Carcinoma of Head and Neck
Metalloproteinases and their inhibitors: Influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
MMP-9 Knockdown Inhibits Oral Squamous Cell Carcinoma Lymph Node Metastasis in the Nude Mouse Tongue-Xenografted Model through the RhoC/Src Pathway.
Squamous Cell Carcinoma of Head and Neck
MMPs, TIMP-2, and TGF-beta1 in the cancerization of oral lichen planus.
Squamous Cell Carcinoma of Head and Neck
Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression.
Squamous Cell Carcinoma of Head and Neck
Oleic acid-induced ANGPTL4 enhances head and neck squamous cell carcinoma anoikis resistance and metastasis via up-regulation of fibronectin.
Squamous Cell Carcinoma of Head and Neck
Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion.
Squamous Cell Carcinoma of Head and Neck
Polymorphisms of matrix metalloproteinase-7 and -9 are associated with oral tongue squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Prediction of metastasis in oral squamous cell carcinoma through phenotypic evaluation and gene expression of E-cadherin, ?-catenin, matrix metalloproteinase-2, and matrix metalloproteinase-9 biomarkers with clinical correlation.
Squamous Cell Carcinoma of Head and Neck
Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Prognostic significance of CD44v6, p63, Podoplanin, and MMP-9 in oral squamous cell carcinomas.
Squamous Cell Carcinoma of Head and Neck
Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Prognostic value of matrix metalloproteinase-9 expression in oral squamous cell carcinoma and its association with angiogenesis.
Squamous Cell Carcinoma of Head and Neck
Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Prognostic value of transforming growth factor beta 1 [TGF-?1] and matrix metalloproteinase 9 [MMP-9] in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Proteinase suppression by E-cadherin-mediated cell-cell attachment in premalignant oral keratinocytes.
Squamous Cell Carcinoma of Head and Neck
Quercetin suppresses cellular migration and invasion in human head and neck squamous cell carcinoma (HNSCC).
Squamous Cell Carcinoma of Head and Neck
Radiosensitizing Potential of Curcumin in Different Cancer Models.
Squamous Cell Carcinoma of Head and Neck
Regulatory effect of MiR103 on proliferation, EMT and invasion of oral squamous carcinoma cell through SALL4.
Squamous Cell Carcinoma of Head and Neck
Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population.
Squamous Cell Carcinoma of Head and Neck
Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer.
Squamous Cell Carcinoma of Head and Neck
Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma - a Systematic Review with Meta Analysis.
Squamous Cell Carcinoma of Head and Neck
Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Salivary MMP-9 in the detection of oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.
Squamous Cell Carcinoma of Head and Neck
Serum Level of Matrix Metalloproteinase-9 in Patients with Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker.
Squamous Cell Carcinoma of Head and Neck
Serum melatonin is inversely associated with matrix metalloproteinase-9 in oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Sonic hedgehog signaling may promote invasion and metastasis of oral squamous cell carcinoma by activating MMP-9 and E-cadherin expression.
Squamous Cell Carcinoma of Head and Neck
Stromal versus tumoral inflammation differentially contribute to metastasis and poor survival in laryngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
TGF-beta1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway.
Squamous Cell Carcinoma of Head and Neck
The effects of periodontitis associated microbiota on the development of oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
The upregulated ?-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
Squamous Cell Carcinoma of Head and Neck
Tumor-stroma interactions influence cytokine expression and matrix metalloproteinase activities in paired primary and metastatic head and neck cancer cells.
Squamous Cell Carcinoma of Head and Neck
Zinc dependent endopeptidases of matrix metalloproteinases-9 expressions is associated with tumor metastases of oral squamous cell carcinoma in Chinese population: a meta-analysis.
Squamous Cell Carcinoma of Head and Neck
[Effects of HPV 16-E6/E7 oncogene on expression of vascular endothelial growth factor and matrix metalloproteinase 9 in human laryngeal squamous cell carcinoma cell line]
Squamous Cell Carcinoma of Head and Neck
[Expression and clinical significance of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinomas]
Squamous Cell Carcinoma of Head and Neck
[Expression and significance of CD44v6 and MMP-9 in laryngeal squamous cell carcinoma]
Squamous Cell Carcinoma of Head and Neck
[Expression and significance of MTDH and MMP-9 in laryngeal squamous cell carcinoma].
Squamous Cell Carcinoma of Head and Neck
[The influence of urothelial carcinoembryonic antigen 1 on invasion and migration of oral carcinoma cell lines].
ST Elevation Myocardial Infarction
Alteplase treatment affects circulating matrix metalloproteinase concentrations in patients with ST segment elevation acute myocardial infarction.
ST Elevation Myocardial Infarction
Association Between High Serum Matrix Metalloproteinase-9 and MMP-9 (-1562C>T) Polymorphism in Patients With ST-Elevation Acute Myocardial Infarction.
ST Elevation Myocardial Infarction
Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction.
ST Elevation Myocardial Infarction
High serum matrix metalloproteinase-9 level predict increased risk of in-hospital cardiac events in patients with type 2 diabetes and ST segment elevation myocardial infarction.
ST Elevation Myocardial Infarction
In-Vivo Higher Plasma Levels of Platelet-Derived Growth Factor and Matrix Metalloproteinase-9 in Coronary Artery at the Very Onset of Myocardial Infarction with ST-Segment Elevation.
ST Elevation Myocardial Infarction
Innate immunity markers in culprit plaques of acute myocardial infarction or stable angina.
ST Elevation Myocardial Infarction
Local Matrix Metalloproteinase 9 Level Determines Early Clinical Presentation of ST-Segment-Elevation Myocardial Infarction.
ST Elevation Myocardial Infarction
MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy.
ST Elevation Myocardial Infarction
Peri-interventional endothelin-A receptor blockade improves long-term outcome in patients with ST-elevation acute myocardial infarction.
ST Elevation Myocardial Infarction
Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease.
ST Elevation Myocardial Infarction
Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
ST Elevation Myocardial Infarction
Relation of nocturnal melatonin levels to serum matrix metalloproteinase-9 concentrations in patients with myocardial infarction.
ST Elevation Myocardial Infarction
Serum YKL-40 positively correlates with MMP-9 and CRP in patients with acute ST segment elevation myocardial infarction following emergency treatment.
ST Elevation Myocardial Infarction
Systemic Vulnerability, as Expressed by I-CAM and MMP-9 at Presentation, Predicts One Year Outcomes in Patients with Acute Myocardial Infarction-Insights from the VIP Clinical Study.
ST Elevation Myocardial Infarction
The prognostic value of elevated matrix metalloproteinase-9 in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A two-year prospective study.
ST Elevation Myocardial Infarction
[The role of matrix metalloproteinases in assessment of prognosis in patients with ST-elevation myocardial infarction during hospital stay].
ST Elevation Myocardial Infarction
[Values of matrix metalloproteinase-9 in early diagnosis and short-term prognosis of ST-segment elevation myocardial infarction].
Starvation
Arginine deprivation inhibits pancreatic cancer cell migration, invasion and EMT via the down regulation of Snail, Slug, Twist, and MMP1/9.
Starvation
Glutamine-free condition inhibits lipopolysaccharide-induced invasion of BV2 microglial cells by suppressing of matrix metalloproteinase-9 expression.
Status Asthmaticus
Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus.
Status Epilepticus
ETB receptor-mediated MMP-9 activation induces vasogenic edema via ZO-1 protein degradation following status epilepticus.
Status Epilepticus
Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy.
Status Epilepticus
Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures.
Status Epilepticus
The role of MMP-9 in integrin-mediated hippocampal cell death after pilocarpine-induced status epilepticus.
Status Epilepticus
Toll-like Receptor-4 Polymorphisms and Serum Matrix Metalloproteinase-9 in Newly Diagnosed Patients With Calcified Neurocysticercosis and Seizures.
Stevens-Johnson Syndrome
Possible involvement of gelatinase A (MMP2) and gelatinase B (MMP9) in toxic epidermal necrolysis or Stevens-Johnson syndrome.
Stevens-Johnson Syndrome
Prognostic significance of matrix metalloproteinase 9 in COMET operated chronic ocular Stevens-Johnson syndrome.
Stomach Neoplasms
A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer.
Stomach Neoplasms
AA-PMe, a novel asiatic acid derivative, induces apoptosis and suppresses proliferation, migration, and invasion of gastric cancer cells.
Stomach Neoplasms
Aberrant expression of Kiss-1 and matrix metalloproteinase-9 are closely linked to lymph node metastasis of gastric cancer.
Stomach Neoplasms
Activation of matrix metalloproteinase-9 (MMP-9) by neurotensin promotes cell invasion and migration through ERK pathway in gastric cancer.
Stomach Neoplasms
AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression.
Stomach Neoplasms
ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer.
Stomach Neoplasms
An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.
Stomach Neoplasms
An Overview of Matrix Metalloproteinase 9 Polymorphism and Gastric Cancer Risk.
Stomach Neoplasms
Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9.
Stomach Neoplasms
ANP reduced Hedgehog signaling-mediated activation of matrix metalloproteinase-9 in gastric cancer cell line MGC-803.
Stomach Neoplasms
Anti-cancer activity of DHA on gastric cancer-an in vitro and in vivo study.
Stomach Neoplasms
Anti-metastatic activity of fangchinoline in human gastric cancer AGS cells.
Stomach Neoplasms
Apoptosis-promoting and migration-suppressing effect of alantolactone on gastric cancer cell lines BGC-823 and SGC-7901 via regulating p38MAPK and NF-?B pathways.
Stomach Neoplasms
Ara-C increases gastric cancer cell invasion by upregulating CD-147-MMP-2/MMP?9 via the ERK signaling pathway.
Stomach Neoplasms
Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9.
Stomach Neoplasms
Association and Prognostic Significance of the Functional -1562C/T Polymorphism in the Promoter Region of MMP-9 in Turkish Patients with Gastric Cancer.
Stomach Neoplasms
Association of CXCR1 and 2 expressions with gastric cancer metastasis in ex vivo and tumor cell invasion in vitro.
Stomach Neoplasms
Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.
Stomach Neoplasms
Blockade of CXCR6 reduces invasive potential of gastric cancer cells through inhibition of AKT signaling.
Stomach Neoplasms
Blockade of NF-?B nuclear translocation results in the inhibition of the invasiveness of human gastric cancer cells.
Stomach Neoplasms
Chrysin inhibits tumor promoter-induced MMP-9 expression by blocking AP-1 via suppression of ERK and JNK pathways in gastric cancer cells.
Stomach Neoplasms
Circular RNA 0000096 affects cell growth and migration in gastric cancer.
Stomach Neoplasms
Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer.
Stomach Neoplasms
Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer.
Stomach Neoplasms
Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma.
Stomach Neoplasms
Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
Stomach Neoplasms
Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer.
Stomach Neoplasms
Clinicopathological correlation of keratinocyte growth factor and matrix metalloproteinase-9 expression in human gastric cancer.
Stomach Neoplasms
Co-evolution of cancer microenvironment reveals distinctive patterns of gastric cancer invasion: laboratory evidence and clinical significance.
Stomach Neoplasms
Coronin 3 promotes gastric cancer metastasis via the up-regulation of MMP-9 and cathepsin K.
Stomach Neoplasms
Correlation of Vascular Endothelial Growth Factor Expression With Tumor Recurrence and Poor Prognosis in Patients With pN0 Gastric Cancer.
Stomach Neoplasms
Correlative studies on bFGF mRNA and MMP-9 mRNA expressions with microvascular density, progression, and prognosis of gastric carcinomas.
Stomach Neoplasms
CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production.
Stomach Neoplasms
Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer.
Stomach Neoplasms
Effect and prognostic significance of the KAI1 gene in human gastric carcinoma.
Stomach Neoplasms
Effect of BRMS1 expression on proliferation, migration and adhesion of mouse forestomach carcinoma.
Stomach Neoplasms
Effect of geldanamycin on the expression of the matrix molecules and angiogenetic factors in a gastric cancer cell line.
Stomach Neoplasms
Effect of glutamine-enriched nutritional support on intestinal mucosal barrier function, MMP-2, MMP-9 and immune function in patients with advanced gastric cancer during perioperative chemotherapy.
Stomach Neoplasms
Effect of hGC-MSCs from human gastric cancer tissue on cell proliferation, invasion and epithelial-mesenchymal transition in tumor tissue of gastric cancer tumor-bearing mice.
Stomach Neoplasms
Effects of caffeic acid phenethyl ester on matrix molecules and angiogenetic and anti-angiogenetic factors in gastric cancer cells cultured on different substrates.
Stomach Neoplasms
Effects of LY294002 on the invasiveness of human gastric cancer in vivo in nude mice.
Stomach Neoplasms
EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells.
Stomach Neoplasms
Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer.
Stomach Neoplasms
Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer.
Stomach Neoplasms
Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer.
Stomach Neoplasms
Erratum: Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP-2 and MMP-9 expression via the p38MAPK signaling pathway.
Stomach Neoplasms
Evaluation of Important Molecular Pathways and Candidate Diagnostic Biomarkers of Noninvasive to Invasive Stages in Gastric Cancer by In Silico Analysis.
Stomach Neoplasms
Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor.
Stomach Neoplasms
Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis.
Stomach Neoplasms
Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in gastric cancer.
Stomach Neoplasms
Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Stomach Neoplasms
Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and their relation to claudin-4 expression.
Stomach Neoplasms
Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
Stomach Neoplasms
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma.
Stomach Neoplasms
Expression of Vav3 protein and its prognostic value in patients with gastric cancer.
Stomach Neoplasms
Fentanyl inhibits the progression of gastric cancer through the suppression of MMP-9 via the PI3K/Akt signaling pathway.
Stomach Neoplasms
First evidence that g-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-kB pathway.
Stomach Neoplasms
Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Stomach Neoplasms
Gastrin-stimulated gastric epithelial cell invasion: the role and mechanism of increased matrix metalloproteinase 9 expression.
Stomach Neoplasms
Ginkgolic acid (GA) suppresses gastric cancer growth by inducing apoptosis and suppressing STAT3/JAK2 signaling regulated by ROS.
Stomach Neoplasms
Heat shock protein 60 overexpression is associated with the progression and prognosis in gastric cancer.
Stomach Neoplasms
Helicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2-mediated pathway.
Stomach Neoplasms
High expression of heat shock protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer.
Stomach Neoplasms
Hypoxia promotes metastasis in human gastric cancer by up-regulating the 67-kDa laminin receptor.
Stomach Neoplasms
IL-22 promotes the migration and invasion of gastric cancer cells via IL-22R1/AKT/MMP-9 signaling.
Stomach Neoplasms
Inhibition of histone deacetylase activity down-regulates urokinase plasminogen activator and matrix metalloproteinase-9 expression in gastric cancer.
Stomach Neoplasms
Integrin ?v?6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Stomach Neoplasms
Interleukin-8 is associated with adhesion, migration and invasion in human gastric cancer SCG-7901 cells.
Stomach Neoplasms
Kiss-1 suppresses MMP-9 expression by activating p38 MAP kinase in human stomach cancer.
Stomach Neoplasms
LOX inhibition downregulates MMP-2 and MMP-9 in gastric cancer tissues and cells.
Stomach Neoplasms
Matrix metalloproteinase gene expressions might be oxidative stress targets in gastric cancer cell lines.
Stomach Neoplasms
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.
Stomach Neoplasms
Matrix metalloproteinase-9 as a prognostic factor in gastric cancer: a meta-analysis.
Stomach Neoplasms
Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer.
Stomach Neoplasms
Melanoma differentiation-associated gene-7 suppresses human gastric cancer cell invasion and migration.
Stomach Neoplasms
Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-?B pathway, and MMP-9 expression.
Stomach Neoplasms
MicroRNA-524-5p suppresses the growth and invasive abilities of gastric cancer cells.
Stomach Neoplasms
microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1.
Stomach Neoplasms
miR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer.
Stomach Neoplasms
MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.
Stomach Neoplasms
MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma.
Stomach Neoplasms
MMP-9 -1562 Promoter Polymorphism Associated with Gastric Cancer Risk in Females.
Stomach Neoplasms
MMP-9 is increased in the pathogenesis of gastric cancer by the mediation of HER2.
Stomach Neoplasms
MMP-9 secreted by tumor associated macrophages promoted gastric cancer metastasis through a PI3K/AKT/Snail pathway.
Stomach Neoplasms
Mutation analysis of tumor suppressor gene PTEN in patients with gastric carcinomas and its impact on PI3K/AKT pathway.
Stomach Neoplasms
Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms.
Stomach Neoplasms
NDRG1 Controls Gastric Cancer Migration and Invasion through Regulating MMP-9.
Stomach Neoplasms
NDRG1 expression is related to the progression and prognosis of gastric cancer patients through modulating proliferation, invasion and cell cycle of gastric cancer cells.
Stomach Neoplasms
Notch1 and PI3K/Akt signaling blockers DAPT and LY294002 coordinately inhibit metastasis of gastric cancer through mutual enhancement.
Stomach Neoplasms
Osteopontin promotes the progression of gastric cancer through the NF-?B pathway regulated by the MAPK and PI3K.
Stomach Neoplasms
Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Stomach Neoplasms
Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
Stomach Neoplasms
Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
Stomach Neoplasms
Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients.
Stomach Neoplasms
Prognostic and clinical significance of STAT3 and MMP9 in patients with gastric cancer: a meta-analysis of a Chinese cohort.
Stomach Neoplasms
Prognostic value of matrix metalloproteinase-9 in gastric cancer: a meta-analysis.
Stomach Neoplasms
Prognostic Value of Tumor-Related Molecular Expression in Gastric Carcinoma.
Stomach Neoplasms
PTEN Gene Induces Cell Invasion and Migration via Regulating AKT/GSK-3?/?-Catenin Signaling Pathway in Human Gastric Cancer.
Stomach Neoplasms
Qi Ling decoction reduces gastric cancer cell metastasis by inhibiting MMP-9 through the PI3K/Akt signaling pathway.
Stomach Neoplasms
RABEX-5 overexpression in gastric cancer is correlated with elevated MMP-9 level.
Stomach Neoplasms
Reduced expression of tissue inhibitor of metalloproteinase in nodal metastasis of stomach cancer.
Stomach Neoplasms
Regulation of HGF-mediated cell proliferation and invasion through NF-?B, JunB, and MMP-9 cascades in stomach cancer cells.
Stomach Neoplasms
Relation of Matrix Metalloproteinase-9 to Different Stages of Tumors in the Serum of Gastric Cancer.
Stomach Neoplasms
Relationship between clinicopathological features and HIF-2? in gastric adenocarcinoma.
Stomach Neoplasms
Relationship between preoperative staging by endoscopic ultrasonography and MMP-9 expression in gastric carcinoma.
Stomach Neoplasms
Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer.
Stomach Neoplasms
Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells.
Stomach Neoplasms
Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers.
Stomach Neoplasms
Serum matrix metalloproteinase-9 level associated with stromal reaction in patients with gastric cancer.
Stomach Neoplasms
Silencing of EphA2 inhibits invasion of human gastric cancer SGC-7901 cells in vitro and in vivo.
Stomach Neoplasms
Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP-2 and MMP-9 expression via the p38MAPK signaling pathway.
Stomach Neoplasms
Silibinin suppresses TNF-alpha-induced MMP-9 expression in gastric cancer cells through inhibition of the MAPK pathway.
Stomach Neoplasms
Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products.
Stomach Neoplasms
Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer.
Stomach Neoplasms
Src/ERK but not phospholipase D is involved in keratinocyte growth factor-stimulated secretion of matrix metalloprotease-9 and urokinase-type plasminogen activator in SNU-16 human stomach cancer cell.
Stomach Neoplasms
Stimulation of Peritoneal Mesothelial Cells to Secrete Matrix Metalloproteinase-9 (MMP-9) by TNF-?: A Role in the Invasion of Gastric Carcinoma Cells.
Stomach Neoplasms
Stomach Cancer: Interconnection between the Redox State, Activity of MMP-2, MMP-9 and Stage of Tumor Growth.
Stomach Neoplasms
Study of the Relationship between MMP-2 and MMP-9 and Her2/neu Overexpression in Gastric Cancer: Clinico- Pathological Correlations.
Stomach Neoplasms
The association of matrix metalloproteinase-9 promoter polymorphisms with gastric cancer risk: a meta-analysis.
Stomach Neoplasms
The influence of transforming growth factor-?, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
Stomach Neoplasms
THE ROLE OF SERUM CK-18, MMP-9 AND TIPM-1 LEVELS IN PREDICTING R0 RESECTION IN PATIENTS WITH GASTRIC CANCER.
Stomach Neoplasms
The Role of Serum CK18, TIMP1, and MMP-9 Levels in Predicting R0 Resection in Patients with Gastric Cancer.
Stomach Neoplasms
The validation of matrix metalloproteinase-9 mRNA gene expression as a predictor of outcome in patients with metastatic gastric cancer.
Stomach Neoplasms
TMPRSS4 promotes invasiveness of human gastric cancer cells through activation of NF-?B/MMP-9 signaling.
Stomach Neoplasms
Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer.
Stomach Neoplasms
Upregulation of circulating cytokeratin 20, urokinase plasminogen activator and C-reactive protein is associated with poor prognosis in gastric cancer.
Stomach Neoplasms
Urinary ADAM12 and MMP-9/NGAL Complex Detect the Presence of Gastric Cancer.
Stomach Neoplasms
ZBTB20 promotes cell migration and invasion of gastric cancer by inhibiting I?B? to induce NF-?B activation.
Stomach Neoplasms
ZNF139 promotes tumor metastasis by increasing migration and invasion in human gastric cancer cells.
Stomach Neoplasms
[A multianalysis study on clinicopathologic factors related to lymph node metastasis in gastric cancer]
Stomach Neoplasms
[Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population.]
Stomach Neoplasms
[Effect of mi-138 targeting PLD2 gene on proliferation and migration of oral cancer cells].
Stomach Neoplasms
[Effect of tumor-associated macrophages on invasion and metastasis of gastric cancer cells].
Stomach Neoplasms
[Effects of FRZB on growth and metastasis of gastric cancer cell line SGC-7901]
Stomach Neoplasms
[Expression of MMP-9 and MMP-9 mRNA in gastric carcinoma and its correlation with angiogenesis]
Stomach Neoplasms
[Expressions of TGIF, MMP9 and VEGF proteins and their clinicopathological relationship in gastric cancer]
Stomach Neoplasms
[Infection with L-form of Helicobacter pylori and expressions of MIF, MMP9 and VEGF in gastric carcinoma].
Stomach Neoplasms
[Osteopontin expression and its relation to invasion and metastases in gastric cancer]
Stomach Neoplasms
[Relationship between bFGF mRNA and MMP-9 mRNA expression in gastric carcinoma and their clinicopathological features as well as patients survival]
Stomach Neoplasms
[Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas]
Stomach Neoplasms
[RETRACTED ARTICLE]: THE ROLE OF SERUM CK-18, MMP-9 AND TIPM-1 LEVELS IN PREDICTING R0 RESECTION IN PATIENTS WITH GASTRIC CANCER.
Stomach Neoplasms
[Significance in gene expression of matrix metalloproteinase-9, urokinase-type plasminogen activator and tissue inhibitor of metalloproteinase for metastases of gastric and/or colo-rectal cancer]
Stomach Neoplasms
[The expression of integrin???6 and MMP-9 in gastric cancer and the correlation with clinicopathologic characteristic].
Stomach Ulcer
Chronic gastric ulceration causes matrix metalloproteinases-9 and -3 augmentation: Alleviation by melatonin.
Stomach Ulcer
Chrysin Modulates Genes Related to Inflammation, Tissue Remodeling, and Cell Proliferation in the Gastric Ulcer Healing.
Stomach Ulcer
Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer.
Stomach Ulcer
Effect of melatonin on secreted and induced matrix metalloproteinase-9 and -2 activity during prevention of indomethacin-induced gastric ulcer.
Stomach Ulcer
Genetic variants in matrix metalloproteinase genes are associated with development of gastric ulcer in H. Pylori infection.
Stomach Ulcer
Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer.
Stomach Ulcer
Increased expression of matrix metalloproteinase-9 associated with gastric ulcer recurrence.
Stomach Ulcer
Induction of matrix metalloproteinase-9 and -3 in nonsteroidal anti-inflammatory drug-induced acute gastric ulcers in mice: regulation by melatonin.
Stomach Ulcer
Matrix metalloproteinase-9 activity and expression is reduced by melatonin during prevention of ethanol-induced gastric ulcer in mice.
Stomach Ulcer
Melatonin inhibits matrix metalloproteinase-9 activity by binding to its active site.
Stomach Ulcer
Novel role of famotidine in downregulation of matrix metalloproteinase-9 during protection of ethanol-induced acute gastric ulcer.
Stomach Ulcer
The use of nano-quercetin to arrest mitochondrial damage and MMP-9 upregulation during prevention of gastric inflammation induced by ethanol in rat.
Stomach Ulcer
Zinc(II)-curcumin accelerates the healing of acetic acid-induced chronic gastric ulcers in rats by decreasing oxidative stress and downregulation of matrix metalloproteinase-9.
Stomach Ulcer
[Role of Allelic Genes of Matrix Metalloproteinases and Their Tissue Inhibitors in the Peptic Ulcer Disease Development].
Stomatitis
Involvement of matrix metalloproteinases (MMP-3 and MMP-9) in the pathogenesis of irinotecan-induced oral mucositis.
Stroke
1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.
Stroke
A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model.
Stroke
A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia.
Stroke
A Lipoxin A(4) Analog Ameliorates Blood-Brain Barrier Dysfunction and Reduces MMP-9 Expression in a Rat Model of Focal Cerebral Ischemia-Reperfusion Injury.
Stroke
A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke.
Stroke
Acute hepatocyte growth factor treatment induces long-term neuroprotection and stroke recovery via mechanisms involving neural precursor cell proliferation and differentiation.
Stroke
Adjudin protects against cerebral ischemia reperfusion injury by inhibition of neuroinflammation and blood-brain barrier disruption.
Stroke
Anticoagulants affect matrix metalloproteinase 9 levels in blood samples of stroke patients and healthy controls.
Stroke
Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
Stroke
Association between serum matrix metalloproteinase-9 and poor prognosis in acute ischemic stroke patients: The role of dyslipidemia.
Stroke
Association between the MMP-9-1562 C>T polymorphism and the risk of stroke: a meta-analysis.
Stroke
Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
Stroke
Association of blood active matrix metalloproteinase-3 with carotid plaque score from a community population in Taiwan.
Stroke
Association of Matrix Metalloproteinase 9 and Cellular Fibronectin and Outcome in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Stroke
Association of matrix metalloproteinases with MRI indices of brain ischemia and aging.
Stroke
Association of MMP-9 Haplotypes and TIMP-1 Polymorphism with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population.
Stroke
Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment.
Stroke
Biomarkers of Unfavorable Outcome in Acute Ischemic Stroke Patients with Successful Recanalization by Endovascular Thrombectomy.
Stroke
Blood biomarkers for the diagnosis and differentiation of stroke: A systematic review and meta-analysis.
Stroke
Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.
Stroke
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Inhibits MMP-9-Mediated Blood-Brain-Barrier Breakdown in a Mouse Model for Ischemic Stroke.
Stroke
Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients.
Stroke
Changes in plasma matrix metalloproteinase-9 levels in patients with acute ischemic stroke.
Stroke
Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events.
Stroke
Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients.
Stroke
Clinical severity of ischemic stroke and neural damage biomarkers In the acute setting: The STROke-MArkers (STROMA) Study.
Stroke
Complexity in differentiating truncated or matured forms of MMP-2 and MMP-9 by zymography in acute ischemic stroke induced rat brain tissues.
Stroke
Connective Tissue Growth Factor Is Associated With a Stable Atherosclerotic Plaque Phenotype and Is Involved in Plaque Stabilization After Stroke.
Stroke
Correlations of inflammatory factors, CCCK-18, MMP-9 and D-Dimer with APACHE II score and prognosis of patients with acute cerebral hemorrhage.
Stroke
Correlative study between serum matrix metalloproteinase 9 values and neurologic deficit in acute, primary, supratentorial, intracerebral haemorrhage.
Stroke
Course of matrix metalloproteinase-9 isoforms after the administration of uric acid in patients with acute stroke: a proof-of-concept study.
Stroke
Critical Role of Matrix Metalloproteinase-9 in Acute Cold Exposure-Induced Stroke in Renovascular Hypertensive Rats.
Stroke
Curcumin ameliorates ischemic stroke injury in rats by protecting the integrity of the blood-brain barrier.
Stroke
Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke.
Stroke
Diabetes mellitus aggravates hemorrhagic transformation after ischemic stroke via mitochondrial defects leading to endothelial apoptosis.
Stroke
Differential immunological profiles herald magnetic resonance imaging-defined perioperative cerebral infarction.
Stroke
Dipyridamole decreases inflammatory metalloproteinase-9 expression and release by human monocytes.
Stroke
Dynamic change of MMP-9 in diabetic stroke visualized by optical imaging and treated with CD28 superagonist.
Stroke
Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction.
Stroke
Effect of Tianhuang Granule on intracranial pressure and serum matrix metalloproteinase-9 in patients with acute cerebral hemorrhage.
Stroke
Effects of ezetimibe and anticoagulant combined therapy on progressing stroke: a randomized, placebo-controlled study.
Stroke
Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis.
Stroke
EMMPRIN/CD147 plays a detrimental role in clinical and experimental ischemic stroke.
Stroke
Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke.
Stroke
Engineering autoactivating forms of matrix metalloproteinase-9 and expression of the active enzyme in cultured cells and transgenic mouse brain.
Stroke
Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke.
Stroke
Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice.
Stroke
Exercise pre-conditioning reduces brain inflammation in stroke via tumor necrosis factor-alpha, extracellular signal-regulated kinase 1/2 and matrix metalloproteinase-9 activity.
Stroke
Fisetin Prolongs Therapy Window of Brain Ischemic Stroke Using Tissue Plasminogen Activator: A Double-Blind Randomized Placebo-Controlled Clinical Trial.
Stroke
Fluid-attenuated inversion recovery hyperintensity correlates with matrix metalloproteinase-9 level and hemorrhagic transformation in acute ischemic stroke.
Stroke
Genetic Deletion or Pharmacological Inhibition of Cyclooxygenase-2 Reduces Blood-Brain Barrier Damage in Experimental Ischemic Stroke.
Stroke
Ginsenoside Represses Symptomatic Intracerebral Hemorrhage after Recombinant Tissue Plasminogen Activator Therapy by Promoting Transforming Growth Factor-?1.
Stroke
Human neural stem cells improve early stage stroke outcome in delayed tissue plasminogen activator-treated aged stroke brains.
Stroke
Hyperthermia in human ischemic and hemorrhagic stroke: similar outcome, different mechanisms.
Stroke
Hypoxia Response Element-Regulated MMP-9 Promotes Neurological Recovery via Glial Scar Degradation and Angiogenesis in Delayed Stroke.
Stroke
Hypoxia-controlled matrix metalloproteinase-9 hyperexpression promotes behavioral recovery after ischemia.
Stroke
Impaired vascular remodeling after endothelial progenitor cell transplantation in MMP9-deficient mice suffering cortical cerebral ischemia.
Stroke
Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke.
Stroke
Increase in plasma matrix metalloproteinase-9 in acute stroke patients with thrombolysis failure.
Stroke
Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke.
Stroke
Increased brain microvascular MMP-9 and incidence of haemorrhagic transformation in obese mice after experimental stroke.
Stroke
Increased cerebral matrix metalloprotease-9 activity is associated with compromised recovery in the diabetic db/db mouse following a stroke.
Stroke
Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption.
Stroke
Increased MMP-9 activity in acute carotid plaques: therapeutic avenues to prevent stroke.
Stroke
Increased plasma and tissue MMP levels are associated with BCSFB and BBB disruption evident on post-contrast FLAIR after experimental stroke.
Stroke
Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
Stroke
Inflammatory marker expression and its implication in Korean ischemic stroke patients.
Stroke
Inhibition of Gelatinases (MMP-2 and MMP-9) by Withania somnifera Phytochemicals Confers Neuroprotection in Stroke: An In Silico Analysis.
Stroke
Interactions among variants in P53 apoptotic pathway genes are associated with neurologic deterioration and functional outcome after acute ischemic stroke.
Stroke
Intranasal Delivery of Apelin-13 Is Neuroprotective and Promotes Angiogenesis After Ischemic Stroke in Mice.
Stroke
Involvement of Matrix Metalloproteinase 9 in Vertebral Arterial Dissection With Posterior Circulation Ischemic Stroke.
Stroke
Involvement of thromboxane A2 receptor in the cerebrovascular damage of salt-loaded, stroke-prone rats.
Stroke
Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia.
Stroke
Matrix metalloproteinase 9 mRNA: An early prognostic marker for patients with acute stroke.
Stroke
Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
Stroke
Matrix metalloproteinase-9 (MMP-9) expression and extracellular signal-regulated kinase 1 and 2 (ERK1/2) activation in exercise-reduced neuronal apoptosis after stroke.
Stroke
Matrix Metalloproteinase-9 and Monocyte Chemoattractant Protein-1 Are Associated With Collateral Status in Acute Ischemic Stroke With Large Vessel Occlusion.
Stroke
Matrix metalloproteinase-9 and myeloperoxidase expression: quantitative analysis by antigen immunohistochemistry in a model of transient focal cerebral ischemia.
Stroke
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Stroke
Matrix Metalloproteinase-9 as a Marker for Acute Ischemic Stroke: A Systematic Review.
Stroke
Matrix metalloproteinase-9 expression in the nuclear compartment of neurons and glial cells in aging and stroke.
Stroke
Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke.
Stroke
Matrix metalloproteinase-9 gene polymorphisms and their interaction with environment on subarachnoid hemorrhage risk.
Stroke
Matrix metalloproteinase-9 gene polymorphisms are associated with ischemic stroke severity and early neurologic deterioration in patients with atrial fibrillation.
Stroke
Matrix Metalloproteinase-9 Mediates the Deleterious Effects of ?2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.
Stroke
Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.
Stroke
Measurement of a plasma stroke biomarker panel and cardiac troponin T in marathon runners before and after the 2005 Boston marathon.
Stroke
Melatonin improves neuroplasticity by upregulating the growth-associated protein-43 (GAP-43) and NMDAR postsynaptic density-95 (PSD-95) proteins in cultured neurons exposed to glutamate excitotoxicity and in rats subjected to transient focal cerebral ischemia even during a long-term recovery period.
Stroke
Melatonin reduced the elevated matrix metalloproteinase-9 level in a rat photothrombotic stroke model.
Stroke
Metalloproteinases and their inhibitors are associated with pulmonary arterial stiffness and ventricular function in pediatric pulmonary hypertension.
Stroke
Microvascular thrombosis, fibrinolysis, ischemic injury, and death after cerebral thromboembolism are affected by levels of circulating ?2-antiplasmin.
Stroke
Minocycline and matrix metalloproteinase inhibition in acute intracerebral hemorrhage: a pilot study.
Stroke
MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke.
Stroke
MPO is partially associated with neutrophil deleterious effect in acute cerebral ischemia.
Stroke
Multiple biomarkers covering several pathways for the prediction of depression after ischemic stroke.
Stroke
Neural Progenitor Cell-Derived Extracellular Vesicles Enhance Blood-Brain Barrier Integrity by NF-?B (Nuclear Factor-?B)-Dependent Regulation of ABCB1 (ATP-Binding Cassette Transporter B1) in Stroke Mice.
Stroke
New insights into mechanism for the effect of resveratrol preconditioning against cerebral ischemic stroke: Possible role of matrix metalloprotease-9.
Stroke
Niaspan reduces high-mobility group box 1/receptor for advanced glycation endproducts after stroke in type-1 diabetic rats.
Stroke
Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke.
Stroke
Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
Stroke
Optical Interference-Free Surface-Enhanced Raman Scattering CO-Nanotags for Logical Multiplex Detection of Vascular Disease-Related Biomarkers.
Stroke
Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study.
Stroke
Peripheral blood levels of matrix metalloproteinase-9 predict lesion volume in acute stroke.
Stroke
Peroxynitrite decomposition catalyst prevents matrix metalloproteinase-9 activation and neurovascular injury after hemoglobin injection into the caudate nucleus of rats.
Stroke
Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats.
Stroke
Plasma Glial Fibrillary Acidic Protein, Copeptin, and Matrix Metalloproteinase-9 Concentrations among West African Stroke Subjects Compared with Stroke-Free Controls.
Stroke
Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.
Stroke
Plasma levels of matrix metalloproteinase-9: A possible marker for cold-induced stroke risk in hypertensive rats.
Stroke
Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke.
Stroke
Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke.
Stroke
Predictive value of plasma matrix metalloproteinase-9 concentrations for spontaneous haemorrhagic transformation in patients with acute ischaemic stroke: A cohort study in Chinese patients.
Stroke
Preischemic induction of TNF-alpha by physical exercise reduces blood-brain barrier dysfunction in stroke.
Stroke
Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women.
Stroke
Protective effect of ginsenoside Rb1 on integrity of blood-brain barrier following cerebral ischemia.
Stroke
Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats.
Stroke
Protective effects of Vitex agnus-castus in ovariectomy mice following permanent middle cerebral artery occlusion.
Stroke
Reduction of tissue plasminogen activator-induced matrix metalloproteinase-9 by simvastatin in astrocytes.
Stroke
Relationship between matrix metalloproteinase-9 and common carotid artery intima media thickness.
Stroke
Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke.
Stroke
Renin-angiotensin system activation and imbalance of matrix metalloproteinase-9/tissue inhibitor of matrix metalloproteinase-1 in cold-induced stroke.
Stroke
Rutin improves functional outcome via reducing the elevated matrix metalloproteinase-9 level in a photothrombotic focal ischemic model of rats.
Stroke
Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
Stroke
Serum Matrix Metalloproteinase-9 and Cognitive Impairment After Acute Ischemic Stroke.
Stroke
Serum Matrix Metalloproteinase-9 Is Associated With Depression After Acute Ischemic Stroke.
Stroke
Simvastatin could prevent increase of the serum MMP-9/TIMP-1 ratio in acute ischaemic stroke.
Stroke
Spreading Depressions and Periinfarct Spreading Depolarizations in the Context of Cortical Plasticity.
Stroke
Synaptic cell adhesion molecule-2 and collapsin response mediator protein-2 are novel members of the matrix metalloproteinase-9 degradome.
Stroke
Temporal profile of molecular signatures associated with circulating endothelial progenitor cells in human ischemic stroke.
Stroke
The effects of memantine on the serum concentrations of matrix metalloproteinases and neurologic function of patients with ischemic stroke.
Stroke
The effects of previous statin treatment on plasma matrix metalloproteinase-9 level in chinese stroke patients undergoing thrombolysis.
Stroke
The expression of matrix metalloproteinase-13 is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.
Stroke
The role of carotid plaque vulnerability and inflammation in the pathogenesis of acute ischemic stroke.
Stroke
The role of neutrophils in mediating stroke injury in the diabetic db/db mouse brain following hypoxia-ischemia.
Stroke
The role of progestogens in regulating matrix metalloproteinase activity in macrophages and microglial cells.
Stroke
The Sigma-1 Receptor Antagonist, S1RA, Reduces Stroke Damage, Ameliorates Post-Stroke Neurological Deficits and Suppresses the Overexpression of MMP-9.
Stroke
The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.
Stroke
Therapeutic Target and Cell-signal Communication of Chlorpromazine and Promethazine in Attenuating Blood-Brain Barrier Disruption after Ischemic Stroke.
Stroke
Thrombopoietin could protect cerebral tissue against ischemia-reperfusion injury by suppressing NF-?B and MMP-9 expression in rats.
Stroke
Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release.
Stroke
Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.
Stroke
Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
Stroke
Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke.
Stroke
Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
Stroke
Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia.
Stroke
Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke.
Stroke
[Alterations of serum neurospecific proteins concentrations in patients with metabolic syndrome].
Stroke
[Matrix metalloproteinase-9 expression by endothelial cells incubated with peripheral blood leukocytes from patients with cerebral infarction]
Stroke
[Study on relationship between constitution and syndrome of MMP-9, IL-6 and MTHFR gene in patients with ischemic stroke].
Stroke
[The relationship between matrix metalloproteinase-9, high-sensitivity C-reactive protein and stroke of stable stage].
Stroke, Lacunar
Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke.
Stroke, Lacunar
Microbleeds and free active MMP-9 are independent risk factors for neurological deterioration in acute lacunar stroke.
Stroke, Lacunar
Neutrophil Infiltration and Matrix Metalloproteinase-9 in Lacunar Infarction.
Stroke, Lacunar
The role of matrix metalloproteinase 9 in early neurological worsening of acute lacunar infarction.
stromelysin 1 deficiency
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response.
Subacute Sclerosing Panencephalitis
Cerebrospinal fluid levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in subacute sclerosing panencephalitis.
Subacute Sclerosing Panencephalitis
Serum levels of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in subacute sclerosing panencephalitis.
Subarachnoid Hemorrhage
A therapeutic target of cerebral hemorrhagic stroke: matrix metalloproteinase-9.
Subarachnoid Hemorrhage
Astaxanthin reduces matrix metalloproteinase-9 expression and activity in the brain after experimental subarachnoid hemorrhage in rats.
Subarachnoid Hemorrhage
Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage.
Subarachnoid Hemorrhage
Correlation of MMP-9 gene polymorphisms with aneurysmal subarachnoid hemorrhage and its prognosis.
Subarachnoid Hemorrhage
Cyclosporine A alleviated matrix metalloproteinase 9 associated blood-brain barrier disruption after subarachnoid hemorrhage in mice.
Subarachnoid Hemorrhage
Elevated Peripheral Neutrophils and Matrix Metalloproteinase 9 as Biomarkers of Functional Outcome Following Subarachnoid Hemorrhage.
Subarachnoid Hemorrhage
Expression of MMP-9 and IL-6 in patients with subarachnoid hemorrhage and the clinical significance.
Subarachnoid Hemorrhage
Hydrogen sulfide attenuates brain edema in early brain injury after subarachnoid hemorrhage in rats: Possible involvement of MMP-9 induced blood-brain barrier disruption and AQP4 expression.
Subarachnoid Hemorrhage
Matrix metalloproteinase 9 inhibition reduces early brain injury in cortex after subarachnoid hemorrhage.
Subarachnoid Hemorrhage
Matrix metalloproteinase 9 may be involved in contraction of vascular smooth muscle cells in an in vitro rat model of subarachnoid hemorrhage.
Subarachnoid Hemorrhage
Matrix metalloproteinase-9 concentration in the cerebral extracellular fluid of patients during the acute phase of aneurysmal subarachnoid hemorrhage.
Subarachnoid Hemorrhage
Matrix metalloproteinase-9 gene polymorphisms and their interaction with environment on subarachnoid hemorrhage risk.
Subarachnoid Hemorrhage
Matrix metalloproteinase-9 potentiates early brain injury after subarachnoid hemorrhage.
Subarachnoid Hemorrhage
Measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm.
Subarachnoid Hemorrhage
Minocycline protects against delayed cerebral ischemia after subarachnoid hemorrhage via matrix metalloproteinase-9 inhibition.
Subarachnoid Hemorrhage
MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage.
Subarachnoid Hemorrhage
MMP-9 expression and activity is concurrent with endothelial cell apoptosis in the basilar artery after subarachnoid hemorrhaging in rats.
Subarachnoid Hemorrhage
Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage.
Subarachnoid Hemorrhage
Potential contribution of hypoxia-inducible factor-1?, aquaporin-4, and matrix metalloproteinase-9 to blood-brain barrier disruption and brain edema after experimental subarachnoid hemorrhage.
Subarachnoid Hemorrhage
Potential contribution of matrix metalloproteinase-9 (mmp-9) to cerebral vasospasm after experimental subarachnoid hemorrhage in rats.
Subarachnoid Hemorrhage
Role of matrix metalloproteinase-9 in apoptosis of hippocampal neurons in rats during early brain injury after subarachnoid hemorrhage.
Subarachnoid Hemorrhage
S100B, NSE and MMP-9 fail to predict neurologic outcome while elevated S100B associates with milder initial clinical presentation after aneurysmal subarachnoid hemorrhage.
Subarachnoid Hemorrhage
Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Subarachnoid Hemorrhage
Toll-like receptor 4 mediates blood-brain barrier permeability and disease in C3H mice during Venezuelan equine encephalitis virus infection.
Subarachnoid Hemorrhage
White Matter Injury After Subarachnoid Hemorrhage: Role of Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9.
Subarachnoid Hemorrhage
[Role of acute alcohol poisoning and craniocerebral trauma in the mechanism of death caused by subarachnoid hemorrhage].
Subdural Effusion
[Role of matrix metalloproteinase in transformation of subdural effusion into chronic subdural hematoma]
Sunburn
A topical formulation containing quercetin-loaded microcapsules protects against oxidative and inflammatory skin alterations triggered by UVB irradiation: enhancement of activity by microencapsulation.
Sunburn
Lipoxin A4 inhibits UV radiation-induced skin inflammation and oxidative stress in mice.
Sunburn
Protective effects of a topical antioxidant mixture containing vitamin C, ferulic acid, and phloretin against ultraviolet-induced photodamage in human skin.
Sunburn
Topical emulsion containing pyrrolidine dithiocarbamate: effectiveness against ultraviolet B irradiation-induced injury of hairless mouse skin.
Sweet Syndrome
Inflammatory cells, cytokines and matrix metalloproteinases in amicrobial pustulosis of the folds and other neutrophilic dermatoses.
Sweet Syndrome
Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases.
Synovitis
Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
Synovitis
Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
Synovitis
The significance of altered gelatinase expression in the synovium of patient with arthritic effusions.
Syringomyelia
[Relationship between expression of MMP-9 and presyrinx state of experimental syringomyelia of rabbits].
Systemic Vasculitis
Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease.
Systemic Vasculitis
Plasma levels of matrix metalloproteinase-9 in Henoch-Schönlein purpura.
Takayasu Arteritis
MMP-9 and IL-6 are potential biomarkers for disease activity in Takayasu's arteritis.
Takayasu Arteritis
Serum MMP-2 and MMP-9 in patients with Behçet's disease: Do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Temporomandibular Joint Disorders
Association of Functional Polymorphisms in Matrix Metalloproteinase-9 and Glutathione S-Transferase T1 Genes with Temporomandibular Disorders.
Temporomandibular Joint Disorders
MMPs in tissues retrieved during surgery from patients with TMJ disorders relate to pain more than to radiological damage score.
Teratocarcinoma
Imbalance of MMP-2 and MMP-9 expression versus TIMP-1 and TIMP-2 reflects increased invasiveness of human testicular germ cell tumours.
Teratoma
MIF produced by bone marrow-derived macrophages contributes to teratoma progression after embryonic stem cell transplantation.
Teratoma
Tissue inhibitor of metalloproteinase proteins inhibit teratoma growth in mice transplanted with pluripotent stem cells.
Teratoma
Tumorigenic Development of Induced Pluripotent Stem Cells in Ischemic Mouse Brain.
Testicular Neoplasms
Imbalance of MMP-2 and MMP-9 expression versus TIMP-1 and TIMP-2 reflects increased invasiveness of human testicular germ cell tumours.
Testicular Neoplasms
Inhibitory effects of a nutrient mixture on human testicular cancer cell line NT 2/DT matrigel invasion and MMP activity.
Testicular Neoplasms
[Regulatory effect of the pannexin1 channel on invasion and migration of testicular cancer Tcam-2 cells and its possible mechanism].
Tetralogy of Fallot
Modulating effects of matrix metalloproteinase-3 and -9 polymorphisms on aortic stiffness and aortic root dilation in patients after tetralogy of Fallot repair.
Thromboangiitis Obliterans
Imbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans.
Thromboangiitis Obliterans
Increased serum HMGB-1, ICAM-1 and Metalloproteinase-9 levels in Buerger's patients.
Thrombocytopenia
Inhaled nitric oxide inhibits the release of matrix metalloproteinase-2, but not platelet activation, during extracorporeal membrane oxygenation in adult rabbits.
Thrombocytosis
Importance of plasma matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinase (TIMP) in development of fibrosis in agnogenic myeloid metaplasia.
Thromboembolism
Microvascular thrombosis, fibrinolysis, ischemic injury, and death after cerebral thromboembolism are affected by levels of circulating ?2-antiplasmin.
Thrombosis
A lower admission level of interleukin-6 is associated with first-pass effect in ischemic stroke patients.
Thrombosis
Absence of IFN-? accelerates thrombus resolution through enhanced MMP-9 and VEGF expression in mice.
Thrombosis
Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease.
Thrombosis
Aneurysm Organization Effects of Gellan Sulfate Core Platinum Coil with Tenascin-C in a Simulated Clinical Setting and the Possible Mechanism.
Thrombosis
Association Between High Serum Matrix Metalloproteinase-9 and MMP-9 (-1562C>T) Polymorphism in Patients With ST-Elevation Acute Myocardial Infarction.
Thrombosis
Caveolin-1 influences vascular protease activity and is a potential stabilizing factor in human atherosclerotic disease.
Thrombosis
Contribution of the TNF-? (Tumor Necrosis Factor-?)-TNF-Rp55 (Tumor Necrosis Factor Receptor p55) Axis in the Resolution of Venous Thrombus.
Thrombosis
Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model.
Thrombosis
Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm.
Thrombosis
Differences in carotid plaque content of macrophages, T cells and MMP-9 between patients with embolic and hemodynamic cerebral ischemia due to symptomatic carotid stenosis.
Thrombosis
Differential expression of 92-kDa gelatinase in primary atherosclerotic versus restenotic coronary lesions.
Thrombosis
Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management.
Thrombosis
Dynamic expression of the main related indicators of thrombosis, inflammatory reaction and tissue damage in a rat model of myocardial infarction.
Thrombosis
Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model.
Thrombosis
Expression changes and roles of matrix metalloproteinases in a rat model of traumatic deep vein thrombosis.
Thrombosis
Granulocytes in coronary thrombus evolution after myocardial infarction - time-dependent changes in expression of matrix metalloproteinases.
Thrombosis
Immunohistochemical detection of MMP-2 and MMP-9 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation.
Thrombosis
Increase in plasma matrix metalloproteinase-9 in acute stroke patients with thrombolysis failure.
Thrombosis
Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms.
Thrombosis
Local Matrix Metalloproteinase 9 Level Determines Early Clinical Presentation of ST-Segment-Elevation Myocardial Infarction.
Thrombosis
Matrix Metalloproteinase 9 (MMP-9) Regulates Vein Wall Biomechanics in Murine Thrombus Resolution.
Thrombosis
Matrix metalloproteinase-9 expression in post-hypoxic human brain capillary endothelial cells: H2O2 as a trigger and NF-kappaB as a signal transducer.
Thrombosis
Microvascular thrombosis, fibrinolysis, ischemic injury, and death after cerebral thromboembolism are affected by levels of circulating ?2-antiplasmin.
Thrombosis
MMP-9, homocysteine and CRP circulating levels are associated with intraluminal thrombus thickness of abdominal aortic aneurysms: new implication of the old biomarkers.
Thrombosis
MR imaging of iron phagocytosis in intraluminal thrombi of abdominal aortic aneurysms in humans.
Thrombosis
Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Thrombosis
Overexpression of matrix metalloproteinase-9 promotes intravascular thrombus formation in porcine coronary arteries in vivo.
Thrombosis
Physiologic variations in blood plasminogen levels affect outcomes after acute cerebral thromboembolism in mice: a pathophysiologic role for microvascular thrombosis.
Thrombosis
Platelet-Associated Matrix Metalloproteinases Regulate Thrombus Formation and Exert Local Collagenolytic Activity.
Thrombosis
Pre-Clinical Model to Study Recurrent Venous Thrombosis in the Inferior Vena Cava.
Thrombosis
Protective effects of S-nitrosoalbumin on lung injury induced by hypoxia-reoxygenation in mouse model of sickle cell disease.
Thrombosis
Resistin Promotes Thrombosis in Rats with Deep Vein Thrombosis via Up-Regulating MMP-2, MMP-9, and PAI-1.
Thrombosis
Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?
Thrombosis
Spatial differences of matrix metalloproteinase-2 and matrix metalloproteinase-9 within abdominal aortic aneurysm wall and intraluminal thrombus.
Thrombosis
Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity.
Thrombosis
[Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma]
Thymoma
Expression of matrix metalloproteinases 2 and 7 in tumor cells correlates with the World Health Organization classification subtype and clinical stage of thymic epithelial tumors.
Thymoma
METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion.
Thymoma
[Correlation between MMP-2 activation and MT1-MMP mRNA expression in thymic epithelial tumors]
Thyroid Cancer, Papillary
Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 induction.
Thyroid Cancer, Papillary
Clinical value of matrix metalloproteinase-2 and -9 in ultrasound-guided radiofrequency ablation treatment for papillary thyroid carcinoma.
Thyroid Cancer, Papillary
Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma.
Thyroid Cancer, Papillary
Correlations between papillary thyroid cancer and peripheral blood levels of matrix metalloproteinase-2, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and tissue inhibitor of metalloproteinase-2.
Thyroid Cancer, Papillary
Curcumin inhibits the metastasis of K1 papillary thyroid cancer cells via modulating E-cadherin and matrix metalloproteinase-9 expression
Thyroid Cancer, Papillary
Curcumin inhibits the metastasis of K1 papillary thyroid cancer cells via modulating E-cadherin and matrix metalloproteinase-9 expression.
Thyroid Cancer, Papillary
Enhanced activation of matrix metalloproteinase-9 correlates with the degree of papillary thyroid carcinoma infiltration.
Thyroid Cancer, Papillary
Expression of TGF-?1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.
Thyroid Cancer, Papillary
Immunohistochemical analysis of matrix metalloproteinase-9 predicts papillary thyroid carcinoma prognosis.
Thyroid Cancer, Papillary
Immunohistochemical Demonstration of Membrane-bound Prostaglandin E(2) Synthase-1 in Papillary Thyroid Carcinoma.
Thyroid Cancer, Papillary
Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
Thyroid Cancer, Papillary
LAMB3 mediates metastatic tumor behavior in papillary thyroid cancer by regulating c-MET/Akt signals.
Thyroid Cancer, Papillary
Long Noncoding RNA LINC00460 Modulates MMP-9 to Promote Cell Proliferation, Invasion and Apoptosis by Targeting miR-539 in Papillary Thyroid Cancer.
Thyroid Cancer, Papillary
Matrix metalloproteinase-9 and the cu/zn ratio as ancillary diagnostic tools in distinguishing between the classical and follicular variants of papillary thyroid carcinoma.
Thyroid Cancer, Papillary
MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
Thyroid Cancer, Papillary
Predictive Significance of Serum MMP-9 in Papillary Thyroid Carcinoma.
Thyroid Cancer, Papillary
Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.
Thyroid Cancer, Papillary
Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.
Thyroid Cancer, Papillary
Serum Matrix metalloproteinase-9 (MMP-9) can help identify patients with papillary thyroid cancer at high risk of persistent disease: Value and limitations of a potential marker of neoplasia.
Thyroid Cancer, Papillary
The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer.
Thyroid Cancer, Papillary
Values of ultrasound features and MMP-9 of papillary thyroid carcinoma in predicting cervical lymph node metastases.
Thyroid Cancer, Papillary
[Correlations of serous levels of matrix metalloproteinases (MMP-2 and MMP-9) to invasion and metastasis of papillary thyroid carcinoma]
Thyroid Cancer, Papillary
[Expression of matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in papillary thyroid cancer: an association with the clinical, morphological and ultrastructural characteristics of a tumor].
Thyroid Cancer, Papillary
[Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid.]
Thyroid Diseases
Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
Thyroid Diseases
MMP-2, MMP-9, TIMP-1, and TIMP-2 in the Peripheral Blood of Patients with Differentiated Thyroid Carcinoma.
Thyroid Diseases
Serum Matrix metalloproteinase-9 (MMP-9) can help identify patients with papillary thyroid cancer at high risk of persistent disease: Value and limitations of a potential marker of neoplasia.
Thyroid Dysgenesis
Clinical characteristics and molecular pathology of skull ectopic thyroid cancer.
Thyroid Neoplasms
Circular RNA DOCK1 downregulates microRNA-124 to induce the growth of human thyroid cancer cell lines.
Thyroid Neoplasms
Clinical characteristics and molecular pathology of skull ectopic thyroid cancer.
Thyroid Neoplasms
Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin.
Thyroid Neoplasms
Epidermal growth factor stimulates matrix metalloproteinase-9 expression and invasion in human follicular thyroid carcinoma cells through Focal adhesion kinase.
Thyroid Neoplasms
Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer.
Thyroid Neoplasms
Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors.
Thyroid Neoplasms
Ginsenoside Rg3 Inhibition of Thyroid Cancer Metastasis Is Associated with Alternation of Actin Skeleton.
Thyroid Neoplasms
IL-17RB enhances thyroid cancer cell invasion and metastasis via ERK1/2 pathway-mediated MMP-9 expression.
Thyroid Neoplasms
Immunohistochemical analysis of matrix metalloproteinase-9 predicts papillary thyroid carcinoma prognosis.
Thyroid Neoplasms
Long non-coding RNA LIFR-AS1 regulates the proliferation, migration and invasion of human thyroid cancer cells.
Thyroid Neoplasms
MMP-2, MMP-9, TIMP-1, and TIMP-2 in the Peripheral Blood of Patients with Differentiated Thyroid Carcinoma.
Thyroid Neoplasms
Modulation of matrix metalloproteinase activity in human thyroid cancer cell lines using demethylating agents and histone deacetylase inhibitors.
Thyroid Neoplasms
mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Thyroid Neoplasms
PLK1 gene suppresses cell invasion of undifferentiated thyroid carcinoma through the inhibition of CD44v6, MMP-2 and MMP-9.
Thyroid Neoplasms
Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.
Thyroid Neoplasms
Reduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma.
Thyroid Neoplasms
S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
Thyroid Neoplasms
Serum Matrix metalloproteinase-9 (MMP-9) can help identify patients with papillary thyroid cancer at high risk of persistent disease: Value and limitations of a potential marker of neoplasia.
Thyroid Neoplasms
Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells.
Thyroid Neoplasms
[Effect of Nifuroxazide on Proliferation, Migration, and Invasion of Thyroid Papillary Carcinoma Cells].
Thyroid Nodule
Immunohistochemical analysis of matrix metalloproteinase-9 predicts papillary thyroid carcinoma prognosis.
Thyrotoxicosis
Effects of radioiodine administration on serum concentrations of matrix metalloproteinases, adiponectin and thrombospondin-1.
Tongue Neoplasms
Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9.
Tongue Neoplasms
Gypenosides inhibited invasion and migration of human tongue cancer SCC4 cells through down-regulation of NFkappaB and matrix metalloproteinase-9.
Tongue Neoplasms
LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
Tooth Mobility
Oxymatrine alleviates periodontitis in rats by inhibiting inflammatory factor secretion and regulating MMPs/TIMP protein expression1.
Tooth Resorption
Expression of matrix metalloproteinase-9 mRNA and protein during deciduous tooth resorption in bovine odontoclasts.
Tooth Resorption
Transcriptomic profiling of feline teeth highlights the role of matrix metalloproteinase 9 (MMP9) in tooth resorption.
Toxocariasis
Induction of matrix metalloproteinase-9 in mice during Toxocara canis larvae migration.
Toxocariasis
Matrix metalloproteinase-2 and matrix metalloproteinase-9 in mice with ocular toxocariasis.
Toxoplasmosis
Induction of matrix metalloproteinase-2 and -9 via Erk1/2-NF-?B pathway in human astroglia infected with Toxoplasma gondii.
Toxoplasmosis
Matrix metalloproteinase-2 and -9 lead to fibronectin degradation in astroglia infected with Toxoplasma gondii.
Toxoplasmosis
Relationship between Toxoplasma gondii seropositivity and schizophrenia in the Lebanese population: potential implication of genetic polymorphism of MMP-9.
Toxoplasmosis
Up-regulation of matrix metalloproteinases-2 and -9 via an Erk1/2/NF-?B pathway in murine mast cells infected with Toxoplasma gondii.
Trachoma
A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection.
Trauma, Nervous System
Induction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injury.
Trauma, Nervous System
Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system.
Trichinellosis
Matrix metalloproteinase (MMP)-9: A realiable marker for inflammation in early human trichinellosis.
Triple Negative Breast Neoplasms
Brucine suppresses breast cancer metastasis via inhibiting epithelial mesenchymal transition and matrix metalloproteinases expressions.
Triple Negative Breast Neoplasms
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Triple Negative Breast Neoplasms
Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis.
Triple Negative Breast Neoplasms
Effect of Bicalutamide on the proliferation and invasion of human triple negative breast cancer MDA-MB-231 cells.
Triple Negative Breast Neoplasms
GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer.
Triple Negative Breast Neoplasms
High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients.
Triple Negative Breast Neoplasms
miR-103 regulates triple negative breast cancer cells migration and invasion through targeting olfactomedin 4.
Triple Negative Breast Neoplasms
Polysaccharides from Korean Citrus hallabong peels inhibit angiogenesis and breast cancer cell migration.
Triple Negative Breast Neoplasms
Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients.
Triple Negative Breast Neoplasms
The clinical significance and biological function of olfactomedin 4 in triple negative breast cancer.
Triple Negative Breast Neoplasms
Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.
Trypanosomiasis, African
Matrix metalloproteinase-9 and intercellular adhesion molecule 1 are powerful staging markers for human African trypanosomiasis.
Tuberculoma
Dynamic contrast-enhanced (DCE) derived transfer coefficient (ktrans) is a surrogate marker of matrix metalloproteinase 9 (MMP-9) expression in brain tuberculomas.
Tuberculosis
Activity of matrix metalloproteinase 2 and 9 isoforms in sputum samples from individuals infected with M. tuberculosis.
Tuberculosis
Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas.
Tuberculosis
Author Correction: Matrix metalloproteinase-9 activity and a downregulated Hedgehog pathway impair blood-brain barrier function in an in vitro model of CNS tuberculosis.
Tuberculosis
Circulation level of matrix metalloproteinase-9 is correlated with disease severity in tuberculosis patients.
Tuberculosis
Complex regulation of neutrophil-derived MMP-9 secretion in central nervous system tuberculosis.
Tuberculosis
Comprehensive analysis of immune, extracellular matrices and pathogens profile in lung granulomatosis of unexplained etiology.
Tuberculosis
Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis.
Tuberculosis
Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases.
Tuberculosis
Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.
Tuberculosis
Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo.
Tuberculosis
IFNgamma synergizes with IL-1beta to up-regulate MMP-9 secretion in a cellular model of central nervous system tuberculosis.
Tuberculosis
Induction of MMP-9 mediated gelatinolytic activity in human monocytic cells by cell wall components of Mycobacterium tuberculosis.
Tuberculosis
M. tuberculosis induction of matrix metalloproteinase-9: the role of mannose and receptor-mediated mechanisms.
Tuberculosis
Matrix metalloproteinase-9 activity and a downregulated Hedgehog pathway impair blood-brain barrier function in an in vitro model of CNS tuberculosis.
Tuberculosis
MMP-9 activity is induced by Leishmania braziliensis infection and correlates with mucosal leishmaniasis.
Tuberculosis
Monocyte-astrocyte networks regulate matrix metalloproteinase gene expression and secretion in central nervous system tuberculosis in vitro and in vivo.
Tuberculosis
Monocytes infected with Mycobacterium tuberculosis regulate MAP kinase-dependent astrocyte MMP-9 secretion.
Tuberculosis
Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9.
Tuberculosis
Multinucleate giant cells release functionally unopposed matrix metalloproteinase-9 in vitro and in vivo.
Tuberculosis
Mycobacterial trehalose dimycolate reprograms macrophage global gene expression and activates matrix metalloproteinases.
Tuberculosis
Mycobacterium tuberculosis Upregulates TNF-? Expression via TLR2/ERK Signaling and Induces MMP-1 and MMP-9 Production in Human Pleural Mesothelial Cells.
Tuberculosis
Non-acylated Mycobacterium bovis glycoprotein MPB83 binds to TLR1/2 and stimulates production of matrix metalloproteinase 9.
Tuberculosis
Pattern of matrix metalloproteinases-9, P53 and BCL-2 proteins in Egyptian patients with pulmonary Mycobacterium tuberculosis.
Tuberculosis
Production of matrix metalloproteinases in response to mycobacterial infection.
Tuberculosis
Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection.
Tuberculosis
Synergistic up-regulation of epithelial cell matrix metalloproteinase-9 secretion in tuberculosis.
Tuberculosis
Title: role of matrix metalloproteinase -9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease.
Tuberculosis
Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion.
Tuberculosis
[Clinical significance of detecting VEGF, CD44v6, MMP-2, and MMP-9 in malignant ascites]
Tuberculosis
[The system of matrix metalloproteinases and their role in patients with pulmonary tuberculosis].
Tuberculosis, Central Nervous System
Complex regulation of neutrophil-derived MMP-9 secretion in central nervous system tuberculosis.
Tuberculosis, Central Nervous System
IFNgamma synergizes with IL-1beta to up-regulate MMP-9 secretion in a cellular model of central nervous system tuberculosis.
Tuberculosis, Meningeal
Adjunctive role of MMP-9 inhibition along with conventional anti-tubercular drugs against experimental tuberculous meningitis.
Tuberculosis, Meningeal
Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.
Tuberculosis, Meningeal
Effect of matrix metalloproteinase-9 -1562C/T gene polymorphism on manifestations of pulmonary tuberculosis.
Tuberculosis, Meningeal
Elevated Matrix Metalloproteinase Concentrations Offer Novel Insight Into Their Role in Pediatric Tuberculous Meningitis.
Tuberculosis, Meningeal
Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo.
Tuberculosis, Meningeal
Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Tuberculosis, Meningeal
Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.
Tuberculosis, Meningeal
Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis.
Tuberculosis, Meningeal
Title: role of matrix metalloproteinase -9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease.
Tuberculosis, Pleural
High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation.
Tuberculosis, Pulmonary
Circulation level of matrix metalloproteinase-9 is correlated with disease severity in tuberculosis patients.
Tuberculosis, Pulmonary
Diagnostic performance of serum interferon gamma, matrix metalloproteinases, and periostin measurements for pulmonary tuberculosis in Japanese patients with pneumonia.
Tuberculosis, Pulmonary
Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis.
Tuberculosis, Pulmonary
Effect of matrix metalloproteinase-9 -1562C/T gene polymorphism on manifestations of pulmonary tuberculosis.
Tuberous Sclerosis
Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Tularemia
Matrix metalloproteinase 9 activity enhances host susceptibility to pulmonary infection with type A and B strains of Francisella tularensis.
u-plasminogen activator deficiency
Plasmin and matrix metalloproteinases in vascular remodeling.
Ureaplasma Infections
Ureaplasma Infection Mediated Release of Matrix Metalloproteinase-9 and PGP - a Novel Mechanism of Preterm Rupture of Membranes and Chorioamnionitis.
Uremia
Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes.
Uremia
Association of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 With Endothelial Dysfunction, Cardiovascular Disease Risk Factors and thrombotic events in Children With End-stage Renal Disease.
Uremia
Peripheral blood level alterations of MMP-2 and MMP-9 in patients with chronic kidney disease on conservative treatment and on hemodialysis.
Uremia
Plasma and Aorta Biochemistry and MMPs Activities in Female Rabbit Fed Methionine Enriched Diet and Their Offspring.
Uremia
The serum levels of MMP-9, MMP-2 and vWF in patients with low doses of urokinase peritoneal dialysis decreased uremia complicated with cerebral infarction.
Ureteral Obstruction
Erythropoietin protects the tubular basement membrane by promoting the bone marrow to release extracellular vesicles containing tPA-targeting miR-144.
Ureteral Obstruction
Influence of dietary iron intake restriction on the development of hypertension in weanling prehypertensive rats.
Ureteral Obstruction
Integrating Polydopamine Nanosphere/Aptamers Nanoplatform with DNase-I-assisted Recycling Amplification Strategy for Simultaneous Detection of MMP-9 and MMP-2 During Renal Interstitial Fibrosis.
Ureteral Obstruction
Matrix metalloproteinase 9 induces endothelial-mesenchymal transition via Notch activation in human kidney glomerular endothelial cells.
Ureteral Obstruction
Matrix metalloproteinase 9-dependent Notch signaling contributes to kidney fibrosis through peritubular endothelial-mesenchymal transition.
Ureteral Obstruction
Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage.
Ureteral Obstruction
Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy.
Ureteral Obstruction
Prediction of the mechanisms of action of shenkang in chronic kidney disease: A network pharmacology study and experimental validation.
Ureteral Obstruction
[Role of MMP-9 and TIMP-1 in renal tubular epithelial-myofibroblast transdifferentiation]
Urinary Bladder Neoplasms
A Novel Cyclic Pentadepsipeptide, N-Methylsansalvamide, Suppresses Angiogenic Responses and Exhibits Antitumor Efficacy against Bladder Cancer.
Urinary Bladder Neoplasms
Activation of matrix metalloproteinase-9 by TNF-alpha in human urinary bladder cancer HT1376 cells: The role of MAP kinase signaling pathways.
Urinary Bladder Neoplasms
Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer.
Urinary Bladder Neoplasms
Altered redox status accompanies progression to metastatic human bladder cancer.
Urinary Bladder Neoplasms
An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
Urinary Bladder Neoplasms
Analytical validation of ONCURIA a multiplex bead-based immunoassay for the non-invasive bladder cancer detection.
Urinary Bladder Neoplasms
Angiopoietin-like protein 4 potentiates DATS-induced inhibition of proliferation, migration, and invasion of bladder cancer EJ cells; involvement of G2/M-phase cell cycle arrest, signaling pathways, and transcription factors-mediated MMP-9 expression.
Urinary Bladder Neoplasms
Anticancer effect of salidroside reduces viability through autophagy/PI3K/Akt and MMP-9 signaling pathways in human bladder cancer cells.
Urinary Bladder Neoplasms
Antimetastatic effects of licochalcone B on human bladder carcinoma T24 by inhibition of matrix metalloproteinases-9 and NF-?B activity.
Urinary Bladder Neoplasms
Bacillus Calmette-Guérin enhances production and secretion of type IV collagenases in peripheral blood mononuclear cells.
Urinary Bladder Neoplasms
BLCA-4 expression is related to MMP-9, VEGF, IL-1? and IL-8 in bladder cancer but not to PEDF, TNF-? or angiogenesis.
Urinary Bladder Neoplasms
Can serum matrix metalloproteinase-9 and SMAD-2 levels predict lamina propria invasion in bladder urothelial carcinoma?
Urinary Bladder Neoplasms
Capsaicin attenuates cell migration via SIRT1 targeting and inhibition to enhance cortactin and ?-catenin acetylation in bladder cancer cells.
Urinary Bladder Neoplasms
Comment to: "Detection and Molecular Staging of Bladder Cancer Using Real-Time RT-PCR for Gelatinases MMP-2, MMP-9 and TIMP-2 in Peripheral Blood"
Urinary Bladder Neoplasms
Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer.
Urinary Bladder Neoplasms
Cordycepin suppresses TNF-alpha-induced invasion, migration and matrix metalloproteinase-9 expression in human bladder cancer cells.
Urinary Bladder Neoplasms
Detection and Molecular Staging of Bladder Cancer Using Real-Time RT-PCR for Gelatinases (MMP-2, MMP-9) and TIMP-2 in Peripheral Blood.
Urinary Bladder Neoplasms
Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
Urinary Bladder Neoplasms
Editorial: MMP-2 and MMP-9 in lymph-node-positive bladder cancer.
Urinary Bladder Neoplasms
Effects of tumor necrosis factor-alpha and interferon-gamma on expressions of matrix metalloproteinase-2 and -9 in human bladder cancer cells.
Urinary Bladder Neoplasms
EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-?B and MMP-9.
Urinary Bladder Neoplasms
Elevated expression of matrix metalloproteinase-9 is associated with bladder cancer pathogenesis.
Urinary Bladder Neoplasms
Elevated matrix metalloproteinase-9 expression may contribute to the pathogenesis of bladder cancer.
Urinary Bladder Neoplasms
Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor markers.
Urinary Bladder Neoplasms
Epigallocatechin-3-gallate inhibits bladder cancer cell invasion via suppression of NF-?B?mediated matrix metalloproteinase-9 expression.
Urinary Bladder Neoplasms
Evaluation of MMP-2, MMP-9, TIMP-1, TIMP-2, NGAL and MMP-9/NGAL complex in urine and sera from patients with bladder cancer.
Urinary Bladder Neoplasms
Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma.
Urinary Bladder Neoplasms
Expression and activity of MMPS and their regulators in ovarian cancer.
Urinary Bladder Neoplasms
Far from resolved: stromal cell-based iTRAQ research of muscle-invasive bladder cancer regarding heterogeneity.
Urinary Bladder Neoplasms
High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.
Urinary Bladder Neoplasms
HSPA6 augments garlic extract-induced inhibition of proliferation, migration, and invasion of bladder cancer EJ cells; Implication for cell cycle dysregulation, signaling pathway alteration, and transcription factor-associated MMP-9 regulation.
Urinary Bladder Neoplasms
Hydrangenol inhibits the proliferation, migration, and invasion of EJ bladder cancer cells via p21WAF1-mediated G1-phase cell cycle arrest, p38 MAPK activation, and reduction in Sp-1-induced MMP-9 expression.
Urinary Bladder Neoplasms
IL-5-induced migration via ERK1/2-mediated MMP-9 expression by inducing activation of NF-?B in HT1376 cells.
Urinary Bladder Neoplasms
In situ gelatinolytic activity correlates with tumor progression and prognosis in patients with bladder cancer.
Urinary Bladder Neoplasms
Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer.
Urinary Bladder Neoplasms
Inhibitory effect of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells.
Urinary Bladder Neoplasms
Interleukin-20 Promotes Migration of Bladder Cancer Cells through Extracellular Signal-regulated Kinase (ERK)-mediated MMP-9 Protein Expression Leading to Nuclear Factor (NF-?B) Activation by Inducing the Up-regulation of p21WAF1 Protein Expression.
Urinary Bladder Neoplasms
Interleukin-28A triggers wound healing migration of bladder cancer cells via NF-?B-mediated MMP-9 expression inducing the MAPK pathway.
Urinary Bladder Neoplasms
Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-?B/AP-1 pathway: involvement of the p21WAF1 expression.
Urinary Bladder Neoplasms
Loss of GATA3 in bladder cancer promotes cell migration and invasion.
Urinary Bladder Neoplasms
Matrix metalloproteinase-9 (MMP-9) immunoreactive protein in urinary bladder cancer: a marker of favorable prognosis.
Urinary Bladder Neoplasms
Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade.
Urinary Bladder Neoplasms
Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival.
Urinary Bladder Neoplasms
Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications.
Urinary Bladder Neoplasms
METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion.
Urinary Bladder Neoplasms
MiR-221-induced PUMA silencing mediates immune evasion of bladder cancer cells.
Urinary Bladder Neoplasms
MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy.
Urinary Bladder Neoplasms
MMP-2 and MMP-9 as prognostic markers for the early detection of urinary bladder cancer.
Urinary Bladder Neoplasms
Molecular basis for the involvement of thymidine phosphorylase in cancer invasion.
Urinary Bladder Neoplasms
Morin Inhibits Proliferation, Migration, and Invasion of Bladder Cancer EJ Cells via Modulation of Signaling Pathways, Cell Cycle Regulators, and Transcription Factor-Mediated MMP-9 Expression.
Urinary Bladder Neoplasms
Noninvasive Diagnosis of Bladder Cancer by Detection of Matrix Metalloproteinases (MMP-2 and MMP-9) and Their Inhibitor (TIMP-2) in Urine.
Urinary Bladder Neoplasms
Nuclear Factor-?B Overexpression is Correlated with Poor Outcomes after Multimodality Bladder-Preserving Therapy in Patients with Muscle-Invasive Bladder Cancer.
Urinary Bladder Neoplasms
p27KIP1 is involved in ERK1/2-mediated MMP-9 expression via the activation of NF-?B binding in the IL-7-induced migration and invasion of 5637 cells.
Urinary Bladder Neoplasms
p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity.
Urinary Bladder Neoplasms
Pigment epithelium-derived factor expression is down-regulated in bladder tumors and correlates with vascular endothelial growth factor and matrix metalloproteinase-9.
Urinary Bladder Neoplasms
Positive Correlation between Matrix Metalloproteinases and Epithelial-to-Mesenchymal Transition and its Association with Clinical Outcome in Bladder Cancer Patients.
Urinary Bladder Neoplasms
Preoperative levels of matrix metalloproteinase-7 and -9 and tissue inhibitor of matrix metalloproteinase-1 relation to pathologic parameters in bladder carcinoma patients.
Urinary Bladder Neoplasms
Ras induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity.
Urinary Bladder Neoplasms
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.
Urinary Bladder Neoplasms
Role of MMP-3 and MMP-9 and their haplotypes in risk of bladder cancer in North Indian cohort.
Urinary Bladder Neoplasms
Role of serum and urine transforming growth factor beta 1, matrix metallopeptidase 9, tissue inhibitor of metalloproteinase 2, and nerve growth factor beta levels and serum neutrophil-to-lymphocyte ratio in predicting recurrence and progression risks in patients with primary non-muscle invasive bladder cancer.
Urinary Bladder Neoplasms
rs3918242 variant genotype frequency and increased TIMP-2 and MMP-9 expression are positively correlated with cancer invasion in urinary bladder cancer.
Urinary Bladder Neoplasms
Serum levels of endostatin and matrix metalloproteinase-9 associated with high stage and grade primary transitional cell carcinoma of the bladder.
Urinary Bladder Neoplasms
Signaling pathway for TNF-alpha-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells.
Urinary Bladder Neoplasms
Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
Urinary Bladder Neoplasms
Silencing expression of the NANOG gene and changes in migration and metastasis of urinary bladder cancer cells.
Urinary Bladder Neoplasms
Suppressions of Migration and Invasion by Cantharidin in TSGH-8301 Human Bladder Carcinoma Cells through the Inhibitions of Matrix Metalloproteinase-2/-9 Signaling.
Urinary Bladder Neoplasms
The biochemical value of urinary metalloproteinases 3 and 9 in diagnosis and prognosis of bladder cancer in Egypt.
Urinary Bladder Neoplasms
The importance of integrin-linked kinase in the regulation of bladder cancer invasion.
Urinary Bladder Neoplasms
The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis.
Urinary Bladder Neoplasms
The nucleosome binding protein NSBP1 is highly expressed in human bladder cancer and promotes the proliferation and invasion of bladder cancer cells.
Urinary Bladder Neoplasms
The Pathological Significance and Prognostic Roles of Thrombospondin-1, and -2, and 4N1K-peptide in Bladder Cancer.
Urinary Bladder Neoplasms
The role of matrix metalloproteinase MMP-9 and TIMP-2 tissue inhibitor of metalloproteinasas as serum markers of bladder cancer.
Urinary Bladder Neoplasms
The role of matrix metalloproteinases in pathogenesis of human bladder cancer.
Urinary Bladder Neoplasms
Transcriptional regulatory networks in human lung adenocarcinoma.
Urinary Bladder Neoplasms
Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Urinary Bladder Neoplasms
Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species.
Urinary Bladder Neoplasms
Tumour-associated macrophages mediate the invasion and metastasis of bladder cancer cells through CXCL8.
Urinary Bladder Neoplasms
Urinary gelatinase activities (matrix metalloproteinases 2 and 9) in human bladder tumors.
Urinary Bladder Neoplasms
[Detection of serum levels of MMP-9 and VEGF in patients with bladder cancer]
Urinary Bladder Neoplasms
[Gene expressions of type IV collagenase and tissue inhibitor of metalloproteinases (TIMP) in human bladder cancers]
Urinary Incontinence
Collagen metabolism and turnover in women with stress urinary incontinence and pelvic prolapse.
Urinary Incontinence
Elastin metabolism in pelvic tissues: is it modulated by reproductive hormones?
Urinary Incontinence
Prevalence and Predictors of Urinary Incontinence at 1 Year Postpartum.
Urinary Incontinence
[Expression of matrix metalloproteinases-9 and tissue inhibitors of matrix metalloproteinases-1 in connective tissue of vaginal wall of women with stress urinary incontinence]
Urinary Tract Infections
Association of urinary activity of MMP-9 with renal impairment in Mexican patients with type 2 diabetes mellitus.
Urinary Tract Infections
Relationship between metalloproteinase-2 and -9 levels in plasma and vaginal secretion with preterm birth.
Urinary Tract Infections
Spontaneous abortion is preceded by an altered serum concentration of matrix metalloproteinases.
Urinary Tract Infections
Urinary matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 biomarkers for predicting renal scar in children with urinary tract infection.
Urticaria
Plasma Levels of Matrix Metalloproteinase-9 in Children With Chronic Spontaneous Urticaria.
Urticaria
Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors.
Uterine Cervical Neoplasms
A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer.
Uterine Cervical Neoplasms
A novel role of metalloproteinase in cancer-mediated immunosuppression.
Uterine Cervical Neoplasms
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.
Uterine Cervical Neoplasms
Antimetastatic effects of Terminalia catappa leaf extracts on cervical cancer through the inhibition of matrix metalloprotein-9 and MAPK pathway.
Uterine Cervical Neoplasms
Apoptosis Inhibitor 5 Increases Metastasis via Erk-mediated MMP expression.
Uterine Cervical Neoplasms
Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB.
Uterine Cervical Neoplasms
Association between expression of MMP-7 and MMP-9 and pelvic lymph node and para-aortic lymph node metastasis in early cervical cancer.
Uterine Cervical Neoplasms
Association of matrix metalloproteinase-9 and decorin expression with the infiltration of cervical cancer.
Uterine Cervical Neoplasms
Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma.
Uterine Cervical Neoplasms
Dioscorea nipponica Makino suppresses TPA-induced migration and invasion through inhibition of matrix metalloproteinase-9 in human cervical cancer cells.
Uterine Cervical Neoplasms
E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.
Uterine Cervical Neoplasms
Effect of human seminal fluid on production of messenger ribonucleic acid for metalloproteinase 2 and metalloproteinase 9 in cervical epithelial carcinoma cells.
Uterine Cervical Neoplasms
Effects of Galectin-1 on Biological Behavior in Cervical Cancer.
Uterine Cervical Neoplasms
Expression and clinical significance of high risk human papillomavirus and invasive gene in cervical carcinoma.
Uterine Cervical Neoplasms
Expression of MAPK1 in cervical cancer and effect of MAPK1 gene silencing on epithelial-mesenchymal transition, invasion and metastasis.
Uterine Cervical Neoplasms
Expression of matrix metalloproteinase-2 and 9 in cervical intraepithelial neoplasia and cervical carcinoma among different age groups of premenopausal and postmenopausal women.
Uterine Cervical Neoplasms
Extracellular matrix metalloproteinase inducer (EMMPRIN) remodels the extracellular matrix through enhancing matrix metalloproteinases (MMPs) and inhibiting tissue inhibitors of MMPs expression in HPV-positive cervical cancer cells.
Uterine Cervical Neoplasms
FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer.
Uterine Cervical Neoplasms
High Expression of Integrin ?3 Predicts Poor Prognosis and Promotes Tumor Metastasis and Angiogenesis by Activating the c-Src/Extracellular Signal-Regulated Protein Kinase/Focal Adhesion Kinase Signaling Pathway in Cervical Cancer.
Uterine Cervical Neoplasms
HPV 16 infection up-regulates Piwil2, which affects cell proliferation and invasion in cervical cancer by regulating MMP-9 via the MAPK pathway.
Uterine Cervical Neoplasms
Human leucine zipper protein sLZIP induces migration and invasion of cervical cancer cells via expression of matrix metalloproteinase-9.
Uterine Cervical Neoplasms
Human nonmetastatic clone 23 type 1 gene suppresses migration of cervical cancer cells and enhances the migration inhibition of fungal immunomodulatory protein from Ganoderma tsugae.
Uterine Cervical Neoplasms
Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis.
Uterine Cervical Neoplasms
IKK?/NF-?B mediated the low doses of bisphenol A induced migration of cervical cancer cells.
Uterine Cervical Neoplasms
In situ detection of PCR-amplified metalloproteinase cDNAs, their inhibitors and human papillomavirus transcripts in cervical carcinoma cell lines.
Uterine Cervical Neoplasms
In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors.
Uterine Cervical Neoplasms
Inhibition of BAP31 expression inhibits cervical cancer progression by suppressing metastasis and inducing intrinsic and extrinsic apoptosis.
Uterine Cervical Neoplasms
Inhibition of miR-574-5p suppresses cell growth and metastasis and enhances chemosensitivity by targeting RNA binding protein QKI in cervical cancer cells.
Uterine Cervical Neoplasms
Inhibitory effect of genistein on the invasive potential of human cervical cancer cells via modulation of matrix metalloproteinase-9 and tissue inhibitiors of matrix metalloproteinase-1 expression.
Uterine Cervical Neoplasms
Inhibitory effect of Trolox on the migration and invasion of human lung and cervical cancer cells.
Uterine Cervical Neoplasms
Knockdown of Pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells.
Uterine Cervical Neoplasms
Laminin induces matrix metalloproteinase-9 expression and activation in human cervical cancer cell line (SiHa).
Uterine Cervical Neoplasms
Matrix metalloproteinase-9 is a prognostic marker for patients with cervical cancer.
Uterine Cervical Neoplasms
Matrix metalloproteinases-2 and -9 in cervical cancer: different roles in tumor progression.
Uterine Cervical Neoplasms
MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer.
Uterine Cervical Neoplasms
MMP-2 and MMP-9 gene polymorphisms associated with cervical cancer risk.
Uterine Cervical Neoplasms
Non-thermal plasma inhibits human cervical cancer HeLa cells invasiveness by suppressing the MAPK pathway and decreasing matrix metalloproteinase-9 expression.
Uterine Cervical Neoplasms
Phenyllactic acid promotes cell migration and invasion in cervical cancer via IKK/NF-?B-mediated MMP-9 activation.
Uterine Cervical Neoplasms
Plasma levels and diagnostic utility of macrophage-colony stimulating factor, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 as tumor markers in cervical cancer patients.
Uterine Cervical Neoplasms
PP2A Inhibits Cervical Cancer Cell Migration by Dephosphorylation of p-JNK, p-p38 and the p-ERK/MAPK Signaling Pathway.
Uterine Cervical Neoplasms
Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells.
Uterine Cervical Neoplasms
RHCG suppresses cervical cancer progression through inhibiting migration and inducing apoptosis regulated by TGF-?1.
Uterine Cervical Neoplasms
Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer--results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial.
Uterine Cervical Neoplasms
Silencing of long non-coding RNA NCK1-AS1 inhibits cell proliferation and migration via inhibition of microRNA-134 in cervical cancer.
Uterine Cervical Neoplasms
Stability of matrix metalloproteinase-9 as biological marker in colorectal cancer.
Uterine Cervical Neoplasms
Suppressing effect of resveratrol on the migration and invasion of human metastatic lung and cervical cancer cells.
Uterine Cervical Neoplasms
TCEB3 is Regulated by Circ-0000212/miR-140-3p Axis to Promote the Progression of Cervical Cancer.
Uterine Cervical Neoplasms
The association of semaphorin 5A with lymph node metastasis and adverse prognosis in cervical cancer.
Uterine Cervical Neoplasms
The Role of sLZIP in Transcriptional Regulation of c-Jun and Involvement in Migration and Invasion of Cervical Cancer Cells.
Uterine Cervical Neoplasms
TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling.
Uterine Cervical Neoplasms
Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
Uterine Cervical Neoplasms
[Baicalein induces HeLa cell growth inhibition by down-regulation of matrix metalloproteinases and activating extracellular signal-regulated kinase].
Uterine Cervical Neoplasms
[Effects of lanthanum chloride on proliferation and migration of human cervical cancer cell line HeLa cells.]
Uterine Cervical Neoplasms
[Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues]
Uterine Cervical Neoplasms
[FABP5 promotes cell growth, invasion and metastasis in cervical cancer].
Uterine Cervical Neoplasms
[The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship]
Uterine Cervical Neoplasms
[The plasma levels and diagnostic utility of matrix metalloproteinase-9 and CA 125 in cervical cancer patients].
Uterine Diseases
Regulation of uterine matrix metalloproteinase-9 and the role of microRNAs.
Uterine Hemorrhage
Abnormal expression of MMP-9 and imbalance of MMP-9/TIMP-1 is associated with prolonged uterine bleeding after a medical abortion with mifepristone and misoprostol.
Uterine Hemorrhage
Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding?
Uterine Hemorrhage
[Research on hemostatic effect and mechanism of carbonized Scutellariae Radix on rats of uterine bleeding].
Uveitis
Alteration of MCP-1 and MMP-9 in aqueous humor is associated with secondary glaucoma in Fuchs uveitis syndrome.
Uveitis
Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1b, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis.
Uveitis
Interphotoreceptor retinoid-binding protein as biomarker in systemic autoimmunity with eye inflictions.
Vaccinia
Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors.
Vaginosis, Bacterial
Mid-trimester maternal plasma cytokines and CRP as predictors of spontaneous preterm birth.
Vaginosis, Bacterial
Relationship between metalloproteinase-2 and -9 levels in plasma and vaginal secretion with preterm birth.
Vaginosis, Bacterial
Vaginal matrix metalloproteinase levels in pregnant women with bacterial vaginosis.
Varicocele
Impact of micronised purified flavonoid fraction on increased malondialdehyde and decreased metalloproteinase-2 and metalloproteinase-9 levels in varicocele: outcome of an experimentally induced varicocele.
Varicocele
Morinda Officinalis Polysaccharides Attenuate Varicocele-Induced Spermatogenic Impairment through the Modulation of Angiogenesis and Relative Factors.
Varicose Ulcer
Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin.
Varicose Ulcer
Matrix Metalloproteinases in Vascular Disease - A Potential Therapeutic Target?
Varicose Ulcer
The Impact of Valvular Oxidative Stress on the Development of Venous Stasis Ulcer Valvular Oxidative Stress and Venous Ulcers.
Varicose Veins
Effect of a Peptide Construct on Differentiated Macrophage MMP-2 and MMP-9 Levels of Varicose Patients.
Varicose Veins
Glycosaminoglycan Sulodexide Inhibition of MMP-9 Gelatinase Secretion and Activity: Possible Pharmacological Role Against Collagen Degradation in Vascular Chronic Diseases.
Varicose Veins
HMG-CoA reductase inhibitors reduce matrix metalloproteinase-9 activity in human varicose veins.
Varicose Veins
Matrix metalloproteinase-9 and urokinase-type plasminogen activator in varicose veins.
Varicose Veins
Matrix Metalloproteinases in Vascular Disease - A Potential Therapeutic Target?
Varicose Veins
Morphologic characteristics of varicose veins: possible role of metalloproteinases.
Varicose Veins
Plasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veins.
Vascular Calcification
Macrophage-derived MMP-9 enhances the progression of atherosclerotic lesions and vascular calcification in transgenic rabbits.
Vascular Calcification
Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality.
Vascular Calcification
The matrix metalloproteinases 2 and 9 initiate uraemic vascular calcifications.
Vascular Diseases
5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix metalloproteinase 9.
Vascular Diseases
Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
Vascular Diseases
Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
Vascular Diseases
Circulating matrix metalloproteinase-9 levels in atherosclerotic vascular disease: a possible measurement of systemic or specific disease pathophysiology?
Vascular Diseases
Effects of Exercise Training on Vascular Markers of Disease Progression in Patients with Small Abdominal Aortic Aneurysms.
Vascular Diseases
Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
Vascular Diseases
Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm.
Vascular Diseases
Glycosaminoglycan Sulodexide Inhibition of MMP-9 Gelatinase Secretion and Activity: Possible Pharmacological Role Against Collagen Degradation in Vascular Chronic Diseases.
Vascular Diseases
Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9.
Vascular Diseases
Involvement of Matrix Metalloproteinase 9 in Vertebral Arterial Dissection With Posterior Circulation Ischemic Stroke.
Vascular Diseases
Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: A potentially protective mechanism in atherosclerotic vascular disease and cancer.
Vascular Diseases
MMP-9 haplotypes and carotid artery atherosclerosis: an association study introducing a novel multicolour multiplex RealTime PCR protocol.
Vascular Diseases
MMP-9 regulates both positively and negatively collagen gel contraction: a nonproteolytic function of MMP-9.
Vascular Diseases
Optical Interference-Free Surface-Enhanced Raman Scattering CO-Nanotags for Logical Multiplex Detection of Vascular Disease-Related Biomarkers.
Vascular Diseases
Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease.
Vascular Diseases
Postprandial serum induces apoptosis in endothelial cells: Role of polymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity.
Vascular Diseases
Salvianolic acid A, a matrix metalloproteinase-9 inhibitor of Salvia miltiorrhiza, attenuates aortic aneurysm formation in apolipoprotein E-deficient mice.
Vascular Diseases
The effect of ferulic acid ethyl ester on leptin-induced proliferation and migration of aortic smooth muscle cells.
Vascular System Injuries
Adiponectin inhibits oxidized low density lipoprotein-induced increase in matrix metalloproteinase 9 expression in vascular smooth muscle cells.
Vascular System Injuries
Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
Vascular System Injuries
Hydrogen sulfide protects against vascular remodeling from endothelial damage.
Vascular System Injuries
Increased CD147 (EMMPRIN) expression in the rat brain following traumatic brain injury.
Vascular System Injuries
Increased CD147 and MMP-9 expression in the normal rat brain after gamma irradiation.
Vascular System Injuries
Induction of heme oxygenase-1 is a beneficial response in a murine model of venous thrombosis.
Vascular System Injuries
Lp(a)/apo(a) Modulate MMP-9 Activation and Neutrophil Cytokines in Vivo in Inflammation to Regulate Leukocyte Recruitment.
Vascular System Injuries
Matrix Metalloprotease-9 (MMP-9)-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis.
Vascular System Injuries
Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery.
Vascular System Injuries
Montelukast inhibits matrix metalloproteinases expression in atherosclerotic rabbits.
Vascular System Injuries
Regulation of MMP-9 expression by the A2b adenosine receptor and its dependency on TNF-? signaling.
Vascular System Injuries
Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia.
Vascular System Injuries
Role of the fibrinolytic and matrix metalloproteinase systems in arterial neointima formation after vascular injury.
Vascular System Injuries
Rosuvastatin reduces neointima formation in a rat model of balloon injury.
Vascular System Injuries
Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice.
Vascular System Injuries
{beta}-Catenin is Markedly Induced in a Murine Model of an Arteriovenous Fistula: The Effect of Metalloproteinase Inhibition.
Vasculitis
Effects of B7-H3 on the Inflammatory Response and Expression of MMP-9 in Mice with Pneumococcal Meningitis.
Vasculitis
Levels of matrix metalloproteinase-9 within cerebrospinal fluid in a rabbit model of coccidioidal meningitis and vasculitis.
Vasculitis
Matrix Metalloprotease-9 (MMP-9)-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis.
Vasculitis
Modulation of MMP-2 and MMP-9 in Churg-Strauss syndrome respiratory mucosa: potential monitoring parameters.
Vasculitis
Serum MMP-2 and MMP-9 in patients with Behçet's disease: Do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Vasculitis
Temporal expression of inflammatory mediators in brain basilar artery vasculitis and cerebrospinal fluid of rabbits with coccidioidal meningitis.
Vasospasm, Intracranial
Differential regulation of matrix-metalloproteinases and their tissue inhibitors in patients with aneurysmal subarachnoid hemorrhage.
Vasospasm, Intracranial
Measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm.
Vasospasm, Intracranial
Potential contribution of matrix metalloproteinase-9 (mmp-9) to cerebral vasospasm after experimental subarachnoid hemorrhage in rats.
Vasospasm, Intracranial
Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Venereal Tumors, Veterinary
Immunocharacterization of matrix metalloproteinase-2 and matrix metalloproteinase-9 in canine transmissible venereal tumors.
Venous Insufficiency
Genetic predisposition for chronic venous insufficiency in several genes for matrix metalloproteinases (MMP-2, MMP-9, MMP-12) and their inhibitor TIMP-2.
Venous Insufficiency
Sulodexide Improves Contraction and Decreases Matrix Metalloproteinase-2 and -9 in Veins Under Prolonged Stretch.
Venous Thrombosis
Immunohistochemical detection of MMP-2 and MMP-9 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation.
Venous Thrombosis
Matrix Metalloproteinase-9 Levels are Associated with Brain Lesion and Persistent Venous Occlusion in Patients with Cerebral Venous Thrombosis.
Venous Thrombosis
Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution.
Venous Thrombosis
Resistin Promotes Thrombosis in Rats with Deep Vein Thrombosis via Up-Regulating MMP-2, MMP-9, and PAI-1.
Ventilator-Induced Lung Injury
Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury.
Ventilator-Induced Lung Injury
Lack of matrix metalloproteinase-9 worsens ventilator-induced lung injury.
Ventricular Dysfunction
Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme.
Ventricular Dysfunction, Left
Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction.
Ventricular Dysfunction, Left
Relationships between plasma levels of matrix metalloproteinases and neurohormonal profile in patients with heart failure.
Ventricular Dysfunction, Left
Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction.
Ventricular Fibrillation
Imbalance between tissue inhibitor of metalloproteinase 1 and matrix metalloproteinase 9 after cardiopulmonary resuscitation.
Vertigo
Basilar Artery Tortuosity Is Associated With White Matter Hyperintensities by TIMP-1.
Vertigo
MMP-9, Vertebrobasilar Ectasia and Vertebral Artery Dominance in Vertigo or Dizziness Patients With Vascular Risk Factors.
Vesico-Ureteral Reflux
Matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in vesicoureteral reflux.
Virus Diseases
Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection.
Virus Diseases
Aging-associated latent herpes viral infection in normal Japanese individuals and patients with Werner syndrome.
Virus Diseases
Association between matrix metalloproteinase (MMP)-2, MMP-9 and total antioxidant status of patients with asymptomatic hepatitis C virus infection.
Virus Diseases
Diminished matrix metalloproteinase 9 secretion in human immunodeficiency virus-infected mononuclear phagocytes: modulation of innate immunity and implications for neurological disease.
Virus Diseases
Gelatinase B/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy.
Virus Diseases
Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins.
Virus Diseases
Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
Virus Diseases
Influenza A virus infection modulates the expression of type IV collagenase in epithelial cells.
Virus Diseases
Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy.
Virus Diseases
Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection.
Virus Diseases
Mechanisms of matrix metalloproteinase-9 upregulation and tissue destruction in various organs in influenza A virus infection.
Virus Diseases
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Positively Modulates Matrix Metalloproteinase-9 Production in Alveolar Macrophages upon Toll-Like Receptor 7 Signaling and Influenza Virus Infection.
Virus Diseases
Protective and causative killer Ig-like receptor (KIR) and metalloproteinase genetic patterns associated with Herpes simplex virus 1 (HSV-1) encephalitis occurrence.
Virus Diseases
Regulation of Matrix Metalloproteinases-2 and -9 Gene Expression in Cultured Human Fetal Membrane Cells by Influenza Virus Infection.
Virus Diseases
Respiratory syncytial virus infection induces matrix metalloproteinase-9 expression in epithelial cells.
Virus Diseases
Sendai virus infection up-regulates trypsin I and matrix metalloproteinase-9, triggering viral multiplication and matrix degradation in rat lungs and lung L2 cells.
Virus Diseases
Severity of Plasma Leakage Is Associated With High Levels of Interferon ?-Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection.
Virus Diseases
Synergistic enhancement of matrix metalloproteinase-9 expression and pro-inflammatory cytokines by influenza virus infection and oxidized-LDL treatment in human endothelial cells.
Virus Diseases
[Effects of Dureping Injection on the contents of MMP-g and TIMP-1 in the lung tissue of mice with pneumonia of influenza virus infection].
Vitamin D Deficiency
Association between Serum Vitamin D Concentration Status and Matrix Metalloproteinase-9 in Patients Undergoing Elective Percutaneous Coronary Intervention.
Vitamin D Deficiency
Vitamin D Inhibits Activities of Metalloproteinase-9/-13 in Articular Cartilage In Vivo and In Vitro.
Vitiligo
Altered levels of Ets-1 transcription factor and metalloproteinases in melanocytes from vitiligo patients.
Vitiligo
Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.
Vitreoretinopathy, Proliferative
Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders.
Werner Syndrome
Aging-associated latent herpes viral infection in normal Japanese individuals and patients with Werner syndrome.
Whooping Cough
A leading role for NADPH oxidase in an in-vitro study of experimental autoimmune encephalomyelitis.
Whooping Cough
Cyclic strain-mediated regulation of vascular endothelial cell migration and tube formation.
Whooping Cough
Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways.
Whooping Cough
Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.
Whooping Cough
Matrix metalloproteinase-1 activates a pertussis toxin-sensitive signaling pathway that stimulates the release of matrix metalloproteinase-9.
Whooping Cough
Secretion of Matrix Metalloproteinase-9 from Astrocytes by Inhibition of Tonic P2Y(14)-Receptor-Mediated Signal(s).
Whooping Cough
Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNF-alpha-dependent monocyte networks.
Wilms Tumor
BASP1 Suppresses Cell Growth and Metastasis through Inhibiting Wnt/?-Catenin Pathway in Gastric Cancer.
Wilms Tumor
HIF-2?, acting via miR-191, is involved in angiogenesis and metastasis of arsenite-transformed HBE cells.
Wilms Tumor
Pituitary adenylate cyclase-activating polypeptide ameliorates vascular dysfunction induced by hyperglycaemia.
Wilms Tumor
The transcription factor Wilms tumor 1 regulates matrix metalloproteinase-9 through a nitric oxide-mediated pathway.
Zika Virus Infection
Matrix metalloproteinase 9 facilitates Zika virus invasion of the testis by modulating the integrity of the blood-testis barrier.
html completed